Mitch Report
Antony Kaspi & Mark Ziemann
date generated: 2024-04-01
Background
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Input profiles
Here is the first few lines of the input profile.
| x | |
|---|---|
| SLC9A3R1 | -5.582275 |
| TMEM107 | 4.833224 |
| LILRA5 | -4.442043 |
| FAM118A | -4.428367 |
| AC007952.4 | 4.154181 |
| AC253572.2 | 4.122234 |
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 10461 |
| num_genes_in_profile | 12221 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 10072 |
| num_profile_genes_not_in_sets | 2149 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Input genesets
Here are some metrics about the gene sets used:
GMT file of genesets: c5.go.v2023.2.Hs.symbols.gmt| Gene sets metrics | |
|---|---|
| num_genesets | 10461 |
| num_genesets_excluded | 4935 |
| num_genesets_included | 5526 |
Differential pathway expression
Interactive enrichment scatterplot
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Results table
Top N= 50 gene sets| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP RESPONSE TO TYPE III INTERFERON | 6 | 0.001380 | -0.754 | 0.0571 |
| GOBP DNA LIGATION INVOLVED IN DNA REPAIR | 5 | 0.003510 | 0.754 | 0.0941 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 0.004720 | 0.730 | 0.1130 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 5 | 0.005380 | 0.719 | 0.1220 |
| GOBP REGULATION OF MAST CELL CHEMOTAXIS | 5 | 0.005640 | -0.715 | 0.1260 |
| GOCC PHAGOLYSOSOME | 5 | 0.005960 | -0.710 | 0.1310 |
| GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY | 6 | 0.002890 | -0.702 | 0.0836 |
| GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION | 5 | 0.006930 | -0.697 | 0.1420 |
| GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE | 7 | 0.001450 | -0.695 | 0.0590 |
| GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY | 6 | 0.003300 | 0.693 | 0.0908 |
| GOBP BEHAVIORAL RESPONSE TO ETHANOL | 5 | 0.007610 | 0.689 | 0.1490 |
| GOBP MHC CLASS I BIOSYNTHETIC PROCESS | 5 | 0.008230 | 0.682 | 0.1520 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 7 | 0.002070 | -0.672 | 0.0693 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 7 | 0.002070 | -0.672 | 0.0693 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS | 5 | 0.009260 | -0.672 | 0.1590 |
| GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION | 5 | 0.010800 | -0.659 | 0.1710 |
| GOMF RAGE RECEPTOR BINDING | 9 | 0.000631 | -0.658 | 0.0344 |
| GOBP METANEPHRIC EPITHELIUM DEVELOPMENT | 5 | 0.011400 | 0.654 | 0.1730 |
| GOBP METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT | 5 | 0.011400 | 0.654 | 0.1730 |
| GOBP THALAMUS DEVELOPMENT | 5 | 0.011700 | -0.651 | 0.1750 |
| GOCC CILIARY TRANSITION FIBER | 6 | 0.005780 | 0.651 | 0.1280 |
| GOBP DE NOVO AMP BIOSYNTHETIC PROCESS | 6 | 0.006300 | 0.644 | 0.1350 |
| GOBP RRNA BASE METHYLATION | 8 | 0.001700 | 0.641 | 0.0622 |
| GOBP FAT PAD DEVELOPMENT | 7 | 0.003400 | -0.639 | 0.0924 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 0.007250 | 0.633 | 0.1450 |
| GOCC GID COMPLEX | 5 | 0.014400 | -0.632 | 0.1940 |
| GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING | 5 | 0.014800 | -0.629 | 0.1950 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 5 | 0.015400 | 0.626 | 0.1980 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 7 | 0.004180 | -0.625 | 0.1030 |
| GOBP MITOCHONDRIAL RNA MODIFICATION | 10 | 0.000622 | 0.625 | 0.0341 |
| GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING | 6 | 0.008600 | 0.619 | 0.1530 |
| GOBP REGULATION OF HEXOKINASE ACTIVITY | 5 | 0.016700 | -0.618 | 0.2030 |
| GOBP NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION | 5 | 0.016900 | -0.617 | 0.2040 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE | 8 | 0.002570 | -0.616 | 0.0778 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 5 | 0.017200 | -0.615 | 0.2050 |
| GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 0.017800 | -0.612 | 0.2080 |
| GOBP CHONDROCYTE HYPERTROPHY | 5 | 0.019100 | -0.605 | 0.2150 |
| GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING | 5 | 0.019400 | -0.604 | 0.2170 |
| GOBP GLYCINE METABOLIC PROCESS | 6 | 0.012100 | 0.592 | 0.1780 |
| GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION | 5 | 0.022000 | -0.592 | 0.2310 |
| GOMF BH3 DOMAIN BINDING | 5 | 0.022700 | -0.588 | 0.2350 |
| GOBP PLASMA CELL DIFFERENTIATION | 5 | 0.023100 | -0.587 | 0.2370 |
| GOBP REGULATION OF CELLULAR PH REDUCTION | 5 | 0.023600 | -0.585 | 0.2390 |
| GOBP ESTABLISHMENT OF SERTOLI CELL BARRIER | 5 | 0.023700 | -0.584 | 0.2390 |
| GOBP REGULATION OF FAT CELL PROLIFERATION | 6 | 0.013400 | -0.583 | 0.1870 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN | 7 | 0.007640 | -0.582 | 0.1490 |
| GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 7 | 0.007930 | 0.580 | 0.1510 |
| GOBP OPTIC NERVE DEVELOPMENT | 7 | 0.007980 | -0.579 | 0.1510 |
| GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY | 5 | 0.025600 | -0.577 | 0.2460 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION | 7 | 0.008270 | -0.576 | 0.1520 |
Results (complete table)
Click HERE to show results for all gene sets
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOBP RESPONSE TO TYPE III INTERFERON | 6 | 1.38e-03 | -7.54e-01 | 5.71e-02 |
| GOBP DNA LIGATION INVOLVED IN DNA REPAIR | 5 | 3.51e-03 | 7.54e-01 | 9.41e-02 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 4.72e-03 | 7.30e-01 | 1.13e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 5 | 5.38e-03 | 7.19e-01 | 1.22e-01 |
| GOBP REGULATION OF MAST CELL CHEMOTAXIS | 5 | 5.64e-03 | -7.15e-01 | 1.26e-01 |
| GOCC PHAGOLYSOSOME | 5 | 5.96e-03 | -7.10e-01 | 1.31e-01 |
| GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY | 6 | 2.89e-03 | -7.02e-01 | 8.36e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION | 5 | 6.93e-03 | -6.97e-01 | 1.42e-01 |
| GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE | 7 | 1.45e-03 | -6.95e-01 | 5.90e-02 |
| GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY | 6 | 3.30e-03 | 6.93e-01 | 9.08e-02 |
| GOBP BEHAVIORAL RESPONSE TO ETHANOL | 5 | 7.61e-03 | 6.89e-01 | 1.49e-01 |
| GOBP MHC CLASS I BIOSYNTHETIC PROCESS | 5 | 8.23e-03 | 6.82e-01 | 1.52e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 7 | 2.07e-03 | -6.72e-01 | 6.93e-02 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 7 | 2.07e-03 | -6.72e-01 | 6.93e-02 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS | 5 | 9.26e-03 | -6.72e-01 | 1.59e-01 |
| GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION | 5 | 1.08e-02 | -6.59e-01 | 1.71e-01 |
| GOMF RAGE RECEPTOR BINDING | 9 | 6.31e-04 | -6.58e-01 | 3.44e-02 |
| GOBP METANEPHRIC EPITHELIUM DEVELOPMENT | 5 | 1.14e-02 | 6.54e-01 | 1.73e-01 |
| GOBP METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT | 5 | 1.14e-02 | 6.54e-01 | 1.73e-01 |
| GOBP THALAMUS DEVELOPMENT | 5 | 1.17e-02 | -6.51e-01 | 1.75e-01 |
| GOCC CILIARY TRANSITION FIBER | 6 | 5.78e-03 | 6.51e-01 | 1.28e-01 |
| GOBP DE NOVO AMP BIOSYNTHETIC PROCESS | 6 | 6.30e-03 | 6.44e-01 | 1.35e-01 |
| GOBP RRNA BASE METHYLATION | 8 | 1.70e-03 | 6.41e-01 | 6.22e-02 |
| GOBP FAT PAD DEVELOPMENT | 7 | 3.40e-03 | -6.39e-01 | 9.24e-02 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 7.25e-03 | 6.33e-01 | 1.45e-01 |
| GOCC GID COMPLEX | 5 | 1.44e-02 | -6.32e-01 | 1.94e-01 |
| GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING | 5 | 1.48e-02 | -6.29e-01 | 1.95e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 5 | 1.54e-02 | 6.26e-01 | 1.98e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 7 | 4.18e-03 | -6.25e-01 | 1.03e-01 |
| GOBP MITOCHONDRIAL RNA MODIFICATION | 10 | 6.22e-04 | 6.25e-01 | 3.41e-02 |
| GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING | 6 | 8.60e-03 | 6.19e-01 | 1.53e-01 |
| GOBP REGULATION OF HEXOKINASE ACTIVITY | 5 | 1.67e-02 | -6.18e-01 | 2.03e-01 |
| GOBP NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION | 5 | 1.69e-02 | -6.17e-01 | 2.04e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE | 8 | 2.57e-03 | -6.16e-01 | 7.78e-02 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 5 | 1.72e-02 | -6.15e-01 | 2.05e-01 |
| GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 1.78e-02 | -6.12e-01 | 2.08e-01 |
| GOBP CHONDROCYTE HYPERTROPHY | 5 | 1.91e-02 | -6.05e-01 | 2.15e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING | 5 | 1.94e-02 | -6.04e-01 | 2.17e-01 |
| GOBP GLYCINE METABOLIC PROCESS | 6 | 1.21e-02 | 5.92e-01 | 1.78e-01 |
| GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION | 5 | 2.20e-02 | -5.92e-01 | 2.31e-01 |
| GOMF BH3 DOMAIN BINDING | 5 | 2.27e-02 | -5.88e-01 | 2.35e-01 |
| GOBP PLASMA CELL DIFFERENTIATION | 5 | 2.31e-02 | -5.87e-01 | 2.37e-01 |
| GOBP REGULATION OF CELLULAR PH REDUCTION | 5 | 2.36e-02 | -5.85e-01 | 2.39e-01 |
| GOBP ESTABLISHMENT OF SERTOLI CELL BARRIER | 5 | 2.37e-02 | -5.84e-01 | 2.39e-01 |
| GOBP REGULATION OF FAT CELL PROLIFERATION | 6 | 1.34e-02 | -5.83e-01 | 1.87e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN | 7 | 7.64e-03 | -5.82e-01 | 1.49e-01 |
| GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 7 | 7.93e-03 | 5.80e-01 | 1.51e-01 |
| GOBP OPTIC NERVE DEVELOPMENT | 7 | 7.98e-03 | -5.79e-01 | 1.51e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY | 5 | 2.56e-02 | -5.77e-01 | 2.46e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION | 7 | 8.27e-03 | -5.76e-01 | 1.52e-01 |
| GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 2.60e-02 | -5.75e-01 | 2.49e-01 |
| GOBP L SERINE TRANSPORT | 6 | 1.47e-02 | 5.75e-01 | 1.95e-01 |
| GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.47e-02 | 5.75e-01 | 1.95e-01 |
| GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 7 | 8.66e-03 | -5.73e-01 | 1.54e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD | 5 | 2.67e-02 | -5.72e-01 | 2.53e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 10 | 1.74e-03 | -5.72e-01 | 6.28e-02 |
| GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR | 5 | 2.68e-02 | 5.72e-01 | 2.53e-01 |
| GOBP VITAMIN D BIOSYNTHETIC PROCESS | 5 | 2.69e-02 | -5.72e-01 | 2.54e-01 |
| GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 12 | 6.37e-04 | 5.69e-01 | 3.45e-02 |
| GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY | 7 | 9.17e-03 | 5.69e-01 | 1.59e-01 |
| GOBP RESPONSE TO ZINC ION STARVATION | 5 | 2.78e-02 | 5.68e-01 | 2.57e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 8 | 5.51e-03 | -5.67e-01 | 1.24e-01 |
| GOMF PROTEIN TYROSINE KINASE INHIBITOR ACTIVITY | 5 | 2.93e-02 | -5.63e-01 | 2.62e-01 |
| GOMF THIOREDOXIN DISULFIDE REDUCTASE NADP ACTIVITY | 5 | 2.93e-02 | -5.63e-01 | 2.62e-01 |
| GOMF ICOSANOID BINDING | 6 | 1.70e-02 | -5.63e-01 | 2.05e-01 |
| GOBP AMINO ACID SALVAGE | 5 | 2.98e-02 | 5.61e-01 | 2.62e-01 |
| GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE | 5 | 2.98e-02 | 5.61e-01 | 2.62e-01 |
| GOBP MITOCHONDRIAL TRNA PROCESSING | 14 | 2.82e-04 | 5.61e-01 | 2.20e-02 |
| GOBP IRIS MORPHOGENESIS | 5 | 3.01e-02 | -5.60e-01 | 2.64e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 10 | 2.22e-03 | -5.59e-01 | 7.25e-02 |
| GOBP ZINC ION IMPORT INTO ORGANELLE | 5 | 3.07e-02 | -5.58e-01 | 2.66e-01 |
| GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 3.14e-02 | 5.56e-01 | 2.67e-01 |
| GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY | 6 | 1.87e-02 | 5.54e-01 | 2.14e-01 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING | 7 | 1.11e-02 | -5.54e-01 | 1.73e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION | 8 | 6.74e-03 | 5.53e-01 | 1.40e-01 |
| GOCC LEWY BODY | 7 | 1.13e-02 | -5.53e-01 | 1.73e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY | 8 | 6.80e-03 | -5.53e-01 | 1.41e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS | 17 | 8.07e-05 | 5.52e-01 | 9.75e-03 |
| GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY | 10 | 2.52e-03 | -5.52e-01 | 7.78e-02 |
| GOBP CUT CATABOLIC PROCESS | 5 | 3.27e-02 | 5.52e-01 | 2.72e-01 |
| GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 7.26e-03 | 5.48e-01 | 1.45e-01 |
| GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY | 6 | 2.03e-02 | 5.47e-01 | 2.22e-01 |
| GOBP DNA INTEGRATION | 5 | 3.46e-02 | 5.46e-01 | 2.78e-01 |
| GOCC TORC1 COMPLEX | 6 | 2.10e-02 | 5.44e-01 | 2.25e-01 |
| GOMF UBIQUINONE BINDING | 5 | 3.51e-02 | -5.44e-01 | 2.80e-01 |
| GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY | 6 | 2.14e-02 | 5.42e-01 | 2.27e-01 |
| GOBP L SERINE METABOLIC PROCESS | 8 | 8.26e-03 | 5.39e-01 | 1.52e-01 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 7 | 1.37e-02 | -5.38e-01 | 1.89e-01 |
| GOCC SEC61 TRANSLOCON COMPLEX | 5 | 3.82e-02 | -5.35e-01 | 2.93e-01 |
| GOMF PROTEASOME ACTIVATING ACTIVITY | 6 | 2.32e-02 | -5.35e-01 | 2.37e-01 |
| GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY | 6 | 2.38e-02 | -5.33e-01 | 2.40e-01 |
| GOBP PEPTIDYL LYSINE DIMETHYLATION | 10 | 3.63e-03 | 5.31e-01 | 9.51e-02 |
| GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 5 | 3.98e-02 | -5.31e-01 | 2.98e-01 |
| GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY | 6 | 2.45e-02 | -5.30e-01 | 2.42e-01 |
| GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS | 5 | 4.05e-02 | -5.29e-01 | 3.00e-01 |
| GOMF TAP BINDING | 7 | 1.56e-02 | 5.28e-01 | 1.98e-01 |
| GOMF HISTONE DECROTONYLASE ACTIVITY | 5 | 4.15e-02 | 5.26e-01 | 3.03e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 5 | 4.17e-02 | -5.26e-01 | 3.03e-01 |
| GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 9 | 6.33e-03 | -5.26e-01 | 1.35e-01 |
| GOBP PYRUVATE TRANSPORT | 5 | 4.22e-02 | -5.25e-01 | 3.05e-01 |
| GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS | 7 | 1.62e-02 | 5.25e-01 | 2.00e-01 |
| GOMF ISOPRENOID BINDING | 8 | 1.04e-02 | -5.23e-01 | 1.69e-01 |
| GOBP KETONE BODY METABOLIC PROCESS | 5 | 4.34e-02 | 5.22e-01 | 3.08e-01 |
| GOMF MHC CLASS I RECEPTOR ACTIVITY | 9 | 6.88e-03 | -5.20e-01 | 1.41e-01 |
| GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS | 7 | 1.74e-02 | -5.19e-01 | 2.06e-01 |
| GOBP NEGATIVE REGULATION OF FIBRINOLYSIS | 6 | 2.79e-02 | -5.18e-01 | 2.57e-01 |
| GOCC LATERAL PART OF CELL | 5 | 4.50e-02 | -5.18e-01 | 3.12e-01 |
| GOBP REGULATION OF ASTROCYTE DIFFERENTIATION | 12 | 1.99e-03 | -5.16e-01 | 6.78e-02 |
| GOBP PUTRESCINE METABOLIC PROCESS | 5 | 4.75e-02 | -5.12e-01 | 3.17e-01 |
| GOBP PROXIMAL DISTAL PATTERN FORMATION | 6 | 3.08e-02 | -5.09e-01 | 2.66e-01 |
| GOCC ORIGIN RECOGNITION COMPLEX | 6 | 3.09e-02 | 5.09e-01 | 2.66e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY | 9 | 8.28e-03 | 5.08e-01 | 1.52e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS | 6 | 3.14e-02 | 5.07e-01 | 2.67e-01 |
| GOMF LAMININ BINDING | 12 | 2.40e-03 | -5.06e-01 | 7.60e-02 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 8 | 1.32e-02 | -5.06e-01 | 1.86e-01 |
| GOBP POSITIVE REGULATION OF HELICASE ACTIVITY | 7 | 2.05e-02 | 5.06e-01 | 2.23e-01 |
| GOMF THIOL OXIDASE ACTIVITY | 6 | 3.20e-02 | -5.06e-01 | 2.70e-01 |
| GOMF NEUROTROPHIN RECEPTOR BINDING | 6 | 3.20e-02 | -5.05e-01 | 2.70e-01 |
| GOMF TITIN BINDING | 7 | 2.07e-02 | 5.05e-01 | 2.24e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 3.25e-02 | -5.04e-01 | 2.71e-01 |
| GOMF GLUCOSIDASE ACTIVITY | 7 | 2.10e-02 | 5.04e-01 | 2.25e-01 |
| GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 11 | 3.93e-03 | -5.02e-01 | 9.98e-02 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL | 13 | 1.74e-03 | -5.02e-01 | 6.28e-02 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS | 5 | 5.26e-02 | -5.01e-01 | 3.34e-01 |
| GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX | 6 | 3.39e-02 | -5.00e-01 | 2.77e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS | 18 | 2.48e-04 | -4.99e-01 | 2.04e-02 |
| GOBP MALONYL COA METABOLIC PROCESS | 6 | 3.47e-02 | 4.98e-01 | 2.78e-01 |
| GOMF NOTCH BINDING | 12 | 2.90e-03 | -4.97e-01 | 8.36e-02 |
| GOBP POSITIVE REGULATION OF MITOPHAGY | 5 | 5.45e-02 | -4.97e-01 | 3.40e-01 |
| GOBP REGULATION OF MITOTIC RECOMBINATION | 5 | 5.59e-02 | 4.94e-01 | 3.44e-01 |
| GOBP MYOSIN FILAMENT ORGANIZATION | 5 | 5.66e-02 | 4.92e-01 | 3.47e-01 |
| GOMF INSULIN BINDING | 5 | 5.68e-02 | 4.92e-01 | 3.47e-01 |
| GOBP ERBB4 SIGNALING PATHWAY | 5 | 5.74e-02 | -4.91e-01 | 3.50e-01 |
| GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 5 | 5.75e-02 | 4.90e-01 | 3.50e-01 |
| GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 5 | 5.76e-02 | -4.90e-01 | 3.50e-01 |
| GOMF LONG CHAIN FATTY ACID BINDING | 9 | 1.09e-02 | -4.90e-01 | 1.73e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION | 10 | 7.35e-03 | -4.90e-01 | 1.46e-01 |
| GOMF NEUROTROPHIN TRK RECEPTOR BINDING | 5 | 5.82e-02 | -4.89e-01 | 3.52e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 8 | 1.67e-02 | -4.89e-01 | 2.03e-01 |
| GOCC NONHOMOLOGOUS END JOINING COMPLEX | 9 | 1.11e-02 | 4.89e-01 | 1.73e-01 |
| GOBP EXTRACELLULAR EXOSOME ASSEMBLY | 5 | 5.86e-02 | -4.88e-01 | 3.53e-01 |
| GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 6 | 3.86e-02 | -4.88e-01 | 2.95e-01 |
| GOBP INSULIN METABOLIC PROCESS | 8 | 1.70e-02 | -4.87e-01 | 2.05e-01 |
| GOBP MITOCHONDRIAL DNA REPLICATION | 13 | 2.37e-03 | 4.87e-01 | 7.60e-02 |
| GOBP REGULATION OF KERATINOCYTE MIGRATION | 8 | 1.73e-02 | -4.86e-01 | 2.05e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 6 | 3.94e-02 | 4.86e-01 | 2.97e-01 |
| GOBP GERMINAL CENTER FORMATION | 12 | 3.62e-03 | -4.85e-01 | 9.51e-02 |
| GOBP T CELL ANTIGEN PROCESSING AND PRESENTATION | 5 | 6.07e-02 | -4.84e-01 | 3.58e-01 |
| GOBP REGULATION OF PROTEIN DEUBIQUITINATION | 10 | 8.02e-03 | -4.84e-01 | 1.52e-01 |
| GOBP XMP METABOLIC PROCESS | 7 | 2.71e-02 | 4.82e-01 | 2.55e-01 |
| GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION | 5 | 6.21e-02 | -4.82e-01 | 3.60e-01 |
| GOBP LEUKOCYTE AGGREGATION | 10 | 8.37e-03 | -4.82e-01 | 1.52e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 5 | 6.38e-02 | -4.79e-01 | 3.64e-01 |
| GOMF ANKYRIN BINDING | 8 | 1.91e-02 | -4.79e-01 | 2.15e-01 |
| GOBP REGULATION OF FIBRINOLYSIS | 7 | 2.85e-02 | -4.78e-01 | 2.60e-01 |
| GOMF BH DOMAIN BINDING | 7 | 2.87e-02 | -4.78e-01 | 2.60e-01 |
| GOBP CELLULAR RESPONSE TO ETHER | 6 | 4.30e-02 | -4.77e-01 | 3.07e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 2.88e-02 | -4.77e-01 | 2.60e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A RRNA | 21 | 1.54e-04 | 4.77e-01 | 1.55e-02 |
| GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY | 5 | 6.50e-02 | 4.77e-01 | 3.69e-01 |
| GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY | 6 | 4.33e-02 | -4.76e-01 | 3.08e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB | 7 | 2.91e-02 | 4.76e-01 | 2.61e-01 |
| GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 4.41e-02 | 4.75e-01 | 3.10e-01 |
| GOBP UTERUS DEVELOPMENT | 10 | 9.38e-03 | -4.75e-01 | 1.61e-01 |
| GOMF EXTRACELLULAR MATRIX BINDING | 17 | 7.10e-04 | -4.74e-01 | 3.72e-02 |
| GOBP POSITIVE REGULATION OF RNA BINDING | 6 | 4.44e-02 | -4.74e-01 | 3.10e-01 |
| GOBP KERATINIZATION | 6 | 4.45e-02 | -4.74e-01 | 3.10e-01 |
| GOCC ZONULA ADHERENS | 6 | 4.47e-02 | -4.73e-01 | 3.11e-01 |
| GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION | 12 | 4.63e-03 | -4.72e-01 | 1.12e-01 |
| GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 5 | 6.79e-02 | -4.72e-01 | 3.75e-01 |
| GOCC BCL 2 FAMILY PROTEIN COMPLEX | 10 | 1.00e-02 | -4.70e-01 | 1.66e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 9 | 1.46e-02 | -4.70e-01 | 1.94e-01 |
| GOBP GOLGI LUMEN ACIDIFICATION | 13 | 3.37e-03 | -4.70e-01 | 9.18e-02 |
| GOBP KERATINOCYTE MIGRATION | 10 | 1.02e-02 | -4.69e-01 | 1.67e-01 |
| GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.95e-02 | 4.69e-01 | 3.81e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 11 | 7.28e-03 | -4.67e-01 | 1.45e-01 |
| GOBP ISOLEUCINE METABOLIC PROCESS | 7 | 3.23e-02 | 4.67e-01 | 2.71e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY | 9 | 1.52e-02 | -4.67e-01 | 1.97e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 10 | 1.05e-02 | -4.67e-01 | 1.70e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 5 | 7.12e-02 | -4.66e-01 | 3.85e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 5 | 7.12e-02 | -4.66e-01 | 3.85e-01 |
| GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 5 | 7.12e-02 | -4.66e-01 | 3.85e-01 |
| GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS | 5 | 7.12e-02 | 4.66e-01 | 3.85e-01 |
| GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY | 5 | 7.12e-02 | -4.66e-01 | 3.85e-01 |
| GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM | 7 | 3.28e-02 | -4.66e-01 | 2.72e-01 |
| GOBP LEUCINE TRANSPORT | 6 | 4.84e-02 | -4.65e-01 | 3.21e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 9 | 1.58e-02 | 4.65e-01 | 1.98e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 9 | 1.59e-02 | -4.64e-01 | 1.98e-01 |
| GOBP NATURAL KILLER CELL CHEMOTAXIS | 6 | 4.92e-02 | 4.64e-01 | 3.22e-01 |
| GOBP FAT CELL PROLIFERATION | 8 | 2.33e-02 | -4.63e-01 | 2.37e-01 |
| GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS | 7 | 3.42e-02 | -4.62e-01 | 2.77e-01 |
| GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY | 6 | 5.00e-02 | -4.62e-01 | 3.24e-01 |
| GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY | 6 | 5.00e-02 | -4.62e-01 | 3.24e-01 |
| GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION | 8 | 2.36e-02 | -4.62e-01 | 2.39e-01 |
| GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX | 9 | 1.67e-02 | 4.61e-01 | 2.03e-01 |
| GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX | 11 | 8.24e-03 | 4.60e-01 | 1.52e-01 |
| GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT | 7 | 3.52e-02 | 4.60e-01 | 2.81e-01 |
| GOBP NEURONAL ION CHANNEL CLUSTERING | 5 | 7.51e-02 | -4.60e-01 | 3.96e-01 |
| GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER | 5 | 7.53e-02 | -4.59e-01 | 3.96e-01 |
| GOBP GLUTAMINE TRANSPORT | 7 | 3.56e-02 | 4.59e-01 | 2.82e-01 |
| GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 3.56e-02 | 4.59e-01 | 2.82e-01 |
| GOBP LEUCINE CATABOLIC PROCESS | 5 | 7.58e-02 | 4.59e-01 | 3.96e-01 |
| GOBP CHONDROCYTE DEVELOPMENT | 13 | 4.20e-03 | -4.59e-01 | 1.03e-01 |
| GOBP INTERLEUKIN 5 PRODUCTION | 8 | 2.48e-02 | -4.58e-01 | 2.43e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 5 | 7.61e-02 | 4.58e-01 | 3.96e-01 |
| GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE | 6 | 5.21e-02 | -4.58e-01 | 3.32e-01 |
| GOMF D1 DOPAMINE RECEPTOR BINDING | 5 | 7.65e-02 | -4.57e-01 | 3.97e-01 |
| GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 6.11e-03 | 4.57e-01 | 1.33e-01 |
| GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 17 | 1.12e-03 | -4.57e-01 | 4.96e-02 |
| GOBP REGULATION OF GERMINAL CENTER FORMATION | 7 | 3.66e-02 | -4.56e-01 | 2.86e-01 |
| GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 5 | 7.79e-02 | 4.55e-01 | 4.00e-01 |
| GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION | 5 | 7.79e-02 | 4.55e-01 | 4.00e-01 |
| GOBP REGULATION OF PLASMINOGEN ACTIVATION | 12 | 6.39e-03 | -4.55e-01 | 1.35e-01 |
| GOBP PROTEIN REPAIR | 5 | 7.84e-02 | 4.55e-01 | 4.00e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 6 | 5.39e-02 | -4.54e-01 | 3.39e-01 |
| GOCC DYNACTIN COMPLEX | 8 | 2.62e-02 | -4.54e-01 | 2.50e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 16 | 1.68e-03 | 4.54e-01 | 6.22e-02 |
| GOBP NUCLEOBASE BIOSYNTHETIC PROCESS | 17 | 1.22e-03 | 4.53e-01 | 5.17e-02 |
| GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 15 | 2.40e-03 | -4.53e-01 | 7.60e-02 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 9 | 1.88e-02 | -4.52e-01 | 2.14e-01 |
| GOBP REGULATION OF HEPATOCYTE PROLIFERATION | 7 | 3.84e-02 | -4.52e-01 | 2.95e-01 |
| GOBP RESPONSE TO INTERLEUKIN 12 | 10 | 1.34e-02 | -4.52e-01 | 1.87e-01 |
| GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS | 5 | 8.04e-02 | 4.52e-01 | 4.07e-01 |
| GOMF SODIUM CHANNEL INHIBITOR ACTIVITY | 5 | 8.07e-02 | 4.51e-01 | 4.07e-01 |
| GOBP CELLULAR RESPONSE TO FATTY ACID | 16 | 1.80e-03 | -4.51e-01 | 6.44e-02 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY | 7 | 3.92e-02 | -4.50e-01 | 2.97e-01 |
| GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY | 7 | 3.93e-02 | 4.50e-01 | 2.97e-01 |
| GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING | 7 | 4.00e-02 | 4.48e-01 | 2.98e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 5 | 8.27e-02 | -4.48e-01 | 4.09e-01 |
| GOBP METANEPHRIC NEPHRON DEVELOPMENT | 7 | 4.03e-02 | 4.48e-01 | 3.00e-01 |
| GOBP POSITIVE REGULATION OF RRNA PROCESSING | 10 | 1.43e-02 | 4.48e-01 | 1.93e-01 |
| GOBP MITOCHONDRIAL DNA METABOLIC PROCESS | 20 | 5.38e-04 | 4.47e-01 | 3.14e-02 |
| GOMF ACTIVIN RECEPTOR BINDING | 5 | 8.38e-02 | -4.47e-01 | 4.11e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 5 | 8.42e-02 | -4.46e-01 | 4.12e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 21 | 4.05e-04 | -4.46e-01 | 2.66e-02 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 8 | 2.91e-02 | -4.46e-01 | 2.61e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 6 | 5.90e-02 | -4.45e-01 | 3.54e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 5 | 8.49e-02 | -4.45e-01 | 4.12e-01 |
| GOMF DEATH RECEPTOR ACTIVITY | 6 | 5.94e-02 | -4.44e-01 | 3.55e-01 |
| GOCC POSTSYNAPTIC RECYCLING ENDOSOME | 7 | 4.18e-02 | -4.44e-01 | 3.03e-01 |
| GOBP INNATE IMMUNE RESPONSE IN MUCOSA | 5 | 8.57e-02 | -4.44e-01 | 4.15e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT | 9 | 2.11e-02 | -4.44e-01 | 2.25e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION | 5 | 8.63e-02 | -4.43e-01 | 4.16e-01 |
| GOBP REGULATION OF ADHERENS JUNCTION ORGANIZATION | 5 | 8.64e-02 | -4.43e-01 | 4.16e-01 |
| GOCC BETA CATENIN TCF COMPLEX | 11 | 1.11e-02 | -4.42e-01 | 1.73e-01 |
| GOBP IMMUNOLOGICAL MEMORY PROCESS | 11 | 1.12e-02 | -4.42e-01 | 1.73e-01 |
| GOMF U3 SNORNA BINDING | 10 | 1.56e-02 | 4.42e-01 | 1.98e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 7 | 4.30e-02 | -4.42e-01 | 3.07e-01 |
| GOCC F ACTIN CAPPING PROTEIN COMPLEX | 6 | 6.11e-02 | -4.42e-01 | 3.60e-01 |
| GOBP CO TRANSCRIPTIONAL MRNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 5 | 8.73e-02 | 4.42e-01 | 4.18e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX | 12 | 8.13e-03 | 4.41e-01 | 1.52e-01 |
| GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 11 | 1.13e-02 | -4.41e-01 | 1.73e-01 |
| GOMF OXYGEN BINDING | 10 | 1.58e-02 | -4.41e-01 | 1.98e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE REPAIR | 6 | 6.19e-02 | -4.40e-01 | 3.60e-01 |
| GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY | 8 | 3.11e-02 | -4.40e-01 | 2.67e-01 |
| GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 10 | 1.60e-02 | -4.40e-01 | 1.98e-01 |
| GOBP STRESS INDUCED PREMATURE SENESCENCE | 5 | 8.86e-02 | 4.40e-01 | 4.21e-01 |
| GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK | 6 | 6.22e-02 | 4.40e-01 | 3.60e-01 |
| GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY | 7 | 4.40e-02 | 4.40e-01 | 3.10e-01 |
| GOBP OXYGEN TRANSPORT | 5 | 8.87e-02 | -4.40e-01 | 4.21e-01 |
| GOBP OPSONIZATION | 5 | 8.92e-02 | -4.39e-01 | 4.22e-01 |
| GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX | 8 | 3.16e-02 | -4.39e-01 | 2.68e-01 |
| GOBP POSITIVE REGULATION OF PLATELET ACTIVATION | 6 | 6.30e-02 | -4.38e-01 | 3.63e-01 |
| GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY | 6 | 6.30e-02 | 4.38e-01 | 3.63e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION | 10 | 1.66e-02 | 4.38e-01 | 2.03e-01 |
| GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT | 9 | 2.31e-02 | -4.37e-01 | 2.37e-01 |
| GOMF STEROL TRANSFER ACTIVITY | 11 | 1.21e-02 | -4.37e-01 | 1.78e-01 |
| GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 8 | 3.26e-02 | -4.36e-01 | 2.71e-01 |
| GOBP REGULATION OF ENDOSOME ORGANIZATION | 5 | 9.12e-02 | -4.36e-01 | 4.24e-01 |
| GOBP ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 5 | 9.15e-02 | -4.36e-01 | 4.24e-01 |
| GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 4.60e-02 | 4.36e-01 | 3.15e-01 |
| GOBP SYNAPTIC TRANSMISSION CHOLINERGIC | 5 | 9.20e-02 | -4.35e-01 | 4.24e-01 |
| GOBP ISOCITRATE METABOLIC PROCESS | 6 | 6.49e-02 | 4.35e-01 | 3.68e-01 |
| GOBP ELASTIN METABOLIC PROCESS | 5 | 9.21e-02 | -4.35e-01 | 4.24e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC | 5 | 9.24e-02 | -4.35e-01 | 4.24e-01 |
| GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 5 | 9.24e-02 | -4.35e-01 | 4.24e-01 |
| GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI | 9 | 2.41e-02 | 4.34e-01 | 2.41e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 6 | 6.57e-02 | -4.34e-01 | 3.71e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING | 6 | 6.59e-02 | 4.34e-01 | 3.71e-01 |
| GOBP INTESTINAL CHOLESTEROL ABSORPTION | 5 | 9.41e-02 | -4.32e-01 | 4.28e-01 |
| GOBP LIPID DIGESTION | 5 | 9.41e-02 | -4.32e-01 | 4.28e-01 |
| GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS | 6 | 6.71e-02 | 4.32e-01 | 3.74e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE | 5 | 9.46e-02 | -4.32e-01 | 4.30e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY | 5 | 9.50e-02 | -4.31e-01 | 4.30e-01 |
| GOBP C4 DICARBOXYLATE TRANSPORT | 14 | 5.27e-03 | 4.31e-01 | 1.21e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA PROCESSING | 5 | 9.56e-02 | -4.30e-01 | 4.32e-01 |
| GOBP SYNAPTIC VESICLE CLUSTERING | 5 | 9.58e-02 | -4.30e-01 | 4.32e-01 |
| GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION | 20 | 8.83e-04 | -4.30e-01 | 4.24e-02 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 8 | 3.59e-02 | 4.28e-01 | 2.83e-01 |
| GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 6 | 6.94e-02 | -4.28e-01 | 3.81e-01 |
| GOBP AUTOPHAGY OF PEROXISOME | 10 | 1.91e-02 | -4.28e-01 | 2.15e-01 |
| GOBP EMBRYONIC BRAIN DEVELOPMENT | 9 | 2.64e-02 | -4.27e-01 | 2.51e-01 |
| GOCC PARASPECKLES | 8 | 3.65e-02 | -4.27e-01 | 2.86e-01 |
| GOBP MRNA ALTERNATIVE POLYADENYLATION | 5 | 9.83e-02 | -4.27e-01 | 4.38e-01 |
| GOBP PLASMA MEMBRANE FUSION | 6 | 7.11e-02 | -4.26e-01 | 3.85e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION | 5 | 9.98e-02 | -4.25e-01 | 4.41e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY | 8 | 3.79e-02 | -4.24e-01 | 2.93e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 10 | 2.03e-02 | 4.24e-01 | 2.22e-01 |
| GOBP PLASMINOGEN ACTIVATION | 13 | 8.21e-03 | -4.23e-01 | 1.52e-01 |
| GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 38 | 6.39e-06 | -4.23e-01 | 1.92e-03 |
| GOBP REGULATION OF RNA BINDING | 8 | 3.85e-02 | -4.23e-01 | 2.95e-01 |
| GOBP INTRACILIARY RETROGRADE TRANSPORT | 9 | 2.83e-02 | 4.22e-01 | 2.59e-01 |
| GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 5.32e-02 | -4.22e-01 | 3.36e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE | 5 | 1.02e-01 | -4.22e-01 | 4.47e-01 |
| GOBP HYPEROSMOTIC SALINITY RESPONSE | 6 | 7.39e-02 | 4.21e-01 | 3.93e-01 |
| GOBP EMBRYONIC FORELIMB MORPHOGENESIS | 10 | 2.11e-02 | -4.21e-01 | 2.25e-01 |
| GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY | 6 | 7.44e-02 | -4.21e-01 | 3.94e-01 |
| GOBP PROTEIN POLY ADP RIBOSYLATION | 10 | 2.13e-02 | 4.20e-01 | 2.27e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY | 6 | 7.49e-02 | -4.20e-01 | 3.95e-01 |
| GOBP FATTY ACID ALPHA OXIDATION | 5 | 1.05e-01 | 4.19e-01 | 4.50e-01 |
| GOMF C METHYLTRANSFERASE ACTIVITY | 6 | 7.56e-02 | 4.19e-01 | 3.96e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION | 5 | 1.05e-01 | 4.19e-01 | 4.50e-01 |
| GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 5 | 1.05e-01 | -4.19e-01 | 4.50e-01 |
| GOMF DNA DNA ANNEALING ACTIVITY | 5 | 1.05e-01 | 4.18e-01 | 4.50e-01 |
| GOBP MRNA 3 SPLICE SITE RECOGNITION | 6 | 7.62e-02 | -4.18e-01 | 3.96e-01 |
| GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING | 7 | 5.59e-02 | 4.17e-01 | 3.44e-01 |
| GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 9 | 3.03e-02 | -4.17e-01 | 2.64e-01 |
| GOBP DENTATE GYRUS DEVELOPMENT | 9 | 3.03e-02 | -4.17e-01 | 2.64e-01 |
| GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT | 5 | 1.06e-01 | -4.17e-01 | 4.52e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR BINDING | 5 | 1.06e-01 | 4.17e-01 | 4.52e-01 |
| GOCC TRANSLOCON COMPLEX | 6 | 7.78e-02 | -4.16e-01 | 4.00e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND | 7 | 5.68e-02 | -4.16e-01 | 3.47e-01 |
| GOCC POSTSYNAPTIC ENDOSOME | 10 | 2.28e-02 | -4.16e-01 | 2.35e-01 |
| GOMF LNCRNA BINDING | 11 | 1.70e-02 | -4.16e-01 | 2.05e-01 |
| GOBP REGULATION OF DNA DAMAGE CHECKPOINT | 24 | 4.32e-04 | 4.15e-01 | 2.81e-02 |
| GOCC CYTOLYTIC GRANULE | 13 | 9.58e-03 | -4.15e-01 | 1.63e-01 |
| GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 9 | 3.13e-02 | -4.15e-01 | 2.67e-01 |
| GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 5 | 1.08e-01 | 4.15e-01 | 4.54e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 11 | 1.74e-02 | -4.14e-01 | 2.06e-01 |
| GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY | 6 | 7.90e-02 | 4.14e-01 | 4.03e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION | 5 | 1.10e-01 | -4.13e-01 | 4.56e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 10 | 2.39e-02 | -4.13e-01 | 2.40e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX | 13 | 1.01e-02 | -4.12e-01 | 1.67e-01 |
| GOCC SERINE TYPE ENDOPEPTIDASE COMPLEX | 5 | 1.11e-01 | -4.12e-01 | 4.56e-01 |
| GOCC SERINE TYPE PEPTIDASE COMPLEX | 5 | 1.11e-01 | -4.12e-01 | 4.56e-01 |
| GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY | 7 | 5.91e-02 | 4.12e-01 | 3.54e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB | 17 | 3.30e-03 | 4.12e-01 | 9.08e-02 |
| GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 10 | 2.43e-02 | -4.11e-01 | 2.41e-01 |
| GOBP PHOSPHOLIPID EFFLUX | 5 | 1.12e-01 | -4.11e-01 | 4.58e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING | 8 | 4.44e-02 | -4.11e-01 | 3.10e-01 |
| GOBP PROTEIN LINEAR POLYUBIQUITINATION | 5 | 1.12e-01 | -4.11e-01 | 4.58e-01 |
| GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 4.44e-02 | -4.10e-01 | 3.10e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX | 9 | 3.31e-02 | -4.10e-01 | 2.73e-01 |
| GOBP GAS TRANSPORT | 6 | 8.22e-02 | -4.10e-01 | 4.09e-01 |
| GOCC TUBULAR ENDOSOME | 5 | 1.13e-01 | -4.10e-01 | 4.59e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 6 | 8.25e-02 | 4.09e-01 | 4.09e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 8 | 4.52e-02 | -4.09e-01 | 3.12e-01 |
| GOMF DEUBIQUITINASE ACTIVATOR ACTIVITY | 5 | 1.13e-01 | -4.09e-01 | 4.61e-01 |
| GOCC PROTEASE INHIBITOR COMPLEX | 5 | 1.14e-01 | -4.09e-01 | 4.61e-01 |
| GOBP LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER | 5 | 1.14e-01 | -4.09e-01 | 4.61e-01 |
| GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 6 | 8.36e-02 | 4.08e-01 | 4.11e-01 |
| GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 9 | 3.42e-02 | -4.08e-01 | 2.77e-01 |
| GOBP POSITIVE REGULATION OF MYELINATION | 8 | 4.60e-02 | -4.07e-01 | 3.15e-01 |
| GOBP STARTLE RESPONSE | 10 | 2.58e-02 | -4.07e-01 | 2.48e-01 |
| GOMF SIGNAL RECOGNITION PARTICLE BINDING | 6 | 8.48e-02 | -4.06e-01 | 4.12e-01 |
| GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX | 5 | 1.16e-01 | 4.06e-01 | 4.64e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS | 8 | 4.70e-02 | 4.06e-01 | 3.17e-01 |
| GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 55 | 2.00e-07 | -4.06e-01 | 1.62e-04 |
| GOBP OTOLITH DEVELOPMENT | 5 | 1.17e-01 | 4.05e-01 | 4.65e-01 |
| GOBP ADAPTATION OF SIGNALING PATHWAY | 10 | 2.67e-02 | -4.05e-01 | 2.53e-01 |
| GOBP RRNA METHYLATION | 21 | 1.33e-03 | 4.05e-01 | 5.58e-02 |
| GOBP EMBRYONIC HEMOPOIESIS | 15 | 6.71e-03 | -4.04e-01 | 1.40e-01 |
| GOMF GLUTATHIONE PEROXIDASE ACTIVITY | 14 | 8.83e-03 | -4.04e-01 | 1.55e-01 |
| GOBP MONOACYLGLYCEROL CATABOLIC PROCESS | 5 | 1.18e-01 | -4.04e-01 | 4.67e-01 |
| GOBP CENP A CONTAINING CHROMATIN ASSEMBLY | 7 | 6.42e-02 | 4.04e-01 | 3.66e-01 |
| GOCC SECONDARY LYSOSOME | 17 | 3.93e-03 | -4.04e-01 | 9.98e-02 |
| GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION | 5 | 1.18e-01 | -4.04e-01 | 4.67e-01 |
| GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY | 7 | 6.44e-02 | 4.04e-01 | 3.67e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION | 5 | 1.18e-01 | -4.03e-01 | 4.68e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION | 5 | 1.18e-01 | -4.03e-01 | 4.68e-01 |
| GOBP FUCOSYLATION | 11 | 2.08e-02 | 4.03e-01 | 2.25e-01 |
| GOMF CARDIOLIPIN BINDING | 6 | 8.85e-02 | 4.02e-01 | 4.21e-01 |
| GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE | 6 | 8.86e-02 | 4.02e-01 | 4.21e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS | 10 | 2.81e-02 | 4.01e-01 | 2.58e-01 |
| GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS | 7 | 6.64e-02 | 4.01e-01 | 3.73e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 13 | 1.24e-02 | 4.00e-01 | 1.81e-01 |
| GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY | 6 | 8.98e-02 | -4.00e-01 | 4.23e-01 |
| GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 16 | 5.63e-03 | -4.00e-01 | 1.26e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 5 | 1.22e-01 | -4.00e-01 | 4.75e-01 |
| GOBP ALDITOL PHOSPHATE METABOLIC PROCESS | 8 | 5.06e-02 | -3.99e-01 | 3.27e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION | 10 | 2.89e-02 | 3.99e-01 | 2.60e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS | 12 | 1.67e-02 | -3.99e-01 | 2.03e-01 |
| GOBP SERINE TRANSPORT | 8 | 5.08e-02 | 3.99e-01 | 3.28e-01 |
| GOMF SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 5.08e-02 | 3.99e-01 | 3.28e-01 |
| GOBP REGULATION OF MIRNA CATABOLIC PROCESS | 7 | 6.79e-02 | -3.99e-01 | 3.75e-01 |
| GOBP ADRENAL GLAND DEVELOPMENT | 12 | 1.69e-02 | -3.98e-01 | 2.04e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1 | 6 | 9.14e-02 | -3.98e-01 | 4.24e-01 |
| GOBP INTRACELLULAR OXYGEN HOMEOSTASIS | 6 | 9.16e-02 | -3.98e-01 | 4.24e-01 |
| GOBP MUCUS SECRETION | 10 | 2.96e-02 | -3.97e-01 | 2.62e-01 |
| GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY | 8 | 5.19e-02 | -3.97e-01 | 3.31e-01 |
| GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION | 6 | 9.24e-02 | -3.97e-01 | 4.24e-01 |
| GOMF DNA BINDING BENDING | 9 | 3.99e-02 | -3.96e-01 | 2.98e-01 |
| GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III | 12 | 1.80e-02 | -3.94e-01 | 2.10e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 10 | 3.08e-02 | -3.94e-01 | 2.66e-01 |
| GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 9 | 4.08e-02 | -3.94e-01 | 3.01e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 13 | 1.40e-02 | -3.94e-01 | 1.91e-01 |
| GOBP DETECTION OF CALCIUM ION | 8 | 5.40e-02 | 3.93e-01 | 3.39e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 15 | 8.47e-03 | -3.93e-01 | 1.53e-01 |
| GOBP INDUCTION OF POSITIVE CHEMOTAXIS | 5 | 1.29e-01 | -3.92e-01 | 4.85e-01 |
| GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION | 7 | 7.23e-02 | 3.92e-01 | 3.89e-01 |
| GOBP PRENYLATION | 9 | 4.19e-02 | -3.92e-01 | 3.04e-01 |
| GOMF PROTEOGLYCAN BINDING | 12 | 1.89e-02 | -3.91e-01 | 2.15e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 6 | 9.72e-02 | -3.91e-01 | 4.36e-01 |
| GOBP PROTEIN RNA COMPLEX DISASSEMBLY | 7 | 7.32e-02 | -3.91e-01 | 3.91e-01 |
| GOBP WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 5 | 1.30e-01 | -3.91e-01 | 4.87e-01 |
| GOBP MEMBRANE RAFT ASSEMBLY | 6 | 9.75e-02 | -3.91e-01 | 4.36e-01 |
| GOBP REGULATION OF LIPOPROTEIN LIPASE ACTIVITY | 5 | 1.30e-01 | 3.91e-01 | 4.87e-01 |
| GOMF AP 1 ADAPTOR COMPLEX BINDING | 5 | 1.31e-01 | 3.90e-01 | 4.88e-01 |
| GOBP LENS FIBER CELL DIFFERENTIATION | 19 | 3.24e-03 | -3.90e-01 | 9.02e-02 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 14 | 1.16e-02 | -3.90e-01 | 1.75e-01 |
| GOMF LIPOPEPTIDE BINDING | 9 | 4.31e-02 | 3.89e-01 | 3.07e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 8 | 5.65e-02 | -3.89e-01 | 3.47e-01 |
| GOMF PRE MRNA 3 SPLICE SITE BINDING | 5 | 1.32e-01 | -3.89e-01 | 4.89e-01 |
| GOMF TRANSMITTER GATED CHANNEL ACTIVITY | 6 | 9.94e-02 | -3.89e-01 | 4.40e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING | 8 | 5.74e-02 | 3.88e-01 | 3.50e-01 |
| GOBP PEPTIDYL LYSINE MONOMETHYLATION | 8 | 5.80e-02 | 3.87e-01 | 3.51e-01 |
| GOBP SULFUR AMINO ACID TRANSPORT | 7 | 7.67e-02 | -3.86e-01 | 3.97e-01 |
| GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE | 5 | 1.35e-01 | 3.86e-01 | 4.94e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN D | 11 | 2.67e-02 | -3.86e-01 | 2.53e-01 |
| GOBP POSITIVE REGULATION OF HIPPO SIGNALING | 5 | 1.36e-01 | -3.85e-01 | 4.94e-01 |
| GOBP PEPTIDYL LYSINE DEACETYLATION | 6 | 1.02e-01 | 3.85e-01 | 4.46e-01 |
| GOMF THIOESTERASE BINDING | 9 | 4.53e-02 | -3.85e-01 | 3.13e-01 |
| GOCC CIA COMPLEX | 5 | 1.36e-01 | 3.85e-01 | 4.94e-01 |
| GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 16 | 7.65e-03 | -3.85e-01 | 1.49e-01 |
| GOBP REGULATION OF AMPA RECEPTOR ACTIVITY | 5 | 1.36e-01 | -3.85e-01 | 4.94e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 6 | 1.03e-01 | -3.85e-01 | 4.47e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION | 8 | 5.98e-02 | 3.84e-01 | 3.57e-01 |
| GOCC PEPTIDASE INHIBITOR COMPLEX | 7 | 7.83e-02 | -3.84e-01 | 4.00e-01 |
| GOCC POLE PLASM | 12 | 2.13e-02 | -3.84e-01 | 2.26e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 5 | 1.37e-01 | 3.84e-01 | 4.95e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 5 | 1.37e-01 | -3.84e-01 | 4.95e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 1.37e-01 | -3.84e-01 | 4.95e-01 |
| GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE | 8 | 6.03e-02 | 3.84e-01 | 3.57e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION | 8 | 6.06e-02 | 3.83e-01 | 3.58e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 9 | 4.67e-02 | 3.83e-01 | 3.16e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 5 | 1.38e-01 | -3.83e-01 | 4.97e-01 |
| GOCC MCM COMPLEX | 7 | 8.00e-02 | 3.82e-01 | 4.06e-01 |
| GOMF PORIN ACTIVITY | 6 | 1.05e-01 | -3.82e-01 | 4.50e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 7 | 8.01e-02 | 3.82e-01 | 4.06e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT | 7 | 8.01e-02 | 3.82e-01 | 4.06e-01 |
| GOBP PREPULSE INHIBITION | 6 | 1.05e-01 | -3.82e-01 | 4.50e-01 |
| GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS | 12 | 2.20e-02 | -3.82e-01 | 2.31e-01 |
| GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 7 | 8.02e-02 | -3.82e-01 | 4.06e-01 |
| GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT | 9 | 4.75e-02 | -3.82e-01 | 3.17e-01 |
| GOBP REGULATION OF PROTEIN ADP RIBOSYLATION | 8 | 6.18e-02 | 3.81e-01 | 3.60e-01 |
| GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 7 | 8.06e-02 | -3.81e-01 | 4.07e-01 |
| GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 7 | 8.07e-02 | -3.81e-01 | 4.07e-01 |
| GOMF INORGANIC PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.06e-01 | -3.81e-01 | 4.52e-01 |
| GOBP FUCOSE METABOLIC PROCESS | 11 | 2.88e-02 | 3.81e-01 | 2.60e-01 |
| GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM | 11 | 2.88e-02 | -3.81e-01 | 2.60e-01 |
| GOCC ELONGATOR HOLOENZYME COMPLEX | 6 | 1.07e-01 | 3.81e-01 | 4.52e-01 |
| GOBP MAST CELL CHEMOTAXIS | 7 | 8.14e-02 | -3.80e-01 | 4.09e-01 |
| GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS | 6 | 1.07e-01 | 3.80e-01 | 4.52e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET | 6 | 1.07e-01 | -3.80e-01 | 4.53e-01 |
| GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS | 8 | 6.32e-02 | -3.79e-01 | 3.63e-01 |
| GOMF VIRION BINDING | 7 | 8.22e-02 | -3.79e-01 | 4.09e-01 |
| GOBP CANNABINOID SIGNALING PATHWAY | 5 | 1.42e-01 | -3.79e-01 | 5.02e-01 |
| GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 5 | 1.43e-01 | 3.79e-01 | 5.03e-01 |
| GOCC SIGNAL RECOGNITION PARTICLE | 7 | 8.31e-02 | -3.78e-01 | 4.10e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 8 | 6.42e-02 | -3.78e-01 | 3.66e-01 |
| GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY | 5 | 1.43e-01 | 3.78e-01 | 5.05e-01 |
| GOBP MITOCHONDRIAL RNA PROCESSING | 21 | 2.72e-03 | 3.78e-01 | 8.13e-02 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 5 | 1.44e-01 | -3.78e-01 | 5.05e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 17 | 7.10e-03 | -3.77e-01 | 1.44e-01 |
| GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 5 | 1.44e-01 | 3.77e-01 | 5.05e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB | 5 | 1.45e-01 | 3.77e-01 | 5.05e-01 |
| GOBP B CELL LINEAGE COMMITMENT | 5 | 1.45e-01 | 3.77e-01 | 5.05e-01 |
| GOMF LIPID ANTIGEN BINDING | 5 | 1.45e-01 | 3.77e-01 | 5.05e-01 |
| GOBP POSITIVE REGULATION OF TISSUE REMODELING | 6 | 1.10e-01 | 3.77e-01 | 4.56e-01 |
| GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY | 7 | 8.47e-02 | -3.76e-01 | 4.12e-01 |
| GOMF HISTONE H3 KINASE ACTIVITY | 9 | 5.09e-02 | 3.76e-01 | 3.28e-01 |
| GOMF CLATHRIN HEAVY CHAIN BINDING | 9 | 5.10e-02 | -3.76e-01 | 3.28e-01 |
| GOBP FATTY ACYL COA CATABOLIC PROCESS | 5 | 1.46e-01 | 3.76e-01 | 5.07e-01 |
| GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY | 5 | 1.46e-01 | 3.75e-01 | 5.07e-01 |
| GOBP LONG TERM SYNAPTIC DEPRESSION | 14 | 1.52e-02 | -3.75e-01 | 1.96e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 13 | 1.93e-02 | -3.75e-01 | 2.17e-01 |
| GOBP ODONTOBLAST DIFFERENTIATION | 8 | 6.66e-02 | -3.75e-01 | 3.73e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 9 | 5.18e-02 | -3.74e-01 | 3.31e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 21 | 3.01e-03 | 3.74e-01 | 8.58e-02 |
| GOBP MESODERMAL CELL DIFFERENTIATION | 7 | 8.67e-02 | -3.74e-01 | 4.16e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 7 | 8.68e-02 | -3.74e-01 | 4.17e-01 |
| GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE | 6 | 1.13e-01 | 3.74e-01 | 4.61e-01 |
| GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX | 8 | 6.75e-02 | -3.73e-01 | 3.74e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 10 | 4.10e-02 | -3.73e-01 | 3.02e-01 |
| GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE | 5 | 1.49e-01 | 3.73e-01 | 5.10e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 7 | 8.78e-02 | -3.73e-01 | 4.19e-01 |
| GOBP ALDITOL CATABOLIC PROCESS | 6 | 1.14e-01 | -3.72e-01 | 4.61e-01 |
| GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA | 5 | 1.50e-01 | 3.72e-01 | 5.12e-01 |
| GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER | 7 | 8.86e-02 | 3.72e-01 | 4.21e-01 |
| GOMF ACID PHOSPHATASE ACTIVITY | 5 | 1.51e-01 | 3.71e-01 | 5.13e-01 |
| GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 6 | 1.16e-01 | -3.70e-01 | 4.64e-01 |
| GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION | 8 | 6.97e-02 | -3.70e-01 | 3.81e-01 |
| GOCC NUCLEAR ENVELOPE LUMEN | 8 | 6.97e-02 | -3.70e-01 | 3.81e-01 |
| GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT | 8 | 6.97e-02 | -3.70e-01 | 3.81e-01 |
| GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION | 5 | 1.52e-01 | -3.70e-01 | 5.15e-01 |
| GOMF OPSONIN RECEPTOR ACTIVITY | 5 | 1.52e-01 | -3.70e-01 | 5.15e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 10 | 4.30e-02 | -3.70e-01 | 3.07e-01 |
| GOBP MEGAKARYOCYTE DIFFERENTIATION | 36 | 1.26e-04 | -3.69e-01 | 1.36e-02 |
| GOCC PROTEASOME REGULATORY PARTICLE | 19 | 5.33e-03 | -3.69e-01 | 1.22e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING | 5 | 1.53e-01 | -3.69e-01 | 5.15e-01 |
| GOBP SYNAPTIC MEMBRANE ADHESION | 7 | 9.07e-02 | -3.69e-01 | 4.24e-01 |
| GOBP EMBRYONIC BODY MORPHOGENESIS | 7 | 9.09e-02 | -3.69e-01 | 4.24e-01 |
| GOBP POSITIVE REGULATION OF SULFUR METABOLIC PROCESS | 5 | 1.54e-01 | -3.69e-01 | 5.17e-01 |
| GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS | 7 | 9.19e-02 | -3.68e-01 | 4.24e-01 |
| GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS | 6 | 1.19e-01 | -3.68e-01 | 4.70e-01 |
| GOCC CATSPER COMPLEX | 5 | 1.55e-01 | -3.67e-01 | 5.20e-01 |
| GOBP ASTROCYTE DEVELOPMENT | 24 | 1.84e-03 | -3.67e-01 | 6.49e-02 |
| GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY | 5 | 1.55e-01 | -3.67e-01 | 5.20e-01 |
| GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION | 7 | 9.25e-02 | -3.67e-01 | 4.24e-01 |
| GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE | 7 | 9.26e-02 | -3.67e-01 | 4.25e-01 |
| GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 9.28e-02 | -3.67e-01 | 4.25e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION | 5 | 1.56e-01 | 3.66e-01 | 5.22e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS | 7 | 9.34e-02 | 3.66e-01 | 4.26e-01 |
| GOBP DORSAL VENTRAL AXIS SPECIFICATION | 5 | 1.56e-01 | -3.66e-01 | 5.22e-01 |
| GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 21 | 3.69e-03 | -3.66e-01 | 9.61e-02 |
| GOCC RESPIRATORY CHAIN COMPLEX IV | 19 | 5.77e-03 | -3.66e-01 | 1.28e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB | 10 | 4.52e-02 | 3.66e-01 | 3.12e-01 |
| GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY | 12 | 2.83e-02 | 3.66e-01 | 2.59e-01 |
| GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE | 8 | 7.33e-02 | -3.66e-01 | 3.91e-01 |
| GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS | 5 | 1.57e-01 | -3.65e-01 | 5.23e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS | 11 | 3.60e-02 | -3.65e-01 | 2.83e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 20 | 4.74e-03 | -3.65e-01 | 1.13e-01 |
| GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY | 5 | 1.58e-01 | -3.65e-01 | 5.24e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT | 14 | 1.83e-02 | -3.64e-01 | 2.11e-01 |
| GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 1.58e-01 | 3.64e-01 | 5.24e-01 |
| GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS | 6 | 1.22e-01 | -3.64e-01 | 4.75e-01 |
| GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS | 10 | 4.61e-02 | 3.64e-01 | 3.15e-01 |
| GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 8 | 7.47e-02 | -3.64e-01 | 3.94e-01 |
| GOBP POSITIVE REGULATION OF I KAPPAB PHOSPHORYLATION | 5 | 1.59e-01 | 3.64e-01 | 5.25e-01 |
| GOBP ACROSOME ASSEMBLY | 13 | 2.32e-02 | -3.64e-01 | 2.37e-01 |
| GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY | 23 | 2.61e-03 | 3.63e-01 | 7.87e-02 |
| GOBP RENAL FILTRATION | 7 | 9.69e-02 | 3.62e-01 | 4.34e-01 |
| GOBP POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 5 | 1.61e-01 | -3.62e-01 | 5.27e-01 |
| GOBP NEURAL CREST FORMATION | 8 | 7.62e-02 | 3.62e-01 | 3.96e-01 |
| GOBP PIRNA PROCESSING | 5 | 1.61e-01 | -3.62e-01 | 5.27e-01 |
| GOBP CYCLOOXYGENASE PATHWAY | 7 | 9.76e-02 | -3.62e-01 | 4.36e-01 |
| GOBP PULMONARY VALVE DEVELOPMENT | 11 | 3.79e-02 | -3.62e-01 | 2.93e-01 |
| GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR | 14 | 1.92e-02 | 3.61e-01 | 2.16e-01 |
| GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.62e-01 | 3.61e-01 | 5.28e-01 |
| GOBP POSITIVE REGULATION OF BLOOD PRESSURE | 7 | 9.90e-02 | -3.60e-01 | 4.39e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 6 | 1.27e-01 | -3.60e-01 | 4.83e-01 |
| GOCC INNER KINETOCHORE | 14 | 1.98e-02 | 3.60e-01 | 2.19e-01 |
| GOMF ISOCITRATE DEHYDROGENASE NAD P PLUS ACTIVITY | 5 | 1.64e-01 | 3.60e-01 | 5.29e-01 |
| GOMF URIDYLYLTRANSFERASE ACTIVITY | 7 | 9.98e-02 | 3.59e-01 | 4.41e-01 |
| GOMF RECEPTOR SERINE THREONINE KINASE BINDING | 10 | 4.93e-02 | -3.59e-01 | 3.22e-01 |
| GOBP MRNA PSEUDOURIDINE SYNTHESIS | 9 | 6.21e-02 | 3.59e-01 | 3.60e-01 |
| GOCC BRCA1 C COMPLEX | 6 | 1.28e-01 | 3.59e-01 | 4.85e-01 |
| GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS | 17 | 1.05e-02 | 3.59e-01 | 1.70e-01 |
| GOCC ENDOCYTIC VESICLE LUMEN | 11 | 3.96e-02 | -3.58e-01 | 2.97e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION | 7 | 1.01e-01 | 3.58e-01 | 4.44e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 7 | 1.01e-01 | -3.58e-01 | 4.44e-01 |
| GOBP PEXOPHAGY | 6 | 1.29e-01 | -3.58e-01 | 4.86e-01 |
| GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION | 6 | 1.29e-01 | -3.58e-01 | 4.86e-01 |
| GOBP CARDIOBLAST DIFFERENTIATION | 7 | 1.02e-01 | -3.57e-01 | 4.45e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 11 | 4.02e-02 | -3.57e-01 | 2.99e-01 |
| GOBP METANEPHRIC NEPHRON MORPHOGENESIS | 6 | 1.30e-01 | 3.57e-01 | 4.87e-01 |
| GOMF DIPHOSPHOTRANSFERASE ACTIVITY | 5 | 1.68e-01 | 3.56e-01 | 5.34e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION | 5 | 1.68e-01 | -3.56e-01 | 5.34e-01 |
| GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 6 | 1.31e-01 | -3.56e-01 | 4.88e-01 |
| GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION | 7 | 1.03e-01 | 3.56e-01 | 4.47e-01 |
| GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 16 | 1.37e-02 | -3.56e-01 | 1.89e-01 |
| GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX | 5 | 1.68e-01 | -3.56e-01 | 5.34e-01 |
| GOBP RRNA 5 END PROCESSING | 5 | 1.69e-01 | 3.56e-01 | 5.34e-01 |
| GOBP TETRAHYDROFOLATE METABOLIC PROCESS | 13 | 2.65e-02 | 3.55e-01 | 2.52e-01 |
| GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY | 7 | 1.04e-01 | -3.55e-01 | 4.49e-01 |
| GOMF COMPLEMENT RECEPTOR ACTIVITY | 7 | 1.04e-01 | -3.55e-01 | 4.49e-01 |
| GOCC AUTOLYSOSOME | 12 | 3.32e-02 | -3.55e-01 | 2.74e-01 |
| GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 8.21e-02 | -3.55e-01 | 4.09e-01 |
| GOCC HRD1P UBIQUITIN LIGASE ERAD L COMPLEX | 5 | 1.69e-01 | -3.55e-01 | 5.35e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 5 | 1.70e-01 | -3.55e-01 | 5.35e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 9 | 6.58e-02 | 3.54e-01 | 3.71e-01 |
| GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 9 | 6.59e-02 | -3.54e-01 | 3.71e-01 |
| GOBP CELLULAR RESPONSE TO SODIUM ARSENITE | 5 | 1.71e-01 | -3.54e-01 | 5.36e-01 |
| GOBP RESPONSE TO SODIUM ARSENITE | 5 | 1.71e-01 | -3.54e-01 | 5.36e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 6 | 1.34e-01 | -3.53e-01 | 4.92e-01 |
| GOMF DNA INSERTION OR DELETION BINDING | 6 | 1.34e-01 | 3.53e-01 | 4.93e-01 |
| GOBP RESPONSE TO INTERLEUKIN 17 | 12 | 3.43e-02 | -3.53e-01 | 2.77e-01 |
| GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 8 | 8.43e-02 | -3.53e-01 | 4.12e-01 |
| GOBP MAST CELL CYTOKINE PRODUCTION | 6 | 1.35e-01 | -3.52e-01 | 4.94e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 12 | 3.46e-02 | 3.52e-01 | 2.78e-01 |
| GOBP REGULATION OF HELICASE ACTIVITY | 11 | 4.31e-02 | 3.52e-01 | 3.07e-01 |
| GOMF MAP KINASE PHOSPHATASE ACTIVITY | 10 | 5.39e-02 | -3.52e-01 | 3.39e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 21 | 5.25e-03 | -3.52e-01 | 1.21e-01 |
| GOMF PROTEIN PHOSPHATASE ACTIVATOR ACTIVITY | 14 | 2.29e-02 | 3.51e-01 | 2.35e-01 |
| GOCC EKC KEOPS COMPLEX | 5 | 1.74e-01 | 3.51e-01 | 5.39e-01 |
| GOCC PRESYNAPTIC ENDOCYTIC ZONE | 6 | 1.36e-01 | -3.51e-01 | 4.94e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION | 10 | 5.45e-02 | 3.51e-01 | 3.40e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 6 | 1.36e-01 | -3.51e-01 | 4.94e-01 |
| GOBP MAST CELL MIGRATION | 9 | 6.83e-02 | -3.51e-01 | 3.77e-01 |
| GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY | 6 | 1.37e-01 | -3.51e-01 | 4.95e-01 |
| GOBP RESPONSE TO VITAMIN D | 16 | 1.54e-02 | -3.50e-01 | 1.98e-01 |
| GOBP ENDOSOMAL LUMEN ACIDIFICATION | 13 | 2.90e-02 | -3.50e-01 | 2.61e-01 |
| GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS | 5 | 1.76e-01 | -3.49e-01 | 5.43e-01 |
| GOBP AMP BIOSYNTHETIC PROCESS | 11 | 4.49e-02 | 3.49e-01 | 3.12e-01 |
| GOBP TRNA TRANSPORT | 5 | 1.76e-01 | -3.49e-01 | 5.43e-01 |
| GOBP HEME TRANSPORT | 6 | 1.39e-01 | -3.49e-01 | 4.97e-01 |
| GOBP IRON COORDINATION ENTITY TRANSPORT | 6 | 1.39e-01 | -3.49e-01 | 4.97e-01 |
| GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.39e-01 | -3.49e-01 | 4.97e-01 |
| GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY | 16 | 1.57e-02 | -3.49e-01 | 1.98e-01 |
| GOBP S ADENOSYLMETHIONINE CYCLE | 7 | 1.10e-01 | 3.49e-01 | 4.56e-01 |
| GOBP DETERMINATION OF ADULT LIFESPAN | 20 | 7.00e-03 | 3.48e-01 | 1.43e-01 |
| GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 7 | 1.11e-01 | -3.48e-01 | 4.57e-01 |
| GOBP SEMI LUNAR VALVE DEVELOPMENT | 18 | 1.07e-02 | -3.48e-01 | 1.71e-01 |
| GOBP CENTROSOME SEPARATION | 11 | 4.59e-02 | -3.48e-01 | 3.15e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 24 | 3.23e-03 | -3.47e-01 | 9.02e-02 |
| GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION | 5 | 1.79e-01 | -3.47e-01 | 5.47e-01 |
| GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY | 8 | 8.91e-02 | -3.47e-01 | 4.22e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 16 | 1.62e-02 | -3.47e-01 | 2.00e-01 |
| GOBP MITOTIC RECOMBINATION | 20 | 7.22e-03 | 3.47e-01 | 1.45e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 7 | 1.12e-01 | -3.47e-01 | 4.58e-01 |
| GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 12 | 3.75e-02 | -3.47e-01 | 2.91e-01 |
| GOBP CELLULAR RESPONSE TO ANTIBIOTIC | 11 | 4.64e-02 | -3.47e-01 | 3.15e-01 |
| GOBP LEFT RIGHT AXIS SPECIFICATION | 6 | 1.42e-01 | 3.47e-01 | 5.01e-01 |
| GOBP CYTOPLASMIC TRANSLATION | 144 | 7.66e-13 | -3.47e-01 | 6.22e-09 |
| GOMF NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY | 6 | 1.42e-01 | 3.46e-01 | 5.02e-01 |
| GOBP GANGLIOSIDE CATABOLIC PROCESS | 6 | 1.42e-01 | -3.46e-01 | 5.02e-01 |
| GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY | 9 | 7.25e-02 | -3.46e-01 | 3.89e-01 |
| GOBP KILLING BY HOST OF SYMBIONT CELLS | 9 | 7.28e-02 | -3.45e-01 | 3.90e-01 |
| GOBP HEART FORMATION | 10 | 5.86e-02 | -3.45e-01 | 3.53e-01 |
| GOBP TRNA METHYLATION | 40 | 1.59e-04 | 3.45e-01 | 1.56e-02 |
| GOBP RESPONSE TO CORTICOSTERONE | 5 | 1.81e-01 | 3.45e-01 | 5.49e-01 |
| GOCC BRISC COMPLEX | 6 | 1.43e-01 | 3.45e-01 | 5.05e-01 |
| GOMF ACYLGLYCEROL LIPASE ACTIVITY | 11 | 4.76e-02 | -3.45e-01 | 3.18e-01 |
| GOBP OLIGOSACCHARIDE CATABOLIC PROCESS | 12 | 3.86e-02 | -3.45e-01 | 2.95e-01 |
| GOBP PEPTIDYL LYSINE HYDROXYLATION | 5 | 1.82e-01 | 3.45e-01 | 5.50e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 9.14e-02 | -3.45e-01 | 4.24e-01 |
| GOBP CD40 SIGNALING PATHWAY | 12 | 3.87e-02 | -3.45e-01 | 2.95e-01 |
| GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY | 7 | 1.15e-01 | -3.44e-01 | 4.61e-01 |
| GOBP POSITIVE REGULATION OF ERAD PATHWAY | 12 | 3.90e-02 | -3.44e-01 | 2.97e-01 |
| GOMF JUN KINASE BINDING | 8 | 9.20e-02 | -3.44e-01 | 4.24e-01 |
| GOBP NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT | 6 | 1.44e-01 | -3.44e-01 | 5.05e-01 |
| GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX | 12 | 3.92e-02 | 3.44e-01 | 2.97e-01 |
| GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 12 | 3.92e-02 | -3.44e-01 | 2.97e-01 |
| GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 20 | 7.78e-03 | -3.44e-01 | 1.50e-01 |
| GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.83e-01 | -3.44e-01 | 5.53e-01 |
| GOCC RIPOPTOSOME | 6 | 1.45e-01 | -3.44e-01 | 5.05e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 5 | 1.83e-01 | -3.44e-01 | 5.53e-01 |
| GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE | 12 | 3.94e-02 | -3.43e-01 | 2.97e-01 |
| GOMF CERAMIDE BINDING | 12 | 3.95e-02 | -3.43e-01 | 2.97e-01 |
| GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION | 10 | 6.03e-02 | -3.43e-01 | 3.57e-01 |
| GOBP RRNA MODIFICATION | 30 | 1.15e-03 | 3.43e-01 | 5.05e-02 |
| GOBP BODY MORPHOGENESIS | 25 | 3.04e-03 | -3.43e-01 | 8.64e-02 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY | 34 | 5.54e-04 | -3.42e-01 | 3.22e-02 |
| GOCC CYTOSOLIC RIBOSOME | 109 | 6.98e-10 | -3.42e-01 | 2.84e-06 |
| GOBP WYBUTOSINE METABOLIC PROCESS | 5 | 1.86e-01 | 3.42e-01 | 5.54e-01 |
| GOBP REGULATION OF PROTEIN NEDDYLATION | 18 | 1.21e-02 | -3.42e-01 | 1.78e-01 |
| GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS | 14 | 2.71e-02 | 3.41e-01 | 2.55e-01 |
| GOBP TRACHEA DEVELOPMENT | 10 | 6.19e-02 | -3.41e-01 | 3.60e-01 |
| GOBP UDP GLUCOSE METABOLIC PROCESS | 6 | 1.48e-01 | 3.41e-01 | 5.10e-01 |
| GOCC MISMATCH REPAIR COMPLEX | 7 | 1.19e-01 | 3.41e-01 | 4.69e-01 |
| GOBP CELLULAR RESPONSE TO COLD | 8 | 9.53e-02 | -3.41e-01 | 4.31e-01 |
| GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION | 6 | 1.49e-01 | -3.41e-01 | 5.10e-01 |
| GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX | 9 | 7.72e-02 | -3.40e-01 | 3.98e-01 |
| GOBP MOTOR NEURON AXON GUIDANCE | 7 | 1.20e-01 | 3.39e-01 | 4.72e-01 |
| GOBP FIBRINOLYSIS | 9 | 7.81e-02 | -3.39e-01 | 4.00e-01 |
| GOBP ASPARTATE TRANSMEMBRANE TRANSPORT | 10 | 6.35e-02 | 3.39e-01 | 3.64e-01 |
| GOBP EPITHELIAL STRUCTURE MAINTENANCE | 12 | 4.22e-02 | -3.39e-01 | 3.05e-01 |
| GOBP INTESTINAL LIPID ABSORPTION | 7 | 1.21e-01 | -3.39e-01 | 4.74e-01 |
| GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM | 16 | 1.91e-02 | -3.38e-01 | 2.15e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION | 6 | 1.52e-01 | -3.38e-01 | 5.15e-01 |
| GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 8 | 9.81e-02 | 3.38e-01 | 4.37e-01 |
| GOBP AMELOGENESIS | 11 | 5.25e-02 | -3.38e-01 | 3.33e-01 |
| GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 7 | 1.23e-01 | -3.37e-01 | 4.76e-01 |
| GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 8 | 9.91e-02 | 3.37e-01 | 4.39e-01 |
| GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME | 11 | 5.32e-02 | 3.37e-01 | 3.36e-01 |
| GOBP IMMUNOGLOBULIN V D J RECOMBINATION | 8 | 9.92e-02 | 3.37e-01 | 4.39e-01 |
| GOBP REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE | 16 | 2.00e-02 | -3.36e-01 | 2.21e-01 |
| GOMF G PROTEIN ACTIVITY | 31 | 1.21e-03 | -3.36e-01 | 5.17e-02 |
| GOBP MEGAKARYOCYTE DEVELOPMENT | 17 | 1.65e-02 | -3.36e-01 | 2.03e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 11 | 5.39e-02 | 3.36e-01 | 3.39e-01 |
| GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION | 13 | 3.62e-02 | -3.36e-01 | 2.84e-01 |
| GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY | 5 | 1.94e-01 | 3.35e-01 | 5.67e-01 |
| GOBP GANGLIOSIDE METABOLIC PROCESS | 22 | 6.52e-03 | -3.35e-01 | 1.37e-01 |
| GOMF FLAP ENDONUCLEASE ACTIVITY | 5 | 1.95e-01 | -3.35e-01 | 5.67e-01 |
| GOBP MICROVILLUS ORGANIZATION | 18 | 1.40e-02 | -3.35e-01 | 1.91e-01 |
| GOBP VITAMIN D METABOLIC PROCESS | 7 | 1.26e-01 | -3.34e-01 | 4.82e-01 |
| GOBP REGULATION OF POSITIVE CHEMOTAXIS | 7 | 1.26e-01 | -3.34e-01 | 4.83e-01 |
| GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION | 8 | 1.02e-01 | -3.34e-01 | 4.46e-01 |
| GOBP POSITIVE REGULATION OF VASCULOGENESIS | 6 | 1.57e-01 | -3.33e-01 | 5.23e-01 |
| GOBP REGULATION OF VASCULOGENESIS | 6 | 1.57e-01 | -3.33e-01 | 5.23e-01 |
| GOCC DOPAMINERGIC SYNAPSE | 5 | 1.97e-01 | -3.33e-01 | 5.70e-01 |
| GOBP MYOTUBE CELL DEVELOPMENT | 19 | 1.19e-02 | 3.33e-01 | 1.77e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING | 8 | 1.03e-01 | 3.33e-01 | 4.47e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 9 | 8.34e-02 | -3.33e-01 | 4.10e-01 |
| GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE | 7 | 1.27e-01 | 3.33e-01 | 4.83e-01 |
| GOCC MMXD COMPLEX | 5 | 1.97e-01 | 3.33e-01 | 5.71e-01 |
| GOCC AXON INITIAL SEGMENT | 6 | 1.58e-01 | 3.33e-01 | 5.24e-01 |
| GOMF PROTON CHANNEL ACTIVITY | 18 | 1.46e-02 | -3.32e-01 | 1.95e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSLOCATION | 5 | 1.98e-01 | 3.32e-01 | 5.72e-01 |
| GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY | 5 | 1.98e-01 | 3.32e-01 | 5.72e-01 |
| GOCC MEIOTIC COHESIN COMPLEX | 6 | 1.59e-01 | -3.32e-01 | 5.25e-01 |
| GOCC HIGH DENSITY LIPOPROTEIN PARTICLE | 6 | 1.59e-01 | 3.32e-01 | 5.25e-01 |
| GOMF ADENYLATE CYCLASE BINDING | 6 | 1.59e-01 | 3.32e-01 | 5.25e-01 |
| GOBP HEAD MORPHOGENESIS | 18 | 1.48e-02 | -3.32e-01 | 1.95e-01 |
| GOMF C2H2 ZINC FINGER DOMAIN BINDING | 8 | 1.04e-01 | -3.32e-01 | 4.50e-01 |
| GOCC THO COMPLEX | 6 | 1.60e-01 | 3.32e-01 | 5.25e-01 |
| GOBP RESPONSE TO FATTY ACID | 32 | 1.18e-03 | -3.31e-01 | 5.14e-02 |
| GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 6 | 1.60e-01 | 3.31e-01 | 5.25e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING | 5 | 2.00e-01 | 3.31e-01 | 5.75e-01 |
| GOBP REGULATION OF PIGMENTATION | 9 | 8.57e-02 | -3.31e-01 | 4.15e-01 |
| GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION | 5 | 2.00e-01 | -3.31e-01 | 5.75e-01 |
| GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 20 | 1.05e-02 | -3.30e-01 | 1.70e-01 |
| GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 11 | 5.83e-02 | -3.30e-01 | 3.52e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 5 | 2.02e-01 | 3.30e-01 | 5.77e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION | 5 | 2.02e-01 | -3.29e-01 | 5.78e-01 |
| GOBP BASIC AMINO ACID TRANSPORT | 12 | 4.82e-02 | -3.29e-01 | 3.20e-01 |
| GOBP RAP PROTEIN SIGNAL TRANSDUCTION | 11 | 5.86e-02 | -3.29e-01 | 3.53e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 16 | 2.26e-02 | 3.29e-01 | 2.35e-01 |
| GOBP RESPONSE TO LIPOTEICHOIC ACID | 8 | 1.07e-01 | -3.29e-01 | 4.52e-01 |
| GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 8 | 1.07e-01 | 3.29e-01 | 4.52e-01 |
| GOCC MITOCHONDRIAL PYRUVATE DEHYDROGENASE COMPLEX | 7 | 1.32e-01 | 3.29e-01 | 4.89e-01 |
| GOBP BEHAVIORAL RESPONSE TO COCAINE | 7 | 1.32e-01 | 3.29e-01 | 4.89e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION | 5 | 2.03e-01 | 3.29e-01 | 5.79e-01 |
| GOBP GDP MANNOSE METABOLIC PROCESS | 6 | 1.64e-01 | 3.28e-01 | 5.29e-01 |
| GOBP DIGESTIVE TRACT MORPHOGENESIS | 12 | 4.92e-02 | -3.28e-01 | 3.22e-01 |
| GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION | 13 | 4.07e-02 | -3.28e-01 | 3.01e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY | 11 | 6.00e-02 | -3.28e-01 | 3.57e-01 |
| GOBP PROTEIN AUTO ADP RIBOSYLATION | 11 | 6.00e-02 | 3.28e-01 | 3.57e-01 |
| GOBP SEQUESTERING OF METAL ION | 8 | 1.09e-01 | -3.27e-01 | 4.54e-01 |
| GOBP ENDOCRINE PROCESS | 31 | 1.61e-03 | -3.27e-01 | 6.17e-02 |
| GOBP RESPONSE TO ETHER | 10 | 7.32e-02 | -3.27e-01 | 3.91e-01 |
| GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 14 | 3.42e-02 | -3.27e-01 | 2.77e-01 |
| GOCC PARANODE REGION OF AXON | 5 | 2.06e-01 | -3.27e-01 | 5.82e-01 |
| GOBP INTEGRIN ACTIVATION | 11 | 6.09e-02 | -3.26e-01 | 3.59e-01 |
| GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION | 7 | 1.35e-01 | 3.26e-01 | 4.94e-01 |
| GOMF NAD RETINOL DEHYDROGENASE ACTIVITY | 6 | 1.67e-01 | -3.26e-01 | 5.34e-01 |
| GOBP FREE UBIQUITIN CHAIN POLYMERIZATION | 6 | 1.67e-01 | -3.26e-01 | 5.34e-01 |
| GOBP BRANCH ELONGATION OF AN EPITHELIUM | 5 | 2.08e-01 | -3.25e-01 | 5.83e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 5 | 2.08e-01 | -3.25e-01 | 5.83e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 7 | 1.36e-01 | 3.25e-01 | 4.94e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION | 5 | 2.08e-01 | 3.25e-01 | 5.83e-01 |
| GOBP FOREGUT MORPHOGENESIS | 5 | 2.08e-01 | -3.25e-01 | 5.83e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 20 | 1.19e-02 | -3.25e-01 | 1.77e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 29 | 2.48e-03 | -3.25e-01 | 7.73e-02 |
| GOCC INTRACILIARY TRANSPORT PARTICLE A | 7 | 1.37e-01 | 3.24e-01 | 4.95e-01 |
| GOBP DNA REPLICATION CHECKPOINT SIGNALING | 9 | 9.23e-02 | 3.24e-01 | 4.24e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 10 | 7.62e-02 | -3.24e-01 | 3.96e-01 |
| GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION | 5 | 2.10e-01 | -3.24e-01 | 5.85e-01 |
| GOMF PHOSPHOSERINE RESIDUE BINDING | 10 | 7.63e-02 | 3.24e-01 | 3.96e-01 |
| GOBP GMP BIOSYNTHETIC PROCESS | 13 | 4.34e-02 | 3.24e-01 | 3.08e-01 |
| GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 15 | 3.01e-02 | -3.23e-01 | 2.64e-01 |
| GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION | 5 | 2.10e-01 | -3.23e-01 | 5.85e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY | 6 | 1.70e-01 | 3.23e-01 | 5.36e-01 |
| GOBP POLYADENYLATION DEPENDENT RNA CATABOLIC PROCESS | 8 | 1.14e-01 | 3.23e-01 | 4.61e-01 |
| GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY | 21 | 1.05e-02 | -3.23e-01 | 1.70e-01 |
| GOBP RAB PROTEIN SIGNAL TRANSDUCTION | 19 | 1.49e-02 | -3.23e-01 | 1.95e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY | 7 | 1.39e-01 | -3.23e-01 | 4.98e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 9 | 9.38e-02 | 3.23e-01 | 4.27e-01 |
| GOBP UV PROTECTION | 8 | 1.14e-01 | 3.23e-01 | 4.61e-01 |
| GOBP UBIQUITIN RECYCLING | 10 | 7.76e-02 | -3.22e-01 | 3.99e-01 |
| GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 13 | 4.42e-02 | -3.22e-01 | 3.10e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 7 | 1.40e-01 | 3.22e-01 | 4.99e-01 |
| GOCC CORVET COMPLEX | 7 | 1.40e-01 | 3.22e-01 | 5.00e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR | 10 | 7.83e-02 | -3.22e-01 | 4.00e-01 |
| GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 8 | 1.15e-01 | -3.22e-01 | 4.63e-01 |
| GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 8 | 1.16e-01 | -3.21e-01 | 4.64e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION | 5 | 2.14e-01 | -3.21e-01 | 5.90e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 18 | 1.85e-02 | -3.21e-01 | 2.12e-01 |
| GOBP NUCLEOLAR CHROMATIN ORGANIZATION | 9 | 9.57e-02 | 3.21e-01 | 4.32e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C | 12 | 5.45e-02 | -3.21e-01 | 3.40e-01 |
| GOBP ESTABLISHMENT OF SPINDLE ORIENTATION | 24 | 6.56e-03 | -3.21e-01 | 1.37e-01 |
| GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 30 | 2.41e-03 | -3.20e-01 | 7.60e-02 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL MIGRATION | 5 | 2.16e-01 | -3.19e-01 | 5.94e-01 |
| GOBP SEROTONIN METABOLIC PROCESS | 5 | 2.17e-01 | -3.19e-01 | 5.94e-01 |
| GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY | 7 | 1.44e-01 | -3.19e-01 | 5.05e-01 |
| GOMF 3 5 DNA HELICASE ACTIVITY | 12 | 5.62e-02 | 3.18e-01 | 3.46e-01 |
| GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 6 | 1.77e-01 | -3.18e-01 | 5.44e-01 |
| GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING | 22 | 9.81e-03 | -3.18e-01 | 1.66e-01 |
| GOBP THYROID GLAND DEVELOPMENT | 14 | 3.95e-02 | -3.18e-01 | 2.97e-01 |
| GOBP AUTOCRINE SIGNALING | 5 | 2.18e-01 | -3.18e-01 | 5.95e-01 |
| GOBP CELLULAR RESPONSE TO NICOTINE | 5 | 2.18e-01 | -3.18e-01 | 5.95e-01 |
| GOBP EPIBOLY | 23 | 8.39e-03 | -3.18e-01 | 1.52e-01 |
| GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX | 6 | 1.78e-01 | 3.18e-01 | 5.46e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION | 6 | 1.78e-01 | -3.17e-01 | 5.46e-01 |
| GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY | 10 | 8.24e-02 | -3.17e-01 | 4.09e-01 |
| GOBP RESPONSE TO MANGANESE ION | 15 | 3.35e-02 | -3.17e-01 | 2.75e-01 |
| GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY | 6 | 1.80e-01 | -3.16e-01 | 5.48e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 15 | 3.40e-02 | -3.16e-01 | 2.77e-01 |
| GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX | 11 | 6.95e-02 | -3.16e-01 | 3.81e-01 |
| GOBP REGULATION OF RIBONUCLEASE ACTIVITY | 8 | 1.22e-01 | 3.16e-01 | 4.75e-01 |
| GOBP RNA GUANINE N7 METHYLATION | 6 | 1.80e-01 | 3.16e-01 | 5.48e-01 |
| GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION | 16 | 2.89e-02 | -3.16e-01 | 2.60e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 26 | 5.37e-03 | -3.16e-01 | 1.22e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 5 | 2.22e-01 | -3.15e-01 | 5.97e-01 |
| GOBP GLUTAMATE SECRETION | 13 | 4.90e-02 | 3.15e-01 | 3.22e-01 |
| GOBP GUANINE NUCLEOTIDE TRANSPORT | 8 | 1.23e-01 | 3.15e-01 | 4.76e-01 |
| GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 6 | 1.81e-01 | -3.15e-01 | 5.49e-01 |
| GOMF RDNA BINDING | 9 | 1.02e-01 | 3.15e-01 | 4.46e-01 |
| GOMF SNORNA BINDING | 32 | 2.10e-03 | 3.14e-01 | 6.99e-02 |
| GOBP RESPONSE TO AMINE | 20 | 1.50e-02 | 3.14e-01 | 1.96e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION | 5 | 2.24e-01 | -3.14e-01 | 6.00e-01 |
| GOCC BBSOME | 7 | 1.51e-01 | 3.14e-01 | 5.13e-01 |
| GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 6 | 1.84e-01 | -3.14e-01 | 5.53e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS | 8 | 1.25e-01 | -3.13e-01 | 4.81e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 28 | 4.11e-03 | 3.13e-01 | 1.02e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION | 15 | 3.59e-02 | -3.13e-01 | 2.83e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 17 | 2.55e-02 | -3.13e-01 | 2.46e-01 |
| GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY | 5 | 2.26e-01 | -3.13e-01 | 6.01e-01 |
| GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS | 7 | 1.52e-01 | 3.13e-01 | 5.15e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN | 24 | 8.12e-03 | 3.12e-01 | 1.52e-01 |
| GOBP GLYCOSPHINGOLIPID CATABOLIC PROCESS | 10 | 8.77e-02 | -3.12e-01 | 4.19e-01 |
| GOBP MYOFIBROBLAST DIFFERENTIATION | 8 | 1.27e-01 | -3.12e-01 | 4.83e-01 |
| GOBP HYPOTHALAMUS DEVELOPMENT | 9 | 1.05e-01 | -3.12e-01 | 4.50e-01 |
| GOMF DEATH DOMAIN BINDING | 10 | 8.79e-02 | -3.12e-01 | 4.19e-01 |
| GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY | 17 | 2.62e-02 | -3.12e-01 | 2.50e-01 |
| GOMF TRNA CYTOSINE METHYLTRANSFERASE ACTIVITY | 9 | 1.06e-01 | 3.12e-01 | 4.51e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 20 | 1.59e-02 | -3.11e-01 | 1.98e-01 |
| GOBP UV DAMAGE EXCISION REPAIR | 11 | 7.38e-02 | 3.11e-01 | 3.93e-01 |
| GOMF N6 METHYLADENOSINE CONTAINING RNA BINDING | 9 | 1.06e-01 | -3.11e-01 | 4.51e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 17 | 2.64e-02 | -3.11e-01 | 2.51e-01 |
| GOBP RESPONSE TO SORBITOL | 5 | 2.28e-01 | -3.11e-01 | 6.05e-01 |
| GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 5 | 2.29e-01 | 3.11e-01 | 6.06e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 24 | 8.46e-03 | -3.11e-01 | 1.53e-01 |
| GOCC HOPS COMPLEX | 9 | 1.07e-01 | 3.11e-01 | 4.52e-01 |
| GOCC OUTER KINETOCHORE | 8 | 1.29e-01 | 3.10e-01 | 4.85e-01 |
| GOMF MYOSIN II BINDING | 6 | 1.88e-01 | 3.10e-01 | 5.59e-01 |
| GOCC CKM COMPLEX | 5 | 2.31e-01 | -3.10e-01 | 6.08e-01 |
| GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER | 17 | 2.72e-02 | 3.09e-01 | 2.55e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 8 | 1.30e-01 | 3.09e-01 | 4.87e-01 |
| GOBP NADH METABOLIC PROCESS | 6 | 1.90e-01 | -3.09e-01 | 5.60e-01 |
| GOCC PROCENTRIOLE REPLICATION COMPLEX | 5 | 2.31e-01 | 3.09e-01 | 6.09e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION | 5 | 2.31e-01 | -3.09e-01 | 6.09e-01 |
| GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE | 6 | 1.90e-01 | 3.09e-01 | 5.61e-01 |
| GOMF MISMATCH REPAIR COMPLEX BINDING | 10 | 9.10e-02 | 3.09e-01 | 4.24e-01 |
| GOMF CYCLOHYDROLASE ACTIVITY | 5 | 2.32e-01 | 3.09e-01 | 6.09e-01 |
| GOBP MICROVILLUS ASSEMBLY | 16 | 3.27e-02 | -3.09e-01 | 2.72e-01 |
| GOBP DENDRITE SELF AVOIDANCE | 5 | 2.32e-01 | -3.08e-01 | 6.10e-01 |
| GOBP INTERMEDIATE FILAMENT ORGANIZATION | 8 | 1.31e-01 | -3.08e-01 | 4.88e-01 |
| GOBP FEMALE GENITALIA DEVELOPMENT | 7 | 1.58e-01 | -3.08e-01 | 5.25e-01 |
| GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 11 | 7.73e-02 | 3.08e-01 | 3.98e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE | 33 | 2.23e-03 | -3.08e-01 | 7.28e-02 |
| GOBP REGULATION OF DENDRITE EXTENSION | 14 | 4.63e-02 | -3.08e-01 | 3.15e-01 |
| GOMF AMIDINE LYASE ACTIVITY | 5 | 2.34e-01 | 3.07e-01 | 6.12e-01 |
| GOBP REGULATION OF T CELL EXTRAVASATION | 5 | 2.34e-01 | 3.07e-01 | 6.12e-01 |
| GOBP 4FE 4S CLUSTER ASSEMBLY | 5 | 2.34e-01 | 3.07e-01 | 6.12e-01 |
| GOCC ESCRT I COMPLEX | 10 | 9.29e-02 | -3.07e-01 | 4.25e-01 |
| GOCC CMG COMPLEX | 5 | 2.35e-01 | 3.07e-01 | 6.12e-01 |
| GOBP OSTEOBLAST DEVELOPMENT | 5 | 2.35e-01 | -3.07e-01 | 6.12e-01 |
| GOBP LAMELLIPODIUM MORPHOGENESIS | 14 | 4.71e-02 | -3.07e-01 | 3.17e-01 |
| GOBP HEAT GENERATION | 10 | 9.35e-02 | -3.06e-01 | 4.26e-01 |
| GOBP GLOMERULAR MESANGIUM DEVELOPMENT | 6 | 1.94e-01 | 3.06e-01 | 5.67e-01 |
| GOBP ASTROCYTE DIFFERENTIATION | 45 | 3.87e-04 | -3.06e-01 | 2.66e-02 |
| GOMF UBIQUITIN SPECIFIC PROTEASE BINDING | 18 | 2.47e-02 | -3.06e-01 | 2.43e-01 |
| GOBP BRANCHED CHAIN AMINO ACID TRANSPORT | 8 | 1.34e-01 | -3.06e-01 | 4.93e-01 |
| GOBP REGULATION OF CELL CYCLE CHECKPOINT | 36 | 1.51e-03 | 3.06e-01 | 5.98e-02 |
| GOBP REGULATION OF VESICLE SIZE | 18 | 2.48e-02 | -3.06e-01 | 2.43e-01 |
| GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 9 | 1.12e-01 | -3.06e-01 | 4.59e-01 |
| GOBP SIALYLATION | 5 | 2.37e-01 | -3.05e-01 | 6.14e-01 |
| GOMF SODIUM CHANNEL REGULATOR ACTIVITY | 15 | 4.06e-02 | 3.05e-01 | 3.01e-01 |
| GOBP L ARGININE TRANSMEMBRANE TRANSPORT | 9 | 1.13e-01 | -3.05e-01 | 4.60e-01 |
| GOBP CYCLIC NUCLEOTIDE TRANSPORT | 8 | 1.35e-01 | 3.05e-01 | 4.94e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN STARVATION | 9 | 1.13e-01 | -3.05e-01 | 4.61e-01 |
| GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 10 | 9.49e-02 | -3.05e-01 | 4.30e-01 |
| GOBP NEGATIVE REGULATION OF RESPIRATORY BURST | 5 | 2.38e-01 | 3.05e-01 | 6.16e-01 |
| GOMF GLUTATHIONE TRANSFERASE ACTIVITY | 15 | 4.09e-02 | -3.05e-01 | 3.01e-01 |
| GOBP TRANSCYTOSIS | 15 | 4.10e-02 | -3.05e-01 | 3.01e-01 |
| GOBP DNA REPLICATION SYNTHESIS OF RNA PRIMER | 7 | 1.63e-01 | 3.05e-01 | 5.28e-01 |
| GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY | 8 | 1.36e-01 | -3.05e-01 | 4.94e-01 |
| GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING | 8 | 1.36e-01 | 3.04e-01 | 4.94e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 9 | 1.15e-01 | -3.04e-01 | 4.61e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE B | 14 | 4.93e-02 | 3.04e-01 | 3.22e-01 |
| GOBP RESPONSE TO VITAMIN A | 5 | 2.40e-01 | -3.04e-01 | 6.17e-01 |
| GOBP ANATOMICAL STRUCTURE ARRANGEMENT | 6 | 1.98e-01 | -3.04e-01 | 5.72e-01 |
| GOBP DENDRITIC CELL APOPTOTIC PROCESS | 9 | 1.15e-01 | -3.04e-01 | 4.62e-01 |
| GOBP PHAGOSOME LYSOSOME FUSION | 11 | 8.15e-02 | -3.03e-01 | 4.09e-01 |
| GOCC AXONAL GROWTH CONE | 15 | 4.20e-02 | 3.03e-01 | 3.04e-01 |
| GOBP MITOCHONDRIAL GENOME MAINTENANCE | 26 | 7.48e-03 | 3.03e-01 | 1.47e-01 |
| GOBP VISUAL BEHAVIOR | 27 | 6.43e-03 | -3.03e-01 | 1.36e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION | 8 | 1.38e-01 | 3.03e-01 | 4.97e-01 |
| GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY | 8 | 1.38e-01 | -3.03e-01 | 4.97e-01 |
| GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT | 6 | 2.00e-01 | 3.02e-01 | 5.75e-01 |
| GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS | 9 | 1.17e-01 | -3.02e-01 | 4.65e-01 |
| GOCC GAMMA TUBULIN RING COMPLEX | 7 | 1.66e-01 | 3.02e-01 | 5.34e-01 |
| GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION | 6 | 2.00e-01 | -3.02e-01 | 5.75e-01 |
| GOBP SYNAPTIC VESICLE BUDDING | 7 | 1.67e-01 | -3.02e-01 | 5.34e-01 |
| GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY | 8 | 1.39e-01 | -3.02e-01 | 4.98e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 16 | 3.67e-02 | -3.02e-01 | 2.86e-01 |
| GOBP RESPONSE TO GLUCAGON | 8 | 1.40e-01 | -3.02e-01 | 4.99e-01 |
| GOBP NUCLEOPHAGY | 17 | 3.14e-02 | -3.02e-01 | 2.67e-01 |
| GOBP LYSOSOMAL MICROAUTOPHAGY | 11 | 8.34e-02 | -3.02e-01 | 4.10e-01 |
| GOBP CYTOPLASM ORGANIZATION | 8 | 1.40e-01 | -3.01e-01 | 4.99e-01 |
| GOBP LEUCINE METABOLIC PROCESS | 7 | 1.68e-01 | 3.01e-01 | 5.34e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN | 23 | 1.26e-02 | -3.01e-01 | 1.82e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION | 25 | 9.28e-03 | -3.01e-01 | 1.59e-01 |
| GOBP KYNURENINE METABOLIC PROCESS | 8 | 1.41e-01 | 3.01e-01 | 5.00e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 17 | 3.21e-02 | -3.00e-01 | 2.70e-01 |
| GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING | 6 | 2.03e-01 | 3.00e-01 | 5.78e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 6 | 2.03e-01 | -3.00e-01 | 5.78e-01 |
| GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS | 8 | 1.41e-01 | -3.00e-01 | 5.01e-01 |
| GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 7 | 1.69e-01 | 3.00e-01 | 5.35e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION | 5 | 2.45e-01 | -3.00e-01 | 6.22e-01 |
| GOBP HEART TRABECULA FORMATION | 5 | 2.45e-01 | -3.00e-01 | 6.22e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 11 | 8.48e-02 | -3.00e-01 | 4.12e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 2.45e-01 | 3.00e-01 | 6.22e-01 |
| GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST | 12 | 7.20e-02 | -3.00e-01 | 3.88e-01 |
| GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT | 13 | 6.12e-02 | -3.00e-01 | 3.60e-01 |
| GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY | 5 | 2.46e-01 | -3.00e-01 | 6.22e-01 |
| GOMF TELOMERASE ACTIVITY | 5 | 2.46e-01 | -3.00e-01 | 6.22e-01 |
| GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 10 | 1.01e-01 | -3.00e-01 | 4.44e-01 |
| GOMF HISTONE READER ACTIVITY | 11 | 8.52e-02 | 3.00e-01 | 4.13e-01 |
| GOCC COP9 SIGNALOSOME | 14 | 5.23e-02 | -3.00e-01 | 3.33e-01 |
| GOMF PHOSPHATIDIC ACID BINDING | 17 | 3.26e-02 | 3.00e-01 | 2.71e-01 |
| GOBP COCHLEA MORPHOGENESIS | 5 | 2.47e-01 | 2.99e-01 | 6.23e-01 |
| GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 5 | 2.47e-01 | -2.99e-01 | 6.23e-01 |
| GOMF UNMETHYLATED CPG BINDING | 9 | 1.20e-01 | -2.99e-01 | 4.73e-01 |
| GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY | 11 | 8.59e-02 | 2.99e-01 | 4.15e-01 |
| GOBP SNRNA MODIFICATION | 7 | 1.71e-01 | 2.99e-01 | 5.36e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX | 14 | 5.29e-02 | -2.99e-01 | 3.35e-01 |
| GOBP CELLULAR RESPONSE TO ATP | 14 | 5.30e-02 | -2.99e-01 | 3.36e-01 |
| GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE | 20 | 2.08e-02 | -2.99e-01 | 2.25e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION | 8 | 1.44e-01 | 2.98e-01 | 5.05e-01 |
| GOBP NEUROEPITHELIAL CELL DIFFERENTIATION | 13 | 6.27e-02 | -2.98e-01 | 3.62e-01 |
| GOBP RESPONSE TO PEPTIDOGLYCAN | 9 | 1.21e-01 | -2.98e-01 | 4.75e-01 |
| GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING | 8 | 1.44e-01 | -2.98e-01 | 5.05e-01 |
| GOBP PURINE RIBONUCLEOSIDE SALVAGE | 6 | 2.06e-01 | 2.98e-01 | 5.82e-01 |
| GOBP REGULATION OF GLIAL CELL DIFFERENTIATION | 30 | 4.73e-03 | -2.98e-01 | 1.13e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 13 | 6.28e-02 | 2.98e-01 | 3.63e-01 |
| GOBP CENTRIOLE ELONGATION | 8 | 1.44e-01 | 2.98e-01 | 5.05e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY | 20 | 2.11e-02 | -2.98e-01 | 2.25e-01 |
| GOBP REGULATION OF FEEDING BEHAVIOR | 9 | 1.22e-01 | 2.98e-01 | 4.75e-01 |
| GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX | 8 | 1.45e-01 | -2.98e-01 | 5.06e-01 |
| GOMF MUTLALPHA COMPLEX BINDING | 6 | 2.07e-01 | 2.98e-01 | 5.82e-01 |
| GOMF PSEUDOURIDINE SYNTHASE ACTIVITY | 13 | 6.35e-02 | 2.97e-01 | 3.64e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO FOOD | 5 | 2.50e-01 | -2.97e-01 | 6.27e-01 |
| GOBP PROTEIN TO MEMBRANE DOCKING | 5 | 2.50e-01 | -2.97e-01 | 6.27e-01 |
| GOBP L ALANINE TRANSPORT | 6 | 2.08e-01 | 2.97e-01 | 5.83e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 15 | 4.66e-02 | -2.97e-01 | 3.15e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 34 | 2.75e-03 | 2.97e-01 | 8.19e-02 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE | 14 | 5.47e-02 | -2.97e-01 | 3.40e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN | 17 | 3.44e-02 | 2.96e-01 | 2.77e-01 |
| GOCC INSULIN RESPONSIVE COMPARTMENT | 6 | 2.09e-01 | -2.96e-01 | 5.83e-01 |
| GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 10 | 1.05e-01 | -2.96e-01 | 4.50e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION | 15 | 4.69e-02 | -2.96e-01 | 3.17e-01 |
| GOCC CALCINEURIN COMPLEX | 5 | 2.52e-01 | 2.96e-01 | 6.28e-01 |
| GOBP RESPONSE TO BACTERIAL LIPOPROTEIN | 7 | 1.76e-01 | 2.96e-01 | 5.43e-01 |
| GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY | 10 | 1.06e-01 | 2.95e-01 | 4.51e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 6 | 2.11e-01 | -2.95e-01 | 5.85e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE | 20 | 2.24e-02 | 2.95e-01 | 2.33e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 15 | 4.80e-02 | -2.95e-01 | 3.19e-01 |
| GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY | 5 | 2.54e-01 | 2.95e-01 | 6.30e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION | 5 | 2.54e-01 | -2.95e-01 | 6.30e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 6 | 2.11e-01 | -2.95e-01 | 5.86e-01 |
| GOBP REGULATION OF ADIPONECTIN SECRETION | 5 | 2.54e-01 | -2.95e-01 | 6.30e-01 |
| GOBP MITOCHONDRIAL DNA REPAIR | 5 | 2.54e-01 | 2.95e-01 | 6.31e-01 |
| GOBP MDA 5 SIGNALING PATHWAY | 10 | 1.07e-01 | 2.94e-01 | 4.52e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 11 | 9.12e-02 | -2.94e-01 | 4.24e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION | 5 | 2.55e-01 | -2.94e-01 | 6.31e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS | 24 | 1.27e-02 | 2.94e-01 | 1.82e-01 |
| GOCC COPI VESICLE COAT | 12 | 7.79e-02 | 2.94e-01 | 4.00e-01 |
| GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 9 | 1.27e-01 | -2.94e-01 | 4.83e-01 |
| GOBP VENOUS BLOOD VESSEL MORPHOGENESIS | 5 | 2.55e-01 | -2.94e-01 | 6.31e-01 |
| GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC | 5 | 2.55e-01 | -2.94e-01 | 6.31e-01 |
| GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 11 | 9.19e-02 | -2.94e-01 | 4.24e-01 |
| GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 8 | 1.51e-01 | 2.93e-01 | 5.13e-01 |
| GOBP REGULATION OF TORC2 SIGNALING | 8 | 1.51e-01 | 2.93e-01 | 5.14e-01 |
| GOBP SINGLE STRAND BREAK REPAIR | 10 | 1.09e-01 | 2.93e-01 | 4.54e-01 |
| GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING | 7 | 1.80e-01 | 2.93e-01 | 5.48e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION | 5 | 2.57e-01 | -2.93e-01 | 6.33e-01 |
| GOBP NUCLEOBASE METABOLIC PROCESS | 28 | 7.34e-03 | 2.93e-01 | 1.46e-01 |
| GOBP LONG TERM MEMORY | 16 | 4.27e-02 | -2.93e-01 | 3.07e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 21 | 2.03e-02 | 2.93e-01 | 2.22e-01 |
| GOBP PEPTIDE CROSS LINKING | 7 | 1.80e-01 | -2.93e-01 | 5.48e-01 |
| GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 6 | 2.15e-01 | -2.93e-01 | 5.90e-01 |
| GOBP VOCALIZATION BEHAVIOR | 5 | 2.58e-01 | -2.92e-01 | 6.35e-01 |
| GOBP ER OVERLOAD RESPONSE | 10 | 1.10e-01 | -2.92e-01 | 4.56e-01 |
| GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE | 8 | 1.53e-01 | -2.92e-01 | 5.15e-01 |
| GOBP LIPOPROTEIN LOCALIZATION | 14 | 5.87e-02 | -2.92e-01 | 3.53e-01 |
| GOBP TRNA SURVEILLANCE | 8 | 1.53e-01 | 2.92e-01 | 5.16e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 1.30e-01 | -2.92e-01 | 4.87e-01 |
| GOBP LATE NUCLEOPHAGY | 7 | 1.81e-01 | -2.92e-01 | 5.49e-01 |
| GOBP NEUTROPHIL DEGRANULATION | 12 | 8.07e-02 | -2.91e-01 | 4.07e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME | 5 | 2.60e-01 | 2.91e-01 | 6.37e-01 |
| GOBP LYSOSOMAL LUMEN ACIDIFICATION | 22 | 1.83e-02 | -2.91e-01 | 2.11e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL | 15 | 5.14e-02 | 2.91e-01 | 3.29e-01 |
| GOBP REGULATION OF HEAT GENERATION | 7 | 1.83e-01 | -2.91e-01 | 5.53e-01 |
| GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING | 7 | 1.83e-01 | -2.91e-01 | 5.53e-01 |
| GOMF DIPEPTIDYL PEPTIDASE ACTIVITY | 7 | 1.83e-01 | 2.90e-01 | 5.53e-01 |
| GOBP LUNG MORPHOGENESIS | 25 | 1.20e-02 | -2.90e-01 | 1.78e-01 |
| GOMF DNA REPLICATION ORIGIN BINDING | 11 | 9.58e-02 | 2.90e-01 | 4.32e-01 |
| GOBP LENS FIBER CELL DEVELOPMENT | 5 | 2.61e-01 | -2.90e-01 | 6.39e-01 |
| GOMF FOUR WAY JUNCTION HELICASE ACTIVITY | 5 | 2.61e-01 | 2.90e-01 | 6.39e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 10 | 1.12e-01 | 2.90e-01 | 4.59e-01 |
| GOBP NEGATIVE REGULATION OF GLIOGENESIS | 20 | 2.49e-02 | -2.90e-01 | 2.43e-01 |
| GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS | 9 | 1.32e-01 | -2.90e-01 | 4.89e-01 |
| GOBP REGULATION OF RRNA PROCESSING | 15 | 5.20e-02 | 2.90e-01 | 3.32e-01 |
| GOBP AORTIC VALVE MORPHOGENESIS | 13 | 7.05e-02 | -2.90e-01 | 3.84e-01 |
| GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX | 5 | 2.62e-01 | 2.90e-01 | 6.39e-01 |
| GOBP TELOMERIC D LOOP DISASSEMBLY | 6 | 2.20e-01 | -2.89e-01 | 5.95e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS | 20 | 2.52e-02 | 2.89e-01 | 2.44e-01 |
| GOCC UNIPLEX COMPLEX | 5 | 2.63e-01 | 2.89e-01 | 6.40e-01 |
| GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY | 10 | 1.14e-01 | 2.88e-01 | 4.61e-01 |
| GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY | 12 | 8.40e-02 | 2.88e-01 | 4.11e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 8 | 1.58e-01 | -2.88e-01 | 5.24e-01 |
| GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS | 7 | 1.87e-01 | 2.88e-01 | 5.57e-01 |
| GOCC ALPHA DNA POLYMERASE PRIMASE COMPLEX | 5 | 2.65e-01 | 2.88e-01 | 6.42e-01 |
| GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY | 7 | 1.87e-01 | 2.88e-01 | 5.57e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING | 6 | 2.22e-01 | -2.88e-01 | 5.97e-01 |
| GOBP POSITIVE REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 2.22e-01 | -2.88e-01 | 5.97e-01 |
| GOBP ZYMOGEN ACTIVATION | 32 | 4.87e-03 | -2.88e-01 | 1.15e-01 |
| GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 21 | 2.25e-02 | -2.88e-01 | 2.33e-01 |
| GOBP REGULATION OF HAIR CYCLE | 9 | 1.35e-01 | -2.88e-01 | 4.94e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION | 7 | 1.88e-01 | 2.88e-01 | 5.58e-01 |
| GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX | 12 | 8.49e-02 | 2.87e-01 | 4.12e-01 |
| GOCC GOLGI TRANSPORT COMPLEX | 9 | 1.36e-01 | 2.87e-01 | 4.94e-01 |
| GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 13 | 7.32e-02 | 2.87e-01 | 3.91e-01 |
| GOMF CAMP BINDING | 10 | 1.16e-01 | -2.87e-01 | 4.64e-01 |
| GOBP VASCULAR WOUND HEALING | 10 | 1.16e-01 | -2.87e-01 | 4.64e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 6 | 2.24e-01 | 2.87e-01 | 6.00e-01 |
| GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY | 5 | 2.68e-01 | -2.86e-01 | 6.44e-01 |
| GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 1.17e-01 | 2.86e-01 | 4.66e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 8 | 1.61e-01 | -2.86e-01 | 5.27e-01 |
| GOCC DENDRITIC GROWTH CONE | 6 | 2.25e-01 | 2.86e-01 | 6.00e-01 |
| GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE | 6 | 2.25e-01 | -2.86e-01 | 6.00e-01 |
| GOBP SPERMATID NUCLEUS DIFFERENTIATION | 14 | 6.43e-02 | -2.86e-01 | 3.66e-01 |
| GOBP DIENCEPHALON DEVELOPMENT | 19 | 3.13e-02 | -2.85e-01 | 2.67e-01 |
| GOMF CHEMOKINE ACTIVITY | 13 | 7.49e-02 | 2.85e-01 | 3.95e-01 |
| GOBP PROTEIN OXIDATION | 6 | 2.26e-01 | 2.85e-01 | 6.01e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 1.91e-01 | -2.85e-01 | 5.62e-01 |
| GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 8 | 1.62e-01 | 2.85e-01 | 5.28e-01 |
| GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 6 | 2.27e-01 | 2.85e-01 | 6.02e-01 |
| GOMF ARACHIDONATE COA LIGASE ACTIVITY | 7 | 1.92e-01 | -2.85e-01 | 5.63e-01 |
| GOMF AMP BINDING | 12 | 8.75e-02 | -2.85e-01 | 4.18e-01 |
| GOBP REGULATION OF INCLUSION BODY ASSEMBLY | 11 | 1.02e-01 | -2.85e-01 | 4.46e-01 |
| GOBP AUTOPHAGIC CELL DEATH | 8 | 1.63e-01 | -2.85e-01 | 5.29e-01 |
| GOBP NUCLEOLUS ORGANIZATION | 16 | 4.89e-02 | 2.84e-01 | 3.22e-01 |
| GOMF TRNA METHYLTRANSFERASE ACTIVITY | 30 | 7.12e-03 | 2.84e-01 | 1.44e-01 |
| GOMF RNA METHYLTRANSFERASE ACTIVITY | 58 | 1.85e-04 | 2.84e-01 | 1.75e-02 |
| GOBP MONOACYLGLYCEROL METABOLIC PROCESS | 8 | 1.65e-01 | -2.84e-01 | 5.31e-01 |
| GOBP SMOOTH MUSCLE CELL MIGRATION | 41 | 1.68e-03 | -2.84e-01 | 6.22e-02 |
| GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY | 6 | 2.29e-01 | -2.83e-01 | 6.07e-01 |
| GOMF PROTEASOME BINDING | 15 | 5.75e-02 | -2.83e-01 | 3.50e-01 |
| GOBP INTERSTRAND CROSS LINK REPAIR | 27 | 1.09e-02 | 2.83e-01 | 1.73e-01 |
| GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 38 | 2.56e-03 | -2.83e-01 | 7.78e-02 |
| GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 5 | 2.74e-01 | -2.83e-01 | 6.51e-01 |
| GOCC MICROTUBULE MINUS END | 5 | 2.74e-01 | -2.83e-01 | 6.51e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE | 10 | 1.22e-01 | 2.83e-01 | 4.75e-01 |
| GOMF ADRENERGIC RECEPTOR BINDING | 9 | 1.42e-01 | -2.82e-01 | 5.03e-01 |
| GOBP REGULATION OF MEMBRANE TUBULATION | 5 | 2.75e-01 | -2.82e-01 | 6.51e-01 |
| GOBP RESPONSE TO UV A | 5 | 2.75e-01 | 2.82e-01 | 6.51e-01 |
| GOCC MICROVILLUS MEMBRANE | 12 | 9.06e-02 | -2.82e-01 | 4.24e-01 |
| GOBP LUNG SACCULE DEVELOPMENT | 5 | 2.75e-01 | -2.82e-01 | 6.51e-01 |
| GOBP SULFATION | 8 | 1.68e-01 | -2.82e-01 | 5.34e-01 |
| GOBP RESPONSE TO ERYTHROPOIETIN | 5 | 2.75e-01 | -2.82e-01 | 6.52e-01 |
| GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY | 9 | 1.44e-01 | 2.82e-01 | 5.05e-01 |
| GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 6 | 2.33e-01 | 2.81e-01 | 6.10e-01 |
| GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 5 | 2.76e-01 | 2.81e-01 | 6.52e-01 |
| GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY | 7 | 1.98e-01 | 2.81e-01 | 5.71e-01 |
| GOMF NEUREXIN FAMILY PROTEIN BINDING | 7 | 1.98e-01 | -2.81e-01 | 5.72e-01 |
| GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER | 5 | 2.77e-01 | 2.81e-01 | 6.53e-01 |
| GOBP SPLEEN DEVELOPMENT | 25 | 1.52e-02 | -2.81e-01 | 1.97e-01 |
| GOBP SENSORY PERCEPTION OF SMELL | 11 | 1.07e-01 | 2.80e-01 | 4.53e-01 |
| GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 15 | 6.01e-02 | -2.80e-01 | 3.57e-01 |
| GOBP LIMBIC SYSTEM DEVELOPMENT | 58 | 2.24e-04 | -2.80e-01 | 1.90e-02 |
| GOBP REGULATION OF VASCULAR PERMEABILITY | 18 | 3.97e-02 | -2.80e-01 | 2.97e-01 |
| GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 12 | 9.30e-02 | -2.80e-01 | 4.26e-01 |
| GOCC EXTRINSIC COMPONENT OF ENDOSOME MEMBRANE | 5 | 2.78e-01 | -2.80e-01 | 6.53e-01 |
| GOMF NUCLEAR RETINOID X RECEPTOR BINDING | 14 | 7.01e-02 | -2.80e-01 | 3.82e-01 |
| GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 9 | 1.46e-01 | -2.80e-01 | 5.07e-01 |
| GOMF RETROMER COMPLEX BINDING | 9 | 1.47e-01 | 2.79e-01 | 5.08e-01 |
| GOMF 3 5 RNA HELICASE ACTIVITY | 5 | 2.80e-01 | 2.79e-01 | 6.54e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 5 | 2.80e-01 | 2.79e-01 | 6.54e-01 |
| GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 7 | 2.02e-01 | -2.79e-01 | 5.77e-01 |
| GOCC POLYSOME | 61 | 1.68e-04 | -2.79e-01 | 1.63e-02 |
| GOBP HEART VALVE FORMATION | 5 | 2.81e-01 | -2.79e-01 | 6.54e-01 |
| GOMF STEROID HYDROXYLASE ACTIVITY | 5 | 2.81e-01 | -2.79e-01 | 6.54e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 9 | 1.48e-01 | 2.78e-01 | 5.10e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE CAPPING | 8 | 1.73e-01 | 2.78e-01 | 5.39e-01 |
| GOMF AMINO ACID BINDING | 19 | 3.58e-02 | 2.78e-01 | 2.83e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 21 | 2.73e-02 | -2.78e-01 | 2.55e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 19 | 3.58e-02 | -2.78e-01 | 2.83e-01 |
| GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS | 9 | 1.49e-01 | -2.78e-01 | 5.10e-01 |
| GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY | 8 | 1.73e-01 | -2.78e-01 | 5.39e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY | 8 | 1.73e-01 | -2.78e-01 | 5.39e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 7 | 2.03e-01 | -2.78e-01 | 5.79e-01 |
| GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS | 33 | 5.77e-03 | 2.78e-01 | 1.28e-01 |
| GOBP PROSTATE GLAND DEVELOPMENT | 22 | 2.43e-02 | -2.78e-01 | 2.41e-01 |
| GOMF NF KAPPAB INDUCING KINASE ACTIVITY | 5 | 2.83e-01 | -2.78e-01 | 6.55e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 5 | 2.83e-01 | -2.77e-01 | 6.55e-01 |
| GOCC MCRD MEDIATED MRNA STABILITY COMPLEX | 5 | 2.83e-01 | -2.77e-01 | 6.55e-01 |
| GOMF OXYSTEROL BINDING | 7 | 2.04e-01 | 2.77e-01 | 5.79e-01 |
| GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY | 6 | 2.40e-01 | -2.77e-01 | 6.17e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 5 | 2.84e-01 | 2.77e-01 | 6.55e-01 |
| GOBP ARF PROTEIN SIGNAL TRANSDUCTION | 19 | 3.68e-02 | -2.77e-01 | 2.87e-01 |
| GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY | 9 | 1.51e-01 | -2.77e-01 | 5.13e-01 |
| GOBP PROTEIN TRIMERIZATION | 8 | 1.76e-01 | 2.77e-01 | 5.43e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 13 | 8.44e-02 | -2.76e-01 | 4.12e-01 |
| GOBP INCLUSION BODY ASSEMBLY | 16 | 5.57e-02 | -2.76e-01 | 3.44e-01 |
| GOBP PRESYNAPSE ORGANIZATION | 20 | 3.25e-02 | -2.76e-01 | 2.71e-01 |
| GOBP MUSCLE CELL MIGRATION | 49 | 8.26e-04 | -2.76e-01 | 4.09e-02 |
| GOBP RESPONSE TO ALDOSTERONE | 12 | 9.78e-02 | 2.76e-01 | 4.36e-01 |
| GOMF HISTONE H3K27ME2 H3K27ME3 DEMETHYLASE ACTIVITY | 5 | 2.85e-01 | -2.76e-01 | 6.56e-01 |
| GOBP SPHINGOLIPID CATABOLIC PROCESS | 23 | 2.21e-02 | -2.76e-01 | 2.31e-01 |
| GOCC PROTEASOME ACCESSORY COMPLEX | 23 | 2.22e-02 | -2.76e-01 | 2.31e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER UPTAKE | 6 | 2.43e-01 | -2.76e-01 | 6.21e-01 |
| GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING | 15 | 6.48e-02 | -2.75e-01 | 3.68e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5 | 9 | 1.53e-01 | 2.75e-01 | 5.15e-01 |
| GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.86e-01 | -2.75e-01 | 6.57e-01 |
| GOCC DNA REPAIR COMPLEX | 22 | 2.55e-02 | 2.75e-01 | 2.46e-01 |
| GOCC TRANSLATION PREINITIATION COMPLEX | 18 | 4.34e-02 | -2.75e-01 | 3.08e-01 |
| GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 1.78e-01 | 2.75e-01 | 5.46e-01 |
| GOCC BBAF COMPLEX | 9 | 1.53e-01 | 2.75e-01 | 5.16e-01 |
| GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY | 19 | 3.81e-02 | 2.75e-01 | 2.93e-01 |
| GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 5 | 2.87e-01 | 2.75e-01 | 6.57e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY | 6 | 2.44e-01 | -2.75e-01 | 6.22e-01 |
| GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 9 | 1.54e-01 | 2.75e-01 | 5.17e-01 |
| GOBP CONSTITUTIVE SECRETORY PATHWAY | 7 | 2.09e-01 | -2.75e-01 | 5.83e-01 |
| GOBP PHAGOCYTOSIS RECOGNITION | 10 | 1.33e-01 | -2.74e-01 | 4.91e-01 |
| GOBP CAMP CATABOLIC PROCESS | 7 | 2.09e-01 | -2.74e-01 | 5.83e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 5 | 2.89e-01 | -2.74e-01 | 6.58e-01 |
| GOBP PROTEIN POLYUFMYLATION | 5 | 2.89e-01 | -2.74e-01 | 6.58e-01 |
| GOBP INTRACILIARY ANTEROGRADE TRANSPORT | 14 | 7.61e-02 | 2.74e-01 | 3.96e-01 |
| GOBP REGULATION OF NADP METABOLIC PROCESS | 7 | 2.10e-01 | 2.74e-01 | 5.85e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN BINDING | 7 | 2.10e-01 | 2.74e-01 | 5.85e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE | 9 | 1.56e-01 | -2.73e-01 | 5.21e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION | 26 | 1.59e-02 | -2.73e-01 | 1.98e-01 |
| GOMF GDP BINDING | 55 | 4.61e-04 | -2.73e-01 | 2.91e-02 |
| GOBP CENTRAL NERVOUS SYSTEM MYELIN FORMATION | 5 | 2.90e-01 | 2.73e-01 | 6.59e-01 |
| GOCC INTEGRIN COMPLEX | 15 | 6.71e-02 | -2.73e-01 | 3.74e-01 |
| GOBP MODIFICATION OF SYNAPTIC STRUCTURE | 17 | 5.14e-02 | -2.73e-01 | 3.29e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 29 | 1.10e-02 | -2.73e-01 | 1.73e-01 |
| GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY | 15 | 6.75e-02 | 2.73e-01 | 3.74e-01 |
| GOBP RESPONSE TO INACTIVITY | 5 | 2.91e-01 | -2.73e-01 | 6.60e-01 |
| GOBP RESPONSE TO LITHIUM ION | 8 | 1.82e-01 | 2.73e-01 | 5.50e-01 |
| GOCC PERICHROMATIN FIBRILS | 5 | 2.91e-01 | 2.73e-01 | 6.60e-01 |
| GOBP NEGATIVE REGULATION OF OSSIFICATION | 18 | 4.54e-02 | -2.72e-01 | 3.14e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 7 | 2.12e-01 | -2.72e-01 | 5.87e-01 |
| GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 10 | 1.36e-01 | -2.72e-01 | 4.94e-01 |
| GOBP NEURON MATURATION | 22 | 2.72e-02 | -2.72e-01 | 2.55e-01 |
| GOMF CENTROMERIC DNA BINDING | 5 | 2.92e-01 | 2.72e-01 | 6.61e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 24 | 2.11e-02 | -2.72e-01 | 2.25e-01 |
| GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION | 12 | 1.03e-01 | 2.72e-01 | 4.47e-01 |
| GOBP DEFENSE RESPONSE TO TUMOR CELL | 10 | 1.37e-01 | -2.72e-01 | 4.95e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 6 | 2.50e-01 | 2.71e-01 | 6.26e-01 |
| GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS | 8 | 1.84e-01 | 2.71e-01 | 5.53e-01 |
| GOBP VAGINA DEVELOPMENT | 5 | 2.93e-01 | -2.71e-01 | 6.61e-01 |
| GOBP SNRNA PROCESSING | 26 | 1.67e-02 | 2.71e-01 | 2.03e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE | 9 | 1.59e-01 | -2.71e-01 | 5.25e-01 |
| GOCC 90S PRERIBOSOME | 25 | 1.90e-02 | 2.71e-01 | 2.15e-01 |
| GOBP HEART VALVE MORPHOGENESIS | 27 | 1.48e-02 | -2.71e-01 | 1.95e-01 |
| GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.94e-01 | 2.71e-01 | 6.62e-01 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE | 6 | 2.51e-01 | -2.71e-01 | 6.27e-01 |
| GOBP PURINE NUCLEOBASE METABOLIC PROCESS | 15 | 6.94e-02 | 2.71e-01 | 3.81e-01 |
| GOBP HOMOCYSTEINE METABOLIC PROCESS | 8 | 1.85e-01 | -2.71e-01 | 5.54e-01 |
| GOCC TOR COMPLEX | 11 | 1.20e-01 | 2.71e-01 | 4.72e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 8 | 1.85e-01 | -2.71e-01 | 5.54e-01 |
| GOBP LIVER MORPHOGENESIS | 12 | 1.05e-01 | -2.71e-01 | 4.50e-01 |
| GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY | 5 | 2.95e-01 | 2.71e-01 | 6.62e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN MORPHOGENESIS | 5 | 2.95e-01 | -2.70e-01 | 6.62e-01 |
| GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION | 13 | 9.15e-02 | 2.70e-01 | 4.24e-01 |
| GOBP MELANIN METABOLIC PROCESS | 13 | 9.15e-02 | -2.70e-01 | 4.24e-01 |
| GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 25 | 1.94e-02 | -2.70e-01 | 2.17e-01 |
| GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR | 8 | 1.86e-01 | 2.70e-01 | 5.55e-01 |
| GOBP CELLULAR RESPONSE TO CAMP | 26 | 1.72e-02 | -2.70e-01 | 2.05e-01 |
| GOBP FEMALE MEIOSIS I | 5 | 2.96e-01 | 2.70e-01 | 6.62e-01 |
| GOBP NEGATIVE REGULATION OF COAGULATION | 17 | 5.43e-02 | -2.70e-01 | 3.39e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN | 15 | 7.06e-02 | -2.70e-01 | 3.84e-01 |
| GOBP SUGAR MEDIATED SIGNALING PATHWAY | 5 | 2.97e-01 | 2.69e-01 | 6.63e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 7 | 2.17e-01 | 2.69e-01 | 5.94e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 10 | 1.40e-01 | -2.69e-01 | 5.00e-01 |
| GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT | 28 | 1.37e-02 | 2.69e-01 | 1.89e-01 |
| GOBP NON MOTILE CILIUM ASSEMBLY | 52 | 7.96e-04 | 2.69e-01 | 4.04e-02 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 8 | 1.88e-01 | -2.69e-01 | 5.58e-01 |
| GOMF SUMO POLYMER BINDING | 5 | 2.98e-01 | 2.69e-01 | 6.63e-01 |
| GOMF COLLAGEN BINDING | 23 | 2.56e-02 | -2.69e-01 | 2.46e-01 |
| GOCC BRCA1 A COMPLEX | 8 | 1.88e-01 | 2.69e-01 | 5.59e-01 |
| GOBP TROPHOBLAST CELL MIGRATION | 9 | 1.63e-01 | -2.69e-01 | 5.28e-01 |
| GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 5 | 2.98e-01 | 2.69e-01 | 6.63e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE CHECKPOINT | 5 | 2.98e-01 | 2.69e-01 | 6.63e-01 |
| GOBP HEART VALVE DEVELOPMENT | 35 | 6.00e-03 | -2.69e-01 | 1.31e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 7 | 2.19e-01 | 2.68e-01 | 5.95e-01 |
| GOBP CERAMIDE CATABOLIC PROCESS | 12 | 1.07e-01 | -2.68e-01 | 4.53e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION | 25 | 2.02e-02 | -2.68e-01 | 2.22e-01 |
| GOBP TRNA MODIFICATION | 88 | 1.38e-05 | 2.68e-01 | 3.01e-03 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION | 7 | 2.19e-01 | 2.68e-01 | 5.95e-01 |
| GOBP SPERM CAPACITATION | 8 | 1.89e-01 | -2.68e-01 | 5.60e-01 |
| GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 7 | 2.19e-01 | -2.68e-01 | 5.95e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.64e-01 | -2.68e-01 | 5.29e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE | 5 | 2.99e-01 | -2.68e-01 | 6.64e-01 |
| GOBP MISMATCH REPAIR | 25 | 2.05e-02 | 2.68e-01 | 2.23e-01 |
| GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION | 7 | 2.20e-01 | -2.68e-01 | 5.95e-01 |
| GOBP POSITIVE REGULATION OF WOUND HEALING | 28 | 1.42e-02 | -2.68e-01 | 1.93e-01 |
| GOBP VITAMIN TRANSMEMBRANE TRANSPORT | 9 | 1.64e-01 | 2.68e-01 | 5.31e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 7 | 2.20e-01 | -2.68e-01 | 5.95e-01 |
| GOBP RESPONSE TO ACTINOMYCIN D | 5 | 3.01e-01 | -2.67e-01 | 6.65e-01 |
| GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY | 17 | 5.66e-02 | -2.67e-01 | 3.47e-01 |
| GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 37 | 4.97e-03 | -2.67e-01 | 1.17e-01 |
| GOCC MICOS COMPLEX | 8 | 1.91e-01 | 2.67e-01 | 5.62e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE | 18 | 5.00e-02 | -2.67e-01 | 3.24e-01 |
| GOBP MAST CELL PROLIFERATION | 5 | 3.01e-01 | -2.67e-01 | 6.65e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION | 12 | 1.10e-01 | -2.67e-01 | 4.56e-01 |
| GOMF INTRACELLULAR CHLORIDE CHANNEL ACTIVITY | 7 | 2.22e-01 | 2.67e-01 | 5.97e-01 |
| GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT | 12 | 1.11e-01 | 2.66e-01 | 4.56e-01 |
| GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS | 11 | 1.27e-01 | 2.66e-01 | 4.83e-01 |
| GOBP RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE | 5 | 3.03e-01 | 2.66e-01 | 6.67e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 16 | 6.56e-02 | 2.66e-01 | 3.71e-01 |
| GOCC BRAHMA COMPLEX | 12 | 1.11e-01 | 2.66e-01 | 4.57e-01 |
| GOBP MITRAL VALVE DEVELOPMENT | 8 | 1.93e-01 | -2.66e-01 | 5.65e-01 |
| GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE | 10 | 1.46e-01 | -2.66e-01 | 5.07e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 23 | 2.76e-02 | -2.65e-01 | 2.57e-01 |
| GOBP REGULATION OF AMINE METABOLIC PROCESS | 18 | 5.14e-02 | -2.65e-01 | 3.29e-01 |
| GOBP AGGREPHAGY | 8 | 1.94e-01 | -2.65e-01 | 5.67e-01 |
| GOBP LEUKOTRIENE TRANSPORT | 6 | 2.61e-01 | 2.65e-01 | 6.38e-01 |
| GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 8 | 1.94e-01 | 2.65e-01 | 5.67e-01 |
| GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 8 | 1.95e-01 | 2.65e-01 | 5.67e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 8 | 1.95e-01 | 2.65e-01 | 5.67e-01 |
| GOBP ECTODERM DEVELOPMENT | 11 | 1.28e-01 | -2.65e-01 | 4.85e-01 |
| GOMF U4 SNRNA BINDING | 6 | 2.62e-01 | -2.65e-01 | 6.39e-01 |
| GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR | 10 | 1.47e-01 | 2.65e-01 | 5.09e-01 |
| GOBP REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 16 | 6.69e-02 | -2.65e-01 | 3.73e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION | 15 | 7.61e-02 | -2.65e-01 | 3.96e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY CADHERIN | 16 | 6.70e-02 | -2.65e-01 | 3.74e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 10 | 1.48e-01 | 2.64e-01 | 5.09e-01 |
| GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 9 | 1.70e-01 | -2.64e-01 | 5.35e-01 |
| GOBP METANEPHROS MORPHOGENESIS | 7 | 2.26e-01 | 2.64e-01 | 6.01e-01 |
| GOBP REGULATION OF PROTEIN POLYUBIQUITINATION | 23 | 2.83e-02 | -2.64e-01 | 2.59e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE | 6 | 2.63e-01 | -2.64e-01 | 6.39e-01 |
| GOBP TOLL SIGNALING PATHWAY | 10 | 1.48e-01 | -2.64e-01 | 5.10e-01 |
| GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 11 | 1.30e-01 | -2.64e-01 | 4.87e-01 |
| GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT | 8 | 1.96e-01 | 2.64e-01 | 5.69e-01 |
| GOMF ANTIOXIDANT ACTIVITY | 48 | 1.57e-03 | -2.64e-01 | 6.12e-02 |
| GOMF FIBROBLAST GROWTH FACTOR BINDING | 12 | 1.14e-01 | -2.64e-01 | 4.61e-01 |
| GOBP BASEMENT MEMBRANE ASSEMBLY | 5 | 3.07e-01 | -2.64e-01 | 6.69e-01 |
| GOBP UROGENITAL SYSTEM DEVELOPMENT | 27 | 1.78e-02 | -2.64e-01 | 2.08e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 20 | 4.15e-02 | -2.63e-01 | 3.03e-01 |
| GOBP ERBB2 SIGNALING PATHWAY | 9 | 1.71e-01 | -2.63e-01 | 5.36e-01 |
| GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 8.81e-02 | 2.63e-01 | 4.20e-01 |
| GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY | 13 | 1.00e-01 | -2.63e-01 | 4.43e-01 |
| GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL | 6 | 2.64e-01 | -2.63e-01 | 6.42e-01 |
| GOBP GASTRIC ACID SECRETION | 6 | 2.64e-01 | 2.63e-01 | 6.42e-01 |
| GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS | 11 | 1.31e-01 | 2.63e-01 | 4.88e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 65 | 2.51e-04 | -2.63e-01 | 2.04e-02 |
| GOBP ADHERENS JUNCTION ORGANIZATION | 26 | 2.04e-02 | -2.63e-01 | 2.23e-01 |
| GOBP RESPONSE TO GONADOTROPIN | 9 | 1.72e-01 | -2.63e-01 | 5.38e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 7 | 2.29e-01 | 2.62e-01 | 6.07e-01 |
| GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX | 11 | 1.32e-01 | 2.62e-01 | 4.89e-01 |
| GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 40 | 4.12e-03 | -2.62e-01 | 1.02e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 48 | 1.68e-03 | -2.62e-01 | 6.22e-02 |
| GOBP OVULATION | 6 | 2.66e-01 | -2.62e-01 | 6.44e-01 |
| GOCC TRANSCRIPTION REPRESSOR COMPLEX | 59 | 5.07e-04 | -2.62e-01 | 3.05e-02 |
| GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 10 | 1.52e-01 | -2.62e-01 | 5.15e-01 |
| GOBP REGULATION OF FIBROBLAST MIGRATION | 30 | 1.31e-02 | -2.62e-01 | 1.86e-01 |
| GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 8 | 2.00e-01 | -2.62e-01 | 5.75e-01 |
| GOBP HISTONE UBIQUITINATION | 8 | 2.00e-01 | -2.62e-01 | 5.75e-01 |
| GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX | 8 | 2.00e-01 | -2.62e-01 | 5.75e-01 |
| GOBP HORMONE BIOSYNTHETIC PROCESS | 27 | 1.88e-02 | -2.61e-01 | 2.14e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT | 5 | 3.12e-01 | 2.61e-01 | 6.75e-01 |
| GOCC CELL BODY MEMBRANE | 7 | 2.31e-01 | 2.61e-01 | 6.09e-01 |
| GOMF PH DOMAIN BINDING | 7 | 2.31e-01 | 2.61e-01 | 6.09e-01 |
| GOBP RESPONSE TO AMPHETAMINE | 15 | 7.98e-02 | 2.61e-01 | 4.05e-01 |
| GOCC POSTSYNAPTIC DENSITY INTRACELLULAR COMPONENT | 10 | 1.53e-01 | -2.61e-01 | 5.15e-01 |
| GOMF CALCIUM RELEASE CHANNEL ACTIVITY | 14 | 9.08e-02 | -2.61e-01 | 4.24e-01 |
| GOMF INTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 14 | 9.08e-02 | -2.61e-01 | 4.24e-01 |
| GOMF DOPAMINE RECEPTOR BINDING | 10 | 1.53e-01 | -2.61e-01 | 5.16e-01 |
| GOBP FORELIMB MORPHOGENESIS | 14 | 9.09e-02 | -2.61e-01 | 4.24e-01 |
| GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT | 25 | 2.40e-02 | 2.61e-01 | 2.40e-01 |
| GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 13 | 1.04e-01 | -2.61e-01 | 4.49e-01 |
| GOBP AORTA MORPHOGENESIS | 14 | 9.13e-02 | -2.61e-01 | 4.24e-01 |
| GOBP SOMATIC STEM CELL DIVISION | 5 | 3.13e-01 | 2.61e-01 | 6.76e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION | 5 | 3.13e-01 | 2.61e-01 | 6.76e-01 |
| GOBP NATURAL KILLER CELL PROLIFERATION | 9 | 1.76e-01 | 2.60e-01 | 5.43e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY | 16 | 7.14e-02 | -2.60e-01 | 3.86e-01 |
| GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX | 15 | 8.09e-02 | -2.60e-01 | 4.07e-01 |
| GOCC PORE COMPLEX | 17 | 6.33e-02 | -2.60e-01 | 3.63e-01 |
| GOBP RESPONSE TO LEAD ION | 16 | 7.16e-02 | -2.60e-01 | 3.87e-01 |
| GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY | 8 | 2.03e-01 | -2.60e-01 | 5.78e-01 |
| GOMF DIACYLGLYCEROL BINDING | 8 | 2.03e-01 | 2.60e-01 | 5.79e-01 |
| GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 48 | 1.85e-03 | -2.60e-01 | 6.52e-02 |
| GOCC TRNA METHYLTRANSFERASE COMPLEX | 7 | 2.34e-01 | 2.60e-01 | 6.12e-01 |
| GOBP PHOTOTRANSDUCTION VISIBLE LIGHT | 7 | 2.34e-01 | 2.60e-01 | 6.12e-01 |
| GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 33 | 9.92e-03 | 2.59e-01 | 1.66e-01 |
| GOMF PHOSPHOLIPASE C ACTIVITY | 15 | 8.20e-02 | 2.59e-01 | 4.09e-01 |
| GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS | 27 | 1.97e-02 | -2.59e-01 | 2.19e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING | 7 | 2.35e-01 | -2.59e-01 | 6.12e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 23 | 3.15e-02 | -2.59e-01 | 2.67e-01 |
| GOBP REGULATION OF GASTRULATION | 8 | 2.04e-01 | -2.59e-01 | 5.80e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE | 95 | 1.30e-05 | -2.59e-01 | 3.01e-03 |
| GOBP DAMP METABOLIC PROCESS | 5 | 3.16e-01 | 2.59e-01 | 6.78e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 16 | 7.28e-02 | -2.59e-01 | 3.90e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 14 | 9.33e-02 | -2.59e-01 | 4.26e-01 |
| GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING | 8 | 2.05e-01 | -2.59e-01 | 5.80e-01 |
| GOMF MUSCLE ALPHA ACTININ BINDING | 7 | 2.35e-01 | 2.59e-01 | 6.13e-01 |
| GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 29 | 1.59e-02 | -2.59e-01 | 1.98e-01 |
| GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY | 9 | 1.79e-01 | -2.59e-01 | 5.47e-01 |
| GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT | 6 | 2.72e-01 | -2.59e-01 | 6.50e-01 |
| GOBP POSITIVE REGULATION OF BONE RESORPTION | 10 | 1.57e-01 | -2.59e-01 | 5.23e-01 |
| GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS | 10 | 1.57e-01 | -2.59e-01 | 5.23e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE | 6 | 2.73e-01 | -2.59e-01 | 6.51e-01 |
| GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE | 21 | 4.04e-02 | -2.58e-01 | 3.00e-01 |
| GOMF NUCLEAR STEROID RECEPTOR ACTIVITY | 15 | 8.34e-02 | -2.58e-01 | 4.10e-01 |
| GOBP GANGLION DEVELOPMENT | 6 | 2.73e-01 | -2.58e-01 | 6.51e-01 |
| GOCC PHOTORECEPTOR DISC MEMBRANE | 5 | 3.18e-01 | 2.58e-01 | 6.79e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY | 8 | 2.06e-01 | -2.58e-01 | 5.82e-01 |
| GOBP IMMATURE B CELL DIFFERENTIATION | 10 | 1.58e-01 | -2.58e-01 | 5.24e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS | 6 | 2.74e-01 | -2.58e-01 | 6.51e-01 |
| GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY | 9 | 1.81e-01 | -2.58e-01 | 5.49e-01 |
| GOCC CYTOCHROME COMPLEX | 30 | 1.47e-02 | -2.57e-01 | 1.95e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 29 | 1.65e-02 | 2.57e-01 | 2.03e-01 |
| GOBP AGGRESOME ASSEMBLY | 5 | 3.19e-01 | -2.57e-01 | 6.80e-01 |
| GOMF FUCOSYLTRANSFERASE ACTIVITY | 7 | 2.39e-01 | 2.57e-01 | 6.16e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 10 | 1.59e-01 | -2.57e-01 | 5.25e-01 |
| GOBP RESPONSE TO VITAMIN | 42 | 3.94e-03 | -2.57e-01 | 9.98e-02 |
| GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY | 13 | 1.08e-01 | -2.57e-01 | 4.54e-01 |
| GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 13 | 1.08e-01 | -2.57e-01 | 4.54e-01 |
| GOMF DEATH RECEPTOR BINDING | 13 | 1.08e-01 | -2.57e-01 | 4.54e-01 |
| GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 22 | 3.69e-02 | -2.57e-01 | 2.87e-01 |
| GOBP ENDOCRINE SYSTEM DEVELOPMENT | 53 | 1.22e-03 | -2.57e-01 | 5.17e-02 |
| GOMF METAL CATION PROTON ANTIPORTER ACTIVITY | 13 | 1.09e-01 | -2.57e-01 | 4.54e-01 |
| GOBP FACE DEVELOPMENT | 28 | 1.86e-02 | -2.57e-01 | 2.14e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 12 | 1.23e-01 | 2.57e-01 | 4.77e-01 |
| GOMF I SMAD BINDING | 13 | 1.09e-01 | -2.57e-01 | 4.55e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION | 13 | 1.09e-01 | -2.57e-01 | 4.55e-01 |
| GOMF UBIQUITIN CONJUGATING ENZYME BINDING | 24 | 2.97e-02 | -2.56e-01 | 2.62e-01 |
| GOMF L ASCORBIC ACID BINDING | 16 | 7.59e-02 | 2.56e-01 | 3.96e-01 |
| GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION | 10 | 1.61e-01 | 2.56e-01 | 5.27e-01 |
| GOCC CILIARY TIP | 31 | 1.37e-02 | 2.56e-01 | 1.89e-01 |
| GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT | 14 | 9.78e-02 | 2.56e-01 | 4.36e-01 |
| GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS | 18 | 6.05e-02 | -2.56e-01 | 3.58e-01 |
| GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 3.39e-02 | -2.56e-01 | 2.77e-01 |
| GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 7 | 2.42e-01 | -2.56e-01 | 6.20e-01 |
| GOCC PICLN SM PROTEIN COMPLEX | 6 | 2.79e-01 | 2.55e-01 | 6.53e-01 |
| GOBP POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 6 | 2.79e-01 | 2.55e-01 | 6.53e-01 |
| GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 8 | 2.11e-01 | -2.55e-01 | 5.87e-01 |
| GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS | 10 | 1.62e-01 | 2.55e-01 | 5.28e-01 |
| GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION | 30 | 1.56e-02 | 2.55e-01 | 1.98e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE | 27 | 2.18e-02 | -2.55e-01 | 2.30e-01 |
| GOBP POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION | 12 | 1.26e-01 | -2.55e-01 | 4.83e-01 |
| GOCC PINOSOME | 5 | 3.24e-01 | 2.55e-01 | 6.81e-01 |
| GOBP ESTABLISHMENT OF GOLGI LOCALIZATION | 7 | 2.43e-01 | -2.55e-01 | 6.21e-01 |
| GOCC AZUROPHIL GRANULE MEMBRANE | 51 | 1.66e-03 | -2.55e-01 | 6.22e-02 |
| GOMF CARBONYL REDUCTASE NADPH ACTIVITY | 7 | 2.43e-01 | 2.55e-01 | 6.21e-01 |
| GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE | 8 | 2.12e-01 | -2.55e-01 | 5.87e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 18 | 6.16e-02 | -2.55e-01 | 3.60e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE | 7 | 2.44e-01 | -2.55e-01 | 6.21e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE ELONGATION | 5 | 3.24e-01 | 2.54e-01 | 6.81e-01 |
| GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY | 6 | 2.81e-01 | -2.54e-01 | 6.54e-01 |
| GOMF PHOSPHATE ION BINDING | 6 | 2.81e-01 | -2.54e-01 | 6.54e-01 |
| GOBP CRANIOFACIAL SUTURE MORPHOGENESIS | 6 | 2.81e-01 | 2.54e-01 | 6.54e-01 |
| GOCC PRP19 COMPLEX | 12 | 1.27e-01 | -2.54e-01 | 4.84e-01 |
| GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 2.45e-01 | 2.54e-01 | 6.22e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION | 23 | 3.51e-02 | -2.54e-01 | 2.80e-01 |
| GOBP REGULATION OF MDA 5 SIGNALING PATHWAY | 6 | 2.82e-01 | 2.54e-01 | 6.55e-01 |
| GOCC POLYSOMAL RIBOSOME | 29 | 1.82e-02 | -2.54e-01 | 2.11e-01 |
| GOBP TELOMERE MAINTENANCE VIA RECOMBINATION | 13 | 1.14e-01 | 2.53e-01 | 4.61e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 33 | 1.18e-02 | -2.53e-01 | 1.76e-01 |
| GOBP PROTEIN K11 LINKED UBIQUITINATION | 27 | 2.27e-02 | -2.53e-01 | 2.35e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR BINDING | 7 | 2.46e-01 | -2.53e-01 | 6.22e-01 |
| GOBP SENSORY PERCEPTION OF TASTE | 7 | 2.46e-01 | 2.53e-01 | 6.22e-01 |
| GOBP DETECTION OF VIRUS | 5 | 3.27e-01 | 2.53e-01 | 6.84e-01 |
| GOBP POSITIVE REGULATION OF LIPID STORAGE | 14 | 1.01e-01 | -2.53e-01 | 4.45e-01 |
| GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS | 19 | 5.63e-02 | 2.53e-01 | 3.46e-01 |
| GOBP NEGATIVE REGULATION OF VASOCONSTRICTION | 5 | 3.27e-01 | -2.53e-01 | 6.85e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING | 25 | 2.86e-02 | -2.53e-01 | 2.60e-01 |
| GOBP TELOMERIC LOOP DISASSEMBLY | 7 | 2.47e-01 | -2.53e-01 | 6.23e-01 |
| GOBP MITOCHONDRIAL RNA METABOLIC PROCESS | 50 | 2.00e-03 | 2.53e-01 | 6.78e-02 |
| GOBP NEGATIVE REGULATION OF HORMONE SECRETION | 31 | 1.50e-02 | -2.53e-01 | 1.96e-01 |
| GOBP BILE ACID AND BILE SALT TRANSPORT | 12 | 1.30e-01 | 2.53e-01 | 4.87e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION | 5 | 3.29e-01 | -2.52e-01 | 6.86e-01 |
| GOBP HISTONE DEACETYLATION | 19 | 5.72e-02 | 2.52e-01 | 3.49e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 7 | 2.48e-01 | -2.52e-01 | 6.25e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 7 | 2.48e-01 | -2.52e-01 | 6.25e-01 |
| GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 2.49e-01 | -2.52e-01 | 6.25e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA | 8 | 2.17e-01 | 2.52e-01 | 5.94e-01 |
| GOBP CELL SUBSTRATE JUNCTION ORGANIZATION | 62 | 6.11e-04 | -2.52e-01 | 3.38e-02 |
| GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT | 10 | 1.68e-01 | -2.52e-01 | 5.34e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 8 | 2.18e-01 | 2.52e-01 | 5.94e-01 |
| GOBP REGULATION OF COLLATERAL SPROUTING | 8 | 2.18e-01 | -2.52e-01 | 5.94e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION | 12 | 1.31e-01 | -2.52e-01 | 4.89e-01 |
| GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS | 6 | 2.86e-01 | 2.52e-01 | 6.56e-01 |
| GOBP PHOTOTRANSDUCTION | 13 | 1.16e-01 | 2.52e-01 | 4.64e-01 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 8 | 2.18e-01 | 2.51e-01 | 5.95e-01 |
| GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX | 7 | 2.49e-01 | -2.51e-01 | 6.26e-01 |
| GOBP SNRNA 3 END PROCESSING | 21 | 4.62e-02 | 2.51e-01 | 3.15e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 38 | 7.36e-03 | -2.51e-01 | 1.46e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 27 | 2.38e-02 | -2.51e-01 | 2.40e-01 |
| GOBP COPII COATED VESICLE CARGO LOADING | 16 | 8.20e-02 | -2.51e-01 | 4.09e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 50 | 2.14e-03 | -2.51e-01 | 7.05e-02 |
| GOBP REGULATION OF ACYL COA BIOSYNTHETIC PROCESS | 5 | 3.31e-01 | 2.51e-01 | 6.87e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION | 33 | 1.26e-02 | -2.51e-01 | 1.82e-01 |
| GOCC KINOCILIUM | 5 | 3.31e-01 | 2.51e-01 | 6.87e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 30 | 1.75e-02 | -2.51e-01 | 2.07e-01 |
| GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 7 | 2.51e-01 | -2.51e-01 | 6.27e-01 |
| GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 12 | 1.33e-01 | 2.51e-01 | 4.91e-01 |
| GOBP MOTOR NEURON APOPTOTIC PROCESS | 14 | 1.05e-01 | -2.51e-01 | 4.50e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS | 11 | 1.50e-01 | -2.51e-01 | 5.13e-01 |
| GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY | 14 | 1.05e-01 | -2.51e-01 | 4.50e-01 |
| GOBP CRD MEDIATED MRNA STABILIZATION | 9 | 1.93e-01 | -2.50e-01 | 5.66e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING | 30 | 1.77e-02 | -2.50e-01 | 2.08e-01 |
| GOMF MIRNA BINDING | 31 | 1.59e-02 | -2.50e-01 | 1.98e-01 |
| GOBP REGULATION OF MIRNA METABOLIC PROCESS | 55 | 1.33e-03 | -2.50e-01 | 5.58e-02 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 40 | 6.19e-03 | -2.50e-01 | 1.34e-01 |
| GOBP ESTROUS CYCLE | 10 | 1.71e-01 | 2.50e-01 | 5.36e-01 |
| GOMF INTERLEUKIN 1 BINDING | 6 | 2.88e-01 | 2.50e-01 | 6.58e-01 |
| GOCC SPINDLE POLE CENTROSOME | 9 | 1.94e-01 | -2.50e-01 | 5.66e-01 |
| GOBP BILE ACID SIGNALING PATHWAY | 5 | 3.33e-01 | 2.50e-01 | 6.88e-01 |
| GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY | 7 | 2.52e-01 | -2.50e-01 | 6.28e-01 |
| GOBP UTP BIOSYNTHETIC PROCESS | 8 | 2.21e-01 | 2.50e-01 | 5.96e-01 |
| GOBP POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 5 | 3.33e-01 | -2.50e-01 | 6.88e-01 |
| GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE | 21 | 4.75e-02 | 2.50e-01 | 3.17e-01 |
| GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY | 6 | 2.89e-01 | 2.50e-01 | 6.59e-01 |
| GOMF SINGLE STRANDED DNA HELICASE ACTIVITY | 17 | 7.47e-02 | 2.50e-01 | 3.94e-01 |
| GOBP SKELETAL MUSCLE CELL PROLIFERATION | 14 | 1.06e-01 | -2.50e-01 | 4.51e-01 |
| GOBP RADIAL GLIAL CELL DIFFERENTIATION | 6 | 2.90e-01 | -2.50e-01 | 6.59e-01 |
| GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS | 5 | 3.34e-01 | 2.49e-01 | 6.88e-01 |
| GOBP RRNA 3 END PROCESSING | 10 | 1.72e-01 | 2.49e-01 | 5.38e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 9 | 1.96e-01 | -2.49e-01 | 5.68e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 7 | 2.54e-01 | 2.49e-01 | 6.31e-01 |
| GOCC EUKARYOTIC 48S PREINITIATION COMPLEX | 16 | 8.49e-02 | -2.49e-01 | 4.12e-01 |
| GOBP COBALAMIN TRANSPORT | 5 | 3.36e-01 | 2.49e-01 | 6.90e-01 |
| GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS | 6 | 2.92e-01 | -2.49e-01 | 6.60e-01 |
| GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 15 | 9.57e-02 | -2.49e-01 | 4.32e-01 |
| GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS | 10 | 1.74e-01 | -2.49e-01 | 5.39e-01 |
| GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 31 | 1.67e-02 | -2.48e-01 | 2.03e-01 |
| GOBP INTRACELLULAR PH REDUCTION | 47 | 3.24e-03 | -2.48e-01 | 9.02e-02 |
| GOBP CMP METABOLIC PROCESS | 7 | 2.56e-01 | 2.48e-01 | 6.31e-01 |
| GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY | 7 | 2.56e-01 | -2.48e-01 | 6.31e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX | 18 | 6.86e-02 | -2.48e-01 | 3.78e-01 |
| GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION | 10 | 1.75e-01 | 2.48e-01 | 5.41e-01 |
| GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 15 | 9.65e-02 | -2.48e-01 | 4.33e-01 |
| GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING | 17 | 7.68e-02 | -2.48e-01 | 3.97e-01 |
| GOBP RETROGRADE AXONAL TRANSPORT | 13 | 1.22e-01 | -2.48e-01 | 4.75e-01 |
| GOBP DESMOSOME ORGANIZATION | 5 | 3.38e-01 | 2.48e-01 | 6.91e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS | 5 | 3.38e-01 | -2.48e-01 | 6.91e-01 |
| GOBP IMMUNOLOGICAL SYNAPSE FORMATION | 14 | 1.10e-01 | -2.47e-01 | 4.56e-01 |
| GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY | 28 | 2.39e-02 | -2.47e-01 | 2.40e-01 |
| GOMF CASPASE BINDING | 7 | 2.58e-01 | -2.47e-01 | 6.35e-01 |
| GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT | 6 | 2.95e-01 | 2.47e-01 | 6.62e-01 |
| GOBP PURINE NUCLEOSIDE METABOLIC PROCESS | 17 | 7.84e-02 | 2.47e-01 | 4.00e-01 |
| GOMF TYPE 5 METABOTROPIC GLUTAMATE RECEPTOR BINDING | 5 | 3.40e-01 | -2.47e-01 | 6.93e-01 |
| GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION | 6 | 2.96e-01 | 2.46e-01 | 6.62e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS | 21 | 5.07e-02 | 2.46e-01 | 3.28e-01 |
| GOMF VINCULIN BINDING | 9 | 2.01e-01 | -2.46e-01 | 5.76e-01 |
| GOBP REELIN MEDIATED SIGNALING PATHWAY | 5 | 3.41e-01 | -2.46e-01 | 6.94e-01 |
| GOBP RNA METHYLATION | 83 | 1.09e-04 | 2.46e-01 | 1.20e-02 |
| GOCC ENDOLYSOSOME LUMEN | 5 | 3.41e-01 | -2.46e-01 | 6.94e-01 |
| GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 5 | 3.41e-01 | 2.46e-01 | 6.95e-01 |
| GOBP HEAT ACCLIMATION | 5 | 3.42e-01 | 2.45e-01 | 6.95e-01 |
| GOBP 2FE 2S CLUSTER ASSEMBLY | 11 | 1.59e-01 | 2.45e-01 | 5.25e-01 |
| GOBP REGULATION OF PROTON TRANSPORT | 13 | 1.26e-01 | -2.45e-01 | 4.81e-01 |
| GOBP RESPONSE TO INDOLE 3 METHANOL | 6 | 2.99e-01 | -2.45e-01 | 6.63e-01 |
| GOBP NECROPTOTIC SIGNALING PATHWAY | 7 | 2.62e-01 | 2.45e-01 | 6.39e-01 |
| GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY | 11 | 1.60e-01 | -2.45e-01 | 5.25e-01 |
| GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX | 8 | 2.31e-01 | -2.45e-01 | 6.08e-01 |
| GOBP PEPTIDE CATABOLIC PROCESS | 14 | 1.13e-01 | -2.45e-01 | 4.60e-01 |
| GOBP REGULATION OF STRESS GRANULE ASSEMBLY | 7 | 2.62e-01 | 2.45e-01 | 6.39e-01 |
| GOBP NEGATIVE REGULATION OF ANOIKIS | 12 | 1.42e-01 | -2.45e-01 | 5.03e-01 |
| GOCC SHELTERIN COMPLEX | 6 | 3.00e-01 | -2.45e-01 | 6.64e-01 |
| GOBP LYMPH VESSEL MORPHOGENESIS | 7 | 2.63e-01 | -2.45e-01 | 6.39e-01 |
| GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT | 18 | 7.25e-02 | -2.45e-01 | 3.89e-01 |
| GOBP DEVELOPMENTAL INDUCTION | 7 | 2.63e-01 | -2.44e-01 | 6.40e-01 |
| GOCC PLATELET DENSE GRANULE LUMEN | 5 | 3.44e-01 | -2.44e-01 | 6.97e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 13 | 1.28e-01 | -2.44e-01 | 4.85e-01 |
| GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 10 | 1.82e-01 | -2.44e-01 | 5.50e-01 |
| GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY | 6 | 3.01e-01 | 2.44e-01 | 6.65e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 9 | 2.05e-01 | -2.44e-01 | 5.81e-01 |
| GOBP FOLIC ACID METABOLIC PROCESS | 12 | 1.44e-01 | 2.44e-01 | 5.05e-01 |
| GOMF PHOSPHATASE ACTIVATOR ACTIVITY | 16 | 9.16e-02 | 2.44e-01 | 4.24e-01 |
| GOBP REGULATION OF HIPPO SIGNALING | 15 | 1.02e-01 | -2.44e-01 | 4.47e-01 |
| GOBP HIPPOCAMPUS DEVELOPMENT | 50 | 2.91e-03 | -2.44e-01 | 8.36e-02 |
| GOBP PROTEIN GERANYLGERANYLATION | 6 | 3.02e-01 | -2.44e-01 | 6.65e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 5 | 3.46e-01 | -2.44e-01 | 6.98e-01 |
| GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 5 | 3.46e-01 | -2.43e-01 | 6.98e-01 |
| GOBP FOCAL ADHESION ASSEMBLY | 53 | 2.20e-03 | -2.43e-01 | 7.24e-02 |
| GOCC COPII VESICLE COAT | 16 | 9.21e-02 | -2.43e-01 | 4.24e-01 |
| GOCC FLOTILLIN COMPLEX | 7 | 2.66e-01 | -2.43e-01 | 6.43e-01 |
| GOBP REGULATION OF LYSOSOME SIZE | 8 | 2.34e-01 | -2.43e-01 | 6.12e-01 |
| GOCC BORC COMPLEX | 8 | 2.34e-01 | -2.43e-01 | 6.12e-01 |
| GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS | 7 | 2.66e-01 | -2.43e-01 | 6.44e-01 |
| GOBP NCRNA EXPORT FROM NUCLEUS | 9 | 2.07e-01 | -2.43e-01 | 5.83e-01 |
| GOBP LIPID PHOSPHORYLATION | 8 | 2.35e-01 | 2.43e-01 | 6.12e-01 |
| GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY | 8 | 2.35e-01 | 2.43e-01 | 6.12e-01 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION | 10 | 1.84e-01 | 2.43e-01 | 5.53e-01 |
| GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS | 6 | 3.03e-01 | -2.43e-01 | 6.67e-01 |
| GOBP VACUOLAR ACIDIFICATION | 31 | 1.95e-02 | -2.42e-01 | 2.18e-01 |
| GOBP REGULATION OF CENTRIOLE REPLICATION | 20 | 6.07e-02 | 2.42e-01 | 3.58e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE CAPPING | 14 | 1.17e-01 | 2.42e-01 | 4.65e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 15 | 1.05e-01 | -2.42e-01 | 4.50e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS | 7 | 2.67e-01 | 2.42e-01 | 6.44e-01 |
| GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX | 15 | 1.05e-01 | 2.42e-01 | 4.50e-01 |
| GOBP GROWTH HORMONE SECRETION | 8 | 2.36e-01 | -2.42e-01 | 6.14e-01 |
| GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY | 6 | 3.06e-01 | 2.42e-01 | 6.69e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 12 | 1.48e-01 | -2.41e-01 | 5.09e-01 |
| GOMF PENTOSYLTRANSFERASE ACTIVITY | 44 | 5.65e-03 | 2.41e-01 | 1.26e-01 |
| GOBP BROWN FAT CELL DIFFERENTIATION | 30 | 2.22e-02 | -2.41e-01 | 2.31e-01 |
| GOBP NEUROBLAST DIVISION | 7 | 2.69e-01 | -2.41e-01 | 6.46e-01 |
| GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE | 6 | 3.06e-01 | -2.41e-01 | 6.69e-01 |
| GOCC CENTRIOLAR SUBDISTAL APPENDAGE | 8 | 2.38e-01 | 2.41e-01 | 6.16e-01 |
| GOMF PHOSPHOFRUCTOKINASE ACTIVITY | 6 | 3.07e-01 | -2.41e-01 | 6.69e-01 |
| GOMF POLY ADP D RIBOSE BINDING | 6 | 3.07e-01 | 2.41e-01 | 6.69e-01 |
| GOBP NODAL SIGNALING PATHWAY | 7 | 2.70e-01 | -2.41e-01 | 6.47e-01 |
| GOMF DEOXYCYTIDINE DEAMINASE ACTIVITY | 5 | 3.51e-01 | -2.41e-01 | 7.01e-01 |
| GOBP INTERLEUKIN 4 PRODUCTION | 23 | 4.57e-02 | -2.41e-01 | 3.15e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT | 11 | 1.67e-01 | 2.41e-01 | 5.34e-01 |
| GOBP NUCLEAR RNA SURVEILLANCE | 14 | 1.19e-01 | 2.41e-01 | 4.71e-01 |
| GOBP OUTFLOW TRACT MORPHOGENESIS | 34 | 1.53e-02 | -2.40e-01 | 1.97e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 16 | 9.60e-02 | -2.40e-01 | 4.32e-01 |
| GOBP VITAMIN K METABOLIC PROCESS | 5 | 3.52e-01 | 2.40e-01 | 7.02e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 17 | 8.64e-02 | -2.40e-01 | 4.16e-01 |
| GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY | 6 | 3.08e-01 | -2.40e-01 | 6.70e-01 |
| GOBP TRNA CATABOLIC PROCESS | 16 | 9.65e-02 | 2.40e-01 | 4.33e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY | 23 | 4.64e-02 | 2.40e-01 | 3.15e-01 |
| GOBP REGULATION OF SUPEROXIDE ANION GENERATION | 14 | 1.20e-01 | -2.40e-01 | 4.72e-01 |
| GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION | 13 | 1.34e-01 | -2.40e-01 | 4.93e-01 |
| GOBP IMP BIOSYNTHETIC PROCESS | 10 | 1.89e-01 | 2.40e-01 | 5.60e-01 |
| GOBP ESTABLISHMENT OF SKIN BARRIER | 11 | 1.69e-01 | -2.40e-01 | 5.34e-01 |
| GOBP PHAGOLYSOSOME ASSEMBLY | 14 | 1.21e-01 | -2.40e-01 | 4.74e-01 |
| GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 27 | 3.15e-02 | -2.39e-01 | 2.67e-01 |
| GOMF DIPEPTIDASE ACTIVITY | 10 | 1.91e-01 | 2.39e-01 | 5.62e-01 |
| GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 32 | 1.95e-02 | 2.39e-01 | 2.18e-01 |
| GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS | 25 | 3.90e-02 | -2.39e-01 | 2.97e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS | 13 | 1.36e-01 | -2.39e-01 | 4.94e-01 |
| GOBP URONIC ACID METABOLIC PROCESS | 7 | 2.74e-01 | 2.39e-01 | 6.51e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 15 | 1.10e-01 | -2.38e-01 | 4.56e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 6 | 3.12e-01 | -2.38e-01 | 6.75e-01 |
| GOMF NUCLEAR VITAMIN D RECEPTOR BINDING | 15 | 1.10e-01 | -2.38e-01 | 4.56e-01 |
| GOBP FACE MORPHOGENESIS | 14 | 1.23e-01 | -2.38e-01 | 4.76e-01 |
| GOMF O METHYLTRANSFERASE ACTIVITY | 19 | 7.24e-02 | 2.38e-01 | 3.89e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 10 | 1.93e-01 | 2.38e-01 | 5.65e-01 |
| GOBP ENDOTHELIAL CELL DEVELOPMENT | 44 | 6.35e-03 | -2.38e-01 | 1.35e-01 |
| GOBP GROWTH PLATE CARTILAGE DEVELOPMENT | 9 | 2.17e-01 | -2.38e-01 | 5.94e-01 |
| GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 8 | 2.44e-01 | -2.38e-01 | 6.22e-01 |
| GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 8 | 2.44e-01 | -2.38e-01 | 6.22e-01 |
| GOMF HISTONE KINASE ACTIVITY | 13 | 1.38e-01 | 2.38e-01 | 4.97e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 9 | 2.17e-01 | 2.37e-01 | 5.94e-01 |
| GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION | 17 | 9.02e-02 | -2.37e-01 | 4.24e-01 |
| GOMF G PROTEIN ALPHA SUBUNIT BINDING | 17 | 9.02e-02 | 2.37e-01 | 4.24e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE | 9 | 2.18e-01 | -2.37e-01 | 5.94e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX | 11 | 1.73e-01 | -2.37e-01 | 5.39e-01 |
| GOBP REGULATION OF APPETITE | 8 | 2.45e-01 | -2.37e-01 | 6.22e-01 |
| GOBP SUCCINYL COA CATABOLIC PROCESS | 6 | 3.15e-01 | 2.37e-01 | 6.78e-01 |
| GOBP AMIDE CATABOLIC PROCESS | 7 | 2.77e-01 | -2.37e-01 | 6.53e-01 |
| GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX | 9 | 2.18e-01 | -2.37e-01 | 5.95e-01 |
| GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION | 21 | 6.03e-02 | -2.37e-01 | 3.57e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 7 | 2.78e-01 | 2.37e-01 | 6.53e-01 |
| GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I | 18 | 8.22e-02 | 2.37e-01 | 4.09e-01 |
| GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH | 5 | 3.60e-01 | -2.37e-01 | 7.10e-01 |
| GOCC U2AF COMPLEX | 5 | 3.60e-01 | -2.37e-01 | 7.10e-01 |
| GOBP PROTEIN CONTAINING COMPLEX REMODELING | 10 | 1.95e-01 | 2.36e-01 | 5.68e-01 |
| GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT | 19 | 7.45e-02 | -2.36e-01 | 3.94e-01 |
| GOBP TRANSLOCATION OF MOLECULES INTO HOST | 8 | 2.47e-01 | 2.36e-01 | 6.23e-01 |
| GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY | 7 | 2.79e-01 | 2.36e-01 | 6.54e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE BINDING | 6 | 3.17e-01 | 2.36e-01 | 6.79e-01 |
| GOBP HARD PALATE DEVELOPMENT | 5 | 3.61e-01 | 2.36e-01 | 7.10e-01 |
| GOBP RIBOSOME DISASSEMBLY | 13 | 1.41e-01 | 2.36e-01 | 5.00e-01 |
| GOBP HEART TRABECULA MORPHOGENESIS | 15 | 1.14e-01 | -2.36e-01 | 4.61e-01 |
| GOBP CHOLESTEROL IMPORT | 6 | 3.17e-01 | -2.36e-01 | 6.79e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 10 | 1.97e-01 | -2.36e-01 | 5.70e-01 |
| GOCC INTEGRATOR COMPLEX | 16 | 1.03e-01 | 2.36e-01 | 4.47e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS | 8 | 2.49e-01 | -2.36e-01 | 6.25e-01 |
| GOMF PHOSPHATIDYLGLYCEROL BINDING | 8 | 2.49e-01 | 2.36e-01 | 6.25e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION | 40 | 1.00e-02 | -2.35e-01 | 1.66e-01 |
| GOBP MATURATION OF SSU RRNA | 50 | 4.00e-03 | 2.35e-01 | 1.01e-01 |
| GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS | 6 | 3.18e-01 | 2.35e-01 | 6.80e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 6 | 3.19e-01 | -2.35e-01 | 6.80e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE | 19 | 7.61e-02 | -2.35e-01 | 3.96e-01 |
| GOMF DEACETYLASE ACTIVITY | 32 | 2.14e-02 | 2.35e-01 | 2.27e-01 |
| GOBP LINOLEIC ACID METABOLIC PROCESS | 9 | 2.22e-01 | -2.35e-01 | 5.97e-01 |
| GOBP CHRONIC INFLAMMATORY RESPONSE | 11 | 1.77e-01 | -2.35e-01 | 5.45e-01 |
| GOBP REGULATION OF CAMP MEDIATED SIGNALING | 12 | 1.59e-01 | -2.35e-01 | 5.25e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS | 10 | 1.98e-01 | -2.35e-01 | 5.72e-01 |
| GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY | 6 | 3.19e-01 | 2.35e-01 | 6.80e-01 |
| GOBP CHOLESTEROL STORAGE | 19 | 7.65e-02 | -2.35e-01 | 3.97e-01 |
| GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY | 7 | 2.82e-01 | -2.35e-01 | 6.55e-01 |
| GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY | 7 | 2.82e-01 | 2.35e-01 | 6.55e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY | 7 | 2.82e-01 | 2.35e-01 | 6.55e-01 |
| GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 14 | 1.29e-01 | -2.35e-01 | 4.85e-01 |
| GOBP RESPONSE TO CAFFEINE | 11 | 1.78e-01 | 2.35e-01 | 5.46e-01 |
| GOBP PROTEIN DEMETHYLATION | 12 | 1.59e-01 | -2.35e-01 | 5.25e-01 |
| GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS | 22 | 5.69e-02 | 2.35e-01 | 3.48e-01 |
| GOCC MICROBODY LUMEN | 34 | 1.80e-02 | 2.34e-01 | 2.10e-01 |
| GOBP BASE EXCISION REPAIR GAP FILLING | 12 | 1.60e-01 | 2.34e-01 | 5.25e-01 |
| GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION | 6 | 3.20e-01 | -2.34e-01 | 6.80e-01 |
| GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS | 5 | 3.64e-01 | -2.34e-01 | 7.11e-01 |
| GOBP MYELOID DENDRITIC CELL DIFFERENTIATION | 13 | 1.44e-01 | -2.34e-01 | 5.05e-01 |
| GOMF METALLOCARBOXYPEPTIDASE ACTIVITY | 7 | 2.84e-01 | -2.34e-01 | 6.55e-01 |
| GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE | 6 | 3.21e-01 | 2.34e-01 | 6.81e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION | 11 | 1.79e-01 | 2.34e-01 | 5.48e-01 |
| GOCC MHC CLASS I PEPTIDE LOADING COMPLEX | 8 | 2.52e-01 | 2.34e-01 | 6.29e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 17 | 9.52e-02 | -2.34e-01 | 4.31e-01 |
| GOBP LIPID DROPLET DISASSEMBLY | 5 | 3.66e-01 | -2.34e-01 | 7.11e-01 |
| GOCC HAUS COMPLEX | 8 | 2.53e-01 | -2.34e-01 | 6.29e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 15 | 1.17e-01 | -2.34e-01 | 4.66e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY | 5 | 3.66e-01 | -2.34e-01 | 7.11e-01 |
| GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE | 37 | 1.40e-02 | -2.34e-01 | 1.91e-01 |
| GOCC SMAD PROTEIN COMPLEX | 7 | 2.85e-01 | -2.34e-01 | 6.55e-01 |
| GOBP CARTILAGE CONDENSATION | 5 | 3.66e-01 | 2.33e-01 | 7.11e-01 |
| GOBP CELL AGGREGATION | 5 | 3.66e-01 | 2.33e-01 | 7.11e-01 |
| GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS | 6 | 3.22e-01 | 2.33e-01 | 6.81e-01 |
| GOBP PEPTIDYL LYSINE TRIMETHYLATION | 8 | 2.53e-01 | 2.33e-01 | 6.30e-01 |
| GOBP RESPONSE TO NITRIC OXIDE | 11 | 1.80e-01 | -2.33e-01 | 5.48e-01 |
| GOCC GOLGI MEDIAL CISTERNA | 11 | 1.80e-01 | 2.33e-01 | 5.48e-01 |
| GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY | 27 | 3.62e-02 | -2.33e-01 | 2.84e-01 |
| GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 6 | 3.23e-01 | -2.33e-01 | 6.81e-01 |
| GOMF TRANSCRIPTION COACTIVATOR BINDING | 31 | 2.50e-02 | -2.33e-01 | 2.44e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSLATION | 25 | 4.41e-02 | 2.33e-01 | 3.10e-01 |
| GOBP POSITIVE REGULATION OF TORC2 SIGNALING | 5 | 3.68e-01 | 2.33e-01 | 7.12e-01 |
| GOBP TOLERANCE INDUCTION | 17 | 9.69e-02 | -2.33e-01 | 4.34e-01 |
| GOBP DNA REPLICATION INITIATION | 23 | 5.36e-02 | 2.33e-01 | 3.38e-01 |
| GOBP TYPE B PANCREATIC CELL PROLIFERATION | 14 | 1.32e-01 | -2.32e-01 | 4.89e-01 |
| GOBP NUCLEAR PORE LOCALIZATION | 5 | 3.68e-01 | -2.32e-01 | 7.13e-01 |
| GOCC NUCLEAR STRESS GRANULE | 6 | 3.24e-01 | 2.32e-01 | 6.81e-01 |
| GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES | 7 | 2.87e-01 | 2.32e-01 | 6.57e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET | 35 | 1.75e-02 | -2.32e-01 | 2.07e-01 |
| GOMF K63 LINKED DEUBIQUITINASE ACTIVITY | 14 | 1.33e-01 | -2.32e-01 | 4.91e-01 |
| GOBP DNA LIGATION | 16 | 1.08e-01 | 2.32e-01 | 4.54e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA BINDING | 14 | 1.33e-01 | -2.32e-01 | 4.91e-01 |
| GOBP REGULATION OF INTEGRIN ACTIVATION | 7 | 2.88e-01 | -2.32e-01 | 6.58e-01 |
| GOBP ENDOCARDIAL CUSHION FORMATION | 11 | 1.84e-01 | -2.31e-01 | 5.53e-01 |
| GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA | 20 | 7.34e-02 | -2.31e-01 | 3.91e-01 |
| GOMF ABC TYPE TRANSPORTER ACTIVITY | 26 | 4.15e-02 | 2.31e-01 | 3.03e-01 |
| GOBP WALKING BEHAVIOR | 19 | 8.14e-02 | -2.31e-01 | 4.09e-01 |
| GOMF SPHINGOLIPID BINDING | 16 | 1.10e-01 | -2.31e-01 | 4.56e-01 |
| GOMF MYOSIN V BINDING | 10 | 2.07e-01 | -2.31e-01 | 5.82e-01 |
| GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY | 5 | 3.72e-01 | 2.31e-01 | 7.15e-01 |
| GOCC RAGULATOR COMPLEX | 5 | 3.72e-01 | -2.31e-01 | 7.15e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER | 37 | 1.53e-02 | -2.31e-01 | 1.97e-01 |
| GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 31 | 2.64e-02 | -2.30e-01 | 2.51e-01 |
| GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS | 41 | 1.07e-02 | -2.30e-01 | 1.71e-01 |
| GOCC TERTIARY GRANULE LUMEN | 40 | 1.17e-02 | -2.30e-01 | 1.76e-01 |
| GOBP MITOCHONDRIAL RNA 3 END PROCESSING | 6 | 3.29e-01 | 2.30e-01 | 6.86e-01 |
| GOBP CHONDROCYTE PROLIFERATION | 7 | 2.91e-01 | -2.30e-01 | 6.60e-01 |
| GOMF CD4 RECEPTOR BINDING | 7 | 2.92e-01 | -2.30e-01 | 6.60e-01 |
| GOBP RESPONSE TO STEROL DEPLETION | 15 | 1.23e-01 | -2.30e-01 | 4.76e-01 |
| GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 8 | 2.60e-01 | -2.30e-01 | 6.37e-01 |
| GOMF SUPERCOILED DNA BINDING | 6 | 3.29e-01 | -2.30e-01 | 6.86e-01 |
| GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 6 | 3.29e-01 | 2.30e-01 | 6.86e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 14 | 1.36e-01 | -2.30e-01 | 4.94e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 12 | 1.68e-01 | -2.30e-01 | 5.34e-01 |
| GOBP CELL MATRIX ADHESION | 122 | 1.19e-05 | -2.30e-01 | 3.01e-03 |
| GOBP CELL CELL JUNCTION MAINTENANCE | 7 | 2.92e-01 | -2.30e-01 | 6.61e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 7 | 2.93e-01 | -2.30e-01 | 6.61e-01 |
| GOBP T HELPER 1 CELL CYTOKINE PRODUCTION | 6 | 3.30e-01 | -2.30e-01 | 6.86e-01 |
| GOBP TRNA WOBBLE BASE MODIFICATION | 18 | 9.21e-02 | 2.29e-01 | 4.24e-01 |
| GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 12 | 1.69e-01 | -2.29e-01 | 5.35e-01 |
| GOBP PHOTORECEPTOR CELL MAINTENANCE | 18 | 9.22e-02 | -2.29e-01 | 4.24e-01 |
| GOBP SKELETAL MUSCLE ADAPTATION | 8 | 2.62e-01 | -2.29e-01 | 6.39e-01 |
| GOCC PLATELET ALPHA GRANULE LUMEN | 37 | 1.59e-02 | -2.29e-01 | 1.98e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 5 | 3.75e-01 | 2.29e-01 | 7.17e-01 |
| GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS | 5 | 3.75e-01 | 2.29e-01 | 7.17e-01 |
| GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 7 | 2.94e-01 | -2.29e-01 | 6.62e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING | 7 | 2.94e-01 | 2.29e-01 | 6.62e-01 |
| GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS | 5 | 3.76e-01 | -2.29e-01 | 7.17e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX | 7 | 2.95e-01 | -2.29e-01 | 6.62e-01 |
| GOBP SPERMINE METABOLIC PROCESS | 5 | 3.76e-01 | -2.29e-01 | 7.17e-01 |
| GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 15 | 1.25e-01 | 2.29e-01 | 4.81e-01 |
| GOCC RETROMER COMPLEX | 12 | 1.70e-01 | -2.29e-01 | 5.36e-01 |
| GOCC CUTICULAR PLATE | 5 | 3.76e-01 | 2.28e-01 | 7.17e-01 |
| GOBP REGULATION OF MIRNA TRANSCRIPTION | 43 | 9.62e-03 | -2.28e-01 | 1.63e-01 |
| GOMF 5 3 DNA EXONUCLEASE ACTIVITY | 5 | 3.77e-01 | -2.28e-01 | 7.18e-01 |
| GOBP NUCLEAR MRNA SURVEILLANCE | 10 | 2.12e-01 | 2.28e-01 | 5.87e-01 |
| GOBP POSITIVE REGULATION OF HEART GROWTH | 12 | 1.71e-01 | -2.28e-01 | 5.36e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 10 | 2.12e-01 | -2.28e-01 | 5.87e-01 |
| GOMF T CELL RECEPTOR BINDING | 10 | 2.12e-01 | 2.28e-01 | 5.87e-01 |
| GOBP NUCLEOBASE TRANSPORT | 5 | 3.77e-01 | -2.28e-01 | 7.18e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 7 | 2.96e-01 | 2.28e-01 | 6.63e-01 |
| GOBP SIGNAL COMPLEX ASSEMBLY | 7 | 2.97e-01 | -2.28e-01 | 6.63e-01 |
| GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 16 | 1.15e-01 | -2.27e-01 | 4.63e-01 |
| GOBP REGULATION OF CELL MATRIX ADHESION | 73 | 7.95e-04 | -2.27e-01 | 4.04e-02 |
| GOBP PROTEIN NEDDYLATION | 25 | 4.93e-02 | -2.27e-01 | 3.22e-01 |
| GOBP REGULATION OF MEMBRANE INVAGINATION | 9 | 2.38e-01 | 2.27e-01 | 6.16e-01 |
| GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS | 39 | 1.42e-02 | -2.27e-01 | 1.93e-01 |
| GOCC GABA ERGIC SYNAPSE | 21 | 7.18e-02 | -2.27e-01 | 3.87e-01 |
| GOBP CELL ADHESION MEDIATED BY INTEGRIN | 46 | 7.87e-03 | -2.27e-01 | 1.50e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 8 | 2.67e-01 | -2.27e-01 | 6.44e-01 |
| GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR | 46 | 7.89e-03 | -2.27e-01 | 1.50e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SYNAPSE | 9 | 2.39e-01 | -2.27e-01 | 6.17e-01 |
| GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS | 13 | 1.58e-01 | 2.26e-01 | 5.24e-01 |
| GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 3.00e-01 | -2.26e-01 | 6.64e-01 |
| GOMF PRE MRNA BINDING | 29 | 3.50e-02 | -2.26e-01 | 2.80e-01 |
| GOCC MITOCHONDRIAL CRISTA | 6 | 3.37e-01 | -2.26e-01 | 6.91e-01 |
| GOBP NEGATIVE REGULATION OF WOUND HEALING | 26 | 4.61e-02 | -2.26e-01 | 3.15e-01 |
| GOBP U4 SNRNA 3 END PROCESSING | 8 | 2.69e-01 | 2.26e-01 | 6.45e-01 |
| GOBP REGULATION OF MUCUS SECRETION | 5 | 3.82e-01 | -2.26e-01 | 7.23e-01 |
| GOMF PHOSPHATIDYLSERINE BINDING | 31 | 2.98e-02 | 2.26e-01 | 2.62e-01 |
| GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY | 13 | 1.59e-01 | 2.26e-01 | 5.25e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO FUNGUS | 5 | 3.82e-01 | 2.26e-01 | 7.23e-01 |
| GOBP NUCLEOSIDE SALVAGE | 9 | 2.42e-01 | 2.25e-01 | 6.20e-01 |
| GOMF HYALURONIC ACID BINDING | 10 | 2.17e-01 | 2.25e-01 | 5.94e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 17 | 1.08e-01 | 2.25e-01 | 4.54e-01 |
| GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY | 6 | 3.39e-01 | -2.25e-01 | 6.93e-01 |
| GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 20 | 8.16e-02 | 2.25e-01 | 4.09e-01 |
| GOMF CCR CHEMOKINE RECEPTOR BINDING | 9 | 2.43e-01 | 2.25e-01 | 6.21e-01 |
| GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS | 18 | 9.90e-02 | -2.25e-01 | 4.39e-01 |
| GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 5 | 3.85e-01 | 2.25e-01 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 6 | 3.41e-01 | -2.24e-01 | 6.94e-01 |
| GOMF MONOCARBOXYLIC ACID BINDING | 35 | 2.17e-02 | -2.24e-01 | 2.29e-01 |
| GOMF 7S RNA BINDING | 7 | 3.04e-01 | -2.24e-01 | 6.68e-01 |
| GOBP MICROTUBULE SEVERING | 7 | 3.04e-01 | -2.24e-01 | 6.68e-01 |
| GOBP REGULATION OF TELOMERE CAPPING | 23 | 6.28e-02 | 2.24e-01 | 3.63e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX | 21 | 7.55e-02 | -2.24e-01 | 3.96e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 5 | 3.85e-01 | 2.24e-01 | 7.25e-01 |
| GOBP POLYOL CATABOLIC PROCESS | 7 | 3.05e-01 | -2.24e-01 | 6.68e-01 |
| GOBP PROTEIN DENEDDYLATION | 10 | 2.20e-01 | -2.24e-01 | 5.95e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 54 | 4.44e-03 | -2.24e-01 | 1.08e-01 |
| GOBP VESICLE CARGO LOADING | 27 | 4.40e-02 | -2.24e-01 | 3.10e-01 |
| GOBP GLUTAMINE METABOLIC PROCESS | 17 | 1.10e-01 | 2.24e-01 | 4.56e-01 |
| GOCC PLATELET DENSE GRANULE | 10 | 2.20e-01 | -2.24e-01 | 5.96e-01 |
| GOBP REGULATION OF LIPOPHAGY | 5 | 3.86e-01 | 2.24e-01 | 7.25e-01 |
| GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS | 9 | 2.45e-01 | -2.24e-01 | 6.22e-01 |
| GOBP HYALURONAN CATABOLIC PROCESS | 9 | 2.46e-01 | -2.23e-01 | 6.22e-01 |
| GOMF CARBON NITROGEN LYASE ACTIVITY | 10 | 2.21e-01 | 2.23e-01 | 5.97e-01 |
| GOBP MITOCHONDRION DISTRIBUTION | 13 | 1.63e-01 | 2.23e-01 | 5.29e-01 |
| GOBP PEPTIDYL HISTIDINE MODIFICATION | 7 | 3.06e-01 | 2.23e-01 | 6.69e-01 |
| GOBP CELLULAR RESPONSE TO SALT STRESS | 9 | 2.46e-01 | 2.23e-01 | 6.23e-01 |
| GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION | 5 | 3.87e-01 | -2.23e-01 | 7.26e-01 |
| GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION | 5 | 3.87e-01 | 2.23e-01 | 7.26e-01 |
| GOBP COBALAMIN METABOLIC PROCESS | 7 | 3.06e-01 | 2.23e-01 | 6.69e-01 |
| GOBP RESPONSE TO MUSCLE STRETCH | 16 | 1.22e-01 | -2.23e-01 | 4.75e-01 |
| GOMF SULFOTRANSFERASE ACTIVITY | 18 | 1.01e-01 | -2.23e-01 | 4.45e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 6 | 3.44e-01 | 2.23e-01 | 6.96e-01 |
| GOCC JUXTAPARANODE REGION OF AXON | 7 | 3.07e-01 | -2.23e-01 | 6.69e-01 |
| GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 10 | 2.22e-01 | -2.23e-01 | 5.97e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 11 | 2.01e-01 | 2.23e-01 | 5.76e-01 |
| GOBP MITOCHONDRIAL FUSION | 31 | 3.20e-02 | -2.23e-01 | 2.70e-01 |
| GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 5 | 3.89e-01 | -2.23e-01 | 7.27e-01 |
| GOBP REGULATION OF ENDOSOME SIZE | 13 | 1.65e-01 | -2.23e-01 | 5.31e-01 |
| GOCC MICROVILLUS | 44 | 1.07e-02 | -2.22e-01 | 1.71e-01 |
| GOMF COPPER CHAPERONE ACTIVITY | 7 | 3.08e-01 | 2.22e-01 | 6.70e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 32 | 2.96e-02 | -2.22e-01 | 2.62e-01 |
| GOBP ARACHIDONIC ACID METABOLIC PROCESS | 24 | 5.95e-02 | -2.22e-01 | 3.55e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 7 | 3.09e-01 | 2.22e-01 | 6.70e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 3.46e-01 | 2.22e-01 | 6.98e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON BETA | 20 | 8.56e-02 | 2.22e-01 | 4.14e-01 |
| GOBP QUATERNARY AMMONIUM GROUP TRANSPORT | 13 | 1.66e-01 | -2.22e-01 | 5.33e-01 |
| GOBP RNA SURVEILLANCE | 17 | 1.13e-01 | 2.22e-01 | 4.61e-01 |
| GOBP AMINO ACID BETAINE METABOLIC PROCESS | 10 | 2.24e-01 | 2.22e-01 | 6.00e-01 |
| GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 37 | 1.96e-02 | -2.22e-01 | 2.18e-01 |
| GOBP RETICULOPHAGY | 16 | 1.25e-01 | -2.22e-01 | 4.81e-01 |
| GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 25 | 5.51e-02 | -2.22e-01 | 3.42e-01 |
| GOMF MHC CLASS II RECEPTOR ACTIVITY | 9 | 2.50e-01 | 2.22e-01 | 6.27e-01 |
| GOBP INTRACELLULAR STEROL TRANSPORT | 27 | 4.65e-02 | -2.21e-01 | 3.15e-01 |
| GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION | 5 | 3.91e-01 | 2.21e-01 | 7.29e-01 |
| GOCC LARGE RIBOSOMAL SUBUNIT | 112 | 5.33e-05 | -2.21e-01 | 7.73e-03 |
| GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY | 7 | 3.11e-01 | 2.21e-01 | 6.74e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS | 14 | 1.52e-01 | 2.21e-01 | 5.15e-01 |
| GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT | 8 | 2.79e-01 | -2.21e-01 | 6.53e-01 |
| GOBP PROTEIN NITROSYLATION | 9 | 2.51e-01 | -2.21e-01 | 6.28e-01 |
| GOMF PROTEIN GERANYLGERANYLTRANSFERASE ACTIVITY | 5 | 3.92e-01 | -2.21e-01 | 7.30e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN | 12 | 1.85e-01 | 2.21e-01 | 5.54e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 6 | 3.49e-01 | -2.21e-01 | 7.00e-01 |
| GOCC CHLORIDE CHANNEL COMPLEX | 13 | 1.68e-01 | -2.21e-01 | 5.34e-01 |
| GOBP REGULATION OF LYSOSOMAL LUMEN PH | 27 | 4.74e-02 | -2.21e-01 | 3.17e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 39 | 1.73e-02 | -2.20e-01 | 2.05e-01 |
| GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 17 | 1.16e-01 | -2.20e-01 | 4.64e-01 |
| GOBP FILOPODIUM ASSEMBLY | 45 | 1.06e-02 | -2.20e-01 | 1.70e-01 |
| GOCC CENTRIOLE | 112 | 5.76e-05 | 2.20e-01 | 7.79e-03 |
| GOBP WATER TRANSPORT | 8 | 2.80e-01 | -2.20e-01 | 6.54e-01 |
| GOMF ADENOSINE DEAMINASE ACTIVITY | 9 | 2.52e-01 | 2.20e-01 | 6.29e-01 |
| GOBP T HELPER 17 CELL LINEAGE COMMITMENT | 10 | 2.28e-01 | -2.20e-01 | 6.04e-01 |
| GOBP METHIONINE METABOLIC PROCESS | 12 | 1.87e-01 | 2.20e-01 | 5.55e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 18 | 1.06e-01 | 2.20e-01 | 4.52e-01 |
| GOBP RESPONSE TO FUNGICIDE | 6 | 3.51e-01 | -2.20e-01 | 7.01e-01 |
| GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY | 11 | 2.07e-01 | 2.20e-01 | 5.82e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT | 16 | 1.28e-01 | -2.20e-01 | 4.85e-01 |
| GOBP REGULATION OF WOUND HEALING | 52 | 6.17e-03 | -2.20e-01 | 1.34e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY | 13 | 1.70e-01 | 2.20e-01 | 5.36e-01 |
| GOMF UBIQUITIN BINDING | 96 | 2.06e-04 | -2.20e-01 | 1.83e-02 |
| GOBP LOCOMOTOR RHYTHM | 10 | 2.29e-01 | 2.20e-01 | 6.07e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY | 7 | 3.15e-01 | -2.20e-01 | 6.78e-01 |
| GOBP SEBACEOUS GLAND DEVELOPMENT | 5 | 3.96e-01 | -2.19e-01 | 7.34e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 8 | 2.83e-01 | -2.19e-01 | 6.55e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 10 | 2.30e-01 | 2.19e-01 | 6.07e-01 |
| GOBP B CELL APOPTOTIC PROCESS | 22 | 7.53e-02 | -2.19e-01 | 3.96e-01 |
| GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 9 | 2.55e-01 | 2.19e-01 | 6.31e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM | 46 | 1.03e-02 | -2.19e-01 | 1.68e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY PHOSPHOTRANSFERASES | 8 | 2.84e-01 | 2.19e-01 | 6.55e-01 |
| GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY | 21 | 8.26e-02 | 2.19e-01 | 4.09e-01 |
| GOBP PRIMITIVE HEMOPOIESIS | 6 | 3.53e-01 | -2.19e-01 | 7.04e-01 |
| GOMF MUTSALPHA COMPLEX BINDING | 6 | 3.53e-01 | 2.19e-01 | 7.04e-01 |
| GOCC IMMUNOLOGICAL SYNAPSE | 43 | 1.31e-02 | -2.19e-01 | 1.86e-01 |
| GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS | 8 | 2.84e-01 | 2.19e-01 | 6.55e-01 |
| GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 42 | 1.43e-02 | -2.19e-01 | 1.93e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY | 5 | 3.98e-01 | 2.18e-01 | 7.35e-01 |
| GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL | 9 | 2.57e-01 | -2.18e-01 | 6.33e-01 |
| GOBP HEMOGLOBIN METABOLIC PROCESS | 11 | 2.10e-01 | -2.18e-01 | 5.85e-01 |
| GOMF NAD BINDING | 45 | 1.14e-02 | 2.18e-01 | 1.74e-01 |
| GOCC NADPH OXIDASE COMPLEX | 8 | 2.86e-01 | -2.18e-01 | 6.56e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 31 | 3.58e-02 | -2.18e-01 | 2.83e-01 |
| GOBP MRNA 5 SPLICE SITE RECOGNITION | 5 | 3.99e-01 | 2.18e-01 | 7.37e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION | 6 | 3.56e-01 | -2.18e-01 | 7.06e-01 |
| GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 9 | 2.58e-01 | 2.18e-01 | 6.35e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 23 | 7.09e-02 | -2.18e-01 | 3.85e-01 |
| GOBP ENDOTHELIAL CELL MORPHOGENESIS | 5 | 4.00e-01 | -2.18e-01 | 7.37e-01 |
| GOBP CENTROMERIC SISTER CHROMATID COHESION | 8 | 2.87e-01 | -2.17e-01 | 6.57e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION | 7 | 3.19e-01 | 2.17e-01 | 6.80e-01 |
| GOMF CYCLIN BINDING | 22 | 7.77e-02 | -2.17e-01 | 4.00e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 8 | 2.87e-01 | -2.17e-01 | 6.57e-01 |
| GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 14 | 1.59e-01 | -2.17e-01 | 5.25e-01 |
| GOBP T HELPER 2 CELL DIFFERENTIATION | 14 | 1.59e-01 | -2.17e-01 | 5.25e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 11 | 2.12e-01 | -2.17e-01 | 5.87e-01 |
| GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION | 39 | 1.90e-02 | -2.17e-01 | 2.15e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS | 15 | 1.46e-01 | 2.17e-01 | 5.07e-01 |
| GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 17 | 1.21e-01 | 2.17e-01 | 4.75e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 25 | 6.05e-02 | -2.17e-01 | 3.58e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 18 | 1.11e-01 | -2.17e-01 | 4.57e-01 |
| GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 10 | 2.35e-01 | -2.17e-01 | 6.12e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 46 | 1.09e-02 | -2.17e-01 | 1.73e-01 |
| GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT | 11 | 2.13e-01 | 2.17e-01 | 5.88e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR | 7 | 3.20e-01 | 2.17e-01 | 6.80e-01 |
| GOBP REGULATION OF PRO B CELL DIFFERENTIATION | 6 | 3.58e-01 | -2.17e-01 | 7.09e-01 |
| GOBP PROTEIN RETENTION IN ER LUMEN | 6 | 3.58e-01 | -2.17e-01 | 7.09e-01 |
| GOBP ANIMAL ORGAN MATURATION | 13 | 1.76e-01 | -2.17e-01 | 5.43e-01 |
| GOMF NADPLUS NUCLEOSIDASE ACTIVITY | 13 | 1.76e-01 | -2.17e-01 | 5.43e-01 |
| GOBP NEGATIVE REGULATION OF ATP METABOLIC PROCESS | 5 | 4.02e-01 | -2.17e-01 | 7.40e-01 |
| GOBP ERROR FREE TRANSLESION SYNTHESIS | 5 | 4.02e-01 | -2.16e-01 | 7.41e-01 |
| GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION | 7 | 3.22e-01 | -2.16e-01 | 6.81e-01 |
| GOBP SUPEROXIDE ANION GENERATION | 23 | 7.27e-02 | -2.16e-01 | 3.90e-01 |
| GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT | 32 | 3.45e-02 | 2.16e-01 | 2.78e-01 |
| GOBP POSTSYNAPSE ASSEMBLY | 15 | 1.48e-01 | -2.16e-01 | 5.09e-01 |
| GOMF MANNOSYLTRANSFERASE ACTIVITY | 21 | 8.70e-02 | 2.16e-01 | 4.17e-01 |
| GOBP NEGATIVE REGULATION OF MYELINATION | 7 | 3.23e-01 | -2.16e-01 | 6.81e-01 |
| GOBP AMINO ACID BETAINE TRANSPORT | 7 | 3.24e-01 | -2.15e-01 | 6.81e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 3.24e-01 | 2.15e-01 | 6.81e-01 |
| GOMF DNA POLYMERASE BINDING | 20 | 9.59e-02 | 2.15e-01 | 4.32e-01 |
| GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS | 54 | 6.32e-03 | -2.15e-01 | 1.35e-01 |
| GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION | 5 | 4.05e-01 | -2.15e-01 | 7.42e-01 |
| GOBP REGULATION OF MYELINATION | 27 | 5.34e-02 | -2.15e-01 | 3.37e-01 |
| GOMF CCR5 CHEMOKINE RECEPTOR BINDING | 6 | 3.62e-01 | 2.15e-01 | 7.10e-01 |
| GOBP KERATINOCYTE DIFFERENTIATION | 59 | 4.36e-03 | -2.15e-01 | 1.07e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS | 7 | 3.25e-01 | -2.15e-01 | 6.82e-01 |
| GOCC SITE OF DOUBLE STRAND BREAK | 78 | 1.06e-03 | 2.15e-01 | 4.85e-02 |
| GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 13 | 1.80e-01 | 2.15e-01 | 5.48e-01 |
| GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY | 12 | 1.98e-01 | -2.14e-01 | 5.72e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 11 | 2.18e-01 | -2.14e-01 | 5.95e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 13 | 1.81e-01 | -2.14e-01 | 5.49e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 15 | 1.51e-01 | -2.14e-01 | 5.13e-01 |
| GOCC ER UBIQUITIN LIGASE COMPLEX | 7 | 3.27e-01 | -2.14e-01 | 6.84e-01 |
| GOMF MHC CLASS I PROTEIN BINDING | 16 | 1.39e-01 | -2.14e-01 | 4.97e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 157 | 3.97e-06 | -2.14e-01 | 1.50e-03 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE | 11 | 2.20e-01 | -2.14e-01 | 5.95e-01 |
| GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION | 34 | 3.11e-02 | -2.14e-01 | 2.67e-01 |
| GOMF HORMONE RECEPTOR BINDING | 7 | 3.28e-01 | -2.14e-01 | 6.85e-01 |
| GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 14 | 1.66e-01 | -2.14e-01 | 5.34e-01 |
| GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 8 | 2.95e-01 | -2.14e-01 | 6.62e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 53 | 7.21e-03 | -2.14e-01 | 1.45e-01 |
| GOMF SULFATIDE BINDING | 5 | 4.08e-01 | -2.13e-01 | 7.44e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR | 79 | 1.06e-03 | 2.13e-01 | 4.85e-02 |
| GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY | 9 | 2.68e-01 | -2.13e-01 | 6.44e-01 |
| GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION | 10 | 2.43e-01 | -2.13e-01 | 6.21e-01 |
| GOMF MAP KINASE ACTIVITY | 12 | 2.01e-01 | -2.13e-01 | 5.76e-01 |
| GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 75 | 1.43e-03 | -2.13e-01 | 5.85e-02 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING | 33 | 3.42e-02 | -2.13e-01 | 2.77e-01 |
| GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION | 9 | 2.68e-01 | -2.13e-01 | 6.45e-01 |
| GOBP PROTEIN K48 LINKED UBIQUITINATION | 57 | 5.43e-03 | -2.13e-01 | 1.23e-01 |
| GOCC MITOTIC COHESIN COMPLEX | 6 | 3.66e-01 | 2.13e-01 | 7.11e-01 |
| GOBP DOPAMINE TRANSPORT | 16 | 1.40e-01 | 2.13e-01 | 5.00e-01 |
| GOBP NEUTROPHIL MEDIATED IMMUNITY | 24 | 7.11e-02 | -2.13e-01 | 3.85e-01 |
| GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS | 11 | 2.22e-01 | 2.13e-01 | 5.97e-01 |
| GOCC VARICOSITY | 5 | 4.10e-01 | -2.13e-01 | 7.46e-01 |
| GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY | 8 | 2.97e-01 | -2.13e-01 | 6.63e-01 |
| GOCC ENDOPEPTIDASE COMPLEX | 74 | 1.57e-03 | -2.13e-01 | 6.12e-02 |
| GOBP POSITIVE REGULATION OF DNA LIGATION | 5 | 4.10e-01 | 2.13e-01 | 7.46e-01 |
| GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING | 14 | 1.68e-01 | 2.13e-01 | 5.34e-01 |
| GOMF DYSTROGLYCAN BINDING | 7 | 3.30e-01 | -2.13e-01 | 6.86e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 14 | 1.68e-01 | -2.13e-01 | 5.34e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 13 | 1.84e-01 | 2.13e-01 | 5.53e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT | 9 | 2.70e-01 | -2.12e-01 | 6.48e-01 |
| GOBP B CELL HOMEOSTASIS | 30 | 4.45e-02 | -2.12e-01 | 3.10e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 7 | 3.31e-01 | -2.12e-01 | 6.87e-01 |
| GOCC ESC E Z COMPLEX | 9 | 2.71e-01 | -2.12e-01 | 6.49e-01 |
| GOBP LAYER FORMATION IN CEREBRAL CORTEX | 6 | 3.69e-01 | -2.12e-01 | 7.13e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT | 5 | 4.12e-01 | 2.12e-01 | 7.48e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 29 | 4.86e-02 | -2.12e-01 | 3.21e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 50 | 9.68e-03 | -2.12e-01 | 1.64e-01 |
| GOMF PRIMARY MIRNA BINDING | 10 | 2.47e-01 | -2.12e-01 | 6.23e-01 |
| GOBP DENDRITIC CELL DIFFERENTIATION | 34 | 3.29e-02 | -2.12e-01 | 2.72e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY | 9 | 2.72e-01 | -2.12e-01 | 6.49e-01 |
| GOBP AMINO SUGAR BIOSYNTHETIC PROCESS | 10 | 2.47e-01 | 2.11e-01 | 6.23e-01 |
| GOBP INTRACILIARY TRANSPORT | 33 | 3.59e-02 | 2.11e-01 | 2.83e-01 |
| GOBP REGULATION OF ISOMERASE ACTIVITY | 7 | 3.34e-01 | -2.11e-01 | 6.88e-01 |
| GOBP ONE CARBON METABOLIC PROCESS | 22 | 8.67e-02 | 2.11e-01 | 4.16e-01 |
| GOCC PHOTORECEPTOR INNER SEGMENT | 24 | 7.36e-02 | -2.11e-01 | 3.92e-01 |
| GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM | 25 | 6.80e-02 | -2.11e-01 | 3.75e-01 |
| GOBP MELANOCYTE DIFFERENTIATION | 11 | 2.26e-01 | -2.11e-01 | 6.01e-01 |
| GOBP REGULATION OF LIPID STORAGE | 35 | 3.09e-02 | -2.11e-01 | 2.66e-01 |
| GOCC SITE OF DNA DAMAGE | 104 | 2.09e-04 | 2.11e-01 | 1.83e-02 |
| GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE | 23 | 8.03e-02 | -2.11e-01 | 4.07e-01 |
| GOBP B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE | 5 | 4.15e-01 | 2.11e-01 | 7.50e-01 |
| GOBP 2 OXOGLUTARATE METABOLIC PROCESS | 13 | 1.89e-01 | 2.11e-01 | 5.59e-01 |
| GOMF PHOSPHATE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.72e-01 | 2.11e-01 | 7.15e-01 |
| GOBP GLAND MORPHOGENESIS | 48 | 1.17e-02 | -2.10e-01 | 1.76e-01 |
| GOBP REGULATION OF NK T CELL DIFFERENTIATION | 5 | 4.15e-01 | 2.10e-01 | 7.51e-01 |
| GOBP POSITIVE REGULATION OF ORGAN GROWTH | 18 | 1.22e-01 | -2.10e-01 | 4.75e-01 |
| GOBP T CELL TOLERANCE INDUCTION | 9 | 2.75e-01 | -2.10e-01 | 6.51e-01 |
| GOMF HEPARIN BINDING | 42 | 1.85e-02 | -2.10e-01 | 2.12e-01 |
| GOBP FEEDING BEHAVIOR | 29 | 5.02e-02 | 2.10e-01 | 3.25e-01 |
| GOMF EPHRIN RECEPTOR BINDING | 17 | 1.34e-01 | -2.10e-01 | 4.92e-01 |
| GOBP PROTEIN UFMYLATION | 6 | 3.73e-01 | -2.10e-01 | 7.16e-01 |
| GOBP REGULATION OF RECEPTOR CLUSTERING | 9 | 2.76e-01 | -2.10e-01 | 6.52e-01 |
| GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 3.04e-01 | -2.10e-01 | 6.68e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE | 6 | 3.73e-01 | -2.10e-01 | 7.16e-01 |
| GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS | 8 | 3.04e-01 | 2.10e-01 | 6.68e-01 |
| GOCC SUPER ELONGATION COMPLEX | 5 | 4.17e-01 | -2.10e-01 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 6 | 3.74e-01 | -2.10e-01 | 7.16e-01 |
| GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY | 7 | 3.37e-01 | -2.10e-01 | 6.91e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS | 25 | 6.99e-02 | -2.10e-01 | 3.82e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY | 7 | 3.37e-01 | -2.09e-01 | 6.91e-01 |
| GOBP AROMATIC AMINO ACID TRANSPORT | 7 | 3.37e-01 | -2.09e-01 | 6.91e-01 |
| GOBP ATRIAL SEPTUM DEVELOPMENT | 9 | 2.77e-01 | -2.09e-01 | 6.53e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 9 | 2.77e-01 | -2.09e-01 | 6.53e-01 |
| GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT | 7 | 3.37e-01 | 2.09e-01 | 6.91e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 11 | 2.29e-01 | -2.09e-01 | 6.07e-01 |
| GOBP ENDOCRINE HORMONE SECRETION | 22 | 8.94e-02 | -2.09e-01 | 4.22e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION | 37 | 2.77e-02 | -2.09e-01 | 2.57e-01 |
| GOMF DNA HELICASE ACTIVITY | 47 | 1.32e-02 | 2.09e-01 | 1.86e-01 |
| GOCC SMN COMPLEX | 10 | 2.52e-01 | 2.09e-01 | 6.29e-01 |
| GOBP EMBRYONIC CLEAVAGE | 7 | 3.38e-01 | -2.09e-01 | 6.91e-01 |
| GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY | 6 | 3.75e-01 | 2.09e-01 | 7.17e-01 |
| GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY | 18 | 1.25e-01 | -2.09e-01 | 4.81e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 25 | 7.08e-02 | 2.09e-01 | 3.85e-01 |
| GOBP DIOL METABOLIC PROCESS | 18 | 1.25e-01 | 2.09e-01 | 4.81e-01 |
| GOCC CYTOPLASMIC DYNEIN COMPLEX | 15 | 1.62e-01 | 2.09e-01 | 5.28e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE | 16 | 1.48e-01 | -2.09e-01 | 5.10e-01 |
| GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY | 23 | 8.32e-02 | 2.09e-01 | 4.10e-01 |
| GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 18 | 1.25e-01 | -2.09e-01 | 4.81e-01 |
| GOBP REGULATION OF FILOPODIUM ASSEMBLY | 34 | 3.53e-02 | -2.09e-01 | 2.81e-01 |
| GOMF HYALURONONGLUCOSAMINIDASE ACTIVITY | 5 | 4.19e-01 | -2.09e-01 | 7.53e-01 |
| GOBP PROTEIN PALMITOYLATION | 23 | 8.34e-02 | -2.09e-01 | 4.10e-01 |
| GOBP GLUCOSE CATABOLIC PROCESS | 18 | 1.26e-01 | -2.09e-01 | 4.81e-01 |
| GOBP AIM2 INFLAMMASOME COMPLEX ASSEMBLY | 5 | 4.19e-01 | -2.09e-01 | 7.53e-01 |
| GOMF REGULATORY RNA BINDING | 39 | 2.43e-02 | -2.09e-01 | 2.41e-01 |
| GOBP MANNOSYLATION | 17 | 1.37e-01 | 2.09e-01 | 4.95e-01 |
| GOBP ALCOHOL CATABOLIC PROCESS | 16 | 1.49e-01 | -2.08e-01 | 5.11e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 47 | 1.35e-02 | -2.08e-01 | 1.88e-01 |
| GOBP TRNA PROCESSING | 125 | 6.03e-05 | 2.08e-01 | 8.03e-03 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE | 8 | 3.08e-01 | 2.08e-01 | 6.70e-01 |
| GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 19 | 1.16e-01 | -2.08e-01 | 4.64e-01 |
| GOBP RESPONSE TO ANTIBIOTIC | 31 | 4.51e-02 | -2.08e-01 | 3.12e-01 |
| GOBP PROTEIN LIPID COMPLEX ASSEMBLY | 18 | 1.27e-01 | -2.08e-01 | 4.84e-01 |
| GOBP POSITIVE REGULATION OF STEROL TRANSPORT | 20 | 1.08e-01 | -2.08e-01 | 4.54e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS | 14 | 1.79e-01 | -2.08e-01 | 5.47e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 10 | 2.56e-01 | -2.08e-01 | 6.31e-01 |
| GOCC SPERM PLASMA MEMBRANE | 5 | 4.22e-01 | -2.08e-01 | 7.54e-01 |
| GOBP FEAR RESPONSE | 17 | 1.39e-01 | -2.07e-01 | 4.97e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS | 7 | 3.42e-01 | 2.07e-01 | 6.95e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 5 | 4.22e-01 | 2.07e-01 | 7.54e-01 |
| GOBP T HELPER CELL LINEAGE COMMITMENT | 14 | 1.80e-01 | -2.07e-01 | 5.48e-01 |
| GOMF NUCLEAR RECEPTOR ACTIVITY | 31 | 4.61e-02 | -2.07e-01 | 3.15e-01 |
| GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 18 | 1.29e-01 | -2.07e-01 | 4.85e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 11 | 2.35e-01 | 2.07e-01 | 6.12e-01 |
| GOBP INTERLEUKIN 10 PRODUCTION | 38 | 2.75e-02 | -2.07e-01 | 2.56e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 18 | 1.29e-01 | -2.07e-01 | 4.86e-01 |
| GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 42 | 2.06e-02 | -2.07e-01 | 2.24e-01 |
| GOCC PRESPLICEOSOME | 16 | 1.53e-01 | -2.07e-01 | 5.15e-01 |
| GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 25 | 7.41e-02 | 2.06e-01 | 3.93e-01 |
| GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE | 5 | 4.24e-01 | 2.06e-01 | 7.56e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 15 | 1.67e-01 | -2.06e-01 | 5.34e-01 |
| GOCC TORC2 COMPLEX | 9 | 2.84e-01 | 2.06e-01 | 6.55e-01 |
| GOBP DETECTION OF BACTERIUM | 11 | 2.36e-01 | 2.06e-01 | 6.14e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 38 | 2.80e-02 | -2.06e-01 | 2.57e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 19 | 1.20e-01 | -2.06e-01 | 4.72e-01 |
| GOCC LSM1 7 PAT1 COMPLEX | 5 | 4.25e-01 | 2.06e-01 | 7.56e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 7 | 3.46e-01 | -2.06e-01 | 6.98e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX 2 | 5 | 4.25e-01 | 2.06e-01 | 7.56e-01 |
| GOMF O ACETYLTRANSFERASE ACTIVITY | 6 | 3.83e-01 | 2.06e-01 | 7.23e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY | 22 | 9.51e-02 | -2.06e-01 | 4.31e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 3.47e-01 | 2.06e-01 | 6.98e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY | 6 | 3.83e-01 | 2.05e-01 | 7.24e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY | 7 | 3.47e-01 | 2.05e-01 | 6.98e-01 |
| GOMF FMN BINDING | 9 | 2.86e-01 | -2.05e-01 | 6.56e-01 |
| GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY | 6 | 3.84e-01 | -2.05e-01 | 7.24e-01 |
| GOBP CHONDROITIN SULFATE METABOLIC PROCESS | 18 | 1.32e-01 | -2.05e-01 | 4.89e-01 |
| GOMF HISTONE UBIQUITIN LIGASE ACTIVITY | 10 | 2.61e-01 | -2.05e-01 | 6.38e-01 |
| GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 16 | 1.55e-01 | -2.05e-01 | 5.20e-01 |
| GOCC U7 SNRNP | 6 | 3.84e-01 | 2.05e-01 | 7.24e-01 |
| GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 15 | 1.69e-01 | -2.05e-01 | 5.35e-01 |
| GOCC MANCHETTE | 9 | 2.87e-01 | -2.05e-01 | 6.57e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 2.87e-01 | -2.05e-01 | 6.57e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATION | 27 | 6.56e-02 | -2.05e-01 | 3.71e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX | 40 | 2.51e-02 | -2.05e-01 | 2.44e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY | 8 | 3.17e-01 | -2.04e-01 | 6.79e-01 |
| GOCC NUCLEAR REPLICATION FORK | 28 | 6.12e-02 | 2.04e-01 | 3.60e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR | 33 | 4.22e-02 | -2.04e-01 | 3.05e-01 |
| GOBP AMMONIUM ION METABOLIC PROCESS | 9 | 2.89e-01 | -2.04e-01 | 6.58e-01 |
| GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 16 | 1.57e-01 | 2.04e-01 | 5.23e-01 |
| GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY | 28 | 6.14e-02 | -2.04e-01 | 3.60e-01 |
| GOBP SPINDLE LOCALIZATION | 36 | 3.41e-02 | -2.04e-01 | 2.77e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING | 22 | 9.74e-02 | -2.04e-01 | 4.36e-01 |
| GOCC PHAGOCYTIC CUP | 24 | 8.37e-02 | -2.04e-01 | 4.11e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 23 | 9.04e-02 | -2.04e-01 | 4.24e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 27 | 6.67e-02 | -2.04e-01 | 3.73e-01 |
| GOMF PEPTIDOGLYCAN BINDING | 7 | 3.50e-01 | -2.04e-01 | 7.01e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION | 9 | 2.90e-01 | 2.04e-01 | 6.59e-01 |
| GOBP NEGATIVE REGULATION OF EXOCYTOSIS | 26 | 7.23e-02 | -2.04e-01 | 3.89e-01 |
| GOBP IRON ION TRANSPORT | 33 | 4.29e-02 | -2.04e-01 | 3.07e-01 |
| GOBP NEGATIVE REGULATION OF AMINE TRANSPORT | 10 | 2.65e-01 | 2.04e-01 | 6.42e-01 |
| GOBP SCARNA LOCALIZATION TO CAJAL BODY | 5 | 4.30e-01 | -2.04e-01 | 7.58e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION | 6 | 3.88e-01 | 2.04e-01 | 7.26e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 44 | 1.95e-02 | -2.04e-01 | 2.18e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 26 | 7.25e-02 | -2.04e-01 | 3.89e-01 |
| GOCC TRAPPIII PROTEIN COMPLEX | 12 | 2.22e-01 | 2.04e-01 | 5.97e-01 |
| GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 26 | 7.26e-02 | -2.03e-01 | 3.89e-01 |
| GOCC FANCONI ANAEMIA NUCLEAR COMPLEX | 8 | 3.19e-01 | 2.03e-01 | 6.80e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION | 9 | 2.91e-01 | -2.03e-01 | 6.60e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS | 15 | 1.73e-01 | 2.03e-01 | 5.39e-01 |
| GOBP POSITIVE REGULATION OF COAGULATION | 16 | 1.60e-01 | -2.03e-01 | 5.25e-01 |
| GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 19 | 1.26e-01 | -2.03e-01 | 4.81e-01 |
| GOMF UBIQUITIN MODIFICATION DEPENDENT HISTONE BINDING | 6 | 3.89e-01 | -2.03e-01 | 7.28e-01 |
| GOBP CELLULAR RESPONSE TO POTASSIUM ION | 8 | 3.20e-01 | 2.03e-01 | 6.80e-01 |
| GOBP DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT | 5 | 4.32e-01 | 2.03e-01 | 7.59e-01 |
| GOBP LABYRINTHINE LAYER MORPHOGENESIS | 10 | 2.67e-01 | -2.03e-01 | 6.44e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION | 16 | 1.61e-01 | 2.03e-01 | 5.27e-01 |
| GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR | 25 | 7.96e-02 | 2.03e-01 | 4.05e-01 |
| GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE | 11 | 2.45e-01 | -2.03e-01 | 6.22e-01 |
| GOBP TRANSFERRIN TRANSPORT | 8 | 3.21e-01 | -2.03e-01 | 6.81e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 5 | 4.33e-01 | -2.02e-01 | 7.60e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 13 | 2.06e-01 | 2.02e-01 | 5.82e-01 |
| GOBP RESPONSE TO MINERALOCORTICOID | 18 | 1.37e-01 | 2.02e-01 | 4.95e-01 |
| GOCC AMPHISOME MEMBRANE | 10 | 2.68e-01 | 2.02e-01 | 6.44e-01 |
| GOBP REGULATION OF SNARE COMPLEX ASSEMBLY | 12 | 2.25e-01 | 2.02e-01 | 6.00e-01 |
| GOBP EOSINOPHIL MIGRATION | 8 | 3.22e-01 | 2.02e-01 | 6.81e-01 |
| GOBP CELLULAR RESPONSE TO STEROL DEPLETION | 13 | 2.07e-01 | -2.02e-01 | 5.82e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING | 8 | 3.22e-01 | 2.02e-01 | 6.81e-01 |
| GOCC ATG1 ULK1 KINASE COMPLEX | 6 | 3.91e-01 | -2.02e-01 | 7.29e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION | 11 | 2.46e-01 | -2.02e-01 | 6.22e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 6 | 3.91e-01 | -2.02e-01 | 7.29e-01 |
| GOBP ETHANOL METABOLIC PROCESS | 7 | 3.55e-01 | -2.02e-01 | 7.05e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 11 | 2.46e-01 | -2.02e-01 | 6.23e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 16 | 1.62e-01 | -2.02e-01 | 5.28e-01 |
| GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING | 12 | 2.26e-01 | -2.02e-01 | 6.01e-01 |
| GOBP FEVER GENERATION | 5 | 4.35e-01 | -2.02e-01 | 7.61e-01 |
| GOBP CELL FATE DETERMINATION | 9 | 2.95e-01 | -2.02e-01 | 6.62e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 13 | 2.08e-01 | 2.02e-01 | 5.83e-01 |
| GOBP N TERMINAL PROTEIN LIPIDATION | 5 | 4.36e-01 | -2.01e-01 | 7.61e-01 |
| GOBP ECTODERMAL PLACODE DEVELOPMENT | 5 | 4.36e-01 | 2.01e-01 | 7.61e-01 |
| GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 7 | 3.57e-01 | -2.01e-01 | 7.08e-01 |
| GOBP ACTIN FILAMENT BUNDLE ORGANIZATION | 101 | 4.87e-04 | -2.01e-01 | 2.95e-02 |
| GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION | 5 | 4.36e-01 | 2.01e-01 | 7.61e-01 |
| GOBP POSITIVE REGULATION OF CELL SIZE | 8 | 3.25e-01 | -2.01e-01 | 6.82e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 34 | 4.27e-02 | -2.01e-01 | 3.07e-01 |
| GOBP REGULATION OF AMINO ACID TRANSPORT | 22 | 1.03e-01 | 2.01e-01 | 4.47e-01 |
| GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS | 7 | 3.57e-01 | -2.01e-01 | 7.09e-01 |
| GOBP LUNG ALVEOLUS DEVELOPMENT | 24 | 8.86e-02 | -2.01e-01 | 4.21e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 6 | 3.95e-01 | -2.01e-01 | 7.33e-01 |
| GOBP ACID SECRETION | 19 | 1.30e-01 | 2.01e-01 | 4.87e-01 |
| GOBP RESPONSE TO SALT STRESS | 16 | 1.65e-01 | 2.01e-01 | 5.31e-01 |
| GOBP ENAMEL MINERALIZATION | 9 | 2.97e-01 | -2.01e-01 | 6.63e-01 |
| GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS | 5 | 4.38e-01 | -2.00e-01 | 7.62e-01 |
| GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS | 5 | 4.38e-01 | -2.00e-01 | 7.62e-01 |
| GOMF QUINONE BINDING | 12 | 2.29e-01 | -2.00e-01 | 6.07e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 37 | 3.51e-02 | -2.00e-01 | 2.80e-01 |
| GOCC CATALYTIC STEP 1 SPLICEOSOME | 12 | 2.30e-01 | 2.00e-01 | 6.07e-01 |
| GOBP INTERLEUKIN 13 PRODUCTION | 11 | 2.50e-01 | -2.00e-01 | 6.27e-01 |
| GOCC MALE PRONUCLEUS | 6 | 3.96e-01 | 2.00e-01 | 7.34e-01 |
| GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS | 40 | 2.86e-02 | -2.00e-01 | 2.60e-01 |
| GOBP XENOPHAGY | 13 | 2.12e-01 | -2.00e-01 | 5.87e-01 |
| GOBP TRNA PSEUDOURIDINE SYNTHESIS | 6 | 3.96e-01 | 2.00e-01 | 7.35e-01 |
| GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY | 8 | 3.27e-01 | -2.00e-01 | 6.85e-01 |
| GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY | 8 | 3.27e-01 | 2.00e-01 | 6.85e-01 |
| GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 2.74e-01 | 2.00e-01 | 6.51e-01 |
| GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS | 9 | 2.99e-01 | 2.00e-01 | 6.64e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN LEVELS | 106 | 3.92e-04 | -2.00e-01 | 2.66e-02 |
| GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS | 20 | 1.22e-01 | 2.00e-01 | 4.75e-01 |
| GOBP EXTRACELLULAR MATRIX ASSEMBLY | 17 | 1.54e-01 | -2.00e-01 | 5.18e-01 |
| GOMF MHC PROTEIN BINDING | 24 | 9.07e-02 | -2.00e-01 | 4.24e-01 |
| GOBP PANCREAS DEVELOPMENT | 31 | 5.47e-02 | -1.99e-01 | 3.40e-01 |
| GOBP ASSOCIATIVE LEARNING | 40 | 2.92e-02 | -1.99e-01 | 2.61e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 9 | 3.00e-01 | -1.99e-01 | 6.64e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE BINDING | 7 | 3.61e-01 | -1.99e-01 | 7.10e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 9 | 3.01e-01 | 1.99e-01 | 6.65e-01 |
| GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING | 5 | 4.41e-01 | -1.99e-01 | 7.64e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK | 7 | 3.62e-01 | -1.99e-01 | 7.10e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE | 7 | 3.62e-01 | -1.99e-01 | 7.10e-01 |
| GOBP PURINE RIBONUCLEOTIDE SALVAGE | 7 | 3.62e-01 | -1.99e-01 | 7.10e-01 |
| GOBP MAINTENANCE OF BLOOD BRAIN BARRIER | 16 | 1.68e-01 | -1.99e-01 | 5.34e-01 |
| GOBP MYOBLAST PROLIFERATION | 12 | 2.33e-01 | -1.99e-01 | 6.10e-01 |
| GOBP PLATELET MORPHOGENESIS | 19 | 1.33e-01 | -1.99e-01 | 4.91e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION | 14 | 1.98e-01 | -1.99e-01 | 5.72e-01 |
| GOCC NUCLEOLAR EXOSOME RNASE COMPLEX | 10 | 2.77e-01 | 1.99e-01 | 6.53e-01 |
| GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 24 | 9.23e-02 | -1.99e-01 | 4.24e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDINES | 5 | 4.42e-01 | -1.99e-01 | 7.66e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 24 | 9.23e-02 | -1.99e-01 | 4.24e-01 |
| GOBP IMMATURE T CELL PROLIFERATION | 7 | 3.63e-01 | -1.99e-01 | 7.10e-01 |
| GOBP PROTEIN POLYGLUTAMYLATION | 8 | 3.31e-01 | 1.98e-01 | 6.87e-01 |
| GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL | 5 | 4.42e-01 | 1.98e-01 | 7.66e-01 |
| GOBP MYOBLAST MIGRATION | 7 | 3.64e-01 | -1.98e-01 | 7.10e-01 |
| GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 239 | 1.45e-07 | -1.98e-01 | 1.31e-04 |
| GOMF TRANSFERRIN RECEPTOR BINDING | 8 | 3.32e-01 | -1.98e-01 | 6.87e-01 |
| GOBP PSEUDOPODIUM ORGANIZATION | 10 | 2.78e-01 | -1.98e-01 | 6.53e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 35 | 4.26e-02 | -1.98e-01 | 3.07e-01 |
| GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY | 8 | 3.32e-01 | 1.98e-01 | 6.87e-01 |
| GOBP REGULATION OF TOLERANCE INDUCTION | 12 | 2.35e-01 | -1.98e-01 | 6.12e-01 |
| GOCC PLATELET ALPHA GRANULE | 51 | 1.45e-02 | -1.98e-01 | 1.94e-01 |
| GOBP STEROID HORMONE BIOSYNTHETIC PROCESS | 19 | 1.35e-01 | -1.98e-01 | 4.94e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 6 | 4.01e-01 | -1.98e-01 | 7.39e-01 |
| GOCC TRAPP COMPLEX | 15 | 1.85e-01 | 1.98e-01 | 5.53e-01 |
| GOBP ACUTE PHASE RESPONSE | 18 | 1.46e-01 | -1.98e-01 | 5.07e-01 |
| GOBP T HELPER 2 CELL CYTOKINE PRODUCTION | 6 | 4.02e-01 | -1.98e-01 | 7.40e-01 |
| GOBP CYTIDINE TO URIDINE EDITING | 5 | 4.45e-01 | -1.97e-01 | 7.67e-01 |
| GOMF NUCLEOSIDE KINASE ACTIVITY | 9 | 3.05e-01 | 1.97e-01 | 6.69e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE | 5 | 4.45e-01 | 1.97e-01 | 7.67e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION | 9 | 3.05e-01 | -1.97e-01 | 6.69e-01 |
| GOBP OXALOACETATE METABOLIC PROCESS | 7 | 3.66e-01 | 1.97e-01 | 7.11e-01 |
| GOCC NUCLEAR EXOSOME RNASE COMPLEX | 12 | 2.37e-01 | 1.97e-01 | 6.14e-01 |
| GOBP NEUTRAL LIPID CATABOLIC PROCESS | 17 | 1.60e-01 | -1.97e-01 | 5.25e-01 |
| GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 12 | 2.37e-01 | 1.97e-01 | 6.15e-01 |
| GOBP RECEPTOR INTERNALIZATION | 79 | 2.52e-03 | -1.97e-01 | 7.78e-02 |
| GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 14 | 2.02e-01 | 1.97e-01 | 5.78e-01 |
| GOMF EXOGENOUS PROTEIN BINDING | 51 | 1.52e-02 | -1.97e-01 | 1.96e-01 |
| GOMF GTPASE ACTIVATING PROTEIN BINDING | 11 | 2.59e-01 | -1.97e-01 | 6.36e-01 |
| GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 6 | 4.04e-01 | 1.97e-01 | 7.42e-01 |
| GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX | 8 | 3.36e-01 | -1.97e-01 | 6.90e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACTIVITY | 5 | 4.47e-01 | 1.97e-01 | 7.68e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION | 11 | 2.59e-01 | -1.97e-01 | 6.36e-01 |
| GOBP REGULATION OF CHROMATIN BINDING | 9 | 3.08e-01 | 1.96e-01 | 6.70e-01 |
| GOCC A BAND | 14 | 2.04e-01 | 1.96e-01 | 5.79e-01 |
| GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 72 | 4.02e-03 | -1.96e-01 | 1.01e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 14 | 2.04e-01 | -1.96e-01 | 5.79e-01 |
| GOCC CORTICAL ENDOPLASMIC RETICULUM | 6 | 4.05e-01 | 1.96e-01 | 7.42e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY | 13 | 2.21e-01 | -1.96e-01 | 5.96e-01 |
| GOBP REPLICATIVE SENESCENCE | 11 | 2.60e-01 | 1.96e-01 | 6.37e-01 |
| GOCC RNAI EFFECTOR COMPLEX | 20 | 1.29e-01 | -1.96e-01 | 4.86e-01 |
| GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS | 26 | 8.36e-02 | 1.96e-01 | 4.11e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 7 | 3.69e-01 | 1.96e-01 | 7.13e-01 |
| GOBP MEMBRANE LIPID CATABOLIC PROCESS | 27 | 7.80e-02 | -1.96e-01 | 4.00e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION | 22 | 1.12e-01 | -1.96e-01 | 4.58e-01 |
| GOCC MIB COMPLEX | 13 | 2.21e-01 | 1.96e-01 | 5.97e-01 |
| GOBP CAMKK AMPK SIGNALING CASCADE | 5 | 4.48e-01 | 1.96e-01 | 7.68e-01 |
| GOMF TRANSLATION INITIATION FACTOR ACTIVITY | 48 | 1.90e-02 | -1.96e-01 | 2.15e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN | 18 | 1.50e-01 | -1.96e-01 | 5.13e-01 |
| GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION | 10 | 2.84e-01 | -1.96e-01 | 6.55e-01 |
| GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 37 | 3.95e-02 | -1.96e-01 | 2.97e-01 |
| GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY | 31 | 5.96e-02 | 1.96e-01 | 3.56e-01 |
| GOCC SIGNAL PEPTIDASE COMPLEX | 5 | 4.49e-01 | -1.96e-01 | 7.69e-01 |
| GOBP MRNA SPLICE SITE RECOGNITION | 25 | 9.08e-02 | -1.96e-01 | 4.24e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSPORT | 8 | 3.38e-01 | 1.95e-01 | 6.92e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 10 | 2.85e-01 | -1.95e-01 | 6.55e-01 |
| GOMF MISMATCHED DNA BINDING | 13 | 2.23e-01 | 1.95e-01 | 5.98e-01 |
| GOBP IRON ION TRANSMEMBRANE TRANSPORT | 16 | 1.76e-01 | -1.95e-01 | 5.43e-01 |
| GOBP REGULATION OF VASCULAR WOUND HEALING | 7 | 3.71e-01 | -1.95e-01 | 7.15e-01 |
| GOBP REGULATION OF DNA CATABOLIC PROCESS | 8 | 3.39e-01 | 1.95e-01 | 6.93e-01 |
| GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS | 11 | 2.62e-01 | -1.95e-01 | 6.39e-01 |
| GOBP POSITIVE REGULATION OF LIPID KINASE ACTIVITY | 11 | 2.63e-01 | -1.95e-01 | 6.39e-01 |
| GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION | 16 | 1.77e-01 | -1.95e-01 | 5.44e-01 |
| GOBP POLYADENYLATION DEPENDENT SNORNA 3 END PROCESSING | 8 | 3.39e-01 | 1.95e-01 | 6.93e-01 |
| GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 9 | 3.11e-01 | -1.95e-01 | 6.74e-01 |
| GOBP LATERAL VENTRICLE DEVELOPMENT | 6 | 4.08e-01 | -1.95e-01 | 7.44e-01 |
| GOBP REGULATION OF CHOLESTEROL STORAGE | 14 | 2.07e-01 | -1.95e-01 | 5.82e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 6 | 4.08e-01 | -1.95e-01 | 7.44e-01 |
| GOMF U2 SNRNA BINDING | 6 | 4.09e-01 | -1.95e-01 | 7.45e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 9 | 3.12e-01 | 1.95e-01 | 6.75e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE | 53 | 1.44e-02 | -1.95e-01 | 1.93e-01 |
| GOBP RESPONSE TO ESTRADIOL | 55 | 1.26e-02 | -1.95e-01 | 1.82e-01 |
| GOCC PERICENTRIOLAR MATERIAL | 19 | 1.42e-01 | 1.94e-01 | 5.03e-01 |
| GOBP CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS | 94 | 1.14e-03 | -1.94e-01 | 5.03e-02 |
| GOBP DISTAL TUBULE DEVELOPMENT | 5 | 4.52e-01 | 1.94e-01 | 7.70e-01 |
| GOBP TETRAHYDROFOLATE INTERCONVERSION | 8 | 3.41e-01 | 1.94e-01 | 6.94e-01 |
| GOBP PHAGOSOME ACIDIFICATION | 7 | 3.74e-01 | -1.94e-01 | 7.16e-01 |
| GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS | 34 | 5.01e-02 | -1.94e-01 | 3.25e-01 |
| GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 12 | 2.44e-01 | 1.94e-01 | 6.22e-01 |
| GOCC CILIARY ROOTLET | 9 | 3.14e-01 | 1.94e-01 | 6.77e-01 |
| GOBP REGULATION OF THE FORCE OF HEART CONTRACTION | 11 | 2.65e-01 | -1.94e-01 | 6.43e-01 |
| GOBP CERAMIDE BIOSYNTHETIC PROCESS | 44 | 2.61e-02 | -1.94e-01 | 2.50e-01 |
| GOBP DEFINITIVE HEMOPOIESIS | 13 | 2.26e-01 | -1.94e-01 | 6.02e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 33 | 5.42e-02 | -1.94e-01 | 3.39e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 10 | 2.89e-01 | -1.94e-01 | 6.58e-01 |
| GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY | 10 | 2.89e-01 | -1.94e-01 | 6.58e-01 |
| GOBP REGULATION OF STEROL TRANSPORT | 32 | 5.80e-02 | -1.94e-01 | 3.51e-01 |
| GOCC BOX C D RNP COMPLEX | 5 | 4.53e-01 | 1.94e-01 | 7.72e-01 |
| GOBP RESPONSE TO MOLECULE OF FUNGAL ORIGIN | 5 | 4.53e-01 | 1.94e-01 | 7.72e-01 |
| GOMF S100 PROTEIN BINDING | 11 | 2.66e-01 | -1.94e-01 | 6.44e-01 |
| GOCC DNA REPLICATION PREINITIATION COMPLEX | 6 | 4.12e-01 | 1.94e-01 | 7.48e-01 |
| GOBP TUBULIN COMPLEX ASSEMBLY | 8 | 3.43e-01 | 1.93e-01 | 6.96e-01 |
| GOMF HORMONE BINDING | 30 | 6.68e-02 | -1.93e-01 | 3.73e-01 |
| GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS | 19 | 1.45e-01 | -1.93e-01 | 5.05e-01 |
| GOBP SARCOMERE ORGANIZATION | 16 | 1.81e-01 | -1.93e-01 | 5.48e-01 |
| GOBP POSITIVE REGULATION OF HEART RATE | 9 | 3.16e-01 | -1.93e-01 | 6.78e-01 |
| GOBP AMINO ACID ACTIVATION | 24 | 1.01e-01 | 1.93e-01 | 4.45e-01 |
| GOBP NEURON FATE SPECIFICATION | 5 | 4.54e-01 | 1.93e-01 | 7.72e-01 |
| GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE | 72 | 4.66e-03 | -1.93e-01 | 1.12e-01 |
| GOBP MALE MEIOSIS I | 11 | 2.68e-01 | -1.93e-01 | 6.44e-01 |
| GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS | 172 | 1.33e-05 | -1.93e-01 | 3.01e-03 |
| GOMF CULLIN FAMILY PROTEIN BINDING | 24 | 1.02e-01 | -1.93e-01 | 4.46e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX | 10 | 2.91e-01 | 1.93e-01 | 6.60e-01 |
| GOCC UBIQUINONE BIOSYNTHESIS COMPLEX | 5 | 4.55e-01 | 1.93e-01 | 7.72e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 7 | 3.77e-01 | -1.93e-01 | 7.18e-01 |
| GOBP GLIAL CELL DEVELOPMENT | 61 | 9.28e-03 | -1.93e-01 | 1.59e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 8 | 3.45e-01 | -1.93e-01 | 6.98e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 22 | 1.18e-01 | -1.93e-01 | 4.67e-01 |
| GOBP REGULATION OF OSTEOBLAST PROLIFERATION | 11 | 2.69e-01 | -1.93e-01 | 6.45e-01 |
| GOCC SCAR COMPLEX | 9 | 3.18e-01 | 1.92e-01 | 6.79e-01 |
| GOMF SIALYLTRANSFERASE ACTIVITY | 13 | 2.30e-01 | -1.92e-01 | 6.07e-01 |
| GOMF FATTY ACID BINDING | 23 | 1.10e-01 | -1.92e-01 | 4.56e-01 |
| GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS | 5 | 4.57e-01 | -1.92e-01 | 7.74e-01 |
| GOBP ENDOCRINE PANCREAS DEVELOPMENT | 19 | 1.47e-01 | -1.92e-01 | 5.08e-01 |
| GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 68 | 6.22e-03 | -1.92e-01 | 1.34e-01 |
| GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY | 7 | 3.79e-01 | 1.92e-01 | 7.19e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN | 14 | 2.14e-01 | -1.92e-01 | 5.89e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 19 | 1.48e-01 | 1.92e-01 | 5.09e-01 |
| GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 56 | 1.31e-02 | -1.92e-01 | 1.86e-01 |
| GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION | 9 | 3.19e-01 | 1.92e-01 | 6.80e-01 |
| GOBP ACTIVATION OF JANUS KINASE ACTIVITY | 7 | 3.79e-01 | 1.92e-01 | 7.19e-01 |
| GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 8 | 3.47e-01 | 1.92e-01 | 6.99e-01 |
| GOBP PROTEIN TARGETING TO LYSOSOME | 29 | 7.41e-02 | -1.92e-01 | 3.93e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 10 | 2.94e-01 | -1.92e-01 | 6.62e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 29 | 7.42e-02 | -1.92e-01 | 3.93e-01 |
| GOCC PROTEASOME COMPLEX | 57 | 1.24e-02 | -1.92e-01 | 1.81e-01 |
| GOBP INTESTINAL ABSORPTION | 16 | 1.85e-01 | -1.92e-01 | 5.53e-01 |
| GOBP PROTEIN O LINKED MANNOSYLATION | 13 | 2.32e-01 | 1.92e-01 | 6.09e-01 |
| GOBP LYMPHOCYTE COSTIMULATION | 31 | 6.51e-02 | -1.92e-01 | 3.69e-01 |
| GOMF PHOSPHOTYROSINE RESIDUE BINDING | 38 | 4.12e-02 | -1.91e-01 | 3.02e-01 |
| GOMF VITAMIN B6 BINDING | 31 | 6.52e-02 | 1.91e-01 | 3.69e-01 |
| GOBP MORPHOGENESIS OF AN ENDOTHELIUM | 11 | 2.72e-01 | -1.91e-01 | 6.49e-01 |
| GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS | 12 | 2.51e-01 | -1.91e-01 | 6.28e-01 |
| GOBP CEREBELLAR CORTEX MORPHOGENESIS | 17 | 1.72e-01 | -1.91e-01 | 5.37e-01 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE | 7 | 3.81e-01 | -1.91e-01 | 7.21e-01 |
| GOBP DETECTION OF LIGHT STIMULUS | 20 | 1.39e-01 | 1.91e-01 | 4.97e-01 |
| GOBP NEGATIVE REGULATION OF LIPID STORAGE | 16 | 1.85e-01 | -1.91e-01 | 5.54e-01 |
| GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 98 | 1.10e-03 | -1.91e-01 | 4.93e-02 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 27 | 8.59e-02 | -1.91e-01 | 4.15e-01 |
| GOMF MYOSIN PHOSPHATASE ACTIVITY | 57 | 1.27e-02 | -1.91e-01 | 1.82e-01 |
| GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS | 10 | 2.96e-01 | -1.91e-01 | 6.62e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 63 | 8.87e-03 | -1.91e-01 | 1.55e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION | 6 | 4.18e-01 | -1.91e-01 | 7.52e-01 |
| GOBP VENTRICULAR SYSTEM DEVELOPMENT | 21 | 1.30e-01 | -1.91e-01 | 4.87e-01 |
| GOMF STRUCTURAL CONSTITUENT OF RIBOSOME | 156 | 4.12e-05 | -1.91e-01 | 6.32e-03 |
| GOMF GAMMA CATENIN BINDING | 5 | 4.60e-01 | -1.91e-01 | 7.76e-01 |
| GOBP UTP METABOLIC PROCESS | 10 | 2.97e-01 | 1.91e-01 | 6.63e-01 |
| GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 12 | 2.53e-01 | -1.91e-01 | 6.30e-01 |
| GOBP FIBROBLAST GROWTH FACTOR PRODUCTION | 5 | 4.61e-01 | -1.91e-01 | 7.76e-01 |
| GOBP ODONTOGENESIS | 42 | 3.28e-02 | -1.90e-01 | 2.72e-01 |
| GOBP ASTROCYTE ACTIVATION | 15 | 2.02e-01 | -1.90e-01 | 5.78e-01 |
| GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION | 31 | 6.69e-02 | -1.90e-01 | 3.73e-01 |
| GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 1.88e-01 | 1.90e-01 | 5.59e-01 |
| GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 51 | 1.90e-02 | -1.90e-01 | 2.15e-01 |
| GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT | 12 | 2.55e-01 | 1.90e-01 | 6.31e-01 |
| GOBP VASODILATION | 21 | 1.32e-01 | 1.90e-01 | 4.89e-01 |
| GOBP PALLIUM DEVELOPMENT | 104 | 8.37e-04 | -1.90e-01 | 4.09e-02 |
| GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 11 | 2.76e-01 | -1.90e-01 | 6.52e-01 |
| GOMF PROTEASE BINDING | 92 | 1.69e-03 | -1.90e-01 | 6.22e-02 |
| GOBP PROLINE TRANSPORT | 6 | 4.21e-01 | 1.90e-01 | 7.54e-01 |
| GOMF POLY PYRIMIDINE TRACT BINDING | 22 | 1.24e-01 | -1.90e-01 | 4.78e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 26 | 9.43e-02 | -1.90e-01 | 4.28e-01 |
| GOBP CELLULAR OXIDANT DETOXIFICATION | 57 | 1.34e-02 | -1.90e-01 | 1.87e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX | 14 | 2.20e-01 | -1.90e-01 | 5.95e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 66 | 7.86e-03 | -1.89e-01 | 1.50e-01 |
| GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS | 10 | 3.00e-01 | -1.89e-01 | 6.64e-01 |
| GOBP TRABECULA MORPHOGENESIS | 22 | 1.24e-01 | -1.89e-01 | 4.80e-01 |
| GOBP AXIS ELONGATION | 8 | 3.54e-01 | -1.89e-01 | 7.04e-01 |
| GOBP REGULATION OF GLIOGENESIS | 49 | 2.20e-02 | -1.89e-01 | 2.31e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 10 | 3.00e-01 | 1.89e-01 | 6.64e-01 |
| GOCC OMEGASOME | 5 | 4.64e-01 | -1.89e-01 | 7.77e-01 |
| GOMF TRANSLATION ACTIVATOR ACTIVITY | 7 | 3.86e-01 | -1.89e-01 | 7.25e-01 |
| GOMF ACTININ BINDING | 15 | 2.05e-01 | -1.89e-01 | 5.80e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE | 5 | 4.64e-01 | -1.89e-01 | 7.77e-01 |
| GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 10 | 3.01e-01 | -1.89e-01 | 6.65e-01 |
| GOBP REGULATION OF MONOCYTE CHEMOTAXIS | 16 | 1.91e-01 | 1.89e-01 | 5.61e-01 |
| GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING | 5 | 4.64e-01 | -1.89e-01 | 7.77e-01 |
| GOBP REGULATION OF ANOIKIS | 16 | 1.91e-01 | -1.89e-01 | 5.61e-01 |
| GOMF HISTONE METHYLTRANSFERASE BINDING | 14 | 2.21e-01 | 1.89e-01 | 5.96e-01 |
| GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY | 5 | 4.65e-01 | -1.89e-01 | 7.77e-01 |
| GOBP RNA 5 END PROCESSING | 22 | 1.25e-01 | 1.89e-01 | 4.81e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS | 11 | 2.78e-01 | 1.89e-01 | 6.53e-01 |
| GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY | 9 | 3.27e-01 | -1.89e-01 | 6.84e-01 |
| GOMF K48 LINKED DEUBIQUITINASE ACTIVITY | 13 | 2.39e-01 | -1.89e-01 | 6.16e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 15 | 2.06e-01 | -1.89e-01 | 5.82e-01 |
| GOBP GENOMIC IMPRINTING | 11 | 2.79e-01 | -1.89e-01 | 6.53e-01 |
| GOBP ANTIMICROBIAL HUMORAL RESPONSE | 34 | 5.72e-02 | -1.89e-01 | 3.49e-01 |
| GOMF PHOSPHOLIPASE A1 ACTIVITY | 7 | 3.88e-01 | 1.89e-01 | 7.26e-01 |
| GOBP RNA MODIFICATION | 157 | 4.78e-05 | 1.89e-01 | 7.20e-03 |
| GOBP POSITIVE REGULATION OF EXOCYTOSIS | 51 | 2.00e-02 | -1.88e-01 | 2.21e-01 |
| GOCC EARLY PHAGOSOME | 10 | 3.02e-01 | 1.88e-01 | 6.66e-01 |
| GOBP IRON SULFUR CLUSTER ASSEMBLY | 29 | 7.95e-02 | 1.88e-01 | 4.04e-01 |
| GOBP L KYNURENINE METABOLIC PROCESS | 5 | 4.66e-01 | 1.88e-01 | 7.78e-01 |
| GOBP REGULATION OF MYOBLAST PROLIFERATION | 6 | 4.25e-01 | -1.88e-01 | 7.56e-01 |
| GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY | 8 | 3.57e-01 | -1.88e-01 | 7.08e-01 |
| GOMF TROPOMYOSIN BINDING | 7 | 3.89e-01 | -1.88e-01 | 7.27e-01 |
| GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY | 7 | 3.89e-01 | -1.88e-01 | 7.27e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING | 17 | 1.80e-01 | 1.88e-01 | 5.48e-01 |
| GOCC RECYCLING ENDOSOME MEMBRANE | 74 | 5.25e-03 | -1.88e-01 | 1.21e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 11 | 2.81e-01 | -1.88e-01 | 6.54e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM | 9 | 3.29e-01 | -1.88e-01 | 6.86e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 3.58e-01 | 1.88e-01 | 7.09e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 27 | 9.15e-02 | -1.88e-01 | 4.24e-01 |
| GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 22 | 1.28e-01 | -1.88e-01 | 4.85e-01 |
| GOBP OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION | 15 | 2.09e-01 | 1.88e-01 | 5.83e-01 |
| GOBP POSITIVE REGULATION OF PLATELET AGGREGATION | 5 | 4.68e-01 | -1.88e-01 | 7.78e-01 |
| GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 3.58e-01 | 1.88e-01 | 7.09e-01 |
| GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX | 9 | 3.30e-01 | -1.88e-01 | 6.86e-01 |
| GOBP APOPTOTIC CELL CLEARANCE | 26 | 9.85e-02 | -1.87e-01 | 4.38e-01 |
| GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX | 5 | 4.68e-01 | -1.87e-01 | 7.78e-01 |
| GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY | 7 | 3.91e-01 | 1.87e-01 | 7.29e-01 |
| GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY | 33 | 6.30e-02 | 1.87e-01 | 3.63e-01 |
| GOBP TRNA METABOLIC PROCESS | 169 | 2.85e-05 | 1.87e-01 | 4.80e-03 |
| GOBP CORPUS CALLOSUM MORPHOGENESIS | 5 | 4.69e-01 | 1.87e-01 | 7.78e-01 |
| GOMF POLY G BINDING | 8 | 3.60e-01 | -1.87e-01 | 7.10e-01 |
| GOBP ENDOCARDIAL CUSHION MORPHOGENESIS | 15 | 2.10e-01 | -1.87e-01 | 5.85e-01 |
| GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT | 10 | 3.06e-01 | 1.87e-01 | 6.69e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 29 | 8.20e-02 | -1.87e-01 | 4.09e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 8 | 3.61e-01 | -1.87e-01 | 7.10e-01 |
| GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS | 24 | 1.14e-01 | 1.87e-01 | 4.61e-01 |
| GOBP RRNA TRANSCRIPTION | 32 | 6.78e-02 | 1.87e-01 | 3.75e-01 |
| GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS | 6 | 4.29e-01 | -1.87e-01 | 7.58e-01 |
| GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 12 | 2.63e-01 | -1.87e-01 | 6.40e-01 |
| GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 25 | 1.07e-01 | -1.87e-01 | 4.52e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE BINDING | 9 | 3.33e-01 | -1.86e-01 | 6.88e-01 |
| GOCC PODOSOME | 24 | 1.14e-01 | -1.86e-01 | 4.61e-01 |
| GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 43 | 3.47e-02 | -1.86e-01 | 2.78e-01 |
| GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING | 10 | 3.08e-01 | -1.86e-01 | 6.70e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 73 | 6.01e-03 | -1.86e-01 | 1.31e-01 |
| GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 20 | 1.50e-01 | 1.86e-01 | 5.12e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 6 | 4.30e-01 | 1.86e-01 | 7.58e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 6 | 4.30e-01 | 1.86e-01 | 7.58e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 9 | 3.34e-01 | 1.86e-01 | 6.88e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 6 | 4.30e-01 | -1.86e-01 | 7.58e-01 |
| GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY | 6 | 4.30e-01 | -1.86e-01 | 7.58e-01 |
| GOMF FIBRONECTIN BINDING | 15 | 2.13e-01 | -1.86e-01 | 5.88e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 11 | 2.86e-01 | -1.86e-01 | 6.56e-01 |
| GOBP ADP TRANSPORT | 8 | 3.64e-01 | -1.86e-01 | 7.10e-01 |
| GOBP MITOCHONDRIAL TRANSCRIPTION | 18 | 1.73e-01 | 1.86e-01 | 5.39e-01 |
| GOBP RESPONSE TO MURAMYL DIPEPTIDE | 19 | 1.62e-01 | -1.86e-01 | 5.28e-01 |
| GOBP HYALURONAN BIOSYNTHETIC PROCESS | 9 | 3.35e-01 | -1.85e-01 | 6.90e-01 |
| GOBP MODULATION BY HOST OF VIRAL PROCESS | 38 | 4.81e-02 | -1.85e-01 | 3.19e-01 |
| GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE | 6 | 4.32e-01 | 1.85e-01 | 7.59e-01 |
| GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS | 5 | 4.73e-01 | 1.85e-01 | 7.79e-01 |
| GOBP BONE MATURATION | 12 | 2.67e-01 | -1.85e-01 | 6.44e-01 |
| GOBP T HELPER 17 CELL DIFFERENTIATION | 22 | 1.33e-01 | -1.85e-01 | 4.91e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 16 | 2.00e-01 | 1.85e-01 | 5.75e-01 |
| GOMF GROWTH FACTOR ACTIVITY | 39 | 4.59e-02 | -1.85e-01 | 3.15e-01 |
| GOCC RIBOSOMAL SUBUNIT | 180 | 2.02e-05 | -1.85e-01 | 3.73e-03 |
| GOBP OXIDATIVE DEMETHYLATION | 6 | 4.33e-01 | 1.85e-01 | 7.60e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR | 10 | 3.12e-01 | -1.85e-01 | 6.75e-01 |
| GOBP LOCOMOTORY EXPLORATION BEHAVIOR | 5 | 4.75e-01 | 1.85e-01 | 7.80e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 82 | 3.94e-03 | -1.84e-01 | 9.98e-02 |
| GOBP PULMONARY VALVE MORPHOGENESIS | 7 | 3.98e-01 | -1.84e-01 | 7.36e-01 |
| GOBP ARTERY MORPHOGENESIS | 28 | 9.16e-02 | -1.84e-01 | 4.24e-01 |
| GOMF MAP KINASE KINASE KINASE KINASE ACTIVITY | 5 | 4.76e-01 | 1.84e-01 | 7.81e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS | 63 | 1.16e-02 | 1.84e-01 | 1.75e-01 |
| GOCC KINESIN COMPLEX | 26 | 1.04e-01 | -1.84e-01 | 4.50e-01 |
| GOBP SCHWANN CELL MIGRATION | 5 | 4.76e-01 | -1.84e-01 | 7.81e-01 |
| GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 28 | 9.21e-02 | -1.84e-01 | 4.24e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY | 6 | 4.35e-01 | 1.84e-01 | 7.61e-01 |
| GOBP HEPARIN BIOSYNTHETIC PROCESS | 9 | 3.39e-01 | 1.84e-01 | 6.93e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 8 | 3.68e-01 | -1.84e-01 | 7.12e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 22 | 1.36e-01 | -1.84e-01 | 4.94e-01 |
| GOCC STRIATED MUSCLE THIN FILAMENT | 8 | 3.68e-01 | -1.84e-01 | 7.12e-01 |
| GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 48 | 2.77e-02 | -1.84e-01 | 2.57e-01 |
| GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION | 13 | 2.52e-01 | -1.84e-01 | 6.28e-01 |
| GOBP MAST CELL ACTIVATION | 56 | 1.76e-02 | -1.84e-01 | 2.07e-01 |
| GOBP AMINE CATABOLIC PROCESS | 10 | 3.15e-01 | -1.83e-01 | 6.78e-01 |
| GOBP REGULATION OF SREBP SIGNALING PATHWAY | 6 | 4.37e-01 | -1.83e-01 | 7.61e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 12 | 2.72e-01 | 1.83e-01 | 6.49e-01 |
| GOBP SERTOLI CELL DEVELOPMENT | 9 | 3.41e-01 | -1.83e-01 | 6.94e-01 |
| GOBP REGULATION OF NEURON MIGRATION | 21 | 1.46e-01 | -1.83e-01 | 5.07e-01 |
| GOBP POLYAMINE BIOSYNTHETIC PROCESS | 11 | 2.93e-01 | -1.83e-01 | 6.61e-01 |
| GOBP RESPONSE TO ELECTRICAL STIMULUS | 23 | 1.29e-01 | -1.83e-01 | 4.85e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 13 | 2.53e-01 | -1.83e-01 | 6.30e-01 |
| GOMF NUCLEOTIDASE ACTIVITY | 8 | 3.70e-01 | 1.83e-01 | 7.14e-01 |
| GOMF SCAVENGER RECEPTOR ACTIVITY | 14 | 2.36e-01 | -1.83e-01 | 6.13e-01 |
| GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 8 | 3.70e-01 | -1.83e-01 | 7.14e-01 |
| GOCC TERTIARY GRANULE | 130 | 3.26e-04 | -1.83e-01 | 2.39e-02 |
| GOBP NEUROTRANSMITTER METABOLIC PROCESS | 10 | 3.17e-01 | -1.83e-01 | 6.79e-01 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 6 | 4.38e-01 | 1.83e-01 | 7.62e-01 |
| GOMF PROTEIN KINASE B BINDING | 9 | 3.42e-01 | -1.83e-01 | 6.95e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 62 | 1.30e-02 | -1.83e-01 | 1.86e-01 |
| GOBP NEUROBLAST PROLIFERATION | 35 | 6.17e-02 | -1.83e-01 | 3.60e-01 |
| GOBP HEART FIELD SPECIFICATION | 5 | 4.80e-01 | -1.83e-01 | 7.83e-01 |
| GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 7 | 4.03e-01 | -1.83e-01 | 7.41e-01 |
| GOBP REGULATION OF CELL JUNCTION ASSEMBLY | 102 | 1.48e-03 | -1.82e-01 | 5.91e-02 |
| GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS | 5 | 4.80e-01 | 1.82e-01 | 7.83e-01 |
| GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 15 | 2.21e-01 | -1.82e-01 | 5.97e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY | 13 | 2.55e-01 | 1.82e-01 | 6.31e-01 |
| GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION | 32 | 7.42e-02 | -1.82e-01 | 3.93e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 8 | 3.72e-01 | -1.82e-01 | 7.15e-01 |
| GOBP NEGATIVE REGULATION OF HEART RATE | 5 | 4.80e-01 | 1.82e-01 | 7.83e-01 |
| GOMF CHEMOATTRACTANT ACTIVITY | 11 | 2.95e-01 | -1.82e-01 | 6.62e-01 |
| GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 10 | 3.19e-01 | -1.82e-01 | 6.80e-01 |
| GOBP SERTOLI CELL DIFFERENTIATION | 11 | 2.96e-01 | -1.82e-01 | 6.62e-01 |
| GOMF THIAMINE PYROPHOSPHATE BINDING | 5 | 4.81e-01 | 1.82e-01 | 7.83e-01 |
| GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 6 | 4.40e-01 | -1.82e-01 | 7.64e-01 |
| GOBP DETOXIFICATION | 76 | 6.13e-03 | -1.82e-01 | 1.33e-01 |
| GOBP ALANINE TRANSPORT | 10 | 3.19e-01 | 1.82e-01 | 6.80e-01 |
| GOMF ARYL HYDROCARBON RECEPTOR BINDING | 6 | 4.40e-01 | 1.82e-01 | 7.64e-01 |
| GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT | 6 | 4.40e-01 | 1.82e-01 | 7.64e-01 |
| GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS | 5 | 4.81e-01 | -1.82e-01 | 7.83e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION | 7 | 4.05e-01 | 1.82e-01 | 7.42e-01 |
| GOMF WIDE PORE CHANNEL ACTIVITY | 10 | 3.19e-01 | -1.82e-01 | 6.80e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 34 | 6.67e-02 | 1.82e-01 | 3.73e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 158 | 8.37e-05 | -1.82e-01 | 9.85e-03 |
| GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS | 5 | 4.82e-01 | 1.82e-01 | 7.84e-01 |
| GOBP AUTOPHAGOSOME MEMBRANE DOCKING | 7 | 4.05e-01 | 1.82e-01 | 7.42e-01 |
| GOMF LAMIN BINDING | 12 | 2.76e-01 | -1.82e-01 | 6.52e-01 |
| GOBP REGULATION OF RESPONSE TO TUMOR CELL | 14 | 2.39e-01 | -1.82e-01 | 6.17e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS | 5 | 4.82e-01 | 1.82e-01 | 7.84e-01 |
| GOBP REGULATION OF EXOSOMAL SECRETION | 16 | 2.09e-01 | -1.82e-01 | 5.83e-01 |
| GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 62 | 1.35e-02 | -1.81e-01 | 1.88e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 10 | 3.20e-01 | 1.81e-01 | 6.80e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS | 10 | 3.20e-01 | 1.81e-01 | 6.80e-01 |
| GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY | 8 | 3.74e-01 | -1.81e-01 | 7.16e-01 |
| GOCC BRUSH BORDER MEMBRANE | 21 | 1.50e-01 | -1.81e-01 | 5.13e-01 |
| GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 61 | 1.44e-02 | -1.81e-01 | 1.93e-01 |
| GOBP PITUITARY GLAND DEVELOPMENT | 7 | 4.06e-01 | -1.81e-01 | 7.42e-01 |
| GOBP HINDBRAIN MORPHOGENESIS | 22 | 1.41e-01 | -1.81e-01 | 5.00e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 21 | 1.51e-01 | 1.81e-01 | 5.13e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY | 11 | 2.98e-01 | -1.81e-01 | 6.63e-01 |
| GOCC MKS COMPLEX | 8 | 3.75e-01 | 1.81e-01 | 7.17e-01 |
| GOCC LUMENAL SIDE OF MEMBRANE | 32 | 7.63e-02 | 1.81e-01 | 3.96e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 135 | 2.89e-04 | -1.81e-01 | 2.24e-02 |
| GOBP NUCLEAR PORE ORGANIZATION | 15 | 2.25e-01 | 1.81e-01 | 6.00e-01 |
| GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY | 16 | 2.11e-01 | -1.81e-01 | 5.85e-01 |
| GOBP TOOTH MINERALIZATION | 11 | 2.99e-01 | -1.81e-01 | 6.64e-01 |
| GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY | 7 | 4.08e-01 | 1.81e-01 | 7.44e-01 |
| GOBP CLATHRIN COAT ASSEMBLY | 12 | 2.79e-01 | -1.81e-01 | 6.53e-01 |
| GOBP REGULATION OF PROTEIN KINASE A SIGNALING | 10 | 3.23e-01 | 1.80e-01 | 6.81e-01 |
| GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL | 5 | 4.85e-01 | -1.80e-01 | 7.85e-01 |
| GOBP HETEROTYPIC CELL CELL ADHESION | 36 | 6.12e-02 | -1.80e-01 | 3.60e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING | 10 | 3.24e-01 | -1.80e-01 | 6.81e-01 |
| GOBP GOLGI TO LYSOSOME TRANSPORT | 10 | 3.24e-01 | -1.80e-01 | 6.81e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS | 5 | 4.85e-01 | -1.80e-01 | 7.85e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 5 | 4.86e-01 | -1.80e-01 | 7.85e-01 |
| GOBP PSEUDOURIDINE SYNTHESIS | 18 | 1.86e-01 | 1.80e-01 | 5.55e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION | 9 | 3.50e-01 | 1.80e-01 | 7.01e-01 |
| GOMF INTERLEUKIN 6 RECEPTOR BINDING | 5 | 4.87e-01 | -1.80e-01 | 7.85e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION | 8 | 3.79e-01 | -1.80e-01 | 7.19e-01 |
| GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 36 | 6.24e-02 | -1.80e-01 | 3.61e-01 |
| GOBP RESPONSE TO X RAY | 23 | 1.36e-01 | 1.80e-01 | 4.94e-01 |
| GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS | 44 | 3.95e-02 | -1.79e-01 | 2.97e-01 |
| GOBP ORNITHINE METABOLIC PROCESS | 6 | 4.47e-01 | -1.79e-01 | 7.68e-01 |
| GOBP RENAL WATER HOMEOSTASIS | 8 | 3.80e-01 | -1.79e-01 | 7.19e-01 |
| GOBP NEGATIVE REGULATION OF JNK CASCADE | 26 | 1.14e-01 | -1.79e-01 | 4.61e-01 |
| GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY | 8 | 3.81e-01 | -1.79e-01 | 7.21e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL | 7 | 4.12e-01 | -1.79e-01 | 7.48e-01 |
| GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY | 25 | 1.22e-01 | -1.79e-01 | 4.75e-01 |
| GOCC CASPASE COMPLEX | 9 | 3.53e-01 | -1.79e-01 | 7.03e-01 |
| GOBP REGULATION OF FATTY ACID BETA OXIDATION | 12 | 2.83e-01 | 1.79e-01 | 6.55e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY | 12 | 2.83e-01 | 1.79e-01 | 6.55e-01 |
| GOBP T CELL CYTOKINE PRODUCTION | 26 | 1.15e-01 | -1.79e-01 | 4.61e-01 |
| GOBP ER NUCLEUS SIGNALING PATHWAY | 41 | 4.77e-02 | -1.79e-01 | 3.18e-01 |
| GOBP REGULATION OF TRANSLATIONAL FIDELITY | 13 | 2.64e-01 | 1.79e-01 | 6.42e-01 |
| GOBP PML BODY ORGANIZATION | 6 | 4.48e-01 | -1.79e-01 | 7.68e-01 |
| GOBP CRISTAE FORMATION | 17 | 2.02e-01 | 1.79e-01 | 5.78e-01 |
| GOBP TRANSMISSION OF NERVE IMPULSE | 19 | 1.78e-01 | -1.79e-01 | 5.46e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION | 6 | 4.49e-01 | -1.79e-01 | 7.69e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY | 75 | 7.60e-03 | -1.79e-01 | 1.49e-01 |
| GOBP SECRETION BY TISSUE | 19 | 1.78e-01 | -1.78e-01 | 5.46e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 15 | 2.32e-01 | 1.78e-01 | 6.09e-01 |
| GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 7 | 4.14e-01 | 1.78e-01 | 7.50e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE PRIMING | 6 | 4.50e-01 | -1.78e-01 | 7.70e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 12 | 2.85e-01 | 1.78e-01 | 6.56e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION | 11 | 3.06e-01 | 1.78e-01 | 6.69e-01 |
| GOBP VACUOLE FUSION | 11 | 3.06e-01 | 1.78e-01 | 6.69e-01 |
| GOMF UBIQUITIN LIKE PROTEIN BINDING | 114 | 1.05e-03 | -1.78e-01 | 4.85e-02 |
| GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 62 | 1.54e-02 | -1.78e-01 | 1.98e-01 |
| GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT | 14 | 2.49e-01 | -1.78e-01 | 6.26e-01 |
| GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY | 24 | 1.31e-01 | -1.78e-01 | 4.89e-01 |
| GOMF GLYCOSAMINOGLYCAN BINDING | 70 | 1.02e-02 | -1.78e-01 | 1.67e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 10 | 3.31e-01 | -1.78e-01 | 6.87e-01 |
| GOBP IMP METABOLIC PROCESS | 13 | 2.68e-01 | 1.78e-01 | 6.44e-01 |
| GOBP RESPONSE TO YEAST | 5 | 4.92e-01 | -1.78e-01 | 7.88e-01 |
| GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM | 7 | 4.16e-01 | -1.77e-01 | 7.51e-01 |
| GOMF SUMO BINDING | 16 | 2.20e-01 | 1.77e-01 | 5.95e-01 |
| GOCC AUTOPHAGOSOME MEMBRANE | 43 | 4.45e-02 | -1.77e-01 | 3.10e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 8 | 3.86e-01 | -1.77e-01 | 7.25e-01 |
| GOBP SOMATIC STEM CELL POPULATION MAINTENANCE | 39 | 5.57e-02 | -1.77e-01 | 3.44e-01 |
| GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION | 7 | 4.17e-01 | 1.77e-01 | 7.52e-01 |
| GOBP MYELOID PROGENITOR CELL DIFFERENTIATION | 7 | 4.18e-01 | -1.77e-01 | 7.52e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 7 | 4.18e-01 | -1.77e-01 | 7.52e-01 |
| GOBP REGULATION OF RNA EXPORT FROM NUCLEUS | 13 | 2.70e-01 | 1.77e-01 | 6.47e-01 |
| GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY | 9 | 3.59e-01 | 1.77e-01 | 7.10e-01 |
| GOBP CENTRIOLE CENTRIOLE COHESION | 14 | 2.53e-01 | 1.77e-01 | 6.29e-01 |
| GOBP INTEGRIN MEDIATED SIGNALING PATHWAY | 66 | 1.32e-02 | -1.77e-01 | 1.86e-01 |
| GOBP POSITIVE REGULATION OF T CELL PROLIFERATION | 66 | 1.32e-02 | -1.77e-01 | 1.86e-01 |
| GOBP REGULATION OF SECONDARY METABOLIC PROCESS | 10 | 3.34e-01 | -1.76e-01 | 6.88e-01 |
| GOCC GLYCOGEN GRANULE | 7 | 4.19e-01 | -1.76e-01 | 7.53e-01 |
| GOBP REGULATION OF EXOCYTOSIS | 116 | 1.05e-03 | -1.76e-01 | 4.85e-02 |
| GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME | 83 | 5.53e-03 | -1.76e-01 | 1.24e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 5 | 4.95e-01 | -1.76e-01 | 7.90e-01 |
| GOBP AUTOPHAGOSOME ORGANIZATION | 105 | 1.84e-03 | -1.76e-01 | 6.49e-02 |
| GOMF LIGAND GATED CHANNEL ACTIVITY | 31 | 8.96e-02 | -1.76e-01 | 4.23e-01 |
| GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION | 19 | 1.84e-01 | -1.76e-01 | 5.53e-01 |
| GOBP COMMISSURAL NEURON AXON GUIDANCE | 7 | 4.20e-01 | -1.76e-01 | 7.53e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES | 51 | 2.97e-02 | 1.76e-01 | 2.62e-01 |
| GOCC RNA CAP BINDING COMPLEX | 19 | 1.84e-01 | -1.76e-01 | 5.53e-01 |
| GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 29 | 1.01e-01 | -1.76e-01 | 4.45e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 7 | 4.21e-01 | -1.76e-01 | 7.54e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 7 | 4.21e-01 | -1.76e-01 | 7.54e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS | 44 | 4.38e-02 | 1.76e-01 | 3.09e-01 |
| GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION | 11 | 3.13e-01 | -1.76e-01 | 6.76e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF NF KAPPAB | 7 | 4.21e-01 | -1.76e-01 | 7.54e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION | 5 | 4.96e-01 | -1.76e-01 | 7.91e-01 |
| GOCC MITOTIC SPINDLE MICROTUBULE | 14 | 2.55e-01 | -1.76e-01 | 6.31e-01 |
| GOMF NUCLEOSOME BINDING | 52 | 2.86e-02 | 1.76e-01 | 2.60e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE | 23 | 1.45e-01 | -1.76e-01 | 5.06e-01 |
| GOBP INOSITOL METABOLIC PROCESS | 6 | 4.57e-01 | 1.76e-01 | 7.74e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY | 28 | 1.08e-01 | 1.76e-01 | 4.54e-01 |
| GOBP TRACHEA MORPHOGENESIS | 7 | 4.21e-01 | -1.75e-01 | 7.54e-01 |
| GOBP RRNA CATABOLIC PROCESS | 19 | 1.86e-01 | 1.75e-01 | 5.55e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING | 55 | 2.47e-02 | -1.75e-01 | 2.43e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 13 | 2.74e-01 | 1.75e-01 | 6.51e-01 |
| GOBP DETOXIFICATION OF INORGANIC COMPOUND | 11 | 3.15e-01 | -1.75e-01 | 6.78e-01 |
| GOMF CUPROUS ION BINDING | 6 | 4.58e-01 | 1.75e-01 | 7.74e-01 |
| GOBP REGULATION OF COAGULATION | 27 | 1.16e-01 | -1.75e-01 | 4.64e-01 |
| GOBP HISTONE H3 K9 METHYLATION | 5 | 4.98e-01 | 1.75e-01 | 7.92e-01 |
| GOCC FICOLIN 1 RICH GRANULE MEMBRANE | 51 | 3.07e-02 | -1.75e-01 | 2.66e-01 |
| GOMF INTEGRIN BINDING | 61 | 1.83e-02 | -1.75e-01 | 2.11e-01 |
| GOBP V D J RECOMBINATION | 16 | 2.26e-01 | 1.75e-01 | 6.01e-01 |
| GOBP RESPONSE TO MUSCLE ACTIVITY | 12 | 2.95e-01 | -1.75e-01 | 6.62e-01 |
| GOBP EMBRYONIC EYE MORPHOGENESIS | 11 | 3.16e-01 | -1.75e-01 | 6.79e-01 |
| GOBP EPITHELIAL CELL APOPTOTIC PROCESS | 67 | 1.36e-02 | -1.75e-01 | 1.88e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING | 37 | 6.64e-02 | -1.75e-01 | 3.73e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 38 | 6.30e-02 | 1.74e-01 | 3.63e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 7 | 4.24e-01 | 1.74e-01 | 7.56e-01 |
| GOBP KIDNEY MESENCHYME DEVELOPMENT | 5 | 5.00e-01 | 1.74e-01 | 7.92e-01 |
| GOBP METANEPHRIC MESENCHYME DEVELOPMENT | 5 | 5.00e-01 | 1.74e-01 | 7.92e-01 |
| GOBP TRICARBOXYLIC ACID METABOLIC PROCESS | 11 | 3.17e-01 | 1.74e-01 | 6.79e-01 |
| GOCC CATENIN COMPLEX | 7 | 4.25e-01 | -1.74e-01 | 7.56e-01 |
| GOBP EPIDERMIS MORPHOGENESIS | 10 | 3.40e-01 | -1.74e-01 | 6.94e-01 |
| GOCC SMN SM PROTEIN COMPLEX | 17 | 2.14e-01 | 1.74e-01 | 5.90e-01 |
| GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 27 | 1.18e-01 | 1.74e-01 | 4.67e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS | 7 | 4.25e-01 | -1.74e-01 | 7.56e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 25 | 1.32e-01 | -1.74e-01 | 4.89e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 21 | 1.68e-01 | -1.74e-01 | 5.34e-01 |
| GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT | 26 | 1.25e-01 | -1.74e-01 | 4.81e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 13 | 2.78e-01 | -1.74e-01 | 6.53e-01 |
| GOBP REGULATION OF T HELPER CELL DIFFERENTIATION | 31 | 9.40e-02 | -1.74e-01 | 4.28e-01 |
| GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES | 12 | 2.97e-01 | -1.74e-01 | 6.63e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 28 | 1.12e-01 | 1.74e-01 | 4.58e-01 |
| GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY | 8 | 3.95e-01 | 1.74e-01 | 7.34e-01 |
| GOBP BLOOD VESSEL MORPHOGENESIS | 290 | 4.14e-07 | -1.74e-01 | 3.04e-04 |
| GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS | 9 | 3.68e-01 | -1.73e-01 | 7.12e-01 |
| GOMF MYOSIN HEAVY CHAIN BINDING | 6 | 4.62e-01 | 1.73e-01 | 7.77e-01 |
| GOMF INSULIN RECEPTOR SUBSTRATE BINDING | 11 | 3.20e-01 | 1.73e-01 | 6.80e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 33 | 8.51e-02 | -1.73e-01 | 4.13e-01 |
| GOBP ENDOTHELIUM DEVELOPMENT | 77 | 8.66e-03 | -1.73e-01 | 1.54e-01 |
| GOMF LEUCINE ZIPPER DOMAIN BINDING | 10 | 3.43e-01 | 1.73e-01 | 6.95e-01 |
| GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION | 9 | 3.68e-01 | -1.73e-01 | 7.13e-01 |
| GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 8 | 3.96e-01 | -1.73e-01 | 7.35e-01 |
| GOMF CHROMO SHADOW DOMAIN BINDING | 6 | 4.63e-01 | -1.73e-01 | 7.77e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 8 | 3.97e-01 | 1.73e-01 | 7.35e-01 |
| GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY | 8 | 3.97e-01 | 1.73e-01 | 7.35e-01 |
| GOBP PROTEIN K11 LINKED DEUBIQUITINATION | 6 | 4.63e-01 | -1.73e-01 | 7.77e-01 |
| GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE | 5 | 5.03e-01 | 1.73e-01 | 7.94e-01 |
| GOBP DOPAMINERGIC NEURON DIFFERENTIATION | 12 | 3.00e-01 | -1.73e-01 | 6.64e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 12 | 3.00e-01 | 1.73e-01 | 6.64e-01 |
| GOCC RECYCLING ENDOSOME | 138 | 4.72e-04 | -1.73e-01 | 2.91e-02 |
| GOBP RESPONSE TO ACIDIC PH | 10 | 3.44e-01 | -1.73e-01 | 6.97e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS | 28 | 1.14e-01 | 1.73e-01 | 4.61e-01 |
| GOBP METHIONINE BIOSYNTHETIC PROCESS | 10 | 3.45e-01 | 1.72e-01 | 6.98e-01 |
| GOBP AMINO ACID BIOSYNTHETIC PROCESS | 49 | 3.70e-02 | 1.72e-01 | 2.88e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 9 | 3.71e-01 | -1.72e-01 | 7.14e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 15 | 2.48e-01 | 1.72e-01 | 6.25e-01 |
| GOBP CELLULAR RESPONSE TO MANGANESE ION | 8 | 3.99e-01 | -1.72e-01 | 7.37e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY | 21 | 1.72e-01 | -1.72e-01 | 5.37e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS | 17 | 2.19e-01 | -1.72e-01 | 5.95e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 11 | 3.23e-01 | 1.72e-01 | 6.81e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME | 84 | 6.46e-03 | 1.72e-01 | 1.36e-01 |
| GOMF ANAPHASE PROMOTING COMPLEX BINDING | 5 | 5.05e-01 | 1.72e-01 | 7.96e-01 |
| GOCC CLATHRIN SCULPTED VESICLE | 6 | 4.66e-01 | -1.72e-01 | 7.78e-01 |
| GOBP TAURINE TRANSPORT | 6 | 4.66e-01 | -1.72e-01 | 7.78e-01 |
| GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 78 | 8.72e-03 | -1.72e-01 | 1.54e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION | 11 | 3.23e-01 | 1.72e-01 | 6.81e-01 |
| GOCC RIBONUCLEASE MRP COMPLEX | 10 | 3.47e-01 | 1.72e-01 | 6.98e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING | 13 | 2.84e-01 | 1.72e-01 | 6.55e-01 |
| GOBP REGULATION OF T CELL CHEMOTAXIS | 8 | 4.00e-01 | 1.72e-01 | 7.38e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING | 22 | 1.63e-01 | 1.72e-01 | 5.29e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 80 | 8.03e-03 | -1.72e-01 | 1.52e-01 |
| GOMF GDP PHOSPHATASE ACTIVITY | 7 | 4.32e-01 | -1.72e-01 | 7.59e-01 |
| GOBP RESPONSE TO DSRNA | 33 | 8.82e-02 | -1.72e-01 | 4.20e-01 |
| GOBP CORNIFIED ENVELOPE ASSEMBLY | 5 | 5.06e-01 | 1.72e-01 | 7.97e-01 |
| GOBP EMBRYONIC PLACENTA MORPHOGENESIS | 14 | 2.67e-01 | -1.72e-01 | 6.44e-01 |
| GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS | 19 | 1.96e-01 | -1.71e-01 | 5.68e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 3.73e-01 | 1.71e-01 | 7.16e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 7 | 4.32e-01 | -1.71e-01 | 7.59e-01 |
| GOBP PROTEIN K27 LINKED UBIQUITINATION | 6 | 4.67e-01 | -1.71e-01 | 7.78e-01 |
| GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 1.55e-01 | 1.71e-01 | 5.20e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 76 | 9.93e-03 | -1.71e-01 | 1.66e-01 |
| GOBP REGULATION OF ERAD PATHWAY | 18 | 2.09e-01 | -1.71e-01 | 5.83e-01 |
| GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 4.68e-01 | -1.71e-01 | 7.78e-01 |
| GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING | 7 | 4.33e-01 | -1.71e-01 | 7.60e-01 |
| GOBP PEPTIDYL SERINE DEPHOSPHORYLATION | 14 | 2.67e-01 | -1.71e-01 | 6.44e-01 |
| GOBP THYMOCYTE APOPTOTIC PROCESS | 14 | 2.68e-01 | -1.71e-01 | 6.44e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 10 | 3.49e-01 | -1.71e-01 | 7.00e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION | 6 | 4.68e-01 | -1.71e-01 | 7.78e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN RADICAL | 12 | 3.05e-01 | 1.71e-01 | 6.68e-01 |
| GOMF CYTOKINE RECEPTOR BINDING | 115 | 1.57e-03 | -1.71e-01 | 6.12e-02 |
| GOCC REPLISOME | 14 | 2.68e-01 | 1.71e-01 | 6.45e-01 |
| GOBP DECIDUALIZATION | 14 | 2.68e-01 | -1.71e-01 | 6.45e-01 |
| GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY | 8 | 4.03e-01 | 1.71e-01 | 7.41e-01 |
| GOMF AMINOACYL TRNA EDITING ACTIVITY | 8 | 4.03e-01 | 1.71e-01 | 7.41e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 6 | 4.69e-01 | -1.71e-01 | 7.78e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A TRNA | 103 | 2.78e-03 | 1.71e-01 | 8.23e-02 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 22 | 1.66e-01 | -1.71e-01 | 5.33e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE | 54 | 3.02e-02 | -1.71e-01 | 2.64e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 17 | 2.23e-01 | 1.71e-01 | 5.99e-01 |
| GOBP ATRIAL SEPTUM MORPHOGENESIS | 6 | 4.69e-01 | -1.71e-01 | 7.78e-01 |
| GOBP EAR MORPHOGENESIS | 36 | 7.69e-02 | 1.71e-01 | 3.97e-01 |
| GOBP ALDEHYDE BIOSYNTHETIC PROCESS | 8 | 4.04e-01 | -1.70e-01 | 7.42e-01 |
| GOBP DENDRITE EXTENSION | 21 | 1.77e-01 | -1.70e-01 | 5.44e-01 |
| GOBP EPITHELIAL CELL DEVELOPMENT | 112 | 1.89e-03 | -1.70e-01 | 6.56e-02 |
| GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY | 6 | 4.70e-01 | -1.70e-01 | 7.79e-01 |
| GOBP ENDODERM DEVELOPMENT | 36 | 7.74e-02 | -1.70e-01 | 3.99e-01 |
| GOBP PHOSPHATIDIC ACID METABOLIC PROCESS | 25 | 1.41e-01 | 1.70e-01 | 5.00e-01 |
| GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY | 5 | 5.11e-01 | 1.70e-01 | 7.99e-01 |
| GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 9 | 3.78e-01 | -1.70e-01 | 7.18e-01 |
| GOCC NURF COMPLEX | 6 | 4.71e-01 | 1.70e-01 | 7.79e-01 |
| GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 2.12e-01 | -1.70e-01 | 5.88e-01 |
| GOBP REGULATION OF FIBROBLAST PROLIFERATION | 52 | 3.46e-02 | -1.70e-01 | 2.78e-01 |
| GOBP REGULATION OF GLUCOCORTICOID SECRETION | 6 | 4.73e-01 | -1.69e-01 | 7.79e-01 |
| GOMF MRNA 3 UTR AU RICH REGION BINDING | 21 | 1.79e-01 | -1.69e-01 | 5.48e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP | 8 | 4.07e-01 | -1.69e-01 | 7.43e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 4.73e-01 | -1.69e-01 | 7.79e-01 |
| GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 59 | 2.47e-02 | -1.69e-01 | 2.43e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY | 49 | 4.08e-02 | 1.69e-01 | 3.01e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY | 7 | 4.39e-01 | 1.69e-01 | 7.63e-01 |
| GOMF POLY A RNA POLYMERASE ACTIVITY | 9 | 3.80e-01 | -1.69e-01 | 7.20e-01 |
| GOBP REGULATION OF DNA BINDING | 56 | 2.88e-02 | -1.69e-01 | 2.60e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 5 | 5.13e-01 | -1.69e-01 | 8.01e-01 |
| GOBP BONE GROWTH | 13 | 2.92e-01 | -1.69e-01 | 6.61e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION | 49 | 4.11e-02 | -1.69e-01 | 3.02e-01 |
| GOBP MAST CELL MEDIATED IMMUNITY | 46 | 4.80e-02 | -1.69e-01 | 3.19e-01 |
| GOBP RESPONSE TO BILE ACID | 5 | 5.14e-01 | 1.69e-01 | 8.01e-01 |
| GOCC MEDIATOR COMPLEX | 37 | 7.61e-02 | -1.69e-01 | 3.96e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER | 12 | 3.12e-01 | 1.69e-01 | 6.75e-01 |
| GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE | 6 | 4.75e-01 | 1.69e-01 | 7.80e-01 |
| GOBP ONE CARBON COMPOUND TRANSPORT | 22 | 1.71e-01 | -1.69e-01 | 5.36e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 17 | 2.29e-01 | 1.69e-01 | 6.07e-01 |
| GOBP CELL ADHESION MOLECULE PRODUCTION | 7 | 4.40e-01 | 1.68e-01 | 7.64e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 31 | 1.05e-01 | -1.68e-01 | 4.50e-01 |
| GOBP CAP DEPENDENT TRANSLATIONAL INITIATION | 7 | 4.40e-01 | -1.68e-01 | 7.64e-01 |
| GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION | 9 | 3.82e-01 | 1.68e-01 | 7.22e-01 |
| GOBP PROTON TRANSMEMBRANE TRANSPORT | 106 | 2.80e-03 | -1.68e-01 | 8.23e-02 |
| GOCC CHROMATOID BODY | 5 | 5.15e-01 | -1.68e-01 | 8.02e-01 |
| GOBP TYROSINE METABOLIC PROCESS | 6 | 4.75e-01 | -1.68e-01 | 7.81e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION | 23 | 1.63e-01 | -1.68e-01 | 5.28e-01 |
| GOBP BONE CELL DEVELOPMENT | 13 | 2.94e-01 | -1.68e-01 | 6.62e-01 |
| GOBP REGULATION OF XENOPHAGY | 8 | 4.10e-01 | -1.68e-01 | 7.46e-01 |
| GOBP CARDIOCYTE DIFFERENTIATION | 70 | 1.51e-02 | -1.68e-01 | 1.96e-01 |
| GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 25 | 1.46e-01 | -1.68e-01 | 5.07e-01 |
| GOBP MITOTIC G2 M TRANSITION CHECKPOINT | 43 | 5.67e-02 | 1.68e-01 | 3.47e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 41 | 6.28e-02 | -1.68e-01 | 3.63e-01 |
| GOMF NEDD8 TRANSFERASE ACTIVITY | 6 | 4.77e-01 | -1.68e-01 | 7.81e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 35 | 8.64e-02 | 1.68e-01 | 4.16e-01 |
| GOBP POSITIVE REGULATION OF BEHAVIOR | 7 | 4.43e-01 | 1.68e-01 | 7.66e-01 |
| GOMF DYNEIN HEAVY CHAIN BINDING | 8 | 4.12e-01 | 1.68e-01 | 7.48e-01 |
| GOBP RESPONSE TO SODIUM PHOSPHATE | 5 | 5.17e-01 | -1.68e-01 | 8.03e-01 |
| GOBP VASCULOGENESIS | 36 | 8.23e-02 | -1.67e-01 | 4.09e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS | 8 | 4.12e-01 | -1.67e-01 | 7.48e-01 |
| GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION | 7 | 4.44e-01 | -1.67e-01 | 7.66e-01 |
| GOBP SCHWANN CELL PROLIFERATION | 7 | 4.44e-01 | -1.67e-01 | 7.66e-01 |
| GOMF DOUBLE STRANDED TELOMERIC DNA BINDING | 9 | 3.85e-01 | 1.67e-01 | 7.25e-01 |
| GOBP RISC COMPLEX ASSEMBLY | 10 | 3.60e-01 | -1.67e-01 | 7.10e-01 |
| GOBP BINDING OF SPERM TO ZONA PELLUCIDA | 15 | 2.63e-01 | 1.67e-01 | 6.40e-01 |
| GOCC POTASSIUM CHANNEL COMPLEX | 21 | 1.85e-01 | 1.67e-01 | 5.54e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 3.86e-01 | -1.67e-01 | 7.25e-01 |
| GOBP STRESS FIBER ASSEMBLY | 74 | 1.31e-02 | -1.67e-01 | 1.86e-01 |
| GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 12 | 3.17e-01 | 1.67e-01 | 6.79e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION | 22 | 1.75e-01 | 1.67e-01 | 5.43e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 32 | 1.03e-01 | -1.67e-01 | 4.47e-01 |
| GOBP INNER EAR MORPHOGENESIS | 28 | 1.27e-01 | 1.67e-01 | 4.83e-01 |
| GOBP GAMMA DELTA T CELL ACTIVATION | 18 | 2.21e-01 | 1.67e-01 | 5.96e-01 |
| GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 80 | 1.00e-02 | -1.67e-01 | 1.66e-01 |
| GOBP LEPTIN MEDIATED SIGNALING PATHWAY | 8 | 4.14e-01 | -1.67e-01 | 7.50e-01 |
| GOBP REGULATION OF PROTEIN MATURATION | 42 | 6.19e-02 | -1.67e-01 | 3.60e-01 |
| GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY | 7 | 4.45e-01 | -1.67e-01 | 7.67e-01 |
| GOMF JUN KINASE KINASE KINASE ACTIVITY | 10 | 3.62e-01 | 1.66e-01 | 7.10e-01 |
| GOCC P BODY | 83 | 8.85e-03 | -1.66e-01 | 1.55e-01 |
| GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE | 33 | 9.82e-02 | 1.66e-01 | 4.37e-01 |
| GOMF LIPASE INHIBITOR ACTIVITY | 7 | 4.46e-01 | 1.66e-01 | 7.67e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM PROCESS | 47 | 4.86e-02 | -1.66e-01 | 3.21e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION | 5 | 5.19e-01 | -1.66e-01 | 8.05e-01 |
| GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE | 5 | 5.19e-01 | -1.66e-01 | 8.05e-01 |
| GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY | 13 | 2.99e-01 | 1.66e-01 | 6.64e-01 |
| GOMF NADP RETINOL DEHYDROGENASE ACTIVITY | 8 | 4.15e-01 | -1.66e-01 | 7.51e-01 |
| GOBP REGULATION OF GLIAL CELL PROLIFERATION | 23 | 1.68e-01 | -1.66e-01 | 5.34e-01 |
| GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY | 7 | 4.46e-01 | 1.66e-01 | 7.67e-01 |
| GOMF SEQUENCE SPECIFIC MRNA BINDING | 7 | 4.46e-01 | -1.66e-01 | 7.68e-01 |
| GOBP CARDIAC VENTRICLE MORPHOGENESIS | 27 | 1.35e-01 | -1.66e-01 | 4.94e-01 |
| GOCC CCR4 NOT CORE COMPLEX | 6 | 4.81e-01 | -1.66e-01 | 7.83e-01 |
| GOBP COPULATION | 5 | 5.20e-01 | -1.66e-01 | 8.05e-01 |
| GOCC CLATHRIN SCULPTED GAMMA AMINOBUTYRIC ACID TRANSPORT VESICLE | 5 | 5.20e-01 | -1.66e-01 | 8.05e-01 |
| GOBP REGULATION OF ANIMAL ORGAN FORMATION | 5 | 5.20e-01 | 1.66e-01 | 8.05e-01 |
| GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS | 25 | 1.51e-01 | -1.66e-01 | 5.13e-01 |
| GOBP SMOOTH MUSCLE CELL DIFFERENTIATION | 29 | 1.22e-01 | -1.66e-01 | 4.75e-01 |
| GOBP ENDOCARDIAL CUSHION DEVELOPMENT | 19 | 2.11e-01 | -1.66e-01 | 5.86e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION | 13 | 3.01e-01 | -1.66e-01 | 6.65e-01 |
| GOBP SALIVARY GLAND DEVELOPMENT | 11 | 3.42e-01 | -1.65e-01 | 6.95e-01 |
| GOBP PIGMENT ACCUMULATION | 9 | 3.90e-01 | 1.65e-01 | 7.28e-01 |
| GOBP PIGMENT GRANULE MATURATION | 9 | 3.90e-01 | 1.65e-01 | 7.28e-01 |
| GOBP CAMP METABOLIC PROCESS | 12 | 3.21e-01 | -1.65e-01 | 6.81e-01 |
| GOBP MEMBRANE RAFT ORGANIZATION | 17 | 2.38e-01 | -1.65e-01 | 6.16e-01 |
| GOBP 3 UTR MEDIATED MRNA DESTABILIZATION | 15 | 2.68e-01 | -1.65e-01 | 6.44e-01 |
| GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY | 20 | 2.01e-01 | -1.65e-01 | 5.76e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 24 | 1.61e-01 | -1.65e-01 | 5.28e-01 |
| GOBP NATURAL KILLER CELL CYTOKINE PRODUCTION | 5 | 5.23e-01 | 1.65e-01 | 8.07e-01 |
| GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY | 22 | 1.80e-01 | 1.65e-01 | 5.48e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 11 | 3.43e-01 | 1.65e-01 | 6.96e-01 |
| GOMF ARYLSULFATASE ACTIVITY | 8 | 4.19e-01 | 1.65e-01 | 7.53e-01 |
| GOBP NEUTROPHIL HOMEOSTASIS | 14 | 2.85e-01 | -1.65e-01 | 6.56e-01 |
| GOBP MIRNA METABOLIC PROCESS | 70 | 1.72e-02 | -1.65e-01 | 2.05e-01 |
| GOBP FAS SIGNALING PATHWAY | 6 | 4.85e-01 | -1.65e-01 | 7.85e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS | 36 | 8.73e-02 | 1.65e-01 | 4.18e-01 |
| GOBP REGULATION OF PROTEIN UBIQUITINATION | 163 | 2.95e-04 | -1.65e-01 | 2.24e-02 |
| GOBP T HELPER 1 TYPE IMMUNE RESPONSE | 36 | 8.74e-02 | -1.65e-01 | 4.18e-01 |
| GOBP METHYLGUANOSINE CAP DECAPPING | 15 | 2.70e-01 | -1.65e-01 | 6.47e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 60 | 2.76e-02 | -1.65e-01 | 2.56e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT | 7 | 4.51e-01 | -1.65e-01 | 7.70e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 154 | 4.38e-04 | -1.65e-01 | 2.82e-02 |
| GOMF NITRIC OXIDE SYNTHASE BINDING | 5 | 5.24e-01 | -1.65e-01 | 8.08e-01 |
| GOCC PTW PP1 PHOSPHATASE COMPLEX | 7 | 4.51e-01 | -1.65e-01 | 7.70e-01 |
| GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS | 12 | 3.24e-01 | -1.64e-01 | 6.81e-01 |
| GOBP ANDROGEN METABOLIC PROCESS | 14 | 2.87e-01 | -1.64e-01 | 6.57e-01 |
| GOBP LYSOSOMAL MEMBRANE ORGANIZATION | 12 | 3.24e-01 | 1.64e-01 | 6.81e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 25 | 1.55e-01 | 1.64e-01 | 5.20e-01 |
| GOBP REGULATION OF RECEPTOR INTERNALIZATION | 39 | 7.61e-02 | -1.64e-01 | 3.96e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 60 | 2.80e-02 | -1.64e-01 | 2.57e-01 |
| GOBP LONG TERM SYNAPTIC POTENTIATION | 38 | 8.05e-02 | -1.64e-01 | 4.07e-01 |
| GOMF ATP DEPENDENT PROTEIN BINDING | 6 | 4.87e-01 | -1.64e-01 | 7.85e-01 |
| GOBP POLYAMINE METABOLIC PROCESS | 14 | 2.89e-01 | -1.64e-01 | 6.58e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 41 | 6.98e-02 | -1.64e-01 | 3.81e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS | 70 | 1.79e-02 | 1.64e-01 | 2.09e-01 |
| GOBP ANTRAL OVARIAN FOLLICLE GROWTH | 6 | 4.88e-01 | 1.64e-01 | 7.86e-01 |
| GOBP GAMMA DELTA T CELL DIFFERENTIATION | 8 | 4.23e-01 | 1.64e-01 | 7.55e-01 |
| GOBP GLYOXYLATE METABOLIC PROCESS | 5 | 5.26e-01 | 1.64e-01 | 8.09e-01 |
| GOBP HOMOLOGOUS RECOMBINATION | 37 | 8.54e-02 | 1.64e-01 | 4.14e-01 |
| GOBP FOAM CELL DIFFERENTIATION | 22 | 1.84e-01 | -1.64e-01 | 5.53e-01 |
| GOBP INTRACELLULAR MRNA LOCALIZATION | 10 | 3.71e-01 | -1.64e-01 | 7.14e-01 |
| GOBP DNA DEALKYLATION INVOLVED IN DNA REPAIR | 9 | 3.96e-01 | 1.63e-01 | 7.34e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 18 | 2.30e-01 | -1.63e-01 | 6.07e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 21 | 1.95e-01 | -1.63e-01 | 5.68e-01 |
| GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY | 7 | 4.54e-01 | -1.63e-01 | 7.72e-01 |
| GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 16 | 2.58e-01 | -1.63e-01 | 6.35e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE | 42 | 6.73e-02 | -1.63e-01 | 3.74e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 9 | 3.97e-01 | -1.63e-01 | 7.35e-01 |
| GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION | 15 | 2.74e-01 | -1.63e-01 | 6.51e-01 |
| GOBP FIBROBLAST APOPTOTIC PROCESS | 20 | 2.07e-01 | -1.63e-01 | 5.82e-01 |
| GOBP COENZYME A METABOLIC PROCESS | 19 | 2.19e-01 | 1.63e-01 | 5.95e-01 |
| GOBP LIPID STORAGE | 64 | 2.43e-02 | -1.63e-01 | 2.41e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 6 | 4.89e-01 | -1.63e-01 | 7.87e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 19 | 2.19e-01 | 1.63e-01 | 5.95e-01 |
| GOBP CELL SUBSTRATE ADHESION | 187 | 1.28e-04 | -1.63e-01 | 1.36e-02 |
| GOMF AMYLOID BETA BINDING | 52 | 4.23e-02 | -1.63e-01 | 3.05e-01 |
| GOBP CELLULAR RESPONSE TO PH | 8 | 4.25e-01 | -1.63e-01 | 7.56e-01 |
| GOCC EARLY ENDOSOME MEMBRANE | 129 | 1.44e-03 | -1.63e-01 | 5.89e-02 |
| GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 24 | 1.68e-01 | -1.63e-01 | 5.34e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 5 | 5.29e-01 | -1.63e-01 | 8.11e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION | 32 | 1.12e-01 | 1.63e-01 | 4.58e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 11 | 3.50e-01 | -1.63e-01 | 7.01e-01 |
| GOBP DNA PROTECTION | 5 | 5.29e-01 | 1.63e-01 | 8.11e-01 |
| GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 6 | 4.91e-01 | 1.63e-01 | 7.88e-01 |
| GOBP SNORNA LOCALIZATION | 6 | 4.91e-01 | -1.63e-01 | 7.88e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID TRANSPORT | 5 | 5.29e-01 | 1.62e-01 | 8.11e-01 |
| GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 4.57e-01 | 1.62e-01 | 7.74e-01 |
| GOBP G0 TO G1 TRANSITION | 29 | 1.31e-01 | 1.62e-01 | 4.88e-01 |
| GOMF CHANNEL REGULATOR ACTIVITY | 57 | 3.42e-02 | 1.62e-01 | 2.77e-01 |
| GOMF MICROTUBULE MINUS END BINDING | 13 | 3.11e-01 | 1.62e-01 | 6.74e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 6 | 4.92e-01 | 1.62e-01 | 7.88e-01 |
| GOMF 5 3 DNA HELICASE ACTIVITY | 6 | 4.92e-01 | 1.62e-01 | 7.88e-01 |
| GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 12 | 3.31e-01 | -1.62e-01 | 6.87e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 10 | 3.75e-01 | -1.62e-01 | 7.17e-01 |
| GOCC PRESYNAPTIC MEMBRANE | 61 | 2.89e-02 | -1.62e-01 | 2.60e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 6 | 4.92e-01 | -1.62e-01 | 7.88e-01 |
| GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 15 | 2.78e-01 | -1.62e-01 | 6.53e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 22 | 1.89e-01 | -1.62e-01 | 5.60e-01 |
| GOBP STRIATED MUSCLE CELL PROLIFERATION | 36 | 9.34e-02 | -1.62e-01 | 4.26e-01 |
| GOCC NSL COMPLEX | 11 | 3.53e-01 | -1.62e-01 | 7.04e-01 |
| GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 22 | 1.90e-01 | -1.62e-01 | 5.60e-01 |
| GOBP APICAL PROTEIN LOCALIZATION | 6 | 4.93e-01 | -1.62e-01 | 7.89e-01 |
| GOBP T CELL LINEAGE COMMITMENT | 22 | 1.90e-01 | -1.62e-01 | 5.60e-01 |
| GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS | 29 | 1.33e-01 | 1.61e-01 | 4.91e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOTAXIS | 32 | 1.15e-01 | 1.61e-01 | 4.61e-01 |
| GOBP CYSTEINE METABOLIC PROCESS | 7 | 4.60e-01 | -1.61e-01 | 7.76e-01 |
| GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 10 | 3.78e-01 | 1.61e-01 | 7.18e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION | 35 | 9.92e-02 | -1.61e-01 | 4.39e-01 |
| GOBP REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS | 5 | 5.33e-01 | 1.61e-01 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION | 7 | 4.61e-01 | 1.61e-01 | 7.76e-01 |
| GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY | 16 | 2.66e-01 | -1.61e-01 | 6.43e-01 |
| GOBP SPINDLE MIDZONE ASSEMBLY | 7 | 4.61e-01 | -1.61e-01 | 7.77e-01 |
| GOBP MONOCYTE EXTRAVASATION | 8 | 4.31e-01 | -1.61e-01 | 7.59e-01 |
| GOBP P BODY ASSEMBLY | 21 | 2.03e-01 | -1.61e-01 | 5.78e-01 |
| GOBP MITOCHONDRIAL GENE EXPRESSION | 160 | 4.72e-04 | 1.61e-01 | 2.91e-02 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 2.14e-01 | 1.61e-01 | 5.90e-01 |
| GOBP CELLULAR RESPONSE TO MECHANICAL STIMULUS | 52 | 4.54e-02 | -1.61e-01 | 3.13e-01 |
| GOBP CARNITINE METABOLIC PROCESS | 8 | 4.32e-01 | 1.61e-01 | 7.59e-01 |
| GOBP RESPONSE TO OXYGEN LEVELS | 199 | 1.00e-04 | -1.60e-01 | 1.12e-02 |
| GOCC GAMMA TUBULIN COMPLEX | 15 | 2.82e-01 | -1.60e-01 | 6.55e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 30 | 1.29e-01 | 1.60e-01 | 4.85e-01 |
| GOCC TERTIARY GRANULE MEMBRANE | 61 | 3.04e-02 | -1.60e-01 | 2.65e-01 |
| GOMF HISTONE DEACETYLASE BINDING | 88 | 9.41e-03 | -1.60e-01 | 1.61e-01 |
| GOBP FIBROBLAST PROLIFERATION | 62 | 2.92e-02 | -1.60e-01 | 2.61e-01 |
| GOCC ASTER | 7 | 4.63e-01 | -1.60e-01 | 7.77e-01 |
| GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 9 | 4.05e-01 | 1.60e-01 | 7.42e-01 |
| GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 9 | 4.05e-01 | 1.60e-01 | 7.42e-01 |
| GOBP ENTEROENDOCRINE CELL DIFFERENTIATION | 13 | 3.17e-01 | -1.60e-01 | 6.79e-01 |
| GOMF GLUTAMATE RECEPTOR BINDING | 21 | 2.04e-01 | -1.60e-01 | 5.80e-01 |
| GOBP POSITIVE REGULATION OF GROWTH | 133 | 1.47e-03 | -1.60e-01 | 5.91e-02 |
| GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION | 7 | 4.64e-01 | -1.60e-01 | 7.77e-01 |
| GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 67 | 2.37e-02 | -1.60e-01 | 2.39e-01 |
| GOCC MYELIN SHEATH ABAXONAL REGION | 5 | 5.36e-01 | 1.60e-01 | 8.15e-01 |
| GOMF DNA DAMAGE SENSOR ACTIVITY | 15 | 2.84e-01 | 1.60e-01 | 6.55e-01 |
| GOCC RIBONUCLEASE P COMPLEX | 13 | 3.18e-01 | 1.60e-01 | 6.80e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION | 86 | 1.05e-02 | -1.60e-01 | 1.70e-01 |
| GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY | 6 | 4.98e-01 | -1.60e-01 | 7.92e-01 |
| GOBP REGULATION OF NK T CELL ACTIVATION | 7 | 4.65e-01 | 1.60e-01 | 7.77e-01 |
| GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 36 | 9.76e-02 | -1.60e-01 | 4.36e-01 |
| GOCC CILIARY TRANSITION ZONE | 44 | 6.71e-02 | 1.60e-01 | 3.74e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 24 | 1.76e-01 | -1.60e-01 | 5.43e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 23 | 1.85e-01 | -1.60e-01 | 5.54e-01 |
| GOBP REGULATION OF MACROPHAGE DIFFERENTIATION | 14 | 3.01e-01 | -1.60e-01 | 6.65e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY | 13 | 3.19e-01 | -1.60e-01 | 6.80e-01 |
| GOMF CYTOKINE RECEPTOR ACTIVITY | 52 | 4.67e-02 | -1.60e-01 | 3.16e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 7 | 4.65e-01 | -1.60e-01 | 7.78e-01 |
| GOCC LYSOSOMAL LUMEN | 60 | 3.27e-02 | -1.60e-01 | 2.72e-01 |
| GOBP POSITIVE REGULATION OF JNK CASCADE | 59 | 3.44e-02 | -1.59e-01 | 2.77e-01 |
| GOMF METALLOCHAPERONE ACTIVITY | 12 | 3.39e-01 | 1.59e-01 | 6.93e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 40 | 8.17e-02 | -1.59e-01 | 4.09e-01 |
| GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 56 | 3.96e-02 | -1.59e-01 | 2.97e-01 |
| GOCC PROTEIN PHOSPHATASE 4 COMPLEX | 5 | 5.38e-01 | -1.59e-01 | 8.16e-01 |
| GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 10 | 3.84e-01 | -1.59e-01 | 7.24e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS | 20 | 2.18e-01 | -1.59e-01 | 5.95e-01 |
| GOBP EYE MORPHOGENESIS | 64 | 2.79e-02 | -1.59e-01 | 2.57e-01 |
| GOBP ALPHA AMINO ACID CATABOLIC PROCESS | 51 | 4.97e-02 | 1.59e-01 | 3.24e-01 |
| GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY | 91 | 8.87e-03 | -1.59e-01 | 1.55e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 14 | 3.03e-01 | -1.59e-01 | 6.67e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 6 | 5.00e-01 | 1.59e-01 | 7.92e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL | 6 | 5.00e-01 | 1.59e-01 | 7.92e-01 |
| GOBP POST EMBRYONIC ANIMAL MORPHOGENESIS | 8 | 4.37e-01 | -1.59e-01 | 7.61e-01 |
| GOBP TONGUE DEVELOPMENT | 6 | 5.00e-01 | 1.59e-01 | 7.92e-01 |
| GOMF HISTONE DEUBIQUITINASE ACTIVITY | 5 | 5.39e-01 | -1.59e-01 | 8.17e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION | 9 | 4.10e-01 | -1.59e-01 | 7.46e-01 |
| GOBP DEVELOPMENTAL PIGMENTATION | 28 | 1.46e-01 | -1.59e-01 | 5.07e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 32 | 1.21e-01 | -1.59e-01 | 4.73e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 107 | 4.66e-03 | -1.59e-01 | 1.12e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 62 | 3.10e-02 | 1.59e-01 | 2.67e-01 |
| GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION | 6 | 5.01e-01 | -1.59e-01 | 7.92e-01 |
| GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION | 75 | 1.78e-02 | -1.59e-01 | 2.08e-01 |
| GOBP NEGATIVE REGULATION OF BONE MINERALIZATION | 10 | 3.86e-01 | -1.58e-01 | 7.25e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 14 | 3.05e-01 | 1.58e-01 | 6.68e-01 |
| GOBP CARBOHYDRATE PHOSPHORYLATION | 19 | 2.32e-01 | -1.58e-01 | 6.09e-01 |
| GOBP NUCLEAR BODY ORGANIZATION | 11 | 3.63e-01 | -1.58e-01 | 7.10e-01 |
| GOBP POSITIVE REGULATION OF ACTIN NUCLEATION | 9 | 4.11e-01 | 1.58e-01 | 7.47e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION | 12 | 3.42e-01 | -1.58e-01 | 6.95e-01 |
| GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 7 | 4.69e-01 | -1.58e-01 | 7.78e-01 |
| GOMF NADPLUS BINDING | 15 | 2.89e-01 | 1.58e-01 | 6.58e-01 |
| GOBP MUSCLE ATROPHY | 6 | 5.02e-01 | -1.58e-01 | 7.94e-01 |
| GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 220 | 5.63e-05 | -1.58e-01 | 7.79e-03 |
| GOBP POSITIVE REGULATION OF RNA SPLICING | 33 | 1.16e-01 | -1.58e-01 | 4.64e-01 |
| GOMF PDZ DOMAIN BINDING | 50 | 5.34e-02 | -1.58e-01 | 3.37e-01 |
| GOMF TPR DOMAIN BINDING | 7 | 4.69e-01 | -1.58e-01 | 7.78e-01 |
| GOMF ADP BINDING | 30 | 1.34e-01 | -1.58e-01 | 4.93e-01 |
| GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS | 43 | 7.33e-02 | 1.58e-01 | 3.91e-01 |
| GOBP CARDIAC SEPTUM MORPHOGENESIS | 32 | 1.22e-01 | -1.58e-01 | 4.75e-01 |
| GOCC METHYLOSOME | 12 | 3.44e-01 | 1.58e-01 | 6.96e-01 |
| GOBP ALDITOL METABOLIC PROCESS | 14 | 3.06e-01 | -1.58e-01 | 6.69e-01 |
| GOBP MALATE METABOLIC PROCESS | 6 | 5.03e-01 | 1.58e-01 | 7.94e-01 |
| GOBP VACUOLAR LOCALIZATION | 72 | 2.09e-02 | -1.58e-01 | 2.25e-01 |
| GOBP COPPER ION TRANSPORT | 12 | 3.45e-01 | 1.58e-01 | 6.97e-01 |
| GOBP POSITIVE REGULATION OF GLIOGENESIS | 32 | 1.23e-01 | -1.58e-01 | 4.77e-01 |
| GOBP CERAMIDE METABOLIC PROCESS | 71 | 2.20e-02 | -1.57e-01 | 2.31e-01 |
| GOBP GLUTAMATE METABOLIC PROCESS | 16 | 2.76e-01 | -1.57e-01 | 6.52e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS | 13 | 3.26e-01 | 1.57e-01 | 6.83e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 5.42e-01 | 1.57e-01 | 8.19e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 13 | 3.26e-01 | -1.57e-01 | 6.83e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION | 64 | 2.97e-02 | -1.57e-01 | 2.62e-01 |
| GOBP RESPIRATORY SYSTEM DEVELOPMENT | 95 | 8.24e-03 | -1.57e-01 | 1.52e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS | 173 | 3.80e-04 | 1.57e-01 | 2.64e-02 |
| GOBP BILE ACID SECRETION | 6 | 5.05e-01 | 1.57e-01 | 7.96e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY | 20 | 2.24e-01 | -1.57e-01 | 6.00e-01 |
| GOBP CAMERA TYPE EYE MORPHOGENESIS | 54 | 4.62e-02 | -1.57e-01 | 3.15e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 5 | 5.43e-01 | 1.57e-01 | 8.20e-01 |
| GOCC PRE SNORNP COMPLEX | 7 | 4.72e-01 | 1.57e-01 | 7.79e-01 |
| GOBP ENDOCHONDRAL BONE MORPHOGENESIS | 23 | 1.93e-01 | -1.57e-01 | 5.65e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION | 35 | 1.09e-01 | 1.57e-01 | 4.54e-01 |
| GOBP CARDIAC MUSCLE CELL DIFFERENTIATION | 56 | 4.26e-02 | -1.57e-01 | 3.07e-01 |
| GOMF TETRAPYRROLE BINDING | 64 | 3.03e-02 | -1.57e-01 | 2.64e-01 |
| GOBP RESPONSE TO PROGESTERONE | 24 | 1.84e-01 | -1.57e-01 | 5.53e-01 |
| GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 41 | 8.27e-02 | -1.57e-01 | 4.09e-01 |
| GOBP INTERLEUKIN 1 ALPHA PRODUCTION | 5 | 5.44e-01 | 1.57e-01 | 8.20e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE | 6 | 5.06e-01 | -1.57e-01 | 7.97e-01 |
| GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 12 | 3.47e-01 | -1.57e-01 | 6.99e-01 |
| GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 38 | 9.49e-02 | -1.57e-01 | 4.30e-01 |
| GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 31 | 1.31e-01 | -1.57e-01 | 4.89e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 7 | 4.73e-01 | 1.57e-01 | 7.79e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 9 | 4.16e-01 | 1.57e-01 | 7.51e-01 |
| GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY | 8 | 4.43e-01 | 1.57e-01 | 7.66e-01 |
| GOBP RESPONSE TO DIETARY EXCESS | 13 | 3.29e-01 | 1.57e-01 | 6.86e-01 |
| GOBP REGULATION OF URINE VOLUME | 8 | 4.44e-01 | -1.56e-01 | 7.66e-01 |
| GOBP PROTEASOME ASSEMBLY | 12 | 3.48e-01 | -1.56e-01 | 7.00e-01 |
| GOMF POLY A BINDING | 19 | 2.38e-01 | -1.56e-01 | 6.16e-01 |
| GOCC CD40 RECEPTOR COMPLEX | 11 | 3.70e-01 | -1.56e-01 | 7.13e-01 |
| GOBP REGULATION OF GENE EXPRESSION BY GENOMIC IMPRINTING | 8 | 4.44e-01 | -1.56e-01 | 7.67e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 53 | 4.93e-02 | 1.56e-01 | 3.22e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 19 | 2.39e-01 | -1.56e-01 | 6.16e-01 |
| GOBP ISG15 PROTEIN CONJUGATION | 6 | 5.08e-01 | 1.56e-01 | 7.97e-01 |
| GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 16 | 2.80e-01 | 1.56e-01 | 6.54e-01 |
| GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION | 8 | 4.45e-01 | -1.56e-01 | 7.67e-01 |
| GOMF RRNA BINDING | 63 | 3.23e-02 | -1.56e-01 | 2.71e-01 |
| GOMF CHEMOKINE RECEPTOR BINDING | 20 | 2.27e-01 | 1.56e-01 | 6.03e-01 |
| GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX | 30 | 1.39e-01 | 1.56e-01 | 4.98e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 8 | 4.45e-01 | -1.56e-01 | 7.67e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 12 | 3.49e-01 | -1.56e-01 | 7.00e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION | 126 | 2.55e-03 | 1.56e-01 | 7.78e-02 |
| GOBP ENSHEATHMENT OF NEURONS | 80 | 1.61e-02 | -1.56e-01 | 1.99e-01 |
| GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME | 30 | 1.40e-01 | -1.56e-01 | 4.99e-01 |
| GOBP RESPONSE TO INTERFERON BETA | 27 | 1.61e-01 | 1.56e-01 | 5.27e-01 |
| GOMF LIPID PHOSPHATASE ACTIVITY | 8 | 4.45e-01 | -1.56e-01 | 7.67e-01 |
| GOBP PROTEIN TARGETING TO MEMBRANE | 91 | 1.03e-02 | -1.56e-01 | 1.69e-01 |
| GOBP NOREPINEPHRINE TRANSPORT | 6 | 5.09e-01 | -1.56e-01 | 7.98e-01 |
| GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY | 11 | 3.71e-01 | -1.56e-01 | 7.15e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 39 | 9.27e-02 | -1.56e-01 | 4.25e-01 |
| GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE | 11 | 3.71e-01 | -1.56e-01 | 7.15e-01 |
| GOBP TRANSEPITHELIAL TRANSPORT | 13 | 3.31e-01 | 1.56e-01 | 6.87e-01 |
| GOBP CELLULAR RESPONSE TO INTERLEUKIN 1 | 60 | 3.72e-02 | -1.56e-01 | 2.89e-01 |
| GOBP CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS | 5 | 5.47e-01 | -1.56e-01 | 8.23e-01 |
| GOBP FIBROBLAST MIGRATION | 42 | 8.14e-02 | -1.56e-01 | 4.09e-01 |
| GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING | 27 | 1.62e-01 | -1.55e-01 | 5.28e-01 |
| GOBP ENDOSOME ORGANIZATION | 83 | 1.45e-02 | -1.55e-01 | 1.94e-01 |
| GOCC BRUSH BORDER | 49 | 6.01e-02 | -1.55e-01 | 3.57e-01 |
| GOBP RESPONSE TO COLD | 27 | 1.63e-01 | -1.55e-01 | 5.28e-01 |
| GOBP TRIPARTITE REGIONAL SUBDIVISION | 5 | 5.49e-01 | 1.55e-01 | 8.23e-01 |
| GOMF PROTEIN KINASE C ACTIVITY | 13 | 3.34e-01 | 1.55e-01 | 6.88e-01 |
| GOBP THYROID HORMONE GENERATION | 7 | 4.78e-01 | -1.55e-01 | 7.82e-01 |
| GOBP GMP METABOLIC PROCESS | 24 | 1.89e-01 | 1.55e-01 | 5.60e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 6 | 5.11e-01 | 1.55e-01 | 8.00e-01 |
| GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY | 6 | 5.11e-01 | -1.55e-01 | 8.00e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 61 | 3.67e-02 | -1.55e-01 | 2.86e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 9 | 4.22e-01 | 1.55e-01 | 7.54e-01 |
| GOBP POSITIVE REGULATION OF VASOCONSTRICTION | 10 | 3.97e-01 | -1.55e-01 | 7.35e-01 |
| GOCC PRC1 COMPLEX | 13 | 3.35e-01 | -1.55e-01 | 6.88e-01 |
| GOBP PHAGOCYTOSIS | 168 | 5.68e-04 | -1.55e-01 | 3.27e-02 |
| GOBP MICROGLIA DIFFERENTIATION | 10 | 3.98e-01 | -1.55e-01 | 7.35e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING VIA ENDOSOME | 5 | 5.50e-01 | -1.54e-01 | 8.23e-01 |
| GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION | 62 | 3.56e-02 | -1.54e-01 | 2.82e-01 |
| GOBP TETRAPYRROLE METABOLIC PROCESS | 43 | 7.99e-02 | 1.54e-01 | 4.06e-01 |
| GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 29 | 1.50e-01 | -1.54e-01 | 5.13e-01 |
| GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY | 18 | 2.57e-01 | -1.54e-01 | 6.33e-01 |
| GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 11 | 3.76e-01 | 1.54e-01 | 7.17e-01 |
| GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 16 | 2.85e-01 | -1.54e-01 | 6.56e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 21 | 2.21e-01 | -1.54e-01 | 5.97e-01 |
| GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 4.23e-01 | -1.54e-01 | 7.55e-01 |
| GOCC FEMALE GERM CELL NUCLEUS | 8 | 4.50e-01 | -1.54e-01 | 7.70e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION | 17 | 2.71e-01 | 1.54e-01 | 6.49e-01 |
| GOBP PROTEOGLYCAN CATABOLIC PROCESS | 9 | 4.23e-01 | -1.54e-01 | 7.55e-01 |
| GOBP OSTEOBLAST PROLIFERATION | 14 | 3.18e-01 | -1.54e-01 | 6.80e-01 |
| GOBP GLUCOCORTICOID SECRETION | 7 | 4.80e-01 | -1.54e-01 | 7.83e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY | 9 | 4.24e-01 | 1.54e-01 | 7.55e-01 |
| GOBP RESPONSE TO CAMP | 45 | 7.42e-02 | -1.54e-01 | 3.93e-01 |
| GOMF TRANSCRIPTION COREGULATOR BINDING | 88 | 1.27e-02 | -1.54e-01 | 1.82e-01 |
| GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE | 71 | 2.51e-02 | 1.54e-01 | 2.44e-01 |
| GOBP TERPENOID BIOSYNTHETIC PROCESS | 8 | 4.51e-01 | 1.54e-01 | 7.70e-01 |
| GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY | 32 | 1.32e-01 | -1.54e-01 | 4.89e-01 |
| GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY | 5 | 5.51e-01 | -1.54e-01 | 8.24e-01 |
| GOBP CEREBRAL CORTEX DEVELOPMENT | 73 | 2.32e-02 | -1.54e-01 | 2.37e-01 |
| GOCC CORE MEDIATOR COMPLEX | 26 | 1.75e-01 | -1.54e-01 | 5.42e-01 |
| GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS | 11 | 3.78e-01 | 1.54e-01 | 7.18e-01 |
| GOBP CATECHOLAMINE SECRETION | 18 | 2.59e-01 | -1.54e-01 | 6.36e-01 |
| GOBP GLYCOSIDE METABOLIC PROCESS | 11 | 3.78e-01 | 1.54e-01 | 7.18e-01 |
| GOBP LYMPH VESSEL DEVELOPMENT | 9 | 4.26e-01 | -1.53e-01 | 7.56e-01 |
| GOCC PIGMENT GRANULE | 89 | 1.26e-02 | -1.53e-01 | 1.82e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE | 11 | 3.79e-01 | -1.53e-01 | 7.19e-01 |
| GOBP PHAGOSOME MATURATION | 24 | 1.94e-01 | -1.53e-01 | 5.67e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M | 7 | 4.83e-01 | -1.53e-01 | 7.84e-01 |
| GOBP HISTONE METHYLATION | 33 | 1.29e-01 | 1.53e-01 | 4.85e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR | 11 | 3.80e-01 | 1.53e-01 | 7.20e-01 |
| GOCC PHAGOCYTIC VESICLE | 122 | 3.61e-03 | -1.53e-01 | 9.51e-02 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 58 | 4.43e-02 | -1.53e-01 | 3.10e-01 |
| GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY | 10 | 4.03e-01 | -1.53e-01 | 7.41e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 93 | 1.10e-02 | -1.53e-01 | 1.73e-01 |
| GOCC X CHROMOSOME | 6 | 5.17e-01 | -1.53e-01 | 8.04e-01 |
| GOBP HIPPO SIGNALING | 23 | 2.05e-01 | -1.53e-01 | 5.81e-01 |
| GOBP CARDIAC ATRIUM MORPHOGENESIS | 10 | 4.03e-01 | -1.53e-01 | 7.41e-01 |
| GOCC BLOC 1 COMPLEX | 8 | 4.55e-01 | 1.53e-01 | 7.72e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE | 233 | 6.51e-05 | -1.52e-01 | 8.53e-03 |
| GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS | 5 | 5.55e-01 | -1.52e-01 | 8.26e-01 |
| GOBP MITOCHONDRIAL PROTEIN PROCESSING | 12 | 3.61e-01 | 1.52e-01 | 7.10e-01 |
| GOBP MICROGLIAL CELL MEDIATED CYTOTOXICITY | 5 | 5.55e-01 | -1.52e-01 | 8.26e-01 |
| GOBP PROTEIN HEXAMERIZATION | 8 | 4.56e-01 | 1.52e-01 | 7.73e-01 |
| GOCC CHROMOSOME TELOMERIC REGION | 127 | 3.10e-03 | 1.52e-01 | 8.75e-02 |
| GOBP PROTEIN LOCALIZATION TO CILIUM | 48 | 6.83e-02 | 1.52e-01 | 3.77e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 13 | 3.42e-01 | -1.52e-01 | 6.95e-01 |
| GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 21 | 2.27e-01 | -1.52e-01 | 6.03e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 4.29e-01 | 1.52e-01 | 7.58e-01 |
| GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 49 | 6.58e-02 | -1.52e-01 | 3.71e-01 |
| GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS | 31 | 1.43e-01 | -1.52e-01 | 5.05e-01 |
| GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 12 | 3.62e-01 | 1.52e-01 | 7.10e-01 |
| GOBP REGULATION OF BLOOD PRESSURE | 68 | 3.04e-02 | -1.52e-01 | 2.65e-01 |
| GOBP BRAIN MORPHOGENESIS | 20 | 2.40e-01 | -1.52e-01 | 6.17e-01 |
| GOMF DYNACTIN BINDING | 9 | 4.30e-01 | -1.52e-01 | 7.58e-01 |
| GOBP RESPONSE TO LEPTIN | 12 | 3.63e-01 | -1.52e-01 | 7.10e-01 |
| GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY | 5 | 5.57e-01 | -1.52e-01 | 8.27e-01 |
| GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC | 12 | 3.63e-01 | -1.52e-01 | 7.10e-01 |
| GOMF RIBONUCLEASE P ACTIVITY | 11 | 3.83e-01 | 1.52e-01 | 7.24e-01 |
| GOBP REGULATION OF SYNAPTIC PLASTICITY | 87 | 1.46e-02 | -1.52e-01 | 1.94e-01 |
| GOCC MON1 CCZ1 COMPLEX | 5 | 5.57e-01 | -1.52e-01 | 8.27e-01 |
| GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY | 20 | 2.40e-01 | 1.52e-01 | 6.18e-01 |
| GOBP REGULATION OF PODOSOME ASSEMBLY | 11 | 3.84e-01 | -1.52e-01 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY | 28 | 1.65e-01 | -1.52e-01 | 5.31e-01 |
| GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 8 | 4.58e-01 | 1.52e-01 | 7.74e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 100 | 8.94e-03 | -1.52e-01 | 1.56e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS | 13 | 3.44e-01 | -1.52e-01 | 6.97e-01 |
| GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 61 | 4.13e-02 | -1.51e-01 | 3.02e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 17 | 2.81e-01 | 1.51e-01 | 6.54e-01 |
| GOBP RESPONSE TO INTERLEUKIN 3 | 7 | 4.89e-01 | 1.51e-01 | 7.87e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS | 20 | 2.42e-01 | 1.51e-01 | 6.21e-01 |
| GOBP ESTROGEN METABOLIC PROCESS | 11 | 3.86e-01 | -1.51e-01 | 7.25e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 62 | 4.00e-02 | -1.51e-01 | 2.98e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 12 | 3.65e-01 | -1.51e-01 | 7.11e-01 |
| GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 5 | 5.59e-01 | 1.51e-01 | 8.29e-01 |
| GOCC FILOPODIUM | 60 | 4.34e-02 | -1.51e-01 | 3.08e-01 |
| GOBP POSITIVE REGULATION OF MACROAUTOPHAGY | 61 | 4.19e-02 | -1.51e-01 | 3.04e-01 |
| GOBP MACROMOLECULE METHYLATION | 172 | 6.72e-04 | 1.51e-01 | 3.61e-02 |
| GOBP AMYLOID BETA CLEARANCE | 25 | 1.92e-01 | -1.51e-01 | 5.65e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 79 | 2.08e-02 | -1.51e-01 | 2.25e-01 |
| GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION | 5 | 5.60e-01 | -1.51e-01 | 8.29e-01 |
| GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 5 | 5.61e-01 | -1.50e-01 | 8.29e-01 |
| GOCC FICOLIN 1 RICH GRANULE | 170 | 7.48e-04 | -1.50e-01 | 3.84e-02 |
| GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 9 | 4.35e-01 | 1.50e-01 | 7.61e-01 |
| GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 3.88e-01 | 1.50e-01 | 7.26e-01 |
| GOBP CRANIAL NERVE DEVELOPMENT | 19 | 2.57e-01 | -1.50e-01 | 6.33e-01 |
| GOCC MITOTIC SPINDLE MIDZONE | 8 | 4.62e-01 | -1.50e-01 | 7.77e-01 |
| GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS | 9 | 4.36e-01 | -1.50e-01 | 7.61e-01 |
| GOCC GROWTH CONE MEMBRANE | 5 | 5.61e-01 | -1.50e-01 | 8.29e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 26 | 1.86e-01 | -1.50e-01 | 5.54e-01 |
| GOCC LOW DENSITY LIPOPROTEIN PARTICLE | 7 | 4.92e-01 | 1.50e-01 | 7.88e-01 |
| GOBP DIOL BIOSYNTHETIC PROCESS | 14 | 3.31e-01 | 1.50e-01 | 6.87e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 15 | 3.15e-01 | -1.50e-01 | 6.78e-01 |
| GOBP CEREBELLAR CORTEX DEVELOPMENT | 26 | 1.86e-01 | -1.50e-01 | 5.55e-01 |
| GOMF PROTEIN TRANSPORTER ACTIVITY | 33 | 1.36e-01 | -1.50e-01 | 4.94e-01 |
| GOCC SARCOPLASMIC RETICULUM | 36 | 1.20e-01 | 1.50e-01 | 4.72e-01 |
| GOBP CORTICOSPINAL TRACT MORPHOGENESIS | 5 | 5.62e-01 | 1.50e-01 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 19 | 2.59e-01 | 1.50e-01 | 6.35e-01 |
| GOMF N ACETYLTRANSFERASE ACTIVITY | 56 | 5.30e-02 | -1.50e-01 | 3.35e-01 |
| GOMF PRE MRNA INTRONIC BINDING | 9 | 4.37e-01 | -1.50e-01 | 7.61e-01 |
| GOBP PROTEIN TARGETING TO PEROXISOME | 18 | 2.72e-01 | -1.50e-01 | 6.50e-01 |
| GOBP MITOTIC SISTER CHROMATID SEPARATION | 38 | 1.11e-01 | 1.50e-01 | 4.57e-01 |
| GOBP I KAPPAB PHOSPHORYLATION | 14 | 3.33e-01 | 1.50e-01 | 6.88e-01 |
| GOBP BASEMENT MEMBRANE ORGANIZATION | 14 | 3.33e-01 | -1.50e-01 | 6.88e-01 |
| GOBP COBALT ION TRANSPORT | 6 | 5.26e-01 | -1.50e-01 | 8.09e-01 |
| GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION | 24 | 2.05e-01 | 1.49e-01 | 5.81e-01 |
| GOBP KERATINOCYTE DEVELOPMENT | 7 | 4.94e-01 | -1.49e-01 | 7.90e-01 |
| GOBP NEGATIVE REGULATION OF RNA SPLICING | 23 | 2.16e-01 | -1.49e-01 | 5.92e-01 |
| GOCC ENDOSOME LUMEN | 23 | 2.16e-01 | -1.49e-01 | 5.92e-01 |
| GOBP INTRACELLULAR LIPID TRANSPORT | 38 | 1.12e-01 | -1.49e-01 | 4.58e-01 |
| GOCC ATG12 ATG5 ATG16 COMPLEX | 5 | 5.64e-01 | -1.49e-01 | 8.31e-01 |
| GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 15 | 3.18e-01 | -1.49e-01 | 6.79e-01 |
| GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 15 | 3.18e-01 | 1.49e-01 | 6.79e-01 |
| GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS | 70 | 3.12e-02 | -1.49e-01 | 2.67e-01 |
| GOBP MEIOTIC SPINDLE ASSEMBLY | 8 | 4.65e-01 | -1.49e-01 | 7.78e-01 |
| GOBP REGULATION OF CELL MORPHOGENESIS | 163 | 1.06e-03 | -1.49e-01 | 4.85e-02 |
| GOBP CALCIUM IMPORT INTO THE MITOCHONDRION | 10 | 4.15e-01 | 1.49e-01 | 7.50e-01 |
| GOBP REGULATION OF VASCULATURE DEVELOPMENT | 140 | 2.40e-03 | -1.49e-01 | 7.60e-02 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 66 | 3.66e-02 | -1.49e-01 | 2.86e-01 |
| GOBP MRNA MODIFICATION | 30 | 1.58e-01 | 1.49e-01 | 5.24e-01 |
| GOBP RESPIRATORY SYSTEM PROCESS | 20 | 2.49e-01 | -1.49e-01 | 6.26e-01 |
| GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 5.28e-01 | 1.49e-01 | 8.10e-01 |
| GOCC DENDRITE TERMINUS | 9 | 4.39e-01 | 1.49e-01 | 7.64e-01 |
| GOBP REGULATION OF PH | 69 | 3.27e-02 | -1.49e-01 | 2.72e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MATURATION | 17 | 2.88e-01 | -1.49e-01 | 6.58e-01 |
| GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE | 75 | 2.61e-02 | -1.49e-01 | 2.50e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 31 | 1.52e-01 | 1.49e-01 | 5.15e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 7 | 4.96e-01 | -1.49e-01 | 7.91e-01 |
| GOBP HISTONE H4 K16 ACETYLATION | 7 | 4.96e-01 | -1.49e-01 | 7.91e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM | 14 | 3.36e-01 | 1.49e-01 | 6.90e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 12 | 3.73e-01 | 1.49e-01 | 7.16e-01 |
| GOBP RESPONSE TO IRON ION | 21 | 2.39e-01 | -1.49e-01 | 6.16e-01 |
| GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS | 20 | 2.50e-01 | 1.49e-01 | 6.27e-01 |
| GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY | 6 | 5.29e-01 | -1.48e-01 | 8.11e-01 |
| GOBP INFLAMMATORY RESPONSE TO WOUNDING | 20 | 2.51e-01 | -1.48e-01 | 6.28e-01 |
| GOBP POSITIVE REGULATION OF BONE MINERALIZATION | 23 | 2.19e-01 | -1.48e-01 | 5.95e-01 |
| GOBP REGULATION OF PROTEIN GLYCOSYLATION | 8 | 4.68e-01 | 1.48e-01 | 7.78e-01 |
| GOBP TRNA 3 END PROCESSING | 7 | 4.98e-01 | -1.48e-01 | 7.92e-01 |
| GOBP RETINOIC ACID METABOLIC PROCESS | 7 | 4.98e-01 | -1.48e-01 | 7.92e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 5 | 5.67e-01 | 1.48e-01 | 8.33e-01 |
| GOBP MEIOTIC SPINDLE ORGANIZATION | 12 | 3.75e-01 | -1.48e-01 | 7.17e-01 |
| GOBP REGULATION OF MONOCYTE DIFFERENTIATION | 14 | 3.38e-01 | 1.48e-01 | 6.91e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS | 27 | 1.84e-01 | 1.48e-01 | 5.53e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 6 | 5.30e-01 | -1.48e-01 | 8.12e-01 |
| GOCC PHAGOCYTIC VESICLE MEMBRANE | 69 | 3.39e-02 | -1.48e-01 | 2.77e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER | 90 | 1.55e-02 | -1.48e-01 | 1.98e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE | 5 | 5.67e-01 | 1.48e-01 | 8.33e-01 |
| GOBP SPHINGOMYELIN CATABOLIC PROCESS | 7 | 4.98e-01 | -1.48e-01 | 7.92e-01 |
| GOBP CELL MATURATION | 81 | 2.18e-02 | -1.48e-01 | 2.30e-01 |
| GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS | 7 | 4.99e-01 | -1.47e-01 | 7.92e-01 |
| GOBP STRIATUM DEVELOPMENT | 15 | 3.23e-01 | -1.47e-01 | 6.81e-01 |
| GOBP SUBPALLIUM DEVELOPMENT | 15 | 3.23e-01 | -1.47e-01 | 6.81e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT | 22 | 2.32e-01 | -1.47e-01 | 6.09e-01 |
| GOBP PLACENTA DEVELOPMENT | 81 | 2.20e-02 | -1.47e-01 | 2.31e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN | 15 | 3.23e-01 | -1.47e-01 | 6.81e-01 |
| GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY | 18 | 2.79e-01 | 1.47e-01 | 6.54e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 7 | 5.00e-01 | -1.47e-01 | 7.92e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 20 | 2.54e-01 | -1.47e-01 | 6.31e-01 |
| GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 45 | 8.77e-02 | -1.47e-01 | 4.19e-01 |
| GOBP GALACTOSE CATABOLIC PROCESS | 5 | 5.69e-01 | 1.47e-01 | 8.34e-01 |
| GOBP REGULATION OF MACROAUTOPHAGY | 134 | 3.33e-03 | -1.47e-01 | 9.10e-02 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE | 29 | 1.71e-01 | -1.47e-01 | 5.36e-01 |
| GOBP PODOSOME ASSEMBLY | 17 | 2.94e-01 | -1.47e-01 | 6.62e-01 |
| GOBP STRIATED MUSCLE ADAPTATION | 20 | 2.55e-01 | -1.47e-01 | 6.31e-01 |
| GOBP DNA REPLICATION | 216 | 2.07e-04 | 1.47e-01 | 1.83e-02 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 12 | 3.78e-01 | -1.47e-01 | 7.18e-01 |
| GOBP PROTEIN RETENTION IN GOLGI APPARATUS | 5 | 5.69e-01 | -1.47e-01 | 8.34e-01 |
| GOBP MYELIN ASSEMBLY | 13 | 3.59e-01 | -1.47e-01 | 7.10e-01 |
| GOBP ZINC ION TRANSPORT | 18 | 2.81e-01 | 1.47e-01 | 6.54e-01 |
| GOBP AMYLOID FIBRIL FORMATION | 29 | 1.71e-01 | -1.47e-01 | 5.36e-01 |
| GOMF MHC CLASS II PROTEIN BINDING | 5 | 5.70e-01 | -1.47e-01 | 8.34e-01 |
| GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 2.04e-01 | 1.47e-01 | 5.79e-01 |
| GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 10 | 4.22e-01 | 1.47e-01 | 7.54e-01 |
| GOBP POSITIVE REGULATION OF SECRETION | 167 | 1.10e-03 | -1.47e-01 | 4.93e-02 |
| GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 4.46e-01 | 1.47e-01 | 7.67e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 43 | 9.61e-02 | -1.47e-01 | 4.32e-01 |
| GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE | 5 | 5.70e-01 | 1.47e-01 | 8.34e-01 |
| GOBP MICROTUBULE BASED PROTEIN TRANSPORT | 6 | 5.34e-01 | -1.47e-01 | 8.15e-01 |
| GOMF MODIFIED AMINO ACID BINDING | 41 | 1.04e-01 | 1.47e-01 | 4.50e-01 |
| GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 83 | 2.11e-02 | -1.47e-01 | 2.25e-01 |
| GOCC NLRP3 INFLAMMASOME COMPLEX | 8 | 4.73e-01 | 1.47e-01 | 7.79e-01 |
| GOCC CIS GOLGI NETWORK MEMBRANE | 5 | 5.70e-01 | 1.47e-01 | 8.34e-01 |
| GOBP REGULATION OF BILE ACID METABOLIC PROCESS | 6 | 5.34e-01 | -1.47e-01 | 8.15e-01 |
| GOBP VESICLE TRANSPORT ALONG MICROTUBULE | 33 | 1.45e-01 | -1.47e-01 | 5.06e-01 |
| GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 13 | 3.61e-01 | 1.47e-01 | 7.10e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 8 | 4.73e-01 | -1.46e-01 | 7.79e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 17 | 2.96e-01 | -1.46e-01 | 6.63e-01 |
| GOMF TAU PROTEIN KINASE ACTIVITY | 18 | 2.83e-01 | 1.46e-01 | 6.55e-01 |
| GOBP REGULATION OF EPITHELIAL CELL MIGRATION | 134 | 3.53e-03 | -1.46e-01 | 9.41e-02 |
| GOMF LEUKOTRIENE C4 SYNTHASE ACTIVITY | 5 | 5.71e-01 | -1.46e-01 | 8.34e-01 |
| GOBP TRNA 5 LEADER REMOVAL | 13 | 3.61e-01 | 1.46e-01 | 7.10e-01 |
| GOCC RIBBON SYNAPSE | 9 | 4.48e-01 | -1.46e-01 | 7.68e-01 |
| GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 13 | 3.62e-01 | 1.46e-01 | 7.10e-01 |
| GOCC ENDOPLASMIC RETICULUM EXIT SITE | 25 | 2.06e-01 | -1.46e-01 | 5.82e-01 |
| GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY | 53 | 6.62e-02 | -1.46e-01 | 3.72e-01 |
| GOBP SPHINGOLIPID METABOLIC PROCESS | 106 | 9.52e-03 | -1.46e-01 | 1.62e-01 |
| GOBP SEX DETERMINATION | 6 | 5.36e-01 | 1.46e-01 | 8.15e-01 |
| GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING | 24 | 2.16e-01 | -1.46e-01 | 5.92e-01 |
| GOCC RIBOSOME | 221 | 1.99e-04 | -1.46e-01 | 1.83e-02 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 27 | 1.90e-01 | -1.46e-01 | 5.61e-01 |
| GOBP CELL JUNCTION DISASSEMBLY | 14 | 3.46e-01 | -1.46e-01 | 6.98e-01 |
| GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 6 | 5.37e-01 | -1.46e-01 | 8.16e-01 |
| GOBP RESPONSE TO PROTOZOAN | 22 | 2.38e-01 | -1.45e-01 | 6.16e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE | 11 | 4.04e-01 | 1.45e-01 | 7.41e-01 |
| GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE | 15 | 3.30e-01 | -1.45e-01 | 6.86e-01 |
| GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING | 31 | 1.61e-01 | 1.45e-01 | 5.28e-01 |
| GOBP CYTOPLASMIC TRANSLATIONAL INITIATION | 37 | 1.26e-01 | -1.45e-01 | 4.83e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION | 7 | 5.06e-01 | -1.45e-01 | 7.96e-01 |
| GOBP EMBRYONIC AXIS SPECIFICATION | 13 | 3.65e-01 | -1.45e-01 | 7.11e-01 |
| GOMF AP 2 ADAPTOR COMPLEX BINDING | 10 | 4.27e-01 | 1.45e-01 | 7.57e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 64 | 4.48e-02 | -1.45e-01 | 3.12e-01 |
| GOBP RECOMBINATIONAL REPAIR | 144 | 2.71e-03 | 1.45e-01 | 8.12e-02 |
| GOBP NEGATIVE REGULATION OF SECRETION | 85 | 2.09e-02 | -1.45e-01 | 2.25e-01 |
| GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 32 | 1.56e-01 | 1.45e-01 | 5.22e-01 |
| GOBP TELOMERE CAPPING | 35 | 1.38e-01 | 1.45e-01 | 4.97e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 14 | 3.48e-01 | 1.45e-01 | 7.00e-01 |
| GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY | 19 | 2.74e-01 | 1.45e-01 | 6.51e-01 |
| GOMF HISTONE CHAPERONE ACTIVITY | 10 | 4.28e-01 | 1.45e-01 | 7.58e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING | 25 | 2.10e-01 | -1.45e-01 | 5.85e-01 |
| GOBP RESPONSE TO TUMOR NECROSIS FACTOR | 155 | 1.92e-03 | -1.45e-01 | 6.62e-02 |
| GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS | 6 | 5.39e-01 | 1.45e-01 | 8.17e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION | 7 | 5.07e-01 | -1.45e-01 | 7.97e-01 |
| GOBP DNA CONFORMATION CHANGE | 72 | 3.39e-02 | 1.45e-01 | 2.77e-01 |
| GOBP EXTRACELLULAR VESICLE BIOGENESIS | 21 | 2.51e-01 | -1.45e-01 | 6.28e-01 |
| GOBP CYTOCHROME COMPLEX ASSEMBLY | 37 | 1.28e-01 | 1.45e-01 | 4.85e-01 |
| GOBP REGULATION OF CELL SHAPE | 93 | 1.61e-02 | -1.45e-01 | 2.00e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 32 | 1.57e-01 | -1.45e-01 | 5.23e-01 |
| GOBP REGULATION OF ENDOCRINE PROCESS | 14 | 3.49e-01 | -1.45e-01 | 7.00e-01 |
| GOBP NEGATIVE REGULATION OF DNA RECOMBINATION | 32 | 1.57e-01 | 1.45e-01 | 5.24e-01 |
| GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 5 | 5.76e-01 | -1.44e-01 | 8.37e-01 |
| GOBP RNA SECONDARY STRUCTURE UNWINDING | 9 | 4.53e-01 | -1.44e-01 | 7.72e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON ALPHA | 7 | 5.08e-01 | 1.44e-01 | 7.98e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 7 | 5.09e-01 | -1.44e-01 | 7.98e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 22 | 2.42e-01 | -1.44e-01 | 6.20e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 12 | 3.88e-01 | -1.44e-01 | 7.26e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 10 | 4.31e-01 | 1.44e-01 | 7.58e-01 |
| GOBP CELLULAR RESPONSE TO VIRUS | 42 | 1.07e-01 | -1.44e-01 | 4.52e-01 |
| GOBP POSITIVE REGULATION OF RESPIRATORY BURST | 5 | 5.77e-01 | -1.44e-01 | 8.38e-01 |
| GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 239 | 1.36e-04 | -1.44e-01 | 1.38e-02 |
| GOCC AP 3 ADAPTOR COMPLEX | 8 | 4.81e-01 | 1.44e-01 | 7.83e-01 |
| GOCC TRANSCRIPTION PREINITIATION COMPLEX | 13 | 3.69e-01 | 1.44e-01 | 7.13e-01 |
| GOMF ARMADILLO REPEAT DOMAIN BINDING | 7 | 5.10e-01 | -1.44e-01 | 7.99e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 11 | 4.09e-01 | -1.44e-01 | 7.45e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 15 | 3.35e-01 | -1.44e-01 | 6.89e-01 |
| GOBP REGULATION OF I KAPPAB PHOSPHORYLATION | 6 | 5.42e-01 | 1.44e-01 | 8.19e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 8 | 4.82e-01 | 1.44e-01 | 7.84e-01 |
| GOBP VASCULATURE DEVELOPMENT | 357 | 3.70e-06 | -1.43e-01 | 1.50e-03 |
| GOMF INTERLEUKIN 1 RECEPTOR BINDING | 10 | 4.32e-01 | -1.43e-01 | 7.59e-01 |
| GOBP RETINAL METABOLIC PROCESS | 8 | 4.83e-01 | -1.43e-01 | 7.84e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 38 | 1.27e-01 | -1.43e-01 | 4.83e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 73 | 3.46e-02 | -1.43e-01 | 2.78e-01 |
| GOMF NUCLEAR ANDROGEN RECEPTOR BINDING | 22 | 2.46e-01 | -1.43e-01 | 6.22e-01 |
| GOBP CELLULAR RESPONSE TO ETHANOL | 10 | 4.34e-01 | -1.43e-01 | 7.60e-01 |
| GOBP ENDODERM FORMATION | 23 | 2.35e-01 | -1.43e-01 | 6.12e-01 |
| GOCC LATERAL ELEMENT | 10 | 4.34e-01 | 1.43e-01 | 7.60e-01 |
| GOBP GLIAL CELL DIFFERENTIATION | 114 | 8.48e-03 | -1.43e-01 | 1.53e-01 |
| GOBP MACROAUTOPHAGY | 293 | 2.80e-05 | -1.43e-01 | 4.80e-03 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CPG ISLAND METHYLATION | 6 | 5.44e-01 | 1.43e-01 | 8.21e-01 |
| GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 32 | 1.62e-01 | -1.43e-01 | 5.28e-01 |
| GOBP WOUND HEALING | 229 | 2.09e-04 | -1.43e-01 | 1.83e-02 |
| GOMF SNRNP BINDING | 9 | 4.58e-01 | -1.43e-01 | 7.75e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 17 | 3.08e-01 | -1.43e-01 | 6.70e-01 |
| GOCC SPECIFIC GRANULE MEMBRANE | 77 | 3.06e-02 | -1.43e-01 | 2.66e-01 |
| GOCC T CELL RECEPTOR COMPLEX | 13 | 3.73e-01 | 1.43e-01 | 7.16e-01 |
| GOBP REGULATION OF BMP SIGNALING PATHWAY | 40 | 1.19e-01 | -1.43e-01 | 4.70e-01 |
| GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY | 147 | 2.91e-03 | 1.43e-01 | 8.36e-02 |
| GOBP DOUBLE STRAND BREAK REPAIR | 245 | 1.29e-04 | 1.43e-01 | 1.36e-02 |
| GOMF GROWTH FACTOR RECEPTOR BINDING | 62 | 5.24e-02 | -1.43e-01 | 3.33e-01 |
| GOBP REGULATION OF HORMONE SECRETION | 121 | 6.86e-03 | -1.43e-01 | 1.41e-01 |
| GOBP PROTEIN K29 LINKED UBIQUITINATION | 5 | 5.81e-01 | -1.43e-01 | 8.39e-01 |
| GOBP RESPONSE TO ATP | 20 | 2.70e-01 | -1.43e-01 | 6.47e-01 |
| GOBP RESPONSE TO PH | 14 | 3.56e-01 | -1.43e-01 | 7.07e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 19 | 2.83e-01 | -1.42e-01 | 6.55e-01 |
| GOMF TRANSLATION INITIATION FACTOR BINDING | 28 | 1.93e-01 | -1.42e-01 | 5.65e-01 |
| GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY | 5 | 5.82e-01 | 1.42e-01 | 8.40e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION | 11 | 4.14e-01 | -1.42e-01 | 7.50e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING | 5 | 5.82e-01 | 1.42e-01 | 8.40e-01 |
| GOMF DNA DEMETHYLASE ACTIVITY | 5 | 5.82e-01 | 1.42e-01 | 8.40e-01 |
| GOBP RESPONSE TO HYDROGEN PEROXIDE | 81 | 2.73e-02 | -1.42e-01 | 2.55e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H | 71 | 3.87e-02 | 1.42e-01 | 2.95e-01 |
| GOBP BASE EXCISION REPAIR | 37 | 1.35e-01 | 1.42e-01 | 4.94e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SECRETION | 34 | 1.52e-01 | -1.42e-01 | 5.15e-01 |
| GOBP GASTRULATION WITH MOUTH FORMING SECOND | 15 | 3.41e-01 | -1.42e-01 | 6.94e-01 |
| GOBP ESCRT COMPLEX DISASSEMBLY | 10 | 4.37e-01 | 1.42e-01 | 7.61e-01 |
| GOBP BLOOD VESSEL REMODELING | 20 | 2.72e-01 | -1.42e-01 | 6.50e-01 |
| GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 6 | 5.47e-01 | -1.42e-01 | 8.23e-01 |
| GOBP CELL JUNCTION MAINTENANCE | 19 | 2.84e-01 | -1.42e-01 | 6.55e-01 |
| GOBP OLIGODENDROCYTE DEVELOPMENT | 21 | 2.61e-01 | -1.42e-01 | 6.38e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING | 6 | 5.47e-01 | -1.42e-01 | 8.23e-01 |
| GOCC ACTIN BASED CELL PROJECTION | 117 | 8.20e-03 | -1.42e-01 | 1.52e-01 |
| GOBP EPITHELIAL CELL MATURATION | 9 | 4.62e-01 | -1.42e-01 | 7.77e-01 |
| GOBP NEUROTRANSMITTER SECRETION | 75 | 3.41e-02 | -1.42e-01 | 2.77e-01 |
| GOBP REGULATION OF RESPONSE TO WOUNDING | 73 | 3.65e-02 | -1.42e-01 | 2.86e-01 |
| GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE | 19 | 2.85e-01 | -1.42e-01 | 6.56e-01 |
| GOBP RESPONSE TO COPPER ION | 18 | 2.99e-01 | -1.42e-01 | 6.63e-01 |
| GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS | 39 | 1.26e-01 | -1.42e-01 | 4.83e-01 |
| GOBP REGULATION OF SECRETION | 320 | 1.54e-05 | -1.41e-01 | 3.05e-03 |
| GOBP REGULATION OF SYNAPSE MATURATION | 8 | 4.89e-01 | 1.41e-01 | 7.87e-01 |
| GOCC SECRETORY GRANULE MEMBRANE | 223 | 2.92e-04 | -1.41e-01 | 2.24e-02 |
| GOBP PORE COMPLEX ASSEMBLY | 20 | 2.74e-01 | 1.41e-01 | 6.51e-01 |
| GOBP POSITIVE REGULATION OF NEURON MIGRATION | 12 | 3.97e-01 | -1.41e-01 | 7.35e-01 |
| GOBP EMBRYONIC PATTERN SPECIFICATION | 25 | 2.22e-01 | -1.41e-01 | 5.97e-01 |
| GOBP TELENCEPHALON DEVELOPMENT | 141 | 3.90e-03 | -1.41e-01 | 9.98e-02 |
| GOCC NUCLEAR PORE NUCLEAR BASKET | 11 | 4.18e-01 | 1.41e-01 | 7.52e-01 |
| GOCC LAMELLIPODIUM MEMBRANE | 11 | 4.18e-01 | 1.41e-01 | 7.52e-01 |
| GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS | 6 | 5.50e-01 | 1.41e-01 | 8.23e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 4.90e-01 | 1.41e-01 | 7.88e-01 |
| GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS | 36 | 1.44e-01 | 1.41e-01 | 5.05e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 26 | 2.14e-01 | 1.41e-01 | 5.90e-01 |
| GOCC CELL SUBSTRATE JUNCTION | 325 | 1.45e-05 | -1.41e-01 | 3.01e-03 |
| GOBP GAMMA AMINOBUTYRIC ACID SECRETION | 6 | 5.51e-01 | 1.41e-01 | 8.23e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE | 21 | 2.65e-01 | 1.41e-01 | 6.42e-01 |
| GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE | 5 | 5.86e-01 | 1.41e-01 | 8.42e-01 |
| GOBP VENOUS BLOOD VESSEL DEVELOPMENT | 8 | 4.91e-01 | -1.41e-01 | 7.88e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH | 37 | 1.39e-01 | -1.41e-01 | 4.98e-01 |
| GOBP POSITIVE REGULATION OF DNA REPAIR | 111 | 1.07e-02 | 1.41e-01 | 1.71e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN | 17 | 3.16e-01 | -1.40e-01 | 6.79e-01 |
| GOBP REGULATION OF HORMONE METABOLIC PROCESS | 20 | 2.77e-01 | -1.40e-01 | 6.53e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 107 | 1.23e-02 | -1.40e-01 | 1.80e-01 |
| GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 8 | 4.92e-01 | -1.40e-01 | 7.88e-01 |
| GOBP GLAND DEVELOPMENT | 211 | 4.65e-04 | -1.40e-01 | 2.91e-02 |
| GOMF HORMONE ACTIVITY | 14 | 3.63e-01 | -1.40e-01 | 7.10e-01 |
| GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION | 71 | 4.12e-02 | -1.40e-01 | 3.02e-01 |
| GOBP TRIGLYCERIDE CATABOLIC PROCESS | 10 | 4.43e-01 | -1.40e-01 | 7.66e-01 |
| GOBP CARTILAGE DEVELOPMENT | 82 | 2.84e-02 | -1.40e-01 | 2.60e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 20 | 2.78e-01 | -1.40e-01 | 6.53e-01 |
| GOMF TOLL LIKE RECEPTOR BINDING | 13 | 3.82e-01 | 1.40e-01 | 7.22e-01 |
| GOBP HISTONE H4 ACETYLATION | 12 | 4.01e-01 | -1.40e-01 | 7.39e-01 |
| GOBP PHOSPHATE ION TRANSPORT | 14 | 3.64e-01 | -1.40e-01 | 7.11e-01 |
| GOCC NON MOTILE CILIUM | 72 | 4.00e-02 | 1.40e-01 | 2.98e-01 |
| GOMF HISTONE ACETYLTRANSFERASE BINDING | 19 | 2.91e-01 | 1.40e-01 | 6.60e-01 |
| GOBP PROTEIN TETRAMERIZATION | 59 | 6.31e-02 | 1.40e-01 | 3.63e-01 |
| GOBP ARGININE METABOLIC PROCESS | 10 | 4.43e-01 | -1.40e-01 | 7.66e-01 |
| GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT | 80 | 3.06e-02 | -1.40e-01 | 2.66e-01 |
| GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 53 | 7.82e-02 | -1.40e-01 | 4.00e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 15 | 3.49e-01 | -1.40e-01 | 7.00e-01 |
| GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT | 7 | 5.22e-01 | -1.40e-01 | 8.07e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 14 | 3.65e-01 | -1.40e-01 | 7.11e-01 |
| GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY | 5 | 5.88e-01 | -1.40e-01 | 8.44e-01 |
| GOBP PLATELET AGGREGATION | 45 | 1.05e-01 | -1.40e-01 | 4.50e-01 |
| GOBP REGULATION OF CELL SUBSTRATE ADHESION | 122 | 7.87e-03 | -1.40e-01 | 1.50e-01 |
| GOBP REGULATION OF FERTILIZATION | 5 | 5.89e-01 | -1.40e-01 | 8.44e-01 |
| GOCC ALPHA BETA T CELL RECEPTOR COMPLEX | 7 | 5.23e-01 | 1.40e-01 | 8.07e-01 |
| GOBP ANIMAL ORGAN FORMATION | 19 | 2.93e-01 | -1.39e-01 | 6.61e-01 |
| GOBP ENTRY OF BACTERIUM INTO HOST CELL | 7 | 5.23e-01 | -1.39e-01 | 8.08e-01 |
| GOBP AMINOGLYCAN CATABOLIC PROCESS | 16 | 3.35e-01 | -1.39e-01 | 6.88e-01 |
| GOBP NK T CELL ACTIVATION | 9 | 4.69e-01 | 1.39e-01 | 7.78e-01 |
| GOBP POSITIVE REGULATION OF P38MAPK CASCADE | 20 | 2.81e-01 | -1.39e-01 | 6.54e-01 |
| GOBP REGULATION OF VASOCONSTRICTION | 22 | 2.58e-01 | -1.39e-01 | 6.35e-01 |
| GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 5 | 5.90e-01 | 1.39e-01 | 8.45e-01 |
| GOCC PALMITOYLTRANSFERASE COMPLEX | 8 | 4.95e-01 | -1.39e-01 | 7.90e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 7 | 5.24e-01 | 1.39e-01 | 8.08e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS | 5 | 5.90e-01 | 1.39e-01 | 8.45e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING | 24 | 2.38e-01 | -1.39e-01 | 6.16e-01 |
| GOBP REGULATION OF STEM CELL PROLIFERATION | 32 | 1.73e-01 | -1.39e-01 | 5.39e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION | 5 | 5.90e-01 | -1.39e-01 | 8.45e-01 |
| GOBP CELL PROLIFERATION IN FOREBRAIN | 11 | 4.24e-01 | 1.39e-01 | 7.56e-01 |
| GOBP CENTROMERE COMPLEX ASSEMBLY | 24 | 2.38e-01 | 1.39e-01 | 6.16e-01 |
| GOBP REGULATION OF NEURON DIFFERENTIATION | 77 | 3.51e-02 | -1.39e-01 | 2.80e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION | 33 | 1.67e-01 | 1.39e-01 | 5.34e-01 |
| GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 194 | 8.77e-04 | -1.39e-01 | 4.24e-02 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE | 212 | 5.17e-04 | -1.39e-01 | 3.08e-02 |
| GOCC MYOSIN FILAMENT | 8 | 4.97e-01 | 1.39e-01 | 7.91e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 6 | 5.56e-01 | 1.39e-01 | 8.27e-01 |
| GOBP REGULATION OF MITOTIC NUCLEAR DIVISION | 64 | 5.53e-02 | 1.39e-01 | 3.42e-01 |
| GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS | 6 | 5.56e-01 | 1.39e-01 | 8.27e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 13 | 3.87e-01 | -1.39e-01 | 7.25e-01 |
| GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 10 | 4.48e-01 | -1.39e-01 | 7.68e-01 |
| GOBP INTRACELLULAR TRANSPORT OF VIRUS | 8 | 4.97e-01 | 1.39e-01 | 7.92e-01 |
| GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY | 43 | 1.16e-01 | -1.39e-01 | 4.64e-01 |
| GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY | 29 | 1.97e-01 | -1.39e-01 | 5.70e-01 |
| GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 5.26e-01 | 1.38e-01 | 8.09e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 25 | 2.31e-01 | -1.38e-01 | 6.09e-01 |
| GOCC FICOLIN 1 RICH GRANULE LUMEN | 119 | 9.27e-03 | -1.38e-01 | 1.59e-01 |
| GOBP PROTEIN K63 LINKED UBIQUITINATION | 53 | 8.19e-02 | -1.38e-01 | 4.09e-01 |
| GOBP HORMONE METABOLIC PROCESS | 89 | 2.44e-02 | -1.38e-01 | 2.42e-01 |
| GOBP ENDOTHELIAL CELL CHEMOTAXIS | 15 | 3.54e-01 | -1.38e-01 | 7.04e-01 |
| GOBP RESPONSE TO GLYCOPROTEIN | 8 | 4.99e-01 | 1.38e-01 | 7.92e-01 |
| GOCC CILIARY BASE | 26 | 2.23e-01 | 1.38e-01 | 5.98e-01 |
| GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 27 | 2.15e-01 | -1.38e-01 | 5.90e-01 |
| GOMF S ADENOSYL L METHIONINE BINDING | 14 | 3.72e-01 | 1.38e-01 | 7.15e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR DIVISION | 25 | 2.33e-01 | -1.38e-01 | 6.10e-01 |
| GOMF CTPASE ACTIVITY | 5 | 5.93e-01 | -1.38e-01 | 8.47e-01 |
| GOMF C ACYLTRANSFERASE ACTIVITY | 11 | 4.29e-01 | 1.38e-01 | 7.58e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 29 | 1.99e-01 | 1.38e-01 | 5.74e-01 |
| GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS | 10 | 4.51e-01 | -1.38e-01 | 7.70e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 6 | 5.59e-01 | 1.38e-01 | 8.29e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 27 | 2.16e-01 | -1.38e-01 | 5.93e-01 |
| GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS | 10 | 4.51e-01 | 1.38e-01 | 7.70e-01 |
| GOCC RIBONUCLEOPROTEIN GRANULE | 211 | 6.00e-04 | -1.38e-01 | 3.36e-02 |
| GOBP RETINOL METABOLIC PROCESS | 20 | 2.87e-01 | -1.38e-01 | 6.57e-01 |
| GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 34 | 1.66e-01 | -1.38e-01 | 5.33e-01 |
| GOBP HORMONE TRANSPORT | 152 | 3.52e-03 | -1.37e-01 | 9.41e-02 |
| GOBP T CELL EXTRAVASATION | 11 | 4.30e-01 | -1.37e-01 | 7.58e-01 |
| GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 28 | 2.08e-01 | 1.37e-01 | 5.83e-01 |
| GOBP TUBE MORPHOGENESIS | 410 | 2.13e-06 | -1.37e-01 | 9.60e-04 |
| GOBP REGULATION OF CYTOCHROME C OXIDASE ACTIVITY | 5 | 5.95e-01 | -1.37e-01 | 8.48e-01 |
| GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY | 5 | 5.95e-01 | -1.37e-01 | 8.48e-01 |
| GOBP ALPHA AMINO ACID METABOLIC PROCESS | 115 | 1.11e-02 | 1.37e-01 | 1.73e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION | 8 | 5.01e-01 | 1.37e-01 | 7.92e-01 |
| GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 13 | 3.92e-01 | 1.37e-01 | 7.29e-01 |
| GOCC PEPTIDASE COMPLEX | 104 | 1.58e-02 | -1.37e-01 | 1.98e-01 |
| GOBP MRNA TRANSCRIPTION | 47 | 1.04e-01 | -1.37e-01 | 4.49e-01 |
| GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON | 11 | 4.31e-01 | 1.37e-01 | 7.58e-01 |
| GOBP GASTRULATION | 91 | 2.39e-02 | -1.37e-01 | 2.40e-01 |
| GOMF TBP CLASS PROTEIN BINDING | 23 | 2.55e-01 | -1.37e-01 | 6.31e-01 |
| GOBP POSITIVE REGULATION OF B CELL PROLIFERATION | 33 | 1.73e-01 | -1.37e-01 | 5.39e-01 |
| GOBP MIDBODY ABSCISSION | 14 | 3.75e-01 | 1.37e-01 | 7.17e-01 |
| GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING | 5 | 5.96e-01 | -1.37e-01 | 8.49e-01 |
| GOCC FILAMENTOUS ACTIN | 12 | 4.12e-01 | 1.37e-01 | 7.48e-01 |
| GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 160 | 2.89e-03 | -1.37e-01 | 8.36e-02 |
| GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 10 | 4.54e-01 | 1.37e-01 | 7.72e-01 |
| GOBP NEUROMUSCULAR PROCESS | 71 | 4.64e-02 | -1.37e-01 | 3.15e-01 |
| GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 53 | 8.53e-02 | -1.37e-01 | 4.13e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 6 | 5.62e-01 | -1.37e-01 | 8.30e-01 |
| GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 8 | 5.03e-01 | 1.37e-01 | 7.94e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE | 35 | 1.62e-01 | -1.37e-01 | 5.28e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 6 | 5.62e-01 | 1.37e-01 | 8.30e-01 |
| GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS | 8 | 5.04e-01 | 1.37e-01 | 7.94e-01 |
| GOBP SPROUTING ANGIOGENESIS | 59 | 6.99e-02 | -1.37e-01 | 3.82e-01 |
| GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY | 47 | 1.06e-01 | -1.37e-01 | 4.51e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING | 9 | 4.78e-01 | -1.37e-01 | 7.82e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER | 12 | 4.13e-01 | -1.36e-01 | 7.49e-01 |
| GOBP KETONE CATABOLIC PROCESS | 9 | 4.78e-01 | 1.36e-01 | 7.82e-01 |
| GOMF SPHINGOMYELIN PHOSPHODIESTERASE ACTIVITY | 6 | 5.63e-01 | -1.36e-01 | 8.31e-01 |
| GOMF PEPTIDE ANTIGEN BINDING | 28 | 2.12e-01 | 1.36e-01 | 5.87e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 81 | 3.41e-02 | -1.36e-01 | 2.77e-01 |
| GOBP TISSUE MIGRATION | 177 | 1.82e-03 | -1.36e-01 | 6.47e-02 |
| GOBP PLATELET ACTIVATION | 80 | 3.53e-02 | -1.36e-01 | 2.81e-01 |
| GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 3.78e-01 | -1.36e-01 | 7.18e-01 |
| GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT | 14 | 3.78e-01 | -1.36e-01 | 7.18e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 29 | 2.04e-01 | -1.36e-01 | 5.80e-01 |
| GOBP CYTIDINE METABOLIC PROCESS | 6 | 5.64e-01 | -1.36e-01 | 8.31e-01 |
| GOMF CYTIDINE DEAMINASE ACTIVITY | 6 | 5.64e-01 | -1.36e-01 | 8.31e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING | 6 | 5.64e-01 | -1.36e-01 | 8.31e-01 |
| GOBP NK T CELL DIFFERENTIATION | 10 | 4.56e-01 | 1.36e-01 | 7.73e-01 |
| GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 8 | 5.05e-01 | 1.36e-01 | 7.96e-01 |
| GOBP REGULATION OF PROTEIN AUTOUBIQUITINATION | 5 | 5.98e-01 | 1.36e-01 | 8.50e-01 |
| GOMF CYTOKINE BINDING | 76 | 4.07e-02 | -1.36e-01 | 3.01e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 50 | 9.67e-02 | -1.36e-01 | 4.34e-01 |
| GOBP LEUKOCYTE TETHERING OR ROLLING | 19 | 3.05e-01 | 1.36e-01 | 6.69e-01 |
| GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY | 9 | 4.81e-01 | -1.36e-01 | 7.83e-01 |
| GOBP ADULT LOCOMOTORY BEHAVIOR | 40 | 1.38e-01 | -1.36e-01 | 4.96e-01 |
| GOBP MYELOID CELL HOMEOSTASIS | 132 | 7.23e-03 | -1.36e-01 | 1.45e-01 |
| GOBP CELL JUNCTION ASSEMBLY | 189 | 1.35e-03 | -1.36e-01 | 5.61e-02 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 80 | 3.63e-02 | -1.36e-01 | 2.85e-01 |
| GOMF NUCLEOSIDE BINDING | 7 | 5.35e-01 | 1.35e-01 | 8.15e-01 |
| GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION | 171 | 2.31e-03 | -1.35e-01 | 7.48e-02 |
| GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION | 5 | 6.00e-01 | 1.35e-01 | 8.51e-01 |
| GOBP OVARIAN FOLLICLE DEVELOPMENT | 29 | 2.07e-01 | -1.35e-01 | 5.83e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE | 66 | 5.76e-02 | -1.35e-01 | 3.50e-01 |
| GOBP RETINA HOMEOSTASIS | 31 | 1.93e-01 | -1.35e-01 | 5.65e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 6 | 5.66e-01 | 1.35e-01 | 8.33e-01 |
| GOBP REGULATION OF ENDOCYTIC RECYCLING | 10 | 4.59e-01 | -1.35e-01 | 7.75e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY | 8 | 5.08e-01 | -1.35e-01 | 7.98e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 9 | 4.83e-01 | -1.35e-01 | 7.84e-01 |
| GOBP REGULATION OF HORMONE LEVELS | 234 | 3.93e-04 | -1.35e-01 | 2.66e-02 |
| GOBP DIPEPTIDE TRANSMEMBRANE TRANSPORT | 6 | 5.67e-01 | -1.35e-01 | 8.33e-01 |
| GOBP OLIGOPEPTIDE TRANSMEMBRANE TRANSPORT | 6 | 5.67e-01 | -1.35e-01 | 8.33e-01 |
| GOBP POSITIVE REGULATION OF CELL GROWTH | 94 | 2.39e-02 | -1.35e-01 | 2.40e-01 |
| GOBP STEROL TRANSPORT | 74 | 4.50e-02 | -1.35e-01 | 3.12e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 11 | 4.39e-01 | -1.35e-01 | 7.63e-01 |
| GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY | 119 | 1.12e-02 | 1.35e-01 | 1.73e-01 |
| GOBP POSITIVE REGULATION OF GLYCOLYTIC PROCESS | 13 | 4.00e-01 | 1.35e-01 | 7.38e-01 |
| GOBP REGULATION OF MICROVILLUS ORGANIZATION | 5 | 6.02e-01 | -1.35e-01 | 8.52e-01 |
| GOBP MITOCHONDRIAL TRANSLATION | 128 | 8.60e-03 | 1.35e-01 | 1.53e-01 |
| GOMF ALPHA ACTININ BINDING | 12 | 4.19e-01 | -1.35e-01 | 7.53e-01 |
| GOBP CARDIAC CELL DEVELOPMENT | 41 | 1.36e-01 | -1.35e-01 | 4.94e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 29 | 2.10e-01 | -1.35e-01 | 5.84e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE | 7 | 5.37e-01 | -1.35e-01 | 8.16e-01 |
| GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY | 7 | 5.37e-01 | -1.35e-01 | 8.16e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 49 | 1.03e-01 | -1.35e-01 | 4.48e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING | 9 | 4.84e-01 | 1.35e-01 | 7.85e-01 |
| GOBP T CELL SELECTION | 38 | 1.51e-01 | -1.35e-01 | 5.14e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 6 | 5.68e-01 | -1.35e-01 | 8.34e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 18 | 3.23e-01 | -1.35e-01 | 6.81e-01 |
| GOCC CILIARY MEMBRANE | 30 | 2.03e-01 | 1.34e-01 | 5.79e-01 |
| GOBP MESENCHYME MORPHOGENESIS | 20 | 2.99e-01 | -1.34e-01 | 6.63e-01 |
| GOMF COMPLEMENT BINDING | 9 | 4.86e-01 | 1.34e-01 | 7.85e-01 |
| GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX | 90 | 2.80e-02 | -1.34e-01 | 2.57e-01 |
| GOBP GLYCOLIPID CATABOLIC PROCESS | 12 | 4.21e-01 | -1.34e-01 | 7.54e-01 |
| GOBP REGULATION OF OSTEOCLAST DEVELOPMENT | 6 | 5.69e-01 | -1.34e-01 | 8.34e-01 |
| GOCC MHC PROTEIN COMPLEX | 22 | 2.76e-01 | 1.34e-01 | 6.52e-01 |
| GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX | 115 | 1.32e-02 | -1.34e-01 | 1.86e-01 |
| GOBP PROTEIN LIPID COMPLEX ORGANIZATION | 24 | 2.56e-01 | -1.34e-01 | 6.31e-01 |
| GOBP REGULATION OF PROTEIN ACETYLATION | 32 | 1.90e-01 | 1.34e-01 | 5.60e-01 |
| GOBP CELLULAR DEFENSE RESPONSE | 33 | 1.83e-01 | -1.34e-01 | 5.53e-01 |
| GOBP CELL RECOGNITION | 67 | 5.83e-02 | -1.34e-01 | 3.52e-01 |
| GOMF UDP XYLOSYLTRANSFERASE ACTIVITY | 8 | 5.12e-01 | 1.34e-01 | 8.00e-01 |
| GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING | 10 | 4.64e-01 | 1.34e-01 | 7.77e-01 |
| GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY | 6 | 5.70e-01 | 1.34e-01 | 8.34e-01 |
| GOCC RISC LOADING COMPLEX | 8 | 5.13e-01 | -1.34e-01 | 8.00e-01 |
| GOBP CELLULAR RESPONSE TO ALDEHYDE | 9 | 4.88e-01 | 1.34e-01 | 7.86e-01 |
| GOCC COPI COATED VESICLE | 22 | 2.79e-01 | 1.33e-01 | 6.53e-01 |
| GOCC NPBAF COMPLEX | 14 | 3.88e-01 | 1.33e-01 | 7.26e-01 |
| GOMF POLY PURINE TRACT BINDING | 25 | 2.49e-01 | -1.33e-01 | 6.25e-01 |
| GOCC INO80 TYPE COMPLEX | 26 | 2.39e-01 | 1.33e-01 | 6.17e-01 |
| GOBP GDP METABOLIC PROCESS | 11 | 4.44e-01 | -1.33e-01 | 7.67e-01 |
| GOBP PROTEIN METHYLATION | 63 | 6.79e-02 | 1.33e-01 | 3.75e-01 |
| GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY | 5 | 6.06e-01 | -1.33e-01 | 8.54e-01 |
| GOBP REGULATION OF CELL MATURATION | 8 | 5.14e-01 | -1.33e-01 | 8.02e-01 |
| GOCC FLEMMING BODY | 27 | 2.31e-01 | -1.33e-01 | 6.09e-01 |
| GOBP BODY FLUID SECRETION | 45 | 1.23e-01 | -1.33e-01 | 4.76e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 41 | 1.41e-01 | -1.33e-01 | 5.00e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS | 86 | 3.32e-02 | 1.33e-01 | 2.74e-01 |
| GOBP RNA STABILIZATION | 52 | 9.78e-02 | -1.33e-01 | 4.36e-01 |
| GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 82 | 3.79e-02 | 1.33e-01 | 2.93e-01 |
| GOBP UBIQUITIN DEPENDENT ERAD PATHWAY | 70 | 5.50e-02 | -1.33e-01 | 3.41e-01 |
| GOCC SECRETORY GRANULE | 565 | 9.25e-08 | -1.33e-01 | 9.39e-05 |
| GOBP REGULATION OF AMYLOID BETA CLEARANCE | 10 | 4.67e-01 | -1.33e-01 | 7.78e-01 |
| GOCC ACROSOMAL VESICLE | 58 | 8.08e-02 | -1.33e-01 | 4.07e-01 |
| GOBP DICARBOXYLIC ACID TRANSPORT | 48 | 1.12e-01 | 1.33e-01 | 4.58e-01 |
| GOBP VACUOLE ORGANIZATION | 192 | 1.58e-03 | -1.33e-01 | 6.12e-02 |
| GOBP SKIN DEVELOPMENT | 117 | 1.34e-02 | -1.33e-01 | 1.87e-01 |
| GOBP REGULATION OF FATTY ACID OXIDATION | 18 | 3.30e-01 | 1.33e-01 | 6.87e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 7 | 5.44e-01 | -1.33e-01 | 8.20e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 11 | 4.47e-01 | -1.32e-01 | 7.68e-01 |
| GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 8 | 5.17e-01 | -1.32e-01 | 8.03e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 10 | 4.69e-01 | 1.32e-01 | 7.78e-01 |
| GOBP MYELOID CELL DEVELOPMENT | 64 | 6.74e-02 | -1.32e-01 | 3.74e-01 |
| GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER | 10 | 4.69e-01 | -1.32e-01 | 7.78e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 14 | 3.92e-01 | 1.32e-01 | 7.29e-01 |
| GOBP NEGATIVE REGULATION OF MRNA PROCESSING | 20 | 3.06e-01 | -1.32e-01 | 6.69e-01 |
| GOMF SODIUM CHANNEL ACTIVITY | 8 | 5.17e-01 | 1.32e-01 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 11 | 4.48e-01 | -1.32e-01 | 7.68e-01 |
| GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 6 | 5.75e-01 | 1.32e-01 | 8.37e-01 |
| GOMF PROTEIN KINASE C BINDING | 37 | 1.64e-01 | -1.32e-01 | 5.31e-01 |
| GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 33 | 1.89e-01 | 1.32e-01 | 5.60e-01 |
| GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE | 39 | 1.54e-01 | 1.32e-01 | 5.17e-01 |
| GOMF PHOSPHOLIPASE A2 ACTIVITY | 15 | 3.76e-01 | 1.32e-01 | 7.17e-01 |
| GOBP POSITIVE REGULATION OF URINE VOLUME | 5 | 6.09e-01 | -1.32e-01 | 8.56e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL BINDING | 12 | 4.29e-01 | -1.32e-01 | 7.58e-01 |
| GOBP REGULATION OF MRNA PROCESSING | 104 | 2.03e-02 | -1.32e-01 | 2.22e-01 |
| GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY | 15 | 3.77e-01 | -1.32e-01 | 7.17e-01 |
| GOBP REGULATION OF MYELOID CELL DIFFERENTIATION | 136 | 8.07e-03 | -1.32e-01 | 1.52e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING | 28 | 2.27e-01 | 1.32e-01 | 6.03e-01 |
| GOBP PROSTATE GLAND MORPHOGENESIS | 7 | 5.46e-01 | -1.32e-01 | 8.22e-01 |
| GOMF TRANSCRIPTION COREPRESSOR BINDING | 42 | 1.40e-01 | -1.32e-01 | 4.99e-01 |
| GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX | 16 | 3.62e-01 | 1.32e-01 | 7.10e-01 |
| GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 19 | 3.21e-01 | -1.32e-01 | 6.80e-01 |
| GOBP OVULATION CYCLE | 32 | 1.98e-01 | 1.32e-01 | 5.71e-01 |
| GOCC NUCLEAR PORE OUTER RING | 9 | 4.94e-01 | 1.32e-01 | 7.90e-01 |
| GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY | 26 | 2.46e-01 | -1.32e-01 | 6.22e-01 |
| GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 41 | 1.45e-01 | -1.32e-01 | 5.06e-01 |
| GOMF CORECEPTOR ACTIVITY | 25 | 2.55e-01 | -1.32e-01 | 6.31e-01 |
| GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 8 | 5.19e-01 | 1.32e-01 | 8.05e-01 |
| GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING | 77 | 4.63e-02 | -1.32e-01 | 3.15e-01 |
| GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS | 18 | 3.34e-01 | -1.32e-01 | 6.88e-01 |
| GOBP LEARNING | 69 | 5.92e-02 | -1.32e-01 | 3.54e-01 |
| GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 37 | 1.67e-01 | -1.32e-01 | 5.34e-01 |
| GOBP AMINO ACID METABOLIC PROCESS | 165 | 3.67e-03 | 1.31e-01 | 9.58e-02 |
| GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION | 43 | 1.36e-01 | 1.31e-01 | 4.94e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL | 8 | 5.20e-01 | -1.31e-01 | 8.05e-01 |
| GOBP CELL CELL RECOGNITION | 34 | 1.85e-01 | -1.31e-01 | 5.54e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION | 169 | 3.31e-03 | -1.31e-01 | 9.08e-02 |
| GOCC SMC5 SMC6 COMPLEX | 9 | 4.95e-01 | 1.31e-01 | 7.90e-01 |
| GOBP MYELOID LEUKOCYTE MIGRATION | 130 | 9.92e-03 | -1.31e-01 | 1.66e-01 |
| GOBP REGULATION OF NMDA RECEPTOR ACTIVITY | 9 | 4.95e-01 | 1.31e-01 | 7.90e-01 |
| GOBP VENTRICULAR SEPTUM DEVELOPMENT | 37 | 1.67e-01 | -1.31e-01 | 5.34e-01 |
| GOCC ENDOCYTIC VESICLE | 242 | 4.64e-04 | -1.31e-01 | 2.91e-02 |
| GOBP CELLULAR RESPONSE TO CAFFEINE | 7 | 5.48e-01 | 1.31e-01 | 8.23e-01 |
| GOCC SPECIFIC GRANULE | 125 | 1.15e-02 | -1.31e-01 | 1.74e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS | 31 | 2.07e-01 | -1.31e-01 | 5.82e-01 |
| GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 10 | 4.73e-01 | 1.31e-01 | 7.79e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 10 | 4.73e-01 | -1.31e-01 | 7.79e-01 |
| GOBP CELLULAR RESPONSE TO INDOLE 3 METHANOL | 5 | 6.12e-01 | -1.31e-01 | 8.58e-01 |
| GOBP REGULATION OF COLLAGEN METABOLIC PROCESS | 14 | 3.96e-01 | -1.31e-01 | 7.35e-01 |
| GOBP GLIAL CELL PROLIFERATION | 30 | 2.15e-01 | -1.31e-01 | 5.90e-01 |
| GOBP MAMMARY GLAND MORPHOGENESIS | 18 | 3.37e-01 | -1.31e-01 | 6.91e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOLYTIC PROCESS | 14 | 3.97e-01 | -1.31e-01 | 7.35e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY | 29 | 2.24e-01 | 1.31e-01 | 5.99e-01 |
| GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY | 21 | 3.00e-01 | 1.31e-01 | 6.64e-01 |
| GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 17 | 3.51e-01 | -1.31e-01 | 7.01e-01 |
| GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY | 6 | 5.80e-01 | -1.31e-01 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 33 | 1.95e-01 | -1.31e-01 | 5.67e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 7 | 5.50e-01 | 1.30e-01 | 8.23e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 13 | 4.15e-01 | 1.30e-01 | 7.51e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 18 | 3.39e-01 | 1.30e-01 | 6.92e-01 |
| GOBP ACYLGLYCEROL HOMEOSTASIS | 13 | 4.17e-01 | 1.30e-01 | 7.52e-01 |
| GOBP GTP BIOSYNTHETIC PROCESS | 9 | 4.99e-01 | 1.30e-01 | 7.92e-01 |
| GOCC DENDRITIC SHAFT | 21 | 3.02e-01 | 1.30e-01 | 6.66e-01 |
| GOBP RESPONSE TO INTERLEUKIN 1 | 77 | 4.89e-02 | -1.30e-01 | 3.22e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 10 | 4.77e-01 | -1.30e-01 | 7.81e-01 |
| GOMF CHROMATIN DNA BINDING | 79 | 4.61e-02 | -1.30e-01 | 3.15e-01 |
| GOBP AMINE METABOLIC PROCESS | 55 | 9.58e-02 | -1.30e-01 | 4.32e-01 |
| GOCC GLIAL CELL PROJECTION | 15 | 3.84e-01 | -1.30e-01 | 7.24e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE CYCLE | 9 | 5.00e-01 | -1.30e-01 | 7.92e-01 |
| GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS | 253 | 4.03e-04 | -1.30e-01 | 2.66e-02 |
| GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX | 8 | 5.25e-01 | -1.30e-01 | 8.08e-01 |
| GOCC ATAC COMPLEX | 13 | 4.18e-01 | 1.30e-01 | 7.52e-01 |
| GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 21 | 3.04e-01 | 1.30e-01 | 6.68e-01 |
| GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE | 128 | 1.15e-02 | -1.30e-01 | 1.74e-01 |
| GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS | 253 | 4.07e-04 | -1.30e-01 | 2.66e-02 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 12 | 4.37e-01 | -1.30e-01 | 7.61e-01 |
| GOBP INTERLEUKIN 2 PRODUCTION | 51 | 1.10e-01 | -1.30e-01 | 4.56e-01 |
| GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS | 38 | 1.67e-01 | 1.30e-01 | 5.34e-01 |
| GOBP GLUCAN BIOSYNTHETIC PROCESS | 28 | 2.36e-01 | 1.29e-01 | 6.13e-01 |
| GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS | 5 | 6.16e-01 | -1.29e-01 | 8.61e-01 |
| GOBP SYNAPSE MATURATION | 13 | 4.20e-01 | 1.29e-01 | 7.53e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION | 6 | 5.83e-01 | 1.29e-01 | 8.41e-01 |
| GOBP MODIFIED AMINO ACID TRANSPORT | 27 | 2.45e-01 | -1.29e-01 | 6.22e-01 |
| GOBP GLYCOSYL COMPOUND METABOLIC PROCESS | 53 | 1.04e-01 | 1.29e-01 | 4.49e-01 |
| GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION | 14 | 4.03e-01 | -1.29e-01 | 7.41e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY | 8 | 5.27e-01 | -1.29e-01 | 8.10e-01 |
| GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS | 22 | 2.95e-01 | 1.29e-01 | 6.62e-01 |
| GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX | 22 | 2.95e-01 | 1.29e-01 | 6.62e-01 |
| GOBP PROTEOGLYCAN METABOLIC PROCESS | 51 | 1.11e-01 | -1.29e-01 | 4.58e-01 |
| GOMF MOLECULAR TRANSDUCER ACTIVITY | 424 | 6.19e-06 | -1.29e-01 | 1.92e-03 |
| GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION | 10 | 4.80e-01 | -1.29e-01 | 7.83e-01 |
| GOMF MRNA METHYLTRANSFERASE ACTIVITY | 13 | 4.21e-01 | 1.29e-01 | 7.54e-01 |
| GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION | 7 | 5.55e-01 | -1.29e-01 | 8.26e-01 |
| GOBP REGULATION OF REGULATED SECRETORY PATHWAY | 77 | 5.10e-02 | -1.29e-01 | 3.28e-01 |
| GOCC VESICLE TETHERING COMPLEX | 51 | 1.12e-01 | 1.29e-01 | 4.58e-01 |
| GOBP TISSUE HOMEOSTASIS | 132 | 1.08e-02 | -1.29e-01 | 1.72e-01 |
| GOBP REGULATION OF HISTONE ACETYLATION | 16 | 3.73e-01 | 1.29e-01 | 7.16e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR | 50 | 1.16e-01 | 1.29e-01 | 4.64e-01 |
| GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE | 12 | 4.40e-01 | -1.29e-01 | 7.64e-01 |
| GOBP AMEBOIDAL TYPE CELL MIGRATION | 234 | 7.28e-04 | -1.29e-01 | 3.77e-02 |
| GOBP REGULATION OF SPINDLE ASSEMBLY | 27 | 2.47e-01 | 1.29e-01 | 6.23e-01 |
| GOBP CELLULAR RESPONSE TO NUTRIENT | 28 | 2.39e-01 | -1.29e-01 | 6.16e-01 |
| GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 5 | 6.19e-01 | -1.29e-01 | 8.62e-01 |
| GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY | 14 | 4.05e-01 | -1.29e-01 | 7.42e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 15 | 3.89e-01 | -1.29e-01 | 7.27e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDE SECRETION | 52 | 1.09e-01 | -1.28e-01 | 4.55e-01 |
| GOCC NEURON PROJECTION MEMBRANE | 17 | 3.60e-01 | 1.28e-01 | 7.10e-01 |
| GOBP NEUTROPHIL DIFFERENTIATION | 9 | 5.05e-01 | -1.28e-01 | 7.96e-01 |
| GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX | 20 | 3.21e-01 | -1.28e-01 | 6.81e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY | 26 | 2.59e-01 | -1.28e-01 | 6.35e-01 |
| GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 12 | 4.43e-01 | -1.28e-01 | 7.66e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA | 95 | 3.13e-02 | 1.28e-01 | 2.67e-01 |
| GOBP REGULATION OF JNK CASCADE | 94 | 3.23e-02 | -1.28e-01 | 2.71e-01 |
| GOMF POTASSIUM CHANNEL ACTIVITY | 19 | 3.34e-01 | 1.28e-01 | 6.88e-01 |
| GOBP MYELOID DENDRITIC CELL ACTIVATION | 20 | 3.22e-01 | -1.28e-01 | 6.81e-01 |
| GOMF GLUCOSYLTRANSFERASE ACTIVITY | 15 | 3.91e-01 | 1.28e-01 | 7.29e-01 |
| GOBP FORMATION OF PRIMARY GERM LAYER | 49 | 1.22e-01 | -1.28e-01 | 4.75e-01 |
| GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS | 14 | 4.08e-01 | -1.28e-01 | 7.44e-01 |
| GOBP PINOCYTOSIS | 17 | 3.62e-01 | -1.28e-01 | 7.10e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY | 31 | 2.18e-01 | -1.28e-01 | 5.95e-01 |
| GOBP REGULATION OF DNA REPAIR | 184 | 2.88e-03 | 1.28e-01 | 8.36e-02 |
| GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS | 10 | 4.84e-01 | 1.28e-01 | 7.85e-01 |
| GOCC DNA POLYMERASE COMPLEX | 18 | 3.48e-01 | 1.28e-01 | 7.00e-01 |
| GOBP REGULATION OF NEUTROPHIL DEGRANULATION | 7 | 5.58e-01 | -1.28e-01 | 8.29e-01 |
| GOBP EATING BEHAVIOR | 11 | 4.63e-01 | 1.28e-01 | 7.77e-01 |
| GOBP ALDEHYDE CATABOLIC PROCESS | 10 | 4.85e-01 | 1.28e-01 | 7.85e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 9 | 5.07e-01 | 1.28e-01 | 7.97e-01 |
| GOBP NEURON NEURON SYNAPTIC TRANSMISSION | 5 | 6.21e-01 | 1.28e-01 | 8.62e-01 |
| GOCC DNA REPLICATION FACTOR C COMPLEX | 5 | 6.21e-01 | -1.28e-01 | 8.62e-01 |
| GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 13 | 4.26e-01 | -1.28e-01 | 7.56e-01 |
| GOCC ENDOCYTIC VESICLE MEMBRANE | 135 | 1.07e-02 | -1.28e-01 | 1.71e-01 |
| GOBP INSULIN SECRETION | 105 | 2.42e-02 | -1.28e-01 | 2.41e-01 |
| GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX | 18 | 3.49e-01 | 1.28e-01 | 7.00e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY | 112 | 2.00e-02 | -1.27e-01 | 2.21e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT | 15 | 3.93e-01 | -1.27e-01 | 7.31e-01 |
| GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 10 | 4.85e-01 | 1.27e-01 | 7.85e-01 |
| GOBP SYNAPSE ASSEMBLY | 72 | 6.20e-02 | -1.27e-01 | 3.60e-01 |
| GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 3.64e-01 | -1.27e-01 | 7.10e-01 |
| GOBP REGULATION OF HETEROCHROMATIN ORGANIZATION | 18 | 3.50e-01 | 1.27e-01 | 7.01e-01 |
| GOBP SNO S RNA PROCESSING | 12 | 4.46e-01 | 1.27e-01 | 7.67e-01 |
| GOMF VITAMIN BINDING | 80 | 4.96e-02 | 1.27e-01 | 3.23e-01 |
| GOBP T CELL PROLIFERATION | 146 | 8.20e-03 | -1.27e-01 | 1.52e-01 |
| GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 39 | 1.70e-01 | 1.27e-01 | 5.36e-01 |
| GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS | 5 | 6.23e-01 | 1.27e-01 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 110 | 2.17e-02 | -1.27e-01 | 2.29e-01 |
| GOBP REGULATION OF TELOMERASE ACTIVITY | 42 | 1.55e-01 | 1.27e-01 | 5.20e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION | 11 | 4.66e-01 | -1.27e-01 | 7.78e-01 |
| GOBP PROTEIN STABILIZATION | 164 | 5.20e-03 | -1.27e-01 | 1.21e-01 |
| GOBP CYTOKINE MEDIATED SIGNALING PATHWAY | 299 | 1.75e-04 | -1.27e-01 | 1.67e-02 |
| GOCC SET1C COMPASS COMPLEX | 12 | 4.47e-01 | 1.27e-01 | 7.68e-01 |
| GOCC CANONICAL INFLAMMASOME COMPLEX | 14 | 4.12e-01 | 1.27e-01 | 7.48e-01 |
| GOCC SEH1 ASSOCIATED COMPLEX | 7 | 5.62e-01 | -1.27e-01 | 8.30e-01 |
| GOBP DETECTION OF CELL DENSITY | 5 | 6.24e-01 | 1.27e-01 | 8.63e-01 |
| GOMF 4 IRON 4 SULFUR CLUSTER BINDING | 41 | 1.61e-01 | 1.27e-01 | 5.27e-01 |
| GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 4.68e-01 | 1.26e-01 | 7.78e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 6 | 5.92e-01 | -1.26e-01 | 8.46e-01 |
| GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT | 11 | 4.68e-01 | 1.26e-01 | 7.78e-01 |
| GOMF GABA RECEPTOR BINDING | 9 | 5.12e-01 | -1.26e-01 | 8.00e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION | 84 | 4.58e-02 | -1.26e-01 | 3.15e-01 |
| GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL | 11 | 4.69e-01 | 1.26e-01 | 7.78e-01 |
| GOBP POSITIVE T CELL SELECTION | 30 | 2.33e-01 | -1.26e-01 | 6.10e-01 |
| GOCC DYNEIN COMPLEX | 27 | 2.57e-01 | 1.26e-01 | 6.34e-01 |
| GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 26 | 2.67e-01 | -1.26e-01 | 6.44e-01 |
| GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT | 5 | 6.26e-01 | 1.26e-01 | 8.64e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 20 | 3.30e-01 | -1.26e-01 | 6.86e-01 |
| GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY | 83 | 4.78e-02 | -1.26e-01 | 3.18e-01 |
| GOBP RETINAL GANGLION CELL AXON GUIDANCE | 8 | 5.38e-01 | -1.26e-01 | 8.16e-01 |
| GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION | 7 | 5.64e-01 | 1.26e-01 | 8.31e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 23 | 2.97e-01 | -1.26e-01 | 6.63e-01 |
| GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 82 | 4.94e-02 | -1.26e-01 | 3.22e-01 |
| GOMF PROTEIN SEQUESTERING ACTIVITY | 21 | 3.19e-01 | -1.26e-01 | 6.80e-01 |
| GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 8 | 5.38e-01 | -1.26e-01 | 8.16e-01 |
| GOBP RESPONSE TO RETINOIC ACID | 44 | 1.50e-01 | -1.26e-01 | 5.12e-01 |
| GOMF IMMUNE RECEPTOR ACTIVITY | 86 | 4.44e-02 | -1.26e-01 | 3.10e-01 |
| GOCC PRESYNAPSE | 282 | 3.04e-04 | -1.26e-01 | 2.28e-02 |
| GOBP ANATOMICAL STRUCTURE MATURATION | 110 | 2.32e-02 | -1.26e-01 | 2.37e-01 |
| GOCC APICAL JUNCTION COMPLEX | 67 | 7.62e-02 | -1.25e-01 | 3.96e-01 |
| GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS | 30 | 2.35e-01 | -1.25e-01 | 6.12e-01 |
| GOMF SCAFFOLD PROTEIN BINDING | 39 | 1.76e-01 | -1.25e-01 | 5.43e-01 |
| GOBP REGULATION OF CHOLESTEROL EFFLUX | 20 | 3.33e-01 | -1.25e-01 | 6.88e-01 |
| GOBP AXONAL TRANSPORT | 46 | 1.43e-01 | -1.25e-01 | 5.04e-01 |
| GOBP REGULATION OF SPINDLE ORGANIZATION | 36 | 1.95e-01 | 1.25e-01 | 5.67e-01 |
| GOBP MEMBRANE PROTEIN PROTEOLYSIS | 41 | 1.67e-01 | -1.25e-01 | 5.34e-01 |
| GOCC ANNULATE LAMELLAE | 5 | 6.29e-01 | 1.25e-01 | 8.66e-01 |
| GOBP SNO S RNA METABOLIC PROCESS | 15 | 4.02e-01 | 1.25e-01 | 7.41e-01 |
| GOBP PROTEIN K63 LINKED DEUBIQUITINATION | 25 | 2.80e-01 | -1.25e-01 | 6.54e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 87 | 4.45e-02 | -1.25e-01 | 3.10e-01 |
| GOCC AMPHISOME | 12 | 4.54e-01 | 1.25e-01 | 7.72e-01 |
| GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS | 75 | 6.20e-02 | -1.25e-01 | 3.60e-01 |
| GOCC SWR1 COMPLEX | 13 | 4.36e-01 | 1.25e-01 | 7.61e-01 |
| GOCC AMPA GLUTAMATE RECEPTOR COMPLEX | 5 | 6.29e-01 | -1.25e-01 | 8.66e-01 |
| GOBP CELLULAR RESPONSE TO UNFOLDED PROTEIN | 73 | 6.57e-02 | -1.25e-01 | 3.71e-01 |
| GOBP DETECTION OF ABIOTIC STIMULUS | 47 | 1.39e-01 | 1.25e-01 | 4.98e-01 |
| GOBP GLYCEROL ETHER METABOLIC PROCESS | 18 | 3.60e-01 | 1.25e-01 | 7.10e-01 |
| GOMF ADENOSINE RECEPTOR BINDING | 5 | 6.29e-01 | -1.25e-01 | 8.67e-01 |
| GOMF OXO ACID LYASE ACTIVITY | 5 | 6.30e-01 | 1.25e-01 | 8.67e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT | 49 | 1.32e-01 | -1.24e-01 | 4.89e-01 |
| GOBP MULTIVESICULAR BODY ORGANIZATION | 30 | 2.38e-01 | -1.24e-01 | 6.16e-01 |
| GOCC SPECTRIN | 5 | 6.30e-01 | 1.24e-01 | 8.67e-01 |
| GOBP MUSCLE CELL PROLIFERATION | 109 | 2.51e-02 | -1.24e-01 | 2.44e-01 |
| GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 5.98e-01 | -1.24e-01 | 8.50e-01 |
| GOCC PROTEIN LIPID COMPLEX | 14 | 4.21e-01 | 1.24e-01 | 7.54e-01 |
| GOBP PROTEIN HYDROXYLATION | 19 | 3.48e-01 | 1.24e-01 | 7.00e-01 |
| GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 5 | 6.30e-01 | -1.24e-01 | 8.67e-01 |
| GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING | 103 | 2.95e-02 | 1.24e-01 | 2.62e-01 |
| GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 31 | 2.31e-01 | -1.24e-01 | 6.09e-01 |
| GOCC SECRETORY VESICLE | 656 | 8.02e-08 | -1.24e-01 | 9.39e-05 |
| GOBP B CELL RECEPTOR SIGNALING PATHWAY | 57 | 1.05e-01 | 1.24e-01 | 4.50e-01 |
| GOBP RESPONSE TO TUMOR CELL | 30 | 2.40e-01 | -1.24e-01 | 6.17e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 28 | 2.56e-01 | 1.24e-01 | 6.32e-01 |
| GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 13 | 4.39e-01 | -1.24e-01 | 7.63e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE | 6 | 5.99e-01 | -1.24e-01 | 8.51e-01 |
| GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS | 76 | 6.21e-02 | -1.24e-01 | 3.60e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT | 50 | 1.30e-01 | -1.24e-01 | 4.87e-01 |
| GOBP CENTRIOLE ASSEMBLY | 40 | 1.75e-01 | 1.24e-01 | 5.43e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION | 300 | 2.44e-04 | -1.24e-01 | 2.04e-02 |
| GOCC ENDOSOME MEMBRANE | 413 | 1.86e-05 | -1.24e-01 | 3.50e-03 |
| GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 8 | 5.45e-01 | -1.24e-01 | 8.21e-01 |
| GOCC ER MEMBRANE INSERTION COMPLEX | 13 | 4.40e-01 | -1.24e-01 | 7.64e-01 |
| GOBP SPERMATID DIFFERENTIATION | 85 | 4.94e-02 | -1.23e-01 | 3.22e-01 |
| GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 79 | 5.82e-02 | -1.23e-01 | 3.52e-01 |
| GOBP NEGATIVE REGULATION OF CELL SIZE | 7 | 5.72e-01 | -1.23e-01 | 8.34e-01 |
| GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM | 7 | 5.72e-01 | -1.23e-01 | 8.34e-01 |
| GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY | 6 | 6.01e-01 | 1.23e-01 | 8.51e-01 |
| GOCC CYTOPLASMIC STRESS GRANULE | 75 | 6.50e-02 | -1.23e-01 | 3.69e-01 |
| GOBP PROTEIN HOMOTETRAMERIZATION | 38 | 1.88e-01 | 1.23e-01 | 5.59e-01 |
| GOBP NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 6.33e-01 | 1.23e-01 | 8.68e-01 |
| GOBP ENDOTHELIAL CELL MIGRATION | 127 | 1.66e-02 | -1.23e-01 | 2.03e-01 |
| GOBP SELECTIVE AUTOPHAGY | 86 | 4.85e-02 | -1.23e-01 | 3.21e-01 |
| GOCC EXTERNAL ENCAPSULATING STRUCTURE | 140 | 1.20e-02 | -1.23e-01 | 1.78e-01 |
| GOBP EXIT FROM MITOSIS | 25 | 2.86e-01 | -1.23e-01 | 6.57e-01 |
| GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY | 14 | 4.25e-01 | 1.23e-01 | 7.56e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE | 8 | 5.46e-01 | -1.23e-01 | 8.22e-01 |
| GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 10 | 5.00e-01 | -1.23e-01 | 7.92e-01 |
| GOBP POSITIVE REGULATION OF BINDING | 87 | 4.74e-02 | -1.23e-01 | 3.17e-01 |
| GOBP INTERMEMBRANE LIPID TRANSFER | 30 | 2.44e-01 | -1.23e-01 | 6.21e-01 |
| GOMF LIPID TRANSFER ACTIVITY | 30 | 2.44e-01 | -1.23e-01 | 6.21e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION | 31 | 2.36e-01 | 1.23e-01 | 6.13e-01 |
| GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY | 21 | 3.29e-01 | 1.23e-01 | 6.86e-01 |
| GOBP T CELL CHEMOTAXIS | 15 | 4.10e-01 | 1.23e-01 | 7.46e-01 |
| GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS | 38 | 1.90e-01 | -1.23e-01 | 5.61e-01 |
| GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION | 64 | 8.94e-02 | -1.23e-01 | 4.22e-01 |
| GOBP RESPONSE TO CYTOKINE | 590 | 4.49e-07 | -1.23e-01 | 3.04e-04 |
| GOMF CELL ADHESION MEDIATOR ACTIVITY | 26 | 2.78e-01 | -1.23e-01 | 6.53e-01 |
| GOCC KINETOCHORE MICROTUBULE | 18 | 3.67e-01 | 1.23e-01 | 7.12e-01 |
| GOBP REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 8 | 5.48e-01 | -1.23e-01 | 8.23e-01 |
| GOBP NEUTROPHIL MIGRATION | 70 | 7.62e-02 | -1.23e-01 | 3.96e-01 |
| GOBP NATURAL KILLER CELL DEGRANULATION | 11 | 4.81e-01 | -1.23e-01 | 7.83e-01 |
| GOBP REGULATION OF PRESYNAPSE ORGANIZATION | 12 | 4.62e-01 | -1.23e-01 | 7.77e-01 |
| GOBP POSITIVE CHEMOTAXIS | 24 | 2.99e-01 | -1.23e-01 | 6.63e-01 |
| GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 9 | 5.24e-01 | 1.23e-01 | 8.08e-01 |
| GOBP CELLULAR RESPONSE TO HYDROPEROXIDE | 6 | 6.03e-01 | -1.23e-01 | 8.52e-01 |
| GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 560 | 9.22e-07 | -1.23e-01 | 4.68e-04 |
| GOBP SPERMIDINE METABOLIC PROCESS | 8 | 5.49e-01 | -1.22e-01 | 8.23e-01 |
| GOMF STEROL ESTERASE ACTIVITY | 5 | 6.35e-01 | 1.22e-01 | 8.70e-01 |
| GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 92 | 4.28e-02 | -1.22e-01 | 3.07e-01 |
| GOBP SMOOTH MUSCLE CELL PROLIFERATION | 78 | 6.21e-02 | -1.22e-01 | 3.60e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT | 11 | 4.83e-01 | 1.22e-01 | 7.84e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION BY VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 6 | 6.04e-01 | 1.22e-01 | 8.53e-01 |
| GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS | 8 | 5.50e-01 | -1.22e-01 | 8.23e-01 |
| GOBP RESPONSE TO CARBOHYDRATE | 126 | 1.81e-02 | -1.22e-01 | 2.10e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT | 5 | 6.36e-01 | 1.22e-01 | 8.70e-01 |
| GOBP ASTRAL MICROTUBULE ORGANIZATION | 9 | 5.26e-01 | -1.22e-01 | 8.09e-01 |
| GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 23 | 3.11e-01 | 1.22e-01 | 6.74e-01 |
| GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 7 | 5.76e-01 | 1.22e-01 | 8.37e-01 |
| GOCC DENDRITE MEMBRANE | 7 | 5.76e-01 | 1.22e-01 | 8.37e-01 |
| GOBP RESPONSE TO WOUNDING | 295 | 3.37e-04 | -1.22e-01 | 2.45e-02 |
| GOMF 3 5 DNA EXONUCLEASE ACTIVITY | 11 | 4.84e-01 | 1.22e-01 | 7.85e-01 |
| GOBP REGULATION OF ACTIN NUCLEATION | 27 | 2.73e-01 | 1.22e-01 | 6.51e-01 |
| GOBP CELL FATE SPECIFICATION | 30 | 2.48e-01 | 1.22e-01 | 6.25e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 6 | 6.05e-01 | -1.22e-01 | 8.54e-01 |
| GOBP 7 METHYLGUANOSINE RNA CAPPING | 8 | 5.50e-01 | -1.22e-01 | 8.23e-01 |
| GOBP SNRNA METABOLIC PROCESS | 53 | 1.25e-01 | 1.22e-01 | 4.81e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION | 18 | 3.71e-01 | 1.22e-01 | 7.14e-01 |
| GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI | 6 | 6.05e-01 | 1.22e-01 | 8.54e-01 |
| GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS | 15 | 4.14e-01 | -1.22e-01 | 7.50e-01 |
| GOBP HISTIDINE METABOLIC PROCESS | 5 | 6.37e-01 | -1.22e-01 | 8.70e-01 |
| GOMF RECEPTOR TYROSINE KINASE BINDING | 52 | 1.29e-01 | -1.22e-01 | 4.86e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 9 | 5.27e-01 | -1.22e-01 | 8.10e-01 |
| GOBP REGULATION OF OSSIFICATION | 58 | 1.09e-01 | -1.22e-01 | 4.55e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 130 | 1.68e-02 | -1.22e-01 | 2.03e-01 |
| GOBP POSITIVE REGULATION OF DNA REPLICATION | 26 | 2.83e-01 | 1.22e-01 | 6.55e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 16 | 4.00e-01 | -1.22e-01 | 7.38e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 8 | 5.52e-01 | -1.22e-01 | 8.24e-01 |
| GOBP NEGATIVE REGULATION OF P38MAPK CASCADE | 6 | 6.06e-01 | -1.22e-01 | 8.54e-01 |
| GOBP REGULATION OF LEUKOCYTE DEGRANULATION | 37 | 2.01e-01 | -1.21e-01 | 5.76e-01 |
| GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS | 19 | 3.60e-01 | -1.21e-01 | 7.10e-01 |
| GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS | 54 | 1.23e-01 | -1.21e-01 | 4.76e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 7 | 5.78e-01 | -1.21e-01 | 8.38e-01 |
| GOBP ARTERY DEVELOPMENT | 44 | 1.64e-01 | -1.21e-01 | 5.29e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 41 | 1.79e-01 | -1.21e-01 | 5.47e-01 |
| GOBP BIOGENIC AMINE METABOLIC PROCESS | 47 | 1.51e-01 | -1.21e-01 | 5.13e-01 |
| GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 136 | 1.49e-02 | -1.21e-01 | 1.95e-01 |
| GOCC PHOTORECEPTOR RIBBON SYNAPSE | 7 | 5.79e-01 | -1.21e-01 | 8.38e-01 |
| GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT | 5 | 6.39e-01 | -1.21e-01 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 21 | 3.36e-01 | -1.21e-01 | 6.91e-01 |
| GOBP EXOCYTOSIS | 220 | 2.03e-03 | -1.21e-01 | 6.84e-02 |
| GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION | 322 | 2.01e-04 | -1.21e-01 | 1.83e-02 |
| GOCC CD95 DEATH INDUCING SIGNALING COMPLEX | 6 | 6.07e-01 | -1.21e-01 | 8.55e-01 |
| GOBP MEIOTIC SISTER CHROMATID COHESION | 11 | 4.87e-01 | -1.21e-01 | 7.85e-01 |
| GOBP POSITIVE REGULATION OF MRNA PROCESSING | 25 | 2.95e-01 | -1.21e-01 | 6.62e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 20 | 3.49e-01 | -1.21e-01 | 7.00e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING | 6 | 6.08e-01 | 1.21e-01 | 8.55e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 38 | 1.97e-01 | -1.21e-01 | 5.71e-01 |
| GOCC SPINDLE MIDZONE | 25 | 2.95e-01 | -1.21e-01 | 6.62e-01 |
| GOBP RESPONSE TO TOXIC SUBSTANCE | 131 | 1.71e-02 | -1.21e-01 | 2.05e-01 |
| GOBP ERYTHROCYTE HOMEOSTASIS | 109 | 2.95e-02 | -1.21e-01 | 2.62e-01 |
| GOCC CELL CORTEX REGION | 19 | 3.62e-01 | -1.21e-01 | 7.10e-01 |
| GOBP PURINE CONTAINING COMPOUND SALVAGE | 13 | 4.51e-01 | 1.21e-01 | 7.70e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH | 7 | 5.80e-01 | -1.21e-01 | 8.39e-01 |
| GOBP REGULATION OF PEPTIDE TRANSPORT | 99 | 3.82e-02 | -1.21e-01 | 2.94e-01 |
| GOBP PROTEIN PROCESSING | 140 | 1.39e-02 | -1.21e-01 | 1.91e-01 |
| GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT | 6 | 6.09e-01 | 1.21e-01 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 5 | 6.40e-01 | 1.21e-01 | 8.72e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 8 | 5.55e-01 | -1.21e-01 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 22 | 3.28e-01 | -1.21e-01 | 6.85e-01 |
| GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS | 7 | 5.81e-01 | 1.21e-01 | 8.39e-01 |
| GOBP DOPAMINE SECRETION | 12 | 4.70e-01 | 1.20e-01 | 7.79e-01 |
| GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS | 10 | 5.10e-01 | 1.20e-01 | 7.99e-01 |
| GOCC EXORIBONUCLEASE COMPLEX | 19 | 3.63e-01 | 1.20e-01 | 7.10e-01 |
| GOBP CALCINEURIN MEDIATED SIGNALING | 30 | 2.54e-01 | 1.20e-01 | 6.31e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 19 | 3.64e-01 | -1.20e-01 | 7.11e-01 |
| GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS | 62 | 1.02e-01 | -1.20e-01 | 4.45e-01 |
| GOMF MRNA 3 UTR BINDING | 79 | 6.48e-02 | -1.20e-01 | 3.68e-01 |
| GOBP SNRNA CATABOLIC PROCESS | 5 | 6.41e-01 | -1.20e-01 | 8.73e-01 |
| GOCC GERM CELL NUCLEUS | 41 | 1.83e-01 | 1.20e-01 | 5.52e-01 |
| GOBP MIDDLE EAR MORPHOGENESIS | 6 | 6.10e-01 | 1.20e-01 | 8.56e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION | 174 | 6.36e-03 | -1.20e-01 | 1.35e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 375 | 7.14e-05 | -1.20e-01 | 8.93e-03 |
| GOBP HEMOSTASIS | 130 | 1.82e-02 | -1.20e-01 | 2.11e-01 |
| GOBP VIRAL RNA GENOME REPLICATION | 24 | 3.08e-01 | -1.20e-01 | 6.70e-01 |
| GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 3.65e-01 | -1.20e-01 | 7.11e-01 |
| GOBP ENDOPLASMIC RETICULUM ORGANIZATION | 80 | 6.36e-02 | -1.20e-01 | 3.64e-01 |
| GOBP REGULATION OF KIDNEY DEVELOPMENT | 9 | 5.33e-01 | 1.20e-01 | 8.14e-01 |
| GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY | 271 | 7.08e-04 | -1.20e-01 | 3.72e-02 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 11 | 4.91e-01 | -1.20e-01 | 7.88e-01 |
| GOBP RESPONSE TO VITAMIN E | 5 | 6.42e-01 | 1.20e-01 | 8.73e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT | 5 | 6.42e-01 | -1.20e-01 | 8.73e-01 |
| GOBP MULTICELLULAR ORGANISMAL MOVEMENT | 26 | 2.90e-01 | -1.20e-01 | 6.59e-01 |
| GOMF SOLUTE SODIUM SYMPORTER ACTIVITY | 19 | 3.66e-01 | -1.20e-01 | 7.11e-01 |
| GOBP NUCLEAR PORE COMPLEX ASSEMBLY | 11 | 4.91e-01 | 1.20e-01 | 7.88e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS | 162 | 8.64e-03 | -1.20e-01 | 1.54e-01 |
| GOBP NEGATIVE REGULATION OF ENDOCYTOSIS | 49 | 1.47e-01 | -1.20e-01 | 5.09e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY | 9 | 5.34e-01 | -1.20e-01 | 8.15e-01 |
| GOMF PROTEIN TYROSINE KINASE BINDING | 74 | 7.53e-02 | -1.20e-01 | 3.96e-01 |
| GOBP SIGNAL RELEASE | 233 | 1.72e-03 | -1.20e-01 | 6.28e-02 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 20 | 3.54e-01 | -1.20e-01 | 7.05e-01 |
| GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 19 | 3.67e-01 | -1.20e-01 | 7.11e-01 |
| GOBP MODULATION BY HOST OF SYMBIONT PROCESS | 66 | 9.31e-02 | -1.20e-01 | 4.26e-01 |
| GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 16 | 4.08e-01 | -1.20e-01 | 7.44e-01 |
| GOMF GLUCOSE BINDING | 9 | 5.35e-01 | 1.20e-01 | 8.15e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY | 15 | 4.23e-01 | 1.20e-01 | 7.55e-01 |
| GOBP POSITIVE REGULATION OF TORC1 SIGNALING | 48 | 1.53e-01 | -1.19e-01 | 5.15e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 68 | 8.90e-02 | -1.19e-01 | 4.22e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION | 8 | 5.59e-01 | -1.19e-01 | 8.29e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION | 7 | 5.84e-01 | -1.19e-01 | 8.41e-01 |
| GOCC EXTERNAL SIDE OF PLASMA MEMBRANE | 198 | 3.91e-03 | -1.19e-01 | 9.98e-02 |
| GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS | 12 | 4.74e-01 | -1.19e-01 | 7.80e-01 |
| GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR | 70 | 8.48e-02 | -1.19e-01 | 4.12e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS | 19 | 3.68e-01 | 1.19e-01 | 7.13e-01 |
| GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION | 53 | 1.34e-01 | -1.19e-01 | 4.92e-01 |
| GOBP RESPIRATORY BURST | 28 | 2.75e-01 | -1.19e-01 | 6.52e-01 |
| GOBP RIBOSOME ASSEMBLY | 57 | 1.20e-01 | -1.19e-01 | 4.72e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION | 116 | 2.70e-02 | -1.19e-01 | 2.54e-01 |
| GOBP PYRAMIDAL NEURON DIFFERENTIATION | 7 | 5.86e-01 | -1.19e-01 | 8.42e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 12 | 4.75e-01 | -1.19e-01 | 7.81e-01 |
| GOBP PRIMARY MIRNA PROCESSING | 17 | 3.96e-01 | -1.19e-01 | 7.34e-01 |
| GOBP DIAPEDESIS | 6 | 6.14e-01 | -1.19e-01 | 8.59e-01 |
| GOCC PROTEIN FOLDING CHAPERONE COMPLEX | 38 | 2.05e-01 | -1.19e-01 | 5.81e-01 |
| GOBP TYPE B PANCREATIC CELL DIFFERENTIATION | 12 | 4.76e-01 | -1.19e-01 | 7.81e-01 |
| GOBP PROSTANOID BIOSYNTHETIC PROCESS | 19 | 3.70e-01 | -1.19e-01 | 7.14e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS | 10 | 5.15e-01 | -1.19e-01 | 8.02e-01 |
| GOBP ANOIKIS | 24 | 3.14e-01 | -1.19e-01 | 6.77e-01 |
| GOBP MONOATOMIC ANION HOMEOSTASIS | 10 | 5.16e-01 | 1.19e-01 | 8.03e-01 |
| GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 8 | 5.61e-01 | -1.19e-01 | 8.29e-01 |
| GOMF GLUCURONOSYLTRANSFERASE ACTIVITY | 8 | 5.61e-01 | 1.19e-01 | 8.29e-01 |
| GOBP MIRNA CATABOLIC PROCESS | 15 | 4.26e-01 | -1.19e-01 | 7.56e-01 |
| GOBP DOSAGE COMPENSATION | 28 | 2.78e-01 | -1.19e-01 | 6.53e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING | 6 | 6.15e-01 | 1.19e-01 | 8.59e-01 |
| GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS | 6 | 6.15e-01 | 1.19e-01 | 8.59e-01 |
| GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY | 31 | 2.54e-01 | -1.19e-01 | 6.30e-01 |
| GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 9 | 5.38e-01 | -1.19e-01 | 8.16e-01 |
| GOCC MULTI PASS TRANSLOCON COMPLEX | 9 | 5.38e-01 | -1.19e-01 | 8.16e-01 |
| GOBP T CELL RECEPTOR SIGNALING PATHWAY | 111 | 3.13e-02 | -1.19e-01 | 2.67e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR | 76 | 7.44e-02 | 1.19e-01 | 3.94e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY | 121 | 2.48e-02 | -1.18e-01 | 2.43e-01 |
| GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE | 14 | 4.43e-01 | 1.18e-01 | 7.66e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 41 | 1.90e-01 | -1.18e-01 | 5.61e-01 |
| GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS | 19 | 3.72e-01 | 1.18e-01 | 7.15e-01 |
| GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 15 | 4.28e-01 | -1.18e-01 | 7.58e-01 |
| GOBP REGULATED EXOCYTOSIS | 136 | 1.75e-02 | -1.18e-01 | 2.07e-01 |
| GOBP PROTEIN LOCALIZATION TO PRESYNAPSE | 5 | 6.47e-01 | -1.18e-01 | 8.76e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT | 78 | 7.16e-02 | -1.18e-01 | 3.87e-01 |
| GOCC AXON CYTOPLASM | 44 | 1.75e-01 | -1.18e-01 | 5.43e-01 |
| GOBP NEGATIVE CHEMOTAXIS | 14 | 4.44e-01 | -1.18e-01 | 7.67e-01 |
| GOBP VENTRICULAR SEPTUM MORPHOGENESIS | 21 | 3.49e-01 | -1.18e-01 | 7.00e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 19 | 3.73e-01 | 1.18e-01 | 7.16e-01 |
| GOBP MUSCLE ADAPTATION | 58 | 1.21e-01 | -1.18e-01 | 4.73e-01 |
| GOBP SECONDARY PALATE DEVELOPMENT | 11 | 4.98e-01 | -1.18e-01 | 7.92e-01 |
| GOCC VESICLE LUMEN | 236 | 1.88e-03 | -1.18e-01 | 6.56e-02 |
| GOBP REGULATION OF BODY FLUID LEVELS | 191 | 5.10e-03 | -1.18e-01 | 1.19e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 102 | 4.00e-02 | -1.18e-01 | 2.98e-01 |
| GOBP NEGATIVE REGULATION OF HIPPO SIGNALING | 7 | 5.89e-01 | -1.18e-01 | 8.44e-01 |
| GOBP MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY | 23 | 3.28e-01 | 1.18e-01 | 6.85e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 103 | 3.91e-02 | -1.18e-01 | 2.97e-01 |
| GOCC MYELIN SHEATH | 27 | 2.89e-01 | 1.18e-01 | 6.59e-01 |
| GOMF PHOSPHATIDYLCHOLINE BINDING | 19 | 3.74e-01 | -1.18e-01 | 7.16e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE | 14 | 4.46e-01 | -1.18e-01 | 7.67e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 25 | 3.08e-01 | -1.18e-01 | 6.70e-01 |
| GOCC SMALL RIBOSOMAL SUBUNIT | 72 | 8.44e-02 | -1.18e-01 | 4.12e-01 |
| GOBP ANTEROGRADE AXONAL TRANSPORT | 34 | 2.35e-01 | -1.18e-01 | 6.12e-01 |
| GOMF CHANNEL INHIBITOR ACTIVITY | 23 | 3.29e-01 | 1.18e-01 | 6.86e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 36 | 2.22e-01 | -1.18e-01 | 5.97e-01 |
| GOCC MULTIMERIC RIBONUCLEASE P COMPLEX | 10 | 5.20e-01 | 1.18e-01 | 8.05e-01 |
| GOMF RIBONUCLEASE P RNA BINDING | 10 | 5.20e-01 | 1.18e-01 | 8.05e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX | 13 | 4.63e-01 | -1.18e-01 | 7.77e-01 |
| GOBP CELL ADHESION | 739 | 7.88e-08 | -1.18e-01 | 9.39e-05 |
| GOMF SIRNA BINDING | 10 | 5.20e-01 | -1.18e-01 | 8.05e-01 |
| GOBP AMINO SUGAR CATABOLIC PROCESS | 9 | 5.41e-01 | -1.18e-01 | 8.18e-01 |
| GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING | 69 | 9.17e-02 | 1.18e-01 | 4.24e-01 |
| GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 6 | 6.18e-01 | -1.17e-01 | 8.62e-01 |
| GOCC SYNAPSE | 740 | 8.14e-08 | -1.17e-01 | 9.39e-05 |
| GOBP ACROSOME REACTION | 13 | 4.64e-01 | -1.17e-01 | 7.77e-01 |
| GOBP HOMOLOGOUS CHROMOSOME SEGREGATION | 29 | 2.75e-01 | 1.17e-01 | 6.51e-01 |
| GOMF CYCLASE ACTIVATOR ACTIVITY | 6 | 6.19e-01 | -1.17e-01 | 8.62e-01 |
| GOBP METHYLATION | 218 | 2.99e-03 | 1.17e-01 | 8.56e-02 |
| GOBP P38MAPK CASCADE | 41 | 1.95e-01 | -1.17e-01 | 5.67e-01 |
| GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT | 139 | 1.75e-02 | -1.17e-01 | 2.07e-01 |
| GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION | 14 | 4.49e-01 | 1.17e-01 | 7.69e-01 |
| GOCC RNA POLYMERASE I COMPLEX | 10 | 5.22e-01 | 1.17e-01 | 8.07e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY | 159 | 1.12e-02 | -1.17e-01 | 1.73e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING | 92 | 5.32e-02 | -1.17e-01 | 3.36e-01 |
| GOBP SECRETORY GRANULE ORGANIZATION | 42 | 1.91e-01 | -1.17e-01 | 5.62e-01 |
| GOMF PROTEIN DEMETHYLASE ACTIVITY | 25 | 3.13e-01 | -1.17e-01 | 6.76e-01 |
| GOBP CELL CYCLE CHECKPOINT SIGNALING | 145 | 1.55e-02 | 1.17e-01 | 1.98e-01 |
| GOCC RESPIRASOME | 88 | 5.90e-02 | -1.17e-01 | 3.54e-01 |
| GOBP REGULATION OF VITAMIN METABOLIC PROCESS | 7 | 5.93e-01 | -1.17e-01 | 8.47e-01 |
| GOBP AUTOPHAGY OF MITOCHONDRION | 84 | 6.53e-02 | -1.17e-01 | 3.69e-01 |
| GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.52e-01 | -1.17e-01 | 8.78e-01 |
| GOBP CELL CELL ADHESION | 476 | 1.58e-05 | -1.17e-01 | 3.06e-03 |
| GOBP SUPEROXIDE METABOLIC PROCESS | 38 | 2.14e-01 | -1.16e-01 | 5.90e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 12 | 4.85e-01 | 1.16e-01 | 7.85e-01 |
| GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY | 195 | 5.21e-03 | -1.16e-01 | 1.21e-01 |
| GOBP NEUTROPHIL APOPTOTIC PROCESS | 5 | 6.53e-01 | -1.16e-01 | 8.78e-01 |
| GOBP ERAD PATHWAY | 92 | 5.44e-02 | -1.16e-01 | 3.40e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 8 | 5.69e-01 | -1.16e-01 | 8.34e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 56 | 1.33e-01 | -1.16e-01 | 4.91e-01 |
| GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE | 26 | 3.06e-01 | 1.16e-01 | 6.69e-01 |
| GOBP DOPAMINE METABOLIC PROCESS | 15 | 4.37e-01 | -1.16e-01 | 7.61e-01 |
| GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM | 485 | 1.44e-05 | -1.16e-01 | 3.01e-03 |
| GOBP CGMP MEDIATED SIGNALING | 8 | 5.70e-01 | -1.16e-01 | 8.34e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT | 33 | 2.49e-01 | -1.16e-01 | 6.26e-01 |
| GOBP GLYCOLIPID BIOSYNTHETIC PROCESS | 51 | 1.52e-01 | -1.16e-01 | 5.15e-01 |
| GOBP MAINTENANCE OF CELL POLARITY | 12 | 4.87e-01 | -1.16e-01 | 7.85e-01 |
| GOBP COGNITION | 151 | 1.43e-02 | -1.16e-01 | 1.93e-01 |
| GOBP NEGATIVE REGULATION OF BEHAVIOR | 5 | 6.54e-01 | -1.16e-01 | 8.78e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 55 | 1.39e-01 | 1.16e-01 | 4.97e-01 |
| GOCC MALE GERM CELL NUCLEUS | 33 | 2.51e-01 | 1.16e-01 | 6.28e-01 |
| GOCC MRNA CAP BINDING COMPLEX | 11 | 5.07e-01 | -1.16e-01 | 7.97e-01 |
| GOBP TYPE 2 IMMUNE RESPONSE | 29 | 2.83e-01 | -1.15e-01 | 6.55e-01 |
| GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 28 | 2.91e-01 | -1.15e-01 | 6.60e-01 |
| GOBP RRNA TRANSPORT | 5 | 6.55e-01 | 1.15e-01 | 8.78e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION | 5 | 6.55e-01 | -1.15e-01 | 8.78e-01 |
| GOBP LIPID OXIDATION | 76 | 8.26e-02 | 1.15e-01 | 4.09e-01 |
| GOBP PROTEIN LOCALIZATION TO VACUOLE | 73 | 8.89e-02 | -1.15e-01 | 4.22e-01 |
| GOBP REGULATION OF LIPID LOCALIZATION | 88 | 6.20e-02 | -1.15e-01 | 3.60e-01 |
| GOBP NEUROTRANSMITTER REUPTAKE | 9 | 5.49e-01 | -1.15e-01 | 8.23e-01 |
| GOBP LYMPHOCYTE ANERGY | 6 | 6.25e-01 | -1.15e-01 | 8.64e-01 |
| GOBP MOTOR BEHAVIOR | 16 | 4.25e-01 | -1.15e-01 | 7.56e-01 |
| GOBP CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 207 | 4.43e-03 | -1.15e-01 | 1.08e-01 |
| GOBP GLUTAMATE SECRETION NEUROTRANSMISSION | 6 | 6.25e-01 | 1.15e-01 | 8.64e-01 |
| GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT | 85 | 6.69e-02 | -1.15e-01 | 3.73e-01 |
| GOBP ANTIVIRAL INNATE IMMUNE RESPONSE | 34 | 2.46e-01 | -1.15e-01 | 6.22e-01 |
| GOMF PROTEIN DISULFIDE REDUCTASE ACTIVITY | 25 | 3.20e-01 | -1.15e-01 | 6.80e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING | 10 | 5.29e-01 | 1.15e-01 | 8.11e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR | 7 | 5.98e-01 | -1.15e-01 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 11 | 5.09e-01 | -1.15e-01 | 7.98e-01 |
| GOBP EARLY ENDOSOME TO GOLGI TRANSPORT | 11 | 5.09e-01 | -1.15e-01 | 7.98e-01 |
| GOBP REPLACEMENT OSSIFICATION | 12 | 4.91e-01 | -1.15e-01 | 7.88e-01 |
| GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE | 66 | 1.07e-01 | -1.15e-01 | 4.52e-01 |
| GOCC LIPID DROPLET | 72 | 9.27e-02 | -1.15e-01 | 4.25e-01 |
| GOBP MULTICELLULAR ORGANISM GROWTH | 88 | 6.33e-02 | -1.15e-01 | 3.63e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION | 59 | 1.28e-01 | -1.15e-01 | 4.85e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 91 | 5.93e-02 | -1.15e-01 | 3.55e-01 |
| GOMF PROTEIN PHOSPHATASE 1 BINDING | 18 | 4.00e-01 | 1.15e-01 | 7.38e-01 |
| GOBP LIPOSACCHARIDE METABOLIC PROCESS | 77 | 8.27e-02 | -1.15e-01 | 4.09e-01 |
| GOBP VESICLE CYTOSKELETAL TRAFFICKING | 48 | 1.70e-01 | -1.14e-01 | 5.36e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION | 210 | 4.42e-03 | -1.14e-01 | 1.08e-01 |
| GOMF STEROL TRANSPORTER ACTIVITY | 22 | 3.54e-01 | -1.14e-01 | 7.04e-01 |
| GOBP CYCLIC NUCLEOTIDE MEDIATED SIGNALING | 32 | 2.64e-01 | -1.14e-01 | 6.41e-01 |
| GOBP ARACHIDONIC ACID SECRETION | 9 | 5.53e-01 | 1.14e-01 | 8.24e-01 |
| GOBP ENDOSOMAL VESICLE FUSION | 12 | 4.94e-01 | 1.14e-01 | 7.90e-01 |
| GOBP INTERMEDIATE FILAMENT BASED PROCESS | 21 | 3.65e-01 | -1.14e-01 | 7.11e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS | 47 | 1.76e-01 | -1.14e-01 | 5.43e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 5 | 6.59e-01 | -1.14e-01 | 8.81e-01 |
| GOBP NCRNA PROCESSING | 386 | 1.32e-04 | 1.14e-01 | 1.36e-02 |
| GOBP CEREBELLAR CORTEX FORMATION | 14 | 4.60e-01 | -1.14e-01 | 7.76e-01 |
| GOBP INFLAMMATORY RESPONSE | 501 | 1.49e-05 | -1.14e-01 | 3.03e-03 |
| GOBP CELL JUNCTION ORGANIZATION | 342 | 3.17e-04 | -1.14e-01 | 2.34e-02 |
| GOBP REGULATION OF INSULIN SECRETION | 87 | 6.65e-02 | -1.14e-01 | 3.73e-01 |
| GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 11 | 5.13e-01 | -1.14e-01 | 8.00e-01 |
| GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 18 | 4.03e-01 | -1.14e-01 | 7.41e-01 |
| GOBP GLYCOSIDE CATABOLIC PROCESS | 7 | 6.02e-01 | 1.14e-01 | 8.52e-01 |
| GOMF CELL ADHESION MOLECULE BINDING | 337 | 3.57e-04 | -1.14e-01 | 2.53e-02 |
| GOMF N ACYLTRANSFERASE ACTIVITY | 68 | 1.05e-01 | -1.14e-01 | 4.50e-01 |
| GOBP BOX C D SNORNP ASSEMBLY | 8 | 5.77e-01 | -1.14e-01 | 8.38e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY | 8 | 5.77e-01 | 1.14e-01 | 8.38e-01 |
| GOBP TUBE DEVELOPMENT | 519 | 1.11e-05 | -1.14e-01 | 2.91e-03 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 71 | 9.79e-02 | -1.14e-01 | 4.37e-01 |
| GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY | 8 | 5.78e-01 | 1.14e-01 | 8.38e-01 |
| GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS | 134 | 2.33e-02 | -1.14e-01 | 2.37e-01 |
| GOBP NEGATIVE REGULATION OF RIBOSOME BIOGENESIS | 7 | 6.02e-01 | 1.14e-01 | 8.52e-01 |
| GOBP PROTEIN DNA COMPLEX DISASSEMBLY | 18 | 4.04e-01 | 1.14e-01 | 7.41e-01 |
| GOBP REGULATION OF NEUROBLAST PROLIFERATION | 20 | 3.79e-01 | -1.14e-01 | 7.19e-01 |
| GOBP ACETYL COA METABOLIC PROCESS | 26 | 3.16e-01 | 1.14e-01 | 6.79e-01 |
| GOBP GROOMING BEHAVIOR | 5 | 6.60e-01 | -1.14e-01 | 8.82e-01 |
| GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 17 | 4.18e-01 | -1.14e-01 | 7.52e-01 |
| GOMF MRNA 5 UTR BINDING | 22 | 3.57e-01 | -1.14e-01 | 7.08e-01 |
| GOCC U2 TYPE SPLICEOSOMAL COMPLEX | 89 | 6.46e-02 | -1.14e-01 | 3.67e-01 |
| GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION | 14 | 4.62e-01 | -1.13e-01 | 7.77e-01 |
| GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 32 | 2.67e-01 | 1.13e-01 | 6.44e-01 |
| GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS | 15 | 4.47e-01 | -1.13e-01 | 7.68e-01 |
| GOBP REGULATION OF DEVELOPMENTAL GROWTH | 160 | 1.36e-02 | -1.13e-01 | 1.88e-01 |
| GOBP CILIUM ORGANIZATION | 263 | 1.63e-03 | 1.13e-01 | 6.18e-02 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 11 | 5.15e-01 | -1.13e-01 | 8.02e-01 |
| GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE | 5 | 6.61e-01 | 1.13e-01 | 8.82e-01 |
| GOBP CELLULAR RESPONSE TO LIPID | 367 | 2.13e-04 | -1.13e-01 | 1.84e-02 |
| GOBP RRNA METABOLIC PROCESS | 241 | 2.56e-03 | 1.13e-01 | 7.78e-02 |
| GOCC NEURON TO NEURON SYNAPSE | 187 | 7.77e-03 | -1.13e-01 | 1.50e-01 |
| GOBP NEUROTRANSMITTER TRANSPORT | 90 | 6.37e-02 | -1.13e-01 | 3.64e-01 |
| GOBP SECRETION | 515 | 1.32e-05 | -1.13e-01 | 3.01e-03 |
| GOBP RAS PROTEIN SIGNAL TRANSDUCTION | 235 | 2.91e-03 | -1.13e-01 | 8.36e-02 |
| GOCC GOLGI LUMEN | 19 | 3.93e-01 | -1.13e-01 | 7.31e-01 |
| GOCC SCHAFFER COLLATERAL CA1 SYNAPSE | 49 | 1.71e-01 | -1.13e-01 | 5.36e-01 |
| GOBP HEPARIN METABOLIC PROCESS | 13 | 4.81e-01 | 1.13e-01 | 7.83e-01 |
| GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY | 10 | 5.36e-01 | -1.13e-01 | 8.16e-01 |
| GOBP ASTROCYTE CELL MIGRATION | 5 | 6.62e-01 | 1.13e-01 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 602 | 2.90e-06 | -1.13e-01 | 1.24e-03 |
| GOMF PROTEIN PHOSPHATASE 2A BINDING | 23 | 3.49e-01 | -1.13e-01 | 7.00e-01 |
| GOBP REGULATION OF B CELL MEDIATED IMMUNITY | 44 | 1.96e-01 | -1.13e-01 | 5.68e-01 |
| GOCC GAMMA SECRETASE COMPLEX | 7 | 6.05e-01 | 1.13e-01 | 8.54e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 14 | 4.65e-01 | -1.13e-01 | 7.78e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION | 98 | 5.42e-02 | -1.13e-01 | 3.39e-01 |
| GOCC SYNAPTIC MEMBRANE | 133 | 2.52e-02 | -1.13e-01 | 2.44e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION | 17 | 4.21e-01 | -1.13e-01 | 7.54e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE | 12 | 4.99e-01 | -1.13e-01 | 7.92e-01 |
| GOBP DNA INTEGRITY CHECKPOINT SIGNALING | 110 | 4.18e-02 | 1.13e-01 | 3.04e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION | 23 | 3.51e-01 | -1.12e-01 | 7.01e-01 |
| GOBP REGULATION OF HEART GROWTH | 27 | 3.12e-01 | -1.12e-01 | 6.75e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 9 | 5.60e-01 | -1.12e-01 | 8.29e-01 |
| GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 31 | 2.79e-01 | -1.12e-01 | 6.54e-01 |
| GOBP REGULATION OF PROTEIN KINASE C SIGNALING | 10 | 5.39e-01 | 1.12e-01 | 8.17e-01 |
| GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS | 6 | 6.34e-01 | -1.12e-01 | 8.69e-01 |
| GOBP TRANSLATIONAL INITIATION | 111 | 4.16e-02 | -1.12e-01 | 3.03e-01 |
| GOBP REGULATION OF SISTER CHROMATID COHESION | 13 | 4.84e-01 | -1.12e-01 | 7.85e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX | 5 | 6.64e-01 | -1.12e-01 | 8.84e-01 |
| GOCC NUCLEAR SPECK | 350 | 3.43e-04 | -1.12e-01 | 2.46e-02 |
| GOCC CCAAT BINDING FACTOR COMPLEX | 5 | 6.64e-01 | 1.12e-01 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION | 8 | 5.84e-01 | 1.12e-01 | 8.41e-01 |
| GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 116 | 3.78e-02 | -1.12e-01 | 2.93e-01 |
| GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH | 12 | 5.03e-01 | -1.12e-01 | 7.94e-01 |
| GOCC CONDENSED CHROMOSOME CENTROMERIC REGION | 144 | 2.10e-02 | 1.12e-01 | 2.25e-01 |
| GOMF TELOMERASE RNA BINDING | 21 | 3.76e-01 | -1.12e-01 | 7.17e-01 |
| GOMF NF KAPPAB BINDING | 27 | 3.16e-01 | -1.12e-01 | 6.78e-01 |
| GOBP ACIDIC AMINO ACID TRANSPORT | 32 | 2.75e-01 | 1.12e-01 | 6.51e-01 |
| GOCC REPLICATION FORK | 55 | 1.53e-01 | 1.12e-01 | 5.15e-01 |
| GOBP MONOCYTE CHEMOTAXIS | 27 | 3.16e-01 | 1.12e-01 | 6.78e-01 |
| GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 84 | 7.79e-02 | -1.11e-01 | 4.00e-01 |
| GOBP DNA RECOMBINATION | 245 | 2.79e-03 | 1.11e-01 | 8.23e-02 |
| GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION | 6 | 6.37e-01 | -1.11e-01 | 8.70e-01 |
| GOBP INTERLEUKIN 8 PRODUCTION | 55 | 1.54e-01 | -1.11e-01 | 5.17e-01 |
| GOBP EPIDERMAL CELL DIFFERENTIATION | 84 | 7.84e-02 | -1.11e-01 | 4.00e-01 |
| GOMF S METHYLTRANSFERASE ACTIVITY | 5 | 6.67e-01 | -1.11e-01 | 8.86e-01 |
| GOBP UNSATURATED FATTY ACID METABOLIC PROCESS | 54 | 1.58e-01 | -1.11e-01 | 5.24e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE | 6 | 6.38e-01 | -1.11e-01 | 8.70e-01 |
| GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 5.87e-01 | 1.11e-01 | 8.42e-01 |
| GOBP AMINE BIOSYNTHETIC PROCESS | 17 | 4.28e-01 | -1.11e-01 | 7.58e-01 |
| GOBP ACTIN FILAMENT BASED TRANSPORT | 14 | 4.72e-01 | -1.11e-01 | 7.79e-01 |
| GOBP HEPATOCYTE APOPTOTIC PROCESS | 16 | 4.42e-01 | -1.11e-01 | 7.66e-01 |
| GOMF MHC CLASS II PROTEIN COMPLEX BINDING | 25 | 3.37e-01 | 1.11e-01 | 6.91e-01 |
| GOBP REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME | 13 | 4.89e-01 | -1.11e-01 | 7.87e-01 |
| GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS | 17 | 4.29e-01 | -1.11e-01 | 7.58e-01 |
| GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 43 | 2.09e-01 | -1.11e-01 | 5.83e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN E | 14 | 4.73e-01 | 1.11e-01 | 7.79e-01 |
| GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION | 5 | 6.68e-01 | -1.11e-01 | 8.86e-01 |
| GOBP OSTEOCLAST FUSION | 5 | 6.68e-01 | -1.11e-01 | 8.86e-01 |
| GOCC SARCOPLASM | 48 | 1.85e-01 | 1.11e-01 | 5.54e-01 |
| GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY | 6 | 6.39e-01 | 1.11e-01 | 8.71e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 26 | 3.29e-01 | 1.11e-01 | 6.86e-01 |
| GOCC CHROMATIN SILENCING COMPLEX | 12 | 5.07e-01 | 1.11e-01 | 7.97e-01 |
| GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS | 18 | 4.17e-01 | -1.11e-01 | 7.52e-01 |
| GOCC MLL3 4 COMPLEX | 12 | 5.08e-01 | -1.11e-01 | 7.97e-01 |
| GOBP AMINO ACID CATABOLIC PROCESS | 65 | 1.24e-01 | 1.10e-01 | 4.79e-01 |
| GOBP REGULATION OF CYCLASE ACTIVITY | 19 | 4.05e-01 | -1.10e-01 | 7.42e-01 |
| GOBP RESPONSE TO UV B | 14 | 4.74e-01 | -1.10e-01 | 7.80e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 29 | 3.04e-01 | -1.10e-01 | 6.68e-01 |
| GOBP CENTROSOME DUPLICATION | 61 | 1.37e-01 | 1.10e-01 | 4.94e-01 |
| GOBP MEMBRANE LIPID METABOLIC PROCESS | 143 | 2.31e-02 | -1.10e-01 | 2.37e-01 |
| GOBP RESPONSE TO ORGANOPHOSPHORUS | 70 | 1.11e-01 | -1.10e-01 | 4.58e-01 |
| GOBP REGULATION OF MUSCLE ADAPTATION | 46 | 1.97e-01 | -1.10e-01 | 5.71e-01 |
| GOBP CARDIAC SEPTUM DEVELOPMENT | 54 | 1.63e-01 | -1.10e-01 | 5.28e-01 |
| GOBP PROTEIN AUTOUBIQUITINATION | 54 | 1.63e-01 | -1.10e-01 | 5.28e-01 |
| GOBP METHYLGLYOXAL METABOLIC PROCESS | 6 | 6.41e-01 | 1.10e-01 | 8.73e-01 |
| GOBP REGULATION OF PROTEIN MONOUBIQUITINATION | 6 | 6.41e-01 | -1.10e-01 | 8.73e-01 |
| GOBP OOCYTE MATURATION | 15 | 4.62e-01 | -1.10e-01 | 7.77e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIVISION | 6 | 6.42e-01 | 1.10e-01 | 8.73e-01 |
| GOBP INTERFERON ALPHA PRODUCTION | 23 | 3.63e-01 | 1.10e-01 | 7.10e-01 |
| GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION | 29 | 3.07e-01 | -1.10e-01 | 6.69e-01 |
| GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 28 | 3.16e-01 | -1.10e-01 | 6.78e-01 |
| GOMF LRR DOMAIN BINDING | 15 | 4.62e-01 | 1.10e-01 | 7.77e-01 |
| GOBP MAINTENANCE OF SISTER CHROMATID COHESION | 10 | 5.48e-01 | 1.10e-01 | 8.23e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY | 178 | 1.19e-02 | -1.10e-01 | 1.77e-01 |
| GOMF MRNA BINDING | 255 | 2.70e-03 | -1.10e-01 | 8.11e-02 |
| GOMF OXIDIZED DNA BINDING | 10 | 5.49e-01 | 1.10e-01 | 8.23e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 12 | 5.11e-01 | 1.10e-01 | 8.00e-01 |
| GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 10 | 5.49e-01 | -1.09e-01 | 8.23e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION | 14 | 4.78e-01 | -1.09e-01 | 7.82e-01 |
| GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION | 12 | 5.12e-01 | -1.09e-01 | 8.00e-01 |
| GOBP RRNA PSEUDOURIDINE SYNTHESIS | 8 | 5.92e-01 | 1.09e-01 | 8.46e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION | 60 | 1.43e-01 | 1.09e-01 | 5.05e-01 |
| GOBP CARDIAC VENTRICLE DEVELOPMENT | 57 | 1.54e-01 | -1.09e-01 | 5.17e-01 |
| GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION | 8 | 5.92e-01 | 1.09e-01 | 8.46e-01 |
| GOBP DIGESTION | 38 | 2.44e-01 | -1.09e-01 | 6.22e-01 |
| GOBP DIGESTIVE SYSTEM PROCESS | 38 | 2.44e-01 | -1.09e-01 | 6.22e-01 |
| GOBP REGULATION OF CARDIAC CONDUCTION | 10 | 5.50e-01 | -1.09e-01 | 8.23e-01 |
| GOBP REGULATION OF GROWTH | 337 | 6.11e-04 | -1.09e-01 | 3.38e-02 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE I | 58 | 1.51e-01 | 1.09e-01 | 5.13e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH | 351 | 4.76e-04 | -1.09e-01 | 2.91e-02 |
| GOCC GTPASE COMPLEX | 26 | 3.35e-01 | -1.09e-01 | 6.89e-01 |
| GOMF ACTIVIN BINDING | 9 | 5.71e-01 | -1.09e-01 | 8.34e-01 |
| GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS | 16 | 4.50e-01 | 1.09e-01 | 7.70e-01 |
| GOMF CYTIDYLYLTRANSFERASE ACTIVITY | 9 | 5.71e-01 | 1.09e-01 | 8.34e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX | 14 | 4.80e-01 | 1.09e-01 | 7.83e-01 |
| GOBP MRNA POLYADENYLATION | 23 | 3.66e-01 | 1.09e-01 | 7.11e-01 |
| GOBP CARDIOLIPIN METABOLIC PROCESS | 13 | 4.97e-01 | 1.09e-01 | 7.91e-01 |
| GOBP FERTILIZATION | 73 | 1.08e-01 | -1.09e-01 | 4.54e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE | 65 | 1.30e-01 | 1.09e-01 | 4.87e-01 |
| GOBP REGULATION OF MONOCYTE EXTRAVASATION | 5 | 6.73e-01 | -1.09e-01 | 8.88e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 26 | 3.37e-01 | 1.09e-01 | 6.91e-01 |
| GOCC SAGA COMPLEX | 23 | 3.67e-01 | 1.09e-01 | 7.11e-01 |
| GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX | 43 | 2.18e-01 | -1.09e-01 | 5.94e-01 |
| GOMF CXCR CHEMOKINE RECEPTOR BINDING | 6 | 6.45e-01 | -1.09e-01 | 8.75e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE | 10 | 5.52e-01 | 1.09e-01 | 8.24e-01 |
| GOCC MHC CLASS II PROTEIN COMPLEX | 15 | 4.66e-01 | 1.09e-01 | 7.78e-01 |
| GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM | 10 | 5.52e-01 | -1.09e-01 | 8.24e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 60 | 1.46e-01 | 1.09e-01 | 5.07e-01 |
| GOMF PROTEIN BINDING INVOLVED IN HETEROTYPIC CELL CELL ADHESION | 5 | 6.74e-01 | -1.09e-01 | 8.89e-01 |
| GOMF NUCLEAR RECEPTOR BINDING | 116 | 4.38e-02 | -1.09e-01 | 3.09e-01 |
| GOMF ALDEHYDE LYASE ACTIVITY | 5 | 6.74e-01 | 1.09e-01 | 8.89e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION | 9 | 5.73e-01 | 1.09e-01 | 8.35e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR | 112 | 4.78e-02 | 1.08e-01 | 3.18e-01 |
| GOBP REGULATION OF SPROUTING ANGIOGENESIS | 19 | 4.13e-01 | -1.08e-01 | 7.49e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 15 | 4.67e-01 | -1.08e-01 | 7.78e-01 |
| GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 9 | 5.73e-01 | 1.08e-01 | 8.35e-01 |
| GOBP DETECTION OF STIMULUS | 87 | 8.10e-02 | 1.08e-01 | 4.08e-01 |
| GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 18 | 4.26e-01 | -1.08e-01 | 7.56e-01 |
| GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS | 31 | 2.97e-01 | -1.08e-01 | 6.63e-01 |
| GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT | 11 | 5.34e-01 | -1.08e-01 | 8.15e-01 |
| GOCC MEMBRANE MICRODOMAIN | 165 | 1.67e-02 | -1.08e-01 | 2.03e-01 |
| GOBP REGULATION OF AUTOPHAGY | 289 | 1.63e-03 | -1.08e-01 | 6.18e-02 |
| GOBP T CELL MEDIATED CYTOTOXICITY | 42 | 2.25e-01 | 1.08e-01 | 6.00e-01 |
| GOBP MEIOTIC TELOMERE CLUSTERING | 6 | 6.46e-01 | 1.08e-01 | 8.75e-01 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION | 21 | 3.91e-01 | -1.08e-01 | 7.29e-01 |
| GOCC INTERCELLULAR BRIDGE | 52 | 1.78e-01 | -1.08e-01 | 5.46e-01 |
| GOBP REGULATION OF P38MAPK CASCADE | 32 | 2.90e-01 | -1.08e-01 | 6.59e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY | 41 | 2.32e-01 | -1.08e-01 | 6.09e-01 |
| GOMF SIGNALING RECEPTOR BINDING | 637 | 4.24e-06 | -1.08e-01 | 1.50e-03 |
| GOBP BILE ACID METABOLIC PROCESS | 24 | 3.60e-01 | 1.08e-01 | 7.10e-01 |
| GOBP RESPONSE TO OXYGEN RADICAL | 15 | 4.69e-01 | 1.08e-01 | 7.78e-01 |
| GOBP MAINTENANCE OF CENTROSOME LOCATION | 5 | 6.76e-01 | 1.08e-01 | 8.90e-01 |
| GOBP FATTY ACID ELONGATION | 8 | 5.97e-01 | 1.08e-01 | 8.49e-01 |
| GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE | 16 | 4.55e-01 | -1.08e-01 | 7.72e-01 |
| GOBP RESPONSE TO INCREASED OXYGEN LEVELS | 19 | 4.16e-01 | -1.08e-01 | 7.51e-01 |
| GOBP EXPORT FROM CELL | 483 | 5.76e-05 | -1.08e-01 | 7.79e-03 |
| GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS | 6 | 6.48e-01 | 1.08e-01 | 8.76e-01 |
| GOBP RAC PROTEIN SIGNAL TRANSDUCTION | 32 | 2.92e-01 | -1.08e-01 | 6.60e-01 |
| GOBP SPHINGOID METABOLIC PROCESS | 13 | 5.01e-01 | 1.08e-01 | 7.92e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION | 5 | 6.77e-01 | 1.08e-01 | 8.90e-01 |
| GOMF DAMAGED DNA BINDING | 60 | 1.50e-01 | 1.08e-01 | 5.12e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL | 32 | 2.92e-01 | 1.08e-01 | 6.61e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION | 12 | 5.19e-01 | -1.08e-01 | 8.05e-01 |
| GOBP HYALURONAN METABOLIC PROCESS | 18 | 4.30e-01 | -1.08e-01 | 7.58e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON RNA | 332 | 8.13e-04 | 1.08e-01 | 4.05e-02 |
| GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION | 27 | 3.34e-01 | -1.08e-01 | 6.88e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 16 | 4.57e-01 | 1.07e-01 | 7.74e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS | 34 | 2.78e-01 | -1.07e-01 | 6.53e-01 |
| GOBP RESPONSE TO INTERLEUKIN 2 | 8 | 5.99e-01 | -1.07e-01 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 55 | 1.69e-01 | -1.07e-01 | 5.34e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION | 300 | 1.46e-03 | -1.07e-01 | 5.91e-02 |
| GOBP CELL MIGRATION IN HINDBRAIN | 8 | 5.99e-01 | -1.07e-01 | 8.51e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS | 18 | 4.31e-01 | -1.07e-01 | 7.58e-01 |
| GOBP LEUKOCYTE CELL CELL ADHESION | 283 | 2.00e-03 | -1.07e-01 | 6.78e-02 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 24 | 3.63e-01 | 1.07e-01 | 7.10e-01 |
| GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY | 56 | 1.65e-01 | -1.07e-01 | 5.32e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 5 | 6.78e-01 | -1.07e-01 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS | 5 | 6.78e-01 | 1.07e-01 | 8.91e-01 |
| GOBP REGULATION OF MITOTIC CYTOKINESIS | 5 | 6.78e-01 | 1.07e-01 | 8.91e-01 |
| GOMF GALACTOSYLTRANSFERASE ACTIVITY | 17 | 4.44e-01 | -1.07e-01 | 7.67e-01 |
| GOBP REGULATION OF LIPID KINASE ACTIVITY | 24 | 3.64e-01 | -1.07e-01 | 7.10e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 5 | 6.78e-01 | -1.07e-01 | 8.91e-01 |
| GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 11 | 5.38e-01 | -1.07e-01 | 8.16e-01 |
| GOBP PLATELET DEGRANULATION | 6 | 6.50e-01 | -1.07e-01 | 8.76e-01 |
| GOBP LACTATE METABOLIC PROCESS | 12 | 5.21e-01 | -1.07e-01 | 8.05e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY | 229 | 5.41e-03 | -1.07e-01 | 1.23e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 43 | 2.25e-01 | -1.07e-01 | 6.00e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY | 16 | 4.59e-01 | 1.07e-01 | 7.75e-01 |
| GOBP QUINONE METABOLIC PROCESS | 25 | 3.55e-01 | 1.07e-01 | 7.05e-01 |
| GOBP LAMELLIPODIUM ORGANIZATION | 61 | 1.49e-01 | -1.07e-01 | 5.11e-01 |
| GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY | 9 | 5.79e-01 | 1.07e-01 | 8.38e-01 |
| GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT | 59 | 1.56e-01 | -1.07e-01 | 5.22e-01 |
| GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY | 14 | 4.89e-01 | -1.07e-01 | 7.87e-01 |
| GOBP NATURAL KILLER CELL DIFFERENTIATION | 18 | 4.33e-01 | 1.07e-01 | 7.60e-01 |
| GOBP REGULATION OF LIPID CATABOLIC PROCESS | 33 | 2.88e-01 | 1.07e-01 | 6.58e-01 |
| GOBP REGULATION OF ORGANIC ACID TRANSPORT | 41 | 2.37e-01 | 1.07e-01 | 6.14e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 72 | 1.18e-01 | 1.07e-01 | 4.67e-01 |
| GOMF CALCIUM CHANNEL REGULATOR ACTIVITY | 19 | 4.20e-01 | 1.07e-01 | 7.54e-01 |
| GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 17 | 4.46e-01 | 1.07e-01 | 7.67e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH | 542 | 2.57e-05 | -1.07e-01 | 4.62e-03 |
| GOBP NEUTROPHIL CLEARANCE | 6 | 6.51e-01 | -1.07e-01 | 8.77e-01 |
| GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND | 10 | 5.59e-01 | 1.07e-01 | 8.29e-01 |
| GOCC TETRASPANIN ENRICHED MICRODOMAIN | 8 | 6.01e-01 | -1.07e-01 | 8.52e-01 |
| GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS | 34 | 2.82e-01 | -1.07e-01 | 6.55e-01 |
| GOBP SINGLE FERTILIZATION | 53 | 1.80e-01 | -1.07e-01 | 5.48e-01 |
| GOBP REGULATION OF CELL CELL ADHESION | 315 | 1.21e-03 | -1.07e-01 | 5.17e-02 |
| GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 15 | 4.75e-01 | -1.07e-01 | 7.80e-01 |
| GOBP RESPONSE TO LIPID | 525 | 3.51e-05 | -1.07e-01 | 5.60e-03 |
| GOBP TYPE II INTERFERON PRODUCTION | 77 | 1.07e-01 | -1.07e-01 | 4.52e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 34 | 2.83e-01 | -1.06e-01 | 6.55e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 16 | 4.61e-01 | 1.06e-01 | 7.76e-01 |
| GOBP CORONARY ARTERY MORPHOGENESIS | 6 | 6.52e-01 | -1.06e-01 | 8.77e-01 |
| GOBP EMBRYONIC HINDLIMB MORPHOGENESIS | 7 | 6.26e-01 | -1.06e-01 | 8.64e-01 |
| GOBP GROWTH | 506 | 4.89e-05 | -1.06e-01 | 7.21e-03 |
| GOCC AUTOPHAGOSOME | 98 | 6.92e-02 | -1.06e-01 | 3.80e-01 |
| GOCC DYNEIN AXONEMAL PARTICLE | 11 | 5.41e-01 | 1.06e-01 | 8.18e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS | 470 | 8.95e-05 | -1.06e-01 | 1.02e-02 |
| GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN | 8 | 6.03e-01 | -1.06e-01 | 8.52e-01 |
| GOMF MANNOSIDASE ACTIVITY | 14 | 4.91e-01 | 1.06e-01 | 7.88e-01 |
| GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR | 7 | 6.26e-01 | -1.06e-01 | 8.65e-01 |
| GOBP REGULATION OF BINDING | 178 | 1.48e-02 | -1.06e-01 | 1.95e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 9 | 5.81e-01 | 1.06e-01 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION | 11 | 5.42e-01 | 1.06e-01 | 8.19e-01 |
| GOMF FATTY ACID DERIVATIVE BINDING | 12 | 5.24e-01 | 1.06e-01 | 8.08e-01 |
| GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT | 10 | 5.61e-01 | -1.06e-01 | 8.29e-01 |
| GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS | 11 | 5.42e-01 | 1.06e-01 | 8.19e-01 |
| GOBP NEGATIVE REGULATION OF ERAD PATHWAY | 6 | 6.53e-01 | 1.06e-01 | 8.78e-01 |
| GOBP DNA STRAND ELONGATION | 34 | 2.85e-01 | 1.06e-01 | 6.55e-01 |
| GOBP PEPTIDE TRANSPORT | 129 | 3.80e-02 | -1.06e-01 | 2.93e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 9 | 5.82e-01 | -1.06e-01 | 8.40e-01 |
| GOBP PROTEIN RNA COMPLEX ORGANIZATION | 191 | 1.19e-02 | -1.06e-01 | 1.77e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 19 | 4.25e-01 | 1.06e-01 | 7.56e-01 |
| GOBP PROTEIN TRANSMEMBRANE TRANSPORT | 57 | 1.68e-01 | -1.06e-01 | 5.34e-01 |
| GOMF MICROTUBULE BINDING | 177 | 1.56e-02 | -1.06e-01 | 1.98e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 30 | 3.17e-01 | -1.06e-01 | 6.79e-01 |
| GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 27 | 3.43e-01 | -1.06e-01 | 6.95e-01 |
| GOBP POSITIVE REGULATION OF OSSIFICATION | 28 | 3.34e-01 | -1.05e-01 | 6.88e-01 |
| GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS | 9 | 5.84e-01 | -1.05e-01 | 8.41e-01 |
| GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY | 5 | 6.83e-01 | 1.05e-01 | 8.95e-01 |
| GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS | 9 | 5.84e-01 | 1.05e-01 | 8.41e-01 |
| GOBP XENOBIOTIC EXPORT FROM CELL | 5 | 6.83e-01 | -1.05e-01 | 8.95e-01 |
| GOBP AROMATIC AMINO ACID METABOLIC PROCESS | 16 | 4.66e-01 | 1.05e-01 | 7.78e-01 |
| GOBP CARDIAC MUSCLE CELL PROLIFERATION | 22 | 3.93e-01 | -1.05e-01 | 7.31e-01 |
| GOBP 3 UTR MEDIATED MRNA STABILIZATION | 17 | 4.53e-01 | -1.05e-01 | 7.71e-01 |
| GOBP COENZYME A BIOSYNTHETIC PROCESS | 11 | 5.46e-01 | 1.05e-01 | 8.22e-01 |
| GOBP CELLULAR RESPONSE TO GAMMA RADIATION | 22 | 3.93e-01 | 1.05e-01 | 7.31e-01 |
| GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 20 | 4.15e-01 | -1.05e-01 | 7.51e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 17 | 4.53e-01 | 1.05e-01 | 7.71e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 7 | 6.30e-01 | 1.05e-01 | 8.67e-01 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 9 | 5.85e-01 | -1.05e-01 | 8.42e-01 |
| GOCC FILOPODIUM TIP | 13 | 5.12e-01 | -1.05e-01 | 8.00e-01 |
| GOMF HISTONE BINDING | 204 | 9.98e-03 | 1.05e-01 | 1.66e-01 |
| GOCC COPI COATED VESICLE MEMBRANE | 16 | 4.67e-01 | 1.05e-01 | 7.78e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION | 14 | 4.97e-01 | -1.05e-01 | 7.91e-01 |
| GOBP TERTIARY ALCOHOL METABOLIC PROCESS | 7 | 6.31e-01 | 1.05e-01 | 8.67e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER SECRETION | 45 | 2.24e-01 | -1.05e-01 | 5.99e-01 |
| GOBP REGULATION OF NCRNA TRANSCRIPTION | 61 | 1.57e-01 | -1.05e-01 | 5.23e-01 |
| GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT | 23 | 3.84e-01 | 1.05e-01 | 7.24e-01 |
| GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE | 116 | 5.15e-02 | -1.05e-01 | 3.29e-01 |
| GOBP CHROMOSOME SEPARATION | 51 | 1.96e-01 | 1.05e-01 | 5.68e-01 |
| GOBP RECEPTOR CATABOLIC PROCESS | 24 | 3.74e-01 | -1.05e-01 | 7.16e-01 |
| GOBP HOMOTYPIC CELL CELL ADHESION | 58 | 1.68e-01 | -1.05e-01 | 5.34e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY | 71 | 1.27e-01 | -1.05e-01 | 4.84e-01 |
| GOBP VALINE METABOLIC PROCESS | 7 | 6.31e-01 | 1.05e-01 | 8.67e-01 |
| GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS | 9 | 5.87e-01 | 1.05e-01 | 8.42e-01 |
| GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 15 | 4.83e-01 | 1.05e-01 | 7.84e-01 |
| GOBP MESENCHYMAL CELL DIFFERENTIATION | 114 | 5.41e-02 | -1.05e-01 | 3.39e-01 |
| GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 67 | 1.39e-01 | -1.05e-01 | 4.98e-01 |
| GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 121 | 4.74e-02 | -1.05e-01 | 3.17e-01 |
| GOBP CHROMATIN LOOPING | 11 | 5.48e-01 | 1.05e-01 | 8.23e-01 |
| GOCC CAVEOLA | 41 | 2.47e-01 | 1.05e-01 | 6.23e-01 |
| GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 25 | 3.66e-01 | -1.05e-01 | 7.11e-01 |
| GOCC OUTER MEMBRANE | 194 | 1.24e-02 | -1.04e-01 | 1.81e-01 |
| GOCC NEURON PROJECTION CYTOPLASM | 60 | 1.62e-01 | -1.04e-01 | 5.28e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 18 | 4.43e-01 | 1.04e-01 | 7.66e-01 |
| GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION | 8 | 6.09e-01 | 1.04e-01 | 8.56e-01 |
| GOBP REGULATION OF LIPID TRANSPORT | 71 | 1.29e-01 | -1.04e-01 | 4.85e-01 |
| GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS | 9 | 5.88e-01 | -1.04e-01 | 8.43e-01 |
| GOMF BIOTIN BINDING | 5 | 6.86e-01 | 1.04e-01 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY | 12 | 5.32e-01 | -1.04e-01 | 8.13e-01 |
| GOMF CARBOHYDRATE KINASE ACTIVITY | 17 | 4.57e-01 | -1.04e-01 | 7.74e-01 |
| GOMF CARBOHYDRATE BINDING | 149 | 2.85e-02 | 1.04e-01 | 2.60e-01 |
| GOMF DOLICHYL DIPHOSPHOOLIGOSACCHARIDE PROTEIN GLYCOTRANSFERASE ACTIVITY | 5 | 6.87e-01 | -1.04e-01 | 8.96e-01 |
| GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS | 8 | 6.10e-01 | -1.04e-01 | 8.56e-01 |
| GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY | 44 | 2.33e-01 | 1.04e-01 | 6.10e-01 |
| GOBP LACTATION | 25 | 3.68e-01 | -1.04e-01 | 7.13e-01 |
| GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY | 8 | 6.11e-01 | -1.04e-01 | 8.57e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 94 | 8.22e-02 | 1.04e-01 | 4.09e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS | 229 | 6.99e-03 | -1.04e-01 | 1.43e-01 |
| GOBP RESPONSE TO MECHANICAL STIMULUS | 116 | 5.38e-02 | -1.04e-01 | 3.39e-01 |
| GOBP REGULATION OF RNA SPLICING | 150 | 2.86e-02 | -1.04e-01 | 2.60e-01 |
| GOBP ARGININE CATABOLIC PROCESS | 6 | 6.60e-01 | 1.04e-01 | 8.82e-01 |
| GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION | 20 | 4.22e-01 | -1.04e-01 | 7.54e-01 |
| GOBP CELLULAR METABOLIC COMPOUND SALVAGE | 26 | 3.60e-01 | 1.04e-01 | 7.10e-01 |
| GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY | 15 | 4.87e-01 | -1.04e-01 | 7.85e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION | 123 | 4.74e-02 | -1.04e-01 | 3.17e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 35 | 2.89e-01 | -1.04e-01 | 6.58e-01 |
| GOCC NBAF COMPLEX | 13 | 5.18e-01 | 1.04e-01 | 8.04e-01 |
| GOBP MEIOTIC CYTOKINESIS | 5 | 6.88e-01 | 1.04e-01 | 8.97e-01 |
| GOBP NEURON FATE COMMITMENT | 14 | 5.02e-01 | -1.04e-01 | 7.94e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 65 | 1.49e-01 | -1.04e-01 | 5.12e-01 |
| GOCC VESICLE MEMBRANE | 829 | 6.10e-07 | -1.04e-01 | 3.31e-04 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 11 | 5.52e-01 | 1.04e-01 | 8.24e-01 |
| GOMF METAL CLUSTER BINDING | 62 | 1.59e-01 | 1.03e-01 | 5.25e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 20 | 4.23e-01 | 1.03e-01 | 7.55e-01 |
| GOCC GLUTAMATERGIC SYNAPSE | 215 | 9.21e-03 | -1.03e-01 | 1.59e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS | 99 | 7.60e-02 | 1.03e-01 | 3.96e-01 |
| GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 59 | 1.70e-01 | -1.03e-01 | 5.36e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 71 | 1.33e-01 | -1.03e-01 | 4.90e-01 |
| GOBP MACROMOLECULE DEPALMITOYLATION | 10 | 5.72e-01 | -1.03e-01 | 8.34e-01 |
| GOMF PALMITOYL HYDROLASE ACTIVITY | 10 | 5.72e-01 | -1.03e-01 | 8.34e-01 |
| GOBP RESPONSE TO INTERLEUKIN 7 | 14 | 5.03e-01 | -1.03e-01 | 7.94e-01 |
| GOBP GLYCEROLIPID CATABOLIC PROCESS | 35 | 2.90e-01 | -1.03e-01 | 6.60e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.89e-01 | 1.03e-01 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MATURATION | 14 | 5.04e-01 | -1.03e-01 | 7.95e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 20 | 4.25e-01 | -1.03e-01 | 7.56e-01 |
| GOBP REGULATION OF GERM CELL PROLIFERATION | 6 | 6.62e-01 | -1.03e-01 | 8.83e-01 |
| GOBP POLYAMINE TRANSPORT | 7 | 6.37e-01 | 1.03e-01 | 8.70e-01 |
| GOBP PROTEIN K6 LINKED UBIQUITINATION | 9 | 5.92e-01 | -1.03e-01 | 8.46e-01 |
| GOBP DE NOVO PROTEIN FOLDING | 36 | 2.85e-01 | -1.03e-01 | 6.56e-01 |
| GOBP ANTEROGRADE DENDRITIC TRANSPORT | 6 | 6.62e-01 | 1.03e-01 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF LIPASE ACTIVITY | 31 | 3.21e-01 | -1.03e-01 | 6.81e-01 |
| GOBP INTERFERON BETA PRODUCTION | 52 | 1.99e-01 | -1.03e-01 | 5.74e-01 |
| GOBP T CELL MEDIATED IMMUNITY | 91 | 9.02e-02 | -1.03e-01 | 4.24e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 197 | 1.31e-02 | -1.03e-01 | 1.86e-01 |
| GOCC EXON EXON JUNCTION COMPLEX | 11 | 5.55e-01 | 1.03e-01 | 8.25e-01 |
| GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY | 8 | 6.14e-01 | -1.03e-01 | 8.59e-01 |
| GOMF SPECTRIN BINDING | 14 | 5.05e-01 | -1.03e-01 | 7.96e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION | 5 | 6.91e-01 | 1.03e-01 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT | 93 | 8.73e-02 | 1.03e-01 | 4.18e-01 |
| GOBP DEVELOPMENTAL GROWTH | 339 | 1.24e-03 | -1.03e-01 | 5.23e-02 |
| GOBP ENDOCYTIC RECYCLING | 67 | 1.46e-01 | -1.03e-01 | 5.07e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 5 | 6.91e-01 | 1.03e-01 | 8.97e-01 |
| GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 7 | 6.38e-01 | 1.03e-01 | 8.71e-01 |
| GOBP REGULATION OF CELL ADHESION | 470 | 1.59e-04 | -1.03e-01 | 1.56e-02 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 5 | 6.91e-01 | -1.03e-01 | 8.97e-01 |
| GOBP SYNAPTIC VESICLE LOCALIZATION | 35 | 2.94e-01 | -1.03e-01 | 6.62e-01 |
| GOBP OLEFINIC COMPOUND METABOLIC PROCESS | 67 | 1.47e-01 | -1.02e-01 | 5.09e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 67 | 1.47e-01 | 1.02e-01 | 5.09e-01 |
| GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 6 | 6.64e-01 | -1.02e-01 | 8.84e-01 |
| GOBP VIRAL TRANSLATION | 20 | 4.28e-01 | -1.02e-01 | 7.58e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 49 | 2.15e-01 | -1.02e-01 | 5.92e-01 |
| GOBP CYTOSOLIC RIBOSOME ASSEMBLY | 5 | 6.92e-01 | -1.02e-01 | 8.97e-01 |
| GOCC T TUBULE | 22 | 4.06e-01 | 1.02e-01 | 7.43e-01 |
| GOCC NUCLEAR PORE | 85 | 1.04e-01 | 1.02e-01 | 4.49e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS | 38 | 2.76e-01 | -1.02e-01 | 6.52e-01 |
| GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 6 | 6.65e-01 | -1.02e-01 | 8.85e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINESIS | 24 | 3.86e-01 | 1.02e-01 | 7.25e-01 |
| GOBP ORGAN GROWTH | 82 | 1.10e-01 | -1.02e-01 | 4.56e-01 |
| GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 7 | 6.40e-01 | -1.02e-01 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS | 9 | 5.96e-01 | -1.02e-01 | 8.48e-01 |
| GOBP G QUADRUPLEX DNA UNWINDING | 7 | 6.40e-01 | 1.02e-01 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS | 12 | 5.40e-01 | 1.02e-01 | 8.18e-01 |
| GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 31 | 3.26e-01 | -1.02e-01 | 6.83e-01 |
| GOBP VITAMIN METABOLIC PROCESS | 60 | 1.72e-01 | 1.02e-01 | 5.37e-01 |
| GOCC SPECIFIC GRANULE LUMEN | 42 | 2.53e-01 | -1.02e-01 | 6.30e-01 |
| GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS | 13 | 5.25e-01 | -1.02e-01 | 8.08e-01 |
| GOBP REGULATION OF ORGAN GROWTH | 44 | 2.42e-01 | -1.02e-01 | 6.21e-01 |
| GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS | 10 | 5.77e-01 | 1.02e-01 | 8.38e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION | 6 | 6.66e-01 | 1.02e-01 | 8.85e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 4.19e-01 | 1.02e-01 | 7.53e-01 |
| GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY | 6 | 6.66e-01 | -1.02e-01 | 8.85e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN | 8 | 6.18e-01 | -1.02e-01 | 8.62e-01 |
| GOBP COPI COATED VESICLE BUDDING | 6 | 6.66e-01 | 1.02e-01 | 8.85e-01 |
| GOBP CARDIAC CHAMBER MORPHOGENESIS | 49 | 2.18e-01 | -1.02e-01 | 5.95e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING | 33 | 3.12e-01 | -1.02e-01 | 6.75e-01 |
| GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 18 | 4.55e-01 | -1.02e-01 | 7.72e-01 |
| GOBP MALE GENITALIA DEVELOPMENT | 7 | 6.41e-01 | 1.02e-01 | 8.73e-01 |
| GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 22 | 4.09e-01 | -1.02e-01 | 7.45e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 48 | 2.24e-01 | -1.02e-01 | 5.99e-01 |
| GOBP MIRNA PROCESSING | 39 | 2.73e-01 | -1.02e-01 | 6.50e-01 |
| GOBP RESPONSE TO NITROSATIVE STRESS | 9 | 5.98e-01 | 1.02e-01 | 8.50e-01 |
| GOBP CELL DIFFERENTIATION IN SPINAL CORD | 12 | 5.42e-01 | 1.02e-01 | 8.19e-01 |
| GOCC ACTIVIN RECEPTOR COMPLEX | 5 | 6.94e-01 | 1.02e-01 | 8.98e-01 |
| GOBP ENDOPLASMIC RETICULUM LOCALIZATION | 6 | 6.67e-01 | 1.02e-01 | 8.86e-01 |
| GOBP CORONARY VASCULATURE MORPHOGENESIS | 9 | 5.98e-01 | -1.02e-01 | 8.50e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 32 | 3.21e-01 | -1.01e-01 | 6.80e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION | 89 | 9.86e-02 | -1.01e-01 | 4.38e-01 |
| GOMF GTPASE ACTIVITY | 226 | 8.86e-03 | -1.01e-01 | 1.55e-01 |
| GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY | 5 | 6.95e-01 | 1.01e-01 | 8.98e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING | 1027 | 7.47e-08 | -1.01e-01 | 9.39e-05 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION | 45 | 2.41e-01 | -1.01e-01 | 6.19e-01 |
| GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 17 | 4.71e-01 | -1.01e-01 | 7.79e-01 |
| GOBP SYNAPTIC VESICLE MATURATION | 20 | 4.34e-01 | -1.01e-01 | 7.61e-01 |
| GOMF CHOLESTEROL BINDING | 32 | 3.23e-01 | -1.01e-01 | 6.81e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY | 239 | 7.41e-03 | -1.01e-01 | 1.46e-01 |
| GOBP ENDOCYTOSIS | 473 | 1.91e-04 | -1.01e-01 | 1.78e-02 |
| GOBP SEMINIFEROUS TUBULE DEVELOPMENT | 12 | 5.45e-01 | -1.01e-01 | 8.21e-01 |
| GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY | 15 | 4.99e-01 | 1.01e-01 | 7.92e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 7 | 6.44e-01 | 1.01e-01 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY | 18 | 4.59e-01 | 1.01e-01 | 7.75e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 19 | 4.47e-01 | -1.01e-01 | 7.68e-01 |
| GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS | 24 | 3.93e-01 | 1.01e-01 | 7.31e-01 |
| GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 9 | 6.01e-01 | -1.01e-01 | 8.51e-01 |
| GOBP ETHER METABOLIC PROCESS | 20 | 4.35e-01 | 1.01e-01 | 7.61e-01 |
| GOMF SIALIC ACID BINDING | 11 | 5.63e-01 | 1.01e-01 | 8.31e-01 |
| GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING | 17 | 4.72e-01 | -1.01e-01 | 7.79e-01 |
| GOBP EXOCRINE SYSTEM DEVELOPMENT | 13 | 5.30e-01 | -1.01e-01 | 8.11e-01 |
| GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 93 | 9.38e-02 | -1.01e-01 | 4.27e-01 |
| GOMF SH3 DOMAIN BINDING | 81 | 1.18e-01 | -1.01e-01 | 4.67e-01 |
| GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 39 | 2.77e-01 | -1.01e-01 | 6.53e-01 |
| GOCC CLEAVAGE FURROW | 42 | 2.59e-01 | -1.01e-01 | 6.36e-01 |
| GOBP CIRCULATORY SYSTEM DEVELOPMENT | 548 | 6.65e-05 | -1.01e-01 | 8.57e-03 |
| GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 119 | 5.85e-02 | -1.01e-01 | 3.53e-01 |
| GOBP SENSORY SYSTEM DEVELOPMENT | 166 | 2.58e-02 | -1.01e-01 | 2.48e-01 |
| GOBP DEVELOPMENTAL CELL GROWTH | 122 | 5.56e-02 | -1.01e-01 | 3.43e-01 |
| GOBP MESODERM MORPHOGENESIS | 27 | 3.66e-01 | -1.01e-01 | 7.11e-01 |
| GOCC ANCHORING JUNCTION | 535 | 8.16e-05 | -1.01e-01 | 9.75e-03 |
| GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 34 | 3.11e-01 | -1.01e-01 | 6.74e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 29 | 3.49e-01 | 1.00e-01 | 7.00e-01 |
| GOBP CARDIAC ATRIUM DEVELOPMENT | 14 | 5.15e-01 | -1.00e-01 | 8.02e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR | 30 | 3.41e-01 | 1.00e-01 | 6.94e-01 |
| GOCC CILIARY BASAL BODY | 111 | 6.81e-02 | 1.00e-01 | 3.76e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY | 9 | 6.02e-01 | 1.00e-01 | 8.52e-01 |
| GOMF PALMITOYLTRANSFERASE ACTIVITY | 26 | 3.76e-01 | -1.00e-01 | 7.17e-01 |
| GOBP BLASTODERM SEGMENTATION | 7 | 6.46e-01 | 1.00e-01 | 8.75e-01 |
| GOBP ALPHA BETA T CELL DIFFERENTIATION | 96 | 8.97e-02 | -1.00e-01 | 4.23e-01 |
| GOBP DICARBOXYLIC ACID METABOLIC PROCESS | 59 | 1.83e-01 | 1.00e-01 | 5.52e-01 |
| GOBP LABYRINTHINE LAYER DEVELOPMENT | 23 | 4.05e-01 | -1.00e-01 | 7.42e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 38 | 2.85e-01 | -1.00e-01 | 6.55e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE | 98 | 8.66e-02 | 1.00e-01 | 4.16e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 6 | 6.70e-01 | 1.00e-01 | 8.88e-01 |
| GOBP REGULATION OF DNA LIGATION | 6 | 6.70e-01 | 1.00e-01 | 8.88e-01 |
| GOBP GRANULOCYTE MIGRATION | 82 | 1.17e-01 | -1.00e-01 | 4.65e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE | 7 | 6.46e-01 | -1.00e-01 | 8.75e-01 |
| GOBP RESPONSE TO NUTRIENT | 80 | 1.22e-01 | -1.00e-01 | 4.75e-01 |
| GOBP DETECTION OF VISIBLE LIGHT | 14 | 5.16e-01 | 1.00e-01 | 8.03e-01 |
| GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION | 207 | 1.33e-02 | -1.00e-01 | 1.87e-01 |
| GOBP CELL CELL JUNCTION ORGANIZATION | 94 | 9.39e-02 | -1.00e-01 | 4.27e-01 |
| GOBP TRNA 5 END PROCESSING | 16 | 4.88e-01 | 1.00e-01 | 7.86e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION | 217 | 1.13e-02 | -1.00e-01 | 1.73e-01 |
| GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 121 | 5.78e-02 | -1.00e-01 | 3.50e-01 |
| GOBP REGULATION OF NEUTROPHIL EXTRAVASATION | 6 | 6.71e-01 | -1.00e-01 | 8.88e-01 |
| GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS | 9 | 6.03e-01 | 1.00e-01 | 8.52e-01 |
| GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 6 | 6.71e-01 | -1.00e-01 | 8.88e-01 |
| GOBP GLUTAMATERGIC NEURON DIFFERENTIATION | 5 | 6.99e-01 | -1.00e-01 | 9.01e-01 |
| GOBP PROTEIN HETEROTETRAMERIZATION | 11 | 5.66e-01 | 1.00e-01 | 8.33e-01 |
| GOBP MAMMARY GLAND DEVELOPMENT | 65 | 1.64e-01 | -1.00e-01 | 5.29e-01 |
| GOCC VACUOLAR MEMBRANE | 394 | 7.24e-04 | -9.99e-02 | 3.77e-02 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 6 | 6.72e-01 | -9.99e-02 | 8.88e-01 |
| GOCC EXCITATORY SYNAPSE | 18 | 4.63e-01 | -9.99e-02 | 7.77e-01 |
| GOBP COPPER ION HOMEOSTASIS | 16 | 4.90e-01 | -9.98e-02 | 7.88e-01 |
| GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 24 | 3.98e-01 | 9.98e-02 | 7.35e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 11 | 5.67e-01 | 9.98e-02 | 8.33e-01 |
| GOBP SNARE COMPLEX ASSEMBLY | 19 | 4.52e-01 | 9.97e-02 | 7.71e-01 |
| GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 1132 | 3.10e-08 | -9.97e-02 | 8.39e-05 |
| GOBP MICROTUBULE ANCHORING | 18 | 4.64e-01 | -9.96e-02 | 7.77e-01 |
| GOBP SECRETORY GRANULE LOCALIZATION | 7 | 6.48e-01 | -9.96e-02 | 8.76e-01 |
| GOCC ENDOSOME | 738 | 5.55e-06 | -9.96e-02 | 1.84e-03 |
| GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY | 7 | 6.48e-01 | 9.95e-02 | 8.76e-01 |
| GOMF TRIGLYCERIDE LIPASE ACTIVITY | 10 | 5.86e-01 | -9.95e-02 | 8.42e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 24 | 3.99e-01 | -9.94e-02 | 7.37e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 6 | 6.73e-01 | -9.94e-02 | 8.88e-01 |
| GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION | 28 | 3.63e-01 | -9.94e-02 | 7.10e-01 |
| GOBP RESPONSE TO BACTERIUM | 366 | 1.18e-03 | -9.94e-02 | 5.14e-02 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS | 30 | 3.47e-01 | -9.93e-02 | 6.98e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN | 11 | 5.69e-01 | -9.93e-02 | 8.34e-01 |
| GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 49 | 2.30e-01 | -9.92e-02 | 6.07e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 18 | 4.67e-01 | -9.91e-02 | 7.78e-01 |
| GOCC TERMINAL BOUTON | 17 | 4.79e-01 | 9.91e-02 | 7.83e-01 |
| GOBP MESONEPHROS DEVELOPMENT | 31 | 3.40e-01 | -9.91e-02 | 6.94e-01 |
| GOCC DESMOSOME | 11 | 5.70e-01 | 9.90e-02 | 8.34e-01 |
| GOBP FACULTATIVE HETEROCHROMATIN FORMATION | 34 | 3.18e-01 | 9.90e-02 | 6.80e-01 |
| GOCC CHROMOCENTER | 7 | 6.50e-01 | 9.90e-02 | 8.77e-01 |
| GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS | 13 | 5.37e-01 | 9.90e-02 | 8.16e-01 |
| GOCC EARLY ENDOSOME | 298 | 3.45e-03 | -9.90e-02 | 9.31e-02 |
| GOBP NON LYTIC VIRAL RELEASE | 13 | 5.37e-01 | 9.90e-02 | 8.16e-01 |
| GOBP TRIGLYCERIDE METABOLIC PROCESS | 54 | 2.09e-01 | -9.89e-02 | 5.83e-01 |
| GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 65 | 1.68e-01 | -9.89e-02 | 5.34e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE | 19 | 4.56e-01 | -9.89e-02 | 7.73e-01 |
| GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 7 | 6.51e-01 | -9.89e-02 | 8.77e-01 |
| GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.51e-01 | -9.89e-02 | 8.77e-01 |
| GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 7.02e-01 | -9.88e-02 | 9.01e-01 |
| GOCC TRANSCRIPTION FACTOR TFIID COMPLEX | 32 | 3.34e-01 | 9.88e-02 | 6.88e-01 |
| GOMF BUBBLE DNA BINDING | 6 | 6.76e-01 | 9.87e-02 | 8.90e-01 |
| GOBP STRIATED MUSCLE TISSUE DEVELOPMENT | 106 | 7.98e-02 | -9.87e-02 | 4.05e-01 |
| GOBP MATERNAL PLACENTA DEVELOPMENT | 20 | 4.45e-01 | -9.87e-02 | 7.67e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 7 | 6.52e-01 | -9.86e-02 | 8.77e-01 |
| GOBP INHIBITORY SYNAPSE ASSEMBLY | 5 | 7.03e-01 | -9.86e-02 | 9.01e-01 |
| GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS | 5 | 7.03e-01 | 9.86e-02 | 9.01e-01 |
| GOBP MEMBRANE INVAGINATION | 47 | 2.43e-01 | -9.86e-02 | 6.21e-01 |
| GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA | 11 | 5.72e-01 | -9.85e-02 | 8.34e-01 |
| GOBP REGULATION OF VESICLE MEDIATED TRANSPORT | 338 | 1.98e-03 | -9.85e-02 | 6.78e-02 |
| GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 55 | 2.07e-01 | 9.85e-02 | 5.82e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 57 | 1.99e-01 | -9.84e-02 | 5.74e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 63 | 1.77e-01 | -9.84e-02 | 5.45e-01 |
| GOBP REGULATION OF B CELL DIFFERENTIATION | 24 | 4.04e-01 | 9.84e-02 | 7.42e-01 |
| GOBP REGULATION OF PROTEIN LIPIDATION | 9 | 6.10e-01 | 9.83e-02 | 8.56e-01 |
| GOMF TRNA BINDING | 65 | 1.71e-01 | 9.83e-02 | 5.36e-01 |
| GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 14 | 5.24e-01 | 9.83e-02 | 8.08e-01 |
| GOMF HISTONE H4 DEMETHYLASE ACTIVITY | 5 | 7.04e-01 | 9.82e-02 | 9.02e-01 |
| GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY | 7 | 6.53e-01 | 9.82e-02 | 8.78e-01 |
| GOCC ESCRT COMPLEX | 25 | 3.96e-01 | -9.82e-02 | 7.34e-01 |
| GOMF GLYCOSYLTRANSFERASE ACTIVITY | 170 | 2.77e-02 | 9.82e-02 | 2.57e-01 |
| GOBP MELANOSOME ASSEMBLY | 18 | 4.71e-01 | 9.81e-02 | 7.79e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 90 | 1.08e-01 | -9.81e-02 | 4.54e-01 |
| GOCC FILOPODIUM MEMBRANE | 9 | 6.10e-01 | 9.81e-02 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 19 | 4.59e-01 | 9.81e-02 | 7.75e-01 |
| GOBP MYELOID CELL DIFFERENTIATION | 298 | 3.76e-03 | -9.81e-02 | 9.76e-02 |
| GOBP REGULATION OF TAU PROTEIN KINASE ACTIVITY | 7 | 6.54e-01 | -9.80e-02 | 8.78e-01 |
| GOBP 5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS | 5 | 7.05e-01 | 9.79e-02 | 9.02e-01 |
| GOBP MITOPHAGY | 33 | 3.31e-01 | -9.79e-02 | 6.87e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 15 | 5.12e-01 | 9.79e-02 | 8.00e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 8 | 6.32e-01 | -9.79e-02 | 8.67e-01 |
| GOBP CORPUS CALLOSUM DEVELOPMENT | 16 | 4.98e-01 | 9.78e-02 | 7.92e-01 |
| GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION | 5 | 7.05e-01 | 9.78e-02 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 64 | 1.76e-01 | -9.78e-02 | 5.43e-01 |
| GOBP SLEEP | 9 | 6.11e-01 | -9.78e-02 | 8.57e-01 |
| GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY | 5 | 7.05e-01 | 9.78e-02 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF MRNA 3 END PROCESSING | 6 | 6.78e-01 | 9.78e-02 | 8.91e-01 |
| GOMF TRANSLATION TERMINATION FACTOR ACTIVITY | 6 | 6.78e-01 | 9.78e-02 | 8.91e-01 |
| GOBP DNA REPAIR | 481 | 2.71e-04 | 9.78e-02 | 2.14e-02 |
| GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY | 9 | 6.12e-01 | 9.78e-02 | 8.57e-01 |
| GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 151 | 3.86e-02 | -9.78e-02 | 2.95e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 34 | 3.24e-01 | -9.78e-02 | 6.81e-01 |
| GOBP NEGATIVE REGULATION OF ORGAN GROWTH | 18 | 4.73e-01 | 9.78e-02 | 7.79e-01 |
| GOBP CELLULAR RESPONSE TO STARVATION | 138 | 4.80e-02 | -9.78e-02 | 3.19e-01 |
| GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 141 | 4.57e-02 | -9.77e-02 | 3.15e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT | 14 | 5.27e-01 | 9.77e-02 | 8.10e-01 |
| GOBP NEURONAL ACTION POTENTIAL | 9 | 6.12e-01 | -9.76e-02 | 8.58e-01 |
| GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY | 96 | 9.90e-02 | 9.76e-02 | 4.39e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 17 | 4.86e-01 | -9.76e-02 | 7.85e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 16 | 4.99e-01 | -9.76e-02 | 7.92e-01 |
| GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 6 | 6.79e-01 | -9.75e-02 | 8.91e-01 |
| GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY | 125 | 6.03e-02 | -9.75e-02 | 3.57e-01 |
| GOBP NEURAL PRECURSOR CELL PROLIFERATION | 79 | 1.35e-01 | -9.75e-02 | 4.94e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION | 12 | 5.59e-01 | -9.74e-02 | 8.29e-01 |
| GOBP PROTEIN CATABOLIC PROCESS | 772 | 5.67e-06 | -9.74e-02 | 1.84e-03 |
| GOBP RESPONSE TO EXTRACELLULAR STIMULUS | 331 | 2.48e-03 | -9.74e-02 | 7.73e-02 |
| GOCC CILIUM | 363 | 1.56e-03 | 9.73e-02 | 6.12e-02 |
| GOCC ANAPHASE PROMOTING COMPLEX | 17 | 4.87e-01 | -9.73e-02 | 7.86e-01 |
| GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT | 43 | 2.71e-01 | 9.72e-02 | 6.48e-01 |
| GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 11 | 5.77e-01 | 9.71e-02 | 8.38e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE | 7 | 6.57e-01 | -9.71e-02 | 8.79e-01 |
| GOBP NON CANONICAL WNT SIGNALING PATHWAY | 31 | 3.50e-01 | 9.71e-02 | 7.01e-01 |
| GOBP VACUOLAR TRANSPORT | 139 | 4.88e-02 | -9.70e-02 | 3.22e-01 |
| GOCC POSTSYNAPSE | 317 | 3.15e-03 | -9.70e-02 | 8.85e-02 |
| GOBP TORC2 SIGNALING | 15 | 5.16e-01 | 9.69e-02 | 8.03e-01 |
| GOBP VESICLE TETHERING TO GOLGI | 5 | 7.08e-01 | -9.68e-02 | 9.03e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS | 27 | 3.84e-01 | -9.67e-02 | 7.24e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS | 17 | 4.90e-01 | 9.67e-02 | 7.88e-01 |
| GOMF PROTEIN HETERODIMERIZATION ACTIVITY | 165 | 3.26e-02 | -9.67e-02 | 2.71e-01 |
| GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS | 436 | 5.95e-04 | -9.67e-02 | 3.36e-02 |
| GOBP CELL CELL SIGNALING BY WNT | 244 | 9.63e-03 | -9.67e-02 | 1.63e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 5 | 7.08e-01 | -9.66e-02 | 9.03e-01 |
| GOBP HUMORAL IMMUNE RESPONSE | 88 | 1.18e-01 | -9.66e-02 | 4.67e-01 |
| GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION | 49 | 2.43e-01 | -9.66e-02 | 6.21e-01 |
| GOCC VACUOLE | 646 | 3.50e-05 | -9.66e-02 | 5.60e-03 |
| GOBP STRIATED MUSCLE CELL DEVELOPMENT | 25 | 4.04e-01 | -9.65e-02 | 7.41e-01 |
| GOMF ARP2 3 COMPLEX BINDING | 11 | 5.79e-01 | -9.65e-02 | 8.39e-01 |
| GOBP TELOMERE MAINTENANCE | 138 | 5.09e-02 | 9.65e-02 | 3.28e-01 |
| GOBP METAPHASE CHROMOSOME ALIGNMENT | 74 | 1.52e-01 | 9.64e-02 | 5.15e-01 |
| GOBP NEGATIVE REGULATION OF BONE REMODELING | 8 | 6.37e-01 | 9.64e-02 | 8.70e-01 |
| GOBP LOCOMOTION | 663 | 2.89e-05 | -9.64e-02 | 4.80e-03 |
| GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 70 | 1.64e-01 | 9.64e-02 | 5.29e-01 |
| GOCC COMPACT MYELIN | 6 | 6.83e-01 | -9.64e-02 | 8.94e-01 |
| GOBP NAD METABOLIC PROCESS | 28 | 3.78e-01 | -9.63e-02 | 7.18e-01 |
| GOCC EXTRINSIC COMPONENT OF MEMBRANE | 127 | 6.15e-02 | -9.63e-02 | 3.60e-01 |
| GOBP POSITIVE REGULATION OF VIRAL PROCESS | 56 | 2.13e-01 | -9.62e-02 | 5.89e-01 |
| GOBP REGULATION OF AMYLOID FIBRIL FORMATION | 10 | 5.99e-01 | -9.61e-02 | 8.50e-01 |
| GOBP GOLGI RIBBON FORMATION | 9 | 6.18e-01 | -9.61e-02 | 8.62e-01 |
| GOBP PROTEIN DEACETYLATION | 48 | 2.50e-01 | 9.61e-02 | 6.26e-01 |
| GOBP MATURE B CELL DIFFERENTIATION | 26 | 3.96e-01 | -9.61e-02 | 7.35e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 773 | 7.43e-06 | -9.61e-02 | 2.08e-03 |
| GOCC COHESIN COMPLEX | 9 | 6.18e-01 | -9.61e-02 | 8.62e-01 |
| GOBP LEUKOCYTE MIGRATION | 223 | 1.39e-02 | -9.60e-02 | 1.91e-01 |
| GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.60e-01 | -9.60e-02 | 8.82e-01 |
| GOBP REGULATORY NCRNA MEDIATED GENE SILENCING | 110 | 8.27e-02 | -9.60e-02 | 4.09e-01 |
| GOBP TRANSPOSITION | 16 | 5.07e-01 | -9.59e-02 | 7.97e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION | 10 | 6.00e-01 | -9.58e-02 | 8.51e-01 |
| GOBP VIRAL PROTEIN PROCESSING | 30 | 3.64e-01 | 9.58e-02 | 7.11e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 62 | 1.93e-01 | 9.58e-02 | 5.65e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 20 | 4.59e-01 | -9.58e-02 | 7.75e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR | 10 | 6.00e-01 | 9.58e-02 | 8.51e-01 |
| GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 10 | 6.00e-01 | -9.57e-02 | 8.51e-01 |
| GOBP CELLULAR COMPONENT MAINTENANCE | 36 | 3.20e-01 | -9.57e-02 | 6.80e-01 |
| GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 28 | 3.81e-01 | -9.57e-02 | 7.21e-01 |
| GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX | 23 | 4.27e-01 | 9.57e-02 | 7.57e-01 |
| GOMF SMAD BINDING | 57 | 2.12e-01 | -9.57e-02 | 5.87e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 37 | 3.14e-01 | -9.57e-02 | 6.77e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 5 | 7.11e-01 | -9.57e-02 | 9.04e-01 |
| GOCC CHROMOSOMAL REGION | 306 | 4.21e-03 | 9.57e-02 | 1.03e-01 |
| GOBP PONS DEVELOPMENT | 6 | 6.85e-01 | -9.56e-02 | 8.95e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 9 | 6.19e-01 | 9.56e-02 | 8.62e-01 |
| GOBP ERBB SIGNALING PATHWAY | 76 | 1.50e-01 | -9.56e-02 | 5.13e-01 |
| GOBP POSITIVE REGULATION OF HORMONE SECRETION | 66 | 1.80e-01 | -9.56e-02 | 5.48e-01 |
| GOBP THIOESTER BIOSYNTHETIC PROCESS | 35 | 3.28e-01 | 9.56e-02 | 6.85e-01 |
| GOBP REGULATION OF MITOPHAGY | 12 | 5.67e-01 | -9.56e-02 | 8.33e-01 |
| GOBP RESPONSE TO MONOSACCHARIDE | 111 | 8.26e-02 | -9.56e-02 | 4.09e-01 |
| GOBP RESPONSE TO DEXAMETHASONE | 22 | 4.38e-01 | -9.55e-02 | 7.62e-01 |
| GOBP LEUKOCYTE DEGRANULATION | 64 | 1.87e-01 | -9.55e-02 | 5.56e-01 |
| GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 29 | 3.74e-01 | 9.55e-02 | 7.16e-01 |
| GOBP REGULATION OF BONE MINERALIZATION | 39 | 3.02e-01 | -9.55e-02 | 6.66e-01 |
| GOBP POSTSYNAPTIC DENSITY ASSEMBLY | 9 | 6.20e-01 | -9.55e-02 | 8.62e-01 |
| GOBP LYSOSOMAL TRANSPORT | 108 | 8.70e-02 | -9.55e-02 | 4.17e-01 |
| GOBP CONNECTIVE TISSUE DEVELOPMENT | 129 | 6.18e-02 | -9.55e-02 | 3.60e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 10 | 6.01e-01 | -9.54e-02 | 8.52e-01 |
| GOMF NUCLEOSOMAL DNA BINDING | 23 | 4.28e-01 | 9.54e-02 | 7.58e-01 |
| GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT | 14 | 5.37e-01 | 9.54e-02 | 8.16e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL PROCESS | 68 | 1.74e-01 | 9.54e-02 | 5.41e-01 |
| GOBP POSITIVE REGULATION OF HISTONE ACETYLATION | 9 | 6.20e-01 | 9.54e-02 | 8.62e-01 |
| GOBP VESICLE TETHERING | 32 | 3.51e-01 | 9.53e-02 | 7.01e-01 |
| GOCC LATE ENDOSOME MEMBRANE | 136 | 5.55e-02 | -9.53e-02 | 3.43e-01 |
| GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 9 | 6.21e-01 | -9.53e-02 | 8.62e-01 |
| GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX | 6 | 6.86e-01 | 9.53e-02 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 28 | 3.83e-01 | -9.53e-02 | 7.24e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 450 | 5.92e-04 | -9.53e-02 | 3.36e-02 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 13 | 5.52e-01 | -9.52e-02 | 8.24e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION | 138 | 5.42e-02 | -9.52e-02 | 3.39e-01 |
| GOMF ATP DEPENDENT PEPTIDASE ACTIVITY | 7 | 6.63e-01 | 9.52e-02 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 31 | 3.59e-01 | -9.52e-02 | 7.10e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION | 9 | 6.21e-01 | -9.52e-02 | 8.62e-01 |
| GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING | 27 | 3.93e-01 | 9.51e-02 | 7.31e-01 |
| GOBP FATTY ACID CATABOLIC PROCESS | 77 | 1.50e-01 | 9.51e-02 | 5.12e-01 |
| GOBP DTMP METABOLIC PROCESS | 5 | 7.13e-01 | -9.51e-02 | 9.05e-01 |
| GOCC MYOFILAMENT | 10 | 6.03e-01 | -9.50e-02 | 8.52e-01 |
| GOBP CYTOSOLIC TRANSPORT | 155 | 4.18e-02 | -9.50e-02 | 3.03e-01 |
| GOBP CELLULAR RESPONSE TO RETINOIC ACID | 24 | 4.21e-01 | -9.50e-02 | 7.54e-01 |
| GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN | 6 | 6.87e-01 | -9.50e-02 | 8.96e-01 |
| GOCC CELL SURFACE | 413 | 1.02e-03 | -9.49e-02 | 4.80e-02 |
| GOMF MONOSACCHARIDE BINDING | 56 | 2.20e-01 | 9.49e-02 | 5.95e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 21 | 4.52e-01 | 9.49e-02 | 7.70e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE | 18 | 4.86e-01 | 9.49e-02 | 7.85e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 9 | 6.22e-01 | -9.49e-02 | 8.63e-01 |
| GOBP SULFUR AMINO ACID CATABOLIC PROCESS | 5 | 7.13e-01 | 9.49e-02 | 9.05e-01 |
| GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 37 | 3.19e-01 | -9.48e-02 | 6.80e-01 |
| GOBP REGULATION OF MAP KINASE ACTIVITY | 87 | 1.27e-01 | -9.48e-02 | 4.83e-01 |
| GOBP RESPONSE TO INTERLEUKIN 9 | 6 | 6.88e-01 | 9.47e-02 | 8.97e-01 |
| GOCC PRESYNAPTIC CYTOSOL | 12 | 5.70e-01 | 9.47e-02 | 8.34e-01 |
| GOBP REGULATION OF LEUKOCYTE PROLIFERATION | 174 | 3.18e-02 | -9.47e-02 | 2.69e-01 |
| GOBP PROTEIN TARGETING | 270 | 7.72e-03 | -9.47e-02 | 1.50e-01 |
| GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 126 | 6.73e-02 | -9.46e-02 | 3.74e-01 |
| GOBP REGULATION OF SYSTEM PROCESS | 226 | 1.47e-02 | -9.46e-02 | 1.95e-01 |
| GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION | 19 | 4.76e-01 | -9.46e-02 | 7.81e-01 |
| GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 135 | 5.85e-02 | -9.45e-02 | 3.53e-01 |
| GOBP GLYCOSYLATION | 150 | 4.64e-02 | 9.45e-02 | 3.15e-01 |
| GOMF CARGO ADAPTOR ACTIVITY | 16 | 5.13e-01 | 9.44e-02 | 8.01e-01 |
| GOMF HELICASE ACTIVITY | 130 | 6.37e-02 | 9.44e-02 | 3.64e-01 |
| GOBP SMAD PROTEIN SIGNAL TRANSDUCTION | 44 | 2.80e-01 | -9.41e-02 | 6.54e-01 |
| GOBP REGULATION OF PROTEIN DEPOLYMERIZATION | 53 | 2.36e-01 | -9.41e-02 | 6.14e-01 |
| GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX | 7 | 6.66e-01 | 9.41e-02 | 8.86e-01 |
| GOBP MAINTENANCE OF LENS TRANSPARENCY | 6 | 6.90e-01 | 9.40e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF TORC1 SIGNALING | 41 | 2.98e-01 | -9.40e-02 | 6.63e-01 |
| GOBP REGULATION OF PROGRAMMED CELL DEATH | 947 | 1.49e-06 | -9.40e-02 | 7.11e-04 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 12 | 5.73e-01 | -9.40e-02 | 8.35e-01 |
| GOMF TRANSCRIPTION COREPRESSOR ACTIVITY | 156 | 4.35e-02 | -9.39e-02 | 3.08e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 38 | 3.17e-01 | 9.39e-02 | 6.79e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 151 | 4.71e-02 | -9.39e-02 | 3.17e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 58 | 2.17e-01 | 9.39e-02 | 5.94e-01 |
| GOBP REGULATION OF ERBB SIGNALING PATHWAY | 46 | 2.71e-01 | -9.39e-02 | 6.49e-01 |
| GOBP INTERLEUKIN 12 PRODUCTION | 45 | 2.76e-01 | -9.39e-02 | 6.53e-01 |
| GOBP MAINTENANCE OF LOCATION | 224 | 1.59e-02 | -9.38e-02 | 1.98e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS | 7 | 6.67e-01 | 9.38e-02 | 8.86e-01 |
| GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY | 6 | 6.91e-01 | 9.38e-02 | 8.97e-01 |
| GOBP NEUROPEPTIDE SIGNALING PATHWAY | 14 | 5.44e-01 | -9.38e-02 | 8.20e-01 |
| GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE | 28 | 3.91e-01 | 9.37e-02 | 7.29e-01 |
| GOCC IKAPPAB KINASE COMPLEX | 5 | 7.17e-01 | -9.37e-02 | 9.06e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE | 16 | 5.17e-01 | 9.36e-02 | 8.04e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 37 | 3.25e-01 | 9.36e-02 | 6.82e-01 |
| GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY | 29 | 3.84e-01 | 9.35e-02 | 7.24e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 215 | 1.85e-02 | -9.35e-02 | 2.13e-01 |
| GOBP CELLULAR RESPONSE TO TYPE II INTERFERON | 76 | 1.59e-01 | -9.35e-02 | 5.25e-01 |
| GOMF O ACYLTRANSFERASE ACTIVITY | 37 | 3.25e-01 | 9.35e-02 | 6.82e-01 |
| GOBP REGULATION OF MACROPHAGE MIGRATION | 24 | 4.28e-01 | 9.35e-02 | 7.58e-01 |
| GOBP NEURON APOPTOTIC PROCESS | 158 | 4.32e-02 | -9.35e-02 | 3.08e-01 |
| GOCC CORNIFIED ENVELOPE | 13 | 5.60e-01 | 9.35e-02 | 8.29e-01 |
| GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING | 5 | 7.18e-01 | -9.34e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 19 | 4.82e-01 | -9.33e-02 | 7.84e-01 |
| GOBP ISOTYPE SWITCHING TO IGA ISOTYPES | 8 | 6.48e-01 | 9.32e-02 | 8.76e-01 |
| GOBP ORGANIC ACID CATABOLIC PROCESS | 162 | 4.13e-02 | 9.32e-02 | 3.02e-01 |
| GOCC APICAL DENDRITE | 9 | 6.29e-01 | 9.32e-02 | 8.66e-01 |
| GOBP PEPTIDYL CYSTEINE MODIFICATION | 30 | 3.78e-01 | -9.31e-02 | 7.18e-01 |
| GOBP REGULATION OF FAT CELL DIFFERENTIATION | 68 | 1.85e-01 | -9.31e-02 | 5.54e-01 |
| GOBP REGULATION OF PROTEIN STABILITY | 251 | 1.15e-02 | -9.31e-02 | 1.74e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY | 261 | 9.99e-03 | -9.31e-02 | 1.66e-01 |
| GOBP TEMPERATURE HOMEOSTASIS | 117 | 8.30e-02 | -9.30e-02 | 4.10e-01 |
| GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 29 | 3.86e-01 | -9.30e-02 | 7.25e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 70 | 1.79e-01 | -9.29e-02 | 5.48e-01 |
| GOBP EXTRACELLULAR MATRIX DISASSEMBLY | 23 | 4.41e-01 | -9.29e-02 | 7.64e-01 |
| GOBP CALCIUM ION IMPORT | 18 | 4.95e-01 | 9.29e-02 | 7.90e-01 |
| GOBP REGULATION OF DNA REPLICATION | 94 | 1.20e-01 | 9.29e-02 | 4.73e-01 |
| GOBP NUCLEOSIDE METABOLIC PROCESS | 37 | 3.29e-01 | 9.28e-02 | 6.86e-01 |
| GOBP DEFENSE RESPONSE | 1058 | 5.74e-07 | -9.28e-02 | 3.31e-04 |
| GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 131 | 6.72e-02 | -9.28e-02 | 3.74e-01 |
| GOBP ACTIN FILAMENT ORGANIZATION | 278 | 8.08e-03 | -9.28e-02 | 1.52e-01 |
| GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM | 20 | 4.73e-01 | 9.28e-02 | 7.79e-01 |
| GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION | 8 | 6.50e-01 | 9.27e-02 | 8.77e-01 |
| GOBP PROTEIN POLYUBIQUITINATION | 187 | 2.93e-02 | -9.27e-02 | 2.62e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS | 16 | 5.21e-01 | -9.27e-02 | 8.06e-01 |
| GOBP RESPONSE TO ISCHEMIA | 41 | 3.05e-01 | -9.27e-02 | 6.68e-01 |
| GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY | 31 | 3.72e-01 | 9.27e-02 | 7.15e-01 |
| GOMF PROLINE RICH REGION BINDING | 15 | 5.34e-01 | 9.27e-02 | 8.15e-01 |
| GOBP RESPONSE TO STARVATION | 160 | 4.37e-02 | -9.27e-02 | 3.09e-01 |
| GOBP REGULATION OF VACUOLE ORGANIZATION | 50 | 2.58e-01 | -9.26e-02 | 6.35e-01 |
| GOBP ACTIN MEDIATED CELL CONTRACTION | 41 | 3.06e-01 | 9.25e-02 | 6.69e-01 |
| GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 340 | 3.57e-03 | -9.25e-02 | 9.45e-02 |
| GOMF FERROUS IRON BINDING | 20 | 4.74e-01 | 9.25e-02 | 7.80e-01 |
| GOBP POSITIVE REGULATION OF AMINE TRANSPORT | 18 | 4.97e-01 | 9.25e-02 | 7.92e-01 |
| GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS | 83 | 1.46e-01 | -9.25e-02 | 5.07e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 10 | 6.13e-01 | -9.25e-02 | 8.58e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 7 | 6.72e-01 | 9.24e-02 | 8.88e-01 |
| GOBP CHORION DEVELOPMENT | 5 | 7.20e-01 | 9.24e-02 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS | 19 | 4.86e-01 | 9.24e-02 | 7.85e-01 |
| GOBP SNRNA TRANSPORT | 6 | 6.95e-01 | 9.24e-02 | 8.98e-01 |
| GOMF NUCLEAR ESTROGEN RECEPTOR BINDING | 33 | 3.59e-01 | -9.24e-02 | 7.10e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN BINDING | 46 | 2.79e-01 | -9.24e-02 | 6.53e-01 |
| GOBP APOPTOTIC SIGNALING PATHWAY | 439 | 1.01e-03 | -9.23e-02 | 4.77e-02 |
| GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS | 10 | 6.14e-01 | -9.23e-02 | 8.59e-01 |
| GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION | 169 | 3.92e-02 | -9.22e-02 | 2.97e-01 |
| GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 6.73e-01 | 9.22e-02 | 8.88e-01 |
| GOBP TAXIS | 234 | 1.56e-02 | -9.22e-02 | 1.98e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY | 15 | 5.37e-01 | -9.22e-02 | 8.16e-01 |
| GOBP CELL GROWTH | 287 | 7.63e-03 | -9.20e-02 | 1.49e-01 |
| GOBP BLEB ASSEMBLY | 9 | 6.33e-01 | 9.20e-02 | 8.68e-01 |
| GOCC PRECATALYTIC SPLICEOSOME | 52 | 2.52e-01 | -9.20e-02 | 6.28e-01 |
| GOBP PROGRAMMED NECROTIC CELL DEATH | 42 | 3.03e-01 | -9.19e-02 | 6.67e-01 |
| GOCC NUCLEAR CHROMOSOME | 168 | 4.04e-02 | 9.19e-02 | 3.00e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY | 41 | 3.09e-01 | -9.19e-02 | 6.71e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 8 | 6.53e-01 | 9.19e-02 | 8.78e-01 |
| GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION | 12 | 5.82e-01 | -9.18e-02 | 8.40e-01 |
| GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 83 | 1.49e-01 | -9.18e-02 | 5.10e-01 |
| GOMF MICROTUBULE MOTOR ACTIVITY | 33 | 3.62e-01 | -9.18e-02 | 7.10e-01 |
| GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION | 5 | 7.22e-01 | -9.18e-02 | 9.06e-01 |
| GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX | 9 | 6.34e-01 | 9.16e-02 | 8.69e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 8 | 6.54e-01 | -9.16e-02 | 8.78e-01 |
| GOBP REGULATION OF NEURON APOPTOTIC PROCESS | 124 | 7.88e-02 | -9.16e-02 | 4.02e-01 |
| GOBP MUSCLE CELL DIFFERENTIATION | 185 | 3.24e-02 | -9.15e-02 | 2.71e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 19 | 4.90e-01 | 9.15e-02 | 7.88e-01 |
| GOBP VITAMIN TRANSPORT | 23 | 4.48e-01 | 9.14e-02 | 7.68e-01 |
| GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR | 19 | 4.90e-01 | 9.14e-02 | 7.88e-01 |
| GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING | 5 | 7.23e-01 | 9.14e-02 | 9.07e-01 |
| GOBP RESPONSE TO PAIN | 11 | 6.00e-01 | -9.14e-02 | 8.51e-01 |
| GOBP MALE MEIOTIC NUCLEAR DIVISION | 21 | 4.69e-01 | 9.13e-02 | 7.78e-01 |
| GOBP MESENCHYME DEVELOPMENT | 133 | 6.98e-02 | -9.13e-02 | 3.81e-01 |
| GOBP OXIDATIVE RNA DEMETHYLATION | 5 | 7.24e-01 | 9.12e-02 | 9.07e-01 |
| GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY | 5 | 7.24e-01 | 9.12e-02 | 9.07e-01 |
| GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT | 6 | 6.99e-01 | -9.12e-02 | 9.01e-01 |
| GOBP GLUTAMATE CATABOLIC PROCESS | 5 | 7.24e-01 | -9.12e-02 | 9.07e-01 |
| GOBP MICROTUBULE BUNDLE FORMATION | 50 | 2.65e-01 | -9.12e-02 | 6.43e-01 |
| GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 255 | 1.26e-02 | -9.11e-02 | 1.82e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 6 | 6.99e-01 | 9.11e-02 | 9.01e-01 |
| GOMF CHLORIDE CHANNEL INHIBITOR ACTIVITY | 5 | 7.24e-01 | 9.11e-02 | 9.07e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 8 | 6.56e-01 | 9.11e-02 | 8.78e-01 |
| GOBP RNA CAPPING | 36 | 3.45e-01 | 9.11e-02 | 6.97e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS | 22 | 4.60e-01 | 9.11e-02 | 7.76e-01 |
| GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 21 | 4.71e-01 | 9.10e-02 | 7.79e-01 |
| GOMF PHOSPHATASE INHIBITOR ACTIVITY | 25 | 4.32e-01 | 9.09e-02 | 7.59e-01 |
| GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 122 | 8.36e-02 | -9.09e-02 | 4.11e-01 |
| GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 5 | 7.25e-01 | -9.09e-02 | 9.07e-01 |
| GOCC CONDENSED CHROMOSOME | 210 | 2.37e-02 | 9.09e-02 | 2.39e-01 |
| GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 6.02e-01 | 9.09e-02 | 8.52e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION | 18 | 5.05e-01 | -9.09e-02 | 7.96e-01 |
| GOCC KATANIN COMPLEX | 5 | 7.25e-01 | -9.09e-02 | 9.07e-01 |
| GOBP MATURATION OF LSU RRNA | 28 | 4.06e-01 | -9.08e-02 | 7.42e-01 |
| GOBP REGULATION OF NOTCH SIGNALING PATHWAY | 55 | 2.45e-01 | -9.08e-02 | 6.22e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE | 10 | 6.19e-01 | 9.08e-02 | 8.62e-01 |
| GOBP GLIOGENESIS | 165 | 4.51e-02 | -9.07e-02 | 3.12e-01 |
| GOMF PROTEIN HORMONE RECEPTOR ACTIVITY | 7 | 6.78e-01 | 9.07e-02 | 8.91e-01 |
| GOBP REGULATION OF B CELL PROLIFERATION | 48 | 2.77e-01 | -9.07e-02 | 6.53e-01 |
| GOBP TRACHEA FORMATION | 6 | 7.01e-01 | -9.07e-02 | 9.01e-01 |
| GOBP DEFENSE RESPONSE TO BACTERIUM | 133 | 7.18e-02 | -9.06e-02 | 3.87e-01 |
| GOBP CELL DIFFERENTIATION IN HINDBRAIN | 10 | 6.20e-01 | -9.06e-02 | 8.62e-01 |
| GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY | 17 | 5.18e-01 | 9.06e-02 | 8.04e-01 |
| GOBP PROTEIN K48 LINKED DEUBIQUITINATION | 20 | 4.83e-01 | -9.06e-02 | 7.84e-01 |
| GOBP TUBULIN DEACETYLATION | 19 | 4.95e-01 | 9.06e-02 | 7.90e-01 |
| GOBP RESPONSE TO STEROL | 20 | 4.84e-01 | 9.05e-02 | 7.84e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II | 26 | 4.25e-01 | -9.04e-02 | 7.56e-01 |
| GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY | 11 | 6.04e-01 | -9.04e-02 | 8.53e-01 |
| GOCC RNA POLYMERASE COMPLEX | 94 | 1.31e-01 | 9.04e-02 | 4.88e-01 |
| GOBP MAINTENANCE OF SYNAPSE STRUCTURE | 12 | 5.88e-01 | -9.03e-02 | 8.43e-01 |
| GOBP CELL CELL SIGNALING | 742 | 3.77e-05 | -9.01e-02 | 5.88e-03 |
| GOCC MICROBODY MEMBRANE | 54 | 2.53e-01 | -9.01e-02 | 6.30e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 18 | 5.08e-01 | 9.01e-02 | 7.98e-01 |
| GOMF ATP GATED ION CHANNEL ACTIVITY | 5 | 7.27e-01 | -9.00e-02 | 9.08e-01 |
| GOBP CELL CHEMOTAXIS | 166 | 4.62e-02 | -8.99e-02 | 3.15e-01 |
| GOBP REGULATION OF MACROPHAGE CHEMOTAXIS | 15 | 5.47e-01 | 8.99e-02 | 8.22e-01 |
| GOBP CLATHRIN COATED VESICLE CARGO LOADING | 6 | 7.03e-01 | 8.99e-02 | 9.02e-01 |
| GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 145 | 6.23e-02 | -8.99e-02 | 3.61e-01 |
| GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX | 10 | 6.23e-01 | -8.99e-02 | 8.63e-01 |
| GOBP EMBRYONIC PLACENTA DEVELOPMENT | 46 | 2.92e-01 | -8.98e-02 | 6.61e-01 |
| GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY | 6 | 7.03e-01 | -8.98e-02 | 9.02e-01 |
| GOBP MOTILE CILIUM ASSEMBLY | 27 | 4.20e-01 | 8.97e-02 | 7.53e-01 |
| GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY | 34 | 3.66e-01 | -8.97e-02 | 7.11e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 22 | 4.67e-01 | -8.97e-02 | 7.78e-01 |
| GOBP SYNAPTIC VESICLE TRANSPORT | 32 | 3.81e-01 | -8.96e-02 | 7.21e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FUSION | 11 | 6.07e-01 | -8.96e-02 | 8.55e-01 |
| GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION | 11 | 6.07e-01 | 8.96e-02 | 8.55e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY | 15 | 5.48e-01 | -8.96e-02 | 8.23e-01 |
| GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 16 | 5.35e-01 | 8.96e-02 | 8.15e-01 |
| GOBP GOLGI VESICLE BUDDING | 10 | 6.24e-01 | 8.95e-02 | 8.63e-01 |
| GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 47 | 2.89e-01 | -8.95e-02 | 6.58e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 7 | 6.82e-01 | -8.95e-02 | 8.93e-01 |
| GOBP NEURON PROJECTION EXTENSION | 93 | 1.36e-01 | -8.95e-02 | 4.94e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE | 7 | 6.82e-01 | -8.95e-02 | 8.93e-01 |
| GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION | 111 | 1.04e-01 | -8.95e-02 | 4.50e-01 |
| GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION | 463 | 1.08e-03 | -8.94e-02 | 4.90e-02 |
| GOCC ORGANELLE ENVELOPE LUMEN | 78 | 1.73e-01 | 8.94e-02 | 5.39e-01 |
| GOMF SINGLE STRANDED RNA BINDING | 67 | 2.07e-01 | -8.94e-02 | 5.82e-01 |
| GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 7.05e-01 | 8.93e-02 | 9.02e-01 |
| GOBP CELL MORPHOGENESIS | 488 | 8.09e-04 | -8.93e-02 | 4.05e-02 |
| GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 19 | 5.00e-01 | -8.93e-02 | 7.92e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY | 24 | 4.49e-01 | -8.93e-02 | 7.69e-01 |
| GOBP MEMBRANE REPOLARIZATION | 16 | 5.37e-01 | -8.92e-02 | 8.16e-01 |
| GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 22 | 4.69e-01 | 8.92e-02 | 7.78e-01 |
| GOMF MOLECULAR TAG ACTIVITY | 12 | 5.93e-01 | -8.92e-02 | 8.47e-01 |
| GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE | 67 | 2.07e-01 | -8.92e-02 | 5.83e-01 |
| GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 14 | 5.64e-01 | -8.92e-02 | 8.31e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 11 | 6.09e-01 | 8.92e-02 | 8.56e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE III | 58 | 2.41e-01 | -8.91e-02 | 6.19e-01 |
| GOBP MAINTENANCE OF ORGANELLE LOCATION | 10 | 6.26e-01 | 8.91e-02 | 8.64e-01 |
| GOBP PROSTANOID METABOLIC PROCESS | 29 | 4.07e-01 | -8.90e-02 | 7.43e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 40 | 3.30e-01 | 8.90e-02 | 6.87e-01 |
| GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 15 | 5.51e-01 | 8.90e-02 | 8.24e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 198 | 3.15e-02 | -8.89e-02 | 2.68e-01 |
| GOBP NEURON MIGRATION | 81 | 1.67e-01 | -8.89e-02 | 5.34e-01 |
| GOBP ICOSANOID SECRETION | 17 | 5.26e-01 | 8.89e-02 | 8.09e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID | 504 | 7.10e-04 | 8.89e-02 | 3.72e-02 |
| GOBP RESPONSE TO REDOX STATE | 10 | 6.26e-01 | -8.89e-02 | 8.65e-01 |
| GOBP RETINAL ROD CELL DIFFERENTIATION | 5 | 7.31e-01 | 8.89e-02 | 9.09e-01 |
| GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 20 | 4.92e-01 | 8.89e-02 | 7.88e-01 |
| GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION | 44 | 3.09e-01 | -8.87e-02 | 6.71e-01 |
| GOBP LAMELLIPODIUM ASSEMBLY | 47 | 2.93e-01 | -8.87e-02 | 6.61e-01 |
| GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS | 11 | 6.11e-01 | 8.86e-02 | 8.57e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE | 13 | 5.80e-01 | -8.86e-02 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 41 | 3.27e-01 | -8.85e-02 | 6.85e-01 |
| GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY | 9 | 6.46e-01 | -8.85e-02 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION | 107 | 1.15e-01 | -8.85e-02 | 4.61e-01 |
| GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT | 51 | 2.75e-01 | 8.84e-02 | 6.52e-01 |
| GOBP FATTY ACID BETA OXIDATION | 58 | 2.45e-01 | 8.84e-02 | 6.22e-01 |
| GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 203 | 3.06e-02 | -8.84e-02 | 2.66e-01 |
| GOBP FATTY ACID TRANSMEMBRANE TRANSPORT | 16 | 5.41e-01 | 8.83e-02 | 8.18e-01 |
| GOBP APOPTOTIC DNA FRAGMENTATION | 13 | 5.81e-01 | -8.83e-02 | 8.40e-01 |
| GOBP MATURATION OF 5 8S RRNA | 36 | 3.60e-01 | 8.83e-02 | 7.10e-01 |
| GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 616 | 2.17e-04 | -8.83e-02 | 1.85e-02 |
| GOMF QUATERNARY AMMONIUM GROUP BINDING | 26 | 4.36e-01 | -8.83e-02 | 7.61e-01 |
| GOBP CRANIAL NERVE MORPHOGENESIS | 9 | 6.47e-01 | 8.81e-02 | 8.76e-01 |
| GOMF PROMOTER SPECIFIC CHROMATIN BINDING | 53 | 2.68e-01 | 8.81e-02 | 6.44e-01 |
| GOMF DEAD H BOX RNA HELICASE BINDING | 7 | 6.87e-01 | -8.80e-02 | 8.96e-01 |
| GOCC RUFFLE | 136 | 7.70e-02 | -8.80e-02 | 3.98e-01 |
| GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 6 | 7.09e-01 | -8.80e-02 | 9.03e-01 |
| GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 213 | 2.75e-02 | -8.80e-02 | 2.56e-01 |
| GOBP CARBOHYDRATE DERIVATIVE TRANSPORT | 59 | 2.43e-01 | 8.79e-02 | 6.21e-01 |
| GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 54 | 2.65e-01 | 8.79e-02 | 6.42e-01 |
| GOBP POSITIVE REGULATION OF LOCOMOTION | 314 | 7.78e-03 | -8.79e-02 | 1.50e-01 |
| GOBP FLUID TRANSPORT | 13 | 5.84e-01 | -8.78e-02 | 8.41e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 129 | 8.58e-02 | 8.78e-02 | 4.15e-01 |
| GOBP SEROTONIN TRANSPORT | 7 | 6.88e-01 | 8.78e-02 | 8.97e-01 |
| GOMF 7SK SNRNA BINDING | 7 | 6.88e-01 | -8.78e-02 | 8.97e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION | 70 | 2.05e-01 | -8.78e-02 | 5.80e-01 |
| GOCC SEPTIN CYTOSKELETON | 11 | 6.14e-01 | 8.78e-02 | 8.59e-01 |
| GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS | 13 | 5.84e-01 | -8.77e-02 | 8.41e-01 |
| GOBP CAMP MEDIATED SIGNALING | 25 | 4.48e-01 | -8.77e-02 | 7.68e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS | 46 | 3.04e-01 | 8.77e-02 | 6.68e-01 |
| GOBP MEIOSIS I CELL CYCLE PROCESS | 64 | 2.26e-01 | 8.77e-02 | 6.01e-01 |
| GOBP ICOSANOID TRANSPORT | 23 | 4.67e-01 | 8.76e-02 | 7.78e-01 |
| GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION | 8 | 6.68e-01 | -8.76e-02 | 8.86e-01 |
| GOBP NUCLEAR MIGRATION | 20 | 4.98e-01 | -8.76e-02 | 7.92e-01 |
| GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 32 | 3.91e-01 | -8.76e-02 | 7.29e-01 |
| GOBP RELAXATION OF CARDIAC MUSCLE | 12 | 5.99e-01 | -8.76e-02 | 8.51e-01 |
| GOBP COPII COATED VESICLE BUDDING | 41 | 3.33e-01 | -8.75e-02 | 6.88e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 40 | 3.39e-01 | 8.75e-02 | 6.92e-01 |
| GOMF MEMBRANE INSERTASE ACTIVITY | 17 | 5.33e-01 | -8.74e-02 | 8.14e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 44 | 3.16e-01 | -8.74e-02 | 6.79e-01 |
| GOBP OXIDATIVE PHOSPHORYLATION | 127 | 8.96e-02 | -8.74e-02 | 4.23e-01 |
| GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION | 19 | 5.10e-01 | -8.74e-02 | 7.99e-01 |
| GOBP RESPONSE TO NERVE GROWTH FACTOR | 27 | 4.32e-01 | -8.74e-02 | 7.59e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 11 | 6.16e-01 | -8.74e-02 | 8.60e-01 |
| GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION | 13 | 5.86e-01 | 8.73e-02 | 8.42e-01 |
| GOBP FAT CELL DIFFERENTIATION | 136 | 7.94e-02 | -8.73e-02 | 4.04e-01 |
| GOCC AZUROPHIL GRANULE | 128 | 8.87e-02 | -8.73e-02 | 4.21e-01 |
| GOBP RESPIRATORY ELECTRON TRANSPORT CHAIN | 105 | 1.23e-01 | -8.73e-02 | 4.76e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST CELL | 5 | 7.35e-01 | -8.73e-02 | 9.11e-01 |
| GOMF ENDOPEPTIDASE ACTIVITY | 163 | 5.52e-02 | -8.73e-02 | 3.42e-01 |
| GOMF GATED CHANNEL ACTIVITY | 83 | 1.70e-01 | -8.72e-02 | 5.36e-01 |
| GOCC SPLICEOSOMAL COMPLEX | 189 | 3.94e-02 | -8.72e-02 | 2.97e-01 |
| GOBP REGULATION OF SODIUM ION TRANSPORT | 37 | 3.59e-01 | 8.71e-02 | 7.10e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 33 | 3.87e-01 | 8.71e-02 | 7.25e-01 |
| GOBP ACTIN CROSSLINK FORMATION | 9 | 6.51e-01 | -8.71e-02 | 8.77e-01 |
| GOMF DYNEIN COMPLEX BINDING | 17 | 5.34e-01 | 8.70e-02 | 8.15e-01 |
| GOBP MONOCYTE ACTIVATION | 7 | 6.90e-01 | -8.70e-02 | 8.97e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING | 271 | 1.42e-02 | -8.70e-02 | 1.93e-01 |
| GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 93 | 1.48e-01 | -8.70e-02 | 5.09e-01 |
| GOBP INNER CELL MASS CELL PROLIFERATION | 11 | 6.18e-01 | 8.69e-02 | 8.62e-01 |
| GOBP RESPONSE TO INTERLEUKIN 6 | 21 | 4.91e-01 | -8.69e-02 | 7.88e-01 |
| GOBP LYTIC VACUOLE ORGANIZATION | 86 | 1.64e-01 | -8.69e-02 | 5.31e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 95 | 1.44e-01 | -8.69e-02 | 5.05e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 67 | 2.20e-01 | -8.68e-02 | 5.95e-01 |
| GOMF SULFUR COMPOUND BINDING | 105 | 1.25e-01 | -8.68e-02 | 4.81e-01 |
| GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION | 7 | 6.91e-01 | -8.68e-02 | 8.97e-01 |
| GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION | 7 | 6.91e-01 | -8.68e-02 | 8.97e-01 |
| GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS | 18 | 5.24e-01 | -8.68e-02 | 8.08e-01 |
| GOBP REGULATION OF HISTONE H3 K4 METHYLATION | 12 | 6.03e-01 | -8.68e-02 | 8.52e-01 |
| GOMF PHOSPHOLIPID TRANSFER ACTIVITY | 15 | 5.61e-01 | 8.68e-02 | 8.29e-01 |
| GOBP APOPTOTIC PROCESS | 1223 | 6.11e-07 | -8.68e-02 | 3.31e-04 |
| GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY | 7 | 6.91e-01 | -8.68e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF TISSUE REMODELING | 11 | 6.19e-01 | 8.67e-02 | 8.62e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 27 | 4.36e-01 | -8.66e-02 | 7.61e-01 |
| GOBP HYDROGEN PEROXIDE METABOLIC PROCESS | 27 | 4.36e-01 | -8.66e-02 | 7.61e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION | 9 | 6.53e-01 | 8.66e-02 | 8.78e-01 |
| GOMF CARBON OXYGEN LYASE ACTIVITY | 50 | 2.90e-01 | 8.66e-02 | 6.59e-01 |
| GOBP AMP METABOLIC PROCESS | 16 | 5.49e-01 | 8.66e-02 | 8.23e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 10 | 6.36e-01 | -8.65e-02 | 8.70e-01 |
| GOBP NUCLEUS LOCALIZATION | 26 | 4.45e-01 | -8.65e-02 | 7.67e-01 |
| GOCC DNA RECOMBINASE MEDIATOR COMPLEX | 5 | 7.38e-01 | 8.64e-02 | 9.12e-01 |
| GOMF CARD DOMAIN BINDING | 12 | 6.04e-01 | -8.64e-02 | 8.53e-01 |
| GOBP GRANULOCYTE ACTIVATION | 37 | 3.63e-01 | -8.64e-02 | 7.10e-01 |
| GOBP ISOTYPE SWITCHING TO IGG ISOTYPES | 12 | 6.04e-01 | 8.64e-02 | 8.53e-01 |
| GOCC PRERIBOSOME | 103 | 1.30e-01 | 8.64e-02 | 4.88e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME | 7 | 6.92e-01 | -8.64e-02 | 8.97e-01 |
| GOCC RUFFLE MEMBRANE | 70 | 2.12e-01 | -8.64e-02 | 5.87e-01 |
| GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 5.15e-01 | -8.64e-02 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION | 16 | 5.50e-01 | -8.64e-02 | 8.23e-01 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION | 730 | 8.88e-05 | -8.64e-02 | 1.02e-02 |
| GOBP PIGMENT CELL DIFFERENTIATION | 21 | 4.94e-01 | -8.63e-02 | 7.90e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE | 9 | 6.54e-01 | -8.63e-02 | 8.78e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 12 | 6.05e-01 | 8.63e-02 | 8.54e-01 |
| GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS | 66 | 2.26e-01 | -8.63e-02 | 6.01e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 34 | 3.84e-01 | -8.63e-02 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 114 | 1.13e-01 | -8.62e-02 | 4.59e-01 |
| GOBP GLYCOLIPID TRANSPORT | 6 | 7.15e-01 | -8.62e-02 | 9.05e-01 |
| GOBP REGULATION OF CENTROSOME CYCLE | 44 | 3.23e-01 | 8.62e-02 | 6.81e-01 |
| GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 76 | 1.95e-01 | -8.61e-02 | 5.67e-01 |
| GOBP SYNAPSE ORGANIZATION | 211 | 3.18e-02 | -8.61e-02 | 2.69e-01 |
| GOMF DENEDDYLASE ACTIVITY | 5 | 7.39e-01 | 8.61e-02 | 9.12e-01 |
| GOMF VOLTAGE GATED CHANNEL ACTIVITY | 50 | 2.93e-01 | -8.60e-02 | 6.61e-01 |
| GOBP NEGATIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 6 | 7.15e-01 | 8.60e-02 | 9.05e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 12 | 6.06e-01 | 8.59e-02 | 8.54e-01 |
| GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY | 7 | 6.94e-01 | -8.59e-02 | 8.98e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 7.40e-01 | -8.58e-02 | 9.13e-01 |
| GOCC SIDE OF MEMBRANE | 388 | 3.98e-03 | -8.58e-02 | 1.00e-01 |
| GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY | 6 | 7.16e-01 | 8.58e-02 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 5 | 7.40e-01 | -8.57e-02 | 9.13e-01 |
| GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 69 | 2.19e-01 | -8.57e-02 | 5.95e-01 |
| GOBP VESICLE UNCOATING | 5 | 7.40e-01 | -8.56e-02 | 9.13e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 34 | 3.88e-01 | 8.56e-02 | 7.26e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SECRETION | 84 | 1.76e-01 | -8.55e-02 | 5.43e-01 |
| GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 30 | 4.18e-01 | -8.55e-02 | 7.52e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST | 7 | 6.96e-01 | 8.54e-02 | 8.99e-01 |
| GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 39 | 3.56e-01 | 8.54e-02 | 7.07e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR | 12 | 6.09e-01 | -8.54e-02 | 8.56e-01 |
| GOBP STEROID HORMONE SECRETION | 12 | 6.09e-01 | -8.53e-02 | 8.56e-01 |
| GOBP REGULATION OF CHROMOSOME ORGANIZATION | 200 | 3.81e-02 | 8.53e-02 | 2.93e-01 |
| GOBP IMMUNE RESPONSE TO TUMOR CELL | 18 | 5.31e-01 | -8.53e-02 | 8.13e-01 |
| GOBP EMBRYO IMPLANTATION | 28 | 4.36e-01 | -8.52e-02 | 7.61e-01 |
| GOBP NEUTRAL AMINO ACID TRANSPORT | 30 | 4.20e-01 | 8.52e-02 | 7.53e-01 |
| GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS | 15 | 5.68e-01 | 8.51e-02 | 8.34e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS | 1067 | 4.15e-06 | -8.51e-02 | 1.50e-03 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 25 | 4.62e-01 | 8.51e-02 | 7.77e-01 |
| GOMF ALPHA CATENIN BINDING | 5 | 7.42e-01 | 8.51e-02 | 9.14e-01 |
| GOBP MUSCLE TISSUE DEVELOPMENT | 186 | 4.61e-02 | -8.51e-02 | 3.15e-01 |
| GOBP LIPID MODIFICATION | 127 | 9.86e-02 | 8.51e-02 | 4.38e-01 |
| GOBP ORGANELLE DISASSEMBLY | 125 | 1.01e-01 | -8.50e-02 | 4.45e-01 |
| GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 203 | 3.75e-02 | -8.50e-02 | 2.91e-01 |
| GOBP RESPONSE TO FORSKOLIN | 6 | 7.19e-01 | -8.50e-02 | 9.06e-01 |
| GOBP TETRAPYRROLE CATABOLIC PROCESS | 6 | 7.19e-01 | 8.49e-02 | 9.06e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION | 88 | 1.69e-01 | -8.49e-02 | 5.35e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 36 | 3.79e-01 | 8.48e-02 | 7.19e-01 |
| GOMF ACTIN MONOMER BINDING | 16 | 5.57e-01 | 8.48e-02 | 8.27e-01 |
| GOBP GLYCOLYTIC PROCESS | 64 | 2.41e-01 | -8.48e-02 | 6.19e-01 |
| GOMF AMINOACYL TRNA HYDROLASE ACTIVITY | 5 | 7.43e-01 | 8.48e-02 | 9.14e-01 |
| GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING | 7 | 6.98e-01 | -8.48e-02 | 9.00e-01 |
| GOBP REGULATION OF RIG I SIGNALING PATHWAY | 18 | 5.34e-01 | -8.48e-02 | 8.15e-01 |
| GOBP TUBE FORMATION | 79 | 1.94e-01 | -8.47e-02 | 5.66e-01 |
| GOBP POSITIVE REGULATION OF TOR SIGNALING | 59 | 2.61e-01 | -8.47e-02 | 6.38e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 11 | 6.27e-01 | -8.47e-02 | 8.65e-01 |
| GOBP SULFUR COMPOUND TRANSPORT | 30 | 4.22e-01 | -8.47e-02 | 7.54e-01 |
| GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 20 | 5.12e-01 | -8.46e-02 | 8.00e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 6 | 7.20e-01 | -8.46e-02 | 9.06e-01 |
| GOBP EMBRYONIC DIGIT MORPHOGENESIS | 24 | 4.73e-01 | -8.46e-02 | 7.79e-01 |
| GOBP ACTOMYOSIN STRUCTURE ORGANIZATION | 113 | 1.21e-01 | -8.46e-02 | 4.74e-01 |
| GOBP BONE MORPHOGENESIS | 37 | 3.74e-01 | -8.46e-02 | 7.16e-01 |
| GOBP POSITIVE REGULATION OF B CELL ACTIVATION | 66 | 2.36e-01 | -8.45e-02 | 6.13e-01 |
| GOCC BETA CATENIN DESTRUCTION COMPLEX | 9 | 6.61e-01 | 8.45e-02 | 8.82e-01 |
| GOCC COSTAMERE | 10 | 6.44e-01 | -8.45e-02 | 8.74e-01 |
| GOBP ZYMOGEN INHIBITION | 6 | 7.20e-01 | 8.45e-02 | 9.06e-01 |
| GOBP PEPTIDYL METHIONINE MODIFICATION | 9 | 6.61e-01 | 8.45e-02 | 8.82e-01 |
| GOBP ENDOTHELIAL CELL PROLIFERATION | 75 | 2.07e-01 | -8.44e-02 | 5.82e-01 |
| GOBP EPITHELIUM DEVELOPMENT | 543 | 8.65e-04 | -8.44e-02 | 4.21e-02 |
| GOBP SKELETAL MUSCLE CONTRACTION | 17 | 5.47e-01 | -8.44e-02 | 8.23e-01 |
| GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION | 664 | 2.51e-04 | -8.44e-02 | 2.04e-02 |
| GOMF ACID AMINO ACID LIGASE ACTIVITY | 16 | 5.59e-01 | 8.43e-02 | 8.29e-01 |
| GOMF AMINOACYLTRANSFERASE ACTIVITY | 357 | 6.55e-03 | -8.43e-02 | 1.37e-01 |
| GOBP GAMETE GENERATION | 377 | 5.26e-03 | -8.43e-02 | 1.21e-01 |
| GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY | 5 | 7.44e-01 | 8.43e-02 | 9.15e-01 |
| GOMF LYSINE ACETYLATED HISTONE BINDING | 22 | 4.94e-01 | 8.42e-02 | 7.90e-01 |
| GOBP THYMUS DEVELOPMENT | 32 | 4.10e-01 | -8.42e-02 | 7.46e-01 |
| GOCC RECEPTOR COMPLEX | 180 | 5.24e-02 | -8.41e-02 | 3.33e-01 |
| GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY | 240 | 2.55e-02 | -8.41e-02 | 2.46e-01 |
| GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS | 6 | 7.21e-01 | -8.40e-02 | 9.06e-01 |
| GOBP RESPONSE TO PARATHYROID HORMONE | 6 | 7.21e-01 | -8.40e-02 | 9.06e-01 |
| GOCC CORTICAL CYTOSKELETON | 57 | 2.73e-01 | -8.40e-02 | 6.51e-01 |
| GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS | 15 | 5.73e-01 | 8.40e-02 | 8.35e-01 |
| GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE | 22 | 4.95e-01 | -8.40e-02 | 7.90e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE | 37 | 3.77e-01 | -8.39e-02 | 7.18e-01 |
| GOBP REGULATION OF NEUROGENESIS | 188 | 4.83e-02 | -8.38e-02 | 3.20e-01 |
| GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX | 6 | 7.22e-01 | -8.37e-02 | 9.06e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 26 | 4.60e-01 | 8.37e-02 | 7.76e-01 |
| GOBP EPITHELIAL CELL MORPHOGENESIS | 16 | 5.62e-01 | -8.37e-02 | 8.30e-01 |
| GOBP GLUTATHIONE TRANSPORT | 6 | 7.23e-01 | -8.36e-02 | 9.07e-01 |
| GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 15 | 5.75e-01 | 8.36e-02 | 8.37e-01 |
| GOBP COLLAGEN CATABOLIC PROCESS | 17 | 5.51e-01 | -8.36e-02 | 8.24e-01 |
| GOBP JNK CASCADE | 120 | 1.15e-01 | -8.35e-02 | 4.62e-01 |
| GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING | 252 | 2.30e-02 | -8.35e-02 | 2.37e-01 |
| GOBP RIG I SIGNALING PATHWAY | 24 | 4.79e-01 | -8.35e-02 | 7.82e-01 |
| GOBP CARBOHYDRATE MEDIATED SIGNALING | 6 | 7.23e-01 | 8.35e-02 | 9.07e-01 |
| GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR | 6 | 7.23e-01 | 8.34e-02 | 9.07e-01 |
| GOBP CIRCADIAN REGULATION OF GENE EXPRESSION | 51 | 3.03e-01 | -8.34e-02 | 6.67e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 25 | 4.71e-01 | -8.34e-02 | 7.79e-01 |
| GOBP REGULATION OF MUSCLE HYPERTROPHY | 36 | 3.87e-01 | -8.34e-02 | 7.25e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIUM | 231 | 2.98e-02 | -8.33e-02 | 2.62e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING | 351 | 7.71e-03 | -8.33e-02 | 1.50e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY | 38 | 3.75e-01 | 8.33e-02 | 7.17e-01 |
| GOBP REGULATION OF LOCOMOTION | 565 | 8.09e-04 | -8.33e-02 | 4.05e-02 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS | 33 | 4.08e-01 | -8.33e-02 | 7.44e-01 |
| GOBP PROTEIN DEGLYCOSYLATION | 15 | 5.77e-01 | 8.32e-02 | 8.38e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS | 9 | 6.66e-01 | 8.32e-02 | 8.85e-01 |
| GOBP DEVELOPMENTAL MATURATION | 150 | 7.95e-02 | -8.32e-02 | 4.04e-01 |
| GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 75 | 2.14e-01 | -8.32e-02 | 5.89e-01 |
| GOBP MACROMOLECULE CATABOLIC PROCESS | 1066 | 6.96e-06 | -8.32e-02 | 2.02e-03 |
| GOBP RESPONSE TO REACTIVE OXYGEN SPECIES | 146 | 8.37e-02 | -8.31e-02 | 4.11e-01 |
| GOBP REGULATION OF CALCIUM MEDIATED SIGNALING | 53 | 2.96e-01 | 8.31e-02 | 6.62e-01 |
| GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY | 24 | 4.81e-01 | -8.31e-02 | 7.83e-01 |
| GOBP AMINO ACID TRANSPORT | 74 | 2.17e-01 | 8.31e-02 | 5.94e-01 |
| GOBP ATP TRANSPORT | 12 | 6.18e-01 | -8.31e-02 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF LIPID LOCALIZATION | 56 | 2.83e-01 | -8.30e-02 | 6.55e-01 |
| GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 30 | 4.32e-01 | -8.30e-02 | 7.59e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE | 189 | 5.00e-02 | -8.30e-02 | 3.24e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS | 8 | 6.85e-01 | 8.29e-02 | 8.95e-01 |
| GOBP NOTCH SIGNALING PATHWAY | 92 | 1.70e-01 | -8.29e-02 | 5.36e-01 |
| GOMF TRANSCRIPTION COREGULATOR ACTIVITY | 415 | 4.06e-03 | -8.28e-02 | 1.02e-01 |
| GOCC POSTSYNAPTIC MEMBRANE | 74 | 2.19e-01 | -8.28e-02 | 5.95e-01 |
| GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION | 16 | 5.66e-01 | -8.28e-02 | 8.33e-01 |
| GOBP XENOBIOTIC CATABOLIC PROCESS | 8 | 6.85e-01 | 8.28e-02 | 8.95e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 7 | 7.05e-01 | -8.28e-02 | 9.02e-01 |
| GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX | 32 | 4.18e-01 | 8.27e-02 | 7.52e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX | 16 | 5.67e-01 | -8.27e-02 | 8.33e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS | 31 | 4.26e-01 | -8.27e-02 | 7.56e-01 |
| GOCC CATION CHANNEL COMPLEX | 54 | 2.94e-01 | 8.27e-02 | 6.62e-01 |
| GOBP VASCULAR TRANSPORT | 43 | 3.49e-01 | 8.27e-02 | 7.00e-01 |
| GOBP OLIGOSACCHARIDE METABOLIC PROCESS | 40 | 3.67e-01 | -8.25e-02 | 7.11e-01 |
| GOBP RESPONSE TO GROWTH FACTOR | 378 | 6.31e-03 | -8.24e-02 | 1.35e-01 |
| GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE | 23 | 4.94e-01 | -8.24e-02 | 7.90e-01 |
| GOCC PCG PROTEIN COMPLEX | 31 | 4.28e-01 | -8.23e-02 | 7.58e-01 |
| GOBP T HELPER 1 CELL DIFFERENTIATION | 19 | 5.35e-01 | -8.23e-02 | 8.15e-01 |
| GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE | 6 | 7.27e-01 | -8.23e-02 | 9.08e-01 |
| GOBP CHROMOSOME ORGANIZATION | 448 | 3.07e-03 | 8.23e-02 | 8.70e-02 |
| GOBP ICOSANOID METABOLIC PROCESS | 57 | 2.83e-01 | -8.22e-02 | 6.55e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION | 10 | 6.53e-01 | 8.22e-02 | 8.78e-01 |
| GOCC RNA POLYMERASE II HOLOENZYME | 68 | 2.42e-01 | 8.22e-02 | 6.20e-01 |
| GOBP SYNAPTONEMAL COMPLEX ORGANIZATION | 12 | 6.22e-01 | -8.21e-02 | 8.63e-01 |
| GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 23 | 4.96e-01 | 8.21e-02 | 7.91e-01 |
| GOBP IMPORT INTO CELL | 551 | 1.10e-03 | -8.21e-02 | 4.93e-02 |
| GOBP LOCALIZATION WITHIN MEMBRANE | 479 | 2.28e-03 | -8.21e-02 | 7.41e-02 |
| GOMF P53 BINDING | 54 | 2.97e-01 | 8.21e-02 | 6.63e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 255 | 2.47e-02 | -8.21e-02 | 2.43e-01 |
| GOBP POST EMBRYONIC DEVELOPMENT | 63 | 2.61e-01 | -8.21e-02 | 6.38e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 21 | 5.15e-01 | -8.21e-02 | 8.02e-01 |
| GOBP REGULATION OF SYNAPSE ASSEMBLY | 43 | 3.52e-01 | -8.21e-02 | 7.02e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 702 | 2.58e-04 | -8.20e-02 | 2.07e-02 |
| GOBP CELL MOTILITY | 869 | 5.48e-05 | -8.20e-02 | 7.79e-03 |
| GOBP DUMP METABOLIC PROCESS | 5 | 7.51e-01 | -8.19e-02 | 9.18e-01 |
| GOMF PRE MIRNA BINDING | 7 | 7.08e-01 | 8.19e-02 | 9.03e-01 |
| GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 17 | 5.59e-01 | -8.19e-02 | 8.29e-01 |
| GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 38 | 3.83e-01 | -8.18e-02 | 7.24e-01 |
| GOCC CILIARY PLASM | 63 | 2.62e-01 | 8.17e-02 | 6.39e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C | 5 | 7.52e-01 | -8.17e-02 | 9.19e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 48 | 3.28e-01 | 8.17e-02 | 6.85e-01 |
| GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT | 21 | 5.17e-01 | 8.16e-02 | 8.04e-01 |
| GOBP CYTOLYSIS | 5 | 7.52e-01 | -8.16e-02 | 9.19e-01 |
| GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 159 | 7.66e-02 | -8.16e-02 | 3.97e-01 |
| GOBP REGULATION OF DNA METABOLIC PROCESS | 408 | 5.00e-03 | 8.16e-02 | 1.17e-01 |
| GOBP VESICLE MEDIATED TRANSPORT | 1082 | 9.10e-06 | -8.16e-02 | 2.46e-03 |
| GOMF N METHYLTRANSFERASE ACTIVITY | 76 | 2.20e-01 | 8.15e-02 | 5.95e-01 |
| GOBP PROTEIN MONOUBIQUITINATION | 38 | 3.85e-01 | -8.15e-02 | 7.25e-01 |
| GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 7 | 7.09e-01 | 8.15e-02 | 9.03e-01 |
| GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY | 16 | 5.73e-01 | -8.15e-02 | 8.35e-01 |
| GOBP NEGATIVE REGULATION OF MAPK CASCADE | 101 | 1.58e-01 | -8.15e-02 | 5.24e-01 |
| GOMF ENOYL COA HYDRATASE ACTIVITY | 10 | 6.56e-01 | -8.14e-02 | 8.79e-01 |
| GOMF METHYLATION DEPENDENT PROTEIN BINDING | 68 | 2.47e-01 | 8.13e-02 | 6.23e-01 |
| GOBP REGULATION OF TRANSLATIONAL ELONGATION | 8 | 6.91e-01 | 8.13e-02 | 8.97e-01 |
| GOBP MESENCHYMAL CELL MIGRATION | 16 | 5.74e-01 | -8.13e-02 | 8.36e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 27 | 4.66e-01 | -8.12e-02 | 7.78e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 132 | 1.08e-01 | -8.11e-02 | 4.54e-01 |
| GOBP PARAXIAL MESODERM DEVELOPMENT | 6 | 7.31e-01 | -8.11e-02 | 9.09e-01 |
| GOBP CELLULAR RESPONSE TO LIGHT STIMULUS | 81 | 2.08e-01 | 8.11e-02 | 5.83e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION | 8 | 6.91e-01 | 8.11e-02 | 8.97e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION | 6 | 7.31e-01 | -8.10e-02 | 9.09e-01 |
| GOMF HEPARAN SULFATE SULFOTRANSFERASE ACTIVITY | 6 | 7.31e-01 | -8.10e-02 | 9.09e-01 |
| GOBP RIBOSOME BIOGENESIS | 305 | 1.56e-02 | 8.09e-02 | 1.98e-01 |
| GOBP DIGESTIVE SYSTEM DEVELOPMENT | 48 | 3.33e-01 | -8.09e-02 | 6.88e-01 |
| GOBP VESICLE ORGANIZATION | 279 | 2.07e-02 | -8.09e-02 | 2.24e-01 |
| GOBP REGULATORY T CELL DIFFERENTIATION | 27 | 4.67e-01 | -8.09e-02 | 7.78e-01 |
| GOBP PROTEOLYSIS | 1066 | 1.24e-05 | -8.09e-02 | 3.01e-03 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOLUS | 17 | 5.64e-01 | 8.09e-02 | 8.31e-01 |
| GOBP REGULATION OF NEURON PROJECTION REGENERATION | 15 | 5.88e-01 | 8.08e-02 | 8.43e-01 |
| GOBP LIPID DROPLET ORGANIZATION | 25 | 4.84e-01 | -8.08e-02 | 7.85e-01 |
| GOBP NEGATIVE REGULATION OF TOR SIGNALING | 59 | 2.84e-01 | -8.08e-02 | 6.55e-01 |
| GOBP NOTCH RECEPTOR PROCESSING | 8 | 6.93e-01 | 8.08e-02 | 8.97e-01 |
| GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS | 11 | 6.43e-01 | 8.08e-02 | 8.74e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 5 | 7.55e-01 | 8.07e-02 | 9.20e-01 |
| GOBP SECONDARY METABOLIC PROCESS | 21 | 5.22e-01 | -8.07e-02 | 8.07e-01 |
| GOCC AP 1 ADAPTOR COMPLEX | 9 | 6.75e-01 | 8.07e-02 | 8.90e-01 |
| GOBP NEGATIVE REGULATION OF BINDING | 80 | 2.13e-01 | -8.07e-02 | 5.88e-01 |
| GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 52 | 3.15e-01 | -8.07e-02 | 6.78e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 217 | 4.14e-02 | -8.06e-02 | 3.03e-01 |
| GOBP EOSINOPHIL MEDIATED IMMUNITY | 8 | 6.93e-01 | -8.06e-02 | 8.98e-01 |
| GOMF KINASE BINDING | 543 | 1.49e-03 | -8.05e-02 | 5.94e-02 |
| GOCC COMMITMENT COMPLEX | 5 | 7.55e-01 | -8.05e-02 | 9.20e-01 |
| GOBP MALE GAMETE GENERATION | 283 | 2.05e-02 | -8.05e-02 | 2.23e-01 |
| GOBP MEIOTIC CHROMOSOME CONDENSATION | 5 | 7.55e-01 | 8.05e-02 | 9.20e-01 |
| GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 98 | 1.69e-01 | -8.05e-02 | 5.35e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 25 | 4.87e-01 | -8.04e-02 | 7.85e-01 |
| GOBP RESPONSE TO INTERFERON ALPHA | 16 | 5.78e-01 | 8.04e-02 | 8.38e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING | 839 | 9.99e-05 | -8.03e-02 | 1.12e-02 |
| GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS | 22 | 5.14e-01 | -8.03e-02 | 8.02e-01 |
| GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION | 8 | 6.94e-01 | 8.03e-02 | 8.98e-01 |
| GOBP MULTICELLULAR ORGANISM REPRODUCTION | 440 | 4.18e-03 | -8.03e-02 | 1.03e-01 |
| GOBP SMOOTH MUSCLE CONTRACTION | 46 | 3.47e-01 | 8.02e-02 | 6.98e-01 |
| GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 88 | 1.94e-01 | -8.01e-02 | 5.67e-01 |
| GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE | 6 | 7.34e-01 | -8.01e-02 | 9.10e-01 |
| GOBP REGULATION OF KERATINOCYTE PROLIFERATION | 19 | 5.46e-01 | 8.01e-02 | 8.22e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES | 8 | 6.95e-01 | 8.01e-02 | 8.98e-01 |
| GOBP POSITIVE REGULATION OF GLUCONEOGENESIS | 15 | 5.92e-01 | -8.00e-02 | 8.46e-01 |
| GOMF SIGNAL SEQUENCE BINDING | 38 | 3.94e-01 | -8.00e-02 | 7.32e-01 |
| GOBP EPIDERMIS DEVELOPMENT | 142 | 1.01e-01 | -8.00e-02 | 4.44e-01 |
| GOMF 2 IRON 2 SULFUR CLUSTER BINDING | 21 | 5.26e-01 | 7.99e-02 | 8.09e-01 |
| GOCC RIBONUCLEOPROTEIN COMPLEX | 663 | 5.26e-04 | -7.99e-02 | 3.12e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN BINDING | 43 | 3.65e-01 | -7.99e-02 | 7.11e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 80 | 2.17e-01 | -7.99e-02 | 5.94e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS | 138 | 1.07e-01 | -7.98e-02 | 4.52e-01 |
| GOBP SPHINGOLIPID TRANSLOCATION | 5 | 7.57e-01 | 7.98e-02 | 9.21e-01 |
| GOBP MEMORY | 49 | 3.35e-01 | -7.98e-02 | 6.88e-01 |
| GOBP CHOLESTEROL EFFLUX | 29 | 4.58e-01 | -7.98e-02 | 7.74e-01 |
| GOMF CARBOXYPEPTIDASE ACTIVITY | 21 | 5.27e-01 | 7.97e-02 | 8.10e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 20 | 5.37e-01 | -7.97e-02 | 8.16e-01 |
| GOBP RESPONSE TO ETHANOL | 60 | 2.87e-01 | 7.95e-02 | 6.57e-01 |
| GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR | 31 | 4.44e-01 | 7.95e-02 | 7.67e-01 |
| GOBP PEPTIDYL ARGININE MODIFICATION | 7 | 7.16e-01 | 7.95e-02 | 9.05e-01 |
| GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 7 | 7.16e-01 | -7.95e-02 | 9.05e-01 |
| GOCC IMMUNOGLOBULIN COMPLEX | 11 | 6.48e-01 | 7.95e-02 | 8.76e-01 |
| GOBP CELL VOLUME HOMEOSTASIS | 21 | 5.29e-01 | 7.95e-02 | 8.11e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION | 56 | 3.04e-01 | -7.95e-02 | 6.68e-01 |
| GOBP KETONE BIOSYNTHETIC PROCESS | 28 | 4.67e-01 | 7.94e-02 | 7.78e-01 |
| GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY | 16 | 5.82e-01 | 7.94e-02 | 8.40e-01 |
| GOBP SKELETAL SYSTEM DEVELOPMENT | 226 | 4.05e-02 | -7.94e-02 | 3.00e-01 |
| GOCC RSC TYPE COMPLEX | 14 | 6.07e-01 | 7.94e-02 | 8.55e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 26 | 4.84e-01 | -7.94e-02 | 7.85e-01 |
| GOBP NEGATIVE REGULATION OF HEMOPOIESIS | 69 | 2.55e-01 | -7.93e-02 | 6.31e-01 |
| GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 12 | 6.34e-01 | 7.93e-02 | 8.69e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 19 | 5.50e-01 | 7.93e-02 | 8.23e-01 |
| GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION | 43 | 3.69e-01 | -7.92e-02 | 7.13e-01 |
| GOBP AXONAL TRANSPORT OF MITOCHONDRION | 11 | 6.49e-01 | -7.92e-02 | 8.76e-01 |
| GOCC MRNA EDITING COMPLEX | 13 | 6.21e-01 | -7.92e-02 | 8.62e-01 |
| GOBP MUSCLE ORGAN MORPHOGENESIS | 28 | 4.69e-01 | -7.91e-02 | 7.78e-01 |
| GOBP ELECTRON TRANSPORT CHAIN | 139 | 1.08e-01 | -7.91e-02 | 4.54e-01 |
| GOBP SYNAPTIC VESICLE EXOCYTOSIS | 51 | 3.29e-01 | -7.91e-02 | 6.86e-01 |
| GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS | 14 | 6.09e-01 | -7.91e-02 | 8.56e-01 |
| GOBP DIACYLGLYCEROL METABOLIC PROCESS | 20 | 5.41e-01 | 7.91e-02 | 8.18e-01 |
| GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 8 | 6.99e-01 | -7.90e-02 | 9.01e-01 |
| GOBP REGULATION OF PROTEIN SECRETION | 145 | 1.02e-01 | -7.90e-02 | 4.45e-01 |
| GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND | 1032 | 2.62e-05 | -7.89e-02 | 4.62e-03 |
| GOBP NEGATIVE REGULATION OF LOCOMOTION | 192 | 6.02e-02 | -7.89e-02 | 3.57e-01 |
| GOCC GEMINI OF COILED BODIES | 12 | 6.36e-01 | 7.89e-02 | 8.70e-01 |
| GOBP RESPONSE TO INTERLEUKIN 18 | 8 | 6.99e-01 | -7.89e-02 | 9.01e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 445 | 4.67e-03 | -7.89e-02 | 1.12e-01 |
| GOBP FOREBRAIN DEVELOPMENT | 194 | 5.92e-02 | -7.88e-02 | 3.54e-01 |
| GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT | 120 | 1.37e-01 | -7.88e-02 | 4.95e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 21 | 5.32e-01 | 7.88e-02 | 8.14e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 8 | 7.00e-01 | -7.88e-02 | 9.01e-01 |
| GOBP VESICLE FUSION TO PLASMA MEMBRANE | 11 | 6.51e-01 | 7.87e-02 | 8.77e-01 |
| GOMF MOLECULAR CARRIER ACTIVITY | 79 | 2.27e-01 | 7.87e-02 | 6.03e-01 |
| GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS | 6 | 7.39e-01 | -7.86e-02 | 9.12e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 7 | 7.19e-01 | 7.86e-02 | 9.06e-01 |
| GOBP NEUTROPHIL MEDIATED CYTOTOXICITY | 6 | 7.39e-01 | -7.86e-02 | 9.12e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 12 | 6.37e-01 | -7.86e-02 | 8.70e-01 |
| GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 19 | 5.53e-01 | 7.86e-02 | 8.24e-01 |
| GOCC CATALYTIC STEP 2 SPLICEOSOME | 88 | 2.03e-01 | -7.86e-02 | 5.79e-01 |
| GOBP SELF PROTEOLYSIS | 7 | 7.19e-01 | 7.86e-02 | 9.06e-01 |
| GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY | 8 | 7.01e-01 | 7.85e-02 | 9.01e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION | 19 | 5.54e-01 | -7.85e-02 | 8.24e-01 |
| GOBP REGULATION OF CELLULAR CATABOLIC PROCESS | 514 | 2.54e-03 | -7.85e-02 | 7.78e-02 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 9 | 6.83e-01 | 7.85e-02 | 8.95e-01 |
| GOCC CLATHRIN COATED VESICLE MEMBRANE | 89 | 2.01e-01 | -7.85e-02 | 5.76e-01 |
| GOBP GLIAL CELL MIGRATION | 35 | 4.22e-01 | -7.85e-02 | 7.54e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 49 | 3.42e-01 | 7.85e-02 | 6.95e-01 |
| GOBP NEUTROPHIL CHEMOTAXIS | 55 | 3.15e-01 | -7.84e-02 | 6.78e-01 |
| GOBP TRABECULA FORMATION | 9 | 6.84e-01 | -7.84e-02 | 8.95e-01 |
| GOCC GOLGI ASSOCIATED VESICLE | 70 | 2.57e-01 | -7.84e-02 | 6.34e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 8 | 7.01e-01 | 7.84e-02 | 9.01e-01 |
| GOBP GLIAL CELL APOPTOTIC PROCESS | 13 | 6.25e-01 | 7.83e-02 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH | 105 | 1.67e-01 | -7.82e-02 | 5.34e-01 |
| GOBP HEART MORPHOGENESIS | 109 | 1.59e-01 | -7.82e-02 | 5.25e-01 |
| GOBP FATTY ACYL COA METABOLIC PROCESS | 26 | 4.90e-01 | 7.82e-02 | 7.88e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION | 8 | 7.02e-01 | -7.82e-02 | 9.01e-01 |
| GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 134 | 1.19e-01 | -7.82e-02 | 4.70e-01 |
| GOBP FRUCTOSE METABOLIC PROCESS | 9 | 6.85e-01 | -7.82e-02 | 8.95e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME | 11 | 6.54e-01 | -7.82e-02 | 8.78e-01 |
| GOBP SURFACTANT HOMEOSTASIS | 7 | 7.20e-01 | -7.81e-02 | 9.06e-01 |
| GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 30 | 4.59e-01 | 7.81e-02 | 7.75e-01 |
| GOCC GOLGI CIS CISTERNA | 12 | 6.40e-01 | -7.81e-02 | 8.72e-01 |
| GOBP PYRIMIDINE DIMER REPAIR | 9 | 6.85e-01 | 7.80e-02 | 8.95e-01 |
| GOBP VASOCONSTRICTION | 29 | 4.67e-01 | -7.80e-02 | 7.78e-01 |
| GOMF LIPASE ACTIVATOR ACTIVITY | 14 | 6.14e-01 | 7.80e-02 | 8.59e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 240 | 3.85e-02 | 7.79e-02 | 2.95e-01 |
| GOMF METALLODIPEPTIDASE ACTIVITY | 5 | 7.63e-01 | 7.79e-02 | 9.25e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 745 | 3.58e-04 | -7.79e-02 | 2.53e-02 |
| GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT | 6 | 7.41e-01 | 7.79e-02 | 9.13e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA | 66 | 2.75e-01 | 7.79e-02 | 6.51e-01 |
| GOBP EMBRYONIC APPENDAGE MORPHOGENESIS | 49 | 3.47e-01 | -7.78e-02 | 6.98e-01 |
| GOMF EXOPEPTIDASE ACTIVITY | 58 | 3.06e-01 | 7.78e-02 | 6.69e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS | 222 | 4.68e-02 | -7.77e-02 | 3.16e-01 |
| GOBP ACTIN FILAMENT BASED PROCESS | 454 | 4.89e-03 | -7.77e-02 | 1.15e-01 |
| GOBP ENTRY INTO HOST | 108 | 1.64e-01 | -7.77e-02 | 5.29e-01 |
| GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 22 | 5.28e-01 | 7.77e-02 | 8.11e-01 |
| GOBP STEM CELL PROLIFERATION | 51 | 3.38e-01 | -7.77e-02 | 6.91e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 50 | 3.43e-01 | -7.77e-02 | 6.95e-01 |
| GOBP REGULATION OF RIBOSOME BIOGENESIS | 8 | 7.04e-01 | 7.77e-02 | 9.02e-01 |
| GOBP TELOMERE ORGANIZATION | 143 | 1.10e-01 | 7.76e-02 | 4.56e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT | 107 | 1.67e-01 | -7.75e-02 | 5.34e-01 |
| GOCC WNT SIGNALOSOME | 8 | 7.04e-01 | 7.75e-02 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 10 | 6.71e-01 | 7.75e-02 | 8.88e-01 |
| GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS | 91 | 2.02e-01 | 7.75e-02 | 5.78e-01 |
| GOBP RESPONSE TO ZINC ION | 24 | 5.12e-01 | -7.74e-02 | 8.00e-01 |
| GOBP POST GOLGI VESICLE MEDIATED TRANSPORT | 91 | 2.02e-01 | -7.74e-02 | 5.78e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS | 28 | 4.79e-01 | 7.74e-02 | 7.82e-01 |
| GOBP LIPID LOCALIZATION | 258 | 3.31e-02 | -7.74e-02 | 2.73e-01 |
| GOBP PEPTIDYL LYSINE METHYLATION | 42 | 3.86e-01 | 7.74e-02 | 7.25e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER | 9 | 6.88e-01 | 7.74e-02 | 8.97e-01 |
| GOBP REGULATION OF TRANSPORT | 942 | 7.85e-05 | -7.73e-02 | 9.66e-03 |
| GOBP NADP METABOLIC PROCESS | 33 | 4.43e-01 | -7.73e-02 | 7.66e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY | 77 | 2.42e-01 | 7.73e-02 | 6.20e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 13 | 6.30e-01 | 7.72e-02 | 8.67e-01 |
| GOMF IMMUNOGLOBULIN BINDING | 12 | 6.44e-01 | -7.72e-02 | 8.74e-01 |
| GOMF GROWTH FACTOR BINDING | 57 | 3.14e-01 | -7.72e-02 | 6.77e-01 |
| GOBP C21 STEROID HORMONE METABOLIC PROCESS | 13 | 6.30e-01 | -7.71e-02 | 8.67e-01 |
| GOBP SULFUR AMINO ACID METABOLIC PROCESS | 21 | 5.41e-01 | 7.71e-02 | 8.18e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 7 | 7.24e-01 | -7.71e-02 | 9.07e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 8 | 7.06e-01 | -7.71e-02 | 9.02e-01 |
| GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS | 59 | 3.06e-01 | -7.71e-02 | 6.69e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE | 6 | 7.44e-01 | -7.71e-02 | 9.15e-01 |
| GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING | 13 | 6.31e-01 | 7.71e-02 | 8.67e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 29 | 4.73e-01 | -7.70e-02 | 7.79e-01 |
| GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 88 | 2.13e-01 | -7.70e-02 | 5.88e-01 |
| GOCC GPI ANCHOR TRANSAMIDASE COMPLEX | 5 | 7.66e-01 | 7.69e-02 | 9.26e-01 |
| GOBP REGULATION OF PROTEIN BINDING | 97 | 1.91e-01 | -7.69e-02 | 5.62e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT SIZE | 222 | 4.92e-02 | -7.69e-02 | 3.22e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 39 | 4.07e-01 | -7.69e-02 | 7.43e-01 |
| GOBP TRANSLATIONAL READTHROUGH | 7 | 7.25e-01 | -7.69e-02 | 9.07e-01 |
| GOCC PLASMA MEMBRANE RAFT | 56 | 3.20e-01 | 7.68e-02 | 6.80e-01 |
| GOBP PIGMENTATION | 69 | 2.71e-01 | -7.68e-02 | 6.48e-01 |
| GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT | 8 | 7.07e-01 | 7.68e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION | 14 | 6.19e-01 | -7.67e-02 | 8.62e-01 |
| GOCC M BAND | 9 | 6.90e-01 | 7.67e-02 | 8.97e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 254 | 3.62e-02 | -7.67e-02 | 2.84e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 19 | 5.63e-01 | 7.66e-02 | 8.31e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS | 213 | 5.49e-02 | 7.66e-02 | 3.41e-01 |
| GOBP NUCLEOTIDE TRANSPORT | 34 | 4.40e-01 | 7.66e-02 | 7.64e-01 |
| GOBP POSITIVE REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 5 | 7.67e-01 | -7.65e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION | 335 | 1.68e-02 | -7.65e-02 | 2.03e-01 |
| GOCC PLATELET ALPHA GRANULE MEMBRANE | 10 | 6.75e-01 | -7.65e-02 | 8.90e-01 |
| GOBP PROTEIN MATURATION BY PROTEIN FOLDING | 7 | 7.26e-01 | 7.64e-02 | 9.07e-01 |
| GOBP EMBRYONIC HEART TUBE DEVELOPMENT | 37 | 4.21e-01 | -7.64e-02 | 7.54e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION | 650 | 1.02e-03 | -7.64e-02 | 4.80e-02 |
| GOCC CYTOPLASMIC SIDE OF MEMBRANE | 149 | 1.08e-01 | -7.64e-02 | 4.54e-01 |
| GOMF ANTIGEN BINDING | 55 | 3.28e-01 | 7.64e-02 | 6.85e-01 |
| GOMF G QUADRUPLEX RNA BINDING | 5 | 7.67e-01 | -7.64e-02 | 9.27e-01 |
| GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS | 981 | 7.04e-05 | -7.64e-02 | 8.93e-03 |
| GOBP RESPONSE TO TYPE II INTERFERON | 94 | 2.01e-01 | -7.64e-02 | 5.76e-01 |
| GOBP SKIN EPIDERMIS DEVELOPMENT | 51 | 3.46e-01 | -7.63e-02 | 6.98e-01 |
| GOBP LEUKOCYTE APOPTOTIC PROCESS | 89 | 2.15e-01 | -7.62e-02 | 5.90e-01 |
| GOBP NERVE DEVELOPMENT | 32 | 4.56e-01 | -7.62e-02 | 7.73e-01 |
| GOBP REGULATION OF REPRODUCTIVE PROCESS | 92 | 2.08e-01 | -7.62e-02 | 5.83e-01 |
| GOBP COLLAGEN FIBRIL ORGANIZATION | 18 | 5.76e-01 | -7.61e-02 | 8.37e-01 |
| GOBP EXPORT ACROSS PLASMA MEMBRANE | 29 | 4.78e-01 | 7.61e-02 | 7.82e-01 |
| GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT | 35 | 4.36e-01 | -7.61e-02 | 7.61e-01 |
| GOMF 3 5 EXONUCLEASE ACTIVITY | 51 | 3.48e-01 | 7.60e-02 | 7.00e-01 |
| GOMF RIBOSOME BINDING | 99 | 1.93e-01 | -7.59e-02 | 5.65e-01 |
| GOBP REGULATION OF CELL GROWTH | 242 | 4.29e-02 | -7.59e-02 | 3.07e-01 |
| GOBP DISACCHARIDE METABOLIC PROCESS | 6 | 7.48e-01 | 7.59e-02 | 9.17e-01 |
| GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION | 7 | 7.28e-01 | 7.59e-02 | 9.08e-01 |
| GOBP REGULATION OF T CELL ACTIVATION | 267 | 3.37e-02 | -7.59e-02 | 2.77e-01 |
| GOBP REGULATION OF CELL CYCLE PHASE TRANSITION | 309 | 2.28e-02 | 7.58e-02 | 2.35e-01 |
| GOBP REGULATION OF PROTEIN SUMOYLATION | 20 | 5.58e-01 | 7.58e-02 | 8.28e-01 |
| GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING | 13 | 6.37e-01 | 7.57e-02 | 8.70e-01 |
| GOCC TRAPPII PROTEIN COMPLEX | 11 | 6.64e-01 | 7.57e-02 | 8.84e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY | 5 | 7.69e-01 | 7.57e-02 | 9.28e-01 |
| GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX | 10 | 6.79e-01 | -7.57e-02 | 8.91e-01 |
| GOBP NCRNA METABOLIC PROCESS | 519 | 3.50e-03 | 7.56e-02 | 9.41e-02 |
| GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING | 33 | 4.53e-01 | -7.56e-02 | 7.71e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 9 | 6.95e-01 | -7.56e-02 | 8.98e-01 |
| GOBP LYMPHOCYTE CHEMOTAXIS | 26 | 5.05e-01 | 7.56e-02 | 7.96e-01 |
| GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 24 | 5.22e-01 | 7.56e-02 | 8.07e-01 |
| GOCC GTPASE ACTIVATOR COMPLEX | 11 | 6.64e-01 | -7.56e-02 | 8.84e-01 |
| GOBP LEUKOCYTE MEDIATED IMMUNITY | 279 | 3.07e-02 | -7.55e-02 | 2.66e-01 |
| GOMF RIBONUCLEOPROTEIN COMPLEX BINDING | 156 | 1.05e-01 | -7.55e-02 | 4.50e-01 |
| GOMF OMEGA PEPTIDASE ACTIVITY | 8 | 7.12e-01 | 7.55e-02 | 9.04e-01 |
| GOMF COBALAMIN BINDING | 7 | 7.30e-01 | 7.54e-02 | 9.09e-01 |
| GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 37 | 4.28e-01 | -7.54e-02 | 7.58e-01 |
| GOMF MAGNESIUM ION BINDING | 162 | 9.86e-02 | 7.54e-02 | 4.38e-01 |
| GOCC AXOLEMMA | 6 | 7.49e-01 | -7.54e-02 | 9.18e-01 |
| GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS | 63 | 3.01e-01 | 7.54e-02 | 6.65e-01 |
| GOCC MITOCHONDRIAL MATRIX | 415 | 8.94e-03 | 7.54e-02 | 1.56e-01 |
| GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE | 20 | 5.60e-01 | 7.53e-02 | 8.29e-01 |
| GOBP VENTRAL SPINAL CORD DEVELOPMENT | 15 | 6.14e-01 | 7.53e-02 | 8.59e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 52 | 3.48e-01 | -7.53e-02 | 7.00e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 21 | 5.51e-01 | 7.53e-02 | 8.23e-01 |
| GOBP SUPRAMOLECULAR FIBER ORGANIZATION | 464 | 5.90e-03 | -7.52e-02 | 1.30e-01 |
| GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY | 5 | 7.71e-01 | 7.52e-02 | 9.29e-01 |
| GOBP BONE RESORPTION | 38 | 4.23e-01 | -7.52e-02 | 7.55e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION | 24 | 5.25e-01 | -7.50e-02 | 8.08e-01 |
| GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 10 | 6.81e-01 | 7.50e-02 | 8.93e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 45 | 3.84e-01 | -7.50e-02 | 7.24e-01 |
| GOMF PEPTIDASE REGULATOR ACTIVITY | 99 | 1.98e-01 | -7.50e-02 | 5.72e-01 |
| GOBP VIRAL TRANSCRIPTION | 44 | 3.90e-01 | -7.50e-02 | 7.28e-01 |
| GOBP SNRNA TRANSCRIPTION | 17 | 5.93e-01 | -7.49e-02 | 8.47e-01 |
| GOBP RETINA LAYER FORMATION | 8 | 7.14e-01 | -7.49e-02 | 9.05e-01 |
| GOMF CYTOSKELETAL MOTOR ACTIVITY | 52 | 3.51e-01 | -7.49e-02 | 7.01e-01 |
| GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 170 | 9.32e-02 | -7.49e-02 | 4.26e-01 |
| GOBP SENSORY ORGAN DEVELOPMENT | 224 | 5.46e-02 | -7.48e-02 | 3.40e-01 |
| GOBP NEURAL TUBE FORMATION | 69 | 2.83e-01 | -7.48e-02 | 6.55e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 591 | 2.13e-03 | -7.48e-02 | 7.05e-02 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 8 | 7.14e-01 | 7.48e-02 | 9.05e-01 |
| GOBP ORGANIC CATION TRANSPORT | 26 | 5.10e-01 | -7.47e-02 | 7.99e-01 |
| GOMF MHC PROTEIN COMPLEX BINDING | 31 | 4.72e-01 | 7.47e-02 | 7.79e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 12 | 6.54e-01 | -7.46e-02 | 8.78e-01 |
| GOCC NUCLEOSOME | 34 | 4.52e-01 | 7.46e-02 | 7.70e-01 |
| GOMF BETA TUBULIN BINDING | 31 | 4.72e-01 | -7.46e-02 | 7.79e-01 |
| GOBP DNA METABOLIC PROCESS | 781 | 4.77e-04 | 7.46e-02 | 2.91e-02 |
| GOCC NUCLEOID | 42 | 4.03e-01 | 7.46e-02 | 7.41e-01 |
| GOCC CYTOPLASMIC MICROTUBULE | 52 | 3.53e-01 | -7.45e-02 | 7.03e-01 |
| GOBP AMIDE TRANSPORT | 175 | 9.00e-02 | -7.45e-02 | 4.24e-01 |
| GOMF ATPASE BINDING | 56 | 3.35e-01 | -7.45e-02 | 6.89e-01 |
| GOCC BLOC COMPLEX | 13 | 6.42e-01 | 7.45e-02 | 8.73e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE | 526 | 3.80e-03 | -7.45e-02 | 9.82e-02 |
| GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX | 112 | 1.75e-01 | -7.44e-02 | 5.41e-01 |
| GOBP PEROXISOMAL TRANSPORT | 21 | 5.55e-01 | -7.44e-02 | 8.26e-01 |
| GOBP STEM CELL DIFFERENTIATION | 123 | 1.55e-01 | -7.44e-02 | 5.20e-01 |
| GOBP ACTIN FILAMENT DEPOLYMERIZATION | 38 | 4.28e-01 | -7.43e-02 | 7.58e-01 |
| GOBP NEURAL TUBE PATTERNING | 18 | 5.85e-01 | -7.43e-02 | 8.42e-01 |
| GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX | 6 | 7.53e-01 | -7.43e-02 | 9.19e-01 |
| GOMF GLUTATHIONE BINDING | 7 | 7.34e-01 | -7.42e-02 | 9.10e-01 |
| GOBP HOMEOSTATIC PROCESS | 961 | 1.32e-04 | -7.42e-02 | 1.36e-02 |
| GOBP DENDRITIC CELL CYTOKINE PRODUCTION | 17 | 5.97e-01 | 7.42e-02 | 8.49e-01 |
| GOBP MONOAMINE TRANSPORT | 28 | 4.97e-01 | -7.41e-02 | 7.92e-01 |
| GOCC TRANSCRIPTION REGULATOR COMPLEX | 350 | 1.79e-02 | -7.41e-02 | 2.09e-01 |
| GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING | 5 | 7.74e-01 | -7.41e-02 | 9.30e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 7 | 7.34e-01 | 7.41e-02 | 9.10e-01 |
| GOMF IGG BINDING | 6 | 7.53e-01 | 7.41e-02 | 9.19e-01 |
| GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX | 9 | 7.00e-01 | -7.41e-02 | 9.01e-01 |
| GOBP NEGATIVE REGULATION OF GROWTH | 131 | 1.44e-01 | -7.40e-02 | 5.05e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST FUSION | 9 | 7.01e-01 | -7.40e-02 | 9.01e-01 |
| GOBP REGULATION OF MRNA 3 END PROCESSING | 12 | 6.57e-01 | -7.40e-02 | 8.80e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 90 | 2.26e-01 | -7.40e-02 | 6.01e-01 |
| GOBP INTERLEUKIN 23 PRODUCTION | 6 | 7.54e-01 | -7.39e-02 | 9.19e-01 |
| GOBP NERVOUS SYSTEM PROCESS | 415 | 1.04e-02 | -7.39e-02 | 1.69e-01 |
| GOBP MACROPHAGE CHEMOTAXIS | 20 | 5.67e-01 | 7.39e-02 | 8.33e-01 |
| GOMF C C CHEMOKINE BINDING | 10 | 6.86e-01 | 7.39e-02 | 8.96e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 12 | 6.58e-01 | -7.39e-02 | 8.80e-01 |
| GOBP INDOLALKYLAMINE METABOLIC PROCESS | 9 | 7.02e-01 | 7.38e-02 | 9.01e-01 |
| GOBP TRYPTOPHAN METABOLIC PROCESS | 9 | 7.02e-01 | 7.38e-02 | 9.01e-01 |
| GOBP TORC1 SIGNALING | 89 | 2.30e-01 | -7.37e-02 | 6.07e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMATIN | 32 | 4.71e-01 | 7.37e-02 | 7.79e-01 |
| GOBP PHOTOPERIODISM | 21 | 5.59e-01 | -7.37e-02 | 8.29e-01 |
| GOBP GERM CELL PROLIFERATION | 7 | 7.36e-01 | -7.37e-02 | 9.11e-01 |
| GOBP REGULATION OF HISTONE MODIFICATION | 34 | 4.58e-01 | 7.36e-02 | 7.74e-01 |
| GOBP REGULATION OF METAPHASE PLATE CONGRESSION | 9 | 7.03e-01 | -7.35e-02 | 9.01e-01 |
| GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA | 11 | 6.73e-01 | -7.35e-02 | 8.88e-01 |
| GOBP EXECUTION PHASE OF APOPTOSIS | 49 | 3.74e-01 | -7.35e-02 | 7.16e-01 |
| GOCC BASAL PART OF CELL | 148 | 1.24e-01 | -7.34e-02 | 4.79e-01 |
| GOMF FOUR WAY JUNCTION DNA BINDING | 16 | 6.11e-01 | -7.34e-02 | 8.57e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 50 | 3.70e-01 | -7.33e-02 | 7.14e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNITY | 54 | 3.52e-01 | -7.33e-02 | 7.02e-01 |
| GOBP HEMATOPOIETIC STEM CELL PROLIFERATION | 22 | 5.52e-01 | -7.32e-02 | 8.24e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORT | 518 | 4.78e-03 | -7.31e-02 | 1.13e-01 |
| GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 10 | 6.89e-01 | 7.31e-02 | 8.97e-01 |
| GOMF ACTIVIN RECEPTOR ACTIVITY | 7 | 7.38e-01 | -7.31e-02 | 9.12e-01 |
| GOBP HEART DEVELOPMENT | 291 | 3.30e-02 | -7.30e-02 | 2.72e-01 |
| GOMF SULFURTRANSFERASE ACTIVITY | 9 | 7.04e-01 | -7.30e-02 | 9.02e-01 |
| GOBP REGULATION OF CELL DIFFERENTIATION | 843 | 3.99e-04 | -7.30e-02 | 2.66e-02 |
| GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 141 | 1.36e-01 | -7.29e-02 | 4.94e-01 |
| GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION | 6 | 7.57e-01 | 7.29e-02 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF PINOCYTOSIS | 7 | 7.39e-01 | -7.28e-02 | 9.12e-01 |
| GOMF TRANSCRIPTION FACTOR BINDING | 452 | 8.52e-03 | -7.28e-02 | 1.53e-01 |
| GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 34 | 4.63e-01 | -7.28e-02 | 7.77e-01 |
| GOBP RESPONSE TO HYDROXYUREA | 9 | 7.05e-01 | -7.28e-02 | 9.02e-01 |
| GOBP NEURAL CREST CELL DIFFERENTIATION | 38 | 4.38e-01 | -7.28e-02 | 7.62e-01 |
| GOBP IMMUNE SYSTEM DEVELOPMENT | 136 | 1.44e-01 | -7.27e-02 | 5.05e-01 |
| GOBP REGULATION OF MICROTUBULE BASED PROCESS | 171 | 1.02e-01 | 7.27e-02 | 4.46e-01 |
| GOBP OLIGODENDROCYTE DIFFERENTIATION | 43 | 4.10e-01 | -7.27e-02 | 7.46e-01 |
| GOCC MEMBRANE PROTEIN COMPLEX | 732 | 9.60e-04 | -7.27e-02 | 4.59e-02 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS | 10 | 6.91e-01 | 7.26e-02 | 8.97e-01 |
| GOBP ALPHA BETA T CELL ACTIVATION | 139 | 1.41e-01 | -7.26e-02 | 5.00e-01 |
| GOBP REGULATION OF CATABOLIC PROCESS | 779 | 6.85e-04 | -7.26e-02 | 3.66e-02 |
| GOBP MUSCLE CELL APOPTOTIC PROCESS | 42 | 4.16e-01 | -7.26e-02 | 7.51e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING | 19 | 5.84e-01 | -7.26e-02 | 8.41e-01 |
| GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY | 36 | 4.52e-01 | -7.25e-02 | 7.70e-01 |
| GOBP NADPH REGENERATION | 20 | 5.75e-01 | -7.25e-02 | 8.37e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS | 19 | 5.85e-01 | -7.24e-02 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 12 | 6.64e-01 | 7.24e-02 | 8.84e-01 |
| GOBP RENAL SODIUM ION ABSORPTION | 6 | 7.59e-01 | 7.24e-02 | 9.22e-01 |
| GOBP RENAL SODIUM ION TRANSPORT | 6 | 7.59e-01 | 7.24e-02 | 9.22e-01 |
| GOMF STEROID BINDING | 52 | 3.67e-01 | -7.24e-02 | 7.11e-01 |
| GOBP CITRATE METABOLIC PROCESS | 5 | 7.79e-01 | 7.24e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS | 236 | 5.65e-02 | 7.24e-02 | 3.47e-01 |
| GOBP MYOBLAST DIFFERENTIATION | 65 | 3.13e-01 | -7.24e-02 | 6.76e-01 |
| GOBP REGULATION OF DNA METHYLATION | 13 | 6.51e-01 | 7.24e-02 | 8.77e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 28 | 5.08e-01 | -7.24e-02 | 7.97e-01 |
| GOCC PSEUDOPODIUM | 11 | 6.78e-01 | -7.23e-02 | 8.91e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 7.59e-01 | 7.23e-02 | 9.23e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT | 10 | 6.92e-01 | 7.23e-02 | 8.97e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 21 | 5.67e-01 | 7.23e-02 | 8.33e-01 |
| GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY | 5 | 7.80e-01 | -7.22e-02 | 9.31e-01 |
| GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 14 | 6.40e-01 | -7.21e-02 | 8.72e-01 |
| GOCC MIDBODY | 169 | 1.07e-01 | -7.21e-02 | 4.52e-01 |
| GOBP SISTER CHROMATID COHESION | 43 | 4.14e-01 | -7.21e-02 | 7.50e-01 |
| GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 9 | 7.08e-01 | -7.20e-02 | 9.03e-01 |
| GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS | 5 | 7.80e-01 | -7.20e-02 | 9.32e-01 |
| GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME | 10 | 6.93e-01 | 7.20e-02 | 8.98e-01 |
| GOBP REGULATION OF CIRCADIAN RHYTHM | 78 | 2.72e-01 | -7.20e-02 | 6.50e-01 |
| GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE | 7 | 7.42e-01 | 7.19e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 14 | 6.41e-01 | 7.19e-02 | 8.73e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 10 | 6.94e-01 | 7.19e-02 | 8.98e-01 |
| GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY | 6 | 7.60e-01 | -7.19e-02 | 9.24e-01 |
| GOCC SPLICEOSOMAL SNRNP COMPLEX | 64 | 3.21e-01 | -7.19e-02 | 6.80e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE | 91 | 2.37e-01 | -7.18e-02 | 6.15e-01 |
| GOBP ORGANIC HYDROXY COMPOUND TRANSPORT | 136 | 1.49e-01 | -7.18e-02 | 5.12e-01 |
| GOMF RNA 7 METHYLGUANOSINE CAP BINDING | 12 | 6.67e-01 | 7.18e-02 | 8.86e-01 |
| GOBP VESICLE LOCALIZATION | 162 | 1.16e-01 | -7.17e-02 | 4.64e-01 |
| GOBP MATING BEHAVIOR | 13 | 6.55e-01 | 7.17e-02 | 8.78e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS | 34 | 4.70e-01 | 7.16e-02 | 7.79e-01 |
| GOCC MYOSIN COMPLEX | 23 | 5.52e-01 | -7.16e-02 | 8.24e-01 |
| GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 5 | 7.81e-01 | -7.16e-02 | 9.32e-01 |
| GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 6.81e-01 | -7.16e-02 | 8.93e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 54 | 3.63e-01 | -7.16e-02 | 7.10e-01 |
| GOBP MUSCLE STRUCTURE DEVELOPMENT | 336 | 2.50e-02 | -7.16e-02 | 2.44e-01 |
| GOBP OSTEOCLAST DIFFERENTIATION | 69 | 3.05e-01 | -7.16e-02 | 6.68e-01 |
| GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY | 22 | 5.62e-01 | -7.15e-02 | 8.30e-01 |
| GOBP GERMINAL CENTER B CELL DIFFERENTIATION | 5 | 7.82e-01 | 7.14e-02 | 9.32e-01 |
| GOBP AXO DENDRITIC TRANSPORT | 56 | 3.56e-01 | -7.14e-02 | 7.06e-01 |
| GOMF CADHERIN BINDING | 253 | 5.16e-02 | -7.14e-02 | 3.30e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III | 8 | 7.27e-01 | -7.14e-02 | 9.07e-01 |
| GOCC TIGHT JUNCTION | 58 | 3.48e-01 | -7.14e-02 | 6.99e-01 |
| GOBP CELLULAR RESPONSE TO IONIZING RADIATION | 54 | 3.65e-01 | 7.13e-02 | 7.11e-01 |
| GOMF PHOSPHATASE REGULATOR ACTIVITY | 73 | 2.93e-01 | 7.13e-02 | 6.61e-01 |
| GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY | 8 | 7.27e-01 | -7.13e-02 | 9.08e-01 |
| GOBP CELL KILLING | 124 | 1.71e-01 | -7.13e-02 | 5.36e-01 |
| GOBP CELLULAR RESPONSE TO RADIATION | 124 | 1.71e-01 | 7.13e-02 | 5.36e-01 |
| GOBP RENAL ABSORPTION | 13 | 6.57e-01 | 7.13e-02 | 8.79e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION INITIATION | 123 | 1.73e-01 | -7.12e-02 | 5.39e-01 |
| GOBP ENDODERMAL CELL DIFFERENTIATION | 18 | 6.01e-01 | -7.12e-02 | 8.51e-01 |
| GOBP BIOMINERAL TISSUE DEVELOPMENT | 77 | 2.81e-01 | -7.12e-02 | 6.54e-01 |
| GOBP POST ANAL TAIL MORPHOGENESIS | 7 | 7.44e-01 | 7.12e-02 | 9.15e-01 |
| GOMF HEXOSYLTRANSFERASE ACTIVITY | 113 | 1.92e-01 | 7.12e-02 | 5.64e-01 |
| GOBP PEPTIDE METABOLIC PROCESS | 689 | 1.69e-03 | -7.11e-02 | 6.22e-02 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 27 | 5.23e-01 | -7.11e-02 | 8.08e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT | 10 | 6.97e-01 | 7.11e-02 | 9.00e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE | 45 | 4.10e-01 | -7.10e-02 | 7.46e-01 |
| GOCC ENDOLYSOSOME MEMBRANE | 16 | 6.23e-01 | 7.10e-02 | 8.63e-01 |
| GOBP VIRION ASSEMBLY | 31 | 4.94e-01 | -7.10e-02 | 7.90e-01 |
| GOMF CYTOSKELETAL ANCHOR ACTIVITY | 16 | 6.23e-01 | -7.09e-02 | 8.63e-01 |
| GOMF U6 SNRNA BINDING | 14 | 6.46e-01 | -7.09e-02 | 8.75e-01 |
| GOBP RESPONSE TO ACTIVITY | 37 | 4.56e-01 | -7.09e-02 | 7.73e-01 |
| GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS | 99 | 2.24e-01 | -7.09e-02 | 5.99e-01 |
| GOBP OOGENESIS | 48 | 3.96e-01 | 7.08e-02 | 7.35e-01 |
| GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX | 9 | 7.13e-01 | 7.08e-02 | 9.05e-01 |
| GOBP SUPPRESSION OF VIRAL RELEASE BY HOST | 11 | 6.84e-01 | -7.08e-02 | 8.95e-01 |
| GOBP REGULATION OF MEMBRANE PERMEABILITY | 53 | 3.73e-01 | -7.08e-02 | 7.16e-01 |
| GOCC PERINUCLEAR REGION OF CYTOPLASM | 482 | 8.33e-03 | -7.08e-02 | 1.52e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 17 | 6.14e-01 | -7.08e-02 | 8.59e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I | 27 | 5.25e-01 | 7.07e-02 | 8.08e-01 |
| GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING | 9 | 7.13e-01 | -7.07e-02 | 9.05e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 33 | 4.82e-01 | -7.07e-02 | 7.84e-01 |
| GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 24 | 5.49e-01 | 7.07e-02 | 8.23e-01 |
| GOBP ENDOSOMAL TRANSPORT | 206 | 8.15e-02 | -7.07e-02 | 4.09e-01 |
| GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS | 14 | 6.47e-01 | -7.07e-02 | 8.76e-01 |
| GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 21 | 5.76e-01 | -7.06e-02 | 8.37e-01 |
| GOBP PIGMENT BIOSYNTHETIC PROCESS | 38 | 4.52e-01 | 7.06e-02 | 7.70e-01 |
| GOMF U1 SNRNP BINDING | 6 | 7.65e-01 | -7.06e-02 | 9.26e-01 |
| GOMF LIGASE ACTIVITY | 117 | 1.88e-01 | 7.06e-02 | 5.59e-01 |
| GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION | 29 | 5.11e-01 | 7.06e-02 | 8.00e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 13 | 6.60e-01 | -7.05e-02 | 8.82e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 38 | 4.52e-01 | -7.05e-02 | 7.71e-01 |
| GOBP PROTEIN REFOLDING | 19 | 5.95e-01 | 7.05e-02 | 8.48e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 600 | 3.55e-03 | -7.05e-02 | 9.42e-02 |
| GOBP PEPTIDE BIOSYNTHETIC PROCESS | 610 | 3.30e-03 | -7.05e-02 | 9.08e-02 |
| GOBP CELLULAR RESPONSE TO UV | 69 | 3.12e-01 | 7.04e-02 | 6.75e-01 |
| GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 127 | 1.72e-01 | -7.04e-02 | 5.37e-01 |
| GOBP EPITHELIAL TUBE MORPHOGENESIS | 154 | 1.33e-01 | -7.03e-02 | 4.91e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 26 | 5.35e-01 | 7.03e-02 | 8.15e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 180 | 1.05e-01 | -7.03e-02 | 4.50e-01 |
| GOBP FOREBRAIN NEURON DEVELOPMENT | 11 | 6.86e-01 | -7.03e-02 | 8.96e-01 |
| GOBP LEUKOCYTE PROLIFERATION | 223 | 7.23e-02 | -7.01e-02 | 3.89e-01 |
| GOBP RHO PROTEIN SIGNAL TRANSDUCTION | 85 | 2.65e-01 | -7.01e-02 | 6.42e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 875 | 5.38e-04 | -7.01e-02 | 3.14e-02 |
| GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 241 | 6.21e-02 | -7.01e-02 | 3.60e-01 |
| GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS | 269 | 4.91e-02 | -7.00e-02 | 3.22e-01 |
| GOBP EXPLORATION BEHAVIOR | 11 | 6.88e-01 | 7.00e-02 | 8.97e-01 |
| GOBP REGULATION OF ATP METABOLIC PROCESS | 17 | 6.18e-01 | 7.00e-02 | 8.62e-01 |
| GOBP BEHAVIORAL RESPONSE TO PAIN | 7 | 7.49e-01 | -6.99e-02 | 9.17e-01 |
| GOBP AMP SALVAGE | 5 | 7.87e-01 | 6.99e-02 | 9.34e-01 |
| GOCC EXOCYTIC VESICLE | 129 | 1.72e-01 | -6.99e-02 | 5.37e-01 |
| GOMF MONOATOMIC CATION CHANNEL ACTIVITY | 102 | 2.24e-01 | -6.99e-02 | 5.99e-01 |
| GOBP REGULATION OF ENDOCYTOSIS | 189 | 9.89e-02 | -6.99e-02 | 4.39e-01 |
| GOBP DEFENSE RESPONSE TO OTHER ORGANISM | 742 | 1.41e-03 | -6.98e-02 | 5.81e-02 |
| GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS | 95 | 2.40e-01 | 6.98e-02 | 6.18e-01 |
| GOMF ALCOHOL BINDING | 45 | 4.18e-01 | -6.98e-02 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 17 | 6.19e-01 | -6.97e-02 | 8.62e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS | 22 | 5.72e-01 | 6.97e-02 | 8.34e-01 |
| GOBP ADAPTIVE THERMOGENESIS | 109 | 2.10e-01 | -6.97e-02 | 5.84e-01 |
| GOBP APOPTOTIC MITOCHONDRIAL CHANGES | 83 | 2.73e-01 | -6.97e-02 | 6.51e-01 |
| GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION | 462 | 1.10e-02 | -6.96e-02 | 1.73e-01 |
| GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT | 36 | 4.70e-01 | 6.96e-02 | 7.79e-01 |
| GOCC BASOLATERAL PLASMA MEMBRANE | 123 | 1.84e-01 | -6.96e-02 | 5.53e-01 |
| GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION | 464 | 1.09e-02 | -6.95e-02 | 1.73e-01 |
| GOBP HEMATOPOIETIC STEM CELL MIGRATION | 6 | 7.68e-01 | 6.95e-02 | 9.28e-01 |
| GOMF CHEMOKINE BINDING | 16 | 6.30e-01 | -6.95e-02 | 8.67e-01 |
| GOBP AMIDE BIOSYNTHETIC PROCESS | 699 | 2.00e-03 | -6.95e-02 | 6.78e-02 |
| GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY | 12 | 6.77e-01 | 6.95e-02 | 8.91e-01 |
| GOBP ANIMAL ORGAN MORPHOGENESIS | 423 | 1.50e-02 | -6.95e-02 | 1.96e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 17 | 6.20e-01 | -6.95e-02 | 8.62e-01 |
| GOBP KINETOCHORE ASSEMBLY | 16 | 6.31e-01 | 6.94e-02 | 8.67e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS | 8 | 7.34e-01 | -6.94e-02 | 9.10e-01 |
| GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT | 501 | 8.46e-03 | -6.94e-02 | 1.53e-01 |
| GOMF 14 3 3 PROTEIN BINDING | 27 | 5.33e-01 | 6.93e-02 | 8.15e-01 |
| GOCC CHROMAFFIN GRANULE MEMBRANE | 7 | 7.51e-01 | 6.93e-02 | 9.18e-01 |
| GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 673 | 2.48e-03 | -6.93e-02 | 7.73e-02 |
| GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 10 | 7.05e-01 | -6.93e-02 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 26 | 5.41e-01 | 6.93e-02 | 8.18e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION | 59 | 3.58e-01 | -6.92e-02 | 7.09e-01 |
| GOBP INTERLEUKIN 6 PRODUCTION | 106 | 2.19e-01 | -6.92e-02 | 5.95e-01 |
| GOBP REGULATORY NCRNA PROCESSING | 58 | 3.63e-01 | -6.92e-02 | 7.10e-01 |
| GOCC UBIQUITIN LIGASE COMPLEX | 271 | 5.14e-02 | -6.91e-02 | 3.29e-01 |
| GOMF ELECTRON TRANSFER ACTIVITY | 96 | 2.43e-01 | -6.90e-02 | 6.21e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 154 | 1.41e-01 | 6.90e-02 | 5.00e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS | 10 | 7.06e-01 | 6.90e-02 | 9.02e-01 |
| GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION | 5 | 7.90e-01 | -6.89e-02 | 9.36e-01 |
| GOBP RESPONSE TO ALCOHOL | 139 | 1.62e-01 | 6.88e-02 | 5.28e-01 |
| GOBP REGULATION OF T CELL MIGRATION | 32 | 5.01e-01 | 6.88e-02 | 7.92e-01 |
| GOBP POSITIVE REGULATION OF VESICLE FUSION | 6 | 7.71e-01 | -6.87e-02 | 9.29e-01 |
| GOBP PHOTORECEPTOR CELL DEVELOPMENT | 18 | 6.14e-01 | 6.87e-02 | 8.59e-01 |
| GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION | 21 | 5.86e-01 | -6.87e-02 | 8.42e-01 |
| GOMF SERINE HYDROLASE ACTIVITY | 57 | 3.70e-01 | -6.87e-02 | 7.14e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 38 | 4.64e-01 | -6.87e-02 | 7.77e-01 |
| GOBP MAINTENANCE OF CELL NUMBER | 128 | 1.81e-01 | -6.87e-02 | 5.48e-01 |
| GOCC SAGA TYPE COMPLEX | 36 | 4.77e-01 | 6.86e-02 | 7.81e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 140 | 1.62e-01 | -6.86e-02 | 5.28e-01 |
| GOMF FUCOSE BINDING | 5 | 7.91e-01 | -6.86e-02 | 9.36e-01 |
| GOBP NEURON CELLULAR HOMEOSTASIS | 40 | 4.54e-01 | -6.85e-02 | 7.72e-01 |
| GOBP IMPORT ACROSS PLASMA MEMBRANE | 82 | 2.85e-01 | 6.85e-02 | 6.55e-01 |
| GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT | 5 | 7.91e-01 | -6.85e-02 | 9.36e-01 |
| GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION | 21 | 5.87e-01 | -6.85e-02 | 8.43e-01 |
| GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 5.46e-01 | -6.85e-02 | 8.22e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 22 | 5.79e-01 | 6.84e-02 | 8.38e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 70 | 3.23e-01 | -6.84e-02 | 6.81e-01 |
| GOMF DEUBIQUITINASE ACTIVITY | 80 | 2.91e-01 | -6.84e-02 | 6.60e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HEAT | 15 | 6.47e-01 | -6.84e-02 | 8.75e-01 |
| GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE | 20 | 5.97e-01 | -6.84e-02 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 5 | 7.91e-01 | 6.84e-02 | 9.36e-01 |
| GOBP SKELETAL SYSTEM MORPHOGENESIS | 91 | 2.61e-01 | -6.84e-02 | 6.38e-01 |
| GOBP RESPONSE TO HYDROSTATIC PRESSURE | 5 | 7.92e-01 | -6.83e-02 | 9.36e-01 |
| GOCC TRNA SPLICING LIGASE COMPLEX | 8 | 7.38e-01 | 6.83e-02 | 9.12e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 30 | 5.18e-01 | -6.82e-02 | 8.04e-01 |
| GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA | 12 | 6.83e-01 | 6.81e-02 | 8.94e-01 |
| GOBP CELLULAR COMPONENT MORPHOGENESIS | 374 | 2.47e-02 | -6.81e-02 | 2.43e-01 |
| GOBP UBIQUINONE METABOLIC PROCESS | 15 | 6.48e-01 | 6.80e-02 | 8.76e-01 |
| GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 218 | 8.48e-02 | -6.80e-02 | 4.12e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 52 | 3.97e-01 | -6.80e-02 | 7.35e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 37 | 4.75e-01 | -6.80e-02 | 7.80e-01 |
| GOBP MIDBRAIN DEVELOPMENT | 50 | 4.06e-01 | -6.79e-02 | 7.43e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 115 | 2.09e-01 | -6.79e-02 | 5.84e-01 |
| GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY | 57 | 3.76e-01 | 6.79e-02 | 7.17e-01 |
| GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 136 | 1.73e-01 | -6.79e-02 | 5.39e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 15 | 6.49e-01 | -6.79e-02 | 8.76e-01 |
| GOBP ACTIVATED T CELL PROLIFERATION | 28 | 5.34e-01 | -6.79e-02 | 8.15e-01 |
| GOCC PERIKARYON | 55 | 3.85e-01 | 6.78e-02 | 7.24e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING KINASE ACTIVITY | 5 | 7.93e-01 | 6.78e-02 | 9.36e-01 |
| GOBP INFLAMMATORY CELL APOPTOTIC PROCESS | 16 | 6.39e-01 | -6.78e-02 | 8.71e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 161 | 1.39e-01 | -6.78e-02 | 4.97e-01 |
| GOBP GOLGI LOCALIZATION | 13 | 6.72e-01 | -6.78e-02 | 8.88e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE STARVATION | 12 | 6.85e-01 | 6.77e-02 | 8.95e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS | 132 | 1.80e-01 | -6.77e-02 | 5.48e-01 |
| GOBP T HELPER 17 TYPE IMMUNE RESPONSE | 33 | 5.01e-01 | -6.77e-02 | 7.92e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 750 | 1.87e-03 | -6.77e-02 | 6.56e-02 |
| GOMF ACID THIOL LIGASE ACTIVITY | 19 | 6.10e-01 | 6.77e-02 | 8.56e-01 |
| GOCC MPP7 DLG1 LIN7 COMPLEX | 5 | 7.93e-01 | -6.76e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 23 | 5.75e-01 | 6.75e-02 | 8.37e-01 |
| GOBP REGULATION OF CELL SIZE | 108 | 2.26e-01 | -6.75e-02 | 6.01e-01 |
| GOCC CELL CELL CONTACT ZONE | 41 | 4.55e-01 | -6.75e-02 | 7.72e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I | 9 | 7.26e-01 | -6.75e-02 | 9.07e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 262 | 6.13e-02 | -6.75e-02 | 3.60e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 933 | 6.00e-04 | -6.75e-02 | 3.36e-02 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 8 | 7.41e-01 | 6.74e-02 | 9.13e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 1012 | 3.74e-04 | -6.74e-02 | 2.62e-02 |
| GOBP CELLULAR RESPONSE TO COPPER ION | 13 | 6.74e-01 | -6.74e-02 | 8.89e-01 |
| GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 18 | 6.21e-01 | -6.73e-02 | 8.62e-01 |
| GOBP ADHERENS JUNCTION ASSEMBLY | 10 | 7.13e-01 | -6.73e-02 | 9.05e-01 |
| GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 165 | 1.37e-01 | -6.73e-02 | 4.95e-01 |
| GOBP LIPOPROTEIN METABOLIC PROCESS | 99 | 2.48e-01 | -6.73e-02 | 6.25e-01 |
| GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY | 10 | 7.13e-01 | 6.73e-02 | 9.05e-01 |
| GOBP CARDIAC CHAMBER DEVELOPMENT | 74 | 3.18e-01 | -6.72e-02 | 6.80e-01 |
| GOMF ALPHA TUBULIN BINDING | 30 | 5.25e-01 | 6.71e-02 | 8.08e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 5 | 7.95e-01 | -6.71e-02 | 9.36e-01 |
| GOBP REGULATION OF TISSUE REMODELING | 36 | 4.87e-01 | 6.71e-02 | 7.85e-01 |
| GOBP PLASMA MEMBRANE TUBULATION | 15 | 6.53e-01 | -6.71e-02 | 8.78e-01 |
| GOCC INTERMEDIATE FILAMENT CYTOSKELETON | 60 | 3.70e-01 | 6.70e-02 | 7.13e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSPORT | 7 | 7.59e-01 | 6.70e-02 | 9.22e-01 |
| GOBP RNA 3 END PROCESSING | 87 | 2.81e-01 | 6.70e-02 | 6.54e-01 |
| GOBP INTRACELLULAR IRON ION HOMEOSTASIS | 49 | 4.18e-01 | -6.70e-02 | 7.52e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 68 | 3.40e-01 | -6.69e-02 | 6.94e-01 |
| GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 164 | 1.40e-01 | -6.69e-02 | 5.00e-01 |
| GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY | 18 | 6.23e-01 | 6.69e-02 | 8.63e-01 |
| GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY | 8 | 7.43e-01 | 6.69e-02 | 9.15e-01 |
| GOMF HSP70 PROTEIN BINDING | 39 | 4.70e-01 | -6.68e-02 | 7.79e-01 |
| GOBP ENDOMEMBRANE SYSTEM ORGANIZATION | 425 | 1.91e-02 | -6.68e-02 | 2.15e-01 |
| GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING | 50 | 4.14e-01 | -6.68e-02 | 7.50e-01 |
| GOBP MESODERM DEVELOPMENT | 50 | 4.14e-01 | -6.68e-02 | 7.50e-01 |
| GOCC NEURON SPINE | 85 | 2.88e-01 | -6.68e-02 | 6.58e-01 |
| GOMF ANTIPORTER ACTIVITY | 81 | 3.00e-01 | -6.68e-02 | 6.64e-01 |
| GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION | 5 | 7.96e-01 | 6.68e-02 | 9.37e-01 |
| GOBP CORONARY VASCULATURE DEVELOPMENT | 24 | 5.72e-01 | -6.67e-02 | 8.34e-01 |
| GOBP POSITIVE REGULATION OF CELL KILLING | 47 | 4.29e-01 | 6.67e-02 | 7.58e-01 |
| GOMF METALLOENDOPEPTIDASE ACTIVITY | 37 | 4.83e-01 | 6.67e-02 | 7.84e-01 |
| GOMF PROFILIN BINDING | 6 | 7.77e-01 | -6.66e-02 | 9.31e-01 |
| GOMF ATP HYDROLYSIS ACTIVITY | 292 | 5.14e-02 | 6.66e-02 | 3.29e-01 |
| GOBP INTEGRATED STRESS RESPONSE SIGNALING | 38 | 4.78e-01 | -6.66e-02 | 7.82e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORYLATION | 378 | 2.73e-02 | -6.66e-02 | 2.55e-01 |
| GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION | 7 | 7.60e-01 | 6.66e-02 | 9.24e-01 |
| GOBP KIDNEY EPITHELIUM DEVELOPMENT | 47 | 4.30e-01 | -6.65e-02 | 7.58e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 5 | 7.97e-01 | -6.65e-02 | 9.37e-01 |
| GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 6 | 7.78e-01 | 6.64e-02 | 9.31e-01 |
| GOBP REGULATION OF CELL DEVELOPMENT | 491 | 1.25e-02 | -6.64e-02 | 1.82e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY | 101 | 2.50e-01 | -6.64e-02 | 6.27e-01 |
| GOBP MEMBRANE ORGANIZATION | 581 | 6.85e-03 | -6.64e-02 | 1.41e-01 |
| GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 26 | 5.58e-01 | -6.63e-02 | 8.29e-01 |
| GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 14 | 6.68e-01 | 6.63e-02 | 8.86e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 511 | 1.11e-02 | -6.62e-02 | 1.73e-01 |
| GOMF FATTY ACID LIGASE ACTIVITY | 11 | 7.04e-01 | 6.62e-02 | 9.02e-01 |
| GOBP RESCUE OF STALLED RIBOSOME | 25 | 5.67e-01 | 6.62e-02 | 8.33e-01 |
| GOBP HINDLIMB MORPHOGENESIS | 10 | 7.17e-01 | -6.62e-02 | 9.06e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER | 8 | 7.46e-01 | -6.62e-02 | 9.16e-01 |
| GOBP CONVERGENT EXTENSION | 6 | 7.79e-01 | 6.62e-02 | 9.31e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS | 44 | 4.48e-01 | 6.62e-02 | 7.68e-01 |
| GOBP RIBONUCLEOSIDE CATABOLIC PROCESS | 12 | 6.92e-01 | -6.62e-02 | 8.97e-01 |
| GOCC POSTSYNAPTIC DENSITY MEMBRANE | 28 | 5.45e-01 | -6.62e-02 | 8.21e-01 |
| GOBP DETECTION OF OTHER ORGANISM | 14 | 6.68e-01 | 6.61e-02 | 8.86e-01 |
| GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY | 11 | 7.04e-01 | 6.61e-02 | 9.02e-01 |
| GOBP BERGMANN GLIAL CELL DIFFERENTIATION | 8 | 7.46e-01 | -6.61e-02 | 9.16e-01 |
| GOBP MESONEPHRIC TUBULE MORPHOGENESIS | 18 | 6.27e-01 | -6.61e-02 | 8.65e-01 |
| GOBP DEMETHYLATION | 33 | 5.12e-01 | -6.61e-02 | 8.00e-01 |
| GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY | 6 | 7.79e-01 | 6.60e-02 | 9.31e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CONTRACTION | 45 | 4.44e-01 | -6.60e-02 | 7.67e-01 |
| GOBP MYELOID LEUKOCYTE ACTIVATION | 168 | 1.41e-01 | -6.60e-02 | 5.01e-01 |
| GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 35 | 5.00e-01 | 6.59e-02 | 7.92e-01 |
| GOBP SEXUAL REPRODUCTION | 513 | 1.13e-02 | -6.59e-02 | 1.73e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING | 43 | 4.55e-01 | -6.59e-02 | 7.72e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 375 | 2.95e-02 | -6.59e-02 | 2.62e-01 |
| GOBP NECROPTOTIC PROCESS | 34 | 5.06e-01 | -6.59e-02 | 7.97e-01 |
| GOBP OSSIFICATION | 208 | 1.03e-01 | -6.58e-02 | 4.48e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 24 | 5.77e-01 | -6.58e-02 | 8.38e-01 |
| GOMF S ACYLTRANSFERASE ACTIVITY | 24 | 5.77e-01 | -6.58e-02 | 8.38e-01 |
| GOBP CELLULAR RESPONSE TO DSRNA | 17 | 6.39e-01 | -6.58e-02 | 8.71e-01 |
| GOBP REGULATION OF PROSTAGLANDIN SECRETION | 8 | 7.47e-01 | -6.57e-02 | 9.17e-01 |
| GOBP CELLULAR CATABOLIC PROCESS | 1128 | 2.72e-04 | -6.57e-02 | 2.14e-02 |
| GOBP RESPONSE TO PROSTAGLANDIN | 15 | 6.60e-01 | 6.57e-02 | 8.82e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 622 | 5.73e-03 | -6.56e-02 | 1.28e-01 |
| GOBP CELLULAR HOMEOSTASIS | 462 | 1.65e-02 | -6.56e-02 | 2.03e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 12 | 6.94e-01 | 6.56e-02 | 8.98e-01 |
| GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 26 | 5.63e-01 | 6.56e-02 | 8.31e-01 |
| GOBP NEUROINFLAMMATORY RESPONSE | 47 | 4.37e-01 | -6.56e-02 | 7.61e-01 |
| GOBP OSTEOBLAST DIFFERENTIATION | 119 | 2.18e-01 | -6.56e-02 | 5.94e-01 |
| GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 7.48e-01 | 6.55e-02 | 9.17e-01 |
| GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 64 | 3.66e-01 | -6.55e-02 | 7.11e-01 |
| GOBP RESPONSE TO ENDOGENOUS STIMULUS | 943 | 8.31e-04 | -6.54e-02 | 4.09e-02 |
| GOBP EPITHELIAL CELL CELL ADHESION | 10 | 7.20e-01 | -6.54e-02 | 9.06e-01 |
| GOBP REGULATION OF MRNA METABOLIC PROCESS | 239 | 8.31e-02 | -6.54e-02 | 4.10e-01 |
| GOCC LATE ENDOSOME | 234 | 8.64e-02 | -6.53e-02 | 4.16e-01 |
| GOBP RESPONSE TO IONIZING RADIATION | 111 | 2.35e-01 | 6.53e-02 | 6.12e-01 |
| GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS | 24 | 5.80e-01 | -6.53e-02 | 8.39e-01 |
| GOBP R LOOP PROCESSING | 6 | 7.82e-01 | 6.53e-02 | 9.32e-01 |
| GOMF CYCLASE REGULATOR ACTIVITY | 7 | 7.65e-01 | -6.53e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 77 | 3.23e-01 | -6.53e-02 | 6.81e-01 |
| GOCC TELOMERASE HOLOENZYME COMPLEX | 19 | 6.23e-01 | 6.53e-02 | 8.63e-01 |
| GOCC CHROMOSOME CENTROMERIC REGION | 191 | 1.21e-01 | 6.52e-02 | 4.75e-01 |
| GOCC CALYX OF HELD | 8 | 7.49e-01 | 6.52e-02 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 76 | 3.26e-01 | -6.52e-02 | 6.83e-01 |
| GOMF CELL CELL ADHESION MEDIATOR ACTIVITY | 22 | 5.97e-01 | -6.52e-02 | 8.49e-01 |
| GOCC XY BODY | 10 | 7.22e-01 | 6.51e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 15 | 6.63e-01 | 6.50e-02 | 8.84e-01 |
| GOBP MAPK CASCADE | 428 | 2.22e-02 | -6.50e-02 | 2.31e-01 |
| GOCC HOST CELLULAR COMPONENT | 7 | 7.66e-01 | 6.50e-02 | 9.26e-01 |
| GOMF LIPOPOLYSACCHARIDE BINDING | 20 | 6.16e-01 | -6.49e-02 | 8.60e-01 |
| GOBP RESPONSE TO BMP | 67 | 3.59e-01 | -6.49e-02 | 7.10e-01 |
| GOBP BARBED END ACTIN FILAMENT CAPPING | 19 | 6.25e-01 | -6.48e-02 | 8.64e-01 |
| GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 41 | 4.73e-01 | 6.48e-02 | 7.79e-01 |
| GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE | 153 | 1.68e-01 | -6.48e-02 | 5.34e-01 |
| GOBP REGULATION OF BLOOD CIRCULATION | 97 | 2.71e-01 | -6.48e-02 | 6.49e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 90 | 2.90e-01 | -6.47e-02 | 6.59e-01 |
| GOBP REGULATION OF B CELL ACTIVATION | 102 | 2.60e-01 | -6.47e-02 | 6.37e-01 |
| GOBP CHROMOSOME LOCALIZATION | 87 | 2.98e-01 | 6.46e-02 | 6.63e-01 |
| GOBP HEAD DEVELOPMENT | 391 | 2.96e-02 | -6.46e-02 | 2.62e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 66 | 3.65e-01 | -6.45e-02 | 7.11e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 21 | 6.09e-01 | -6.45e-02 | 8.56e-01 |
| GOCC CELL CELL JUNCTION | 247 | 8.23e-02 | -6.45e-02 | 4.09e-01 |
| GOBP THYMIC T CELL SELECTION | 16 | 6.56e-01 | -6.44e-02 | 8.78e-01 |
| GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 10 | 7.24e-01 | 6.44e-02 | 9.07e-01 |
| GOBP ACTION POTENTIAL | 56 | 4.05e-01 | 6.44e-02 | 7.42e-01 |
| GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 11 | 7.12e-01 | 6.43e-02 | 9.04e-01 |
| GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 17 | 6.46e-01 | 6.43e-02 | 8.75e-01 |
| GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 18 | 6.37e-01 | 6.43e-02 | 8.70e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT | 9 | 7.39e-01 | -6.42e-02 | 9.12e-01 |
| GOMF COA HYDROLASE ACTIVITY | 13 | 6.89e-01 | 6.42e-02 | 8.97e-01 |
| GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY | 54 | 4.15e-01 | 6.42e-02 | 7.51e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION | 75 | 3.37e-01 | -6.41e-02 | 6.91e-01 |
| GOMF PROTEIN METHYLTRANSFERASE ACTIVITY | 75 | 3.38e-01 | 6.41e-02 | 6.91e-01 |
| GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 33 | 5.24e-01 | -6.41e-02 | 8.08e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT | 7 | 7.69e-01 | -6.41e-02 | 9.28e-01 |
| GOBP REGULATION OF TRANSLATIONAL TERMINATION | 7 | 7.69e-01 | -6.40e-02 | 9.28e-01 |
| GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX | 14 | 6.79e-01 | -6.40e-02 | 8.91e-01 |
| GOMF PROTEIN DOMAIN SPECIFIC BINDING | 452 | 2.08e-02 | -6.40e-02 | 2.25e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 112 | 2.43e-01 | 6.40e-02 | 6.21e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 91 | 2.93e-01 | 6.39e-02 | 6.61e-01 |
| GOBP VIRAL LIFE CYCLE | 239 | 9.04e-02 | -6.39e-02 | 4.24e-01 |
| GOBP CAVEOLIN MEDIATED ENDOCYTOSIS | 7 | 7.70e-01 | 6.39e-02 | 9.28e-01 |
| GOBP CARDIAC MUSCLE CELL CONTRACTION | 30 | 5.45e-01 | 6.38e-02 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 319 | 5.14e-02 | -6.38e-02 | 3.29e-01 |
| GOBP TISSUE MORPHOGENESIS | 274 | 7.05e-02 | -6.38e-02 | 3.84e-01 |
| GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE | 14 | 6.80e-01 | -6.38e-02 | 8.91e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION | 67 | 3.68e-01 | 6.37e-02 | 7.12e-01 |
| GOBP OLFACTORY LOBE DEVELOPMENT | 14 | 6.80e-01 | -6.37e-02 | 8.92e-01 |
| GOMF ACETYLTRANSFERASE ACTIVITY | 78 | 3.32e-01 | -6.37e-02 | 6.87e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 7 | 7.71e-01 | 6.35e-02 | 9.29e-01 |
| GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 34 | 5.22e-01 | 6.34e-02 | 8.07e-01 |
| GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY | 11 | 7.16e-01 | -6.34e-02 | 9.05e-01 |
| GOCC NUCLEAR PERIPHERY | 122 | 2.28e-01 | -6.34e-02 | 6.04e-01 |
| GOBP SYNAPTIC SIGNALING | 326 | 5.05e-02 | -6.34e-02 | 3.27e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 9 | 7.42e-01 | -6.33e-02 | 9.14e-01 |
| GOMF PROSTANOID RECEPTOR ACTIVITY | 5 | 8.06e-01 | -6.33e-02 | 9.41e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 22 | 6.08e-01 | -6.33e-02 | 8.55e-01 |
| GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 12 | 7.05e-01 | -6.32e-02 | 9.02e-01 |
| GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY | 12 | 7.05e-01 | -6.32e-02 | 9.02e-01 |
| GOBP REGULATION OF FATTY ACID METABOLIC PROCESS | 53 | 4.26e-01 | 6.32e-02 | 7.56e-01 |
| GOBP PROTEIN LOCALIZATION TO SYNAPSE | 33 | 5.30e-01 | 6.31e-02 | 8.12e-01 |
| GOBP DENDRITIC TRANSPORT | 9 | 7.43e-01 | -6.31e-02 | 9.14e-01 |
| GOBP ETHER BIOSYNTHETIC PROCESS | 11 | 7.17e-01 | 6.31e-02 | 9.06e-01 |
| GOBP REGULATION OF PEPTIDASE ACTIVITY | 194 | 1.31e-01 | -6.31e-02 | 4.88e-01 |
| GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 28 | 5.64e-01 | 6.31e-02 | 8.31e-01 |
| GOBP AMIDE METABOLIC PROCESS | 882 | 1.77e-03 | -6.31e-02 | 6.37e-02 |
| GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY | 58 | 4.07e-01 | 6.31e-02 | 7.43e-01 |
| GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 15 | 6.73e-01 | 6.30e-02 | 8.88e-01 |
| GOBP ACROSOMAL VESICLE EXOCYTOSIS | 5 | 8.07e-01 | 6.30e-02 | 9.41e-01 |
| GOMF SODIUM PROTON ANTIPORTER ACTIVITY | 7 | 7.73e-01 | -6.30e-02 | 9.29e-01 |
| GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS | 837 | 2.38e-03 | -6.28e-02 | 7.60e-02 |
| GOBP ADULT BEHAVIOR | 64 | 3.85e-01 | -6.28e-02 | 7.25e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY | 6 | 7.90e-01 | -6.28e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS | 1225 | 3.06e-04 | -6.28e-02 | 2.28e-02 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 101 | 2.77e-01 | -6.28e-02 | 6.53e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 94 | 2.94e-01 | -6.27e-02 | 6.62e-01 |
| GOBP LYMPHOCYTE MEDIATED IMMUNITY | 207 | 1.22e-01 | -6.27e-02 | 4.75e-01 |
| GOCC CLATHRIN COATED VESICLE | 144 | 1.96e-01 | -6.26e-02 | 5.68e-01 |
| GOBP RNA SPLICING | 398 | 3.33e-02 | -6.26e-02 | 2.74e-01 |
| GOBP REGULATION OF HEART CONTRACTION | 76 | 3.46e-01 | -6.26e-02 | 6.98e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 17 | 6.55e-01 | 6.26e-02 | 8.78e-01 |
| GOBP HEPATIC STELLATE CELL ACTIVATION | 5 | 8.09e-01 | 6.26e-02 | 9.42e-01 |
| GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 185 | 1.44e-01 | 6.25e-02 | 5.05e-01 |
| GOBP DNA BIOSYNTHETIC PROCESS | 148 | 1.90e-01 | 6.25e-02 | 5.61e-01 |
| GOBP CYTOKINE PRODUCTION | 527 | 1.50e-02 | -6.25e-02 | 1.96e-01 |
| GOBP ANIMAL ORGAN REGENERATION | 34 | 5.29e-01 | 6.25e-02 | 8.11e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION | 24 | 5.96e-01 | 6.25e-02 | 8.49e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT | 11 | 7.20e-01 | 6.25e-02 | 9.06e-01 |
| GOBP GRANULOCYTE CHEMOTAXIS | 65 | 3.85e-01 | -6.23e-02 | 7.25e-01 |
| GOBP REGULATION OF PROTEIN MODIFICATION PROCESS | 849 | 2.41e-03 | -6.23e-02 | 7.60e-02 |
| GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 184 | 1.46e-01 | -6.23e-02 | 5.07e-01 |
| GOBP NEURONAL STEM CELL POPULATION MAINTENANCE | 14 | 6.87e-01 | 6.23e-02 | 8.96e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 9 | 7.47e-01 | 6.22e-02 | 9.16e-01 |
| GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 458 | 2.36e-02 | -6.22e-02 | 2.39e-01 |
| GOBP STRIATED MUSCLE CELL DIFFERENTIATION | 131 | 2.20e-01 | -6.22e-02 | 5.95e-01 |
| GOBP DIET INDUCED THERMOGENESIS | 6 | 7.92e-01 | 6.22e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS | 7 | 7.76e-01 | -6.22e-02 | 9.31e-01 |
| GOBP RESPONSE TO ESTROGEN | 34 | 5.31e-01 | 6.21e-02 | 8.13e-01 |
| GOBP RESPONSE TO HYPEROXIA | 12 | 7.09e-01 | -6.21e-02 | 9.03e-01 |
| GOMF LIPID KINASE ACTIVITY | 34 | 5.31e-01 | 6.21e-02 | 8.13e-01 |
| GOBP REGULATION OF NUCLEAR DIVISION | 73 | 3.60e-01 | 6.21e-02 | 7.10e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 7 | 7.76e-01 | -6.20e-02 | 9.31e-01 |
| GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY | 9 | 7.47e-01 | -6.20e-02 | 9.17e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 413 | 3.20e-02 | -6.20e-02 | 2.70e-01 |
| GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS | 100 | 2.85e-01 | 6.20e-02 | 6.56e-01 |
| GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM | 9 | 7.48e-01 | -6.20e-02 | 9.17e-01 |
| GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 130 | 2.24e-01 | -6.19e-02 | 5.99e-01 |
| GOBP ORGANIC ACID METABOLIC PROCESS | 577 | 1.20e-02 | 6.19e-02 | 1.77e-01 |
| GOMF SEMAPHORIN RECEPTOR ACTIVITY | 7 | 7.77e-01 | -6.19e-02 | 9.31e-01 |
| GOBP MEMBRANE FISSION | 40 | 4.99e-01 | -6.18e-02 | 7.92e-01 |
| GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY | 5 | 8.11e-01 | 6.18e-02 | 9.43e-01 |
| GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS | 17 | 6.59e-01 | 6.18e-02 | 8.82e-01 |
| GOBP STRESS GRANULE ASSEMBLY | 28 | 5.72e-01 | -6.18e-02 | 8.34e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL | 97 | 2.94e-01 | -6.17e-02 | 6.62e-01 |
| GOBP MACROMOLECULE DEACYLATION | 58 | 4.17e-01 | 6.17e-02 | 7.52e-01 |
| GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 56 | 4.25e-01 | 6.17e-02 | 7.56e-01 |
| GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY | 8 | 7.63e-01 | -6.17e-02 | 9.25e-01 |
| GOBP REGULATION OF PROTEOLYSIS | 417 | 3.20e-02 | -6.17e-02 | 2.70e-01 |
| GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY | 126 | 2.33e-01 | -6.17e-02 | 6.10e-01 |
| GOBP EPITHELIAL TUBE FORMATION | 73 | 3.63e-01 | -6.17e-02 | 7.10e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION | 55 | 4.30e-01 | 6.16e-02 | 7.58e-01 |
| GOCC ACTIN FILAMENT BUNDLE | 46 | 4.70e-01 | -6.16e-02 | 7.79e-01 |
| GOBP SPERM DNA CONDENSATION | 6 | 7.94e-01 | -6.16e-02 | 9.36e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 7.94e-01 | 6.16e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 51 | 4.48e-01 | -6.15e-02 | 7.68e-01 |
| GOBP SYNCYTIUM FORMATION | 31 | 5.54e-01 | -6.15e-02 | 8.24e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 225 | 1.14e-01 | -6.15e-02 | 4.61e-01 |
| GOBP PROTEIN ACYLATION | 116 | 2.54e-01 | -6.14e-02 | 6.31e-01 |
| GOMF DNA POLYMERASE ACTIVITY | 25 | 5.95e-01 | 6.14e-02 | 8.48e-01 |
| GOMF SINGLE STRANDED DNA BINDING | 101 | 2.88e-01 | 6.13e-02 | 6.58e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 111 | 2.66e-01 | -6.13e-02 | 6.43e-01 |
| GOBP COPPER ION TRANSMEMBRANE TRANSPORT | 6 | 7.95e-01 | 6.12e-02 | 9.36e-01 |
| GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 7.95e-01 | 6.12e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 5 | 8.13e-01 | 6.12e-02 | 9.43e-01 |
| GOBP RIBONUCLEOSIDE METABOLIC PROCESS | 20 | 6.36e-01 | 6.12e-02 | 8.70e-01 |
| GOBP OVULATION CYCLE PROCESS | 20 | 6.36e-01 | 6.12e-02 | 8.70e-01 |
| GOBP MYELOID CELL APOPTOTIC PROCESS | 26 | 5.90e-01 | -6.11e-02 | 8.45e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 16 | 6.72e-01 | 6.11e-02 | 8.88e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 46 | 4.74e-01 | -6.11e-02 | 7.79e-01 |
| GOCC CLATHRIN COAT OF COATED PIT | 14 | 6.92e-01 | -6.11e-02 | 8.97e-01 |
| GOCC 9PLUS0 NON MOTILE CILIUM | 56 | 4.30e-01 | 6.11e-02 | 7.58e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE | 260 | 9.20e-02 | 6.10e-02 | 4.24e-01 |
| GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 245 | 1.02e-01 | -6.10e-02 | 4.46e-01 |
| GOCC SWI SNF COMPLEX | 27 | 5.84e-01 | 6.09e-02 | 8.41e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST | 145 | 2.07e-01 | -6.08e-02 | 5.83e-01 |
| GOBP AMINOGLYCAN METABOLIC PROCESS | 70 | 3.80e-01 | -6.08e-02 | 7.19e-01 |
| GOMF RNA POLYMERASE I ACTIVITY | 9 | 7.52e-01 | 6.08e-02 | 9.19e-01 |
| GOBP MRNA METHYLATION | 18 | 6.55e-01 | 6.08e-02 | 8.78e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 98 | 3.00e-01 | 6.07e-02 | 6.64e-01 |
| GOBP VESICLE BUDDING FROM MEMBRANE | 76 | 3.61e-01 | -6.07e-02 | 7.10e-01 |
| GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY | 6 | 7.97e-01 | 6.07e-02 | 9.37e-01 |
| GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING | 23 | 6.15e-01 | 6.07e-02 | 8.59e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE | 277 | 8.40e-02 | -6.06e-02 | 4.11e-01 |
| GOBP DNA METHYLATION | 37 | 5.24e-01 | -6.06e-02 | 8.08e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 31 | 5.59e-01 | 6.06e-02 | 8.29e-01 |
| GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY | 49 | 4.63e-01 | 6.06e-02 | 7.77e-01 |
| GOBP PROTEIN LOCALIZATION TO LYSOSOME | 48 | 4.68e-01 | -6.06e-02 | 7.78e-01 |
| GOMF HYDRO LYASE ACTIVITY | 39 | 5.13e-01 | 6.05e-02 | 8.01e-01 |
| GOBP RESPONSE TO AMINO ACID STARVATION | 50 | 4.59e-01 | -6.05e-02 | 7.75e-01 |
| GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS | 26 | 5.93e-01 | 6.05e-02 | 8.47e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 30 | 5.66e-01 | 6.05e-02 | 8.33e-01 |
| GOBP T CELL ACTIVATION | 405 | 3.81e-02 | -6.05e-02 | 2.93e-01 |
| GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 38 | 5.19e-01 | -6.05e-02 | 8.05e-01 |
| GOBP POSITIVE REGULATION OF CELL ACTIVATION | 281 | 8.28e-02 | -6.05e-02 | 4.09e-01 |
| GOBP AUDITORY RECEPTOR CELL DEVELOPMENT | 13 | 7.06e-01 | -6.04e-02 | 9.02e-01 |
| GOBP CARBOHYDRATE CATABOLIC PROCESS | 116 | 2.62e-01 | -6.04e-02 | 6.39e-01 |
| GOBP RESPONSE TO ABIOTIC STIMULUS | 674 | 8.33e-03 | -6.04e-02 | 1.52e-01 |
| GOBP RESPONSE TO LECTIN | 19 | 6.49e-01 | 6.03e-02 | 8.76e-01 |
| GOBP NEUROGENESIS | 845 | 3.43e-03 | -6.02e-02 | 9.29e-02 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS | 72 | 3.78e-01 | -6.02e-02 | 7.18e-01 |
| GOBP BONE MINERALIZATION | 58 | 4.29e-01 | -6.02e-02 | 7.58e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS | 150 | 2.05e-01 | 6.01e-02 | 5.81e-01 |
| GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 22 | 6.26e-01 | 6.01e-02 | 8.64e-01 |
| GOMF GUANYL NUCLEOTIDE BINDING | 269 | 9.16e-02 | -6.00e-02 | 4.24e-01 |
| GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC | 42 | 5.01e-01 | -6.00e-02 | 7.92e-01 |
| GOBP INNERVATION | 10 | 7.42e-01 | 6.00e-02 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS | 1003 | 1.61e-03 | -6.00e-02 | 6.17e-02 |
| GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 503 | 2.25e-02 | -6.00e-02 | 2.33e-01 |
| GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS | 21 | 6.34e-01 | 6.00e-02 | 8.69e-01 |
| GOBP DEPYRIMIDINATION | 6 | 7.99e-01 | 6.00e-02 | 9.38e-01 |
| GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 6 | 7.99e-01 | 6.00e-02 | 9.38e-01 |
| GOBP MACROPHAGE CYTOKINE PRODUCTION | 30 | 5.70e-01 | -6.00e-02 | 8.34e-01 |
| GOBP REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 83 | 3.46e-01 | -5.99e-02 | 6.98e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION | 9 | 7.56e-01 | -5.99e-02 | 9.20e-01 |
| GOBP CELL CYCLE G2 M PHASE TRANSITION | 110 | 2.79e-01 | 5.99e-02 | 6.53e-01 |
| GOMF LYASE ACTIVITY | 128 | 2.43e-01 | 5.99e-02 | 6.21e-01 |
| GOMF AMIDE BINDING | 234 | 1.16e-01 | -5.99e-02 | 4.64e-01 |
| GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY | 7 | 7.84e-01 | 5.99e-02 | 9.33e-01 |
| GOMF NUCLEOTIDE RECEPTOR ACTIVITY | 12 | 7.20e-01 | 5.99e-02 | 9.06e-01 |
| GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY | 22 | 6.27e-01 | -5.98e-02 | 8.65e-01 |
| GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 108 | 2.84e-01 | -5.98e-02 | 6.55e-01 |
| GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS | 28 | 5.84e-01 | 5.98e-02 | 8.41e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 160 | 1.93e-01 | 5.98e-02 | 5.66e-01 |
| GOBP POSITIVE REGULATION OF MAPK CASCADE | 238 | 1.14e-01 | -5.97e-02 | 4.61e-01 |
| GOBP TIGHT JUNCTION ORGANIZATION | 33 | 5.53e-01 | 5.97e-02 | 8.24e-01 |
| GOBP HEMOPOIESIS | 657 | 9.96e-03 | -5.97e-02 | 1.66e-01 |
| GOBP HISTONE MRNA METABOLIC PROCESS | 22 | 6.28e-01 | 5.97e-02 | 8.66e-01 |
| GOBP RESPONSE TO PURINE CONTAINING COMPOUND | 81 | 3.54e-01 | -5.96e-02 | 7.04e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 20 | 6.45e-01 | -5.96e-02 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 17 | 6.71e-01 | -5.95e-02 | 8.88e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE | 53 | 4.54e-01 | -5.95e-02 | 7.72e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE | 7 | 7.85e-01 | -5.95e-02 | 9.34e-01 |
| GOBP ADIPOSE TISSUE DEVELOPMENT | 41 | 5.10e-01 | -5.95e-02 | 7.99e-01 |
| GOCC MEIOTIC SPINDLE | 7 | 7.85e-01 | 5.94e-02 | 9.34e-01 |
| GOBP DENDRITIC CELL CHEMOTAXIS | 18 | 6.63e-01 | 5.94e-02 | 8.84e-01 |
| GOBP TYPE I PNEUMOCYTE DIFFERENTIATION | 6 | 8.01e-01 | 5.94e-02 | 9.39e-01 |
| GOBP REGULATION OF RESPIRATORY BURST | 13 | 7.11e-01 | 5.93e-02 | 9.04e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY | 13 | 7.11e-01 | 5.93e-02 | 9.04e-01 |
| GOBP REGULATION OF HEMOPOIESIS | 289 | 8.44e-02 | -5.93e-02 | 4.12e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY | 33 | 5.56e-01 | 5.93e-02 | 8.27e-01 |
| GOBP DNA DOUBLE STRAND BREAK PROCESSING | 17 | 6.73e-01 | 5.92e-02 | 8.88e-01 |
| GOMF ALKALI METAL ION BINDING | 10 | 7.46e-01 | -5.92e-02 | 9.16e-01 |
| GOBP DNA DEAMINATION | 9 | 7.59e-01 | 5.92e-02 | 9.22e-01 |
| GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY | 6 | 8.02e-01 | 5.92e-02 | 9.39e-01 |
| GOBP MITOTIC CYTOKINETIC PROCESS | 21 | 6.39e-01 | 5.92e-02 | 8.71e-01 |
| GOBP RESPONSE TO EPINEPHRINE | 10 | 7.46e-01 | -5.92e-02 | 9.16e-01 |
| GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 14 | 7.02e-01 | 5.91e-02 | 9.01e-01 |
| GOBP PROTEIN KINASE C SIGNALING | 14 | 7.02e-01 | 5.91e-02 | 9.01e-01 |
| GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM | 38 | 5.29e-01 | -5.91e-02 | 8.11e-01 |
| GOCC PLASMA MEMBRANE PROTEIN COMPLEX | 251 | 1.08e-01 | -5.91e-02 | 4.54e-01 |
| GOBP CELLULAR KETONE METABOLIC PROCESS | 125 | 2.55e-01 | 5.90e-02 | 6.31e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 8 | 7.73e-01 | -5.90e-02 | 9.29e-01 |
| GOMF TUBULIN BINDING | 255 | 1.06e-01 | -5.90e-02 | 4.52e-01 |
| GOBP STEM CELL DEVELOPMENT | 36 | 5.41e-01 | -5.89e-02 | 8.18e-01 |
| GOMF DESUMOYLASE ACTIVITY | 7 | 7.87e-01 | 5.89e-02 | 9.35e-01 |
| GOBP ALPHA BETA T CELL PROLIFERATION | 35 | 5.47e-01 | -5.89e-02 | 8.22e-01 |
| GOBP POSTSYNAPSE ORGANIZATION | 100 | 3.10e-01 | -5.89e-02 | 6.71e-01 |
| GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 15 | 6.93e-01 | -5.89e-02 | 8.98e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION | 16 | 6.84e-01 | -5.88e-02 | 8.95e-01 |
| GOBP REGULATION OF SISTER CHROMATID SEGREGATION | 72 | 3.90e-01 | 5.87e-02 | 7.28e-01 |
| GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY | 91 | 3.34e-01 | -5.87e-02 | 6.88e-01 |
| GOBP RESPONSE TO NITROGEN COMPOUND | 681 | 9.93e-03 | -5.87e-02 | 1.66e-01 |
| GOCC CHITOSOME | 9 | 7.61e-01 | -5.87e-02 | 9.24e-01 |
| GOMF ATP DEPENDENT ACTIVITY | 394 | 4.72e-02 | 5.87e-02 | 3.17e-01 |
| GOCC SWI SNF SUPERFAMILY TYPE COMPLEX | 85 | 3.51e-01 | 5.86e-02 | 7.01e-01 |
| GOBP MULTIVESICULAR BODY SORTING PATHWAY | 43 | 5.07e-01 | -5.85e-02 | 7.97e-01 |
| GOBP POSITIVE REGULATION OF CELL DEVELOPMENT | 269 | 1.01e-01 | -5.85e-02 | 4.44e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 80 | 3.67e-01 | -5.84e-02 | 7.11e-01 |
| GOBP NEGATIVE REGULATION OF CELL ACTIVATION | 136 | 2.41e-01 | -5.83e-02 | 6.20e-01 |
| GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR | 12 | 7.27e-01 | -5.83e-02 | 9.07e-01 |
| GOBP LIPID IMPORT INTO CELL | 14 | 7.06e-01 | -5.83e-02 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 21 | 6.44e-01 | -5.83e-02 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 54 | 4.59e-01 | -5.83e-02 | 7.75e-01 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE | 32 | 5.69e-01 | -5.83e-02 | 8.34e-01 |
| GOBP CELL PART MORPHOGENESIS | 331 | 7.02e-02 | -5.82e-02 | 3.83e-01 |
| GOBP PEPTIDYL TYROSINE MODIFICATION | 158 | 2.08e-01 | -5.82e-02 | 5.83e-01 |
| GOBP PROSTAGLANDIN SECRETION | 10 | 7.50e-01 | 5.82e-02 | 9.18e-01 |
| GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS | 6 | 8.05e-01 | 5.82e-02 | 9.41e-01 |
| GOBP GERM CELL DEVELOPMENT | 159 | 2.07e-01 | -5.82e-02 | 5.82e-01 |
| GOBP GOLGI TO ENDOSOME TRANSPORT | 17 | 6.78e-01 | -5.81e-02 | 8.91e-01 |
| GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 10 | 7.50e-01 | -5.81e-02 | 9.18e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION | 10 | 7.50e-01 | 5.81e-02 | 9.18e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY | 519 | 2.49e-02 | -5.81e-02 | 2.43e-01 |
| GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY | 6 | 8.05e-01 | -5.81e-02 | 9.41e-01 |
| GOBP CORTICAL CYTOSKELETON ORGANIZATION | 38 | 5.36e-01 | -5.80e-02 | 8.16e-01 |
| GOBP EXCITATORY SYNAPSE ASSEMBLY | 15 | 6.97e-01 | -5.80e-02 | 9.00e-01 |
| GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 5 | 8.22e-01 | 5.80e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION | 245 | 1.20e-01 | -5.80e-02 | 4.72e-01 |
| GOBP REGULATION OF PROTEIN DEACETYLATION | 27 | 6.02e-01 | 5.79e-02 | 8.52e-01 |
| GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL | 6 | 8.06e-01 | 5.79e-02 | 9.41e-01 |
| GOBP ASYMMETRIC CELL DIVISION | 11 | 7.40e-01 | 5.78e-02 | 9.13e-01 |
| GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 29 | 5.91e-01 | 5.78e-02 | 8.45e-01 |
| GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING | 60 | 4.40e-01 | -5.77e-02 | 7.64e-01 |
| GOBP MITOTIC SISTER CHROMATID SEGREGATION | 134 | 2.50e-01 | 5.77e-02 | 6.27e-01 |
| GOCC TRANSPORT VESICLE | 263 | 1.09e-01 | -5.77e-02 | 4.55e-01 |
| GOCC CLATHRIN COATED PIT | 55 | 4.60e-01 | -5.76e-02 | 7.76e-01 |
| GOBP RNA DECAPPING | 18 | 6.72e-01 | -5.76e-02 | 8.88e-01 |
| GOBP RUFFLE ASSEMBLY | 29 | 5.92e-01 | -5.76e-02 | 8.46e-01 |
| GOBP IMMUNE EFFECTOR PROCESS | 426 | 4.31e-02 | -5.76e-02 | 3.07e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 5 | 8.24e-01 | -5.76e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 49 | 4.86e-01 | -5.76e-02 | 7.85e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE | 6 | 8.07e-01 | 5.76e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL STORAGE | 5 | 8.24e-01 | -5.75e-02 | 9.46e-01 |
| GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 297 | 8.99e-02 | -5.75e-02 | 4.24e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION | 6 | 8.07e-01 | -5.75e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 15 | 7.00e-01 | -5.75e-02 | 9.01e-01 |
| GOBP CATECHOLAMINE UPTAKE | 5 | 8.24e-01 | 5.74e-02 | 9.46e-01 |
| GOBP REGULATION OF SULFUR METABOLIC PROCESS | 12 | 7.31e-01 | -5.74e-02 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION | 5 | 8.24e-01 | 5.74e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF LYASE ACTIVITY | 15 | 7.01e-01 | -5.73e-02 | 9.01e-01 |
| GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION | 16 | 6.92e-01 | 5.73e-02 | 8.97e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 77 | 3.86e-01 | 5.73e-02 | 7.25e-01 |
| GOBP GRANULOCYTE DIFFERENTIATION | 29 | 5.94e-01 | -5.72e-02 | 8.47e-01 |
| GOBP RUFFLE ORGANIZATION | 40 | 5.32e-01 | -5.72e-02 | 8.13e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS | 221 | 1.45e-01 | -5.72e-02 | 5.05e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 8 | 7.80e-01 | -5.72e-02 | 9.31e-01 |
| GOCC COLLAGEN TRIMER | 16 | 6.92e-01 | -5.71e-02 | 8.97e-01 |
| GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 43 | 5.17e-01 | -5.71e-02 | 8.04e-01 |
| GOBP GOLGI TO VACUOLE TRANSPORT | 18 | 6.75e-01 | -5.71e-02 | 8.90e-01 |
| GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX | 12 | 7.32e-01 | -5.70e-02 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION | 20 | 6.60e-01 | -5.69e-02 | 8.82e-01 |
| GOMF ESTROGEN RESPONSE ELEMENT BINDING | 6 | 8.09e-01 | 5.69e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 11 | 7.44e-01 | 5.68e-02 | 9.15e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON DNA | 194 | 1.74e-01 | 5.68e-02 | 5.41e-01 |
| GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 5.91e-01 | -5.67e-02 | 8.46e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS | 440 | 4.31e-02 | 5.67e-02 | 3.07e-01 |
| GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 48 | 4.97e-01 | -5.67e-02 | 7.92e-01 |
| GOBP RESPONSE TO COBALT ION | 10 | 7.56e-01 | -5.67e-02 | 9.20e-01 |
| GOBP DNA DAMAGE RESPONSE | 711 | 1.11e-02 | 5.67e-02 | 1.73e-01 |
| GOBP MYELOID LEUKOCYTE DIFFERENTIATION | 158 | 2.21e-01 | -5.66e-02 | 5.96e-01 |
| GOBP EMBRYONIC ORGAN DEVELOPMENT | 187 | 1.84e-01 | -5.65e-02 | 5.53e-01 |
| GOBP PROTEIN ACTIVATION CASCADE | 7 | 7.96e-01 | -5.65e-02 | 9.37e-01 |
| GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK | 812 | 7.10e-03 | -5.64e-02 | 1.44e-01 |
| GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 131 | 2.66e-01 | 5.64e-02 | 6.43e-01 |
| GOCC MICROBODY | 103 | 3.23e-01 | 5.64e-02 | 6.81e-01 |
| GOMF GUANYLATE KINASE ACTIVITY | 9 | 7.70e-01 | -5.64e-02 | 9.28e-01 |
| GOCC MULTIVESICULAR BODY | 38 | 5.48e-01 | -5.64e-02 | 8.23e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION | 13 | 7.25e-01 | -5.64e-02 | 9.07e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVITY | 1148 | 1.64e-03 | -5.64e-02 | 6.19e-02 |
| GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 15 | 7.06e-01 | 5.63e-02 | 9.02e-01 |
| GOBP COLLAGEN BIOSYNTHETIC PROCESS | 14 | 7.15e-01 | -5.63e-02 | 9.05e-01 |
| GOBP BEHAVIOR | 289 | 1.01e-01 | -5.63e-02 | 4.45e-01 |
| GOBP RESPONSE TO DOPAMINE | 26 | 6.20e-01 | 5.63e-02 | 8.62e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPLICATION | 16 | 6.97e-01 | 5.63e-02 | 9.00e-01 |
| GOBP POSITIVE REGULATION OF PYROPTOSIS | 5 | 8.28e-01 | 5.63e-02 | 9.48e-01 |
| GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 9 | 7.71e-01 | 5.62e-02 | 9.29e-01 |
| GOBP BICARBONATE TRANSPORT | 15 | 7.07e-01 | 5.61e-02 | 9.03e-01 |
| GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT | 20 | 6.64e-01 | 5.60e-02 | 8.84e-01 |
| GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS | 106 | 3.20e-01 | 5.60e-02 | 6.80e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 16 | 6.98e-01 | -5.60e-02 | 9.01e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 33 | 5.78e-01 | -5.59e-02 | 8.38e-01 |
| GOBP MITOTIC SPINDLE ELONGATION | 5 | 8.29e-01 | -5.59e-02 | 9.48e-01 |
| GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY | 6 | 8.13e-01 | -5.59e-02 | 9.43e-01 |
| GOBP CALCIUM ION TRANSPORT INTO CYTOSOL | 9 | 7.72e-01 | -5.58e-02 | 9.29e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 91 | 3.58e-01 | -5.58e-02 | 7.09e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY | 330 | 8.33e-02 | -5.58e-02 | 4.10e-01 |
| GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY | 7 | 7.98e-01 | 5.58e-02 | 9.38e-01 |
| GOCC NEUROTRANSMITTER RECEPTOR COMPLEX | 9 | 7.72e-01 | -5.58e-02 | 9.29e-01 |
| GOMF TAU PROTEIN BINDING | 34 | 5.74e-01 | 5.58e-02 | 8.36e-01 |
| GOBP PLASMA MEMBRANE REPAIR | 23 | 6.44e-01 | 5.58e-02 | 8.74e-01 |
| GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY | 32 | 5.85e-01 | -5.57e-02 | 8.42e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 25 | 6.30e-01 | 5.57e-02 | 8.67e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I | 8 | 7.85e-01 | 5.57e-02 | 9.34e-01 |
| GOBP POSITIVE REGULATION OF HEMOPOIESIS | 141 | 2.55e-01 | -5.57e-02 | 6.31e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 118 | 2.97e-01 | -5.57e-02 | 6.63e-01 |
| GOBP REGULATION OF B CELL APOPTOTIC PROCESS | 16 | 7.00e-01 | -5.57e-02 | 9.01e-01 |
| GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 428 | 5.06e-02 | -5.55e-02 | 3.27e-01 |
| GOBP HISTONE MODIFICATION | 103 | 3.31e-01 | 5.55e-02 | 6.87e-01 |
| GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS | 16 | 7.01e-01 | -5.55e-02 | 9.01e-01 |
| GOCC TRAMP COMPLEX | 5 | 8.30e-01 | -5.54e-02 | 9.49e-01 |
| GOCC VACUOLAR LUMEN | 117 | 3.01e-01 | -5.54e-02 | 6.65e-01 |
| GOBP MYELIN MAINTENANCE | 10 | 7.62e-01 | -5.53e-02 | 9.24e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 36 | 5.66e-01 | -5.53e-02 | 8.33e-01 |
| GOMF MISFOLDED PROTEIN BINDING | 16 | 7.02e-01 | 5.52e-02 | 9.01e-01 |
| GOBP RESPONSE TO GAMMA RADIATION | 42 | 5.36e-01 | 5.52e-02 | 8.15e-01 |
| GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY | 5 | 8.31e-01 | 5.52e-02 | 9.50e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN | 44 | 5.27e-01 | 5.52e-02 | 8.09e-01 |
| GOMF TELOMERIC DNA BINDING | 36 | 5.67e-01 | 5.52e-02 | 8.33e-01 |
| GOMF MOLECULAR SEQUESTERING ACTIVITY | 31 | 5.95e-01 | -5.52e-02 | 8.48e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 9 | 7.75e-01 | -5.52e-02 | 9.30e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL | 15 | 7.12e-01 | 5.51e-02 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION | 13 | 7.31e-01 | -5.51e-02 | 9.09e-01 |
| GOBP REGULATION OF TRANS SYNAPTIC SIGNALING | 215 | 1.66e-01 | -5.51e-02 | 5.33e-01 |
| GOBP REGULATION OF IMMUNE EFFECTOR PROCESS | 265 | 1.25e-01 | -5.50e-02 | 4.81e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY | 20 | 6.70e-01 | -5.50e-02 | 8.88e-01 |
| GOCC MITOCHONDRIAL ALPHA KETOGLUTARATE DEHYDROGENASE COMPLEX | 6 | 8.16e-01 | 5.50e-02 | 9.45e-01 |
| GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 74 | 4.15e-01 | 5.49e-02 | 7.50e-01 |
| GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT | 9 | 7.76e-01 | -5.49e-02 | 9.31e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 6 | 8.16e-01 | 5.48e-02 | 9.45e-01 |
| GOMF THIOLESTER HYDROLASE ACTIVITY | 27 | 6.22e-01 | 5.48e-02 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT | 15 | 7.14e-01 | 5.47e-02 | 9.05e-01 |
| GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION | 6 | 8.16e-01 | -5.47e-02 | 9.45e-01 |
| GOCC ACTIN CYTOSKELETON | 292 | 1.09e-01 | -5.47e-02 | 4.55e-01 |
| GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY | 7 | 8.02e-01 | 5.47e-02 | 9.40e-01 |
| GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 8 | 7.89e-01 | 5.46e-02 | 9.36e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION | 6 | 8.17e-01 | -5.46e-02 | 9.45e-01 |
| GOBP REGULATION OF REGULATORY NCRNA PROCESSING | 11 | 7.54e-01 | -5.45e-02 | 9.19e-01 |
| GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 36 | 5.71e-01 | 5.45e-02 | 8.34e-01 |
| GOBP LEUKOCYTE HOMEOSTASIS | 83 | 3.91e-01 | -5.45e-02 | 7.29e-01 |
| GOCC ARP2 3 PROTEIN COMPLEX | 9 | 7.77e-01 | -5.45e-02 | 9.31e-01 |
| GOCC ORGANELLAR RIBOSOME | 89 | 3.75e-01 | 5.44e-02 | 7.17e-01 |
| GOBP RESPONSE TO ACETYLCHOLINE | 16 | 7.06e-01 | -5.44e-02 | 9.02e-01 |
| GOMF SH2 DOMAIN BINDING | 30 | 6.06e-01 | 5.44e-02 | 8.54e-01 |
| GOBP VIRAL RELEASE FROM HOST CELL | 24 | 6.45e-01 | -5.44e-02 | 8.74e-01 |
| GOBP RESPONSE TO INTERLEUKIN 15 | 12 | 7.44e-01 | -5.44e-02 | 9.15e-01 |
| GOBP PHOSPHOLIPID CATABOLIC PROCESS | 35 | 5.78e-01 | -5.43e-02 | 8.38e-01 |
| GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY | 278 | 1.21e-01 | -5.43e-02 | 4.74e-01 |
| GOMF PEPTIDE BINDING | 179 | 2.11e-01 | -5.43e-02 | 5.87e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 18 | 6.90e-01 | -5.43e-02 | 8.97e-01 |
| GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 14 | 7.25e-01 | -5.43e-02 | 9.07e-01 |
| GOCC CAJAL BODY | 54 | 4.91e-01 | -5.42e-02 | 7.88e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORT | 244 | 1.47e-01 | -5.42e-02 | 5.08e-01 |
| GOBP TRICARBOXYLIC ACID CYCLE | 29 | 6.14e-01 | 5.42e-02 | 8.59e-01 |
| GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 16 | 7.08e-01 | -5.41e-02 | 9.03e-01 |
| GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING | 28 | 6.21e-01 | -5.40e-02 | 8.62e-01 |
| GOBP INNATE IMMUNE RESPONSE | 608 | 2.46e-02 | -5.40e-02 | 2.43e-01 |
| GOBP OUTER DYNEIN ARM ASSEMBLY | 7 | 8.05e-01 | -5.38e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF DNA DEMETHYLATION | 6 | 8.20e-01 | -5.38e-02 | 9.46e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS | 14 | 7.28e-01 | -5.38e-02 | 9.08e-01 |
| GOCC ENDOPLASMIC RETICULUM LUMEN | 148 | 2.60e-01 | -5.37e-02 | 6.38e-01 |
| GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 132 | 2.88e-01 | -5.37e-02 | 6.58e-01 |
| GOBP RECEPTOR RECYCLING | 36 | 5.77e-01 | -5.37e-02 | 8.38e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 351 | 8.59e-02 | -5.37e-02 | 4.15e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 41 | 5.52e-01 | 5.37e-02 | 8.24e-01 |
| GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS | 9 | 7.80e-01 | -5.37e-02 | 9.32e-01 |
| GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 9 | 7.81e-01 | -5.36e-02 | 9.32e-01 |
| GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY | 377 | 7.62e-02 | -5.36e-02 | 3.96e-01 |
| GOBP EXONUCLEOLYTIC CATABOLISM OF DEADENYLATED MRNA | 13 | 7.38e-01 | 5.36e-02 | 9.12e-01 |
| GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 5 | 8.36e-01 | 5.35e-02 | 9.51e-01 |
| GOBP REGULATION OF CELLULAR LOCALIZATION | 645 | 2.20e-02 | -5.35e-02 | 2.31e-01 |
| GOCC CELL LEADING EDGE | 281 | 1.25e-01 | -5.35e-02 | 4.81e-01 |
| GOMF FK506 BINDING | 8 | 7.93e-01 | -5.35e-02 | 9.36e-01 |
| GOMF MACROLIDE BINDING | 8 | 7.93e-01 | -5.35e-02 | 9.36e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CORTEX | 8 | 7.93e-01 | 5.35e-02 | 9.36e-01 |
| GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY | 14 | 7.29e-01 | -5.35e-02 | 9.09e-01 |
| GOBP MICROTUBULE DEPOLYMERIZATION | 27 | 6.31e-01 | 5.34e-02 | 8.67e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 63 | 4.64e-01 | -5.34e-02 | 7.77e-01 |
| GOCC U6 SNRNP | 8 | 7.94e-01 | 5.34e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF CATABOLIC PROCESS | 415 | 6.42e-02 | -5.34e-02 | 3.66e-01 |
| GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS | 118 | 3.18e-01 | -5.33e-02 | 6.80e-01 |
| GOBP ORGANELLE INHERITANCE | 13 | 7.39e-01 | 5.33e-02 | 9.13e-01 |
| GOBP INNER EAR RECEPTOR CELL DEVELOPMENT | 23 | 6.58e-01 | 5.33e-02 | 8.81e-01 |
| GOBP REGULATION OF GLYCOLYTIC PROCESS | 37 | 5.76e-01 | -5.32e-02 | 8.37e-01 |
| GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 6 | 8.21e-01 | -5.32e-02 | 9.46e-01 |
| GOMF RNA POLYMERASE ACTIVITY | 29 | 6.20e-01 | 5.32e-02 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 14 | 7.31e-01 | 5.32e-02 | 9.09e-01 |
| GOCC SARCOPLASMIC RETICULUM MEMBRANE | 21 | 6.74e-01 | 5.31e-02 | 8.88e-01 |
| GOBP MYOTUBE DIFFERENTIATION | 56 | 4.92e-01 | 5.31e-02 | 7.88e-01 |
| GOBP ENDODERMAL CELL FATE COMMITMENT | 6 | 8.22e-01 | -5.31e-02 | 9.46e-01 |
| GOBP VITAMIN BIOSYNTHETIC PROCESS | 14 | 7.31e-01 | 5.30e-02 | 9.09e-01 |
| GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 22 | 6.67e-01 | -5.30e-02 | 8.86e-01 |
| GOBP PEPTIDYL PROLINE MODIFICATION | 29 | 6.21e-01 | -5.30e-02 | 8.62e-01 |
| GOBP CERAMIDE TRANSPORT | 10 | 7.72e-01 | -5.30e-02 | 9.29e-01 |
| GOBP REGULATION OF PHAGOCYTOSIS | 67 | 4.54e-01 | -5.30e-02 | 7.72e-01 |
| GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE | 54 | 5.02e-01 | -5.29e-02 | 7.93e-01 |
| GOBP RECEPTOR LOCALIZATION TO SYNAPSE | 27 | 6.35e-01 | 5.29e-02 | 8.69e-01 |
| GOBP TYPE B PANCREATIC CELL DEVELOPMENT | 11 | 7.62e-01 | -5.28e-02 | 9.24e-01 |
| GOBP PERICARDIUM DEVELOPMENT | 7 | 8.09e-01 | -5.28e-02 | 9.42e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL SURFACE | 39 | 5.69e-01 | -5.28e-02 | 8.34e-01 |
| GOBP AZOLE TRANSMEMBRANE TRANSPORT | 5 | 8.38e-01 | 5.28e-02 | 9.52e-01 |
| GOBP TELOMERE LOCALIZATION | 7 | 8.09e-01 | 5.27e-02 | 9.42e-01 |
| GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY | 6 | 8.23e-01 | 5.27e-02 | 9.46e-01 |
| GOCC CELL CORTEX | 187 | 2.16e-01 | -5.27e-02 | 5.92e-01 |
| GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION | 117 | 3.26e-01 | 5.27e-02 | 6.83e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 11 | 7.63e-01 | 5.26e-02 | 9.25e-01 |
| GOCC NUCLEAR BODY | 689 | 2.02e-02 | -5.26e-02 | 2.22e-01 |
| GOBP TOR SIGNALING | 136 | 2.91e-01 | -5.25e-02 | 6.60e-01 |
| GOMF PROTEIN ANTIGEN BINDING | 6 | 8.24e-01 | -5.25e-02 | 9.46e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY | 43 | 5.52e-01 | 5.25e-02 | 8.24e-01 |
| GOMF SNARE BINDING | 71 | 4.45e-01 | 5.24e-02 | 7.67e-01 |
| GOMF DNA SECONDARY STRUCTURE BINDING | 28 | 6.31e-01 | -5.24e-02 | 8.67e-01 |
| GOBP SULFUR COMPOUND METABOLIC PROCESS | 207 | 1.95e-01 | 5.24e-02 | 5.68e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION | 9 | 7.85e-01 | -5.24e-02 | 9.34e-01 |
| GOCC CLATHRIN ADAPTOR COMPLEX | 21 | 6.78e-01 | 5.24e-02 | 8.91e-01 |
| GOBP CDP CHOLINE PATHWAY | 6 | 8.24e-01 | -5.24e-02 | 9.46e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 19 | 6.93e-01 | -5.24e-02 | 8.98e-01 |
| GOBP SPINAL CORD DEVELOPMENT | 35 | 5.92e-01 | -5.24e-02 | 8.46e-01 |
| GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 7.98e-01 | 5.23e-02 | 9.38e-01 |
| GOCC MICROTUBULE ASSOCIATED COMPLEX | 92 | 3.87e-01 | -5.23e-02 | 7.25e-01 |
| GOBP BLASTOCYST GROWTH | 16 | 7.17e-01 | 5.23e-02 | 9.06e-01 |
| GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 17 | 7.09e-01 | 5.22e-02 | 9.03e-01 |
| GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 121 | 3.22e-01 | -5.22e-02 | 6.81e-01 |
| GOCC GLYCOPROTEIN COMPLEX | 8 | 7.98e-01 | 5.22e-02 | 9.38e-01 |
| GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 153 | 2.67e-01 | -5.22e-02 | 6.44e-01 |
| GOBP REVERSE CHOLESTEROL TRANSPORT | 6 | 8.25e-01 | -5.21e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF NEUROGENESIS | 123 | 3.19e-01 | -5.21e-02 | 6.80e-01 |
| GOMF PEPTIDASE ACTIVITY | 293 | 1.27e-01 | -5.21e-02 | 4.84e-01 |
| GOCC CELL DIVISION SITE | 56 | 5.01e-01 | -5.20e-02 | 7.92e-01 |
| GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 116 | 3.34e-01 | -5.20e-02 | 6.88e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 25 | 6.53e-01 | 5.20e-02 | 8.78e-01 |
| GOMF SIGNALING ADAPTOR ACTIVITY | 74 | 4.41e-01 | -5.19e-02 | 7.64e-01 |
| GOBP PEPTIDYL THREONINE MODIFICATION | 77 | 4.32e-01 | 5.19e-02 | 7.59e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE | 321 | 1.12e-01 | -5.19e-02 | 4.58e-01 |
| GOBP CELL FATE COMMITMENT | 95 | 3.83e-01 | -5.19e-02 | 7.23e-01 |
| GOCC MICROTUBULE END | 25 | 6.54e-01 | -5.17e-02 | 8.78e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 137 | 2.97e-01 | -5.17e-02 | 6.63e-01 |
| GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY | 6 | 8.26e-01 | -5.17e-02 | 9.47e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY | 16 | 7.21e-01 | -5.16e-02 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION | 110 | 3.51e-01 | -5.16e-02 | 7.01e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION | 85 | 4.12e-01 | -5.16e-02 | 7.48e-01 |
| GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 68 | 4.63e-01 | -5.15e-02 | 7.77e-01 |
| GOBP HEXOSE CATABOLIC PROCESS | 29 | 6.32e-01 | -5.15e-02 | 8.67e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 156 | 2.69e-01 | -5.14e-02 | 6.46e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 5 | 8.42e-01 | 5.14e-02 | 9.54e-01 |
| GOMF RIBOSOMAL SMALL SUBUNIT BINDING | 16 | 7.22e-01 | -5.13e-02 | 9.06e-01 |
| GOBP REGULATION OF GOLGI ORGANIZATION | 15 | 7.31e-01 | -5.13e-02 | 9.09e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 100 | 3.76e-01 | -5.13e-02 | 7.17e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS | 54 | 5.15e-01 | 5.13e-02 | 8.02e-01 |
| GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 22 | 6.77e-01 | -5.13e-02 | 8.91e-01 |
| GOMF 1 4 ALPHA OLIGOGLUCAN PHOSPHORYLASE ACTIVITY | 5 | 8.43e-01 | -5.12e-02 | 9.54e-01 |
| GOBP MRNA METABOLIC PROCESS | 626 | 3.06e-02 | -5.12e-02 | 2.66e-01 |
| GOMF CARGO RECEPTOR ACTIVITY | 40 | 5.76e-01 | -5.12e-02 | 8.37e-01 |
| GOMF SMALL MOLECULE SENSOR ACTIVITY | 26 | 6.52e-01 | 5.12e-02 | 8.77e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 33 | 6.11e-01 | -5.12e-02 | 8.57e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE | 328 | 1.13e-01 | -5.12e-02 | 4.61e-01 |
| GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.28e-01 | -5.11e-02 | 9.48e-01 |
| GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY | 14 | 7.41e-01 | 5.11e-02 | 9.13e-01 |
| GOBP REGULATION OF MUSCLE SYSTEM PROCESS | 115 | 3.45e-01 | -5.10e-02 | 6.98e-01 |
| GOCC GRANULAR COMPONENT | 6 | 8.29e-01 | 5.10e-02 | 9.48e-01 |
| GOBP REGULATION OF LYASE ACTIVITY | 21 | 6.86e-01 | -5.10e-02 | 8.96e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 325 | 1.16e-01 | -5.10e-02 | 4.64e-01 |
| GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 31 | 6.24e-01 | 5.10e-02 | 8.63e-01 |
| GOMF PHOSPHOLIPASE BINDING | 18 | 7.08e-01 | 5.09e-02 | 9.03e-01 |
| GOBP EMBRYONIC MORPHOGENESIS | 262 | 1.58e-01 | -5.09e-02 | 5.24e-01 |
| GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY | 50 | 5.34e-01 | -5.09e-02 | 8.15e-01 |
| GOMF COPPER ION BINDING | 33 | 6.13e-01 | 5.09e-02 | 8.59e-01 |
| GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY | 9 | 7.92e-01 | -5.08e-02 | 9.36e-01 |
| GOCC B WICH COMPLEX | 7 | 8.16e-01 | 5.08e-02 | 9.45e-01 |
| GOCC NEUROMUSCULAR JUNCTION | 38 | 5.88e-01 | -5.08e-02 | 8.44e-01 |
| GOBP BILE ACID BIOSYNTHETIC PROCESS | 17 | 7.17e-01 | 5.08e-02 | 9.06e-01 |
| GOBP HEART GROWTH | 40 | 5.79e-01 | -5.08e-02 | 8.38e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 16 | 7.25e-01 | -5.07e-02 | 9.07e-01 |
| GOBP NEGATIVE REGULATION OF AXONOGENESIS | 27 | 6.48e-01 | -5.07e-02 | 8.76e-01 |
| GOBP MULTI MULTICELLULAR ORGANISM PROCESS | 94 | 3.96e-01 | -5.07e-02 | 7.35e-01 |
| GOCC POSTSYNAPTIC CYTOSOL | 10 | 7.82e-01 | 5.07e-02 | 9.32e-01 |
| GOBP SMALL MOLECULE CATABOLIC PROCESS | 236 | 1.82e-01 | 5.06e-02 | 5.51e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 306 | 1.30e-01 | -5.06e-02 | 4.87e-01 |
| GOBP SPECIFICATION OF SYMMETRY | 60 | 4.98e-01 | 5.06e-02 | 7.92e-01 |
| GOBP STEROL BIOSYNTHETIC PROCESS | 41 | 5.75e-01 | 5.06e-02 | 8.37e-01 |
| GOBP ACTIN NUCLEATION | 39 | 5.85e-01 | 5.05e-02 | 8.42e-01 |
| GOMF KINASE ACTIVATOR ACTIVITY | 92 | 4.03e-01 | -5.05e-02 | 7.41e-01 |
| GOBP POST TRANSLATIONAL PROTEIN MODIFICATION | 848 | 1.40e-02 | -5.05e-02 | 1.91e-01 |
| GOBP ENDOCARDIUM DEVELOPMENT | 7 | 8.17e-01 | 5.04e-02 | 9.45e-01 |
| GOBP TRANSPORT OF VIRUS | 17 | 7.19e-01 | -5.03e-02 | 9.06e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY | 12 | 7.63e-01 | 5.02e-02 | 9.25e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE | 47 | 5.52e-01 | -5.02e-02 | 8.24e-01 |
| GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING | 17 | 7.20e-01 | -5.02e-02 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 17 | 7.20e-01 | -5.02e-02 | 9.06e-01 |
| GOBP AXIS SPECIFICATION | 32 | 6.23e-01 | -5.02e-02 | 8.63e-01 |
| GOBP RESPONSE TO PEPTIDE | 310 | 1.31e-01 | -5.01e-02 | 4.89e-01 |
| GOBP RESPONSE TO NICOTINE | 21 | 6.91e-01 | -5.01e-02 | 8.97e-01 |
| GOBP PROTEIN DEPHOSPHORYLATION | 156 | 2.81e-01 | -5.01e-02 | 6.55e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION | 39 | 5.89e-01 | -5.01e-02 | 8.44e-01 |
| GOMF DEMETHYLASE ACTIVITY | 32 | 6.24e-01 | -5.00e-02 | 8.64e-01 |
| GOMF LIPID BINDING | 495 | 5.90e-02 | -5.00e-02 | 3.54e-01 |
| GOBP INTERLEUKIN 1 PRODUCTION | 74 | 4.58e-01 | -5.00e-02 | 7.74e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORYLATION | 216 | 2.07e-01 | -5.00e-02 | 5.82e-01 |
| GOMF ALDO KETO REDUCTASE NADP ACTIVITY | 13 | 7.55e-01 | -5.00e-02 | 9.20e-01 |
| GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 8 | 8.07e-01 | 5.00e-02 | 9.41e-01 |
| GOBP REGULATION OF CELL FATE COMMITMENT | 17 | 7.21e-01 | -5.00e-02 | 9.06e-01 |
| GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION | 348 | 1.12e-01 | -4.99e-02 | 4.58e-01 |
| GOBP REGULATION OF RECEPTOR RECYCLING | 18 | 7.14e-01 | 4.99e-02 | 9.05e-01 |
| GOCC NUCLEAR LAMINA | 10 | 7.85e-01 | 4.99e-02 | 9.34e-01 |
| GOMF PRENYLTRANSFERASE ACTIVITY | 17 | 7.22e-01 | -4.99e-02 | 9.06e-01 |
| GOBP REGULATION OF LEUKOCYTE MIGRATION | 132 | 3.24e-01 | -4.99e-02 | 6.81e-01 |
| GOBP LIPID EXPORT FROM CELL | 24 | 6.72e-01 | -4.99e-02 | 8.88e-01 |
| GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION | 16 | 7.30e-01 | -4.98e-02 | 9.09e-01 |
| GOBP IN UTERO EMBRYONIC DEVELOPMENT | 245 | 1.81e-01 | -4.98e-02 | 5.49e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 6 | 8.33e-01 | 4.98e-02 | 9.50e-01 |
| GOBP T CELL DIFFERENTIATION | 237 | 1.88e-01 | -4.98e-02 | 5.59e-01 |
| GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY | 17 | 7.22e-01 | 4.98e-02 | 9.06e-01 |
| GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS | 225 | 2.00e-01 | 4.98e-02 | 5.75e-01 |
| GOBP VIRAL BUDDING | 23 | 6.79e-01 | 4.98e-02 | 8.91e-01 |
| GOBP REGULATION OF IMMUNE SYSTEM PROCESS | 1016 | 8.51e-03 | -4.98e-02 | 1.53e-01 |
| GOBP LIPID HOMEOSTASIS | 83 | 4.34e-01 | 4.97e-02 | 7.61e-01 |
| GOMF PEPTIDE HORMONE BINDING | 15 | 7.39e-01 | -4.97e-02 | 9.12e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION | 1255 | 3.85e-03 | -4.97e-02 | 9.93e-02 |
| GOBP ICOSANOID BIOSYNTHETIC PROCESS | 32 | 6.27e-01 | -4.97e-02 | 8.65e-01 |
| GOBP INHIBITORY POSTSYNAPTIC POTENTIAL | 6 | 8.33e-01 | -4.97e-02 | 9.50e-01 |
| GOBP REGULATION OF AMIDE METABOLIC PROCESS | 386 | 9.64e-02 | -4.96e-02 | 4.33e-01 |
| GOBP LYMPHOCYTE HOMEOSTASIS | 62 | 5.00e-01 | -4.96e-02 | 7.92e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 15 | 7.39e-01 | -4.96e-02 | 9.13e-01 |
| GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY | 11 | 7.76e-01 | 4.96e-02 | 9.31e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS | 48 | 5.53e-01 | 4.95e-02 | 8.24e-01 |
| GOMF ACTIN FILAMENT BINDING | 124 | 3.42e-01 | -4.95e-02 | 6.95e-01 |
| GOCC SUMO LIGASE COMPLEX | 13 | 7.58e-01 | -4.94e-02 | 9.22e-01 |
| GOBP SCHWANN CELL DIFFERENTIATION | 19 | 7.09e-01 | -4.94e-02 | 9.03e-01 |
| GOBP REGULATION OF LYSOSOME ORGANIZATION | 10 | 7.87e-01 | -4.94e-02 | 9.34e-01 |
| GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 7 | 8.21e-01 | 4.94e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 67 | 4.85e-01 | -4.93e-02 | 7.85e-01 |
| GOBP MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION | 5 | 8.48e-01 | -4.93e-02 | 9.56e-01 |
| GOBP LUNG EPITHELIUM DEVELOPMENT | 21 | 6.96e-01 | -4.93e-02 | 8.99e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS | 6 | 8.35e-01 | 4.92e-02 | 9.50e-01 |
| GOBP GENERATION OF NEURONS | 718 | 2.67e-02 | -4.92e-02 | 2.53e-01 |
| GOBP MONOATOMIC ION TRANSPORT | 561 | 4.90e-02 | -4.91e-02 | 3.22e-01 |
| GOBP HINDBRAIN DEVELOPMENT | 74 | 4.66e-01 | -4.91e-02 | 7.78e-01 |
| GOBP PYROPTOSIS | 28 | 6.53e-01 | -4.91e-02 | 8.78e-01 |
| GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS | 6 | 8.35e-01 | -4.91e-02 | 9.50e-01 |
| GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY | 7 | 8.22e-01 | 4.91e-02 | 9.46e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY | 32 | 6.31e-01 | -4.91e-02 | 8.67e-01 |
| GOCC FIBRILLAR CENTER | 126 | 3.43e-01 | 4.90e-02 | 6.95e-01 |
| GOMF CYTOSKELETAL PROTEIN BINDING | 616 | 4.00e-02 | -4.90e-02 | 2.98e-01 |
| GOCC SOMATODENDRITIC COMPARTMENT | 397 | 9.60e-02 | -4.90e-02 | 4.32e-01 |
| GOBP RESPONSE TO MAGNESIUM ION | 12 | 7.69e-01 | -4.90e-02 | 9.28e-01 |
| GOCC NEURONAL DENSE CORE VESICLE | 8 | 8.10e-01 | -4.90e-02 | 9.42e-01 |
| GOBP PROTEIN LOCALIZATION TO MITOCHONDRION | 117 | 3.62e-01 | -4.89e-02 | 7.10e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNITY | 70 | 4.80e-01 | -4.89e-02 | 7.83e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 14 | 7.52e-01 | -4.89e-02 | 9.19e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 119 | 3.58e-01 | -4.88e-02 | 7.09e-01 |
| GOBP EOSINOPHIL ACTIVATION | 8 | 8.11e-01 | 4.88e-02 | 9.43e-01 |
| GOBP MRNA CIS SPLICING VIA SPLICEOSOME | 22 | 6.92e-01 | 4.88e-02 | 8.97e-01 |
| GOBP CELLULAR RESPONSE TO CHOLESTEROL | 9 | 8.00e-01 | -4.87e-02 | 9.39e-01 |
| GOCC GBAF COMPLEX | 13 | 7.61e-01 | 4.87e-02 | 9.24e-01 |
| GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 124 | 3.51e-01 | -4.87e-02 | 7.01e-01 |
| GOMF APOLIPOPROTEIN BINDING | 6 | 8.37e-01 | -4.86e-02 | 9.51e-01 |
| GOBP GLUTATHIONE METABOLIC PROCESS | 26 | 6.68e-01 | -4.86e-02 | 8.86e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 8 | 8.12e-01 | -4.86e-02 | 9.43e-01 |
| GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION | 123 | 3.54e-01 | 4.85e-02 | 7.04e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED EIF2 ALPHA PHOSPHORYLATION | 5 | 8.51e-01 | -4.85e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 79 | 4.57e-01 | -4.85e-02 | 7.74e-01 |
| GOBP REGULATION OF GTP BINDING | 8 | 8.12e-01 | 4.85e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 5 | 8.51e-01 | 4.84e-02 | 9.58e-01 |
| GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 15 | 7.46e-01 | 4.84e-02 | 9.16e-01 |
| GOBP MONOATOMIC CATION TRANSPORT | 475 | 7.32e-02 | -4.84e-02 | 3.91e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 123 | 3.55e-01 | -4.84e-02 | 7.05e-01 |
| GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 7 | 8.25e-01 | -4.84e-02 | 9.46e-01 |
| GOBP MITOTIC SPINDLE ASSEMBLY | 54 | 5.39e-01 | 4.84e-02 | 8.17e-01 |
| GOBP RESPONSE TO L GLUTAMATE | 11 | 7.82e-01 | 4.83e-02 | 9.32e-01 |
| GOMF STAT FAMILY PROTEIN BINDING | 8 | 8.13e-01 | -4.83e-02 | 9.43e-01 |
| GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 34 | 6.26e-01 | 4.83e-02 | 8.65e-01 |
| GOBP MUSCLE CELL DEVELOPMENT | 83 | 4.48e-01 | -4.82e-02 | 7.68e-01 |
| GOMF STEROL BINDING | 41 | 5.93e-01 | -4.82e-02 | 8.47e-01 |
| GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 329 | 1.35e-01 | -4.82e-02 | 4.94e-01 |
| GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 73 | 4.77e-01 | -4.82e-02 | 7.81e-01 |
| GOBP INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION | 17 | 7.31e-01 | -4.82e-02 | 9.09e-01 |
| GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS | 14 | 7.55e-01 | 4.82e-02 | 9.20e-01 |
| GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 11 | 7.82e-01 | 4.82e-02 | 9.32e-01 |
| GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS | 175 | 2.73e-01 | -4.82e-02 | 6.51e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 15 | 7.48e-01 | 4.80e-02 | 9.17e-01 |
| GOBP ESTABLISHMENT OF CELL POLARITY | 101 | 4.06e-01 | -4.79e-02 | 7.42e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 53 | 5.46e-01 | -4.79e-02 | 8.22e-01 |
| GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 45 | 5.78e-01 | -4.79e-02 | 8.38e-01 |
| GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY | 62 | 5.15e-01 | -4.79e-02 | 8.02e-01 |
| GOBP ATP BIOSYNTHETIC PROCESS | 90 | 4.33e-01 | -4.79e-02 | 7.60e-01 |
| GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS | 50 | 5.59e-01 | -4.79e-02 | 8.29e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL | 11 | 7.84e-01 | 4.78e-02 | 9.33e-01 |
| GOBP AORTA DEVELOPMENT | 29 | 6.56e-01 | -4.78e-02 | 8.79e-01 |
| GOBP GOLGI VESICLE TRANSPORT | 259 | 1.87e-01 | -4.78e-02 | 5.57e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM | 19 | 7.19e-01 | -4.77e-02 | 9.06e-01 |
| GOBP RESPONSE TO HYDROPEROXIDE | 13 | 7.66e-01 | -4.77e-02 | 9.26e-01 |
| GOCC ADHERENS JUNCTION | 102 | 4.06e-01 | -4.77e-02 | 7.42e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 133 | 3.44e-01 | -4.77e-02 | 6.96e-01 |
| GOBP REGULATION OF PROTEIN TARGETING | 60 | 5.24e-01 | -4.77e-02 | 8.08e-01 |
| GOBP CHEMOKINE PRODUCTION | 61 | 5.21e-01 | -4.76e-02 | 8.05e-01 |
| GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY | 9 | 8.05e-01 | 4.75e-02 | 9.41e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER | 6 | 8.40e-01 | -4.75e-02 | 9.53e-01 |
| GOMF INSULIN RECEPTOR BINDING | 15 | 7.50e-01 | 4.75e-02 | 9.18e-01 |
| GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY | 10 | 7.95e-01 | -4.75e-02 | 9.36e-01 |
| GOBP MONOCARBOXYLIC ACID TRANSPORT | 76 | 4.75e-01 | -4.75e-02 | 7.80e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION | 17 | 7.35e-01 | -4.74e-02 | 9.11e-01 |
| GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY | 25 | 6.82e-01 | 4.74e-02 | 8.93e-01 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 10 | 7.95e-01 | -4.74e-02 | 9.37e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER | 7 | 8.28e-01 | 4.73e-02 | 9.48e-01 |
| GOBP CELL ACTIVATION | 755 | 2.94e-02 | -4.72e-02 | 2.62e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL | 52 | 5.56e-01 | -4.72e-02 | 8.27e-01 |
| GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION | 37 | 6.19e-01 | 4.72e-02 | 8.62e-01 |
| GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III | 6 | 8.42e-01 | 4.71e-02 | 9.53e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX | 6 | 8.42e-01 | 4.71e-02 | 9.53e-01 |
| GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE | 15 | 7.53e-01 | 4.70e-02 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION | 12 | 7.78e-01 | -4.70e-02 | 9.31e-01 |
| GOBP MRNA PROCESSING | 420 | 1.01e-01 | -4.70e-02 | 4.45e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 17 | 7.38e-01 | -4.69e-02 | 9.12e-01 |
| GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 17 | 7.38e-01 | -4.69e-02 | 9.12e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY | 13 | 7.70e-01 | 4.69e-02 | 9.28e-01 |
| GOMF CARBON CARBON LYASE ACTIVITY | 34 | 6.36e-01 | 4.69e-02 | 8.70e-01 |
| GOMF DNA TOPOISOMERASE ACTIVITY | 6 | 8.42e-01 | -4.69e-02 | 9.54e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 25 | 6.85e-01 | -4.69e-02 | 8.95e-01 |
| GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 5 | 8.56e-01 | -4.68e-02 | 9.59e-01 |
| GOBP REGULATION OF LYMPHOCYTE ACTIVATION | 366 | 1.27e-01 | -4.68e-02 | 4.83e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR BINDING | 102 | 4.15e-01 | -4.68e-02 | 7.51e-01 |
| GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 8.19e-01 | -4.68e-02 | 9.46e-01 |
| GOMF PEROXIREDOXIN ACTIVITY | 8 | 8.19e-01 | -4.68e-02 | 9.46e-01 |
| GOBP REGULATION OF ACTIN FILAMENT LENGTH | 96 | 4.30e-01 | -4.67e-02 | 7.58e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION | 13 | 7.71e-01 | 4.67e-02 | 9.29e-01 |
| GOCC SARCOLEMMA | 59 | 5.36e-01 | 4.67e-02 | 8.15e-01 |
| GOBP CHROMOSOME SEGREGATION | 312 | 1.59e-01 | 4.67e-02 | 5.25e-01 |
| GOCC SIN3 TYPE COMPLEX | 21 | 7.12e-01 | 4.66e-02 | 9.04e-01 |
| GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION | 14 | 7.63e-01 | 4.66e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 5 | 8.57e-01 | -4.65e-02 | 9.59e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS | 14 | 7.63e-01 | -4.65e-02 | 9.25e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 32 | 6.49e-01 | -4.65e-02 | 8.76e-01 |
| GOBP EMBRYO DEVELOPMENT | 583 | 5.77e-02 | -4.65e-02 | 3.50e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING | 5 | 8.57e-01 | 4.65e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 87 | 4.54e-01 | -4.65e-02 | 7.72e-01 |
| GOCC MRNA CLEAVAGE FACTOR COMPLEX | 19 | 7.26e-01 | 4.65e-02 | 9.07e-01 |
| GOCC MYOSIN II COMPLEX | 9 | 8.09e-01 | -4.64e-02 | 9.42e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION | 15 | 7.56e-01 | -4.64e-02 | 9.20e-01 |
| GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 14 | 7.64e-01 | -4.63e-02 | 9.26e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY | 43 | 6.00e-01 | 4.62e-02 | 8.51e-01 |
| GOMF THREONINE TYPE PEPTIDASE ACTIVITY | 11 | 7.91e-01 | 4.62e-02 | 9.36e-01 |
| GOBP RNA DESTABILIZATION | 93 | 4.42e-01 | -4.62e-02 | 7.66e-01 |
| GOCC CONDENSED NUCLEAR CHROMOSOME | 48 | 5.81e-01 | 4.61e-02 | 8.39e-01 |
| GOBP MEMBRANE BIOGENESIS | 43 | 6.01e-01 | -4.61e-02 | 8.51e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 16 | 7.50e-01 | -4.61e-02 | 9.18e-01 |
| GOMF HEAT SHOCK PROTEIN BINDING | 95 | 4.38e-01 | 4.61e-02 | 7.62e-01 |
| GOCC DENDRITIC TREE | 298 | 1.74e-01 | -4.61e-02 | 5.39e-01 |
| GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY | 8 | 8.22e-01 | -4.60e-02 | 9.46e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS | 654 | 4.74e-02 | -4.60e-02 | 3.17e-01 |
| GOBP NEUTRAL LIPID METABOLIC PROCESS | 75 | 4.92e-01 | -4.59e-02 | 7.88e-01 |
| GOCC SYNAPTIC VESICLE MEMBRANE | 60 | 5.39e-01 | -4.59e-02 | 8.17e-01 |
| GOBP HISTAMINE SECRETION | 11 | 7.92e-01 | -4.59e-02 | 9.36e-01 |
| GOBP HISTAMINE TRANSPORT | 11 | 7.92e-01 | -4.59e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 157 | 3.22e-01 | -4.59e-02 | 6.81e-01 |
| GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 10 | 8.02e-01 | 4.59e-02 | 9.39e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION | 7 | 8.34e-01 | 4.58e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS | 251 | 2.14e-01 | -4.57e-02 | 5.90e-01 |
| GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING | 7 | 8.34e-01 | -4.57e-02 | 9.50e-01 |
| GOMF CARBON SULFUR LYASE ACTIVITY | 13 | 7.76e-01 | 4.57e-02 | 9.31e-01 |
| GOBP EPHRIN RECEPTOR SIGNALING PATHWAY | 23 | 7.05e-01 | -4.57e-02 | 9.02e-01 |
| GOBP MITOCHONDRIAL TRANSPORT | 158 | 3.24e-01 | -4.56e-02 | 6.81e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSPORT | 29 | 6.71e-01 | -4.56e-02 | 8.88e-01 |
| GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 6 | 8.47e-01 | 4.56e-02 | 9.56e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 289 | 1.85e-01 | -4.56e-02 | 5.54e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 42 | 6.10e-01 | 4.55e-02 | 8.56e-01 |
| GOBP SIGNAL PEPTIDE PROCESSING | 13 | 7.76e-01 | -4.55e-02 | 9.31e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS | 8 | 8.24e-01 | -4.55e-02 | 9.46e-01 |
| GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 52 | 5.71e-01 | 4.55e-02 | 8.34e-01 |
| GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 6 | 8.47e-01 | 4.55e-02 | 9.56e-01 |
| GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 12 | 7.85e-01 | -4.54e-02 | 9.34e-01 |
| GOBP REGULATION OF JUN KINASE ACTIVITY | 30 | 6.67e-01 | 4.54e-02 | 8.86e-01 |
| GOBP REPRODUCTION | 699 | 4.39e-02 | -4.53e-02 | 3.10e-01 |
| GOBP MAINTENANCE OF LOCATION IN CELL | 148 | 3.43e-01 | -4.53e-02 | 6.95e-01 |
| GOMF KINASE REGULATOR ACTIVITY | 179 | 2.98e-01 | -4.53e-02 | 6.63e-01 |
| GOBP SPERM AXONEME ASSEMBLY | 14 | 7.69e-01 | -4.53e-02 | 9.28e-01 |
| GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES | 11 | 7.95e-01 | 4.53e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION | 10 | 8.04e-01 | -4.52e-02 | 9.41e-01 |
| GOBP MEMBRANE RAFT LOCALIZATION | 6 | 8.48e-01 | -4.52e-02 | 9.56e-01 |
| GOBP SEQUESTERING OF IRON ION | 5 | 8.61e-01 | 4.52e-02 | 9.61e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 7 | 8.36e-01 | -4.51e-02 | 9.51e-01 |
| GOBP METENCEPHALON DEVELOPMENT | 59 | 5.50e-01 | -4.51e-02 | 8.23e-01 |
| GOBP EXOCYTIC PROCESS | 58 | 5.53e-01 | -4.51e-02 | 8.24e-01 |
| GOBP INTRACELLULAR TRANSPORT | 1249 | 8.93e-03 | -4.51e-02 | 1.56e-01 |
| GOBP TELOMERASE RNA LOCALIZATION | 19 | 7.34e-01 | -4.51e-02 | 9.10e-01 |
| GOBP RESPONSE TO OSMOTIC STRESS | 62 | 5.41e-01 | -4.50e-02 | 8.18e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 62 | 5.41e-01 | -4.49e-02 | 8.18e-01 |
| GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 31 | 6.65e-01 | -4.49e-02 | 8.85e-01 |
| GOBP LYMPHOCYTE APOPTOTIC PROCESS | 62 | 5.41e-01 | -4.49e-02 | 8.18e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING | 8 | 8.26e-01 | 4.49e-02 | 9.47e-01 |
| GOBP VIRAL GENOME REPLICATION | 106 | 4.26e-01 | -4.48e-02 | 7.56e-01 |
| GOBP REGULATION OF RESPONSE TO STRESS | 997 | 1.89e-02 | -4.48e-02 | 2.15e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS | 14 | 7.72e-01 | -4.48e-02 | 9.29e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION | 739 | 4.10e-02 | -4.48e-02 | 3.01e-01 |
| GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION | 30 | 6.72e-01 | 4.47e-02 | 8.88e-01 |
| GOMF GDP DISSOCIATION INHIBITOR ACTIVITY | 14 | 7.72e-01 | 4.47e-02 | 9.29e-01 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 8 | 8.27e-01 | 4.47e-02 | 9.47e-01 |
| GOMF DNA CLAMP LOADER ACTIVITY | 6 | 8.50e-01 | 4.47e-02 | 9.57e-01 |
| GOBP RECEPTOR METABOLIC PROCESS | 59 | 5.53e-01 | -4.47e-02 | 8.24e-01 |
| GOCC ACROSOMAL MEMBRANE | 9 | 8.17e-01 | -4.47e-02 | 9.45e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 15 | 7.65e-01 | 4.46e-02 | 9.26e-01 |
| GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY | 14 | 7.73e-01 | -4.46e-02 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 14 | 7.73e-01 | 4.46e-02 | 9.29e-01 |
| GOBP TRANSITION METAL ION TRANSPORT | 61 | 5.47e-01 | -4.46e-02 | 8.23e-01 |
| GOBP REGULATION OF DNA RECOMBINATION | 104 | 4.33e-01 | 4.46e-02 | 7.60e-01 |
| GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 53 | 5.75e-01 | -4.46e-02 | 8.37e-01 |
| GOBP PEROXISOME ORGANIZATION | 31 | 6.68e-01 | -4.45e-02 | 8.86e-01 |
| GOCC MANNOSYLTRANSFERASE COMPLEX | 5 | 8.63e-01 | 4.45e-02 | 9.61e-01 |
| GOBP ACTIVATION OF IMMUNE RESPONSE | 391 | 1.34e-01 | -4.45e-02 | 4.93e-01 |
| GOMF SYNTAXIN 1 BINDING | 12 | 7.90e-01 | 4.44e-02 | 9.36e-01 |
| GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT | 23 | 7.12e-01 | 4.44e-02 | 9.05e-01 |
| GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION | 11 | 7.99e-01 | -4.44e-02 | 9.38e-01 |
| GOBP CELLULAR RESPIRATION | 201 | 2.80e-01 | -4.44e-02 | 6.54e-01 |
| GOBP REGULATION OF PHOSPHORYLATION | 625 | 6.13e-02 | -4.44e-02 | 3.60e-01 |
| GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION | 5 | 8.64e-01 | -4.43e-02 | 9.61e-01 |
| GOMF TRANSLATION REPRESSOR ACTIVITY | 23 | 7.13e-01 | 4.43e-02 | 9.05e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 14 | 7.74e-01 | -4.43e-02 | 9.30e-01 |
| GOBP SENSORY ORGAN MORPHOGENESIS | 98 | 4.50e-01 | -4.43e-02 | 7.70e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT | 49 | 5.92e-01 | -4.42e-02 | 8.46e-01 |
| GOBP MECHANORECEPTOR DIFFERENTIATION | 27 | 6.91e-01 | 4.42e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF LYASE ACTIVITY | 5 | 8.64e-01 | -4.42e-02 | 9.61e-01 |
| GOBP PROTEIN DELIPIDATION | 5 | 8.64e-01 | -4.41e-02 | 9.61e-01 |
| GOBP SOMITOGENESIS | 26 | 6.97e-01 | -4.41e-02 | 9.00e-01 |
| GOBP THIOESTER METABOLIC PROCESS | 64 | 5.42e-01 | 4.41e-02 | 8.19e-01 |
| GOBP REGULATION OF EXIT FROM MITOSIS | 12 | 7.92e-01 | -4.41e-02 | 9.36e-01 |
| GOBP CALCIUM ION TRANSPORT | 207 | 2.77e-01 | -4.40e-02 | 6.53e-01 |
| GOBP PROTEIN DESTABILIZATION | 42 | 6.22e-01 | -4.40e-02 | 8.63e-01 |
| GOBP DNA CATABOLIC PROCESS | 22 | 7.21e-01 | -4.40e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE IMPORT | 18 | 7.47e-01 | 4.39e-02 | 9.17e-01 |
| GOBP CELLULAR HYPEROSMOTIC RESPONSE | 14 | 7.76e-01 | -4.39e-02 | 9.31e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 9 | 8.20e-01 | -4.39e-02 | 9.46e-01 |
| GOBP ORGANIC ACID BIOSYNTHETIC PROCESS | 188 | 3.01e-01 | 4.39e-02 | 6.65e-01 |
| GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 95 | 4.61e-01 | -4.39e-02 | 7.76e-01 |
| GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST | 36 | 6.49e-01 | -4.38e-02 | 8.76e-01 |
| GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC | 44 | 6.15e-01 | -4.38e-02 | 8.60e-01 |
| GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM | 9 | 8.20e-01 | 4.38e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 18 | 7.48e-01 | 4.38e-02 | 9.17e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN BINDING | 52 | 5.86e-01 | -4.38e-02 | 8.42e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 44 | 6.16e-01 | -4.37e-02 | 8.60e-01 |
| GOBP RESPONSE TO INORGANIC SUBSTANCE | 310 | 1.89e-01 | -4.37e-02 | 5.59e-01 |
| GOBP ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS | 12 | 7.93e-01 | -4.37e-02 | 9.36e-01 |
| GOBP CELL REDOX HOMEOSTASIS | 33 | 6.64e-01 | -4.37e-02 | 8.84e-01 |
| GOBP POLYOL BIOSYNTHETIC PROCESS | 38 | 6.42e-01 | 4.36e-02 | 8.73e-01 |
| GOBP PIGMENT METABOLIC PROCESS | 46 | 6.09e-01 | 4.36e-02 | 8.56e-01 |
| GOMF BETA 2 MICROGLOBULIN BINDING | 8 | 8.31e-01 | -4.36e-02 | 9.50e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 185 | 3.08e-01 | -4.36e-02 | 6.70e-01 |
| GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 38 | 6.43e-01 | -4.35e-02 | 8.73e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 89 | 4.79e-01 | 4.35e-02 | 7.82e-01 |
| GOBP SEGMENT SPECIFICATION | 5 | 8.66e-01 | 4.35e-02 | 9.62e-01 |
| GOBP REGULATION OF CELL DIVISION | 101 | 4.51e-01 | -4.34e-02 | 7.70e-01 |
| GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS | 72 | 5.25e-01 | -4.34e-02 | 8.08e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY | 54 | 5.82e-01 | 4.34e-02 | 8.40e-01 |
| GOMF CLATHRIN BINDING | 41 | 6.32e-01 | -4.33e-02 | 8.67e-01 |
| GOBP REGULATION OF CELL ACTIVATION | 449 | 1.19e-01 | -4.33e-02 | 4.70e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS | 74 | 5.20e-01 | 4.33e-02 | 8.05e-01 |
| GOMF PROTEIN FOLDING CHAPERONE BINDING | 96 | 4.65e-01 | -4.33e-02 | 7.77e-01 |
| GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 10 | 8.13e-01 | 4.32e-02 | 9.43e-01 |
| GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 378 | 1.53e-01 | -4.31e-02 | 5.16e-01 |
| GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM | 45 | 6.17e-01 | -4.31e-02 | 8.62e-01 |
| GOMF SNRNA BINDING | 43 | 6.25e-01 | -4.31e-02 | 8.64e-01 |
| GOMF TRANSCRIPTION COACTIVATOR ACTIVITY | 233 | 2.60e-01 | -4.31e-02 | 6.37e-01 |
| GOMF DELTA CATENIN BINDING | 5 | 8.68e-01 | -4.30e-02 | 9.63e-01 |
| GOBP CARBOHYDRATE TRANSMEMBRANE TRANSPORT | 69 | 5.37e-01 | -4.30e-02 | 8.16e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 5 | 8.68e-01 | 4.29e-02 | 9.63e-01 |
| GOMF DNA NUCLEASE ACTIVITY | 48 | 6.08e-01 | -4.29e-02 | 8.55e-01 |
| GOBP REGULATION OF CELL CYCLE PROCESS | 494 | 1.06e-01 | 4.28e-02 | 4.52e-01 |
| GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS | 21 | 7.34e-01 | 4.28e-02 | 9.10e-01 |
| GOCC WASH COMPLEX | 9 | 8.24e-01 | 4.27e-02 | 9.46e-01 |
| GOBP RELAXATION OF MUSCLE | 22 | 7.29e-01 | -4.27e-02 | 9.09e-01 |
| GOBP LUNG CELL DIFFERENTIATION | 14 | 7.82e-01 | -4.27e-02 | 9.32e-01 |
| GOBP COCHLEA DEVELOPMENT | 11 | 8.06e-01 | 4.27e-02 | 9.41e-01 |
| GOBP RESPONSE TO VIRUS | 309 | 2.00e-01 | -4.27e-02 | 5.75e-01 |
| GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS | 11 | 8.07e-01 | -4.26e-02 | 9.41e-01 |
| GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS | 23 | 7.24e-01 | -4.26e-02 | 9.07e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER | 616 | 7.52e-02 | 4.25e-02 | 3.96e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 59 | 5.73e-01 | -4.25e-02 | 8.35e-01 |
| GOBP CARBOHYDRATE METABOLIC PROCESS | 377 | 1.60e-01 | -4.24e-02 | 5.25e-01 |
| GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY | 305 | 2.05e-01 | -4.24e-02 | 5.81e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION | 6 | 8.57e-01 | 4.24e-02 | 9.59e-01 |
| GOBP SIRNA PROCESSING | 8 | 8.36e-01 | 4.24e-02 | 9.50e-01 |
| GOBP BASE CONVERSION OR SUBSTITUTION EDITING | 9 | 8.26e-01 | -4.24e-02 | 9.47e-01 |
| GOBP POST FERTILIZATION EPIGENETIC REGULATION OF GENE EXPRESSION | 10 | 8.17e-01 | 4.24e-02 | 9.45e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION | 7 | 8.46e-01 | -4.23e-02 | 9.56e-01 |
| GOCC IGG IMMUNOGLOBULIN COMPLEX | 5 | 8.70e-01 | 4.23e-02 | 9.63e-01 |
| GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 366 | 1.67e-01 | -4.23e-02 | 5.34e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING | 17 | 7.63e-01 | -4.23e-02 | 9.25e-01 |
| GOBP NCRNA TRANSCRIPTION | 98 | 4.70e-01 | -4.23e-02 | 7.79e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 32 | 6.79e-01 | -4.23e-02 | 8.91e-01 |
| GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY | 27 | 7.04e-01 | -4.22e-02 | 9.02e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 7 | 8.47e-01 | 4.22e-02 | 9.56e-01 |
| GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 8 | 8.36e-01 | -4.22e-02 | 9.51e-01 |
| GOBP LEUKOCYTE MEDIATED CYTOTOXICITY | 96 | 4.76e-01 | -4.21e-02 | 7.81e-01 |
| GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY | 51 | 6.03e-01 | -4.21e-02 | 8.52e-01 |
| GOBP RECEPTOR SIGNALING PATHWAY VIA STAT | 99 | 4.70e-01 | -4.21e-02 | 7.79e-01 |
| GOBP DICARBOXYLIC ACID CATABOLIC PROCESS | 12 | 8.01e-01 | -4.21e-02 | 9.39e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC | 17 | 7.64e-01 | 4.21e-02 | 9.26e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS | 268 | 2.38e-01 | -4.21e-02 | 6.16e-01 |
| GOCC PERICENTRIC HETEROCHROMATIN | 26 | 7.11e-01 | 4.20e-02 | 9.04e-01 |
| GOBP COMPLEMENT ACTIVATION | 22 | 7.34e-01 | 4.19e-02 | 9.10e-01 |
| GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 34 | 6.73e-01 | 4.19e-02 | 8.88e-01 |
| GOBP NEURON RECOGNITION | 17 | 7.65e-01 | -4.19e-02 | 9.26e-01 |
| GOBP REGULATION OF CILIUM ASSEMBLY | 76 | 5.29e-01 | 4.18e-02 | 8.11e-01 |
| GOMF MAP KINASE KINASE KINASE ACTIVITY | 22 | 7.35e-01 | 4.18e-02 | 9.10e-01 |
| GOCC NADH DEHYDROGENASE COMPLEX | 47 | 6.21e-01 | 4.17e-02 | 8.62e-01 |
| GOBP REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS | 7 | 8.48e-01 | 4.17e-02 | 9.56e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY | 362 | 1.76e-01 | -4.17e-02 | 5.43e-01 |
| GOMF RNA STEM LOOP BINDING | 14 | 7.87e-01 | -4.17e-02 | 9.35e-01 |
| GOBP REGULATION OF TRANSPORTER ACTIVITY | 110 | 4.52e-01 | -4.16e-02 | 7.70e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS | 85 | 5.08e-01 | 4.16e-02 | 7.98e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE | 232 | 2.78e-01 | -4.16e-02 | 6.53e-01 |
| GOCC ORGANELLE SUBCOMPARTMENT | 1026 | 2.73e-02 | -4.16e-02 | 2.55e-01 |
| GOBP REGULATION OF TRANSLATION AT SYNAPSE | 5 | 8.72e-01 | 4.16e-02 | 9.63e-01 |
| GOBP RESPONSE TO UV | 118 | 4.37e-01 | 4.15e-02 | 7.61e-01 |
| GOMF CALCIUM ACTIVATED POTASSIUM CHANNEL ACTIVITY | 5 | 8.72e-01 | 4.15e-02 | 9.63e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY | 8 | 8.39e-01 | -4.15e-02 | 9.52e-01 |
| GOBP PEPTIDYL LYSINE MODIFICATION | 179 | 3.40e-01 | 4.15e-02 | 6.93e-01 |
| GOBP FEMALE SEX DIFFERENTIATION | 55 | 5.95e-01 | -4.15e-02 | 8.48e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY | 7 | 8.49e-01 | -4.15e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 18 | 7.61e-01 | -4.13e-02 | 9.24e-01 |
| GOBP REGULATION OF MICROTUBULE NUCLEATION | 18 | 7.61e-01 | 4.13e-02 | 9.24e-01 |
| GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX | 36 | 6.68e-01 | 4.13e-02 | 8.86e-01 |
| GOBP FOREBRAIN GENERATION OF NEURONS | 19 | 7.55e-01 | -4.13e-02 | 9.20e-01 |
| GOBP PROTEIN AUTOPROCESSING | 15 | 7.82e-01 | -4.13e-02 | 9.32e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 8 | 8.40e-01 | 4.12e-02 | 9.53e-01 |
| GOCC AXONEMAL DYNEIN COMPLEX | 7 | 8.50e-01 | 4.12e-02 | 9.57e-01 |
| GOBP RESPONSE TO CALCIUM ION | 76 | 5.35e-01 | 4.12e-02 | 8.15e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 28 | 7.06e-01 | -4.12e-02 | 9.02e-01 |
| GOMF MYRISTOYLTRANSFERASE ACTIVITY | 10 | 8.22e-01 | -4.12e-02 | 9.46e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE | 345 | 1.92e-01 | 4.12e-02 | 5.63e-01 |
| GOBP REGULATION OF MRNA CATABOLIC PROCESS | 152 | 3.82e-01 | -4.12e-02 | 7.23e-01 |
| GOBP NUCLEOTIDE SALVAGE | 16 | 7.76e-01 | -4.12e-02 | 9.31e-01 |
| GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS | 22 | 7.38e-01 | 4.11e-02 | 9.12e-01 |
| GOBP REGULATION OF IMMUNE RESPONSE | 650 | 7.72e-02 | -4.11e-02 | 3.98e-01 |
| GOBP CELLULAR RESPONSE TO ZINC ION | 11 | 8.13e-01 | -4.11e-02 | 9.43e-01 |
| GOBP TISSUE REMODELING | 80 | 5.26e-01 | -4.11e-02 | 8.09e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 11 | 8.14e-01 | -4.11e-02 | 9.43e-01 |
| GOBP NUCLEAR CHROMOSOME SEGREGATION | 215 | 3.02e-01 | 4.10e-02 | 6.65e-01 |
| GOCC CCR4 NOT COMPLEX | 13 | 7.98e-01 | -4.10e-02 | 9.38e-01 |
| GOBP HISTONE H3 ACETYLATION | 6 | 8.62e-01 | -4.09e-02 | 9.61e-01 |
| GOBP REGULATION OF CHROMOSOME SEGREGATION | 90 | 5.03e-01 | 4.09e-02 | 7.94e-01 |
| GOMF RNA NUCLEASE ACTIVITY | 105 | 4.70e-01 | 4.09e-02 | 7.79e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 16 | 7.77e-01 | 4.09e-02 | 9.31e-01 |
| GOBP PRIMARY ALCOHOL METABOLIC PROCESS | 43 | 6.43e-01 | -4.09e-02 | 8.74e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS | 21 | 7.46e-01 | -4.09e-02 | 9.16e-01 |
| GOCC U2 SNRNP | 25 | 7.24e-01 | -4.09e-02 | 9.07e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSPORT | 700 | 6.89e-02 | -4.09e-02 | 3.80e-01 |
| GOBP PROSTAGLANDIN TRANSPORT | 11 | 8.15e-01 | 4.08e-02 | 9.44e-01 |
| GOBP ENERGY HOMEOSTASIS | 38 | 6.63e-01 | -4.08e-02 | 8.84e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSPORT | 9 | 8.32e-01 | 4.08e-02 | 9.50e-01 |
| GOBP KINETOCHORE ORGANIZATION | 18 | 7.65e-01 | 4.08e-02 | 9.26e-01 |
| GOCC LEADING EDGE MEMBRANE | 96 | 4.91e-01 | -4.07e-02 | 7.88e-01 |
| GOBP REGULATION OF RECEPTOR BINDING | 7 | 8.52e-01 | 4.06e-02 | 9.58e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III | 6 | 8.63e-01 | -4.06e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 38 | 6.65e-01 | -4.06e-02 | 8.85e-01 |
| GOBP SPLICEOSOMAL COMPLEX ASSEMBLY | 67 | 5.66e-01 | -4.06e-02 | 8.33e-01 |
| GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY | 375 | 1.81e-01 | -4.06e-02 | 5.48e-01 |
| GOCC ACTIN FILAMENT | 66 | 5.69e-01 | -4.05e-02 | 8.34e-01 |
| GOBP REGULATION OF RUFFLE ASSEMBLY | 20 | 7.54e-01 | 4.05e-02 | 9.19e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT | 10 | 8.24e-01 | -4.05e-02 | 9.46e-01 |
| GOBP MAMMALIAN OOGENESIS STAGE | 7 | 8.53e-01 | -4.05e-02 | 9.58e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY | 10 | 8.25e-01 | -4.05e-02 | 9.46e-01 |
| GOBP ORGANELLE FUSION | 126 | 4.35e-01 | -4.03e-02 | 7.61e-01 |
| GOMF EXONUCLEASE ACTIVITY | 74 | 5.49e-01 | 4.03e-02 | 8.23e-01 |
| GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY | 36 | 6.76e-01 | 4.03e-02 | 8.90e-01 |
| GOBP LEUKOTRIENE METABOLIC PROCESS | 14 | 7.94e-01 | 4.03e-02 | 9.36e-01 |
| GOBP REGULATION OF DNA STRAND ELONGATION | 17 | 7.74e-01 | 4.03e-02 | 9.30e-01 |
| GOBP SPERM FLAGELLUM ASSEMBLY | 17 | 7.74e-01 | -4.02e-02 | 9.30e-01 |
| GOBP SENSORY PERCEPTION OF PAIN | 28 | 7.13e-01 | -4.02e-02 | 9.05e-01 |
| GOBP BONE DEVELOPMENT | 101 | 4.86e-01 | -4.02e-02 | 7.85e-01 |
| GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT | 6 | 8.65e-01 | -4.02e-02 | 9.61e-01 |
| GOBP REGULATION OF POSTSYNAPSE ORGANIZATION | 59 | 5.94e-01 | -4.02e-02 | 8.47e-01 |
| GOBP CARDIAC CONDUCTION | 40 | 6.61e-01 | -4.01e-02 | 8.82e-01 |
| GOBP NEUTROPHIL EXTRAVASATION | 10 | 8.26e-01 | -4.01e-02 | 9.47e-01 |
| GOBP RESPONSE TO ALKALOID | 53 | 6.15e-01 | 4.00e-02 | 8.59e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 7.51e-01 | 4.00e-02 | 9.19e-01 |
| GOBP SYNAPSE PRUNING | 6 | 8.66e-01 | -3.99e-02 | 9.62e-01 |
| GOBP SMALL MOLECULE METABOLIC PROCESS | 1171 | 2.46e-02 | 3.99e-02 | 2.43e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 17 | 7.76e-01 | 3.98e-02 | 9.31e-01 |
| GOBP REGULATION OF NEUTROPHIL MIGRATION | 31 | 7.01e-01 | -3.98e-02 | 9.01e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 10 | 8.27e-01 | 3.98e-02 | 9.48e-01 |
| GOMF HSP90 PROTEIN BINDING | 31 | 7.02e-01 | 3.98e-02 | 9.01e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE | 29 | 7.11e-01 | -3.98e-02 | 9.04e-01 |
| GOBP POSITIVE REGULATION OF CELL DIVISION | 43 | 6.52e-01 | -3.97e-02 | 8.78e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE | 65 | 5.80e-01 | -3.97e-02 | 8.39e-01 |
| GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE | 65 | 5.80e-01 | -3.97e-02 | 8.39e-01 |
| GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY | 12 | 8.12e-01 | -3.97e-02 | 9.43e-01 |
| GOCC INO80 COMPLEX | 15 | 7.91e-01 | 3.96e-02 | 9.36e-01 |
| GOCC SPLICEOSOMAL TRI SNRNP COMPLEX | 36 | 6.82e-01 | -3.95e-02 | 8.93e-01 |
| GOBP LONG CHAIN FATTY ACID TRANSPORT | 33 | 6.95e-01 | -3.95e-02 | 8.98e-01 |
| GOMF PRERIBOSOME BINDING | 8 | 8.47e-01 | -3.94e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 402 | 1.78e-01 | -3.94e-02 | 5.46e-01 |
| GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION | 6 | 8.67e-01 | 3.94e-02 | 9.63e-01 |
| GOBP NEUROTRANSMITTER UPTAKE | 12 | 8.13e-01 | -3.94e-02 | 9.43e-01 |
| GOBP DENDRITIC SPINE MAINTENANCE | 14 | 7.99e-01 | -3.93e-02 | 9.38e-01 |
| GOBP DEPHOSPHORYLATION | 217 | 3.21e-01 | -3.93e-02 | 6.80e-01 |
| GOBP MYOBLAST FUSION | 22 | 7.50e-01 | -3.93e-02 | 9.18e-01 |
| GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE | 23 | 7.45e-01 | -3.92e-02 | 9.16e-01 |
| GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT | 5 | 8.80e-01 | 3.90e-02 | 9.65e-01 |
| GOBP CHAPERONE MEDIATED AUTOPHAGY | 12 | 8.15e-01 | 3.90e-02 | 9.45e-01 |
| GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT | 56 | 6.14e-01 | -3.90e-02 | 8.59e-01 |
| GOMF TRANSLATION ELONGATION FACTOR ACTIVITY | 17 | 7.81e-01 | -3.90e-02 | 9.32e-01 |
| GOBP PROTEIN INSERTION INTO MEMBRANE | 66 | 5.84e-01 | -3.90e-02 | 8.41e-01 |
| GOBP MONOATOMIC ANION TRANSPORT | 72 | 5.68e-01 | 3.89e-02 | 8.34e-01 |
| GOBP BRANCHING MORPHOGENESIS OF A NERVE | 6 | 8.69e-01 | -3.89e-02 | 9.63e-01 |
| GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX | 6 | 8.69e-01 | 3.89e-02 | 9.63e-01 |
| GOBP VESICLE FUSION WITH GOLGI APPARATUS | 8 | 8.49e-01 | 3.89e-02 | 9.57e-01 |
| GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS | 6 | 8.69e-01 | -3.88e-02 | 9.63e-01 |
| GOMF SPHINGOLIPID TRANSPORTER ACTIVITY | 10 | 8.32e-01 | -3.88e-02 | 9.50e-01 |
| GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY | 30 | 7.13e-01 | 3.88e-02 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTOSIS | 97 | 5.10e-01 | -3.88e-02 | 7.99e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 161 | 3.98e-01 | -3.87e-02 | 7.35e-01 |
| GOCC SPERM MIDPIECE | 25 | 7.38e-01 | 3.87e-02 | 9.12e-01 |
| GOBP REGULATION OF BEHAVIOR | 29 | 7.18e-01 | 3.87e-02 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING | 5 | 8.81e-01 | -3.87e-02 | 9.65e-01 |
| GOBP NEURON PROJECTION REGENERATION | 28 | 7.23e-01 | -3.87e-02 | 9.07e-01 |
| GOCC CENTROSOME | 489 | 1.47e-01 | 3.87e-02 | 5.08e-01 |
| GOCC CENTRIOLAR SATELLITE | 87 | 5.34e-01 | -3.86e-02 | 8.15e-01 |
| GOBP BONE TRABECULA MORPHOGENESIS | 5 | 8.81e-01 | -3.86e-02 | 9.65e-01 |
| GOCC GOLGI ASSOCIATED VESICLE MEMBRANE | 42 | 6.66e-01 | -3.85e-02 | 8.85e-01 |
| GOBP MUSCLE CELL CELLULAR HOMEOSTASIS | 15 | 7.96e-01 | -3.85e-02 | 9.37e-01 |
| GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 33 | 7.02e-01 | 3.85e-02 | 9.01e-01 |
| GOBP ERYTHROCYTE MATURATION | 14 | 8.03e-01 | 3.84e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 56 | 6.19e-01 | -3.84e-02 | 8.62e-01 |
| GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 13 | 8.11e-01 | -3.84e-02 | 9.42e-01 |
| GOMF TRANSMEMBRANE TRANSPORTER BINDING | 76 | 5.64e-01 | -3.84e-02 | 8.31e-01 |
| GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS | 5 | 8.82e-01 | -3.83e-02 | 9.65e-01 |
| GOBP HISTONE MRNA CATABOLIC PROCESS | 15 | 7.97e-01 | -3.83e-02 | 9.38e-01 |
| GOBP REGULATION OF AEROBIC RESPIRATION | 24 | 7.46e-01 | 3.83e-02 | 9.16e-01 |
| GOCC TRANS GOLGI NETWORK | 195 | 3.59e-01 | -3.83e-02 | 7.10e-01 |
| GOMF AMINOPEPTIDASE ACTIVITY | 29 | 7.22e-01 | 3.82e-02 | 9.06e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 8.27e-01 | 3.81e-02 | 9.47e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 7 | 8.61e-01 | 3.81e-02 | 9.61e-01 |
| GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS | 188 | 3.69e-01 | 3.81e-02 | 7.13e-01 |
| GOBP POLYSACCHARIDE METABOLIC PROCESS | 62 | 6.04e-01 | -3.81e-02 | 8.53e-01 |
| GOMF UBIQUITIN LIGASE SUBSTRATE ADAPTOR ACTIVITY | 48 | 6.48e-01 | 3.81e-02 | 8.76e-01 |
| GOBP NCRNA CATABOLIC PROCESS | 49 | 6.45e-01 | 3.80e-02 | 8.75e-01 |
| GOBP DETECTION OF BIOTIC STIMULUS | 24 | 7.47e-01 | 3.80e-02 | 9.17e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION | 120 | 4.73e-01 | 3.80e-02 | 7.79e-01 |
| GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 10 | 8.35e-01 | -3.80e-02 | 9.50e-01 |
| GOBP ANTIBACTERIAL HUMORAL RESPONSE | 15 | 7.99e-01 | -3.80e-02 | 9.38e-01 |
| GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION | 17 | 7.87e-01 | -3.80e-02 | 9.34e-01 |
| GOMF GTPASE ACTIVATOR ACTIVITY | 205 | 3.51e-01 | 3.79e-02 | 7.01e-01 |
| GOBP POSITIVE REGULATION OF BLOOD CIRCULATION | 14 | 8.06e-01 | -3.79e-02 | 9.41e-01 |
| GOMF FLIPPASE ACTIVITY | 10 | 8.36e-01 | -3.79e-02 | 9.50e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS | 118 | 4.78e-01 | -3.79e-02 | 7.82e-01 |
| GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 118 | 4.79e-01 | 3.78e-02 | 7.82e-01 |
| GOBP POSITIVE REGULATION OF LIPID TRANSPORT | 43 | 6.68e-01 | -3.78e-02 | 8.86e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 31 | 7.16e-01 | 3.78e-02 | 9.05e-01 |
| GOBP INOSITOL PHOSPHATE METABOLIC PROCESS | 28 | 7.30e-01 | -3.78e-02 | 9.09e-01 |
| GOBP LIPOPROTEIN CATABOLIC PROCESS | 12 | 8.21e-01 | -3.77e-02 | 9.46e-01 |
| GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY | 5 | 8.84e-01 | -3.77e-02 | 9.66e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN | 88 | 5.41e-01 | 3.77e-02 | 8.18e-01 |
| GOBP LIPID DROPLET FORMATION | 10 | 8.37e-01 | -3.77e-02 | 9.51e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE | 8 | 8.54e-01 | 3.77e-02 | 9.58e-01 |
| GOBP REGULATION OF EPIDERMIS DEVELOPMENT | 28 | 7.30e-01 | -3.77e-02 | 9.09e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 6 | 8.73e-01 | -3.76e-02 | 9.64e-01 |
| GOBP CYTOKINETIC PROCESS | 33 | 7.09e-01 | -3.76e-02 | 9.03e-01 |
| GOBP MRNA TRANSPORT | 110 | 4.97e-01 | 3.75e-02 | 7.92e-01 |
| GOBP ORGANELLE LOCALIZATION | 448 | 1.77e-01 | -3.75e-02 | 5.44e-01 |
| GOBP VIRAL PROCESS | 336 | 2.40e-01 | -3.75e-02 | 6.17e-01 |
| GOCC ACETYLTRANSFERASE COMPLEX | 92 | 5.36e-01 | 3.74e-02 | 8.15e-01 |
| GOCC COATED VESICLE MEMBRANE | 147 | 4.35e-01 | -3.74e-02 | 7.61e-01 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING | 23 | 7.57e-01 | 3.73e-02 | 9.21e-01 |
| GOMF POTASSIUM ION BINDING | 7 | 8.64e-01 | 3.73e-02 | 9.61e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 10 | 8.38e-01 | 3.73e-02 | 9.52e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 14 | 8.09e-01 | -3.73e-02 | 9.42e-01 |
| GOMF DIOXYGENASE ACTIVITY | 68 | 5.96e-01 | 3.73e-02 | 8.48e-01 |
| GOMF LYSOPHOSPHOLIPASE ACTIVITY | 16 | 7.97e-01 | 3.72e-02 | 9.37e-01 |
| GOCC DENSE CORE GRANULE | 12 | 8.23e-01 | -3.72e-02 | 9.46e-01 |
| GOBP REGULATION OF HYPERSENSITIVITY | 9 | 8.47e-01 | 3.72e-02 | 9.56e-01 |
| GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING | 13 | 8.16e-01 | -3.72e-02 | 9.45e-01 |
| GOBP LYMPHOCYTE ACTIVATION | 576 | 1.31e-01 | -3.72e-02 | 4.88e-01 |
| GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS | 41 | 6.81e-01 | 3.72e-02 | 8.92e-01 |
| GOBP REGULATION OF GLUCOSE METABOLIC PROCESS | 67 | 5.99e-01 | -3.72e-02 | 8.51e-01 |
| GOMF SNAP RECEPTOR ACTIVITY | 34 | 7.08e-01 | 3.72e-02 | 9.03e-01 |
| GOBP PROTEIN PHOSPHORYLATION | 825 | 7.47e-02 | -3.71e-02 | 3.94e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION | 10 | 8.39e-01 | -3.71e-02 | 9.52e-01 |
| GOBP MESENCHYMAL STEM CELL DIFFERENTIATION | 6 | 8.75e-01 | -3.71e-02 | 9.64e-01 |
| GOCC POLAR MICROTUBULE | 5 | 8.86e-01 | -3.70e-02 | 9.66e-01 |
| GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 6 | 8.75e-01 | 3.70e-02 | 9.64e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY | 309 | 2.66e-01 | -3.70e-02 | 6.44e-01 |
| GOBP T CELL DIFFERENTIATION IN THYMUS | 65 | 6.07e-01 | -3.70e-02 | 8.55e-01 |
| GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY | 11 | 8.32e-01 | 3.69e-02 | 9.50e-01 |
| GOBP METANEPHROS DEVELOPMENT | 20 | 7.76e-01 | -3.68e-02 | 9.31e-01 |
| GOBP REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 5 | 8.87e-01 | -3.68e-02 | 9.67e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 8.66e-01 | 3.67e-02 | 9.62e-01 |
| GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 11 | 8.33e-01 | -3.67e-02 | 9.50e-01 |
| GOBP MUSCLE ORGAN DEVELOPMENT | 156 | 4.31e-01 | -3.67e-02 | 7.58e-01 |
| GOBP STEROID CATABOLIC PROCESS | 8 | 8.58e-01 | 3.66e-02 | 9.59e-01 |
| GOBP APPENDAGE MORPHOGENESIS | 62 | 6.18e-01 | -3.66e-02 | 8.62e-01 |
| GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY | 27 | 7.42e-01 | -3.66e-02 | 9.14e-01 |
| GOCC ARYL HYDROCARBON RECEPTOR COMPLEX | 5 | 8.87e-01 | -3.66e-02 | 9.67e-01 |
| GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 45 | 6.72e-01 | -3.66e-02 | 8.88e-01 |
| GOBP KERATINOCYTE APOPTOTIC PROCESS | 5 | 8.87e-01 | 3.65e-02 | 9.67e-01 |
| GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 153 | 4.38e-01 | -3.65e-02 | 7.62e-01 |
| GOBP SISTER CHROMATID SEGREGATION | 168 | 4.17e-01 | 3.64e-02 | 7.52e-01 |
| GOBP GLUCOSE METABOLIC PROCESS | 129 | 4.76e-01 | -3.64e-02 | 7.81e-01 |
| GOBP PATTERN SPECIFICATION PROCESS | 168 | 4.19e-01 | -3.63e-02 | 7.53e-01 |
| GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 25 | 7.54e-01 | 3.63e-02 | 9.19e-01 |
| GOBP POSTREPLICATION REPAIR | 30 | 7.31e-01 | -3.63e-02 | 9.09e-01 |
| GOCC MAIN AXON | 28 | 7.41e-01 | 3.62e-02 | 9.13e-01 |
| GOMF ENDONUCLEASE ACTIVITY | 96 | 5.41e-01 | 3.61e-02 | 8.18e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE RESPONSE | 520 | 1.63e-01 | -3.61e-02 | 5.28e-01 |
| GOBP RESPONSE TO AXON INJURY | 39 | 6.97e-01 | -3.61e-02 | 9.00e-01 |
| GOBP PURINE NUCLEOTIDE TRANSPORT | 28 | 7.41e-01 | 3.61e-02 | 9.13e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 84 | 5.68e-01 | -3.61e-02 | 8.34e-01 |
| GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 10 | 8.43e-01 | 3.61e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF AXONOGENESIS | 44 | 6.79e-01 | 3.61e-02 | 8.91e-01 |
| GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 449 | 1.95e-01 | -3.60e-02 | 5.67e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES | 23 | 7.65e-01 | 3.60e-02 | 9.26e-01 |
| GOCC INCLUSION BODY | 53 | 6.51e-01 | -3.60e-02 | 8.77e-01 |
| GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION | 6 | 8.79e-01 | -3.59e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE | 9 | 8.52e-01 | 3.59e-02 | 9.58e-01 |
| GOBP REGULATION OF VIRAL TRANSCRIPTION | 16 | 8.04e-01 | 3.59e-02 | 9.41e-01 |
| GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY | 10 | 8.45e-01 | 3.58e-02 | 9.55e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES | 6 | 8.79e-01 | 3.58e-02 | 9.65e-01 |
| GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 116 | 5.06e-01 | 3.58e-02 | 7.97e-01 |
| GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 8.79e-01 | 3.58e-02 | 9.65e-01 |
| GOBP TRANSCRIPTION INITIATION COUPLED CHROMATIN REMODELING | 33 | 7.22e-01 | 3.58e-02 | 9.06e-01 |
| GOBP REGULATION OF DNA DUPLEX UNWINDING | 5 | 8.90e-01 | 3.58e-02 | 9.67e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION | 34 | 7.19e-01 | -3.57e-02 | 9.06e-01 |
| GOBP POLYSACCHARIDE CATABOLIC PROCESS | 14 | 8.17e-01 | 3.57e-02 | 9.45e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY | 7 | 8.70e-01 | -3.56e-02 | 9.63e-01 |
| GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION | 9 | 8.53e-01 | -3.56e-02 | 9.58e-01 |
| GOMF 5S RRNA BINDING | 9 | 8.53e-01 | -3.56e-02 | 9.58e-01 |
| GOBP ERROR PRONE TRANSLESION SYNTHESIS | 10 | 8.45e-01 | -3.56e-02 | 9.56e-01 |
| GOBP RESPONSE TO CORTICOSTEROID | 71 | 6.04e-01 | -3.56e-02 | 8.53e-01 |
| GOBP PHOSPHOLIPID TRANSPORT | 59 | 6.37e-01 | -3.56e-02 | 8.70e-01 |
| GOBP NEURON PROJECTION ARBORIZATION | 18 | 7.94e-01 | 3.56e-02 | 9.36e-01 |
| GOMF GTP DEPENDENT PROTEIN BINDING | 19 | 7.89e-01 | 3.56e-02 | 9.36e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 78 | 5.88e-01 | -3.56e-02 | 8.43e-01 |
| GOCC HISTONE METHYLTRANSFERASE COMPLEX | 59 | 6.37e-01 | -3.56e-02 | 8.70e-01 |
| GOBP AMINE TRANSPORT | 36 | 7.13e-01 | -3.55e-02 | 9.05e-01 |
| GOBP GLIAL CELL ACTIVATION | 35 | 7.17e-01 | -3.55e-02 | 9.06e-01 |
| GOBP REGULATION OF EMBRYONIC DEVELOPMENT | 62 | 6.29e-01 | -3.55e-02 | 8.67e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES | 10 | 8.46e-01 | 3.55e-02 | 9.56e-01 |
| GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION | 60 | 6.35e-01 | 3.55e-02 | 8.70e-01 |
| GOBP CHROMOSOME CONDENSATION | 23 | 7.69e-01 | 3.55e-02 | 9.28e-01 |
| GOBP IMPORT INTO NUCLEUS | 132 | 4.83e-01 | 3.54e-02 | 7.84e-01 |
| GOBP HAIR FOLLICLE MATURATION | 7 | 8.71e-01 | 3.54e-02 | 9.63e-01 |
| GOBP NK T CELL PROLIFERATION | 7 | 8.71e-01 | 3.54e-02 | 9.63e-01 |
| GOBP PROTEIN KINASE A SIGNALING | 18 | 7.95e-01 | 3.53e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION | 8 | 8.63e-01 | -3.53e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION | 9 | 8.54e-01 | 3.53e-02 | 9.58e-01 |
| GOMF RNA POLYMERASE III ACTIVITY | 10 | 8.47e-01 | -3.53e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 6 | 8.81e-01 | 3.53e-02 | 9.65e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 5 | 8.91e-01 | -3.52e-02 | 9.68e-01 |
| GOMF G QUADRUPLEX DNA BINDING | 10 | 8.47e-01 | -3.52e-02 | 9.56e-01 |
| GOBP STEROID BIOSYNTHETIC PROCESS | 95 | 5.54e-01 | -3.52e-02 | 8.25e-01 |
| GOBP RNA CATABOLIC PROCESS | 253 | 3.37e-01 | -3.52e-02 | 6.91e-01 |
| GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION | 7 | 8.72e-01 | -3.52e-02 | 9.63e-01 |
| GOBP RESPONSE TO IMMOBILIZATION STRESS | 12 | 8.33e-01 | 3.52e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 93 | 5.59e-01 | -3.51e-02 | 8.29e-01 |
| GOBP NEURAL NUCLEUS DEVELOPMENT | 42 | 6.94e-01 | -3.51e-02 | 8.98e-01 |
| GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 9 | 8.55e-01 | -3.51e-02 | 9.58e-01 |
| GOCC CALCIUM CHANNEL COMPLEX | 32 | 7.32e-01 | 3.50e-02 | 9.09e-01 |
| GOCC TRANSPORTER COMPLEX | 179 | 4.21e-01 | -3.50e-02 | 7.54e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 282 | 3.15e-01 | -3.49e-02 | 6.78e-01 |
| GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY | 572 | 1.58e-01 | -3.49e-02 | 5.24e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND | 405 | 2.33e-01 | -3.48e-02 | 6.10e-01 |
| GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 6 | 8.83e-01 | 3.48e-02 | 9.66e-01 |
| GOBP FC RECEPTOR SIGNALING PATHWAY | 50 | 6.71e-01 | -3.48e-02 | 8.88e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 735 | 1.14e-01 | -3.47e-02 | 4.61e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX | 200 | 3.99e-01 | -3.47e-02 | 7.37e-01 |
| GOBP RESPONSE TO ISOQUINOLINE ALKALOID | 7 | 8.74e-01 | 3.47e-02 | 9.64e-01 |
| GOCC NURD COMPLEX | 15 | 8.16e-01 | 3.47e-02 | 9.45e-01 |
| GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS | 356 | 2.65e-01 | 3.46e-02 | 6.42e-01 |
| GOBP MACROPHAGE DIFFERENTIATION | 42 | 6.98e-01 | -3.46e-02 | 9.01e-01 |
| GOBP NEURON REMODELING | 6 | 8.83e-01 | 3.46e-02 | 9.66e-01 |
| GOMF CYCLASE ACTIVITY | 9 | 8.57e-01 | 3.46e-02 | 9.59e-01 |
| GOBP REGULATION OF PLATELET AGGREGATION | 15 | 8.17e-01 | 3.45e-02 | 9.45e-01 |
| GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE | 80 | 5.94e-01 | -3.45e-02 | 8.47e-01 |
| GOBP INTRACELLULAR ZINC ION HOMEOSTASIS | 21 | 7.84e-01 | 3.45e-02 | 9.33e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 697 | 1.26e-01 | -3.45e-02 | 4.81e-01 |
| GOBP TISSUE REGENERATION | 36 | 7.21e-01 | -3.45e-02 | 9.06e-01 |
| GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY | 22 | 7.80e-01 | -3.45e-02 | 9.31e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 42 | 7.00e-01 | -3.44e-02 | 9.01e-01 |
| GOBP MOLTING CYCLE PROCESS | 40 | 7.07e-01 | -3.44e-02 | 9.03e-01 |
| GOMF RNA POLYMERASE CORE ENZYME BINDING | 38 | 7.14e-01 | 3.44e-02 | 9.05e-01 |
| GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS | 21 | 7.85e-01 | -3.43e-02 | 9.34e-01 |
| GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER | 11 | 8.44e-01 | -3.43e-02 | 9.55e-01 |
| GOCC COATED VESICLE | 229 | 3.73e-01 | -3.43e-02 | 7.16e-01 |
| GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY | 7 | 8.75e-01 | 3.43e-02 | 9.64e-01 |
| GOBP REGULATION OF NUCLEASE ACTIVITY | 20 | 7.91e-01 | 3.43e-02 | 9.36e-01 |
| GOBP SEQUESTERING OF ACTIN MONOMERS | 6 | 8.85e-01 | 3.42e-02 | 9.66e-01 |
| GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION | 17 | 8.07e-01 | 3.42e-02 | 9.41e-01 |
| GOBP ESTABLISHMENT OF RNA LOCALIZATION | 140 | 4.86e-01 | 3.42e-02 | 7.85e-01 |
| GOMF PROTEIN CONTAINING COMPLEX BINDING | 1166 | 5.44e-02 | -3.42e-02 | 3.40e-01 |
| GOBP MONONUCLEAR CELL MIGRATION | 118 | 5.23e-01 | -3.41e-02 | 8.07e-01 |
| GOMF ADENYLYLTRANSFERASE ACTIVITY | 23 | 7.77e-01 | 3.41e-02 | 9.31e-01 |
| GOMF ORGANIC ACID BINDING | 98 | 5.60e-01 | -3.41e-02 | 8.29e-01 |
| GOBP REGULATION OF GLIAL CELL MIGRATION | 13 | 8.32e-01 | -3.41e-02 | 9.50e-01 |
| GOBP TYPE I INTERFERON PRODUCTION | 105 | 5.47e-01 | -3.41e-02 | 8.23e-01 |
| GOBP PROTEIN DEPALMITOYLATION | 8 | 8.68e-01 | -3.40e-02 | 9.63e-01 |
| GOMF 3 5 CYCLIC GMP PHOSPHODIESTERASE ACTIVITY | 7 | 8.76e-01 | 3.40e-02 | 9.64e-01 |
| GOMF MAP KINASE SCAFFOLD ACTIVITY | 8 | 8.68e-01 | 3.40e-02 | 9.63e-01 |
| GOBP CELLULAR RESPONSE TO CADMIUM ION | 22 | 7.83e-01 | 3.40e-02 | 9.32e-01 |
| GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS | 51 | 6.75e-01 | -3.39e-02 | 8.90e-01 |
| GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 10 | 8.53e-01 | 3.39e-02 | 9.58e-01 |
| GOBP MRNA CATABOLIC PROCESS | 204 | 4.06e-01 | -3.39e-02 | 7.42e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DIFFERENTIATION | 8 | 8.68e-01 | 3.39e-02 | 9.63e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE | 10 | 8.53e-01 | -3.38e-02 | 9.58e-01 |
| GOBP ACTIN FILAMENT SEVERING | 14 | 8.27e-01 | -3.38e-02 | 9.47e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION | 41 | 7.09e-01 | 3.38e-02 | 9.03e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 448 | 2.25e-01 | -3.37e-02 | 6.00e-01 |
| GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 38 | 7.19e-01 | -3.37e-02 | 9.06e-01 |
| GOBP MACROPHAGE ACTIVATION | 70 | 6.27e-01 | 3.37e-02 | 8.65e-01 |
| GOBP POLYPRENOL METABOLIC PROCESS | 20 | 7.95e-01 | -3.37e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 78 | 6.08e-01 | -3.36e-02 | 8.56e-01 |
| GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 7 | 8.78e-01 | 3.35e-02 | 9.65e-01 |
| GOBP TRANSLESION SYNTHESIS | 21 | 7.90e-01 | -3.35e-02 | 9.36e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSPORT | 34 | 7.35e-01 | -3.35e-02 | 9.11e-01 |
| GOBP NUCLEAR EXPORT | 149 | 4.81e-01 | -3.35e-02 | 7.84e-01 |
| GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 27 | 7.64e-01 | 3.35e-02 | 9.25e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 147 | 4.85e-01 | -3.35e-02 | 7.85e-01 |
| GOBP NEURON DEVELOPMENT | 564 | 1.79e-01 | -3.34e-02 | 5.47e-01 |
| GOCC GOLGI STACK | 102 | 5.60e-01 | 3.34e-02 | 8.29e-01 |
| GOBP SPERM MOTILITY | 44 | 7.02e-01 | -3.34e-02 | 9.01e-01 |
| GOMF CO SMAD BINDING | 8 | 8.70e-01 | -3.34e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION | 329 | 3.01e-01 | -3.34e-02 | 6.65e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION | 5 | 8.97e-01 | 3.34e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION | 18 | 8.07e-01 | -3.33e-02 | 9.41e-01 |
| GOBP CHEMICAL HOMEOSTASIS | 538 | 1.91e-01 | -3.33e-02 | 5.61e-01 |
| GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 7 | 8.79e-01 | -3.33e-02 | 9.65e-01 |
| GOBP HISTONE H3 K4 METHYLATION | 18 | 8.07e-01 | -3.33e-02 | 9.41e-01 |
| GOBP RIBOSE PHOSPHATE METABOLIC PROCESS | 292 | 3.31e-01 | 3.32e-02 | 6.87e-01 |
| GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS | 351 | 2.88e-01 | 3.32e-02 | 6.58e-01 |
| GOBP XENOBIOTIC METABOLIC PROCESS | 41 | 7.13e-01 | 3.32e-02 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 270 | 3.50e-01 | -3.32e-02 | 7.01e-01 |
| GOBP TROPHECTODERMAL CELL DIFFERENTIATION | 12 | 8.42e-01 | 3.32e-02 | 9.54e-01 |
| GOBP PHOSPHOLIPID TRANSLOCATION | 30 | 7.53e-01 | -3.32e-02 | 9.19e-01 |
| GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY | 7 | 8.79e-01 | 3.31e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 38 | 7.24e-01 | 3.31e-02 | 9.07e-01 |
| GOCC AXON | 323 | 3.09e-01 | -3.31e-02 | 6.71e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION | 12 | 8.43e-01 | 3.31e-02 | 9.54e-01 |
| GOBP SYNAPTIC VESICLE PRIMING | 11 | 8.49e-01 | 3.31e-02 | 9.57e-01 |
| GOBP MONOATOMIC ION HOMEOSTASIS | 326 | 3.08e-01 | -3.31e-02 | 6.70e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 88 | 5.93e-01 | -3.30e-02 | 8.47e-01 |
| GOBP RHYTHMIC PROCESS | 174 | 4.55e-01 | 3.30e-02 | 7.72e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 21 | 7.94e-01 | -3.29e-02 | 9.36e-01 |
| GOBP RESPONSE TO PEPTIDE HORMONE | 258 | 3.65e-01 | -3.29e-02 | 7.11e-01 |
| GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY | 40 | 7.19e-01 | -3.29e-02 | 9.06e-01 |
| GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 18 | 8.09e-01 | 3.29e-02 | 9.42e-01 |
| GOBP N ACETYLNEURAMINATE METABOLIC PROCESS | 11 | 8.50e-01 | 3.29e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 255 | 3.69e-01 | -3.29e-02 | 7.13e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 9 | 8.65e-01 | 3.28e-02 | 9.61e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 24 | 7.81e-01 | -3.28e-02 | 9.32e-01 |
| GOBP RESPONSE TO MISFOLDED PROTEIN | 23 | 7.86e-01 | -3.28e-02 | 9.34e-01 |
| GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS | 715 | 1.41e-01 | -3.28e-02 | 5.00e-01 |
| GOMF CYCLOSPORIN A BINDING | 16 | 8.21e-01 | 3.27e-02 | 9.46e-01 |
| GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 8.51e-01 | 3.26e-02 | 9.58e-01 |
| GOBP GOLGI DISASSEMBLY | 5 | 9.00e-01 | 3.26e-02 | 9.71e-01 |
| GOBP FATTY ACID HOMEOSTASIS | 9 | 8.66e-01 | -3.26e-02 | 9.62e-01 |
| GOCC CONTRACTILE RING | 9 | 8.66e-01 | -3.26e-02 | 9.62e-01 |
| GOBP SODIUM ION TRANSPORT | 87 | 6.00e-01 | 3.25e-02 | 8.51e-01 |
| GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE | 8 | 8.73e-01 | -3.25e-02 | 9.64e-01 |
| GOBP CYTOSKELETON ORGANIZATION | 878 | 1.08e-01 | -3.25e-02 | 4.54e-01 |
| GOBP AEROBIC RESPIRATION | 169 | 4.68e-01 | -3.25e-02 | 7.78e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST | 14 | 8.34e-01 | -3.24e-02 | 9.50e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MUSCLE | 19 | 8.07e-01 | 3.24e-02 | 9.41e-01 |
| GOMF MODIFICATION DEPENDENT PROTEIN BINDING | 159 | 4.82e-01 | 3.24e-02 | 7.84e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE | 15 | 8.28e-01 | -3.24e-02 | 9.48e-01 |
| GOBP REGULATION OF PROTEIN FOLDING | 8 | 8.74e-01 | 3.24e-02 | 9.64e-01 |
| GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 9.00e-01 | 3.24e-02 | 9.71e-01 |
| GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS | 17 | 8.18e-01 | -3.23e-02 | 9.45e-01 |
| GOBP TRANSMEMBRANE TRANSPORT | 736 | 1.41e-01 | -3.23e-02 | 5.00e-01 |
| GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS | 1301 | 5.65e-02 | -3.23e-02 | 3.47e-01 |
| GOBP BLASTOCYST DEVELOPMENT | 76 | 6.27e-01 | 3.23e-02 | 8.65e-01 |
| GOBP LIPID BIOSYNTHETIC PROCESS | 451 | 2.44e-01 | -3.23e-02 | 6.22e-01 |
| GOBP RESPONSE TO COCAINE | 22 | 7.94e-01 | 3.22e-02 | 9.36e-01 |
| GOBP ESTABLISHMENT OF TISSUE POLARITY | 33 | 7.49e-01 | 3.22e-02 | 9.18e-01 |
| GOBP CELLULAR RESPONSE TO AMYLOID BETA | 25 | 7.81e-01 | -3.22e-02 | 9.32e-01 |
| GOBP RESPONSE TO AMYLOID BETA | 25 | 7.81e-01 | -3.22e-02 | 9.32e-01 |
| GOMF CALCIUM INDUCED CALCIUM RELEASE ACTIVITY | 5 | 9.01e-01 | -3.22e-02 | 9.72e-01 |
| GOBP ADP METABOLIC PROCESS | 6 | 8.92e-01 | -3.21e-02 | 9.68e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT | 14 | 8.35e-01 | -3.21e-02 | 9.50e-01 |
| GOBP RESPONSE TO TESTOSTERONE | 27 | 7.73e-01 | 3.21e-02 | 9.29e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY | 5 | 9.01e-01 | 3.20e-02 | 9.72e-01 |
| GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY | 5 | 9.02e-01 | 3.19e-02 | 9.72e-01 |
| GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS | 8 | 8.76e-01 | -3.19e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 7 | 8.84e-01 | -3.19e-02 | 9.66e-01 |
| GOMF ATPASE ACTIVATOR ACTIVITY | 23 | 7.91e-01 | -3.19e-02 | 9.36e-01 |
| GOBP NEURON PROJECTION MAINTENANCE | 6 | 8.92e-01 | 3.19e-02 | 9.68e-01 |
| GOBP REGULATION OF INTRACELLULAR TRANSPORT | 251 | 3.87e-01 | -3.19e-02 | 7.25e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 15 | 8.31e-01 | 3.18e-02 | 9.50e-01 |
| GOBP REGULATION OF CELLULAR RESPIRATION | 33 | 7.52e-01 | 3.18e-02 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 8.31e-01 | -3.18e-02 | 9.50e-01 |
| GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 14 | 8.37e-01 | -3.18e-02 | 9.51e-01 |
| GOBP REGULATION OF PROTEIN POLYMERIZATION | 132 | 5.30e-01 | -3.18e-02 | 8.12e-01 |
| GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 44 | 7.16e-01 | -3.17e-02 | 9.05e-01 |
| GOBP GLUCOSE IMPORT | 42 | 7.22e-01 | -3.17e-02 | 9.06e-01 |
| GOBP MACROPHAGE APOPTOTIC PROCESS | 10 | 8.62e-01 | 3.17e-02 | 9.61e-01 |
| GOCC GOLGI CISTERNA | 78 | 6.29e-01 | 3.17e-02 | 8.67e-01 |
| GOBP RESPONSE TO WATER | 6 | 8.93e-01 | -3.16e-02 | 9.68e-01 |
| GOBP PURINE NUCLEOTIDE SALVAGE | 10 | 8.63e-01 | -3.16e-02 | 9.61e-01 |
| GOBP CELL DIVISION | 446 | 2.56e-01 | -3.16e-02 | 6.32e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 35 | 7.47e-01 | 3.16e-02 | 9.17e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 8 | 8.77e-01 | 3.15e-02 | 9.65e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 40 | 7.30e-01 | 3.15e-02 | 9.09e-01 |
| GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING | 20 | 8.07e-01 | 3.15e-02 | 9.41e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS | 47 | 7.09e-01 | 3.15e-02 | 9.03e-01 |
| GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 636 | 1.81e-01 | -3.15e-02 | 5.48e-01 |
| GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 17 | 8.22e-01 | 3.15e-02 | 9.46e-01 |
| GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 173 | 4.77e-01 | -3.15e-02 | 7.81e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION | 58 | 6.79e-01 | 3.14e-02 | 8.91e-01 |
| GOCC NEURON PROJECTION | 627 | 1.84e-01 | -3.14e-02 | 5.53e-01 |
| GOBP ACTIVATION OF INNATE IMMUNE RESPONSE | 216 | 4.28e-01 | -3.14e-02 | 7.58e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION | 45 | 7.16e-01 | -3.14e-02 | 9.05e-01 |
| GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 12 | 8.51e-01 | 3.13e-02 | 9.58e-01 |
| GOBP ALCOHOL BIOSYNTHETIC PROCESS | 83 | 6.23e-01 | 3.12e-02 | 8.63e-01 |
| GOMF PHOSPHOLIPASE ACTIVITY | 54 | 6.92e-01 | 3.12e-02 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 6 | 8.95e-01 | -3.12e-02 | 9.69e-01 |
| GOBP GTP METABOLIC PROCESS | 21 | 8.05e-01 | 3.11e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 12 | 8.52e-01 | 3.11e-02 | 9.58e-01 |
| GOBP REGULATION OF LIGASE ACTIVITY | 9 | 8.72e-01 | 3.11e-02 | 9.63e-01 |
| GOCC EUCHROMATIN | 40 | 7.34e-01 | 3.11e-02 | 9.10e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOSOME | 25 | 7.88e-01 | 3.10e-02 | 9.35e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION | 12 | 8.53e-01 | -3.10e-02 | 9.58e-01 |
| GOBP FEMALE MEIOTIC NUCLEAR DIVISION | 22 | 8.02e-01 | -3.10e-02 | 9.39e-01 |
| GOBP MUSCLE SYSTEM PROCESS | 201 | 4.51e-01 | -3.09e-02 | 7.70e-01 |
| GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS | 255 | 3.98e-01 | -3.09e-02 | 7.35e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 7 | 8.88e-01 | 3.09e-02 | 9.67e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION | 7 | 8.88e-01 | -3.08e-02 | 9.67e-01 |
| GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 16 | 8.31e-01 | -3.08e-02 | 9.50e-01 |
| GOCC TRANSPORT VESICLE MEMBRANE | 138 | 5.33e-01 | -3.08e-02 | 8.15e-01 |
| GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY | 55 | 6.94e-01 | -3.08e-02 | 8.98e-01 |
| GOBP CORTICOSTEROID HORMONE SECRETION | 9 | 8.73e-01 | -3.07e-02 | 9.64e-01 |
| GOBP RESPONSE TO IRON II ION | 5 | 9.05e-01 | -3.07e-02 | 9.73e-01 |
| GOBP PHOSPHORYLATION | 1013 | 1.05e-01 | -3.07e-02 | 4.50e-01 |
| GOMF PHOSPHATASE ACTIVITY | 184 | 4.74e-01 | -3.07e-02 | 7.80e-01 |
| GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION | 33 | 7.60e-01 | -3.07e-02 | 9.24e-01 |
| GOBP CYTOSOLIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 116 | 5.69e-01 | -3.07e-02 | 8.34e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 86 | 6.24e-01 | -3.06e-02 | 8.63e-01 |
| GOMF R SMAD BINDING | 21 | 8.08e-01 | 3.06e-02 | 9.42e-01 |
| GOMF ENDOPEPTIDASE REGULATOR ACTIVITY | 71 | 6.56e-01 | -3.06e-02 | 8.79e-01 |
| GOBP MONONUCLEAR CELL DIFFERENTIATION | 347 | 3.31e-01 | -3.06e-02 | 6.87e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 20 | 8.13e-01 | 3.05e-02 | 9.43e-01 |
| GOBP REGULATION OF EXTENT OF CELL GROWTH | 53 | 7.01e-01 | -3.05e-02 | 9.01e-01 |
| GOBP CELL CYCLE G1 S PHASE TRANSITION | 185 | 4.76e-01 | -3.05e-02 | 7.81e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 36 | 7.53e-01 | 3.04e-02 | 9.19e-01 |
| GOBP RESPONSE TO HEAT | 69 | 6.64e-01 | 3.03e-02 | 8.84e-01 |
| GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 451 | 2.75e-01 | 3.02e-02 | 6.52e-01 |
| GOCC CATALYTIC COMPLEX | 1429 | 6.31e-02 | -3.02e-02 | 3.63e-01 |
| GOBP SULFATE TRANSPORT | 7 | 8.90e-01 | 3.02e-02 | 9.67e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 47 | 7.21e-01 | 3.01e-02 | 9.06e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 52 | 7.08e-01 | -3.01e-02 | 9.03e-01 |
| GOBP CELL PROJECTION ASSEMBLY | 388 | 3.13e-01 | 3.01e-02 | 6.76e-01 |
| GOBP CALCIUM MEDIATED SIGNALING | 108 | 5.90e-01 | 3.01e-02 | 8.45e-01 |
| GOMF MRNA 5 PHOSPHATASE ACTIVITY | 11 | 8.63e-01 | 3.00e-02 | 9.61e-01 |
| GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY | 12 | 8.57e-01 | -3.00e-02 | 9.59e-01 |
| GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS | 15 | 8.41e-01 | 3.00e-02 | 9.53e-01 |
| GOBP MANGANESE ION TRANSPORT | 8 | 8.83e-01 | 3.00e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 52 | 7.09e-01 | 2.99e-02 | 9.03e-01 |
| GOBP CORTICOSTEROID RECEPTOR SIGNALING PATHWAY | 11 | 8.64e-01 | -2.99e-02 | 9.61e-01 |
| GOMF PROTEIN SELF ASSOCIATION | 52 | 7.09e-01 | 2.99e-02 | 9.03e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 17 | 8.31e-01 | -2.99e-02 | 9.50e-01 |
| GOBP SEQUESTERING OF CALCIUM ION | 75 | 6.55e-01 | -2.98e-02 | 8.78e-01 |
| GOBP NEPHRON DEVELOPMENT | 54 | 7.05e-01 | 2.98e-02 | 9.02e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSPORT | 221 | 4.48e-01 | -2.98e-02 | 7.68e-01 |
| GOBP REGULATION OF ATP DEPENDENT ACTIVITY | 43 | 7.36e-01 | 2.97e-02 | 9.11e-01 |
| GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT | 233 | 4.37e-01 | 2.97e-02 | 7.61e-01 |
| GOCC BLEB | 9 | 8.77e-01 | 2.97e-02 | 9.65e-01 |
| GOBP PROTEIN POLYMERIZATION | 190 | 4.82e-01 | -2.97e-02 | 7.84e-01 |
| GOCC 9PLUS2 MOTILE CILIUM | 72 | 6.64e-01 | -2.97e-02 | 8.84e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 32 | 7.72e-01 | -2.96e-02 | 9.29e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY | 20 | 8.19e-01 | 2.96e-02 | 9.46e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 9 | 8.78e-01 | 2.95e-02 | 9.65e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 440 | 2.94e-01 | 2.94e-02 | 6.62e-01 |
| GOCC STEREOCILIUM BUNDLE | 28 | 7.88e-01 | -2.94e-02 | 9.35e-01 |
| GOMF PEPTIDE RECEPTOR ACTIVITY | 23 | 8.08e-01 | -2.93e-02 | 9.41e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 13 | 8.55e-01 | 2.93e-02 | 9.58e-01 |
| GOMF HISTONE MODIFYING ACTIVITY | 169 | 5.12e-01 | -2.93e-02 | 8.00e-01 |
| GOBP REGULATION OF RESPONSE TO FOOD | 7 | 8.93e-01 | -2.93e-02 | 9.68e-01 |
| GOBP MRNA EXPORT FROM NUCLEUS | 62 | 6.91e-01 | 2.93e-02 | 8.97e-01 |
| GOBP CELLULAR RESPONSE TO UV B | 8 | 8.86e-01 | -2.92e-02 | 9.66e-01 |
| GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 5 | 9.10e-01 | -2.92e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 93 | 6.27e-01 | 2.92e-02 | 8.65e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY | 7 | 8.94e-01 | 2.92e-02 | 9.68e-01 |
| GOBP PHAGOCYTOSIS ENGULFMENT | 34 | 7.69e-01 | -2.91e-02 | 9.28e-01 |
| GOBP SYNAPTIC TRANSMISSION GABAERGIC | 20 | 8.22e-01 | 2.91e-02 | 9.46e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 8 | 8.87e-01 | -2.91e-02 | 9.67e-01 |
| GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS | 5 | 9.10e-01 | -2.91e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION | 29 | 7.87e-01 | -2.91e-02 | 9.34e-01 |
| GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION | 21 | 8.18e-01 | 2.90e-02 | 9.45e-01 |
| GOCC GOLGI MEMBRANE | 483 | 2.79e-01 | -2.90e-02 | 6.54e-01 |
| GOMF CARBOXY LYASE ACTIVITY | 22 | 8.14e-01 | 2.90e-02 | 9.44e-01 |
| GOCC NUCLEAR INCLUSION BODY | 12 | 8.62e-01 | 2.90e-02 | 9.61e-01 |
| GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 35 | 7.67e-01 | -2.90e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES | 8 | 8.87e-01 | -2.89e-02 | 9.67e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 168 | 5.19e-01 | -2.89e-02 | 8.05e-01 |
| GOMF LONG CHAIN FATTY ACID TRANSPORTER ACTIVITY | 11 | 8.68e-01 | -2.89e-02 | 9.63e-01 |
| GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 21 | 8.19e-01 | 2.89e-02 | 9.46e-01 |
| GOMF NUCLEASE ACTIVITY | 170 | 5.18e-01 | 2.88e-02 | 8.04e-01 |
| GOBP HORMONE MEDIATED SIGNALING PATHWAY | 125 | 5.79e-01 | -2.88e-02 | 8.38e-01 |
| GOCC BASEMENT MEMBRANE | 24 | 8.07e-01 | -2.88e-02 | 9.41e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 8 | 8.88e-01 | -2.88e-02 | 9.67e-01 |
| GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY | 13 | 8.58e-01 | 2.87e-02 | 9.59e-01 |
| GOMF SEQUENCE SPECIFIC DNA BINDING | 931 | 1.45e-01 | -2.87e-02 | 5.05e-01 |
| GOBP PYRUVATE METABOLIC PROCESS | 86 | 6.46e-01 | -2.87e-02 | 8.75e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN FOLDING | 63 | 6.94e-01 | -2.87e-02 | 8.98e-01 |
| GOBP MEIOTIC CHROMOSOME SEGREGATION | 45 | 7.40e-01 | 2.86e-02 | 9.13e-01 |
| GOCC SCF UBIQUITIN LIGASE COMPLEX | 51 | 7.24e-01 | -2.86e-02 | 9.07e-01 |
| GOMF ENZYME REGULATOR ACTIVITY | 841 | 1.67e-01 | -2.85e-02 | 5.34e-01 |
| GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 138 | 5.64e-01 | -2.85e-02 | 8.31e-01 |
| GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 5 | 9.12e-01 | -2.85e-02 | 9.74e-01 |
| GOCC AGGRESOME | 26 | 8.02e-01 | -2.85e-02 | 9.39e-01 |
| GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS | 9 | 8.83e-01 | -2.84e-02 | 9.66e-01 |
| GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 8 | 8.89e-01 | -2.84e-02 | 9.67e-01 |
| GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY | 201 | 4.89e-01 | -2.84e-02 | 7.87e-01 |
| GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS | 5 | 9.12e-01 | -2.84e-02 | 9.74e-01 |
| GOCC OXIDOREDUCTASE COMPLEX | 106 | 6.15e-01 | -2.83e-02 | 8.59e-01 |
| GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION | 5 | 9.13e-01 | -2.83e-02 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 18 | 8.35e-01 | -2.83e-02 | 9.50e-01 |
| GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION | 103 | 6.20e-01 | -2.83e-02 | 8.62e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVITY | 82 | 6.58e-01 | 2.83e-02 | 8.81e-01 |
| GOBP SENSORY PERCEPTION OF LIGHT STIMULUS | 66 | 6.92e-01 | -2.83e-02 | 8.97e-01 |
| GOMF PROTEIN HOMODIMERIZATION ACTIVITY | 460 | 3.03e-01 | -2.83e-02 | 6.67e-01 |
| GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 95 | 6.35e-01 | -2.83e-02 | 8.69e-01 |
| GOBP REGULATION OF DENDRITE DEVELOPMENT | 56 | 7.15e-01 | -2.83e-02 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 13 | 8.60e-01 | -2.82e-02 | 9.60e-01 |
| GOBP REGULATION OF DNA DEMETHYLATION | 7 | 8.97e-01 | 2.82e-02 | 9.70e-01 |
| GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 97 | 6.32e-01 | 2.82e-02 | 8.67e-01 |
| GOMF ISOMERASE ACTIVITY | 128 | 5.83e-01 | 2.82e-02 | 8.40e-01 |
| GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 52 | 7.26e-01 | -2.82e-02 | 9.07e-01 |
| GOBP REGULATION OF PLATELET ACTIVATION | 26 | 8.04e-01 | -2.82e-02 | 9.41e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 6 | 9.05e-01 | -2.82e-02 | 9.73e-01 |
| GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 67 | 6.92e-01 | -2.81e-02 | 8.97e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS | 120 | 5.96e-01 | -2.81e-02 | 8.49e-01 |
| GOBP CELLULAR PIGMENTATION | 46 | 7.42e-01 | -2.81e-02 | 9.14e-01 |
| GOBP CELLULAR RESPONSE TO OSMOTIC STRESS | 41 | 7.56e-01 | -2.81e-02 | 9.20e-01 |
| GOBP PLACENTA BLOOD VESSEL DEVELOPMENT | 19 | 8.33e-01 | -2.80e-02 | 9.50e-01 |
| GOCC GOLGI APPARATUS | 1077 | 1.28e-01 | -2.80e-02 | 4.85e-01 |
| GOBP FATTY ACID TRANSPORT | 51 | 7.30e-01 | -2.80e-02 | 9.09e-01 |
| GOBP REGULATION OF TRANSMEMBRANE TRANSPORT | 240 | 4.58e-01 | -2.79e-02 | 7.74e-01 |
| GOBP RESPONSE TO SALT | 193 | 5.05e-01 | 2.79e-02 | 7.96e-01 |
| GOBP PROTEIN TARGETING TO MITOCHONDRION | 95 | 6.39e-01 | -2.79e-02 | 8.71e-01 |
| GOBP SCHWANN CELL DEVELOPMENT | 16 | 8.47e-01 | 2.79e-02 | 9.56e-01 |
| GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND | 512 | 2.86e-01 | -2.78e-02 | 6.56e-01 |
| GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS | 10 | 8.79e-01 | 2.78e-02 | 9.65e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 25 | 8.10e-01 | -2.77e-02 | 9.42e-01 |
| GOBP CELLULAR RESPONSE TO ALKALOID | 23 | 8.18e-01 | 2.77e-02 | 9.45e-01 |
| GOBP CELLULAR RESPONSE TO HORMONE STIMULUS | 371 | 3.63e-01 | -2.77e-02 | 7.10e-01 |
| GOBP LOCOMOTORY BEHAVIOR | 94 | 6.43e-01 | -2.77e-02 | 8.74e-01 |
| GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 39 | 7.65e-01 | 2.76e-02 | 9.26e-01 |
| GOCC SPINDLE POLE | 136 | 5.79e-01 | -2.76e-02 | 8.38e-01 |
| GOCC SEX CHROMOSOME | 22 | 8.23e-01 | -2.76e-02 | 9.46e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS | 16 | 8.48e-01 | -2.76e-02 | 9.56e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 53 | 7.29e-01 | -2.76e-02 | 9.08e-01 |
| GOBP NEURAL TUBE DEVELOPMENT | 97 | 6.40e-01 | -2.76e-02 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 5 | 9.15e-01 | -2.75e-02 | 9.75e-01 |
| GOBP N GLYCAN PROCESSING | 13 | 8.64e-01 | 2.75e-02 | 9.61e-01 |
| GOBP REGULATION OF STEROID HORMONE SECRETION | 10 | 8.80e-01 | -2.75e-02 | 9.65e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOSKELETON | 50 | 7.37e-01 | 2.75e-02 | 9.12e-01 |
| GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 9.07e-01 | -2.75e-02 | 9.74e-01 |
| GOMF PROTEIN PHOSPHATASE BINDING | 111 | 6.18e-01 | -2.74e-02 | 8.62e-01 |
| GOBP BONE MARROW DEVELOPMENT | 6 | 9.07e-01 | -2.74e-02 | 9.74e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER | 33 | 7.85e-01 | -2.74e-02 | 9.34e-01 |
| GOBP REGULATION OF TUBE SIZE | 58 | 7.18e-01 | -2.74e-02 | 9.06e-01 |
| GOBP VIRAL GENE EXPRESSION | 92 | 6.50e-01 | -2.74e-02 | 8.77e-01 |
| GOBP REGULATION OF ICOSANOID SECRETION | 9 | 8.87e-01 | -2.74e-02 | 9.67e-01 |
| GOBP TRNA TRANSCRIPTION | 11 | 8.75e-01 | 2.73e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 6 | 9.08e-01 | 2.73e-02 | 9.74e-01 |
| GOBP PROTEIN MATURATION | 375 | 3.69e-01 | -2.72e-02 | 7.13e-01 |
| GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 287 | 4.31e-01 | -2.72e-02 | 7.58e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT | 161 | 5.53e-01 | -2.71e-02 | 8.24e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE | 31 | 7.94e-01 | -2.71e-02 | 9.36e-01 |
| GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY | 36 | 7.78e-01 | 2.71e-02 | 9.31e-01 |
| GOBP REGULATION OF AXONOGENESIS | 75 | 6.85e-01 | 2.71e-02 | 8.95e-01 |
| GOCC TRANSFERASE COMPLEX | 718 | 2.22e-01 | -2.71e-02 | 5.97e-01 |
| GOBP NEGATIVE REGULATION OF KINASE ACTIVITY | 126 | 6.01e-01 | -2.71e-02 | 8.51e-01 |
| GOCC SPINDLE MICROTUBULE | 63 | 7.11e-01 | -2.71e-02 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF CELL KILLING | 22 | 8.26e-01 | 2.70e-02 | 9.47e-01 |
| GOBP MEIOTIC CELL CYCLE PROCESS | 103 | 6.36e-01 | 2.70e-02 | 8.70e-01 |
| GOBP RESPONSE TO HORMONE | 496 | 3.08e-01 | -2.70e-02 | 6.70e-01 |
| GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION | 15 | 8.56e-01 | -2.70e-02 | 9.59e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION | 24 | 8.19e-01 | 2.70e-02 | 9.46e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS | 62 | 7.14e-01 | -2.70e-02 | 9.05e-01 |
| GOBP REGULATION OF CYTOSKELETON ORGANIZATION | 332 | 4.01e-01 | -2.70e-02 | 7.39e-01 |
| GOBP RELAXATION OF SMOOTH MUSCLE | 7 | 9.02e-01 | 2.69e-02 | 9.72e-01 |
| GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY | 237 | 4.77e-01 | -2.69e-02 | 7.81e-01 |
| GOBP RESPONSE TO FLUID SHEAR STRESS | 24 | 8.19e-01 | -2.69e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 728 | 2.22e-01 | -2.69e-02 | 5.97e-01 |
| GOCC CELL PROJECTION MEMBRANE | 165 | 5.52e-01 | -2.69e-02 | 8.24e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE | 79 | 6.80e-01 | 2.69e-02 | 8.92e-01 |
| GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION | 8 | 8.96e-01 | -2.68e-02 | 9.69e-01 |
| GOBP REGULATION OF STEM CELL DIVISION | 6 | 9.10e-01 | 2.68e-02 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY | 5 | 9.18e-01 | -2.68e-02 | 9.75e-01 |
| GOCC ENVELOPE | 1020 | 1.57e-01 | -2.67e-02 | 5.23e-01 |
| GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS | 69 | 7.02e-01 | -2.67e-02 | 9.01e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 54 | 7.35e-01 | 2.67e-02 | 9.10e-01 |
| GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 8.36e-01 | -2.67e-02 | 9.51e-01 |
| GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 21 | 8.33e-01 | -2.66e-02 | 9.50e-01 |
| GOBP AMYLOID BETA METABOLIC PROCESS | 36 | 7.83e-01 | -2.66e-02 | 9.32e-01 |
| GOBP CELLULAR RESPONSE TO ACID CHEMICAL | 59 | 7.25e-01 | 2.65e-02 | 9.07e-01 |
| GOMF FAD BINDING | 27 | 8.12e-01 | -2.64e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 9 | 8.91e-01 | -2.64e-02 | 9.68e-01 |
| GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY | 6 | 9.11e-01 | -2.64e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 6 | 9.11e-01 | 2.64e-02 | 9.74e-01 |
| GOMF PROTEIN KINASE A BINDING | 36 | 7.84e-01 | 2.64e-02 | 9.33e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT | 35 | 7.88e-01 | 2.63e-02 | 9.35e-01 |
| GOMF CIS TRANS ISOMERASE ACTIVITY | 33 | 7.95e-01 | 2.62e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF PHAGOCYTOSIS | 44 | 7.64e-01 | -2.62e-02 | 9.26e-01 |
| GOMF BETA CATENIN BINDING | 52 | 7.44e-01 | -2.62e-02 | 9.15e-01 |
| GOCC ACTOMYOSIN | 48 | 7.54e-01 | 2.61e-02 | 9.20e-01 |
| GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX | 18 | 8.48e-01 | -2.61e-02 | 9.56e-01 |
| GOBP PLASMA MEMBRANE ORGANIZATION | 90 | 6.69e-01 | -2.61e-02 | 8.87e-01 |
| GOBP FATTY ACID METABOLIC PROCESS | 230 | 4.98e-01 | 2.61e-02 | 7.92e-01 |
| GOBP SODIUM ION HOMEOSTASIS | 13 | 8.71e-01 | 2.60e-02 | 9.63e-01 |
| GOBP POTASSIUM ION HOMEOSTASIS | 13 | 8.71e-01 | -2.60e-02 | 9.63e-01 |
| GOBP TELENCEPHALON GLIAL CELL MIGRATION | 17 | 8.53e-01 | -2.60e-02 | 9.58e-01 |
| GOCC PLASMA MEMBRANE REGION | 571 | 2.94e-01 | -2.60e-02 | 6.62e-01 |
| GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION | 5 | 9.20e-01 | -2.59e-02 | 9.77e-01 |
| GOBP REGULATION OF FATTY ACID TRANSPORT | 17 | 8.54e-01 | 2.59e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE | 19 | 8.45e-01 | 2.59e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 6 | 9.13e-01 | 2.58e-02 | 9.74e-01 |
| GOBP REGULATION OF ACTION POTENTIAL | 26 | 8.20e-01 | 2.58e-02 | 9.46e-01 |
| GOCC MITOCHONDRIAL ENVELOPE | 658 | 2.65e-01 | -2.58e-02 | 6.42e-01 |
| GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 11 | 8.82e-01 | -2.58e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 70 | 7.10e-01 | 2.58e-02 | 9.03e-01 |
| GOBP RESPONSE TO AUDITORY STIMULUS | 9 | 8.94e-01 | 2.57e-02 | 9.68e-01 |
| GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX | 16 | 8.59e-01 | -2.57e-02 | 9.59e-01 |
| GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS | 13 | 8.72e-01 | 2.57e-02 | 9.63e-01 |
| GOBP DORSAL VENTRAL PATTERN FORMATION | 30 | 8.07e-01 | 2.57e-02 | 9.41e-01 |
| GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 6 | 9.13e-01 | -2.57e-02 | 9.74e-01 |
| GOCC APICAL PART OF CELL | 183 | 5.50e-01 | 2.57e-02 | 8.23e-01 |
| GOBP REGULATION OF VIRAL GENOME REPLICATION | 69 | 7.13e-01 | 2.57e-02 | 9.05e-01 |
| GOBP CIRCULATORY SYSTEM PROCESS | 252 | 4.85e-01 | -2.56e-02 | 7.85e-01 |
| GOMF MITOCHONDRIAL RIBOSOME BINDING | 8 | 9.00e-01 | 2.56e-02 | 9.71e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE | 9 | 8.94e-01 | 2.56e-02 | 9.69e-01 |
| GOCC NUCLEAR MEMBRANE | 242 | 4.95e-01 | -2.56e-02 | 7.90e-01 |
| GOBP T CELL HOMEOSTASIS | 36 | 7.91e-01 | 2.56e-02 | 9.36e-01 |
| GOMF IRON ION BINDING | 69 | 7.14e-01 | 2.55e-02 | 9.05e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 8 | 9.01e-01 | 2.55e-02 | 9.72e-01 |
| GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 254 | 4.87e-01 | -2.54e-02 | 7.85e-01 |
| GOBP LYMPHOCYTE MIGRATION | 68 | 7.18e-01 | -2.54e-02 | 9.06e-01 |
| GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 21 | 8.41e-01 | -2.54e-02 | 9.53e-01 |
| GOCC MULTIVESICULAR BODY MEMBRANE | 18 | 8.53e-01 | 2.53e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE | 193 | 5.49e-01 | 2.51e-02 | 8.23e-01 |
| GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS | 17 | 8.58e-01 | 2.51e-02 | 9.59e-01 |
| GOMF CALMODULIN BINDING | 108 | 6.53e-01 | -2.51e-02 | 8.78e-01 |
| GOBP INORGANIC ANION TRANSPORT | 69 | 7.19e-01 | -2.51e-02 | 9.06e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 41 | 7.82e-01 | 2.50e-02 | 9.32e-01 |
| GOBP REGULATION OF CELL PROJECTION ASSEMBLY | 160 | 5.86e-01 | -2.50e-02 | 8.42e-01 |
| GOBP REGULATION OF DENDRITE MORPHOGENESIS | 40 | 7.85e-01 | -2.50e-02 | 9.34e-01 |
| GOBP REGULATION OF PHOSPHATASE ACTIVITY | 43 | 7.78e-01 | 2.49e-02 | 9.31e-01 |
| GOBP KIDNEY MORPHOGENESIS | 32 | 8.08e-01 | 2.49e-02 | 9.41e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE | 12 | 8.81e-01 | 2.49e-02 | 9.65e-01 |
| GOBP ERK1 AND ERK2 CASCADE | 154 | 5.95e-01 | -2.49e-02 | 8.48e-01 |
| GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 31 | 8.11e-01 | 2.48e-02 | 9.43e-01 |
| GOCC CONTRACTILE FIBER | 119 | 6.41e-01 | -2.48e-02 | 8.73e-01 |
| GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 116 | 6.45e-01 | 2.48e-02 | 8.75e-01 |
| GOBP CELLULAR DETOXIFICATION OF ALDEHYDE | 6 | 9.16e-01 | -2.48e-02 | 9.75e-01 |
| GOMF ADENYL NUCLEOTIDE BINDING | 1129 | 1.70e-01 | 2.48e-02 | 5.35e-01 |
| GOMF PALMITOYL COA HYDROLASE ACTIVITY | 10 | 8.92e-01 | 2.48e-02 | 9.68e-01 |
| GOCC NUCLEOLUS | 848 | 2.30e-01 | 2.47e-02 | 6.07e-01 |
| GOBP RIBONUCLEOTIDE CATABOLIC PROCESS | 38 | 7.93e-01 | -2.46e-02 | 9.36e-01 |
| GOBP GLYCOPROTEIN METABOLIC PROCESS | 234 | 5.19e-01 | -2.46e-02 | 8.05e-01 |
| GOCC CHROMOSOME | 1193 | 1.63e-01 | 2.45e-02 | 5.29e-01 |
| GOCC SEMAPHORIN RECEPTOR COMPLEX | 6 | 9.17e-01 | 2.45e-02 | 9.75e-01 |
| GOBP REGULATION OF CILIUM MOVEMENT | 12 | 8.83e-01 | -2.45e-02 | 9.66e-01 |
| GOCC NUCLEAR INNER MEMBRANE | 39 | 7.92e-01 | -2.44e-02 | 9.36e-01 |
| GOBP DEFENSE RESPONSE TO SYMBIONT | 241 | 5.16e-01 | -2.44e-02 | 8.02e-01 |
| GOBP FATTY ACID BIOSYNTHETIC PROCESS | 90 | 6.89e-01 | -2.44e-02 | 8.97e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION | 78 | 7.10e-01 | -2.44e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING | 11 | 8.89e-01 | -2.43e-02 | 9.67e-01 |
| GOMF MONOATOMIC ANION CHANNEL ACTIVITY | 32 | 8.12e-01 | 2.43e-02 | 9.43e-01 |
| GOMF GUANYLYLTRANSFERASE ACTIVITY | 6 | 9.18e-01 | 2.43e-02 | 9.76e-01 |
| GOCC CYTOPLASMIC REGION | 142 | 6.18e-01 | -2.43e-02 | 8.62e-01 |
| GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 5 | 9.25e-01 | 2.43e-02 | 9.79e-01 |
| GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS | 24 | 8.37e-01 | 2.43e-02 | 9.51e-01 |
| GOCC SMALL SUBUNIT PROCESSOME | 70 | 7.26e-01 | 2.42e-02 | 9.07e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 46 | 7.76e-01 | 2.42e-02 | 9.31e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 21 | 8.48e-01 | 2.42e-02 | 9.56e-01 |
| GOMF ZINC ION BINDING | 524 | 3.48e-01 | -2.42e-02 | 6.99e-01 |
| GOBP LIPID CATABOLIC PROCESS | 188 | 5.69e-01 | 2.42e-02 | 8.34e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 46 | 7.78e-01 | 2.41e-02 | 9.31e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 660 | 2.98e-01 | 2.41e-02 | 6.63e-01 |
| GOBP REGULATION OF MICROTUBULE BINDING | 5 | 9.26e-01 | -2.40e-02 | 9.79e-01 |
| GOBP MOLTING CYCLE | 46 | 7.78e-01 | -2.40e-02 | 9.31e-01 |
| GOBP CELLULAR HYPOTONIC RESPONSE | 7 | 9.12e-01 | -2.40e-02 | 9.74e-01 |
| GOBP HYPOTONIC RESPONSE | 7 | 9.12e-01 | -2.40e-02 | 9.74e-01 |
| GOBP ENGULFMENT OF APOPTOTIC CELL | 6 | 9.19e-01 | -2.40e-02 | 9.76e-01 |
| GOBP NUCLEAR MEMBRANE REASSEMBLY | 24 | 8.39e-01 | 2.39e-02 | 9.52e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION | 18 | 8.60e-01 | 2.39e-02 | 9.60e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE | 38 | 7.99e-01 | -2.39e-02 | 9.38e-01 |
| GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 16 | 8.69e-01 | -2.39e-02 | 9.63e-01 |
| GOBP SULFUR COMPOUND CATABOLIC PROCESS | 27 | 8.30e-01 | 2.39e-02 | 9.49e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY | 40 | 7.94e-01 | -2.39e-02 | 9.36e-01 |
| GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS | 8 | 9.07e-01 | 2.38e-02 | 9.74e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION | 10 | 8.96e-01 | 2.38e-02 | 9.70e-01 |
| GOBP AXON EXTENSION | 66 | 7.39e-01 | -2.37e-02 | 9.12e-01 |
| GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 27 | 8.31e-01 | -2.37e-02 | 9.50e-01 |
| GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM | 116 | 6.60e-01 | -2.37e-02 | 8.82e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 245 | 5.25e-01 | -2.37e-02 | 8.08e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 51 | 7.70e-01 | -2.37e-02 | 9.29e-01 |
| GOCC MITOCHONDRION | 1317 | 1.61e-01 | 2.36e-02 | 5.27e-01 |
| GOBP SUCCINYL COA METABOLIC PROCESS | 9 | 9.02e-01 | 2.36e-02 | 9.72e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 36 | 8.07e-01 | 2.36e-02 | 9.41e-01 |
| GOMF PHOSPHATASE BINDING | 147 | 6.22e-01 | -2.36e-02 | 8.63e-01 |
| GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY | 72 | 7.30e-01 | 2.36e-02 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 9.08e-01 | -2.36e-02 | 9.74e-01 |
| GOBP DENDRITE MORPHOGENESIS | 77 | 7.21e-01 | -2.36e-02 | 9.06e-01 |
| GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 139 | 6.33e-01 | -2.35e-02 | 8.68e-01 |
| GOMF SULFURIC ESTER HYDROLASE ACTIVITY | 11 | 8.93e-01 | 2.35e-02 | 9.68e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE | 11 | 8.93e-01 | 2.34e-02 | 9.68e-01 |
| GOMF ICOSANOID RECEPTOR ACTIVITY | 8 | 9.09e-01 | 2.34e-02 | 9.74e-01 |
| GOBP THYROID HORMONE METABOLIC PROCESS | 8 | 9.09e-01 | -2.34e-02 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION | 5 | 9.28e-01 | -2.33e-02 | 9.80e-01 |
| GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 30 | 8.25e-01 | -2.33e-02 | 9.46e-01 |
| GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS | 380 | 4.38e-01 | -2.33e-02 | 7.62e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 17 | 8.68e-01 | 2.33e-02 | 9.63e-01 |
| GOBP REGULATION OF MUSCLE CONTRACTION | 75 | 7.28e-01 | -2.33e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 98 | 6.92e-01 | 2.32e-02 | 8.97e-01 |
| GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY | 24 | 8.44e-01 | -2.32e-02 | 9.55e-01 |
| GOBP PEROXISOME FISSION | 7 | 9.16e-01 | -2.32e-02 | 9.75e-01 |
| GOBP HYPERSENSITIVITY | 12 | 8.90e-01 | 2.31e-02 | 9.67e-01 |
| GOMF METHYL CPG BINDING | 17 | 8.69e-01 | -2.31e-02 | 9.63e-01 |
| GOCC ENZYME ACTIVATOR COMPLEX | 15 | 8.78e-01 | -2.30e-02 | 9.65e-01 |
| GOBP VESICLE COATING | 36 | 8.11e-01 | 2.30e-02 | 9.43e-01 |
| GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION | 127 | 6.55e-01 | -2.30e-02 | 8.78e-01 |
| GOBP NEUROTROPHIN SIGNALING PATHWAY | 22 | 8.52e-01 | -2.30e-02 | 9.58e-01 |
| GOCC ATPASE COMPLEX | 129 | 6.53e-01 | -2.30e-02 | 8.78e-01 |
| GOBP ENERGY RESERVE METABOLIC PROCESS | 50 | 7.79e-01 | 2.30e-02 | 9.31e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 9.22e-01 | -2.29e-02 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 105 | 6.85e-01 | -2.29e-02 | 8.95e-01 |
| GOMF CHEMOREPELLENT ACTIVITY | 9 | 9.05e-01 | 2.29e-02 | 9.73e-01 |
| GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX | 148 | 6.31e-01 | -2.29e-02 | 8.67e-01 |
| GOBP MITOTIC SISTER CHROMATID COHESION | 23 | 8.49e-01 | 2.29e-02 | 9.57e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 26 | 8.40e-01 | 2.29e-02 | 9.53e-01 |
| GOBP REGULATION OF STEROID METABOLIC PROCESS | 52 | 7.76e-01 | 2.29e-02 | 9.31e-01 |
| GOBP ORGANELLE ASSEMBLY | 704 | 3.08e-01 | -2.28e-02 | 6.70e-01 |
| GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION | 12 | 8.91e-01 | -2.28e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 20 | 8.60e-01 | -2.28e-02 | 9.60e-01 |
| GOMF TRANSPORTER ACTIVITY | 589 | 3.50e-01 | -2.28e-02 | 7.01e-01 |
| GOBP MRNA 3 END PROCESSING | 46 | 7.89e-01 | 2.28e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY | 313 | 4.91e-01 | -2.28e-02 | 7.88e-01 |
| GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 15 | 8.79e-01 | -2.28e-02 | 9.65e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS | 16 | 8.75e-01 | -2.27e-02 | 9.64e-01 |
| GOBP SPHINGOSINE BIOSYNTHETIC PROCESS | 8 | 9.11e-01 | -2.27e-02 | 9.74e-01 |
| GOMF CGMP BINDING | 5 | 9.30e-01 | 2.27e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 51 | 7.80e-01 | -2.27e-02 | 9.31e-01 |
| GOBP LYMPH NODE DEVELOPMENT | 11 | 8.97e-01 | -2.26e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 33 | 8.22e-01 | -2.26e-02 | 9.46e-01 |
| GOCC ORGANELLE MEMBRANE CONTACT SITE | 43 | 7.98e-01 | -2.26e-02 | 9.38e-01 |
| GOMF DNA N GLYCOSYLASE ACTIVITY | 11 | 8.97e-01 | -2.26e-02 | 9.70e-01 |
| GOCC MITOCHONDRIAL TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 11 | 8.97e-01 | 2.26e-02 | 9.70e-01 |
| GOBP REGULATION OF KINASE ACTIVITY | 360 | 4.66e-01 | -2.25e-02 | 7.78e-01 |
| GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 5 | 9.31e-01 | -2.25e-02 | 9.81e-01 |
| GOMF NADPH BINDING | 14 | 8.85e-01 | -2.24e-02 | 9.66e-01 |
| GOBP DNA CYTOSINE DEAMINATION | 5 | 9.31e-01 | -2.24e-02 | 9.81e-01 |
| GOBP MICROTUBULE BASED PROCESS | 574 | 3.65e-01 | 2.24e-02 | 7.11e-01 |
| GOBP HETEROCYCLE CATABOLIC PROCESS | 369 | 4.64e-01 | -2.24e-02 | 7.77e-01 |
| GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 15 | 8.81e-01 | 2.23e-02 | 9.65e-01 |
| GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 54 | 7.77e-01 | -2.23e-02 | 9.31e-01 |
| GOMF MOLECULAR ADAPTOR ACTIVITY | 446 | 4.23e-01 | -2.23e-02 | 7.55e-01 |
| GOBP STEROL HOMEOSTASIS | 41 | 8.05e-01 | -2.23e-02 | 9.41e-01 |
| GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS | 22 | 8.57e-01 | 2.23e-02 | 9.59e-01 |
| GOBP REGULATION OF NK T CELL PROLIFERATION | 5 | 9.31e-01 | 2.23e-02 | 9.81e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 357 | 4.73e-01 | -2.23e-02 | 7.79e-01 |
| GOBP RESPONSE TO FOOD | 17 | 8.74e-01 | -2.22e-02 | 9.64e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 12 | 8.94e-01 | 2.22e-02 | 9.69e-01 |
| GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 8.78e-01 | 2.22e-02 | 9.65e-01 |
| GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM | 46 | 7.95e-01 | -2.22e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT | 32 | 8.28e-01 | 2.21e-02 | 9.48e-01 |
| GOBP REGULATION OF CELLULAR EXTRAVASATION | 25 | 8.48e-01 | -2.21e-02 | 9.56e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 13 | 8.90e-01 | 2.21e-02 | 9.67e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX | 18 | 8.71e-01 | 2.21e-02 | 9.63e-01 |
| GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 26 | 8.46e-01 | 2.21e-02 | 9.56e-01 |
| GOBP B CELL ACTIVATION | 201 | 5.91e-01 | -2.21e-02 | 8.46e-01 |
| GOBP CELL PROJECTION ORGANIZATION | 871 | 2.79e-01 | -2.20e-02 | 6.53e-01 |
| GOBP MEMBRANE FUSION | 124 | 6.73e-01 | -2.20e-02 | 8.88e-01 |
| GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS | 12 | 8.95e-01 | -2.20e-02 | 9.69e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION | 128 | 6.69e-01 | -2.19e-02 | 8.86e-01 |
| GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT | 10 | 9.05e-01 | 2.19e-02 | 9.73e-01 |
| GOMF HISTONE METHYLTRANSFERASE ACTIVITY | 54 | 7.81e-01 | -2.19e-02 | 9.32e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 12 | 8.96e-01 | 2.19e-02 | 9.69e-01 |
| GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS | 468 | 4.23e-01 | 2.18e-02 | 7.55e-01 |
| GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 9 | 9.10e-01 | -2.18e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 48 | 7.94e-01 | 2.18e-02 | 9.36e-01 |
| GOBP LEUKOCYTE DIFFERENTIATION | 438 | 4.39e-01 | -2.17e-02 | 7.63e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION | 25 | 8.51e-01 | 2.17e-02 | 9.58e-01 |
| GOBP ERYTHROCYTE DEVELOPMENT | 30 | 8.37e-01 | -2.17e-02 | 9.51e-01 |
| GOBP CELLULAR RESPONSE TO ALCOHOL | 59 | 7.73e-01 | 2.17e-02 | 9.30e-01 |
| GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 10 | 9.06e-01 | -2.17e-02 | 9.73e-01 |
| GOBP PRO B CELL DIFFERENTIATION | 10 | 9.06e-01 | 2.17e-02 | 9.73e-01 |
| GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT | 28 | 8.43e-01 | 2.17e-02 | 9.54e-01 |
| GOBP B CELL PROLIFERATION | 63 | 7.67e-01 | -2.17e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 5 | 9.33e-01 | -2.16e-02 | 9.81e-01 |
| GOMF TAT PROTEIN BINDING | 8 | 9.16e-01 | -2.16e-02 | 9.75e-01 |
| GOMF METALLOPEPTIDASE ACTIVITY | 84 | 7.33e-01 | 2.16e-02 | 9.09e-01 |
| GOBP CARBOHYDRATE HOMEOSTASIS | 134 | 6.67e-01 | -2.16e-02 | 8.86e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 46 | 8.00e-01 | -2.16e-02 | 9.39e-01 |
| GOBP RNA PROCESSING | 840 | 2.97e-01 | 2.15e-02 | 6.63e-01 |
| GOCC MICROTUBULE CYTOSKELETON | 948 | 2.70e-01 | 2.15e-02 | 6.48e-01 |
| GOCC CIS GOLGI NETWORK | 47 | 7.99e-01 | -2.15e-02 | 9.38e-01 |
| GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY | 8 | 9.16e-01 | 2.15e-02 | 9.75e-01 |
| GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS | 21 | 8.65e-01 | 2.15e-02 | 9.61e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY | 24 | 8.55e-01 | 2.15e-02 | 9.58e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT | 58 | 7.78e-01 | -2.14e-02 | 9.31e-01 |
| GOBP PROTEIN DEPOLYMERIZATION | 72 | 7.54e-01 | -2.14e-02 | 9.19e-01 |
| GOCC CHAPERONIN CONTAINING T COMPLEX | 9 | 9.12e-01 | 2.14e-02 | 9.74e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION | 45 | 8.04e-01 | -2.14e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 43 | 8.09e-01 | 2.13e-02 | 9.42e-01 |
| GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 6 | 9.28e-01 | 2.13e-02 | 9.80e-01 |
| GOBP DOPAMINE BIOSYNTHETIC PROCESS | 6 | 9.28e-01 | 2.13e-02 | 9.80e-01 |
| GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION | 43 | 8.09e-01 | -2.13e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 33 | 8.33e-01 | -2.12e-02 | 9.50e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 5 | 9.35e-01 | -2.12e-02 | 9.81e-01 |
| GOMF ENZYME ACTIVATOR ACTIVITY | 427 | 4.57e-01 | -2.12e-02 | 7.74e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 12 | 8.99e-01 | -2.11e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 16 | 8.84e-01 | -2.11e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 124 | 6.86e-01 | -2.10e-02 | 8.96e-01 |
| GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS | 19 | 8.74e-01 | -2.10e-02 | 9.64e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT | 27 | 8.51e-01 | 2.09e-02 | 9.58e-01 |
| GOCC SNARE COMPLEX | 39 | 8.22e-01 | 2.09e-02 | 9.46e-01 |
| GOBP DENDRITE DEVELOPMENT | 136 | 6.76e-01 | -2.08e-02 | 8.90e-01 |
| GOBP REGULATION OF CELL FATE SPECIFICATION | 14 | 8.93e-01 | -2.08e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 14 | 8.93e-01 | 2.08e-02 | 9.68e-01 |
| GOBP DENDRITIC CELL MIGRATION | 25 | 8.58e-01 | 2.08e-02 | 9.59e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 17 | 8.83e-01 | -2.07e-02 | 9.66e-01 |
| GOBP REGULATION OF PROTEIN COMPLEX STABILITY | 10 | 9.10e-01 | -2.07e-02 | 9.74e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 32 | 8.40e-01 | -2.06e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 7 | 9.25e-01 | -2.06e-02 | 9.78e-01 |
| GOCC PHOTORECEPTOR CONNECTING CILIUM | 22 | 8.67e-01 | -2.06e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION | 17 | 8.83e-01 | -2.06e-02 | 9.66e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 5 | 9.37e-01 | 2.05e-02 | 9.82e-01 |
| GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS | 186 | 6.32e-01 | 2.04e-02 | 8.67e-01 |
| GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS | 77 | 7.57e-01 | 2.04e-02 | 9.21e-01 |
| GOCC SUPRAMOLECULAR COMPLEX | 776 | 3.41e-01 | -2.04e-02 | 6.94e-01 |
| GOBP XENOBIOTIC TRANSPORT | 21 | 8.72e-01 | 2.04e-02 | 9.63e-01 |
| GOBP REGULATION OF RELAXATION OF MUSCLE | 6 | 9.31e-01 | -2.03e-02 | 9.81e-01 |
| GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT | 83 | 7.49e-01 | 2.03e-02 | 9.18e-01 |
| GOCC EMC COMPLEX | 10 | 9.12e-01 | 2.03e-02 | 9.74e-01 |
| GOBP MITOTIC NUCLEAR DIVISION | 189 | 6.32e-01 | 2.03e-02 | 8.67e-01 |
| GOBP FOLIC ACID TRANSPORT | 6 | 9.31e-01 | -2.03e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 6 | 9.32e-01 | 2.02e-02 | 9.81e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE | 7 | 9.26e-01 | -2.02e-02 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION | 18 | 8.82e-01 | -2.02e-02 | 9.65e-01 |
| GOBP NEPHRON EPITHELIUM DEVELOPMENT | 37 | 8.32e-01 | -2.01e-02 | 9.50e-01 |
| GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 127 | 6.96e-01 | 2.01e-02 | 8.99e-01 |
| GOMF KINASE INHIBITOR ACTIVITY | 54 | 7.99e-01 | -2.00e-02 | 9.38e-01 |
| GOBP FIBROBLAST ACTIVATION | 10 | 9.13e-01 | 2.00e-02 | 9.74e-01 |
| GOBP ORGANELLE MEMBRANE FUSION | 94 | 7.38e-01 | 2.00e-02 | 9.12e-01 |
| GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 177 | 6.47e-01 | -2.00e-02 | 8.76e-01 |
| GOBP REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 71 | 7.71e-01 | -2.00e-02 | 9.29e-01 |
| GOBP REGULATION OF CHROMOSOME CONDENSATION | 9 | 9.17e-01 | 2.00e-02 | 9.75e-01 |
| GOBP SPINDLE ASSEMBLY | 107 | 7.22e-01 | 2.00e-02 | 9.06e-01 |
| GOMF U1 SNRNA BINDING | 8 | 9.22e-01 | -2.00e-02 | 9.78e-01 |
| GOBP EMBRYONIC ORGAN MORPHOGENESIS | 99 | 7.32e-01 | 1.99e-02 | 9.09e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 6 | 9.33e-01 | 1.99e-02 | 9.81e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME MATURATION | 16 | 8.90e-01 | -1.99e-02 | 9.67e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION | 421 | 4.87e-01 | 1.99e-02 | 7.85e-01 |
| GOBP REGULATION OF CARTILAGE DEVELOPMENT | 25 | 8.64e-01 | -1.99e-02 | 9.61e-01 |
| GOBP ONCOGENE INDUCED CELL SENESCENCE | 5 | 9.39e-01 | -1.98e-02 | 9.83e-01 |
| GOBP CLATHRIN DEPENDENT ENDOCYTOSIS | 38 | 8.33e-01 | -1.98e-02 | 9.50e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS | 56 | 7.98e-01 | 1.98e-02 | 9.38e-01 |
| GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING | 20 | 8.78e-01 | 1.98e-02 | 9.65e-01 |
| GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY | 82 | 7.58e-01 | 1.97e-02 | 9.22e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE | 9 | 9.18e-01 | -1.97e-02 | 9.76e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT | 11 | 9.10e-01 | 1.97e-02 | 9.74e-01 |
| GOCC MITOTIC SPINDLE | 137 | 6.92e-01 | -1.96e-02 | 8.97e-01 |
| GOBP REGULATION OF CATION CHANNEL ACTIVITY | 47 | 8.17e-01 | 1.96e-02 | 9.45e-01 |
| GOBP RESPONSE TO XENOBIOTIC STIMULUS | 202 | 6.33e-01 | -1.96e-02 | 8.68e-01 |
| GOBP CELL CELL JUNCTION ASSEMBLY | 62 | 7.90e-01 | -1.96e-02 | 9.36e-01 |
| GOCC PRONUCLEUS | 10 | 9.15e-01 | 1.96e-02 | 9.75e-01 |
| GOBP REGULATION OF ORGANELLE ASSEMBLY | 198 | 6.37e-01 | 1.95e-02 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 73 | 7.73e-01 | -1.95e-02 | 9.30e-01 |
| GOBP PHARYNGEAL SYSTEM DEVELOPMENT | 6 | 9.34e-01 | -1.95e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR BINDING | 5 | 9.40e-01 | 1.95e-02 | 9.83e-01 |
| GOCC PROTEASOME CORE COMPLEX | 18 | 8.86e-01 | -1.95e-02 | 9.66e-01 |
| GOBP CHLORIDE TRANSPORT | 44 | 8.23e-01 | 1.95e-02 | 9.46e-01 |
| GOBP RESPONSE TO LIGHT INTENSITY | 10 | 9.16e-01 | 1.94e-02 | 9.75e-01 |
| GOCC CYTOSOLIC REGION | 17 | 8.90e-01 | -1.93e-02 | 9.67e-01 |
| GOMF TRANSITION METAL ION BINDING | 663 | 4.03e-01 | -1.93e-02 | 7.41e-01 |
| GOBP CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE | 11 | 9.12e-01 | -1.93e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 24 | 8.70e-01 | 1.93e-02 | 9.63e-01 |
| GOBP EPIGENETIC REGULATION OF GENE EXPRESSION | 170 | 6.66e-01 | 1.93e-02 | 8.85e-01 |
| GOBP B CELL MEDIATED IMMUNITY | 92 | 7.50e-01 | -1.92e-02 | 9.18e-01 |
| GOBP REGULATION OF HISTONE METHYLATION | 17 | 8.91e-01 | 1.92e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY | 18 | 8.88e-01 | 1.92e-02 | 9.67e-01 |
| GOBP AXON DEVELOPMENT | 221 | 6.25e-01 | -1.92e-02 | 8.64e-01 |
| GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE | 54 | 8.08e-01 | 1.92e-02 | 9.41e-01 |
| GOCC ISWI TYPE COMPLEX | 12 | 9.09e-01 | -1.92e-02 | 9.74e-01 |
| GOCC BLOOD MICROPARTICLE | 44 | 8.27e-01 | -1.91e-02 | 9.47e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE | 6 | 9.36e-01 | 1.91e-02 | 9.82e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS | 193 | 6.49e-01 | -1.91e-02 | 8.76e-01 |
| GOBP STEROL METABOLIC PROCESS | 86 | 7.61e-01 | 1.90e-02 | 9.24e-01 |
| GOMF SEMAPHORIN RECEPTOR BINDING | 7 | 9.31e-01 | 1.90e-02 | 9.81e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING | 19 | 8.86e-01 | 1.90e-02 | 9.66e-01 |
| GOBP MITOCHONDRIAL DEPOLARIZATION | 16 | 8.96e-01 | 1.89e-02 | 9.69e-01 |
| GOBP G1 TO G0 TRANSITION | 12 | 9.10e-01 | 1.89e-02 | 9.74e-01 |
| GOBP REGULATION OF MEMBRANE POTENTIAL | 171 | 6.71e-01 | -1.89e-02 | 8.88e-01 |
| GOBP PROTEIN HETEROOLIGOMERIZATION | 18 | 8.90e-01 | -1.89e-02 | 9.67e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 356 | 5.44e-01 | -1.89e-02 | 8.20e-01 |
| GOBP RESPONSE TO ANGIOTENSIN | 23 | 8.76e-01 | -1.88e-02 | 9.64e-01 |
| GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 9.03e-01 | 1.88e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS | 15 | 9.00e-01 | -1.88e-02 | 9.71e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY | 179 | 6.66e-01 | 1.88e-02 | 8.85e-01 |
| GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS | 25 | 8.71e-01 | -1.88e-02 | 9.63e-01 |
| GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS | 372 | 5.37e-01 | 1.88e-02 | 8.16e-01 |
| GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY | 5 | 9.42e-01 | -1.88e-02 | 9.84e-01 |
| GOMF FLOPPASE ACTIVITY | 13 | 9.07e-01 | 1.87e-02 | 9.74e-01 |
| GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR | 32 | 8.55e-01 | -1.87e-02 | 9.58e-01 |
| GOBP INTERFERON MEDIATED SIGNALING PATHWAY | 69 | 7.89e-01 | -1.86e-02 | 9.36e-01 |
| GOCC MEMBRANE COAT | 80 | 7.74e-01 | 1.86e-02 | 9.30e-01 |
| GOBP LIPID METABOLIC PROCESS | 812 | 3.75e-01 | -1.86e-02 | 7.17e-01 |
| GOBP RESPONSE TO UV C | 12 | 9.11e-01 | 1.86e-02 | 9.74e-01 |
| GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI | 24 | 8.75e-01 | -1.86e-02 | 9.64e-01 |
| GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE | 23 | 8.78e-01 | 1.86e-02 | 9.65e-01 |
| GOMF RIBOSOMAL LARGE SUBUNIT BINDING | 14 | 9.04e-01 | 1.85e-02 | 9.73e-01 |
| GOMF CALCIUM ION BINDING | 266 | 6.06e-01 | 1.85e-02 | 8.54e-01 |
| GOMF SYNTAXIN BINDING | 42 | 8.36e-01 | 1.85e-02 | 9.51e-01 |
| GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 51 | 8.20e-01 | -1.85e-02 | 9.46e-01 |
| GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 49 | 8.23e-01 | 1.85e-02 | 9.46e-01 |
| GOBP SUBSTANTIA NIGRA DEVELOPMENT | 33 | 8.54e-01 | -1.85e-02 | 9.58e-01 |
| GOBP REGULATION OF INNATE IMMUNE RESPONSE | 322 | 5.72e-01 | -1.84e-02 | 8.35e-01 |
| GOBP ISOPRENOID BIOSYNTHETIC PROCESS | 19 | 8.90e-01 | -1.83e-02 | 9.67e-01 |
| GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX | 32 | 8.58e-01 | 1.83e-02 | 9.59e-01 |
| GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING | 7 | 9.33e-01 | -1.83e-02 | 9.81e-01 |
| GOCC CELL TRAILING EDGE | 13 | 9.09e-01 | -1.82e-02 | 9.74e-01 |
| GOBP RHYTHMIC BEHAVIOR | 24 | 8.77e-01 | -1.82e-02 | 9.65e-01 |
| GOBP MANNOSE METABOLIC PROCESS | 9 | 9.25e-01 | 1.82e-02 | 9.78e-01 |
| GOBP POSITIVE THYMIC T CELL SELECTION | 12 | 9.13e-01 | 1.82e-02 | 9.74e-01 |
| GOMF MICROFILAMENT MOTOR ACTIVITY | 16 | 9.00e-01 | -1.82e-02 | 9.71e-01 |
| GOBP RESPONSE TO KETONE | 116 | 7.36e-01 | 1.82e-02 | 9.11e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS | 65 | 8.01e-01 | 1.81e-02 | 9.39e-01 |
| GOBP MITOCHONDRION MORPHOGENESIS | 19 | 8.92e-01 | 1.81e-02 | 9.68e-01 |
| GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 90 | 7.67e-01 | -1.81e-02 | 9.27e-01 |
| GOBP CELLULAR LIPID METABOLIC PROCESS | 616 | 4.50e-01 | -1.80e-02 | 7.70e-01 |
| GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS | 81 | 7.80e-01 | -1.80e-02 | 9.31e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 17 | 8.98e-01 | 1.80e-02 | 9.70e-01 |
| GOCC MSL COMPLEX | 5 | 9.45e-01 | 1.79e-02 | 9.85e-01 |
| GOBP CARDIAC MUSCLE CONTRACTION | 63 | 8.06e-01 | -1.79e-02 | 9.41e-01 |
| GOMF LYSINE N METHYLTRANSFERASE ACTIVITY | 48 | 8.30e-01 | -1.79e-02 | 9.49e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS | 22 | 8.84e-01 | 1.79e-02 | 9.66e-01 |
| GOBP PHOTORECEPTOR CELL DIFFERENTIATION | 24 | 8.80e-01 | 1.78e-02 | 9.65e-01 |
| GOBP REGULATION OF T CIRCLE FORMATION | 5 | 9.45e-01 | 1.78e-02 | 9.85e-01 |
| GOBP ORGANOPHOSPHATE METABOLIC PROCESS | 686 | 4.34e-01 | 1.77e-02 | 7.61e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION | 36 | 8.54e-01 | 1.77e-02 | 9.58e-01 |
| GOBP CELLULAR RESPONSE TO ACIDIC PH | 5 | 9.45e-01 | -1.77e-02 | 9.85e-01 |
| GOBP REGULATION OF HYDROLASE ACTIVITY | 478 | 5.11e-01 | -1.77e-02 | 8.00e-01 |
| GOCC ENDONUCLEASE COMPLEX | 36 | 8.54e-01 | 1.77e-02 | 9.58e-01 |
| GOBP L AMINO ACID TRANSPORT | 48 | 8.33e-01 | 1.76e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 54 | 8.23e-01 | 1.76e-02 | 9.46e-01 |
| GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 15 | 9.06e-01 | -1.76e-02 | 9.74e-01 |
| GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 7 | 9.36e-01 | -1.76e-02 | 9.82e-01 |
| GOBP PROTEIN ACETYLATION | 85 | 7.80e-01 | -1.76e-02 | 9.31e-01 |
| GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY | 1130 | 3.30e-01 | -1.76e-02 | 6.86e-01 |
| GOBP NUCLEOSOME ORGANIZATION | 58 | 8.18e-01 | 1.75e-02 | 9.45e-01 |
| GOBP MECHANOSENSORY BEHAVIOR | 5 | 9.46e-01 | -1.75e-02 | 9.86e-01 |
| GOBP REGULATION OF DEPHOSPHORYLATION | 81 | 7.86e-01 | 1.75e-02 | 9.34e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 10 | 9.24e-01 | 1.73e-02 | 9.78e-01 |
| GOBP AXON GUIDANCE | 74 | 7.97e-01 | 1.73e-02 | 9.37e-01 |
| GOBP PROGESTERONE METABOLIC PROCESS | 7 | 9.37e-01 | -1.73e-02 | 9.82e-01 |
| GOBP LIPOPHAGY | 7 | 9.37e-01 | 1.72e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION | 15 | 9.08e-01 | -1.72e-02 | 9.74e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY | 57 | 8.22e-01 | -1.72e-02 | 9.46e-01 |
| GOCC ORGANELLE INNER MEMBRANE | 455 | 5.34e-01 | -1.71e-02 | 8.15e-01 |
| GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 22 | 8.90e-01 | -1.71e-02 | 9.67e-01 |
| GOBP EMBRYONIC HEART TUBE MORPHOGENESIS | 32 | 8.68e-01 | 1.70e-02 | 9.63e-01 |
| GOCC PROTEIN KINASE COMPLEX | 108 | 7.61e-01 | -1.70e-02 | 9.24e-01 |
| GOCC LAMELLIPODIUM | 146 | 7.24e-01 | -1.70e-02 | 9.07e-01 |
| GOCC VESICLE COAT | 52 | 8.32e-01 | 1.70e-02 | 9.50e-01 |
| GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 35 | 8.62e-01 | -1.70e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION | 23 | 8.88e-01 | -1.69e-02 | 9.67e-01 |
| GOBP INSULIN RECEPTOR SIGNALING PATHWAY | 89 | 7.83e-01 | 1.69e-02 | 9.32e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 9 | 9.30e-01 | -1.69e-02 | 9.81e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE | 24 | 8.86e-01 | 1.69e-02 | 9.66e-01 |
| GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 254 | 6.45e-01 | 1.69e-02 | 8.74e-01 |
| GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION | 10 | 9.26e-01 | -1.69e-02 | 9.79e-01 |
| GOCC DENDRITE CYTOPLASM | 18 | 9.02e-01 | -1.69e-02 | 9.72e-01 |
| GOBP PROTEIN DNA COMPLEX ORGANIZATION | 640 | 4.73e-01 | 1.68e-02 | 7.79e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 7 | 9.39e-01 | -1.68e-02 | 9.83e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 14 | 9.13e-01 | -1.68e-02 | 9.74e-01 |
| GOBP LIVER REGENERATION | 16 | 9.07e-01 | -1.68e-02 | 9.74e-01 |
| GOCC CELL BODY | 258 | 6.44e-01 | -1.68e-02 | 8.74e-01 |
| GOBP REGULATION OF MYOBLAST FUSION | 12 | 9.20e-01 | -1.67e-02 | 9.77e-01 |
| GOBP EYELID DEVELOPMENT IN CAMERA TYPE EYE | 5 | 9.48e-01 | 1.67e-02 | 9.87e-01 |
| GOMF ACYL COA BINDING | 16 | 9.08e-01 | 1.67e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF T CELL MIGRATION | 24 | 8.88e-01 | 1.66e-02 | 9.67e-01 |
| GOBP NEGATIVE REGULATION OF LIPID TRANSPORT | 16 | 9.09e-01 | -1.66e-02 | 9.74e-01 |
| GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 182 | 7.01e-01 | -1.66e-02 | 9.01e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 37 | 8.62e-01 | 1.66e-02 | 9.61e-01 |
| GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 144 | 7.33e-01 | -1.65e-02 | 9.10e-01 |
| GOMF MHC CLASS IB PROTEIN BINDING | 5 | 9.49e-01 | 1.65e-02 | 9.87e-01 |
| GOMF FRIZZLED BINDING | 11 | 9.25e-01 | 1.65e-02 | 9.78e-01 |
| GOBP CELL CYCLE PROCESS | 898 | 4.11e-01 | 1.64e-02 | 7.48e-01 |
| GOBP CELLULAR EXTRAVASATION | 45 | 8.49e-01 | -1.64e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 26 | 8.85e-01 | 1.64e-02 | 9.66e-01 |
| GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION | 17 | 9.07e-01 | -1.64e-02 | 9.74e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH | 8 | 9.36e-01 | 1.64e-02 | 9.82e-01 |
| GOBP CELLULAR ALDEHYDE METABOLIC PROCESS | 41 | 8.57e-01 | -1.63e-02 | 9.59e-01 |
| GOBP SPINDLE ELONGATION | 7 | 9.41e-01 | -1.63e-02 | 9.83e-01 |
| GOBP FOREBRAIN CELL MIGRATION | 33 | 8.72e-01 | 1.63e-02 | 9.63e-01 |
| GOCC INTERCALATED DISC | 27 | 8.84e-01 | -1.62e-02 | 9.66e-01 |
| GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS | 384 | 5.90e-01 | -1.61e-02 | 8.45e-01 |
| GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 66 | 8.21e-01 | 1.61e-02 | 9.46e-01 |
| GOBP REGULATION OF LIPID METABOLIC PROCESS | 187 | 7.06e-01 | -1.61e-02 | 9.02e-01 |
| GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION | 50 | 8.44e-01 | -1.61e-02 | 9.55e-01 |
| GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY | 40 | 8.61e-01 | -1.61e-02 | 9.60e-01 |
| GOCC NUCLEAR OUTER MEMBRANE | 19 | 9.04e-01 | 1.60e-02 | 9.72e-01 |
| GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS | 135 | 7.49e-01 | 1.60e-02 | 9.18e-01 |
| GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX | 279 | 6.49e-01 | -1.59e-02 | 8.76e-01 |
| GOMF PROTEIN DIMERIZATION ACTIVITY | 622 | 5.03e-01 | -1.59e-02 | 7.94e-01 |
| GOBP AXONEME ASSEMBLY | 31 | 8.78e-01 | -1.59e-02 | 9.65e-01 |
| GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 282 | 6.49e-01 | -1.58e-02 | 8.76e-01 |
| GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION | 37 | 8.68e-01 | 1.58e-02 | 9.63e-01 |
| GOMF ATPASE REGULATOR ACTIVITY | 42 | 8.59e-01 | -1.58e-02 | 9.59e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 80 | 8.07e-01 | 1.58e-02 | 9.41e-01 |
| GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION | 21 | 9.00e-01 | -1.58e-02 | 9.71e-01 |
| GOCC AP 2 ADAPTOR COMPLEX | 7 | 9.42e-01 | 1.58e-02 | 9.84e-01 |
| GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX | 37 | 8.68e-01 | 1.57e-02 | 9.63e-01 |
| GOBP REGULATION OF MONOOXYGENASE ACTIVITY | 20 | 9.03e-01 | -1.57e-02 | 9.72e-01 |
| GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 16 | 9.14e-01 | -1.56e-02 | 9.74e-01 |
| GOCC MOTILE CILIUM | 116 | 7.72e-01 | 1.56e-02 | 9.29e-01 |
| GOCC NUCLEAR ENVELOPE | 383 | 6.03e-01 | -1.56e-02 | 8.52e-01 |
| GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT | 48 | 8.52e-01 | 1.56e-02 | 9.58e-01 |
| GOCC CLATHRIN VESICLE COAT | 25 | 8.93e-01 | 1.55e-02 | 9.68e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 12 | 9.26e-01 | 1.55e-02 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 86 | 8.05e-01 | -1.55e-02 | 9.41e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 23 | 8.98e-01 | -1.54e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 212 | 7.01e-01 | -1.54e-02 | 9.01e-01 |
| GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS | 122 | 7.70e-01 | -1.54e-02 | 9.28e-01 |
| GOMF PROTEIN LIPID COMPLEX BINDING | 13 | 9.24e-01 | 1.54e-02 | 9.78e-01 |
| GOBP MITOTIC SPINDLE ORGANIZATION | 100 | 7.91e-01 | 1.53e-02 | 9.36e-01 |
| GOCC SYNAPTONEMAL STRUCTURE | 19 | 9.08e-01 | -1.53e-02 | 9.74e-01 |
| GOCC AZUROPHIL GRANULE LUMEN | 71 | 8.24e-01 | 1.53e-02 | 9.46e-01 |
| GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 64 | 8.33e-01 | 1.53e-02 | 9.50e-01 |
| GOBP POSITIVE REGULATION OF GTPASE ACTIVITY | 142 | 7.54e-01 | -1.53e-02 | 9.19e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 31 | 8.83e-01 | -1.53e-02 | 9.66e-01 |
| GOMF PROTEIN SERINE KINASE ACTIVITY | 261 | 6.73e-01 | -1.53e-02 | 8.88e-01 |
| GOBP REGULATION OF NEURON PROJECTION ARBORIZATION | 11 | 9.30e-01 | 1.52e-02 | 9.81e-01 |
| GOBP RESPONSE TO POTASSIUM ION | 10 | 9.34e-01 | -1.52e-02 | 9.81e-01 |
| GOBP APICAL JUNCTION ASSEMBLY | 33 | 8.80e-01 | -1.51e-02 | 9.65e-01 |
| GOBP RESPONSE TO CATECHOLAMINE | 36 | 8.75e-01 | 1.51e-02 | 9.64e-01 |
| GOBP POLYOL METABOLIC PROCESS | 66 | 8.32e-01 | -1.51e-02 | 9.50e-01 |
| GOBP PANCREATIC JUICE SECRETION | 5 | 9.53e-01 | 1.51e-02 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 32 | 8.83e-01 | -1.51e-02 | 9.66e-01 |
| GOBP CELLULAR RESPONSE TO KETONE | 62 | 8.38e-01 | 1.50e-02 | 9.52e-01 |
| GOBP SEQUESTERING OF TRIGLYCERIDE | 11 | 9.31e-01 | 1.50e-02 | 9.81e-01 |
| GOBP COLLAGEN METABOLIC PROCESS | 40 | 8.70e-01 | 1.50e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION | 797 | 4.79e-01 | -1.50e-02 | 7.82e-01 |
| GOBP REGULATION OF HEART RATE | 39 | 8.72e-01 | 1.50e-02 | 9.63e-01 |
| GOBP REGULATION OF PINOCYTOSIS | 9 | 9.38e-01 | -1.49e-02 | 9.83e-01 |
| GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION | 157 | 7.48e-01 | -1.49e-02 | 9.17e-01 |
| GOMF MDM2 MDM4 FAMILY PROTEIN BINDING | 8 | 9.42e-01 | 1.49e-02 | 9.84e-01 |
| GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 17 | 9.16e-01 | -1.48e-02 | 9.75e-01 |
| GOBP STEM CELL DIVISION | 18 | 9.14e-01 | 1.48e-02 | 9.74e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 13 | 9.27e-01 | 1.48e-02 | 9.79e-01 |
| GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS | 12 | 9.30e-01 | 1.47e-02 | 9.81e-01 |
| GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE | 32 | 8.86e-01 | -1.47e-02 | 9.66e-01 |
| GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT | 37 | 8.77e-01 | -1.47e-02 | 9.65e-01 |
| GOBP REGULATION OF AXON GUIDANCE | 6 | 9.51e-01 | 1.46e-02 | 9.87e-01 |
| GOBP REGULATION OF MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 137 | 7.69e-01 | -1.46e-02 | 9.28e-01 |
| GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS | 185 | 7.34e-01 | -1.46e-02 | 9.10e-01 |
| GOBP L ASCORBIC ACID METABOLIC PROCESS | 7 | 9.47e-01 | -1.45e-02 | 9.86e-01 |
| GOBP SODIUM ION TRANSMEMBRANE TRANSPORT | 55 | 8.52e-01 | 1.45e-02 | 9.58e-01 |
| GOBP WHITE FAT CELL DIFFERENTIATION | 9 | 9.40e-01 | -1.45e-02 | 9.83e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY | 64 | 8.41e-01 | 1.45e-02 | 9.53e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY | 12 | 9.31e-01 | -1.45e-02 | 9.81e-01 |
| GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS | 41 | 8.73e-01 | -1.44e-02 | 9.64e-01 |
| GOBP RESPONSE TO STEROID HORMONE | 192 | 7.32e-01 | -1.44e-02 | 9.09e-01 |
| GOCC I BAND | 68 | 8.38e-01 | 1.43e-02 | 9.52e-01 |
| GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS | 44 | 8.70e-01 | 1.43e-02 | 9.63e-01 |
| GOBP REGULATION OF LIPASE ACTIVITY | 41 | 8.74e-01 | 1.43e-02 | 9.64e-01 |
| GOBP ORGANIC ANION TRANSPORT | 210 | 7.22e-01 | 1.43e-02 | 9.06e-01 |
| GOBP EXTRACELLULAR TRANSPORT | 18 | 9.16e-01 | 1.43e-02 | 9.75e-01 |
| GOBP MEMBRANE DEPOLARIZATION | 34 | 8.85e-01 | 1.43e-02 | 9.66e-01 |
| GOCC PROTEIN DNA COMPLEX | 790 | 5.01e-01 | -1.43e-02 | 7.92e-01 |
| GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS | 24 | 9.04e-01 | -1.43e-02 | 9.72e-01 |
| GOBP PROTEIN SUMOYLATION | 59 | 8.50e-01 | -1.43e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY | 69 | 8.39e-01 | 1.42e-02 | 9.52e-01 |
| GOBP PIGMENT CATABOLIC PROCESS | 5 | 9.56e-01 | 1.42e-02 | 9.89e-01 |
| GOCC DEATH INDUCING SIGNALING COMPLEX | 9 | 9.41e-01 | 1.42e-02 | 9.83e-01 |
| GOBP PEPTIDYL SERINE MODIFICATION | 205 | 7.28e-01 | -1.42e-02 | 9.08e-01 |
| GOBP HETEROCHROMATIN ORGANIZATION | 75 | 8.33e-01 | -1.41e-02 | 9.50e-01 |
| GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS | 11 | 9.35e-01 | 1.41e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 8 | 9.45e-01 | -1.40e-02 | 9.85e-01 |
| GOBP REGULATION OF MITOCHONDRION ORGANIZATION | 118 | 7.93e-01 | -1.40e-02 | 9.36e-01 |
| GOBP RESPONSE TO TYPE I INTERFERON | 59 | 8.53e-01 | 1.39e-02 | 9.58e-01 |
| GOBP RESPONSE TO CADMIUM ION | 39 | 8.81e-01 | 1.39e-02 | 9.65e-01 |
| GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION | 17 | 9.21e-01 | -1.39e-02 | 9.78e-01 |
| GOBP MONOCYTE DIFFERENTIATION | 25 | 9.05e-01 | 1.39e-02 | 9.73e-01 |
| GOMF SYMPORTER ACTIVITY | 59 | 8.54e-01 | 1.39e-02 | 9.58e-01 |
| GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 39 | 8.81e-01 | -1.38e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS | 9 | 9.43e-01 | -1.38e-02 | 9.84e-01 |
| GOBP STEROID METABOLIC PROCESS | 156 | 7.69e-01 | 1.37e-02 | 9.28e-01 |
| GOBP TERPENOID METABOLIC PROCESS | 40 | 8.82e-01 | -1.36e-02 | 9.65e-01 |
| GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 106 | 8.09e-01 | -1.36e-02 | 9.42e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 91 | 8.25e-01 | -1.34e-02 | 9.46e-01 |
| GOBP REGULATION OF MYOBLAST DIFFERENTIATION | 44 | 8.77e-01 | -1.34e-02 | 9.65e-01 |
| GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS | 26 | 9.06e-01 | 1.34e-02 | 9.73e-01 |
| GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 50 | 8.70e-01 | 1.34e-02 | 9.63e-01 |
| GOBP REGULATION OF GTPASE ACTIVITY | 188 | 7.52e-01 | 1.34e-02 | 9.19e-01 |
| GOBP REGULATION OF MACROPHAGE ACTIVATION | 36 | 8.89e-01 | 1.34e-02 | 9.67e-01 |
| GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX | 779 | 5.31e-01 | -1.34e-02 | 8.13e-01 |
| GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING | 5 | 9.59e-01 | 1.34e-02 | 9.90e-01 |
| GOBP STRIATED MUSCLE CONTRACTION | 81 | 8.35e-01 | -1.34e-02 | 9.50e-01 |
| GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING | 19 | 9.20e-01 | 1.33e-02 | 9.77e-01 |
| GOBP DNA DEALKYLATION | 25 | 9.08e-01 | 1.33e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS | 12 | 9.36e-01 | 1.33e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS | 63 | 8.55e-01 | 1.33e-02 | 9.58e-01 |
| GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY | 9 | 9.45e-01 | 1.32e-02 | 9.85e-01 |
| GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY | 5 | 9.59e-01 | 1.32e-02 | 9.90e-01 |
| GOCC RNA POLYMERASE II CORE COMPLEX | 14 | 9.32e-01 | 1.32e-02 | 9.81e-01 |
| GOBP PROTEIN DESUMOYLATION | 8 | 9.48e-01 | 1.32e-02 | 9.87e-01 |
| GOBP REGULATION OF GLUCOSE IMPORT | 33 | 8.96e-01 | 1.32e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF DNA RECOMBINATION | 61 | 8.59e-01 | -1.32e-02 | 9.59e-01 |
| GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT | 15 | 9.30e-01 | -1.31e-02 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF HYPERSENSITIVITY | 5 | 9.60e-01 | -1.31e-02 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 110 | 8.14e-01 | -1.30e-02 | 9.43e-01 |
| GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY | 10 | 9.43e-01 | -1.30e-02 | 9.84e-01 |
| GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 45 | 8.80e-01 | 1.30e-02 | 9.65e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS | 156 | 7.81e-01 | -1.29e-02 | 9.32e-01 |
| GOBP VESICLE TARGETING | 60 | 8.63e-01 | 1.29e-02 | 9.61e-01 |
| GOBP REGULATION OF STEM CELL DIFFERENTIATION | 51 | 8.73e-01 | -1.29e-02 | 9.64e-01 |
| GOBP MICROTUBULE POLYMERIZATION | 73 | 8.50e-01 | -1.28e-02 | 9.57e-01 |
| GOBP CARDIAC MYOFIBRIL ASSEMBLY | 5 | 9.60e-01 | 1.28e-02 | 9.90e-01 |
| GOMF GTPASE BINDING | 255 | 7.29e-01 | 1.27e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 327 | 6.95e-01 | -1.27e-02 | 8.98e-01 |
| GOBP CILIUM MOVEMENT | 64 | 8.61e-01 | 1.27e-02 | 9.61e-01 |
| GOCC TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 15 | 9.33e-01 | 1.26e-02 | 9.81e-01 |
| GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING | 12 | 9.40e-01 | -1.26e-02 | 9.83e-01 |
| GOMF WNT RECEPTOR ACTIVITY | 7 | 9.54e-01 | 1.26e-02 | 9.89e-01 |
| GOBP CELL CYCLE DNA REPLICATION | 35 | 8.98e-01 | 1.26e-02 | 9.70e-01 |
| GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION | 38 | 8.94e-01 | 1.26e-02 | 9.68e-01 |
| GOMF ACTIN BINDING | 260 | 7.29e-01 | -1.26e-02 | 9.08e-01 |
| GOMF BASAL TRANSCRIPTION MACHINERY BINDING | 56 | 8.71e-01 | -1.25e-02 | 9.63e-01 |
| GOMF ADENYLATE KINASE ACTIVITY | 6 | 9.58e-01 | -1.25e-02 | 9.89e-01 |
| GOBP SKELETAL MUSCLE TISSUE REGENERATION | 23 | 9.18e-01 | -1.25e-02 | 9.75e-01 |
| GOMF PHOSPHOLIPID BINDING | 307 | 7.09e-01 | -1.25e-02 | 9.03e-01 |
| GOMF MYOSIN BINDING | 37 | 8.96e-01 | -1.24e-02 | 9.69e-01 |
| GOBP NEURON PROJECTION ORGANIZATION | 50 | 8.81e-01 | -1.23e-02 | 9.65e-01 |
| GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 9.14e-01 | -1.22e-02 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 22 | 9.21e-01 | 1.22e-02 | 9.78e-01 |
| GOMF RNA CAP BINDING | 19 | 9.27e-01 | -1.22e-02 | 9.79e-01 |
| GOBP MITOTIC CHROMOSOME CONDENSATION | 15 | 9.35e-01 | 1.22e-02 | 9.82e-01 |
| GOMF MANGANESE ION BINDING | 53 | 8.79e-01 | 1.21e-02 | 9.65e-01 |
| GOBP NUCLEAR TRANSPORT | 277 | 7.30e-01 | 1.21e-02 | 9.09e-01 |
| GOBP CEREBRAL CORTEX CELL MIGRATION | 27 | 9.13e-01 | 1.21e-02 | 9.74e-01 |
| GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 16 | 9.33e-01 | -1.21e-02 | 9.81e-01 |
| GOCC STEREOCILIUM TIP | 7 | 9.56e-01 | 1.21e-02 | 9.89e-01 |
| GOBP VESICLE DOCKING | 49 | 8.84e-01 | 1.21e-02 | 9.66e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS | 74 | 8.58e-01 | -1.20e-02 | 9.59e-01 |
| GOBP HEART PROCESS | 102 | 8.34e-01 | -1.20e-02 | 9.50e-01 |
| GOBP RESPONSE TO INTERLEUKIN 4 | 27 | 9.14e-01 | -1.20e-02 | 9.74e-01 |
| GOBP MICROTUBULE NUCLEATION | 41 | 8.94e-01 | 1.20e-02 | 9.69e-01 |
| GOBP SECOND MESSENGER MEDIATED SIGNALING | 143 | 8.05e-01 | -1.20e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF KINASE ACTIVITY | 200 | 7.71e-01 | 1.20e-02 | 9.29e-01 |
| GOBP PIGMENT GRANULE LOCALIZATION | 14 | 9.38e-01 | -1.19e-02 | 9.83e-01 |
| GOBP KERATINOCYTE PROLIFERATION | 23 | 9.22e-01 | -1.18e-02 | 9.78e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM | 8 | 9.54e-01 | 1.18e-02 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 7 | 9.57e-01 | -1.18e-02 | 9.89e-01 |
| GOCC LSM2 8 COMPLEX | 7 | 9.57e-01 | 1.18e-02 | 9.89e-01 |
| GOBP REGULATION OF CELL CYCLE | 756 | 5.88e-01 | 1.17e-02 | 8.43e-01 |
| GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY | 14 | 9.39e-01 | 1.17e-02 | 9.83e-01 |
| GOBP RECEPTOR CLUSTERING | 31 | 9.10e-01 | 1.17e-02 | 9.74e-01 |
| GOBP ORGANIC ACID TRANSPORT | 165 | 7.96e-01 | 1.17e-02 | 9.37e-01 |
| GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY | 17 | 9.33e-01 | -1.17e-02 | 9.81e-01 |
| GOCC HISTONE DEACETYLASE COMPLEX | 73 | 8.63e-01 | -1.17e-02 | 9.61e-01 |
| GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 6 | 9.60e-01 | -1.17e-02 | 9.90e-01 |
| GOBP ORGANOPHOSPHATE ESTER TRANSPORT | 95 | 8.45e-01 | 1.16e-02 | 9.55e-01 |
| GOBP MAGNESIUM ION TRANSPORT | 12 | 9.44e-01 | 1.16e-02 | 9.85e-01 |
| GOBP REGULATION OF GLUCONEOGENESIS | 37 | 9.03e-01 | -1.16e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 52 | 8.85e-01 | -1.16e-02 | 9.66e-01 |
| GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY | 8 | 9.55e-01 | 1.15e-02 | 9.89e-01 |
| GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 8 | 9.55e-01 | 1.15e-02 | 9.89e-01 |
| GOBP CELLULAR RESPONSE TO STRESS | 1452 | 4.78e-01 | -1.15e-02 | 7.82e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE | 15 | 9.39e-01 | 1.14e-02 | 9.83e-01 |
| GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING | 10 | 9.50e-01 | -1.14e-02 | 9.87e-01 |
| GOBP REGULATION OF MYOTUBE DIFFERENTIATION | 17 | 9.36e-01 | 1.13e-02 | 9.82e-01 |
| GOBP RESPONSE TO CHEMOKINE | 39 | 9.03e-01 | 1.13e-02 | 9.72e-01 |
| GOCC U12 TYPE SPLICEOSOMAL COMPLEX | 26 | 9.21e-01 | -1.13e-02 | 9.77e-01 |
| GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 19 | 9.32e-01 | -1.13e-02 | 9.81e-01 |
| GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 13 | 9.44e-01 | -1.12e-02 | 9.85e-01 |
| GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 24 | 9.24e-01 | -1.12e-02 | 9.78e-01 |
| GOBP RESPONSE TO LIGHT STIMULUS | 197 | 7.89e-01 | -1.11e-02 | 9.36e-01 |
| GOCC NUCLEAR PROTEIN CONTAINING COMPLEX | 1042 | 5.54e-01 | 1.11e-02 | 8.25e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 8 | 9.57e-01 | 1.11e-02 | 9.89e-01 |
| GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING | 8 | 9.57e-01 | -1.11e-02 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE | 141 | 8.21e-01 | 1.10e-02 | 9.46e-01 |
| GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 19 | 9.34e-01 | -1.10e-02 | 9.81e-01 |
| GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING | 5 | 9.66e-01 | -1.10e-02 | 9.91e-01 |
| GOBP MITOTIC CYTOKINESIS | 68 | 8.76e-01 | 1.10e-02 | 9.64e-01 |
| GOBP REGULATION OF NEUTROPHIL ACTIVATION | 11 | 9.50e-01 | -1.09e-02 | 9.87e-01 |
| GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 9.63e-01 | 1.09e-02 | 9.91e-01 |
| GOBP MUSCLE CONTRACTION | 147 | 8.20e-01 | 1.09e-02 | 9.46e-01 |
| GOBP REGULATION OF LYMPHOCYTE MIGRATION | 45 | 8.99e-01 | 1.09e-02 | 9.71e-01 |
| GOCC PHOSPHATASE COMPLEX | 46 | 8.98e-01 | 1.09e-02 | 9.70e-01 |
| GOBP RESPONSE TO TEMPERATURE STIMULUS | 105 | 8.47e-01 | 1.09e-02 | 9.56e-01 |
| GOBP AMINO SUGAR METABOLIC PROCESS | 27 | 9.22e-01 | -1.09e-02 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 93 | 8.56e-01 | -1.09e-02 | 9.59e-01 |
| GOBP REGULATION OF CATALYTIC ACTIVITY | 929 | 5.81e-01 | -1.09e-02 | 8.39e-01 |
| GOBP KERATAN SULFATE METABOLIC PROCESS | 12 | 9.48e-01 | 1.09e-02 | 9.87e-01 |
| GOBP SPONTANEOUS SYNAPTIC TRANSMISSION | 7 | 9.60e-01 | -1.09e-02 | 9.90e-01 |
| GOBP REGENERATION | 93 | 8.57e-01 | 1.09e-02 | 9.59e-01 |
| GOMF GLYCOLIPID BINDING | 17 | 9.39e-01 | -1.08e-02 | 9.83e-01 |
| GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS | 67 | 8.79e-01 | -1.08e-02 | 9.65e-01 |
| GOBP DNA MODIFICATION | 74 | 8.73e-01 | -1.08e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 46 | 9.00e-01 | -1.08e-02 | 9.71e-01 |
| GOBP GLOMERULAR EPITHELIUM DEVELOPMENT | 9 | 9.56e-01 | -1.07e-02 | 9.89e-01 |
| GOMF NADP BINDING | 31 | 9.18e-01 | -1.07e-02 | 9.76e-01 |
| GOBP PHOSPHOLIPID METABOLIC PROCESS | 262 | 7.67e-01 | -1.07e-02 | 9.27e-01 |
| GOBP MAINTENANCE OF DNA REPEAT ELEMENTS | 5 | 9.67e-01 | 1.07e-02 | 9.92e-01 |
| GOBP ORGANELLE FISSION | 305 | 7.51e-01 | 1.06e-02 | 9.19e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 14 | 9.45e-01 | -1.06e-02 | 9.85e-01 |
| GOBP PHOSPHOLIPID HOMEOSTASIS | 6 | 9.64e-01 | -1.06e-02 | 9.91e-01 |
| GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY | 38 | 9.11e-01 | -1.05e-02 | 9.74e-01 |
| GOBP GLUCAN METABOLIC PROCESS | 48 | 9.00e-01 | 1.05e-02 | 9.71e-01 |
| GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS | 164 | 8.18e-01 | -1.05e-02 | 9.45e-01 |
| GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION | 8 | 9.59e-01 | 1.04e-02 | 9.90e-01 |
| GOCC LATERAL PLASMA MEMBRANE | 34 | 9.17e-01 | 1.04e-02 | 9.75e-01 |
| GOBP T CELL MIGRATION | 48 | 9.01e-01 | 1.04e-02 | 9.72e-01 |
| GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 9.68e-01 | 1.04e-02 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY | 36 | 9.15e-01 | 1.03e-02 | 9.75e-01 |
| GOMF METALLOAMINOPEPTIDASE ACTIVITY | 18 | 9.39e-01 | 1.03e-02 | 9.83e-01 |
| GOBP AUTOPHAGOSOME MATURATION | 59 | 8.91e-01 | -1.03e-02 | 9.68e-01 |
| GOBP MONOSACCHARIDE METABOLIC PROCESS | 183 | 8.10e-01 | -1.03e-02 | 9.42e-01 |
| GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS | 16 | 9.43e-01 | 1.03e-02 | 9.84e-01 |
| GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS | 9 | 9.57e-01 | 1.03e-02 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF CHEMOTAXIS | 74 | 8.79e-01 | -1.02e-02 | 9.65e-01 |
| GOMF E BOX BINDING | 22 | 9.34e-01 | -1.02e-02 | 9.81e-01 |
| GOBP CELL CYCLE PHASE TRANSITION | 399 | 7.28e-01 | 1.02e-02 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 10 | 9.56e-01 | -1.01e-02 | 9.89e-01 |
| GOMF PHOSPHOPROTEIN BINDING | 74 | 8.81e-01 | -1.01e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 59 | 8.94e-01 | -1.01e-02 | 9.68e-01 |
| GOBP FOREBRAIN NEURON DIFFERENTIATION | 16 | 9.45e-01 | -1.00e-02 | 9.85e-01 |
| GOBP MALE SEX DIFFERENTIATION | 89 | 8.71e-01 | -1.00e-02 | 9.63e-01 |
| GOBP CELLULAR RESPONSE TO SALT | 107 | 8.59e-01 | -9.99e-03 | 9.59e-01 |
| GOMF PROTEIN KINASE ACTIVITY | 390 | 7.37e-01 | -9.97e-03 | 9.12e-01 |
| GOBP RESPONSE TO THYROID HORMONE | 19 | 9.40e-01 | -9.96e-03 | 9.83e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING | 21 | 9.37e-01 | -9.91e-03 | 9.82e-01 |
| GOMF POLYSACCHARIDE BINDING | 13 | 9.51e-01 | -9.84e-03 | 9.87e-01 |
| GOBP REPRODUCTIVE SYSTEM DEVELOPMENT | 151 | 8.35e-01 | -9.83e-03 | 9.50e-01 |
| GOBP PROXIMAL TUBULE DEVELOPMENT | 5 | 9.70e-01 | 9.82e-03 | 9.92e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY | 15 | 9.48e-01 | 9.81e-03 | 9.86e-01 |
| GOCC NEURON PROJECTION TERMINUS | 48 | 9.07e-01 | 9.78e-03 | 9.74e-01 |
| GOBP SEX DIFFERENTIATION | 135 | 8.45e-01 | 9.76e-03 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 86 | 8.76e-01 | 9.72e-03 | 9.65e-01 |
| GOBP RESPONSE TO INSULIN | 180 | 8.23e-01 | -9.67e-03 | 9.46e-01 |
| GOBP PROTEIN EXPORT FROM NUCLEUS | 53 | 9.03e-01 | -9.67e-03 | 9.72e-01 |
| GOCC U1 SNRNP | 18 | 9.43e-01 | -9.66e-03 | 9.85e-01 |
| GOMF DEAMINASE ACTIVITY | 21 | 9.39e-01 | -9.63e-03 | 9.83e-01 |
| GOBP CHROMATIN REMODELING | 459 | 7.26e-01 | 9.62e-03 | 9.07e-01 |
| GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE | 34 | 9.23e-01 | 9.60e-03 | 9.78e-01 |
| GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY | 52 | 9.05e-01 | -9.58e-03 | 9.73e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT | 7 | 9.65e-01 | -9.52e-03 | 9.91e-01 |
| GOBP PROTEIN LOCALIZATION TO ORGANELLE | 752 | 6.62e-01 | -9.51e-03 | 8.83e-01 |
| GOBP DENDRITIC SPINE MORPHOGENESIS | 29 | 9.30e-01 | 9.50e-03 | 9.81e-01 |
| GOBP TRANSLATIONAL ELONGATION | 57 | 9.01e-01 | -9.50e-03 | 9.72e-01 |
| GOMF MAP KINASE KINASE ACTIVITY | 14 | 9.51e-01 | 9.47e-03 | 9.87e-01 |
| GOBP RESPONSE TO METAL ION | 201 | 8.18e-01 | -9.47e-03 | 9.45e-01 |
| GOCC MITOTIC SPINDLE POLE | 29 | 9.30e-01 | 9.42e-03 | 9.81e-01 |
| GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS | 190 | 8.23e-01 | -9.42e-03 | 9.46e-01 |
| GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON | 51 | 9.08e-01 | 9.41e-03 | 9.74e-01 |
| GOCC RNA POLYMERASE III COMPLEX | 17 | 9.46e-01 | -9.41e-03 | 9.86e-01 |
| GOBP INTERLEUKIN 17 PRODUCTION | 25 | 9.35e-01 | -9.40e-03 | 9.82e-01 |
| GOMF LIPID TRANSPORTER ACTIVITY | 88 | 8.79e-01 | -9.40e-03 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY | 21 | 9.41e-01 | 9.36e-03 | 9.83e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING | 123 | 8.58e-01 | -9.33e-03 | 9.59e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 111 | 8.65e-01 | 9.33e-03 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS | 25 | 9.36e-01 | 9.30e-03 | 9.82e-01 |
| GOCC SITE OF POLARIZED GROWTH | 112 | 8.65e-01 | -9.29e-03 | 9.62e-01 |
| GOBP REGULATION OF CELL PROJECTION ORGANIZATION | 398 | 7.52e-01 | -9.28e-03 | 9.19e-01 |
| GOBP B CELL DIFFERENTIATION | 103 | 8.71e-01 | 9.27e-03 | 9.63e-01 |
| GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 30 | 9.30e-01 | -9.26e-03 | 9.81e-01 |
| GOBP REGULATION OF VIRAL PROCESS | 126 | 8.58e-01 | 9.26e-03 | 9.59e-01 |
| GOBP ISOPRENOID METABOLIC PROCESS | 70 | 8.94e-01 | -9.25e-03 | 9.68e-01 |
| GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS | 9 | 9.62e-01 | 9.15e-03 | 9.91e-01 |
| GOBP MACROPINOCYTOSIS | 8 | 9.64e-01 | -9.15e-03 | 9.91e-01 |
| GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS | 12 | 9.56e-01 | -9.15e-03 | 9.89e-01 |
| GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 83 | 8.86e-01 | -9.13e-03 | 9.66e-01 |
| GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 14 | 9.53e-01 | -9.13e-03 | 9.89e-01 |
| GOBP GLYCEROLIPID METABOLIC PROCESS | 258 | 8.02e-01 | -9.10e-03 | 9.40e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO STRESS | 502 | 7.30e-01 | -9.07e-03 | 9.09e-01 |
| GOCC CLATHRIN COAT | 37 | 9.25e-01 | 8.97e-03 | 9.78e-01 |
| GOBP DERMATAN SULFATE METABOLIC PROCESS | 8 | 9.65e-01 | -8.95e-03 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF HEAT GENERATION | 5 | 9.72e-01 | -8.94e-03 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 5 | 9.72e-01 | 8.94e-03 | 9.92e-01 |
| GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 7 | 9.67e-01 | -8.91e-03 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF HISTONE METHYLATION | 14 | 9.54e-01 | -8.91e-03 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION | 28 | 9.35e-01 | 8.90e-03 | 9.82e-01 |
| GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS | 50 | 9.14e-01 | -8.81e-03 | 9.74e-01 |
| GOMF LEUCINE BINDING | 6 | 9.70e-01 | -8.79e-03 | 9.92e-01 |
| GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE | 10 | 9.62e-01 | 8.73e-03 | 9.91e-01 |
| GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION | 230 | 8.21e-01 | -8.72e-03 | 9.46e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 26 | 9.39e-01 | -8.71e-03 | 9.83e-01 |
| GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 198 | 8.34e-01 | -8.67e-03 | 9.50e-01 |
| GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS | 101 | 8.81e-01 | -8.65e-03 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 11 | 9.61e-01 | -8.59e-03 | 9.90e-01 |
| GOCC CHROMAFFIN GRANULE | 8 | 9.66e-01 | 8.58e-03 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 25 | 9.41e-01 | 8.57e-03 | 9.83e-01 |
| GOMF WNT PROTEIN BINDING | 10 | 9.63e-01 | -8.57e-03 | 9.91e-01 |
| GOBP LIPID GLYCOSYLATION | 5 | 9.74e-01 | 8.55e-03 | 9.92e-01 |
| GOCC CRD MEDIATED MRNA STABILITY COMPLEX | 5 | 9.74e-01 | 8.51e-03 | 9.92e-01 |
| GOBP PROTEIN FOLDING | 171 | 8.48e-01 | 8.51e-03 | 9.56e-01 |
| GOBP SKELETAL MUSCLE CELL DIFFERENTIATION | 35 | 9.31e-01 | -8.49e-03 | 9.81e-01 |
| GOCC UNCONVENTIONAL MYOSIN COMPLEX | 6 | 9.71e-01 | 8.46e-03 | 9.92e-01 |
| GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 6 | 9.71e-01 | -8.43e-03 | 9.92e-01 |
| GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY | 5 | 9.74e-01 | -8.42e-03 | 9.92e-01 |
| GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 43 | 9.24e-01 | -8.38e-03 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 64 | 9.08e-01 | 8.36e-03 | 9.74e-01 |
| GOCC GOLGI CISTERNA MEMBRANE | 58 | 9.12e-01 | 8.35e-03 | 9.74e-01 |
| GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 73 | 9.02e-01 | 8.35e-03 | 9.72e-01 |
| GOBP MITOTIC CELL CYCLE PHASE TRANSITION | 326 | 7.98e-01 | 8.31e-03 | 9.38e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN STIMULUS | 145 | 8.64e-01 | 8.29e-03 | 9.61e-01 |
| GOBP NEGATIVE T CELL SELECTION | 8 | 9.68e-01 | -8.27e-03 | 9.92e-01 |
| GOBP CALCIUM ION HOMEOSTASIS | 159 | 8.58e-01 | 8.27e-03 | 9.59e-01 |
| GOBP MITOTIC CELL CYCLE | 654 | 7.22e-01 | 8.26e-03 | 9.06e-01 |
| GOBP DENDRITIC SPINE DEVELOPMENT | 59 | 9.13e-01 | -8.26e-03 | 9.74e-01 |
| GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY | 6 | 9.72e-01 | 8.21e-03 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING | 5 | 9.75e-01 | 8.19e-03 | 9.92e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY | 34 | 9.34e-01 | 8.18e-03 | 9.81e-01 |
| GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR | 10 | 9.64e-01 | 8.17e-03 | 9.91e-01 |
| GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR | 16 | 9.55e-01 | 8.16e-03 | 9.89e-01 |
| GOBP OOCYTE DIFFERENTIATION | 28 | 9.41e-01 | -8.13e-03 | 9.83e-01 |
| GOBP REGULATION OF CELLULAR SENESCENCE | 33 | 9.36e-01 | -8.13e-03 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 44 | 9.26e-01 | 8.12e-03 | 9.79e-01 |
| GOBP ACTIN FILAMENT BASED MOVEMENT | 61 | 9.13e-01 | 8.06e-03 | 9.74e-01 |
| GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 709 | 7.20e-01 | 8.01e-03 | 9.06e-01 |
| GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS | 7 | 9.71e-01 | -8.00e-03 | 9.92e-01 |
| GOCC PERINUCLEAR ENDOPLASMIC RETICULUM | 15 | 9.57e-01 | 7.97e-03 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES | 6 | 9.73e-01 | 7.97e-03 | 9.92e-01 |
| GOCC MICROTUBULE | 291 | 8.16e-01 | -7.96e-03 | 9.45e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION | 29 | 9.41e-01 | -7.95e-03 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL | 6 | 9.73e-01 | -7.94e-03 | 9.92e-01 |
| GOMF HEXOSAMINIDASE ACTIVITY | 12 | 9.62e-01 | 7.93e-03 | 9.91e-01 |
| GOCC TRANS GOLGI NETWORK MEMBRANE | 80 | 9.03e-01 | -7.89e-03 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION | 24 | 9.47e-01 | 7.84e-03 | 9.86e-01 |
| GOCC SPERM PRINCIPAL PIECE | 16 | 9.57e-01 | -7.81e-03 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 21 | 9.51e-01 | -7.80e-03 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION | 19 | 9.53e-01 | 7.80e-03 | 9.89e-01 |
| GOBP GLYCOPROTEIN CATABOLIC PROCESS | 25 | 9.46e-01 | 7.79e-03 | 9.86e-01 |
| GOBP MEMBRANE DISASSEMBLY | 10 | 9.66e-01 | -7.78e-03 | 9.91e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 20 | 9.52e-01 | 7.78e-03 | 9.88e-01 |
| GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 235 | 8.39e-01 | 7.74e-03 | 9.52e-01 |
| GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION | 6 | 9.74e-01 | 7.70e-03 | 9.92e-01 |
| GOMF UNFOLDED PROTEIN BINDING | 87 | 9.02e-01 | -7.65e-03 | 9.72e-01 |
| GOBP REGULATION OF CHEMOTAXIS | 113 | 8.89e-01 | 7.64e-03 | 9.67e-01 |
| GOCC SPINDLE | 327 | 8.14e-01 | -7.63e-03 | 9.43e-01 |
| GOMF SUMO TRANSFERASE ACTIVITY | 22 | 9.51e-01 | -7.63e-03 | 9.87e-01 |
| GOBP RENAL TUBULE DEVELOPMENT | 31 | 9.41e-01 | -7.62e-03 | 9.83e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 66 | 9.15e-01 | 7.61e-03 | 9.75e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 8 | 9.70e-01 | 7.57e-03 | 9.92e-01 |
| GOBP REGULATION OF BONE REMODELING | 24 | 9.49e-01 | 7.55e-03 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 50 | 9.27e-01 | 7.50e-03 | 9.79e-01 |
| GOBP REGULATION OF MICROTUBULE BASED MOVEMENT | 21 | 9.53e-01 | -7.45e-03 | 9.89e-01 |
| GOMF FILAMIN BINDING | 5 | 9.77e-01 | -7.43e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT | 55 | 9.24e-01 | -7.41e-03 | 9.78e-01 |
| GOBP RESPONSE TO ACID CHEMICAL | 84 | 9.07e-01 | 7.37e-03 | 9.74e-01 |
| GOBP DNA TOPOLOGICAL CHANGE | 9 | 9.69e-01 | 7.37e-03 | 9.92e-01 |
| GOBP ALCOHOL METABOLIC PROCESS | 208 | 8.56e-01 | 7.32e-03 | 9.59e-01 |
| GOBP PLATELET DENSE GRANULE ORGANIZATION | 21 | 9.54e-01 | 7.30e-03 | 9.89e-01 |
| GOBP STORE OPERATED CALCIUM ENTRY | 14 | 9.62e-01 | -7.28e-03 | 9.91e-01 |
| GOBP EAR DEVELOPMENT | 72 | 9.15e-01 | 7.28e-03 | 9.75e-01 |
| GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING | 59 | 9.23e-01 | 7.25e-03 | 9.78e-01 |
| GOBP GALACTOSE METABOLIC PROCESS | 8 | 9.72e-01 | -7.25e-03 | 9.92e-01 |
| GOBP CELLULAR RESPONSE TO CALCIUM ION | 44 | 9.34e-01 | -7.24e-03 | 9.81e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 21 | 9.54e-01 | 7.24e-03 | 9.89e-01 |
| GOBP APPENDAGE DEVELOPMENT | 79 | 9.12e-01 | -7.23e-03 | 9.74e-01 |
| GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE | 20 | 9.56e-01 | 7.20e-03 | 9.89e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FISSION | 23 | 9.52e-01 | 7.19e-03 | 9.89e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 6 | 9.76e-01 | -7.18e-03 | 9.92e-01 |
| GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY | 10 | 9.69e-01 | 7.16e-03 | 9.92e-01 |
| GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 6 | 9.76e-01 | 7.15e-03 | 9.92e-01 |
| GOBP MUSCLE HYPERTROPHY | 52 | 9.29e-01 | -7.15e-03 | 9.81e-01 |
| GOBP MITOTIC CELL CYCLE PROCESS | 556 | 7.77e-01 | 7.11e-03 | 9.31e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK | 25 | 9.51e-01 | 7.10e-03 | 9.87e-01 |
| GOBP REGULATION OF AXON EXTENSION | 47 | 9.33e-01 | 7.07e-03 | 9.81e-01 |
| GOMF SUMO LIGASE ACTIVITY | 12 | 9.66e-01 | 7.07e-03 | 9.91e-01 |
| GOMF DYNEIN INTERMEDIATE CHAIN BINDING | 19 | 9.58e-01 | 7.05e-03 | 9.89e-01 |
| GOBP PENTOSE METABOLIC PROCESS | 9 | 9.71e-01 | -7.04e-03 | 9.92e-01 |
| GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 267 | 8.44e-01 | -7.03e-03 | 9.55e-01 |
| GOCC PREFOLDIN COMPLEX | 7 | 9.75e-01 | -6.97e-03 | 9.92e-01 |
| GOBP GLOMERULUS DEVELOPMENT | 26 | 9.51e-01 | -6.96e-03 | 9.87e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 110 | 9.00e-01 | 6.92e-03 | 9.71e-01 |
| GOCC MONOATOMIC ION CHANNEL COMPLEX | 83 | 9.14e-01 | -6.89e-03 | 9.74e-01 |
| GOCC POLYMERIC CYTOSKELETAL FIBER | 381 | 8.19e-01 | -6.88e-03 | 9.46e-01 |
| GOBP RNA LOCALIZATION | 175 | 8.76e-01 | 6.88e-03 | 9.64e-01 |
| GOBP REGULATION OF TRANSFERASE ACTIVITY | 445 | 8.06e-01 | -6.84e-03 | 9.41e-01 |
| GOBP SPERM EGG RECOGNITION | 19 | 9.59e-01 | -6.82e-03 | 9.90e-01 |
| GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 18 | 9.60e-01 | -6.79e-03 | 9.90e-01 |
| GOBP RNA EXPORT FROM NUCLEUS | 81 | 9.16e-01 | 6.77e-03 | 9.75e-01 |
| GOMF FOLIC ACID BINDING | 7 | 9.75e-01 | 6.71e-03 | 9.92e-01 |
| GOBP MITOCHONDRION ORGANIZATION | 461 | 8.09e-01 | -6.62e-03 | 9.42e-01 |
| GOMF DISORDERED DOMAIN SPECIFIC BINDING | 22 | 9.57e-01 | -6.62e-03 | 9.89e-01 |
| GOBP INORGANIC ION HOMEOSTASIS | 270 | 8.53e-01 | -6.60e-03 | 9.58e-01 |
| GOBP MITOTIC DNA REPLICATION | 12 | 9.69e-01 | -6.54e-03 | 9.92e-01 |
| GOBP RESPONSE TO RADIATION | 278 | 8.52e-01 | 6.52e-03 | 9.58e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS | 52 | 9.35e-01 | -6.51e-03 | 9.82e-01 |
| GOBP CELLULAR RESPONSE TO X RAY | 7 | 9.76e-01 | 6.50e-03 | 9.92e-01 |
| GOCC FEMALE PRONUCLEUS | 8 | 9.75e-01 | 6.49e-03 | 9.92e-01 |
| GOMF PROTEIN CARRIER CHAPERONE | 31 | 9.50e-01 | 6.48e-03 | 9.87e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 16 | 9.64e-01 | -6.47e-03 | 9.91e-01 |
| GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE | 54 | 9.35e-01 | -6.46e-03 | 9.81e-01 |
| GOCC GOLGI TRANS CISTERNA | 9 | 9.74e-01 | 6.39e-03 | 9.92e-01 |
| GOBP AUTOPHAGOSOME LYSOSOME FUSION | 9 | 9.74e-01 | 6.37e-03 | 9.92e-01 |
| GOMF ANGIOTENSIN RECEPTOR BINDING | 7 | 9.77e-01 | -6.34e-03 | 9.92e-01 |
| GOMF CALCIUM ACTIVATED CATION CHANNEL ACTIVITY | 12 | 9.70e-01 | -6.32e-03 | 9.92e-01 |
| GOBP NUCLEUS ORGANIZATION | 115 | 9.07e-01 | 6.31e-03 | 9.74e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 9 | 9.74e-01 | 6.30e-03 | 9.92e-01 |
| GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS | 222 | 8.72e-01 | -6.30e-03 | 9.63e-01 |
| GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 153 | 8.94e-01 | 6.29e-03 | 9.68e-01 |
| GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS | 5 | 9.81e-01 | -6.29e-03 | 9.93e-01 |
| GOBP NUCLEAR ENVELOPE ORGANIZATION | 49 | 9.40e-01 | -6.25e-03 | 9.83e-01 |
| GOMF G PROTEIN BETA SUBUNIT BINDING | 9 | 9.74e-01 | -6.22e-03 | 9.92e-01 |
| GOBP SENSORY PERCEPTION | 173 | 8.88e-01 | 6.21e-03 | 9.67e-01 |
| GOBP CELLULAR RESPONSE TO HEAT | 49 | 9.40e-01 | -6.17e-03 | 9.83e-01 |
| GOBP RESPONSE TO OXIDATIVE STRESS | 284 | 8.60e-01 | -6.14e-03 | 9.59e-01 |
| GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL | 7 | 9.78e-01 | 6.13e-03 | 9.92e-01 |
| GOBP MITOCHONDRION LOCALIZATION | 36 | 9.49e-01 | -6.13e-03 | 9.87e-01 |
| GOMF BHLH TRANSCRIPTION FACTOR BINDING | 18 | 9.64e-01 | 6.10e-03 | 9.91e-01 |
| GOCC SM LIKE PROTEIN FAMILY COMPLEX | 83 | 9.24e-01 | -6.08e-03 | 9.78e-01 |
| GOCC MICROTUBULE PLUS END | 19 | 9.64e-01 | -6.03e-03 | 9.91e-01 |
| GOBP INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 5 | 9.81e-01 | -6.02e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 16 | 9.67e-01 | -6.02e-03 | 9.92e-01 |
| GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT | 11 | 9.73e-01 | -5.99e-03 | 9.92e-01 |
| GOBP RESPONSE TO FUNGUS | 36 | 9.51e-01 | -5.97e-03 | 9.87e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 11 | 9.73e-01 | 5.97e-03 | 9.92e-01 |
| GOBP PRE MIRNA PROCESSING | 13 | 9.70e-01 | 5.94e-03 | 9.92e-01 |
| GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 148 | 9.01e-01 | -5.93e-03 | 9.72e-01 |
| GOBP 10 FORMYLTETRAHYDROFOLATE METABOLIC PROCESS | 5 | 9.82e-01 | 5.93e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY | 8 | 9.77e-01 | 5.92e-03 | 9.92e-01 |
| GOCC SUPRAMOLECULAR POLYMER | 490 | 8.24e-01 | -5.91e-03 | 9.46e-01 |
| GOMF GTPASE INHIBITOR ACTIVITY | 10 | 9.75e-01 | -5.83e-03 | 9.92e-01 |
| GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 29 | 9.57e-01 | -5.83e-03 | 9.89e-01 |
| GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX | 7 | 9.79e-01 | -5.80e-03 | 9.92e-01 |
| GOBP BLASTOCYST FORMATION | 31 | 9.56e-01 | -5.77e-03 | 9.89e-01 |
| GOBP MITOCHONDRIAL FISSION | 32 | 9.55e-01 | 5.74e-03 | 9.89e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 12 | 9.73e-01 | 5.71e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 25 | 9.61e-01 | 5.70e-03 | 9.90e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEUS | 253 | 8.78e-01 | 5.65e-03 | 9.65e-01 |
| GOBP BASE EXCISION REPAIR AP SITE FORMATION | 9 | 9.77e-01 | 5.64e-03 | 9.92e-01 |
| GOCC ENDOLYSOSOME | 24 | 9.62e-01 | -5.62e-03 | 9.91e-01 |
| GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS | 15 | 9.70e-01 | 5.61e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY | 41 | 9.51e-01 | -5.54e-03 | 9.87e-01 |
| GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY | 44 | 9.50e-01 | -5.52e-03 | 9.87e-01 |
| GOMF PURINE NUCLEOTIDE BINDING | 1367 | 7.39e-01 | 5.51e-03 | 9.13e-01 |
| GOBP SPHINGOMYELIN METABOLIC PROCESS | 18 | 9.68e-01 | -5.49e-03 | 9.92e-01 |
| GOBP INTERLEUKIN 18 PRODUCTION | 8 | 9.79e-01 | 5.49e-03 | 9.92e-01 |
| GOMF ANNEALING ACTIVITY | 8 | 9.79e-01 | -5.49e-03 | 9.92e-01 |
| GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS | 10 | 9.76e-01 | 5.47e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 29 | 9.60e-01 | 5.44e-03 | 9.90e-01 |
| GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 26 | 9.62e-01 | -5.38e-03 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF B CELL ACTIVATION | 25 | 9.63e-01 | -5.34e-03 | 9.91e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 71 | 9.38e-01 | -5.33e-03 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE | 32 | 9.58e-01 | 5.32e-03 | 9.90e-01 |
| GOCC TRANSCRIPTION FACTOR TFTC COMPLEX | 18 | 9.69e-01 | 5.32e-03 | 9.92e-01 |
| GOCC HETEROCHROMATIN | 58 | 9.45e-01 | 5.28e-03 | 9.85e-01 |
| GOBP CARBOHYDRATE TRANSPORT | 87 | 9.32e-01 | -5.27e-03 | 9.81e-01 |
| GOBP FEMALE GAMETE GENERATION | 75 | 9.38e-01 | 5.23e-03 | 9.83e-01 |
| GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 7 | 9.81e-01 | 5.22e-03 | 9.93e-01 |
| GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 12 | 9.75e-01 | -5.21e-03 | 9.92e-01 |
| GOBP NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS | 20 | 9.68e-01 | 5.20e-03 | 9.92e-01 |
| GOMF GAMMA TUBULIN BINDING | 29 | 9.61e-01 | 5.20e-03 | 9.91e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING | 26 | 9.63e-01 | -5.20e-03 | 9.91e-01 |
| GOBP MESENCHYMAL CELL PROLIFERATION | 13 | 9.74e-01 | 5.19e-03 | 9.92e-01 |
| GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION | 13 | 9.74e-01 | 5.19e-03 | 9.92e-01 |
| GOBP ATP METABOLIC PROCESS | 113 | 9.25e-01 | 5.15e-03 | 9.78e-01 |
| GOBP PIGMENT GRANULE ORGANIZATION | 31 | 9.60e-01 | 5.15e-03 | 9.90e-01 |
| GOBP DE NOVO NAD BIOSYNTHETIC PROCESS | 7 | 9.81e-01 | -5.15e-03 | 9.93e-01 |
| GOBP GOLGI ORGANIZATION | 122 | 9.22e-01 | 5.11e-03 | 9.78e-01 |
| GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY | 14 | 9.74e-01 | 5.09e-03 | 9.92e-01 |
| GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING | 14 | 9.74e-01 | 5.04e-03 | 9.92e-01 |
| GOBP GPI ANCHOR METABOLIC PROCESS | 28 | 9.63e-01 | -5.01e-03 | 9.91e-01 |
| GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS | 124 | 9.25e-01 | 4.94e-03 | 9.78e-01 |
| GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 13 | 9.76e-01 | -4.91e-03 | 9.92e-01 |
| GOMF PROTEIN FOLDING CHAPERONE | 45 | 9.55e-01 | 4.87e-03 | 9.89e-01 |
| GOBP MHC CLASS II BIOSYNTHETIC PROCESS | 15 | 9.74e-01 | 4.86e-03 | 9.92e-01 |
| GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 8 | 9.81e-01 | -4.83e-03 | 9.93e-01 |
| GOMF KINESIN BINDING | 28 | 9.65e-01 | 4.73e-03 | 9.91e-01 |
| GOBP CELLULAR LIPID CATABOLIC PROCESS | 145 | 9.22e-01 | 4.72e-03 | 9.78e-01 |
| GOBP MEIOTIC CELL CYCLE | 148 | 9.21e-01 | 4.71e-03 | 9.78e-01 |
| GOBP SPINDLE ORGANIZATION | 161 | 9.18e-01 | 4.71e-03 | 9.76e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING | 9 | 9.81e-01 | 4.69e-03 | 9.93e-01 |
| GOBP REGULATION OF T CELL APOPTOTIC PROCESS | 30 | 9.65e-01 | 4.68e-03 | 9.91e-01 |
| GOMF MONOOXYGENASE ACTIVITY | 28 | 9.66e-01 | 4.66e-03 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 10 | 9.80e-01 | 4.65e-03 | 9.93e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 43 | 9.58e-01 | -4.61e-03 | 9.90e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 153 | 9.22e-01 | -4.58e-03 | 9.78e-01 |
| GOBP CELLULAR SENESCENCE | 74 | 9.47e-01 | 4.50e-03 | 9.86e-01 |
| GOBP REGULATION OF MONONUCLEAR CELL MIGRATION | 78 | 9.46e-01 | -4.46e-03 | 9.86e-01 |
| GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 27 | 9.68e-01 | 4.46e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 31 | 9.66e-01 | -4.45e-03 | 9.91e-01 |
| GOBP REGULATION OF METAL ION TRANSPORT | 175 | 9.20e-01 | -4.42e-03 | 9.77e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN | 35 | 9.64e-01 | -4.38e-03 | 9.91e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT | 119 | 9.34e-01 | -4.38e-03 | 9.81e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY | 45 | 9.60e-01 | 4.37e-03 | 9.90e-01 |
| GOMF ENZYME INHIBITOR ACTIVITY | 195 | 9.17e-01 | 4.33e-03 | 9.75e-01 |
| GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 30 | 9.67e-01 | 4.30e-03 | 9.92e-01 |
| GOMF CYCLIC NUCLEOTIDE BINDING | 16 | 9.77e-01 | -4.24e-03 | 9.92e-01 |
| GOBP PYRAMIDAL NEURON DEVELOPMENT | 6 | 9.86e-01 | -4.18e-03 | 9.96e-01 |
| GOBP CYTOSKELETON DEPENDENT CYTOKINESIS | 86 | 9.47e-01 | -4.14e-03 | 9.86e-01 |
| GOBP SOMITE DEVELOPMENT | 33 | 9.67e-01 | 4.14e-03 | 9.92e-01 |
| GOBP REGULATION OF VESICLE FUSION | 12 | 9.80e-01 | -4.12e-03 | 9.93e-01 |
| GOMF SOLUTE PROTON SYMPORTER ACTIVITY | 14 | 9.79e-01 | 4.08e-03 | 9.92e-01 |
| GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY | 14 | 9.79e-01 | -4.07e-03 | 9.92e-01 |
| GOBP MICROTUBULE BASED MOVEMENT | 211 | 9.19e-01 | -4.07e-03 | 9.76e-01 |
| GOMF DNA EXONUCLEASE ACTIVITY | 18 | 9.76e-01 | -4.06e-03 | 9.92e-01 |
| GOBP GENITALIA DEVELOPMENT | 18 | 9.76e-01 | 4.03e-03 | 9.92e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 18 | 9.76e-01 | 4.02e-03 | 9.92e-01 |
| GOBP NUCLEAR MEMBRANE ORGANIZATION | 40 | 9.65e-01 | -4.02e-03 | 9.91e-01 |
| GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 116 | 9.41e-01 | 4.01e-03 | 9.83e-01 |
| GOBP T CELL APOPTOTIC PROCESS | 43 | 9.64e-01 | -4.00e-03 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 44 | 9.64e-01 | -3.99e-03 | 9.91e-01 |
| GOMF 5 3 EXONUCLEASE ACTIVITY | 15 | 9.79e-01 | 3.99e-03 | 9.92e-01 |
| GOCC GOLGI APPARATUS SUBCOMPARTMENT | 276 | 9.11e-01 | -3.92e-03 | 9.74e-01 |
| GOBP CELLULAR RESPONSE TO STEROL | 12 | 9.81e-01 | -3.89e-03 | 9.93e-01 |
| GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS | 30 | 9.71e-01 | -3.86e-03 | 9.92e-01 |
| GOBP DEFENSE RESPONSE TO FUNGUS | 26 | 9.73e-01 | 3.84e-03 | 9.92e-01 |
| GOCC U5 SNRNP | 19 | 9.77e-01 | -3.83e-03 | 9.92e-01 |
| GOMF RNA POLYMERASE II ACTIVITY | 10 | 9.84e-01 | 3.77e-03 | 9.94e-01 |
| GOMF WW DOMAIN BINDING | 13 | 9.82e-01 | 3.71e-03 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 66 | 9.59e-01 | 3.70e-03 | 9.90e-01 |
| GOBP ENDOTHELIAL CELL ACTIVATION | 7 | 9.87e-01 | 3.67e-03 | 9.96e-01 |
| GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION | 16 | 9.80e-01 | -3.67e-03 | 9.93e-01 |
| GOBP ENTRAINMENT OF CIRCADIAN CLOCK | 22 | 9.77e-01 | 3.61e-03 | 9.92e-01 |
| GOBP MEMBRANE DOCKING | 74 | 9.57e-01 | 3.60e-03 | 9.89e-01 |
| GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 257 | 9.21e-01 | 3.60e-03 | 9.78e-01 |
| GOCC CDC73 PAF1 COMPLEX | 6 | 9.88e-01 | -3.60e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 21 | 9.77e-01 | -3.58e-03 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 21 | 9.78e-01 | 3.54e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH | 12 | 9.83e-01 | -3.54e-03 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 61 | 9.62e-01 | 3.52e-03 | 9.91e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING | 16 | 9.81e-01 | -3.51e-03 | 9.93e-01 |
| GOBP ORGANOPHOSPHATE CATABOLIC PROCESS | 98 | 9.53e-01 | 3.48e-03 | 9.89e-01 |
| GOBP MONOSACCHARIDE CATABOLIC PROCESS | 36 | 9.71e-01 | -3.45e-03 | 9.92e-01 |
| GOBP PHOSPHOLIPID DEPHOSPHORYLATION | 31 | 9.73e-01 | 3.45e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPAIR | 30 | 9.74e-01 | 3.43e-03 | 9.92e-01 |
| GOCC METHYLTRANSFERASE COMPLEX | 89 | 9.56e-01 | -3.42e-03 | 9.89e-01 |
| GOMF DOUBLE STRANDED RNA BINDING | 66 | 9.62e-01 | -3.42e-03 | 9.91e-01 |
| GOBP PEPTIDYL LYSINE ACETYLATION | 59 | 9.64e-01 | 3.38e-03 | 9.91e-01 |
| GOCC NODE OF RANVIER | 7 | 9.88e-01 | 3.35e-03 | 9.97e-01 |
| GOBP RENAL SYSTEM PROCESS | 40 | 9.71e-01 | -3.34e-03 | 9.92e-01 |
| GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM | 46 | 9.69e-01 | 3.29e-03 | 9.92e-01 |
| GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY | 258 | 9.29e-01 | -3.24e-03 | 9.81e-01 |
| GOBP ACTIVATION OF GTPASE ACTIVITY | 67 | 9.64e-01 | 3.15e-03 | 9.91e-01 |
| GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY | 41 | 9.72e-01 | -3.13e-03 | 9.92e-01 |
| GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 157 | 9.46e-01 | 3.13e-03 | 9.86e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY | 461 | 9.09e-01 | 3.12e-03 | 9.74e-01 |
| GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS | 5 | 9.90e-01 | 3.11e-03 | 9.97e-01 |
| GOBP DETOXIFICATION OF COPPER ION | 6 | 9.90e-01 | 3.06e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 5 | 9.91e-01 | 3.05e-03 | 9.97e-01 |
| GOBP SPLICEOSOMAL SNRNP ASSEMBLY | 38 | 9.74e-01 | -3.04e-03 | 9.92e-01 |
| GOCC ZYMOGEN GRANULE | 7 | 9.89e-01 | -2.99e-03 | 9.97e-01 |
| GOBP EPITHELIAL CELL FATE COMMITMENT | 5 | 9.91e-01 | -2.98e-03 | 9.97e-01 |
| GOBP LUTEINIZATION | 6 | 9.90e-01 | -2.95e-03 | 9.97e-01 |
| GOMF KINASE ACTIVITY | 521 | 9.11e-01 | -2.90e-03 | 9.74e-01 |
| GOMF PROTEIN MACROMOLECULE ADAPTOR ACTIVITY | 323 | 9.31e-01 | 2.80e-03 | 9.81e-01 |
| GOCC ZONA PELLUCIDA RECEPTOR COMPLEX | 5 | 9.91e-01 | 2.78e-03 | 9.97e-01 |
| GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY | 100 | 9.62e-01 | -2.74e-03 | 9.91e-01 |
| GOBP PROTEIN HOMOOLIGOMERIZATION | 109 | 9.62e-01 | 2.65e-03 | 9.91e-01 |
| GOCC DISTAL AXON | 141 | 9.58e-01 | -2.60e-03 | 9.89e-01 |
| GOBP REGULATION OF CELL KILLING | 72 | 9.70e-01 | -2.58e-03 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 32 | 9.80e-01 | 2.56e-03 | 9.93e-01 |
| GOBP CELLULAR RESPONSE TO CHEMICAL STRESS | 235 | 9.48e-01 | 2.50e-03 | 9.86e-01 |
| GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS | 120 | 9.62e-01 | -2.50e-03 | 9.91e-01 |
| GOBP ROOF OF MOUTH DEVELOPMENT | 40 | 9.78e-01 | -2.48e-03 | 9.92e-01 |
| GOBP SECRETION OF LYSOSOMAL ENZYMES | 6 | 9.92e-01 | -2.43e-03 | 9.97e-01 |
| GOBP COLLATERAL SPROUTING | 13 | 9.88e-01 | 2.41e-03 | 9.97e-01 |
| GOBP REPRODUCTIVE BEHAVIOR | 16 | 9.87e-01 | 2.41e-03 | 9.96e-01 |
| GOBP CIRCADIAN RHYTHM | 127 | 9.63e-01 | -2.40e-03 | 9.91e-01 |
| GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY | 9 | 9.90e-01 | 2.37e-03 | 9.97e-01 |
| GOMF CHROMATIN BINDING | 424 | 9.34e-01 | -2.36e-03 | 9.81e-01 |
| GOBP GLUCOCORTICOID METABOLIC PROCESS | 9 | 9.90e-01 | -2.35e-03 | 9.97e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 560 | 9.26e-01 | 2.32e-03 | 9.79e-01 |
| GOMF RNA POLYMERASE BINDING | 53 | 9.78e-01 | 2.19e-03 | 9.92e-01 |
| GOMF CYTOKINE ACTIVITY | 58 | 9.77e-01 | 2.18e-03 | 9.92e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 31 | 9.83e-01 | 2.15e-03 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY | 583 | 9.30e-01 | -2.15e-03 | 9.81e-01 |
| GOBP PEPTIDYL AMINO ACID MODIFICATION | 639 | 9.27e-01 | -2.14e-03 | 9.80e-01 |
| GOCC U4 SNRNP | 10 | 9.91e-01 | -2.11e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 5 | 9.94e-01 | 2.03e-03 | 9.98e-01 |
| GOBP REGULATION OF MICROGLIAL CELL ACTIVATION | 12 | 9.90e-01 | 2.02e-03 | 9.97e-01 |
| GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX | 9 | 9.92e-01 | -2.02e-03 | 9.97e-01 |
| GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 9.85e-01 | -1.99e-03 | 9.95e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY | 35 | 9.84e-01 | -1.98e-03 | 9.94e-01 |
| GOCC MLL1 2 COMPLEX | 32 | 9.85e-01 | 1.97e-03 | 9.95e-01 |
| GOBP AXONAL FASCICULATION | 7 | 9.93e-01 | -1.96e-03 | 9.98e-01 |
| GOMF TUMOR NECROSIS FACTOR BINDING | 6 | 9.93e-01 | 1.96e-03 | 9.98e-01 |
| GOBP SEGMENTATION | 39 | 9.83e-01 | 1.95e-03 | 9.94e-01 |
| GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 42 | 9.83e-01 | -1.95e-03 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 8 | 9.93e-01 | -1.90e-03 | 9.98e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 40 | 9.84e-01 | -1.88e-03 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 20 | 9.88e-01 | -1.88e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 7 | 9.93e-01 | 1.87e-03 | 9.98e-01 |
| GOBP TRANSLATIONAL TERMINATION | 14 | 9.90e-01 | -1.86e-03 | 9.97e-01 |
| GOMF C ACETYLTRANSFERASE ACTIVITY | 6 | 9.94e-01 | -1.86e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION | 6 | 9.94e-01 | -1.83e-03 | 9.98e-01 |
| GOCC CONDENSIN COMPLEX | 6 | 9.94e-01 | -1.83e-03 | 9.98e-01 |
| GOBP REGULATION OF ORGANELLE ORGANIZATION | 845 | 9.31e-01 | -1.79e-03 | 9.81e-01 |
| GOBP BONE REMODELING | 45 | 9.84e-01 | 1.78e-03 | 9.94e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY | 6 | 9.94e-01 | -1.69e-03 | 9.98e-01 |
| GOBP PROTEIN DNA COMPLEX ASSEMBLY | 137 | 9.73e-01 | -1.67e-03 | 9.92e-01 |
| GOBP CELL CYCLE | 1258 | 9.23e-01 | -1.66e-03 | 9.78e-01 |
| GOMF METALLOEXOPEPTIDASE ACTIVITY | 33 | 9.87e-01 | 1.64e-03 | 9.96e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 7 | 9.94e-01 | 1.64e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 74 | 9.81e-01 | -1.62e-03 | 9.93e-01 |
| GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 5 | 9.95e-01 | 1.60e-03 | 9.99e-01 |
| GOMF G RICH STRAND TELOMERIC DNA BINDING | 10 | 9.93e-01 | 1.57e-03 | 9.98e-01 |
| GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 217 | 9.69e-01 | 1.56e-03 | 9.92e-01 |
| GOMF PHOSPHATIDYLINOSITOL BINDING | 195 | 9.71e-01 | 1.53e-03 | 9.92e-01 |
| GOBP L GLUTAMATE IMPORT | 22 | 9.90e-01 | -1.51e-03 | 9.97e-01 |
| GOBP PROTEIN COMPLEX OLIGOMERIZATION | 153 | 9.76e-01 | 1.43e-03 | 9.92e-01 |
| GOBP O GLYCAN PROCESSING | 26 | 9.90e-01 | -1.41e-03 | 9.97e-01 |
| GOBP MICROTUBULE BASED TRANSPORT | 138 | 9.77e-01 | -1.40e-03 | 9.92e-01 |
| GOCC PML BODY | 99 | 9.82e-01 | 1.32e-03 | 9.93e-01 |
| GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS | 196 | 9.76e-01 | -1.26e-03 | 9.92e-01 |
| GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY | 8 | 9.95e-01 | -1.25e-03 | 9.99e-01 |
| GOBP TRYPTOPHAN CATABOLIC PROCESS | 7 | 9.95e-01 | -1.24e-03 | 9.99e-01 |
| GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS | 72 | 9.86e-01 | -1.20e-03 | 9.96e-01 |
| GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI | 31 | 9.91e-01 | -1.16e-03 | 9.97e-01 |
| GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS | 62 | 9.88e-01 | 1.10e-03 | 9.97e-01 |
| GOBP RENAL SYSTEM DEVELOPMENT | 135 | 9.83e-01 | 1.07e-03 | 9.94e-01 |
| GOBP NEURAL RETINA DEVELOPMENT | 27 | 9.92e-01 | -1.07e-03 | 9.98e-01 |
| GOBP SUCKLING BEHAVIOR | 7 | 9.96e-01 | 1.05e-03 | 9.99e-01 |
| GOBP HYPEROSMOTIC RESPONSE | 19 | 9.94e-01 | 9.75e-04 | 9.98e-01 |
| GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 54 | 9.90e-01 | 9.74e-04 | 9.97e-01 |
| GOBP REGULATION OF CHROMATIN ORGANIZATION | 40 | 9.92e-01 | 9.73e-04 | 9.97e-01 |
| GOMF LIPASE ACTIVITY | 67 | 9.89e-01 | 9.53e-04 | 9.97e-01 |
| GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 11 | 9.96e-01 | 8.64e-04 | 9.99e-01 |
| GOBP AMINO ACID TRANSMEMBRANE TRANSPORT | 49 | 9.92e-01 | 8.58e-04 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD PRESSURE | 19 | 9.95e-01 | -8.45e-04 | 9.99e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL JUNCTION | 52 | 9.92e-01 | -8.34e-04 | 9.97e-01 |
| GOMF MICROTUBULE PLUS END BINDING | 19 | 9.95e-01 | 8.20e-04 | 9.99e-01 |
| GOBP REGULATION OF CYTOKINESIS | 60 | 9.91e-01 | 8.17e-04 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 82 | 9.90e-01 | -7.84e-04 | 9.97e-01 |
| GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY | 193 | 9.85e-01 | -7.62e-04 | 9.95e-01 |
| GOBP MAMMARY GLAND DUCT MORPHOGENESIS | 13 | 9.96e-01 | 7.44e-04 | 9.99e-01 |
| GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 5 | 9.98e-01 | 7.20e-04 | 9.99e-01 |
| GOMF OPSONIN BINDING | 9 | 9.97e-01 | -6.91e-04 | 9.99e-01 |
| GOBP RESPONSE TO GROWTH HORMONE | 23 | 9.96e-01 | 6.27e-04 | 9.99e-01 |
| GOBP MARGINAL ZONE B CELL DIFFERENTIATION | 7 | 9.98e-01 | 6.08e-04 | 9.99e-01 |
| GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 5 | 9.98e-01 | -5.89e-04 | 9.99e-01 |
| GOMF TORC2 COMPLEX BINDING | 5 | 9.98e-01 | -5.89e-04 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO IRON ION | 6 | 9.98e-01 | -5.46e-04 | 9.99e-01 |
| GOBP HAIR CELL DIFFERENTIATION | 20 | 9.97e-01 | 5.33e-04 | 9.99e-01 |
| GOMF MANNOSE BINDING | 17 | 9.97e-01 | -4.92e-04 | 9.99e-01 |
| GOBP NEPHRON MORPHOGENESIS | 23 | 9.97e-01 | -4.28e-04 | 9.99e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS | 504 | 9.87e-01 | -4.16e-04 | 9.97e-01 |
| GOMF UBIQUITINATION LIKE MODIFICATION DEPENDENT PROTEIN BINDING | 19 | 9.98e-01 | 3.88e-04 | 9.99e-01 |
| GOCC EXOCYST | 10 | 9.98e-01 | -3.77e-04 | 9.99e-01 |
| GOBP RESPONSE TO LEUCINE | 13 | 9.98e-01 | -3.65e-04 | 9.99e-01 |
| GOCC CHROMOSOME TELOMERIC REPEAT REGION | 12 | 9.99e-01 | -3.00e-04 | 9.99e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 47 | 9.97e-01 | 2.94e-04 | 9.99e-01 |
| GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 122 | 9.96e-01 | 2.55e-04 | 9.99e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS | 86 | 9.98e-01 | 1.95e-04 | 9.99e-01 |
| GOBP POTASSIUM ION TRANSPORT | 71 | 9.98e-01 | 1.79e-04 | 9.99e-01 |
| GOBP CYTOKINESIS | 135 | 9.98e-01 | -1.56e-04 | 9.99e-01 |
| GOBP MACROPHAGE MIGRATION | 30 | 9.99e-01 | 7.66e-05 | 1.00e+00 |
| GOBP PROTEIN AUTOPHOSPHORYLATION | 137 | 9.99e-01 | -7.13e-05 | 9.99e-01 |
| GOCC CORTICAL ACTIN CYTOSKELETON | 42 | 9.99e-01 | 6.65e-05 | 1.00e+00 |
| GOCC AXONEMAL MICROTUBULE | 11 | 1.00e+00 | 5.96e-05 | 1.00e+00 |
| GOCC DIHYDROLIPOYL DEHYDROGENASE COMPLEX | 8 | 1.00e+00 | -4.09e-05 | 1.00e+00 |
| GOBP TRANSPORT ALONG MICROTUBULE | 123 | 1.00e+00 | 2.28e-05 | 1.00e+00 |
Detailed Gene set reports
GOBP RESPONSE TO TYPE III INTERFERON
Top enriched genes
Click HERE to show all gene set members
GOBP DNA LIGATION INVOLVED IN DNA REPAIR
Top enriched genes
Click HERE to show all gene set members
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF MAST CELL CHEMOTAXIS
Top enriched genes
Click HERE to show all gene set members
GOCC PHAGOLYSOSOME
Top enriched genes
Click HERE to show all gene set members
GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION
Top enriched genes
Click HERE to show all gene set members
GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY
Top enriched genes
Click HERE to show all gene set members
GOBP BEHAVIORAL RESPONSE TO ETHANOL
Top enriched genes
Click HERE to show all gene set members
GOBP MHC CLASS I BIOSYNTHETIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION
Top enriched genes
Click HERE to show all gene set members
GOMF RAGE RECEPTOR BINDING
Top enriched genes
Click HERE to show all gene set members
GOBP METANEPHRIC EPITHELIUM DEVELOPMENT
Top enriched genes
Click HERE to show all gene set members
GOBP METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT
Top enriched genes
Click HERE to show all gene set members
GOBP THALAMUS DEVELOPMENT
Top enriched genes
Click HERE to show all gene set members
GOCC CILIARY TRANSITION FIBER
Top enriched genes
Click HERE to show all gene set members
GOBP DE NOVO AMP BIOSYNTHETIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOBP RRNA BASE METHYLATION
Top enriched genes
Click HERE to show all gene set members
GOBP FAT PAD DEVELOPMENT
Top enriched genes
Click HERE to show all gene set members
GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOCC GID COMPLEX
Top enriched genes
Click HERE to show all gene set members
GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING
Top enriched genes
Click HERE to show all gene set members
GOBP NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION
Top enriched genes
Click HERE to show all gene set members
GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS
Top enriched genes
Click HERE to show all gene set members
GOBP MITOCHONDRIAL RNA MODIFICATION
Top enriched genes
Click HERE to show all gene set members
GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF HEXOKINASE ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOBP NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE
Top enriched genes
Click HERE to show all gene set members
GOBP CHONDROCYTE HYPERTROPHY
Top enriched genes
Click HERE to show all gene set members
GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING
Top enriched genes
Click HERE to show all gene set members
GOBP GLYCINE METABOLIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION
Top enriched genes
Click HERE to show all gene set members
GOMF BH3 DOMAIN BINDING
Top enriched genes
Click HERE to show all gene set members
GOBP PLASMA CELL DIFFERENTIATION
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF CELLULAR PH REDUCTION
Top enriched genes
Click HERE to show all gene set members
GOBP ESTABLISHMENT OF SERTOLI CELL BARRIER
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF FAT CELL PROLIFERATION
Top enriched genes
Click HERE to show all gene set members
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN
Top enriched genes
Click HERE to show all gene set members
GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS
Top enriched genes
Click HERE to show all gene set members
GOBP OPTIC NERVE DEVELOPMENT
Top enriched genes
Click HERE to show all gene set members
GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY
Top enriched genes
Click HERE to show all gene set members
GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION
Top enriched genes
Click HERE to show all gene set members
Here is the session info with all the versions of packages used.
sessionInfo()## R version 4.3.3 (2024-02-29)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.3.4 GGally_2.2.1
## [3] ggplot2_3.5.0 reshape2_1.4.4
## [5] gtools_3.9.5 tibble_3.2.1
## [7] dplyr_1.1.4 echarts4r_0.4.5
## [9] gplots_3.1.3.1 kableExtra_1.4.0
## [11] limma_3.58.1 mitch_1.15.0
## [13] DESeq2_1.42.0 muscat_1.16.0
## [15] beeswarm_0.4.0 stringi_1.8.3
## [17] SingleCellExperiment_1.24.0 SummarizedExperiment_1.32.0
## [19] Biobase_2.62.0 GenomicRanges_1.54.1
## [21] GenomeInfoDb_1.38.6 IRanges_2.36.0
## [23] S4Vectors_0.40.2 BiocGenerics_0.48.1
## [25] MatrixGenerics_1.14.0 matrixStats_1.2.0
## [27] hdf5r_1.3.9 Seurat_5.0.1
## [29] SeuratObject_5.0.1 sp_2.1-3
## [31] plyr_1.8.9
##
## loaded via a namespace (and not attached):
## [1] spatstat.sparse_3.0-3 bitops_1.0-7
## [3] httr_1.4.7 RColorBrewer_1.1-3
## [5] doParallel_1.0.17 numDeriv_2016.8-1.1
## [7] backports_1.4.1 tools_4.3.3
## [9] sctransform_0.4.1 utf8_1.2.4
## [11] R6_2.5.1 lazyeval_0.2.2
## [13] uwot_0.1.16 mgcv_1.9-1
## [15] GetoptLong_1.0.5 withr_3.0.0
## [17] prettyunits_1.2.0 gridExtra_2.3
## [19] progressr_0.14.0 cli_3.6.2
## [21] spatstat.explore_3.2-6 fastDummies_1.7.3
## [23] labeling_0.4.3 sass_0.4.8
## [25] mvtnorm_1.2-4 spatstat.data_3.0-4
## [27] blme_1.0-5 ggridges_0.5.6
## [29] pbapply_1.7-2 systemfonts_1.0.5
## [31] svglite_2.1.3 scater_1.30.1
## [33] parallelly_1.37.0 rstudioapi_0.15.0
## [35] generics_0.1.3 shape_1.4.6
## [37] ica_1.0-3 spatstat.random_3.2-2
## [39] Matrix_1.6-5 ggbeeswarm_0.7.2
## [41] fansi_1.0.6 abind_1.4-5
## [43] lifecycle_1.0.4 yaml_2.3.8
## [45] edgeR_4.0.15 SparseArray_1.2.4
## [47] Rtsne_0.17 grid_4.3.3
## [49] promises_1.2.1 crayon_1.5.2
## [51] miniUI_0.1.1.1 lattice_0.22-5
## [53] beachmat_2.18.1 cowplot_1.1.3
## [55] pillar_1.9.0 knitr_1.45
## [57] ComplexHeatmap_2.18.0 rjson_0.2.21
## [59] boot_1.3-28.1 corpcor_1.6.10
## [61] future.apply_1.11.1 codetools_0.2-19
## [63] leiden_0.4.3.1 glue_1.7.0
## [65] data.table_1.15.2 vctrs_0.6.5
## [67] png_0.1-8 spam_2.10-0
## [69] Rdpack_2.6 gtable_0.3.4
## [71] cachem_1.0.8 xfun_0.42
## [73] rbibutils_2.2.16 S4Arrays_1.2.0
## [75] mime_0.12 survival_3.5-8
## [77] iterators_1.0.14 statmod_1.5.0
## [79] ellipsis_0.3.2 fitdistrplus_1.1-11
## [81] ROCR_1.0-11 nlme_3.1-164
## [83] pbkrtest_0.5.2 bit64_4.0.5
## [85] EnvStats_2.8.1 progress_1.2.3
## [87] RcppAnnoy_0.0.22 bslib_0.6.1
## [89] TMB_1.9.10 irlba_2.3.5.1
## [91] vipor_0.4.7 KernSmooth_2.23-22
## [93] colorspace_2.1-0 ggrastr_1.0.2
## [95] tidyselect_1.2.0 bit_4.0.5
## [97] compiler_4.3.3 BiocNeighbors_1.20.2
## [99] xml2_1.3.6 DelayedArray_0.28.0
## [101] plotly_4.10.4 scales_1.3.0
## [103] caTools_1.18.2 remaCor_0.0.18
## [105] lmtest_0.9-40 stringr_1.5.1
## [107] digest_0.6.34 goftest_1.2-3
## [109] spatstat.utils_3.0-4 minqa_1.2.6
## [111] variancePartition_1.32.5 rmarkdown_2.25
## [113] aod_1.3.3 XVector_0.42.0
## [115] RhpcBLASctl_0.23-42 htmltools_0.5.7
## [117] pkgconfig_2.0.3 lme4_1.1-35.1
## [119] sparseMatrixStats_1.14.0 highr_0.10
## [121] fastmap_1.1.1 rlang_1.1.3
## [123] GlobalOptions_0.1.2 htmlwidgets_1.6.4
## [125] shiny_1.8.0 DelayedMatrixStats_1.24.0
## [127] farver_2.1.1 jquerylib_0.1.4
## [129] zoo_1.8-12 jsonlite_1.8.8
## [131] BiocParallel_1.36.0 BiocSingular_1.18.0
## [133] RCurl_1.98-1.14 magrittr_2.0.3
## [135] scuttle_1.12.0 GenomeInfoDbData_1.2.11
## [137] dotCall64_1.1-1 patchwork_1.2.0
## [139] munsell_0.5.0 Rcpp_1.0.12
## [141] viridis_0.6.5 reticulate_1.35.0
## [143] zlibbioc_1.48.0 MASS_7.3-60.0.1
## [145] ggstats_0.5.1 listenv_0.9.1
## [147] ggrepel_0.9.5 deldir_2.0-2
## [149] splines_4.3.3 tensor_1.5
## [151] hms_1.1.3 circlize_0.4.15
## [153] locfit_1.5-9.8 igraph_2.0.2
## [155] spatstat.geom_3.2-8 RcppHNSW_0.6.0
## [157] ScaledMatrix_1.10.0 evaluate_0.23
## [159] nloptr_2.0.3 foreach_1.5.2
## [161] httpuv_1.6.14 RANN_2.6.1
## [163] tidyr_1.3.1 purrr_1.0.2
## [165] polyclip_1.10-6 future_1.33.1
## [167] clue_0.3-65 scattermore_1.2
## [169] rsvd_1.0.5 broom_1.0.5
## [171] xtable_1.8-4 fANCOVA_0.6-1
## [173] RSpectra_0.16-1 later_1.3.2
## [175] viridisLite_0.4.2 lmerTest_3.1-3
## [177] glmmTMB_1.1.9 cluster_2.1.6
## [179] globals_0.16.2END of report